PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kramers, J				Kramers, J			Geology - The smile of the Cheshire cat	SCIENCE			English	Editorial Material							SEDIMENTARY-ROCKS; ISOTOPIC RECORD; LU-HF; EVOLUTION; CARBON; CRUST		Univ Bern, Mineral Petrol Inst, Lab Isotopengeol, CH-3012 Bern, Switzerland	University of Bern	Kramers, J (corresponding author), Univ Bern, Mineral Petrol Inst, Lab Isotopengeol, Erlachstr 9A, CH-3012 Bern, Switzerland.							Amelin Y, 2000, GEOCHIM COSMOCHIM AC, V64, P4205, DOI 10.1016/S0016-7037(00)00493-2; Amelin Y, 1999, NATURE, V399, P252, DOI 10.1038/20426; BlichertToft J, 1997, EARTH PLANET SC LETT, V148, P243, DOI 10.1016/S0012-821X(97)00040-X; NYQUIST LE, 1992, GEOCHIM COSMOCHIM AC, V56, P2213, DOI 10.1016/0016-7037(92)90185-L; PRINN RG, 1987, ANNU REV EARTH PL SC, V15, P171; Rosing MT, 1999, SCIENCE, V283, P674, DOI 10.1126/science.283.5402.674; Scherer E, 2001, SCIENCE, V293, P683, DOI 10.1126/science.1061372; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; Wilde SA, 2001, NATURE, V409, P175, DOI 10.1038/35051550	9	10	10	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					619	620		10.1126/science.1063288	http://dx.doi.org/10.1126/science.1063288			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474092				2022-12-28	WOS:000170204600034
J	Atkinson, MA; Eisenbarth, GS				Atkinson, MA; Eisenbarth, GS			Type 1 diabetes: new perspectives on disease pathogenesis and treatment	LANCET			English	Review							GLUTAMIC-ACID DECARBOXYLASE; BETA-CELL AUTOIMMUNITY; CELIAC-DISEASE; ISLET AUTOIMMUNITY; CEREBRAL EDEMA; RISK-FACTORS; NOD MOUSE; INSULIN; MELLITUS; PANCREAS	As our knowledge of type 1 (insulin-dependent) diabetes increases, so does our appreciation for the pathogenic complexity of this disease and the challenges associated with its treatment. Many new concepts about the pathogenesis of this disorder have arisen. The role of genetics versus environment in disease formation has been questioned, and the basis on which type 1 diabetes is characterised and diagnosed is the subject of much debate. Additionally, the care and treatment of patients with type 1 diabetes has seen a rapid evolution; with genetically engineered insulins, glucose monitoring devices, and algorithms all contributing to a decrease in disease-related complications. We focus this seminar on these changing views, and offer a new perspective on our understanding of the pathogenesis of type 1 diabetes and on principles for therapeutic management of patients with this disorder.	Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA; Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA	State University System of Florida; University of Florida; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Atkinson, MA (corresponding author), Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA.	atkinson@ufl.edu						[Anonymous], 1995, TRANSPLANT P, V27, P3377; ATKINOSN MA, 1992, J CLIN INVEST, V91, P350; ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428; Bao F, 1999, J AUTOIMMUN, V13, P143, DOI 10.1006/jaut.1999.0303; Bennett ST, 1996, ANNU REV GENET, V30, P343, DOI 10.1146/annurev.genet.30.1.343; Berney T, 2000, LANGENBECK ARCH SURG, V385, P373, DOI 10.1007/s004230000118; Boland EA, 1999, DIABETES CARE, V22, P1779, DOI 10.2337/diacare.22.11.1779; Bolli GB, 2000, LANCET, V356, P443, DOI 10.1016/S0140-6736(00)02546-0; BOTTAZZO GF, 1974, LANCET, V2, P1279, DOI 10.1016/S0140-6736(74)90140-8; BOWMAN MA, 1994, IMMUNOL TODAY, V15, P115, DOI 10.1016/0167-5699(94)90154-6; Bursell SE, 1999, DIABETES RES CLIN PR, V45, P169, DOI 10.1016/S0168-8227(99)00047-9; Buzzetti R, 1998, DIABETES METAB REV, V14, P111, DOI 10.1002/(SICI)1099-0895(199806)14:2<111::AID-DMR211>3.3.CO;2-U; CANTRILL HL, 1984, INT OPHTHALMOL CLIN, V24, P13, DOI 10.1097/00004397-198402440-00004; CAPUTO GM, 1994, NEW ENGL J MED, V331, P854, DOI 10.1056/NEJM199409293311307; CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243; Catargi B, 2000, DIABETES METAB, V26, P210; Cheung AT, 2000, SCIENCE, V290, P1959, DOI 10.1126/science.290.5498.1959; Colman PG, 2000, DIABETOLOGIA, V43, P203, DOI 10.1007/s001250050030; Dahlquist GG, 1997, ANN MED, V29, P413, DOI 10.3109/07853899708999371; DAHLQUIST GG, 2000, DIABETOLOGIA, V43, P47; DCCT Res Grp, 1991, AM J MED, V90, P450, DOI 10.1016/0002-9343(91)80085-Z; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; Ellis TM, 1996, LANCET, V347, P1464, DOI 10.1016/S0140-6736(96)91690-6; FOULIS AK, 1986, DIABETOLOGIA, V29, P267, DOI 10.1007/BF00452061; FRANKLIN B, 1982, PEDIATRICS, V69, P87; Garg SK, 1999, DIABETES CARE, V22, P1708, DOI 10.2337/diacare.22.10.1708; Garg SK, 1999, DIABETIC MED, V16, P384, DOI 10.1046/j.1464-5491.1999.00066.x; Glaser N, 2001, NEW ENGL J MED, V344, P264, DOI 10.1056/NEJM200101253440404; Graves PM, 1999, DIABETES CARE, V22, P1694, DOI 10.2337/diacare.22.10.1694; GREEN A, 1992, LANCET, V339, P905, DOI 10.1016/0140-6736(92)90938-Y; Green A, 2000, LANCET, V355, P873; Hattersley AT, 1997, LANCET, V349, P147, DOI 10.1016/S0140-6736(05)60972-5; Hatziagelaki E, 1999, HORM METAB RES, V31, P564, DOI 10.1055/s-2007-978796; Hoffenberg EJ, 2000, J PEDIATR-US, V137, P356, DOI 10.1067/mpd.2000.107582; Horton V, 1999, DIABETOLOGIA, V42, P608, DOI 10.1007/s001250051202; Hummel M, 2000, DIABETES CARE, V23, P969, DOI 10.2337/diacare.23.7.969; Hypponen E, 1999, DIABETES CARE, V22, P1961, DOI 10.2337/diacare.22.12.1961; Imagawa A, 2000, NEW ENGL J MED, V342, P301, DOI 10.1056/NEJM200002033420501; IWAGAWA A, 1999, DIABETOLOGIA, V42, P574; Kimpimaki T, 2000, J CLIN ENDOCR METAB, V85, P1126, DOI 10.1210/jc.85.3.1126; Knip M, 1999, EXP CLIN ENDOCR DIAB, V107, pS93, DOI 10.1055/s-0029-1212160; Knip M, 2000, DIABETOLOGIA, V43, P1337, DOI 10.1007/s001250051536; LAPORTE RE, 1985, DIABETES CARE, V8, P101, DOI 10.2337/diacare.8.1.S101; Lee HC, 2000, NATURE, V408, P483, DOI 10.1038/35044106; LERNMARK A, 1991, DIABETOLOGIA, V34, P534, DOI 10.1007/BF00403293; Lernmark A, 1998, NAT GENET, V19, P213, DOI 10.1038/881; Leslie RDG, 1999, DIABETOLOGIA, V42, P3, DOI 10.1007/s001250051105; Lin D Y, 1999, Diabetes Technol Ther, V1, P477, DOI 10.1089/152091599317035; Litherland SA, 1999, J CLIN INVEST, V104, P515, DOI 10.1172/JCI4852; Lonnrot M, 2000, J MED VIROL, V61, P214, DOI 10.1002/(SICI)1096-9071(200006)61:2&lt;214::AID-JMV7&gt;3.0.CO;2-9; Mastrototaro J, 1999, J PEDIATR ENDOCR MET, V12, P751; Matsushima M, 1997, DIABETOLOGIA, V40, P212, DOI 10.1007/s001250050665; McKinney PA, 1999, DIABETES CARE, V22, P928, DOI 10.2337/diacare.22.6.928; Moriwaki M, 1999, DIABETOLOGIA, V42, P1332, DOI 10.1007/s001250051446; Mortensen HB, 2000, EUR J PEDIATR, V159, P483, DOI 10.1007/s004310051315; Muntoni S, 1999, DIABETES-METAB RES, V15, P133; NERUP J, 1974, ACTA ENDOCRINOL-COP, V76, P142, DOI 10.1530/acta.0.0760142; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Norris JM, 1996, JAMA-J AM MED ASSOC, V276, P609, DOI 10.1001/jama.276.8.609; Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309; Parving HH, 1998, DIABETOLOGIA, V41, P745, DOI 10.1007/s001250050983; Podar T, 2000, DIABETES CARE, V23, P290, DOI 10.2337/diacare.23.3.290; Pundziunte-Lycka A, 2000, DIABETOLOGIA, V43, P1229, DOI 10.1007/s001250051517; Rabinovitch A, 1998, MED CLIN N AM, V82, P739, DOI 10.1016/S0025-7125(05)70022-5; Ratner RE, 2000, DIABETES CARE, V23, P639, DOI 10.2337/diacare.23.5.639; Rebrin K, 1999, AM J PHYSIOL-ENDOC M, V277, pE561, DOI 10.1152/ajpendo.1999.277.3.E561; REDONDO MJ, 1997, ENDOCRINE ORGAN SPEC, P41; RILEY WJ, 1981, J PEDIATR-US, V99, P350, DOI 10.1016/S0022-3476(81)80316-2; Robertson RP, 1996, J INVEST MED, V44, P549; Robertson RP, 1999, ACTA DIABETOL, V36, P3, DOI 10.1007/s005920050138; Rosenbloom AL, 2000, J CLIN ENDOCR METAB, V85, P494; Rutledge KS, 1997, PEDIATRICS, V100, P968, DOI 10.1542/peds.100.6.968; SAVILAHTI E, 1986, J PEDIATR-US, V108, P690, DOI 10.1016/S0022-3476(86)81042-3; Seissler J, 1998, DIABETOLOGIA, V41, P891, DOI 10.1007/s001250051004; Serreze DV, 2000, DIABETES, V49, P708, DOI 10.2337/diabetes.49.5.708; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shannon H, 2000, NEW ENGL J MED, V342, P381; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Smets YFC, 1999, LANCET, V353, P1915, DOI 10.1016/S0140-6736(98)07513-8; SUTHERLAND DER, 1984, T ASSOC AM PHYSICIAN, V97, P80; Todd JA, 1999, BIOESSAYS, V21, P164, DOI 10.1002/(SICI)1521-1878(199902)21:2<164::AID-BIES10>3.3.CO;2-W; Turner R, 1997, LANCET, V350, P1288, DOI 10.1016/S0140-6736(97)03062-6; Vajo Z, 2000, PHARMACOL REV, V52, P1; Verge CF, 1998, DIABETES, V47, P1857, DOI 10.2337/diabetes.47.12.1857; Virtanen SM, 2000, DIABETES, V49, P912, DOI 10.2337/diabetes.49.6.912; Vitoria JC, 1998, J PEDIATR GASTR NUTR, V27, P47, DOI 10.1097/00005176-199807000-00008; Wasmuth HE, 2000, DIABETES-METAB RES, V16, P177; Yu LP, 2000, P NATL ACAD SCI USA, V97, P1701, DOI 10.1073/pnas.040556697; Yu LP, 1999, J CLIN ENDOCR METAB, V84, P328, DOI 10.1210/jc.84.1.328; Ziegler AG, 1999, DIABETES, V48, P460, DOI 10.2337/diabetes.48.3.460; ZIMMET PZ, 1994, DIABETIC MED, V11, P299, DOI 10.1111/j.1464-5491.1994.tb00275.x	91	996	1056	4	218	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 21	2001	358	9277					221	229		10.1016/S0140-6736(01)05415-0	http://dx.doi.org/10.1016/S0140-6736(01)05415-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454HL	11476858				2022-12-28	WOS:000169967100033
J	Wilke, CO; Wang, JL; Ofria, C; Lenski, RE; Adami, C				Wilke, CO; Wang, JL; Ofria, C; Lenski, RE; Adami, C			Evolution of digital organisms at high mutation rates leads to survival of the flattest	NATURE			English	Article							SELECTION BALANCE; POPULATION	Darwinian evolution favours genotypes with high replication rates, a process called 'survival of the fittest'. However, knowing the replication rate of each individual genotype may not suffice to predict the eventual survivor, even in an asexual population. According to quasi-species theory, selection favours the cloud of genotypes, interconnected by mutation, whose average replication rate is highest(1-5). Here we confirm this prediction using digital organisms that self-replicate, mutate and evolve(6-9). Forty pairs of populations were derived from 40 different ancestors in identical selective environments, except that one of each pair experienced a 4-fold higher mutation rate. In 12 cases, the dominant genotype that evolved at the lower mutation rate achieved a replication rate >1.5-fold faster than its counterpart. We allowed each of these disparate pairs to compete across a range of mutation rates. In each case, as mutation rate was increased, the outcome of competition switched to favour the genotype with the lower replication rate. These genotypes, although they occupied lower fitness peaks, were located in flatter regions of the fitness surface and were therefore more robust with respect to mutations.	CALTECH, Digital Life Lab, Pasadena, CA 91125 USA; Michigan State Univ, Ctr Biol Modeling, E Lansing, MI 48824 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	California Institute of Technology; Michigan State University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Wilke, CO (corresponding author), CALTECH, Digital Life Lab, Mail Code 136-93, Pasadena, CA 91125 USA.	wilke@caltech.edu	Wilke, Claus O./B-4643-2008; Adami, Christoph/A-5181-2009; Adami, Chris/A-9675-2011	Adami, Chris/0000-0002-2915-9504; Ofria, Charles/0000-0003-2924-1732; Wilke, Claus/0000-0002-7470-9261; Lenski, Richard/0000-0002-1064-8375				Adami C, 2000, P NATL ACAD SCI USA, V97, P4463, DOI 10.1073/pnas.97.9.4463; Adami C., 1998, INTRO ARTIFICIAL LIF; Burch CL, 2000, NATURE, V406, P625, DOI 10.1038/35020564; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Drake JW, 1998, GENETICS, V148, P1667; DRAKE JW, 1993, P NATL ACAD SCI USA, V90, P4171, DOI 10.1073/pnas.90.9.4171; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; EIGEN M, 1989, ADV CHEM PHYS, V75, P149; Eigen M, 1979, THE HYPERCYCLE, P60; Eyre-Walker A, 1999, NATURE, V397, P344, DOI 10.1038/16915; Freeland SJ, 1998, P ROY SOC B-BIOL SCI, V265, P2111, DOI 10.1098/rspb.1998.0547; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Haldane JBS, 1937, AM NAT, V71, P337, DOI 10.1086/280722; Johnson T, 1999, P ROY SOC B-BIOL SCI, V266, P2389, DOI 10.1098/rspb.1999.0936; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Lynch M, 1999, EVOLUTION, V53, P645, DOI 10.1111/j.1558-5646.1999.tb05361.x; MULLER HJ, 1950, AM J HUM GENET, V2, P111; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; NOWAK MA, 1992, TRENDS ECOL EVOL, V7, P118, DOI 10.1016/0169-5347(92)90145-2; RAY TS, 1991, ARTIF LIFE, V2, P372; SCHUSTER P, 1988, B MATH BIOL, V50, P635, DOI 10.1016/S0092-8240(88)80059-4; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Taddei F, 1997, NATURE, V387, P700, DOI 10.1038/42696; van Nimwegen E, 1999, P NATL ACAD SCI USA, V96, P9716, DOI 10.1073/pnas.96.17.9716; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0; Wagner GP, 1997, EVOLUTION, V51, P329, DOI [10.2307/2411105, 10.1111/j.1558-5646.1997.tb02420.x]; WIKE CO, IN PRESS B MATH BIOL	28	422	430	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2001	412	6844					331	333		10.1038/35085569	http://dx.doi.org/10.1038/35085569			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460163				2022-12-28	WOS:000169918200046
J	Kazin, RA; Lowitt, NR; Lowitt, MH				Kazin, RA; Lowitt, NR; Lowitt, MH			Update in dermatology	ANNALS OF INTERNAL MEDICINE			English	Review							HEPATITIS-C VIRUS; BASAL-CELL CARCINOMA; ATOPIC-DERMATITIS; MYCOSIS-FUNGOIDES; TACROLIMUS OINTMENT; IVERMECTIN; INFECTION; SCABIES; URTICARIA; THERAPY		Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University	Lowitt, MH (corresponding author), Univ Maryland, Sch Med, Dept Dermatol, 405 W Redwood St,6th Floor, Baltimore, MD 21201 USA.							Al-Watban Farouk Ah, 1996, Laser Therapy, V8, P127; AOYAMA H, 1995, BRIT J DERMATOL, V133, P494, DOI 10.1111/j.1365-2133.1995.tb02691.x; Boni R, 2000, DERMATOLOGY, V200, P287, DOI 10.1159/000018389; BUNN PA, 1979, CANCER TREAT REP, V63, P725; Chouela EN, 1999, ARCH DERMATOL, V135, P651, DOI 10.1001/archderm.135.6.651; Chuang TY, 1999, J AM ACAD DERMATOL, V41, P787, DOI 10.1016/S0190-9622(99)70025-3; Chuang TY, 1999, J AM ACAD DERMATOL, V41, P31, DOI 10.1016/S0190-9622(99)70402-0; COOPER KD, 1994, J INVEST DERMATOL, V102, P128, DOI 10.1111/1523-1747.ep12371746; Cordoliani F, 1996, DERMATOLOGY, V192, P351, DOI 10.1159/000246411; CORNELL RC, 1990, J AM ACAD DERMATOL, V23, P694, DOI 10.1016/0190-9622(90)70276-N; Cowan FM, 1996, J INFECT DIS, V174, P470, DOI 10.1093/infdis/174.3.470; DALLOB AL, 1994, J CLIN ENDOCR METAB, V79, P703, DOI 10.1210/jc.79.3.703; del Giudice P, 1999, ARCH DERMATOL, V135, P351, DOI 10.1001/archderm.135.3.351; Doutre MS, 1998, BRIT J DERMATOL, V138, P194, DOI 10.1046/j.1365-2133.1998.02054.x; DRAKE LA, 1992, J AM ACAD DERMATOL, V26, P117; Edwards L, 1998, ARCH DERMATOL, V134, P25, DOI 10.1001/archderm.134.1.25; GLAZIOU P, 1993, TROP MED PARASITOL, V44, P331; GREWE M, 1994, LANCET, V343, P25, DOI 10.1016/S0140-6736(94)90879-6; Grundmann-Kollmann M, 1999, J AM ACAD DERMATOL, V40, P957, DOI 10.1016/S0190-9622(99)70084-8; HOPPE RT, 1990, CURR PROB CANCER, V14, P295; Imbertson LM, 1998, J INVEST DERMATOL, V110, P734, DOI 10.1046/j.1523-1747.1998.00174.x; IMPERATO.J, 1974, SCIENCE, V186, P1213, DOI 10.1126/science.186.4170.1213; Kanazawa K, 1996, J AM ACAD DERMATOL, V35, P195, DOI 10.1016/S0190-9622(96)90322-9; Kaufman KD, 1998, J AM ACAD DERMATOL, V39, P578, DOI 10.1016/S0190-9622(98)70007-6; KIM YH, 1995, ARCH DERMATOL, V131, P1003, DOI 10.1001/archderm.131.9.1003; Kim YH, 1996, ARCH DERMATOL, V132, P1309, DOI 10.1001/archderm.132.11.1309; Kim YH, 1999, ARCH DERMATOL, V135, P26, DOI 10.1001/archderm.135.1.26; Laihia JK, 1996, ARCH DERMATOL RES, V288, P570, DOI 10.1007/s004030050105; LAUERMA AI, 1992, LANCET, V340, P556, DOI 10.1016/0140-6736(92)91757-Y; Llanos F, 1998, J AM ACAD DERMATOL, V38, P646, DOI 10.1016/S0190-9622(98)70149-5; MARTY P, 1994, ANN TROP MED PARASIT, V88, P453, DOI 10.1080/00034983.1994.11812890; Meinking T L, 1990, Adv Dermatol, V5, P131; MEINKING TL, 1995, NEW ENGL J MED, V333, P26, DOI 10.1056/NEJM199507063330105; MUNRO DD, 1974, BRIT J DERMATOL, V90, P325, DOI 10.1111/j.1365-2133.1974.tb06410.x; NAHMIAS AJ, 1990, SCAND J INFECT DIS, P19; NAKAGAWA H, 1994, LANCET, V344, P883, DOI 10.1016/S0140-6736(94)92855-X; PRESTON DS, 1992, NEW ENGL J MED, V327, P1649, DOI 10.1056/NEJM199212033272307; RAJKA G, 1989, ACTA DERM-VENEREOL, P13; Reusser P, 1996, J HOSP INFECT, V33, P235, DOI 10.1016/S0195-6701(96)90010-9; Ruzicka T, 1997, NEW ENGL J MED, V337, P816, DOI 10.1056/NEJM199709183371203; RUZICKA T, 1991, HDB ATOPIC ECZEMA; Schindl A, 1999, J INVEST DERMATOL, V113, P221, DOI 10.1046/j.1523-1747.1999.00684.x; Schnider P, 1997, BRIT J DERMATOL, V136, P548, DOI 10.1046/j.1365-2133.1997.d01-1233.x; Schomogyi M, 1998, INFECT DIS CLIN N AM, V12, P47, DOI 10.1016/S0891-5520(05)70408-6; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Smith R, 1997, BRIT J DERMATOL, V136, P980, DOI 10.1111/j.1365-2133.1997.tb03958.x; TSUI JKC, 1986, LANCET, V2, P245; Whitley RJ, 1998, CLIN INFECT DIS, V26, P541, DOI 10.1086/514600; Yu HS, 1996, J INVEST DERMATOL, V107, P593, DOI 10.1111/1523-1747.ep12583090	49	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2001	135	2					124	132		10.7326/0003-4819-135-2-200107170-00013	http://dx.doi.org/10.7326/0003-4819-135-2-200107170-00013			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452DR	11453712				2022-12-28	WOS:000169842300006
J	Schwartzberg, PL				Schwartzberg, PL			Immunology - Tampering with the immune system	SCIENCE			English	Editorial Material							RECEPTOR TYROSINE KINASE; FAMILY		NHGRI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Schwartzberg, PL (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.							Camenisch TD, 1999, J IMMUNOL, V162, P3498; Crosier KE, 1997, PATHOLOGY, V29, P131, DOI 10.1080/00313029700169744; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603	8	6	7	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					228	229		10.1126/science.1063291	http://dx.doi.org/10.1126/science.1063291			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452106				2022-12-28	WOS:000169875200036
J	Baker, AC				Baker, AC			Ecosystems - Reef corals bleach to survive change	NATURE			English	Article							ZOOXANTHELLAE; DIVERSITY; ECOLOGY; FUTURE		Wildlife Conservat Soc, Osborn Labs Marine Sci, New York Aquarium, Brooklyn, NY 11224 USA	Wildlife Conservation Society	Baker, AC (corresponding author), Wildlife Conservat Soc, Osborn Labs Marine Sci, New York Aquarium, Surf Ave & W 8th St, Brooklyn, NY 11224 USA.			Baker, Andrew/0000-0002-7866-2587				Baker AC., 1999, SYMBIOSIS ECOLOGY RE; Brown BE, 1997, CORAL REEFS, V16, P129; Buddemeier RW, 1999, AM ZOOL, V39, P1; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; GLYNN PW, 1992, AM ZOOL, V32, P707; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Kinzie RA, 2001, BIOL BULL, V200, P51, DOI 10.2307/1543084; ROWAN R, 1991, SCIENCE, V251, P1348, DOI 10.1126/science.251.4999.1348; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Rowan R, 1998, J PHYCOL, V34, P407, DOI 10.1046/j.1529-8817.1998.340407.x; TOLLER WW, IN PRESS BIOL B MAR; Wilkinson C, 1999, AMBIO, V28, P188	14	362	381	3	161	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					765	766		10.1038/35081151	http://dx.doi.org/10.1038/35081151			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459046				2022-12-28	WOS:000169246400036
J	Konner, M				Konner, M			Bad words - Inappropriate terms can confuse rather than aid understanding.	NATURE			English	Editorial Material									Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA	Emory University	Konner, M (corresponding author), Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA.								0	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					743	743		10.1038/35081240	http://dx.doi.org/10.1038/35081240			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459034	Bronze			2022-12-28	WOS:000169246400023
J	Saborio, GP; Permanne, B; Soto, C				Saborio, GP; Permanne, B; Soto, C			Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding	NATURE			English	Article							TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES; CREUTZFELDT-JAKOB-DISEASE; CELL-FREE CONVERSION; SCRAPIE; INHIBITION; AGENT; BSE	Prions are the infectious agents responsible for transmissible spongiform encephalopathies. The principal component of prions is the glycoprotein PrPSc, which is a conformationally modified isoform of a normal cell-surface protein called PrPC (ref. 1). During the time between infection and the appearance of the clinical symptoms, minute amounts of PrPSc replicate by conversion of host PrPC, generating large amounts of PrPSc aggregates in the brains of diseased individuals. We aimed to reproduce this event in vitro. Here we report a procedure involving cyclic amplification of protein misfolding that allows a rapid conversion of large excess PrPC into a protease-resistant, PrPSc-like form in the presence of minute quantities of PrPSc template. In this procedure, conceptually analogous to polymerase chain reaction cycling, aggregates formed when PrPSc is incubated with PrPC are disrupted by sonication to generate multiple smaller units for the continued formation of new PrPSc. After cyclic amplification more than 97% of the protease-resistant PrP present in the sample corresponds to newly converted protein. The method could be applied to diagnose the presence of currently undetectable prion infectious agent in tissues and biological fluids, and may provide a unique opportunity to determine whether PrPSc replication results in the generation of infectivity in vitro.	Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland		Soto, C (corresponding author), Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland.							Aguzzi A, 1997, NATURE, V389, P795, DOI 10.1038/39758; Brown P, 2001, J LAB CLIN MED, V137, P5, DOI 10.1067/mlc.2001.111951; BROWN P, 1991, LANCET, V337, P1019, DOI 10.1016/0140-6736(91)92670-W; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Caughey B, 1995, CHEM BIOL, V2, P807, DOI 10.1016/1074-5521(95)90087-X; Caughey WS, 1998, P NATL ACAD SCI USA, V95, P12117, DOI 10.1073/pnas.95.21.12117; Chabry J, 1998, J BIOL CHEM, V273, P13203, DOI 10.1074/jbc.273.21.13203; Chesebro B, 1998, SCIENCE, V279, P42, DOI 10.1126/science.279.5347.42; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Dormont D, 1999, BIOMED PHARMACOTHER, V53, P3, DOI 10.1016/S0753-3322(99)80053-5; Glatzel M, 2000, J GEN VIROL, V81, P2813, DOI 10.1099/0022-1317-81-11-2813; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Horiuchi M, 1999, STRUCTURE, V7, pR231, DOI 10.1016/S0969-2126(00)80049-0; Johnson RT, 1998, NEW ENGL J MED, V339, P1994, DOI 10.1056/NEJM199812313392707; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Mestel R, 1996, SCIENCE, V273, P184, DOI 10.1126/science.273.5272.184; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saborio GP, 1999, BIOCHEM BIOPH RES CO, V258, P470, DOI 10.1006/bbrc.1999.0660; Schiermeier Q, 2001, NATURE, V409, P658, DOI 10.1038/35055646; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8	23	928	983	2	116	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					810	813		10.1038/35081095	http://dx.doi.org/10.1038/35081095			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459061				2022-12-28	WOS:000169246400052
J	Diddams, SA; Udem, T; Bergquist, JC; Curtis, EA; Drullinger, RE; Hollberg, L; Itano, WM; Lee, WD; Oates, CW; Vogel, KR; Wineland, DJ				Diddams, SA; Udem, T; Bergquist, JC; Curtis, EA; Drullinger, RE; Hollberg, L; Itano, WM; Lee, WD; Oates, CW; Vogel, KR; Wineland, DJ			An optical clock based on a single trapped Hg-199(+) ion	SCIENCE			English	Article							QUANTUM PROJECTION NOISE; FREQUENCY-MEASUREMENT; FEMTOSECOND LASER; PHASE-CONTROL; SPECTROSCOPY; STABILITY; LIGHT; LINE; ULTRAVIOLET; OSCILLATOR	Microwave atomic clocks have been the de facto standards for precision time and frequency metrology over the past 50 years, finding widespread use in basic scientific studies, communications, and navigation. However, with its higher operating frequency, an atomic clock based on an optical transition can be much more stable. We demonstrate an all-optical atomic clock referenced to the 1.064-petahertz transition of a single trapped Hg-199(+) ion. A clock-work based on a mode-locked femtosecond laser provides output pulses at a 1-gigahertz rate that are phase-coherently locked to the optical frequency. By comparison to a laser-cooled calcium optical standard, an upper limit for the fractional frequency instability of 7 x 10(-15) is measured in 1 second of averaging-a value substantially better than that of the world's best microwave atomic clocks.	Natl Inst Stand & Technol, Div Time & Frequency, Boulder, CO 80305 USA; Univ Colorado, Dept Phys, Boulder, CO 80309 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder	Diddams, SA (corresponding author), Natl Inst Stand & Technol, Div Time & Frequency, 325 Broadway, Boulder, CO 80305 USA.	sdiddams@boulder.nist.gov	Itano, Wayne/AAV-8781-2020; Diddams, Scott A/L-2819-2013	Diddams, Scott A/0000-0002-2144-0764; Curtis, Anne/0000-0003-3487-5588				BAGAEV SN, 1968, IEEE J QUANTUM ELECT, VQE 4, P868, DOI 10.1109/JQE.1968.1074976; BARNES JA, 1971, IEEE T INSTRUM MEAS, VIM20, P105, DOI 10.1109/TIM.1971.5570702; Bartels A, 1999, OPT LETT, V24, P996, DOI 10.1364/OL.24.000996; Bear D, 2000, PHYS REV LETT, V85, P5038, DOI 10.1103/PhysRevLett.85.5038; Biraben F, 2001, LECT NOTES PHYS, V570, P17; BORDE CJ, 1989, PHYS LETT A, V140, P10, DOI 10.1016/0375-9601(89)90537-9; BRILLET A, 1979, PHYS REV LETT, V42, P549, DOI 10.1103/PhysRevLett.42.549; Chang S, 2000, ELECTRON LETT, V36, P480, DOI 10.1049/el:20000338; CHEBOTAYEV VP, 1982, APPL PHYS B-PHOTO, V29, P63, DOI 10.1007/BF00694370; COHENTANNOUDJI CN, 1990, PHYS TODAY, V43, P33, DOI 10.1063/1.881239; Diddams SA, 2000, PHYS REV LETT, V84, P5102, DOI 10.1103/PhysRevLett.84.5102; DIEDRICH F, 1989, PHYS REV LETT, V62, P403, DOI 10.1103/PhysRevLett.62.403; ECKSTEIN JN, 1978, PHYS REV LETT, V40, P847, DOI 10.1103/PhysRevLett.40.847; FERGUSON AI, 1979, APPL PHYS, V18, P257, DOI 10.1007/BF00885511; HALL JL, 1978, SCIENCE, V202, P147, DOI 10.1126/science.202.4364.147; HALL JL, 1974, C INT CNRS PARIS, V217, P105; HANSCH TW, 1979, SCI AM, V240, P94; HANSCH TW, 1975, OPT COMMUN, V13, P68, DOI 10.1016/0030-4018(75)90159-5; HAUGAN MP, 1987, PHYS TODAY, V40, P69, DOI 10.1063/1.881074; HILS D, 1990, PHYS REV LETT, V64, P1697, DOI 10.1103/PhysRevLett.64.1697; Holzwarth R, 2000, PHYS REV LETT, V85, P2264, DOI 10.1103/PhysRevLett.85.2264; ITANO WM, 1993, PHYS REV A, V47, P3554, DOI 10.1103/PhysRevA.47.3554; Jefferts SR, 2000, P IEEE INT FREQ CONT, P714, DOI 10.1109/FREQ.2000.887443; Jones DJ, 2000, SCIENCE, V288, P635, DOI 10.1126/science.288.5466.635; Karshenboim SG, 2000, CAN J PHYS, V78, P639, DOI 10.1139/cjp-78-7-639; Katori H, 1999, PHYS REV LETT, V82, P1116, DOI 10.1103/PhysRevLett.82.1116; KISTERS T, 1994, APPL PHYS B-LASERS O, V59, P89, DOI 10.1007/BF01081159; Kostelecky V.A., 1999, CPT LORENTZ SYMMETRY; KUROSU T, 1990, JPN J APPL PHYS 2, V29, pL2127, DOI 10.1143/JJAP.29.L2127; LAURENT P, 1999, LASER SPECTROSCOPY, V14, P41; LESAGE P, 1983, IEEE T INSTRUM MEAS, V32, P204, DOI 10.1109/TIM.1983.4315042; MA LS, 1994, OPT LETT, V19, P1777, DOI 10.1364/OL.19.001777; MADEJ AA, 2001, FREQUENCY MEASUREMEN, V79, P153; Oates CW, 2000, OPT LETT, V25, P1603, DOI 10.1364/OL.25.001603; Oates CW, 1999, EUR PHYS J D, V7, P449, DOI 10.1007/s100530050589; Rafac RJ, 2000, PHYS REV LETT, V85, P2462, DOI 10.1103/PhysRevLett.85.2462; Ranka JK, 2000, OPT LETT, V25, P25, DOI 10.1364/OL.25.000025; Reichert J, 2000, PHYS REV LETT, V84, P3232, DOI 10.1103/PhysRevLett.84.3232; Reichert J, 1999, OPT COMMUN, V172, P59, DOI 10.1016/S0030-4018(99)00491-5; Ruschewitz F, 1998, PHYS REV LETT, V80, P3173, DOI 10.1103/PhysRevLett.80.3173; SALOMON C, 1988, J OPT SOC AM B, V5, P1576, DOI 10.1364/JOSAB.5.001576; Santarelli C, 1999, PHYS REV LETT, V82, P4619, DOI 10.1103/PhysRevLett.82.4619; STEIN S, 1982, P 1982 IEEE INT FREQ, P24; Stenger J, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.021802; Udem T, 1999, PHYS REV LETT, V82, P3568, DOI 10.1103/PhysRevLett.82.3568; Vogel K. R., 1999, Proceedings of the 1999 Joint Meeting of the European Frequency and Time Forum and the IEEE International Frequency Control Symposium (Cat. No.99CH36313), P692, DOI 10.1109/FREQ.1999.841399; Wadsworth WJ, 2000, ELECTRON LETT, V36, P53, DOI 10.1049/el:20000134; WEISS CO, 1988, IEEE J QUANTUM ELECT, V24, P1970, DOI 10.1109/3.8528; WEISS CO, 2001, FREQUENCY MEASUREMEN, P215; Weyers S, 2001, METROLOGIA, V38, P343, DOI 10.1088/0026-1394/38/4/7; WEYERS S, 2001, IN PRESS P 15 EUR FR; WINELAND D, 1975, B AM PHYS SOC, V20, P637; WINELAND DJ, 1987, PHYS TODAY, V40, P34, DOI 10.1063/1.881076; Ye J, 2000, OPT LETT, V25, P1675, DOI 10.1364/OL.25.001675; Young BC, 1999, PHYS REV LETT, V82, P3799, DOI 10.1103/PhysRevLett.82.3799; YOUNG BC, 1999, LASER SPECTROSCOPY, V14, P61	56	535	570	5	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2001	293	5531					825	828		10.1126/science.1061171	http://dx.doi.org/10.1126/science.1061171			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11452082	Green Submitted			2022-12-28	WOS:000170241000035
J	Markl, H				Markl, H			Research doesn't denigrate humanity - Being human is more than simply having the right molecular composition.	NATURE			English	Editorial Material									Max Planck Soc, D-80539 Munich, Germany	Max Planck Society	Markl, H (corresponding author), Max Planck Soc, Hofgartenstr 8, D-80539 Munich, Germany.								0	3	3	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					479	480		10.1038/35087673	http://dx.doi.org/10.1038/35087673			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484022				2022-12-28	WOS:000170202900018
J	Salama, P; Assefa, F; Talley, L; Spiegel, P; van der Veen, A; Gotway, CA				Salama, P; Assefa, F; Talley, L; Spiegel, P; van der Veen, A; Gotway, CA			Malnutrition, measles, mortality, and the humanitarian response during a famine in Ethiopia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC ENERGY DEFICIENCY; REFUGEE POPULATIONS; HEALTH; SITUATIONS; COMMUNITY; THAILAND; SOMALIA; KOSOVO; STATE; SUDAN	Context The World Food Programme estimated that 10 million people were at risk of starvation in Ethiopia in 2000 but later reported that a famine had been averted. However, no population-based data on mortality or nutrition existed for Gode district, at the epicenter of the famine in the Somali region of Ethiopia. Objectives To estimate mortality rates, determine the major causes of death, and estimate the prevalence of malnutrition among children and adults for the population of Gode district. Design and Setting Two-stage cluster survey conducted from July 27 through August 1, 2000, which included anthropometric measures and 8-month retrospective mortality data collection. Participants A total of 595 households comprising 4032 people living in Gode district of Ethiopia. Main Outcome Measures Crude mortality rates and mortality rates for children younger than 5 years, causes of death, weight for height of less than -2 z scores among children aged 6 months to 5 years, and body mass index of less than 18.5 kg/m(2) among adults and older persons. Results Of the 595 households, 346 (58.2%) were displaced from their usual places of residence. From December 1999 through July 2000, total of 293 deaths occurred in the sample population; 159 (54.3%) deaths were among children younger than 5 years and 72 (24.6%) were among children aged 5 to 14 years. The crude mortality rate was 3.2/ 10000 per day (95% confidence interval [CI], 2.4-3.8/10000 per day), which is 3 times the cutoff used to define an emergency. The mortality rate for children younger than 5 years was 6.8/10000 per day (95% CI, 5.4-8.2/10000 per day). Approximately 77% of deaths occurred before major relief interventions began in April/May 2000. Wasting contributed to 72.3% of all deaths among children younger than 5 years. Measles alone or in combination with wasting accounted for 35 (22.0%) of 159 deaths among children younger than 5 years and for 12 (16.7%) of 72 deaths among children aged 5 to 14 years. The prevalence rate for wasting (weight for height of <-2 z score) among children aged 6 months to 5 years was 29.1% (95% CI, 24.7%-33.4%). Using a method to adjust body mass index for body shape, the prevalence of undernutrition (body mass index <18.5 kg/m(2)) among adults aged 18 to 59 years was 22.7% (95% CI, 17.9%-27.5%). Conclusions To prevent unnecessary deaths, the humanitarian response to famine needs to be rapid, well coordinated, and based on sound epidemiological evidence. Public health interventions, such as mass measles vaccination campaigns with coverage extended to children aged 12 to 15 years should be implemented as the first priority. The prevalence of wasting and undernutrition among children and adults, respectively, should be assessed in all prolonged, severe famines.	CDCP, Epidem Intelligence Serv, Epidemiol Program Off, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA; CDCP, Int Emergency & Refugee Hlth Branch, Div Emergency & Environm Hlth Serv, Natl Ctr Environm Hlth, Atlanta, GA USA; CDCP, Int Emergency & Refugee Hlth Branch, Div Environm Hazards & Hlth Effects, Natl Ctr Environm Hlth, Atlanta, GA USA; Save Children USA, Washington, DC USA; Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; WHO, Off Reg Humanitarian Coordinator, Addis Ababa, Ethiopia	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Save the Children; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; World Health Organization	Salama, P (corresponding author), CDCP, Epidem Intelligence Serv, Epidemiol Program Off, Natl Ctr Environm Hlth, 4770 Buford Hwy NE,Mailstop F-48, Atlanta, GA 30341 USA.	psalama@cdc.gov						AABY P, 1988, REV INFECT DIS, V10, P478; AABY P, 1983, J INFECT DIS, V147, P693, DOI 10.1093/infdis/147.4.693; *ACT AG HUNG, 2000, RAP ASS NUTR SIT 5 C, P1; BERTINI C, 2000, FINDINGS RECOMMENDAT; BORREL A, 2001, ADDRESSING NUTR NEED; CDC (Centers for Disease Control and Prevention), 1993, MMWR RECOMM REP, V41, P1; COLLINS S, 1993, LANCET, V341, P1478; COLLINS S, 1993, JAMA-J AM MED ASSOC, V270, P637; COLLINS S, 2000, ASSESSMENT NUTR STAT, P1; Davis AP, 1996, LANCET, V348, P868, DOI 10.1016/S0140-6736(96)02134-4; DEAN AG, 1990, EPI INFO VERSION 6 W; FERROLUZZI A, 1992, EUR J CLIN NUTR, V46, P173; *GOV ETH, 1999, 1994 POP HOUS CENS E, P1; HENDERSON RH, 1982, B WORLD HEALTH ORGAN, V60, P253; JAMES WPT, 1988, EUR J CLIN NUTR, V42, P969; Kaartinen L, 1984, Lancet, V1, P39; KIDANE A, 1989, DEMOGRAPHY, V26, P515, DOI 10.2307/2061610; LINDTJORN B, 1990, BMJ-BRIT MED J, V301, P1123, DOI 10.1136/bmj.301.6761.1123; *MED SANS FRONT BE, 2000, NUTR SURV RETR MORT, P1; Morley D C, 1967, East Afr Med J, V44, P497; MURRAY MJ, 1976, LANCET, V1, P1283; NIEBURG P, 1988, DISASTERS, V12, P253, DOI 10.1111/j.1467-7717.1988.tb00674.x; NORGAN NG, 1994, AM J PHYS ANTHROPOL, V94, P229, DOI 10.1002/ajpa.1330940207; NORGAN NG, 1994, ANN HUM BIOL, V21, P79, DOI 10.1080/03014469400003092; Ronald C, 1999, BMJ, V318; Salama P, 2000, JAMA-J AM MED ASSOC, V284, P578, DOI 10.1001/jama.284.5.578; Salama P, 2001, LANCET, V357, P1430, DOI 10.1016/S0140-6736(00)04570-0; *SAVA CHILDR UK, 2000, ANTHR FOOD SEC ASS F, P1; SNOW RW, 1992, LANCET, V340, P351, DOI 10.1016/0140-6736(92)91414-4; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; *STEER COMM HUM RE, 1998, SPHERE PROJ HUM CHAR; TOOLE M J, 1989, Bulletin of the World Health Organization, V67, P381; TOOLE MJ, 1988, J TROP PEDIATRICS, V34, P218, DOI 10.1093/tropej/34.5.218; Toole MJ, 1997, ANNU REV PUBL HEALTH, V18, P283, DOI 10.1146/annurev.publhealth.18.1.283; TOOLE MJ, 1988, B WORLD HEALTH ORGAN, V66, P237; TOOLE MJ, 1990, JAMA-J AM MED ASSOC, V263, P3296, DOI 10.1001/jama.263.24.3296; TOOLE MJ, 1995, LANCET, V345, P339, DOI 10.1016/S0140-6736(95)90338-0; *UN CHILDR FUND, 2000, STAT WORLDS CHILDR; *UN CHILDR FUND, 2000, SIT REP; *UN CHILDR FUND U, 2000, SUMM RES NUTR SURV C, P1; *UN CHILDR FUND WH, 2000, REP FOOD NUTR SIT GO, P1; UN. High Commission for Refugees, 1999, HDB EM; *US AG INT DEV, 2000, ETH DROUGHT FACT SHE, P1; VESPA J, 1995, BRIT MED J, V311, P652, DOI 10.1136/bmj.311.7006.652; *WHO, 1994, WKLY EPIDEMIOL REC, V69, P245; *WORLD FOOD PROGR, 1999, SUMM CONS AG REP EM; World Health Organization, 1995, PHYS STAT US INT ANT	47	104	104	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2001	286	5					563	571		10.1001/jama.286.5.563	http://dx.doi.org/10.1001/jama.286.5.563			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	458HE	11476658	Bronze			2022-12-28	WOS:000170188300019
J	Scott, S; Knapp, M; Henderson, J; Maughan, B				Scott, S; Knapp, M; Henderson, J; Maughan, B			Financial cost of social exclusion: follow up study of antisocial children into adulthood	BRITISH MEDICAL JOURNAL			English	Article							BEHAVIOR; INTERVIEW; CHILDHOOD	Objectives To compare the cumulative costs of public services used through to adulthood by individuals with three levels of antisocial behaviour in childhood. Design Costs applied to data of 10 year old children from the inner London longitudinal study selectively followed up to adulthood. Setting Inner London borough. Participants 142 individuals divided into three groups in childhood: no problems, conduct problems, and conduct disorder. Main outcome measures Costs in 1998 prices for public services (excluding private, voluntary agency, indirect, and personal costs) used over and above basic universal provision. Results By age 28, costs for individuals with conduct disorder were 10.0 times higher than for those with no problems (95% confidence interval of bootstrap ratio 3.6 to 20.9) and 3.5 (1.7 to 6.2) times higher than for those with conduct problems. Mean individual total costs were pound 70 019 for the conduct disorder group (bootstrap mean difference from no problem group pound 62 898; pound 22 692 to pound 117 896) and pound 24 324 (pound 16 707; pound 6594 to pound 28 149) for the conduct problem group, compared with pound 7423 for the no problem group. In all groups crime incurred the greatest cost, followed by extra educational provision, foster and residential care, and state benefits; health costs were smaller. Parental social class had a relatively small effect on antisocial behaviour, and although substantial independent contributions came from being male, having a low reading age, and attending more than two primary schools, conduct disorder still predicted the greatest cost. Conclusions Antisocial behaviour in childhood is a major predictor of how much an individual will cost society. The cost is high and falls on many agencies, yet few agencies contribute to prevention, which could be cost effective.	Kings Coll London, Inst Psychiat, Dept Child & Adolescent Psychiat, London SE5 8AF, England; Inst Psychiat, Ctr Econ Mental Hlth, London, England; Inst Psychiat, MRC, Social Genet & Dev Psychiat Res Ctr, London, England	University of London; King's College London; University of London; King's College London; University of London; King's College London	Scott, S (corresponding author), Kings Coll London, Inst Psychiat, Dept Child & Adolescent Psychiat, London SE5 8AF, England.	s.scott@iop.kcl.ac.uk	Knapp, Martin RJ/G-3011-2011	Knapp, Martin/0000-0003-1427-0215				[Anonymous], 1999, CLIN CHILD PSYCHOL P, DOI DOI 10.1177/1359104599004004003; *AUD COMM, 1997, MISSP YOUTH; Audit Commission, 1999, CHILDR MIND; Cohen MA, 1998, J QUANT CRIMINOL, V14, P5, DOI 10.1023/A:1023092324459; Durlak J. A., 1997, SCH BASED PREVENTION; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; FARRINGTON DP, 1995, J CHILD PSYCHOL PSYC, V36, P929, DOI 10.1111/j.1469-7610.1995.tb01342.x; GREENWOOD PW, 1996, DIVERTING CHILDREN L; Healey A, 1998, BRIT J PSYCHIAT, V173, P160, DOI 10.1192/bjp.173.2.160; HILL J, 1989, BRIT J PSYCHIAT, V155, P24, DOI 10.1192/bjp.155.1.24; *HOM OFF, 1993, INF CRIM JUST SYST E; *HOUS COMM HLTH CO, 1997, CHILD AD MENT HLTH S; KAZDIN AE, 1997, J AM ACAD CHILD ADOL, V36, P10; Knapp M, 1997, J CHILD PSYCHOL PSYC, V38, P3, DOI 10.1111/j.1469-7610.1997.tb01503.x; Maughan B, 1996, J CHILD PSYCHOL PSYC, V37, P405, DOI 10.1111/j.1469-7610.1996.tb01421.x; Maughan B, 1989, Paediatr Perinat Epidemiol, V3, P195, DOI 10.1111/j.1365-3016.1989.tb00514.x; MCGUFFIN P, 1986, PSYCHOL MED, V16, P461, DOI 10.1017/S0033291700009302; Meltzer H., 2000, MENTAL HLTH CHILDREN; Mental Health Foundation, 1999, BRIGHT FUT PROM CHIL; NEALE MD, 1958, NEALE ANAL READING A; Netten A, 1998, UNIT COSTS HLTH SOCI; RUTTER M, 1967, J CHILD PSYCHOL PSYC, V8, P1, DOI 10.1111/j.1469-7610.1967.tb02175.x; Rutter M., 1998, ANTISOCIAL BEHAV YOU; RUTTER M, 1998, METHODS MODELS STUDY; Scott S, 1998, BRIT MED J, V316, P202; Scott S, 2001, BRIT MED J, V323, P194, DOI 10.1136/bmj.323.7306.194; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197	27	499	508	6	71	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2001	323	7306					191	194		10.1136/bmj.323.7306.191	http://dx.doi.org/10.1136/bmj.323.7306.191			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459UQ	11473907	Bronze, Green Published			2022-12-28	WOS:000170270200014
J	Cornelissen, JJLM; Donners, JJJM; de Gelder, R; Graswinckel, WS; Metselaar, GA; Rowan, AE; Sommerdijk, NAJM; Nolte, RJM				Cornelissen, JJLM; Donners, JJJM; de Gelder, R; Graswinckel, WS; Metselaar, GA; Rowan, AE; Sommerdijk, NAJM; Nolte, RJM			beta-helical polymers from isocyanopeptides	SCIENCE			English	Article							AQUEOUS-SOLUTION; SIDE-CHAINS; SHEET; POLYISOCYANIDES; PROTEIN; WATER; ACIDS	Polymerization of isocyanopeptides results in the formation of high molecular mass polymers that fold in a proteinlike fashion to give helical strands in which the peptide chains are arranged in beta -sheets. The beta -helical polymers retain their structure in water and unfold in a cooperative process at elevated temperatures. The peptide architecture in these polymers is a different form of the beta -helix motif found in proteins. Unlike their natural counterparts, which contain arrays of large beta -sheets stacked in a helical fashion, the isocyanopeptide polymers have a central helical core that acts as a director for the beta -sheet-like arrangement of the peptide side arms. The helical structure of these isocyanopeptide polymers has the potential to be controlled through tailoring of the side branches and the hydrogen-bonding network present in the beta -sheets.	Univ Nijmegen, Dept Organ Chem, NL-6525 ED Nijmegen, Netherlands; Univ Nijmegen, Dept Inorgan Chem, NL-6525 ED Nijmegen, Netherlands; Eindhoven Univ Technol, Lab Macromol & Organ Chem, NL-5600 MB Eindhoven, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Eindhoven University of Technology	Nolte, RJM (corresponding author), Univ Nijmegen, Dept Organ Chem, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.		Rowan, Alan E/F-9702-2015; Nolte, Roeland/C-9930-2013; de Gelder, René/D-4587-2012; Sommerdijk, Nico A.J.M./B-7239-2013	Rowan, Alan E/0000-0003-0728-3851; Nolte, Roeland/0000-0002-5612-7815; de Gelder, René/0000-0001-6152-640X; Sommerdijk, Nico A.J.M./0000-0002-8956-195X				Baumeister B, 2000, CHEM COMMUN, P913, DOI 10.1039/b002113j; Branden C., 1999, INTRO PROTEIN STRUCT; Clericuzio M, 1997, J AM CHEM SOC, V119, P1059, DOI 10.1021/ja961692n; Cornelissen JJLM, 1998, SCIENCE, V280, P1427, DOI 10.1126/science.280.5368.1427; Gellman SH, 1998, ACCOUNTS CHEM RES, V31, P173, DOI 10.1021/ar960298r; GRANT DM, 1996, ENCY NUCL MAGNETIC R, V4; GREEN MM, 1988, MACROMOLECULES, V21, P1839, DOI 10.1021/ma00184a051; Griffiths-Jones SR, 2000, J AM CHEM SOC, V122, P8350, DOI 10.1021/ja000787t; Hirschberg JHKK, 2000, NATURE, V407, P167, DOI 10.1038/35025027; Huang JT, 1997, J POLYM SCI POL CHEM, V35, P439; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; Nesloney CL, 1996, J AM CHEM SOC, V118, P5836, DOI 10.1021/ja952472x; NOLTE RJM, 1974, J AM CHEM SOC, V96, P5932, DOI 10.1021/ja00825a038; NOLTE RJM, 1994, CHEM SOC REV, V23, P11, DOI 10.1039/cs9942300011; Nowick JS, 1999, ACCOUNTS CHEM RES, V32, P287, DOI 10.1021/ar970204t; Percec V, 1998, NATURE, V391, P161, DOI 10.1038/34384; Pimentel G.C., 1960, HYDROGEN BOND; Prokhorova SA, 1998, MACROMOL RAPID COMM, V19, P359; Schenck HL, 1998, J AM CHEM SOC, V120, P4869, DOI 10.1021/ja973984+; Seebach D, 2000, HELV CHIM ACTA, V83, P2115, DOI 10.1002/1522-2675(20000906)83:9<2115::AID-HLCA2115>3.0.CO;2-E; SPEK AL, 1955, PLUTON PROGRAM PLOTT; TSANG KY, 1994, J AM CHEM SOC, V116, P3988, DOI 10.1021/ja00088a039; YODER MD, 1993, SCIENCE, V260, P1503, DOI 10.1126/science.8502994	23	268	271	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					676	680		10.1126/science.1062224	http://dx.doi.org/10.1126/science.1062224			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474106				2022-12-28	WOS:000170204600049
J	Homes, CC; Vogt, T; Shapiro, SM; Wakimoto, S; Ramirez, AP				Homes, CC; Vogt, T; Shapiro, SM; Wakimoto, S; Ramirez, AP			Optical response of high-dielectric-constant perovskite-related oxide	SCIENCE			English	Article								Optical conductivity measurements on the perovskite-related oxide CaCu3Ti4O12 provide a hint of the physics underlying the observed giant dielectric effect in this material. A low-frequency vibration displays anomalous behavior, implying that there is a redistribution of charge within the unit cell at low temperature. At infrared frequencies (terahertz), the value for the dielectric constant is similar to 80 at room temperature, which is far smatter than the value of similar to 10(5) obtained at lower radio frequencies (kilohertz). This discrepancy implies the presence of a strong absorption at very tow frequencies due to dipole relaxation. At room temperature, the characteristic relaxation times are fast (less than or similar to 500 nanoseconds) but increase dramatically at tow temperature, suggesting that the large change in dielectric constant may be due to a relaxor-like dynamical stowing down of dipolar fluctuations in nanosize domains.	Brookhaven Natl Lab, Dept Phys, Upton, NY 11973 USA; MIT, Dept Phys, Cambridge, MA 02139 USA; Los Alamos Natl Lab, Condensed Matter & Thermal Phys Grp, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Los Alamos National Laboratory	Homes, CC (corresponding author), Brookhaven Natl Lab, Dept Phys, Bldg 510B, Upton, NY 11973 USA.	homes@bnl.gov	Vogt, Thomas/A-1562-2011; Wakimoto, Shuichi/V-8177-2019; Ramirez, Arthur/HGD-6619-2022	Vogt, Thomas/0000-0002-4731-2787; 				BOCHU B, 1979, J SOLID STATE CHEM, V29, P291, DOI 10.1016/0022-4596(79)90235-4; BRUCE D, 1981, STRUCTURAL PHASE TRA; Daniel V.V., 1967, DIELECTRIC RELAXATIO, P4; HOMES CC, 1993, APPL OPTICS, V32, P2976, DOI 10.1364/AO.32.002976; Huheey J.E., 1993, INORGANIC CHEM PRINC, P513; JAMES AM, 1992, MCMILLANS CHEM PHYSI; Kim BG, 2001, PHYS REV LETT, V86, P3404, DOI 10.1103/PhysRevLett.86.3404; Porterfield W. W., 1993, INORGANIC CHEM UNIFI; Ramirez AP, 2000, SOLID STATE COMMUN, V115, P217, DOI 10.1016/S0038-1098(00)00182-4; SCOTT JF, 1971, PHYS REV B, V4, P1360, DOI 10.1103/PhysRevB.4.1360; Singh R., 1999, Electrochemical Society Interface, V8, P26; SMITH DY, 1985, HDB OPTICAL CONSTANT, P35; Subramanian MA, 2000, J SOLID STATE CHEM, V151, P323, DOI 10.1006/jssc.2000.8703; TAJIMA S, 1991, PHYS REV B, V43, P10496, DOI 10.1103/PhysRevB.43.10496; Yang CF, 1996, JPN J APPL PHYS 1, V35, P1806, DOI 10.1143/JJAP.35.1806; Zeng Z, 1999, PHYS REV LETT, V82, P3164, DOI 10.1103/PhysRevLett.82.3164	16	1535	1589	17	493	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2001	293	5530					673	676		10.1126/science.1061655	http://dx.doi.org/10.1126/science.1061655			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474105				2022-12-28	WOS:000170204600048
J	Soldatov, AV; Roth, G; Dzyabchenko, A; Johnels, D; Lebedkin, S; Meingast, C; Sundqvist, B; Haluska, M; Kuzmany, H				Soldatov, AV; Roth, G; Dzyabchenko, A; Johnels, D; Lebedkin, S; Meingast, C; Sundqvist, B; Haluska, M; Kuzmany, H			Topochemical polymerization of C-70 controlled by monomer crystal packing	SCIENCE			English	Article							PRESSURE-INDUCED DIMERIZATION; SOLID C-70; PHOTOINDUCED POLYMERIZATION; C-60; RAMAN; FULLERENE; PHASES; POLYMERS; CARBON; FILMS	Polymeric forms of C-60 are now welt known, but numerous attempts to obtain C-70 in a polymeric state have yielded only dimers. Polymeric C-70 has now been synthesized by treatment of hexagonally packed C-70 single crystals under moderate hydrostatic pressure (2 gigapascals) at elevated temperature (300 degreesC), which confirms predictions from our modeling of polymeric structures of C-70 Single-crystal x-ray diffraction shows that the molecules are bridged into polymeric zigzag chains that extend along the c axis of the parent structure. Solid-state nuclear magnetic resonance and Raman data provide evidence for covalent chemical bonding between the C-70 cages.	Forschungszentrum Karlsruhe Tech & Umwelt, Inst Festkorperphys, D-76021 Karlsruhe, Germany; Forschungszentrum Karlsruhe Tech & Umwelt, Inst Nanotechnol, D-76021 Karlsruhe, Germany; Rhein Westfal TH Aachen, Inst Kristallog, D-52056 Aachen, Germany; Karpov Inst Phys Chem, Moscow 103064, Russia; Umea Univ, Dept Expt Phys, S-90187 Umea, Sweden; Univ Vienna, Inst Mat Phys, A-1090 Vienna, Austria	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; RWTH Aachen University; Karpov Institute of Physical Chemistry; Umea University; University of Vienna	Soldatov, AV (corresponding author), Harvard Univ, Dept Phys, Lyman Lab Phys, Cambridge, MA 02138 USA.			Soldatov, Alexander/0000-0002-5145-1560				BAKER J, 1991, CHEM PHYS LETT, V184, P182, DOI 10.1016/0009-2614(91)87184-D; BLANK VD, 1995, PHYS LETT A, V205, P208, DOI 10.1016/0375-9601(95)00564-J; Blank VD, 1998, PHYS LETT A, V248, P415, DOI 10.1016/S0375-9601(98)00630-6; CHANDRABHAS N, 1994, PHYS REV LETT, V73, P3411, DOI 10.1103/PhysRevLett.73.3411; Dzyabchenko AV, 1999, J PHYS CHEM A, V103, P2812, DOI 10.1021/jp983951w; FRISCH MJ, 1998, GAUSSIAN 98W; Goze C, 1996, PHYS REV B, V54, pR3676, DOI 10.1103/PhysRevB.54.R3676; HALUSKA M, 1993, APPL PHYS A-MATER, V56, P161, DOI 10.1007/BF00539469; Iwasa Y, 1997, APPL PHYS A-MATER, V64, P251, DOI 10.1007/s003390050475; IWASA Y, 1994, SCIENCE, V264, P1570, DOI 10.1126/science.264.5165.1570; Lebedkin S, 2000, J PHYS CHEM B, V104, P4101, DOI 10.1021/jp9943301; Marques L, 1999, SCIENCE, V283, P1720, DOI 10.1126/science.283.5408.1720; Moret R, 1997, EUROPHYS LETT, V40, P55, DOI 10.1209/epl/i1997-00424-4; Moret R, 2000, EUR PHYS J B, V15, P253; NUNEZREGUEIRO M, 1995, PHYS REV LETT, V74, P278, DOI 10.1103/PhysRevLett.74.278; Okada S, 1999, PHYS REV LETT, V83, P1986, DOI 10.1103/PhysRevLett.83.1986; Persson PA, 1996, CHEM PHYS LETT, V258, P540, DOI 10.1016/0009-2614(96)00743-9; Premila M, 1997, SOLID STATE COMMUN, V104, P237, DOI 10.1016/S0038-1098(97)00317-7; RAO AM, 1993, SCIENCE, V259, P955, DOI 10.1126/science.259.5097.955; RAO AM, 1994, CHEM PHYS LETT, V224, P106, DOI 10.1016/0009-2614(94)00497-8; Soldatov A, 1996, J PHYS CHEM SOLIDS, V57, P1371, DOI 10.1016/0022-3697(96)00030-3; SOLDATOV A, UNPUB; SPECK L, 1999, PROGRAM SYSTEM PLATO; Sundar CS, 1996, PHYS REV B, V53, P8180, DOI 10.1103/PhysRevB.53.8180; Sundqvist B, 1999, ADV PHYS, V48, P1, DOI 10.1080/000187399243464; VANSMAALEN S, 1994, CHEM PHYS LETT, V223, P323, DOI 10.1016/0009-2614(94)00450-1; VAUGHAN GBM, 1993, CHEM PHYS, V178, P599, DOI 10.1016/0301-0104(93)85096-Q; VERHEIJEN MA, 1992, CHEM PHYS, V166, P287, DOI 10.1016/0301-0104(92)87026-6; Wang GW, 1997, NATURE, V387, P583, DOI 10.1038/42439	29	65	67	5	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					680	683		10.1126/science.1061434	http://dx.doi.org/10.1126/science.1061434			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474107	Green Submitted			2022-12-28	WOS:000170204600050
J	Robles-De-La-Torre, G; Hayward, V				Robles-De-La-Torre, G; Hayward, V			Force can overcome object geometry in the perception of shape through active touch	NATURE			English	Article							MOVEMENTS; FINGER; ELBOW	Haptic (touch) perception normally entails an active exploration of object surfaces over time. This is called active touch(1-3). When exploring the shape of an object, we experience both geometrical(4) and force cues. For example, when sliding a finger across a surface with a rigid bump on it, the finger moves over the bump while being opposed by a force whose direction and magnitude are related to the slope of the bump(5). The steeper the bump, the stronger the resistance. Geometrical and force cues are correlated, but it has been commonly assumed that shape perception relies on object geometry alone. Here we show that regardless of surface geometry, subjects identified and located shape features on the basis of force cues or their correlates. Using paradoxical stimuli, for example combining the force cues of a bump with the geometry of a hole, we found that subjects perceived a bump. Conversely, when combining the force cues of a hole with the geometry of a bump, subjects typically perceived a hole.	McGill Univ, Ctr Intelligent Machines, Montreal, PQ H3A 2A7, Canada	McGill University	Robles-De-La-Torre, G (corresponding author), McGill Univ, Ctr Intelligent Machines, Montreal, PQ H3A 2A7, Canada.		Hayward, Vincent/A-4646-2010	Hayward, Vincent/0000-0002-2102-1965				CLARK FJ, 1986, BRAIN, V109, P1195, DOI 10.1093/brain/109.6.1195; Coren S., 1992, LEFT HANDER SYNDROME; GIBSON JJ, 1962, PSYCHOL REV, V69, P477, DOI 10.1037/h0046962; GORDON IE, 1982, PERCEPT PSYCHOPHYS, V31, P446, DOI 10.3758/BF03204854; HALL LA, 1983, J PHYSIOL-LONDON, V335, P519, DOI 10.1113/jphysiol.1983.sp014548; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; Loomis JM, 1986, HDB PERCEPTION HUMAN, V2, p31/1; Minsky M. D. R, 1995, THESIS MIT; Pont SC, 1999, PERCEPT PSYCHOPHYS, V61, P874, DOI 10.3758/BF03206903; ROBLESDELATORRE G, 2000, P ASME DYN SYST CONT, V2, P1081; TAYLOR JL, 1992, J PHYSIOL-LONDON, V457, P503, DOI 10.1113/jphysiol.1992.sp019390	11	212	223	0	23	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					445	448		10.1038/35086588	http://dx.doi.org/10.1038/35086588			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	456DQ	11473320				2022-12-28	WOS:000170068200050
J	Gorman, JM				Gorman, JM			A 28-year-old woman with panic disorder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; BEHAVIORAL-INHIBITION; NORADRENERGIC FUNCTION; PSYCHIATRIC-DISORDERS; ANXIETY DISORDERS; DOUBLE-BLIND; SHORT-TERM; AGORAPHOBIA; SYMPTOMS; EFFICACY		Columbia Univ, Dept Psychiat, New York, NY 10032 USA	Columbia University	Gorman, JM (corresponding author), Columbia Univ, Dept Psychiat, 1051 Riverside Dr, New York, NY 10032 USA.	jmg9@columbia.edu						Abelson JL, 1996, PSYCHONEUROENDOCRINO, V21, P375, DOI 10.1016/0306-4530(96)00005-4; AGRAS S, 1968, ARCH GEN PSYCHIAT, V19, P423; *AM PSYCH ASS, 1909, DIAGNOSTIC STAT MANU; Amer Psychiat Assoc, 1998, AM J PSYCHIAT, V155, P1; Ballenger JC, 1998, AM J PSYCHIAT, V155, P36, DOI 10.1176/ajp.155.1.36; Ballenger JC, 1998, MED PSYCHIATRY, V10, P1; BALLENGER JC, 1988, ARCH GEN PSYCHIAT, V45, P413; Barlow DH, 2000, JAMA-J AM MED ASSOC, V283, P2529, DOI 10.1001/jama.283.19.2529; BARLOW DH, 1994, TREATMENT OF PANIC DISORDER, P105; BARLOW DH, 1989, BEHAV THER, V20, P261, DOI 10.1016/S0005-7894(89)80073-5; Barlow DH., 2002, ANXIETY ITS DISORDER, VSecond; BLACK B, 1990, J AM ACAD CHILD PSY, V29, P36, DOI 10.1097/00004583-199001000-00007; BLACK DW, 1993, ARCH GEN PSYCHIAT, V50, P44; BRADWEJN J, 1991, ARCH GEN PSYCHIAT, V48, P603; BROWN TA, 1995, J CONSULT CLIN PSYCH, V63, P754, DOI 10.1037/0022-006X.63.5.754; CHARNEY DS, 1989, J CLIN PSYCHIAT, V50, P418; CHARNEY DS, 1984, ARCH GEN PSYCHIAT, V41, P751; CRASKE MG, 1991, BEHAV THER, V22, P289, DOI 10.1016/S0005-7894(05)80367-3; CROWE RR, 1983, ARCH GEN PSYCHIAT, V40, P1065; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; FACCHINETTI F, 1992, PSYCHOSOM MED, V54, P288, DOI 10.1097/00006842-199205000-00005; Furmark T, 1997, NEUROREPORT, V8, P3957, DOI 10.1097/00001756-199712220-00021; Goddard AW, 2001, ARCH GEN PSYCHIAT, V58, P681, DOI 10.1001/archpsyc.58.7.681; GORMAN JM, 1988, PSYCHOSOM MED, V50, P114, DOI 10.1097/00006842-198803000-00002; Gorman JM, 2000, AM HEART J, V140, P577; GORMAN JM, 1994, AM J PSYCHIAT, V151, P547; GORMAN JM, 1994, PSYCHIATRY; GRUNHAUS L, 1984, J CLIN PSYCHIAT, V45, P25; HIRSHFELD DR, 1992, J AM ACAD CHILD ADOL, V31, P814; KAGAN J, 1987, CHILD DEV, V58, P1459, DOI 10.1111/j.1467-8624.1987.tb03858.x; KAGAN J, 1984, CHILD DEV, V55, P2212, DOI 10.1111/j.1467-8624.1984.tb03916.x; KAWACHI I, 1994, CIRCULATION, V89, P1992, DOI 10.1161/01.CIR.89.5.1992; KAWACHI I, 1994, CIRCULATION, V90, P2225, DOI 10.1161/01.CIR.90.5.2225; KENDLER KS, 1993, PSYCHOL MED, V23, P397, DOI 10.1017/S003329170002849X; Kent JM, 2001, AM J PSYCHIAT, V158, P58, DOI 10.1176/appi.ajp.158.1.58; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; KLEIN DF, 1964, PSYCHOPHARMACOLOGIA, V5, P397, DOI 10.1007/BF02193476; Lecrubier Y, 1997, ACTA PSYCHIAT SCAND, V95, P145, DOI 10.1111/j.1600-0447.1997.tb00388.x; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; Lepola U, 1996, ACTA PSYCHIAT SCAND, V93, P181, DOI 10.1111/j.1600-0447.1996.tb10628.x; LESSER IM, 1988, ARCH GEN PSYCHIAT, V45, P437; LIEBOWITZ MR, 1984, ARCH GEN PSYCHIAT, V41, P764; LIPSITZ JD, 1994, AM J PSYCHIAT, V151, P927; LYDIARD RB, 1994, AM J PSYCHIAT, V151, P64; MARKOWITZ JS, 1989, ARCH GEN PSYCHIAT, V46, P984; MAVISSAKALIAN M, 1992, ARCH GEN PSYCHIAT, V49, P318; MERIKANGAS KR, 1990, ARCH GEN PSYCHIAT, V47, P849; MUKERJI V, 1993, TEX HEART I J, V20, P170; MYERS JK, 1984, ARCH GEN PSYCHIAT, V41, P959; NORTON GR, 1992, CLIN PSYCHOL REV, V12, P121, DOI 10.1016/0272-7358(92)90110-T; Otto MW, 1998, MED PSYCHIATRY, V10, P181; PAPP LA, 1990, CONNS CURRENT THERAP; PITTS FN, 1967, NEW ENGL J MED, V277, P1329, DOI 10.1056/NEJM196712212772502; Pohl RB, 1998, AM J PSYCHIAT, V155, P1189, DOI 10.1176/ajp.155.9.1189; PYKE RE, 1986, J CLIN PSYCHOPHARM, V6, P279; RAINEY JM, 1987, AM J PSYCHIAT, V144, P1317; RICKELS K, 1993, ARCH GEN PSYCHIAT, V50, P61; ROSENBAUM JF, 1988, ARCH GEN PSYCHIAT, V45, P463; Rosenbaum JF, 1997, J CLIN PSYCHOPHARM, V17, P390, DOI 10.1097/00004714-199710000-00008; SCHNEIER FR, 1990, J CLIN PSYCHOPHARM, V10, P119, DOI 10.1097/00004714-199004000-00007; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P1723; SHEEHAN DV, 1983, J CLIN PSYCHOPHARM, V3, P28; SHEEHAN DV, 1980, ARCH GEN PSYCHIAT, V37, P51; SOUTHWICK SM, 1993, ARCH GEN PSYCHIAT, V50, P266; Spiegel DA, 1997, AM J PSYCHIAT, V154, P773; STEIN MB, 1989, AM J PSYCHIAT, V146, P235; Stein MB, 1996, AM J PSYCHIAT, V153, P275; TORGERSEN S, 1983, ARCH GEN PSYCHIAT, V40, P1085; TWEED JL, 1989, BRIT J PSYCHIAT, V154, P823, DOI 10.1192/bjp.154.6.823; Wade AG, 1997, BRIT J PSYCHIAT, V170, P549, DOI 10.1192/bjp.170.6.549; Weissman MM, 1997, ARCH GEN PSYCHIAT, V54, P305; WEISSMAN MM, 1989, NEW ENGL J MED, V321, P1209, DOI 10.1056/NEJM198911023211801; WOLFE BE, 1994, TREATMENT PANIC DISO; YELLOWLEES PM, 1987, MED J AUSTRALIA, V146, P305, DOI 10.5694/j.1326-5377.1987.tb120267.x	74	3	3	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2001	286	4					450	457		10.1001/jama.286.4.450	http://dx.doi.org/10.1001/jama.286.4.450			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	456DZ	11466124				2022-12-28	WOS:000170069000017
J	Allen, M; Raper, S; Mitchell, J				Allen, M; Raper, S; Mitchell, J			Climate change - Uncertainty in the IPCC's Third Assessment Report	SCIENCE			English	Editorial Material									Univ Oxford, Dept Phys, Oxford OX1 3PU, England; Met Off, Bracknell RG12 2S7, Berks, England; Alfred Wegener Inst Polar & Marine Res, D-2850 Bremerhaven, Germany	University of Oxford; Met Office - UK; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Allen, M (corresponding author), Univ Oxford, Dept Phys, Oxford OX1 3PU, England.							Allen M, 1999, NATURE, V401, P642, DOI 10.1038/44266; Allen MR, 2000, NATURE, V407, P617, DOI 10.1038/35036559; ANDRONOVA N, IN PRESS J GEOPHYS R; FOREST CE, IN PRESS CLIM DYN; Morgan MG, 1995, ENVIRON SCI TECHNOL, V29, P468, DOI DOI 10.1021/ES00010A003; Reilly J, 2001, SCIENCE, V293, P430; WEBSTER MD, 2001, 73 MIT; Wigley TML, 2001, SCIENCE, V293, P451, DOI 10.1126/science.1061604; 2001, ECONOMIST       0407, P74	9	47	50	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2001	293	5529					430	+						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463898				2022-12-28	WOS:000169966700026
J	Pradhan, AD; Manson, JE; Rifai, N; Buring, JE; Ridker, PM				Pradhan, AD; Manson, JE; Rifai, N; Buring, JE; Ridker, PM			C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NECROSIS-FACTOR-ALPHA; ENDOTHELIUM-DEPENDENT DILATATION; LIPOPROTEIN-LIPASE ACTIVITY; INSULIN-RESISTANCE SYNDROME; APPARENTLY HEALTHY-MEN; ACUTE-PHASE REACTANTS; INNATE IMMUNE-SYSTEM; MIDDLE-AGED MEN; ADIPOSE-TISSUE; IN-VIVO	Context Inflammation is hypothesized to play a role in development of type 2 diabetes mellitus (DM); however, clinical data addressing this issue are limited. Objective To determine whether elevated levels of the inflammatory markers interleukin 6 (IL-6) and C-reactive protein (CRP) are associated with development of type 2 DM in healthy middle-aged women. Design Prospective, nested case-control study. Setting The Women's Health Study, an ongoing US primary prevent ion, randomized clinical trial initiated in 1992. Participants From a nationwide cohort of 27 628 women free of diagnosed DM, cardiovascular disease, and cancer at baseline, 188 women who developed diagnosed DM over a 4-year follow-up period were defined as cases and matched by age and fasting status with 362 disease free controls. Main Outcome Measures Incidence of confirmed clinically diagnosed type 2 DM by baseline levels of IL-6 and CRP. Results Baseline levels of IL-6 (P<.001) and CRP (P<.001) were significantly higher among cases than among controls. The relative risks of future DM for women in the highest vs lowest quartile of these inflammatory markers were 7.5 for IL-6 (95% confidence interval [CI], 3.7-15.4) and 15.7 for CRP (95% CI, 6.5-37.9), Positive associations persisted after adjustment for body mass index, family history of diabetes, smoking, exercise, use of alcohol, and hormone replacement therapy; multivariate relative risks for the highest vs lowest quartiles were 2.3 For IL-6 (95% CI, 0.9-5.6; P for trend =.07) and 4.2 for CRP (95% CI, 1.5-12.0; P for trend =.001). Similar results were observed in analyses limited to women with a baseline hemoglobin Al, of 6.0% or less and after adjustment for fasting insulin level. Conclusions Elevated levels of CRP and IL-6 predict the development of type 2 DM. These data support a possible role for inflammation in diabetogenesis.	Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA; Brigham & Womens Hosp, Leducq Ctr Mol & Genet Epidemiol Cardiovasc Disor, Boston, MA 02215 USA; Brigham & Womens Hosp, Div Cardiol, Boston, MA 02215 USA; Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Childrens Hosp, Med Ctr, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Ridker, PM (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave E, Boston, MA 02215 USA.		CLIHON, Residencia Medica/K-4896-2013	CLIHON, Residencia Medica/0000-0001-6734-2513	NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851, R01HL058755, R01HL063293] Funding Source: NIH RePORTER; NCI NIH HHS [CA47988] Funding Source: Medline; NHLBI NIH HHS [HL58755, HL43851, HL63293, HL07575] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BERG M, 1994, CYTOKINE, V6, P425, DOI 10.1016/1043-4666(94)90067-1; BERGMAN RN, 1989, DIABETES, V38, P1512, DOI 10.2337/diabetes.38.12.1512; Bhagat K, 1997, CIRCULATION, V96, P3042, DOI 10.1161/01.CIR.96.9.3042; Brochu M, 2000, J CLIN ENDOCR METAB, V85, P2378, DOI 10.1210/jc.85.7.2378; Buring JE, 1992, J MYOCARDIAL ISCHEMI, V4, P27; Carey DG, 1996, DIABETES, V45, P633, DOI 10.2337/diabetes.45.5.633; Chevenne D, 1999, DIABETES METAB, V25, P459; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; DESPRES JP, 1993, NUTRITION, V9, P452; Duncan BB, 1999, DIABETES CARE, V22, P767, DOI 10.2337/diacare.22.5.767; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42; Fichtlscherer S, 2000, CIRCULATION, V102, P1000, DOI 10.1161/01.CIR.102.9.1000; Ford ES, 1999, DIABETES CARE, V22, P1971, DOI 10.2337/diacare.22.12.1971; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Frohlich M, 2000, DIABETES CARE, V23, P1835, DOI 10.2337/diacare.23.12.1835; Gavin JR, 1997, DIABETES CARE, V20, P1183; GEWURZ H, 1995, CURR OPIN IMMUNOL, V7, P54, DOI 10.1016/0952-7915(95)80029-8; Grau AJ, 1996, THROMB RES, V82, P245, DOI 10.1016/0049-3848(96)00071-0; GREENBERG AS, 1992, CANCER RES, V52, P4113; GROOP LC, 1991, J CLIN ENDOCR METAB, V72, P96, DOI 10.1210/jcem-72-1-96; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; HARRIS MI, 1995, NIH PUBLICATION, P1; Hingorani AD, 2000, CIRCULATION, V102, P994, DOI 10.1161/01.CIR.102.9.994; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Kanemaki T, 1998, HEPATOLOGY, V27, P1296, DOI 10.1002/hep.510270515; Kieffer TJ, 1997, DIABETES, V46, P1087, DOI 10.2337/diabetes.46.6.1087; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Manson J E, 1996, PREVENTION MYOCARDIA, P241; McNeely MJ, 1999, DIABETES CARE, V22, P65, DOI 10.2337/diacare.22.1.65; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; MILES PDG, 1995, DIABETES, V44, P947, DOI 10.2337/diabetes.44.8.947; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; MORTENSEN R, 1994, MACROPHAGE PATHOGEN, P143; Ockene IS, 2001, CLIN CHEM, V47, P444; Orban Z, 1999, J CLIN ENDOCR METAB, V84, P2126, DOI 10.1210/jc.84.6.2126; Pickup JC, 1997, DIABETOLOGIA, V40, P1286, DOI 10.1007/s001250050822; Pickup JC, 1998, DIABETOLOGIA, V41, P1241, DOI 10.1007/s001250051058; Pinkney JH, 1997, DIABETES, V46, pS9, DOI 10.2337/diab.46.2.S9; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Ridker PM, 1999, CIRCULATION, V100, P230, DOI 10.1161/01.CIR.100.3.230; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rifai N, 1999, CLIN CHEM, V45, P2136; SANDLER S, 1990, ENDOCRINOLOGY, V126, P1288, DOI 10.1210/endo-126-2-1288; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; STITH RD, 1994, CIRC SHOCK, V44, P210; Tsigos C, 1997, J CLIN ENDOCR METAB, V82, P4167, DOI 10.1210/jc.82.12.4167; Vanhala MJ, 1998, INT J OBESITY, V22, P369, DOI 10.1038/sj.ijo.0800597; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972	56	3090	3266	11	286	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2001	286	3					327	334		10.1001/jama.286.3.327	http://dx.doi.org/10.1001/jama.286.3.327			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452QA	11466099	Bronze			2022-12-28	WOS:000169869200024
J	Schmeling, A; Olze, A; Reisinger, W; Geserick, G				Schmeling, A; Olze, A; Reisinger, W; Geserick, G			Age estimation of living people undergoing criminal proceedings	LANCET			English	Editorial Material									Humboldt Univ, Univ Hosp Charite, Fac Med, Inst Legal Med, D-10117 Berlin, Germany; Humboldt Univ, Univ Hosp Charite, Fac Med, Dept Radiol, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schmeling, A (corresponding author), Humboldt Univ, Univ Hosp Charite, Fac Med, Inst Legal Med, D-10117 Berlin, Germany.							Angenendt Steffen, 1999, ASYLUM MIGRATION POL; DUNKEL F, 1997, ENTWICKLUNGSTENDENZE; GESERICK G, 2001, RES LEGAL MED, V26, P255; Greulich WW., 1959, CALIF MED, V91, P53; Lacey K. A., 1973, LANCET, V302, P736; Laier T, 1995, HAND GELESEN ZULASSI; MINCER HH, 1993, J FORENSIC SCI, V38, P379; PFAU RO, 1994, J FORENSIC SCI, V39, P165; Schmeling A, 2000, INT J LEGAL MED, V113, P253, DOI 10.1007/s004149900102; Thiemann HH., 1991, RONTGENATLAS NORMALE	10	108	117	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 14	2001	358	9276					89	90		10.1016/S0140-6736(01)05379-X	http://dx.doi.org/10.1016/S0140-6736(01)05379-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452BR	11463408				2022-12-28	WOS:000169837700007
J	Melino, G				Melino, G			The Sirens' song	NATURE			English	Editorial Material							CELL-DEATH		Univ Roma Tor Vergata, IDI IRCCS, Biochem Lab, I-00133 Rome, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI); University of Rome Tor Vergata	Melino, G (corresponding author), Univ Roma Tor Vergata, IDI IRCCS, Biochem Lab, I-00133 Rome, Italy.			MELINO, GERRY/0000-0001-9428-5972				Aravind L, 2001, SCIENCE, V291, P1279, DOI 10.1126/science.291.5507.1279; ARNEISEN JC, 1999, SCULPTURE VIVANT; Heemels MT, 2000, NATURE, V407, P769; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0	5	45	49	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					23	23		10.1038/35083653	http://dx.doi.org/10.1038/35083653			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452281				2022-12-28	WOS:000169644900020
J	Wang, LL				Wang, LL			Wang Ying-lai (1907-2001) - Obituary	NATURE			English	Biographical-Item									Univ Calif Berkeley, Dept Ethn Studies, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Wang, LL (corresponding author), Univ Calif Berkeley, Dept Ethn Studies, 506 Barrows Hall, Berkeley, CA 94720 USA.								0	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					38	38		10.1038/35083684	http://dx.doi.org/10.1038/35083684			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452292	Bronze			2022-12-28	WOS:000169644900029
J	Heringdorf, FJMZ; Reuter, MC; Tromp, RM				Heringdorf, FJMZ; Reuter, MC; Tromp, RM			Growth dynamics of pentacene thin films	NATURE			English	Article							DIFFUSION-LIMITED AGGREGATION; FIELD-EFFECT TRANSISTOR; CYCLOADDITION CHEMISTRY; ELECTRON-MICROSCOPE; LOW-VOLTAGE; MOLECULES; SURFACES; REFLECTION; INSULATORS; INJECTION	The recent demonstration of single-crystal organic optoelectronic devices has received widespread attention(1-4). But practical applications of such devices require the use of inexpensive organic films deposited on a wide variety of substrates. Unfortunately, the physical properties of these organic thin films do not compare favourably to those of single-crystal materials. Moreover, the basic physical principles governing organic thin-film growth and crystallization are not well understood. Here we report an in situ study of the evolution of pentacene thin films, utilizing the real-time imaging capabilities of photoelectron emission microscopy. By a combination of careful substrate preparation and surface energy control, we succeed in growing thin films with single-crystal grain sizes approaching 0.1 millimetre (a factor of 20-100 larger than previously achieved), which are large enough to fully contain a complete device. We rnd that organic thin-film growth closely mimics epitaxial growth of inorganic materials, and we expect that strategies and concepts developed for these inorganic systems will provide guidance for the further development and optimization of molecular thin-film devices.	IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	International Business Machines (IBM)	Heringdorf, FJMZ (corresponding author), IBM Corp, Thomas J Watson Res Ctr, POB 218, Yorktown Hts, NY 10598 USA.	meyerzh@us.ibm.com	Heringdorf, Frank Meyer zu/AAE-5657-2019					BALL RC, 1985, PHYS REV LETT, V55, P1406, DOI 10.1103/PhysRevLett.55.1406; BAUER E, 1985, ULTRAMICROSCOPY, V17, P51, DOI 10.1016/0304-3991(85)90176-7; BAUER E, 1994, REP PROG PHYS, V57, P895, DOI 10.1088/0034-4885/57/9/002; CAMPBELL RB, 1961, ACTA CRYSTALLOGR, V14, P705, DOI 10.1107/S0365110X61002163; Dimitrakopoulos CD, 1999, ADV MATER, V11, P1372, DOI 10.1002/(SICI)1521-4095(199911)11:16<1372::AID-ADMA1372>3.0.CO;2-V; Dimitrakopoulos CD, 1996, J APPL PHYS, V80, P2501, DOI 10.1063/1.363032; Dimitrakopoulos CD, 1999, SCIENCE, V283, P822, DOI 10.1126/science.283.5403.822; Feder J., 1988, FRACTALS; Gundlach DJ, 1997, IEEE ELECTR DEVICE L, V18, P87, DOI 10.1109/55.556089; Hamers RJ, 2000, ACCOUNTS CHEM RES, V33, P617, DOI 10.1021/ar970281o; Horowitz G, 1999, J APPL PHYS, V85, P3202, DOI 10.1063/1.369661; Kasaya M, 1998, SURF SCI, V400, P367, DOI 10.1016/S0039-6028(97)00893-5; Klauk H, 2000, SOLID STATE TECHNOL, V43, P63; Klauk H, 2000, APPL PHYS LETT, V76, P1692, DOI 10.1063/1.126138; Lee SW, 2000, SURF SCI, V462, P6, DOI 10.1016/S0039-6028(00)00622-1; PICKOVER CA, 1990, COMPUTERS PATTERN CH; Schon JH, 2000, SCIENCE, V290, P963, DOI 10.1126/science.290.5493.963; Schon JH, 2000, NATURE, V406, P702, DOI 10.1038/35021011; Schon JH, 2000, SCIENCE, V289, P599, DOI 10.1126/science.289.5479.599; Schon JH, 2001, J APPL PHYS, V89, P336, DOI 10.1063/1.1329667; Schon JH, 2000, NATURE, V403, P408, DOI 10.1038/35000172; Schon JH, 1998, PHYS REV B, V58, P12952, DOI 10.1103/PhysRevB.58.12952; TELIEPS W, 1985, ULTRAMICROSCOPY, V17, P57, DOI 10.1016/0304-3991(85)90177-9; TERSOFF J, 1994, PHYS REV LETT, V72, P266, DOI 10.1103/PhysRevLett.72.266; Tromp RM, 1998, SURF REV LETT, V5, P1189, DOI 10.1142/S0218625X98001523; WITTEN TA, 1981, PHYS REV LETT, V47, P1400, DOI 10.1103/PhysRevLett.47.1400; Wulfhekel W, 1996, SURF SCI, V348, P227, DOI 10.1016/0039-6028(95)00988-4; Yamaguchi T, 1999, J PHYS SOC JPN, V68, P1321, DOI 10.1143/JPSJ.68.1321; Zhang ZY, 1997, SCIENCE, V276, P377, DOI 10.1126/science.276.5311.377; ZHANG ZY, 1994, PHYS REV LETT, V73, P1829, DOI 10.1103/PhysRevLett.73.1829	30	679	692	6	246	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2001	412	6846					517	520		10.1038/35087532	http://dx.doi.org/10.1038/35087532			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484047				2022-12-28	WOS:000170202900039
J	Schoups, A; Vogels, R; Qian, N; Orban, G				Schoups, A; Vogels, R; Qian, N; Orban, G			Practising orientation identification improves orientation coding in V1 neurons	NATURE			English	Article							DISCRIMINATION TASK; FREQUENCY-DISCRIMINATION; DIRECTION DISCRIMINATION; SPATIAL-FREQUENCY; OWL MONKEYS; CORTEX; SPECIFICITY; REORGANIZATION; REPRESENTATION; PERFORMANCE	The adult brain shows remarkable plasticity, as demonstrated by the improvement in fine sensorial discriminations after intensive practice. The behavioural aspects of such perceptual learning are well documented, especially in the visual system(1-8). Specificity for stimulus attributes clearly implicates an early cortical site, where receptive fields retain fine selectivity for these attributes; however, the neuronal correlates of a simple visual discrimination task remained unidentified. Here we report electrophysiological correlates in the primary visual cortex (V1) of monkeys for learning orientation identification. We link the behavioural improvement in this type of learning to an improved neuronal performance of trained compared to naive neurons. Improved long-term neuronal performance resulted from changes in the characteristics of orientation tuning of individual neurons. More particularly, the slope of the orientation tuning curve that was measured at the trained orientation increased only for the subgroup of trained neurons most likely to code the orientation identified by the monkey. No modifications of the tuning curve were observed for orientations for which the monkey had not been trained. Thus training induces a specific and efficient increase in neuronal sensitivity in V1.	Katholieke Univ Leuven, Sch Med, Lab Neuroen Psychofysiol, B-3000 Louvain, Belgium; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	KU Leuven; Columbia University; Columbia University	Schoups, A (corresponding author), Katholieke Univ Leuven, Sch Med, Lab Neuroen Psychofysiol, B-3000 Louvain, Belgium.			Orban, Guy/0000-0002-8179-9584				Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; BRADLEY A, 1987, J NEUROPHYSIOL, V57, P755, DOI 10.1152/jn.1987.57.3.755; Crist RE, 1997, J NEUROPHYSIOL, V78, P2889, DOI 10.1152/jn.1997.78.6.2889; Dosher BA, 1998, P NATL ACAD SCI USA, V95, P13988, DOI 10.1073/pnas.95.23.13988; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Gold J, 1999, NATURE, V402, P176, DOI 10.1038/46027; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Matthews N, 1999, VISION RES, V39, P3692, DOI 10.1016/S0042-6989(99)00069-3; Nudo RJ, 1996, J NEUROSCI, V16, P785; Oram MW, 1998, TRENDS NEUROSCI, V21, P259, DOI 10.1016/S0166-2236(97)01216-2; Panzeri S, 1999, P ROY SOC B-BIOL SCI, V266, P1001, DOI 10.1098/rspb.1999.0736; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; Qian N., 1999, Society for Neuroscience Abstracts, V25, P1316; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1071, DOI 10.1152/jn.1992.67.5.1071; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; REGAN D, 1985, J OPT SOC AM A, V2, P147, DOI 10.1364/JOSAA.2.000147; SCHOUPS AA, 1995, J PHYSIOL-LONDON, V483, P797, DOI 10.1113/jphysiol.1995.sp020623; Schoups AA, 1996, P NATL ACAD SCI USA, V93, P7358, DOI 10.1073/pnas.93.14.7358; SNODDERLY DM, 1995, J NEUROPHYSIOL, V74, P2100, DOI 10.1152/jn.1995.74.5.2100; SOMERS DC, 1995, J NEUROSCI, V15, P5448; VOGELS R, 1985, VISION RES, V25, P1679, DOI 10.1016/0042-6989(85)90140-3; VOGELS R, 1990, J NEUROSCI, V10, P3543; WETHERILL GB, 1965, BRIT J MATH STAT PSY, V18, P1, DOI 10.1111/j.2044-8317.1965.tb00689.x; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017; ZOHARY E, 1994, SCIENCE, V263, P1289, DOI 10.1126/science.8122114; ZOHARY E, 1994, INVEST OPHTH VIS SCI, V35, P1663	30	604	623	2	45	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					549	553		10.1038/35087601	http://dx.doi.org/10.1038/35087601			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484056	Green Published			2022-12-28	WOS:000170202900048
J	Kalland, M; Pensola, TH; Merilainen, J; Sinkkonen, J				Kalland, M; Pensola, TH; Merilainen, J; Sinkkonen, J			Mortality in children registered in the Finnish child welfare registry: population based study	BRITISH MEDICAL JOURNAL			English	Article							SOCIAL-CLASS		Save Children Finland, FIN-00180 Helsinki, Finland; Univ Helsinki, Dept Sociol, Populat Res Unit, FIN-00014 Helsinki, Finland; Natl Res & Dev Ctr Welf & Hlth, FIN-00531 Helsinki, Finland	Save the Children; University of Helsinki	Kalland, M (corresponding author), Save Children Finland, POB 177,Lapinrinne 2, FIN-00180 Helsinki, Finland.			Kalland, Mirjam/0000-0001-6357-7884				OSTBERG V, 1992, J EPIDEMIOL COMMUN H, V46, P480, DOI 10.1136/jech.46.5.480; Pensola TH, 2000, J EPIDEMIOL COMMUN H, V54, P525, DOI 10.1136/jech.54.7.525; Rosenfeld AA, 1997, J AM ACAD CHILD PSY, V36, P448, DOI 10.1097/00004583-199704000-00006; THOMPSON AH, 1995, CHILD WELFARE, V74, P843; VINNERLJUNG B, 1995, SOCIALVETENSKAPLIG T, V1, P60	5	44	44	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2001	323	7306					207	208		10.1136/bmj.323.7306.207	http://dx.doi.org/10.1136/bmj.323.7306.207			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459UQ	11473912	Green Published, Bronze			2022-12-28	WOS:000170270200019
J	Scarpa, R				Scarpa, R			Volcanology - Predicting volcanic eruptions	SCIENCE			English	Editorial Material							KILAUEA VOLCANO; HAWAII		Univ Aquila, Dipartimento Fis, I-67010 Coppito, Italy	University of L'Aquila	Scarpa, R (corresponding author), Univ Aquila, Dipartimento Fis, Via Vetoio 10, I-67010 Coppito, Italy.		Scarpa, Roberto/AAE-9877-2019					Chouet B, 1999, GEOPHYS RES LETT, V26, P1937, DOI 10.1029/1999GL900400; Chouet BA, 1996, NATURE, V380, P309, DOI 10.1038/380309a0; Crescentini L, 1999, SCIENCE, V286, P2132, DOI 10.1126/science.286.5447.2132; Ishihara K, 1990, MAGMA TRANSPORT STOR, P336; KANESHIMA S, 1996, SCIENCE, V273, P643; KANJO K, 1986, P KAG C VOLC, V300, P1; KLEIN FW, 1984, J GEOPHYS RES, V89, P3059, DOI 10.1029/JB089iB05p03059; Kumagai H, 2001, SCIENCE, V293, P687, DOI 10.1126/science.1062136; LAY T, 1995, MODERN GLOBAL SEISMO, P184; LINDE AT, 1993, NATURE, V365, P737, DOI 10.1038/365737a0; McNutt S. R., 2000, ENCY VOLCANOES, V1st, P1015; Ohminato T, 1998, J GEOPHYS RES-SOL EA, V103, P23839, DOI 10.1029/98JB01122; SACKS IS, 1978, NATURE, V275, P599, DOI 10.1038/275599a0; Scarpa R., 1996, MONIT MITIG VOLCANO, DOI DOI 10.1007/978-3-642-80087-0_1; VOIGHT B, 1991, NATURE, V350, P695, DOI 10.1038/350695a0	15	8	8	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					615	616		10.1126/science.1063606	http://dx.doi.org/10.1126/science.1063606			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474089				2022-12-28	WOS:000170204600031
J	Knapp, MS				Knapp, MS			Using clinical evidence - Randomised controlled trials are not the only evidence	BRITISH MEDICAL JOURNAL			English	Letter											Knapp, MS (corresponding author), 12 Townsend St, Ivanhoe 3079, Australia.							Barton S, 2001, BRIT MED J, V322, P503, DOI 10.1136/bmj.322.7285.503; KNAPP MS, 1983, KIDNEY INT, V24, P474, DOI 10.1038/ki.1983.184; KNAPP MS, 1983, KIDNEY INT, V24, P433, DOI 10.1038/ki.1983.178; TRIMBLE IM, 1983, BMJ-BRIT MED J, V286, P1695, DOI 10.1136/bmj.286.6379.1695	4	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2001	323	7305					165	165		10.1136/bmj.323.7305.165	http://dx.doi.org/10.1136/bmj.323.7305.165			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456WR	11463694	Green Published			2022-12-28	WOS:000170106200032
J	Threlfall, AG; Woodman, CBJ				Threlfall, AG; Woodman, CBJ			Risk of breast cancer in women who attend the NHS breast screening programme: cohort study	BRITISH MEDICAL JOURNAL			English	Article							MORTALITY		Univ Manchester, Ctr Canc Epidemiol, Manchester M20 4QL, Lancs, England	University of Manchester	Woodman, CBJ (corresponding author), Univ Manchester, Ctr Canc Epidemiol, Manchester M20 4QL, Lancs, England.							Frisell J, 1997, BREAST CANCER RES TR, V45, P263, DOI 10.1023/A:1005872617944; Moss S, 1998, J EPIDEMIOL COMMUN H, V52, P111, DOI 10.1136/jech.52.2.111; Prior P, 1996, J Med Screen, V3, P119; QUINN M, 1995, BRIT MED J, V311, P1391, DOI 10.1136/bmj.311.7017.1391; Richardson A, 1997, J Med Screen, V4, P16	5	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2001	323	7305					140	140		10.1136/bmj.323.7305.140	http://dx.doi.org/10.1136/bmj.323.7305.140			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456WR	11463682	Bronze, Green Published			2022-12-28	WOS:000170106200016
J	Goldenberg, SB; Landsea, CW; Mestas-Nunez, AM; Gray, WM				Goldenberg, SB; Landsea, CW; Mestas-Nunez, AM; Gray, WM			The recent increase in Atlantic hurricane activity: Causes and implications	SCIENCE			English	Article							SAHELIAN MONSOON RAINFALL; SEA-SURFACE TEMPERATURES; CYCLONE INTENSITY CHANGE; WEST-AFRICAN RAINFALL; UNITED-STATES; EL-NINO; STRONG ASSOCIATION; VARIABILITY; CIRCULATION; FREQUENCY	The years 1995 to 2000 experienced the highest Level of North Atlantic hurricane activity in the reliable record. Compared with the generally low activity of the previous 24 years (1971 to 1994), the past 6 years have seen a doubling of overall activity for the whole basin, a 2.5-fold increase in major hurricanes (greater than or equal to 50 meters per second), and a fivefold increase in hurricanes affecting the Caribbean. The greater activity results from simultaneous increases in North Atlantic sea-surface temperatures and decreases in vertical wind shear. Because these changes exhibit a multidecadal time scale, the present high Level of hurricane activity is Likely to persist for an additional similar to 10 to 40 years. The shift in climate calls for a reevaluation of preparedness and mitigation strategies.	NOAA, Atlantic Oceanog & Meteorol Lab, Hurricane Res Div, Miami, FL 33149 USA; Univ Miami, Cooperat Inst Marine & Atmospher Studies, Miami, FL 33149 USA; Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML); University of Miami; Colorado State University	Goldenberg, SB (corresponding author), NOAA, Atlantic Oceanog & Meteorol Lab, Hurricane Res Div, Miami, FL 33149 USA.		Goldenberg, Stanley/C-5965-2014; Mestas-Nunez, Alberto/AAL-5678-2020; Mestas-Nunez, Alberto M/A-1427-2012	Goldenberg, Stanley/0000-0001-6730-5819; Mestas-Nunez, Alberto/0000-0002-3546-3668; Mestas-Nunez, Alberto M/0000-0002-3546-3668				Avila LA, 2000, MON WEATHER REV, V128, P3695, DOI 10.1175/1520-0493(2000)128<3695:ATSOAY>2.0.CO;2; Bell GD, 1998, B AM METEOROL SOC, V79, pS1, DOI 10.1175/1520-0477-79.5s.S1; DAVIS RE, 1976, J PHYS OCEANOGR, V6, P247; Delworth TL, 2000, CLIM DYNAM, V16, P661, DOI 10.1007/s003820000075; DeMaria M, 1996, J ATMOS SCI, V53, P2076, DOI 10.1175/1520-0469(1996)053<2076:TEOVSO>2.0.CO;2; DEMARIA M, 1993, J ATMOS SCI, V50, P1133, DOI 10.1175/1520-0469(1993)050<1133:ULEAMF>2.0.CO;2; Elsner JB, 2000, GEOPHYS RES LETT, V27, P1743, DOI 10.1029/2000GL011453; Enfield DB, 1999, J CLIMATE, V12, P2719, DOI 10.1175/1520-0442(1999)012<2719:MVIGSS>2.0.CO;2; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; FOLLAND C, 1991, J FORECASTING, V10, P21, DOI 10.1002/for.3980100104; FRANK NL, 1975, MON WEATHER REV, V103, P294, DOI 10.1175/1520-0493(1975)103<0294:ATSO>2.0.CO;2; Goldenberg SB, 1996, J CLIMATE, V9, P1169, DOI 10.1175/1520-0442(1996)009<1169:PMFTAO>2.0.CO;2; GOLDENBERG SB, 1977, 7 C CLIM CAR LONG BE, P305; GRAY WM, 1968, MON WEATHER REV, V96, P669, DOI 10.1175/1520-0493(1968)096<0669:GVOTOO>2.0.CO;2; Gray WM, 1997, HURRICANES, P15; GRAY WM, 1984, MON WEATHER REV, V112, P1649, DOI 10.1175/1520-0493(1984)112<1649:ASHFPI>2.0.CO;2; GRAY WM, 1990, SCIENCE, V249, P1251, DOI 10.1126/science.249.4974.1251; GRAY WM, 2000, 2000 ATLANTIC TROPIC; HEBERT PJ, 1996, TPC1 NOAA NWS; Henderson-Sellers A, 1998, B AM METEOROL SOC, V79, P19, DOI 10.1175/1520-0477(1998)079<0019:TCAGCC>2.0.CO;2; Jarvinen B., 1984, 22 NWS NHC; Knaff JA, 1997, J CLIMATE, V10, P789, DOI 10.1175/1520-0442(1997)010<0789:IOSSLP>2.0.CO;2; Landsea CW, 1998, MON WEATHER REV, V126, P1174, DOI 10.1175/1520-0493(1998)126<1174:TEAAHS>2.0.CO;2; Landsea CW, 1999, CLIMATIC CHANGE, V42, P89, DOI 10.1023/A:1005416332322; Landsea CW, 1996, GEOPHYS RES LETT, V23, P1697, DOI 10.1029/96GL01029; LANDSEA CW, 1993, MON WEATHER REV, V121, P1703, DOI 10.1175/1520-0493(1993)121<1703:ACOIMA>2.0.CO;2; LANDSEA CW, 1992, J CLIMATE, V5, P1528, DOI 10.1175/1520-0442(1992)005<1528:LTVOWS>2.0.CO;2; LANDSEA CW, 1992, J CLIMATE, V5, P435, DOI 10.1175/1520-0442(1992)005<0435:TSABWS>2.0.CO;2; Mestas-Nunez AM, 1999, J CLIMATE, V12, P2734, DOI 10.1175/1520-0442(1999)012<2734:RGMONE>2.0.CO;2; NEUMANN CJ, 1995, TROPICAL CYCLONES N, P11; PASCH RJ, 1999, WEATHERWISE, V52, P48; PEIXOTO JP, 1992, PHYSICS CLIMATE, P16; Pielke RA, 1998, WEATHER FORECAST, V13, P621, DOI 10.1175/1520-0434(1998)013<0621:NHDITU>2.0.CO;2; Saunders MA, 1997, GEOPHYS RES LETT, V24, P1255, DOI 10.1029/97GL01164; SHAPIRO LJ, 1982, MON WEATHER REV, V110, P1014, DOI 10.1175/1520-0493(1982)110<1014:HCFPIR>2.0.CO;2; SHAPIRO LJ, 1987, MON WEATHER REV, V115, P2598, DOI 10.1175/1520-0493(1987)115<2598:MTMVOT>2.0.CO;2; Shapiro LJ, 1998, J CLIMATE, V11, P578, DOI 10.1175/1520-0442(1998)011<0578:ASSTAT>2.0.CO;2; Shapiro LJ, 1989, MON WEA REV, V117, P2598; SHAY LK, 1989, J PHYS OCEANOGR, V19, P649, DOI 10.1175/1520-0485(1989)019<0649:VSOTOC>2.0.CO;2; Simpson R.H., 1974, WEATHERWISE, V27, P169, DOI [10.1080/00431672.1974.9931702, DOI 10.1080/00431672.1974.9931702]; Trenberth KE, 1996, GEOPHYS RES LETT, V23, P57, DOI 10.1029/95GL03602; Vitart F, 2001, J CLIMATE, V14, P533, DOI 10.1175/1520-0442(2001)014<0533:SOATSF>2.0.CO;2; Wilson RM, 1999, GEOPHYS RES LETT, V26, P2957, DOI 10.1029/1999GL004904	43	1174	1202	6	277	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2001	293	5529					474	479		10.1126/science.1060040	http://dx.doi.org/10.1126/science.1060040			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463911				2022-12-28	WOS:000169966700042
J	Luzzatto, L; Notaro, R				Luzzatto, L; Notaro, R			Malaria - Protecting against bad air	SCIENCE			English	Editorial Material							PLASMODIUM-FALCIPARUM; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE G6PD; DEFICIENCY; MUTATIONS; ORIGIN; GENE; DEHYDROGENASE; POLYMORPHISMS; RESISTANCE; VARIANT		Natl Inst Canc Res, Genoa, Italy	University of Genoa; IRCCS AOU San Martino IST	Luzzatto, L (corresponding author), Natl Inst Canc Res, Genoa, Italy.	luzzatto@hp380.ist.unige.it	Notaro, Rosario/J-7293-2016	Notaro, Rosario/0000-0002-9087-9404				BIENZLE U, 1972, LANCET, V1, P107; Cappadoro M, 1998, BLOOD, V92, P2527, DOI 10.1182/blood.V92.7.2527.2527_2527_2534; Ceppellini M, 1976, G Batteriol Virol Immunol, V69, P39; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; KAY AC, 1992, AM J HUM GENET, V50, P394; KURDIHAIDAR B, 1990, AM J HUM GENET, V47, P1013; Longo L., 1997, Blood, V90, p408A; Luzzatto L, 2000, GENES AND RESISTANCE TO DISEASE, P105; Notaro R, 2000, FASEB J, V14, P485, DOI 10.1096/fasebj.14.3.485; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; Rich SM, 2000, P NATL ACAD SCI USA, V97, P6994, DOI 10.1073/pnas.97.13.6994; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; USANGA EA, 1985, NATURE, V313, P793, DOI 10.1038/313793a0; Volkman SK, 2001, SCIENCE, V293, P482, DOI 10.1126/science.1059878; Vulliamy T, 1996, HUM MUTAT, V8, P311, DOI 10.1002/(SICI)1098-1004(1996)8:4<311::AID-HUMU3>3.0.CO;2-A; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; [No title captured]	19	36	38	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2001	293	5529					442	443		10.1126/science.1063292	http://dx.doi.org/10.1126/science.1063292			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463901				2022-12-28	WOS:000169966700031
J	Longnecker, MP; Klebanoff, MA; Zhou, HB; Brock, JW				Longnecker, MP; Klebanoff, MA; Zhou, HB; Brock, JW			Association between maternal serum concentration of the DDT metabolite DDE and preterm and small-for-gestational-age babies at birth	LANCET			English	Article							POLYCHLORINATED-BIPHENYLS PCBS; HUMAN-MILK; ORGANOCHLORINE PESTICIDES; RESIDUE LEVELS; PREMATURE; P,P'-DDE; DELIVERY; MALARIA; BLOOD; WOMEN	Background DDT (1,1,1-trichloro-2.2-bis(p-chlorophenyl) ethane) is highly effective against most malaria-transmitting mosquitoes and is being widely used in malaria-endemic areas. The metabolite, DDE (1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene), has been linked to preterm birth in small studies, but these findings are inconclusive. Our aim was to investigate the association between DDE exposure and preterm birth. Methods Our study was based on the US Collaborative Perinatal Project (CPP). From this study we selected a subset of more than 44 000 eligible children born between 1959 and 1966 and measured the DDE concentration in their mothers' serum samples stored during pregnancy. Complete data were available for 2380 children, of whom 361 were born preterm and 221 were small-for-gestational age. Findings The median maternal DDE concentration was 25 mug/L (range 3-178)-several fold higher than current US concentrations. The adjusted odds ratios (OR) of preterm birth increased steadily with increasing concentrations of serum DDE (ORs=1, 1.5, 1.6, 2.5, 3.1; trend p<0.0001). Adjusted odds of small-for-gestational-age also increased, but less consistently (ORs=1, 1.9, 1.7, 1.6, 2.6; trend p=0.04). After excluding preterm births, the association of DDE with small-for-gestational-age remained. Interpretation The findings strongly suggest that DDT use increases preterm births, which is a major contributor to infant mortality. If this association is causal, it should be included in any assessment of the costs and benefits of vector control with DDT.	NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; NICHHD, Div Epidemiol Stat & Prevent Res, Rockville, MD USA; Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of North Carolina; University of North Carolina Chapel Hill; Centers for Disease Control & Prevention - USA	Longnecker, MP (corresponding author), NIEHS, Epidemiol Branch, POB 12233 MD A3-05, Res Triangle Pk, NC 27709 USA.			Longnecker, Matthew/0000-0001-6073-5322	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD002531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES049016, Z01ES101170, ZIAES049016, Z01ES100490] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Alexander GR, 1996, PUBLIC HEALTH REP, V111, P408; *ATSDR, 1994, TOX PROF DDT DDE DDD; BERKOWITZ GS, 1993, EPIDEMIOL REV, V15, P414, DOI 10.1093/oxfordjournals.epirev.a036128; Berkowitz GS, 1996, ARCH ENVIRON CON TOX, V30, P139, DOI 10.1007/BF00211340; BOUWMAN H, 1991, J TOXICOL ENV HEALTH, V33, P141, DOI 10.1080/15287399109531514; BRACKBILL Y, 1978, LANCET, V2, P520; Brock JW, 1996, J ANAL TOXICOL, V20, P528, DOI 10.1093/jat/20.7.528; DELONG RL, 1973, SCIENCE, V181, P1168, DOI 10.1126/science.181.4105.1168; HART MM, 1971, ARCH INT PHARMACOD T, V192, P286; Jeong SY, 2000, BIOCHEM BIOPH RES CO, V267, P262, DOI 10.1006/bbrc.1999.1916; JUBERG DR, 1992, TOXICOLOGY, V74, P161, DOI 10.1016/0300-483X(92)90136-3; KELCE WR, 1995, NATURE, V375, P581, DOI 10.1038/375581a0; Klotz DM, 1997, MOL CELL ENDOCRINOL, V129, P63, DOI 10.1016/S0303-7207(96)04041-5; Kramer MS, 2000, JAMA-J AM MED ASSOC, V284, P843, DOI 10.1001/jama.284.7.843; Lang JM, 1996, EPIDEMIOLOGY, V7, P369, DOI 10.1097/00001648-199607000-00006; Longnecker MP, 1999, ARCH ENVIRON HEALTH, V54, P110, DOI 10.1080/00039899909602244; Lunden A, 1998, ARCH ENVIRON CON TOX, V34, P414, DOI 10.1007/s002449900338; LUNDHOLM CE, 1992, ARCH TOXICOL, V66, P387, DOI 10.1007/BF02035127; LYON MF, 1980, PROC R SOC SER B-BIO, V208, P1, DOI 10.1098/rspb.1980.0040; NARAHASHI T, 1997, COMPREHENSIVE TOXICO, V11; Niswander K.R., 1972, WOMEN THEIR PREGNANC; Noren K, 1999, ARCH ENVIRON CON TOX, V37, P408, DOI 10.1007/s002449900532; NOREN K, 1988, CHEMOSPHERE, V17, P39, DOI 10.1016/0045-6535(88)90042-2; OLEARY JA, 1970, AM J OBSTET GYNECOL, V106, P939, DOI 10.1016/0002-9378(70)90499-0; POLLIOTTI B, 1994, PLACENTA, V15, P477, DOI 10.1016/S0143-4004(05)80417-5; PROCIANOY RS, 1981, ACTA PAEDIATR SCAND, V70, P925, DOI 10.1111/j.1651-2227.1981.tb06252.x; Quensen JF, 1998, SCIENCE, V280, P722, DOI 10.1126/science.280.5364.722; Roberts DR, 2000, LANCET, V356, P330, DOI 10.1016/S0140-6736(00)02516-2; ROGAN WJ, 1986, AM J PUBLIC HEALTH, V76, P172, DOI 10.2105/AJPH.76.2.172; Sames WJ, 1996, J AM MOSQUITO CONTR, V12, P487; SAXENA MC, 1981, J ANAL TOXICOL, V5, P6, DOI 10.1093/jat/5.1.6; SIBAI BM, 1993, NEW ENGL J MED, V329, P1213, DOI 10.1056/NEJM199310213291701; Smith AG, 2000, LANCET, V356, P267, DOI 10.1016/S0140-6736(00)02497-1; STEHRGREEN PA, 1989, J TOXICOL ENV HEALTH, V27, P405, DOI 10.1080/15287398909531312; Ware G W, 1975, Residue Rev, V59, P119; WASSERMANN M, 1982, ENVIRON RES, V28, P106, DOI 10.1016/0013-9351(82)90158-X; *WHO, 1995, WHO TECHN REP SER, V857; WWF, 1999, HAZ EXP ASS DDT SYNT	38	331	339	1	40	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 14	2001	358	9276					110	114		10.1016/S0140-6736(01)05329-6	http://dx.doi.org/10.1016/S0140-6736(01)05329-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452BR	11463412				2022-12-28	WOS:000169837700011
J	Thiemens, MH				Thiemens, MH			Atmospheric science - The mass-independent ozone isotope effect	SCIENCE			English	Editorial Material							INTRAMOLECULAR THEORY; RATE COEFFICIENTS		Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Thiemens, MH (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	mthiemens@ucsd.edu						Anderson SM, 1997, J CHEM PHYS, V107, P5385, DOI 10.1063/1.474247; BIGELEISEN J, 1947, J CHEM PHYS, V15, P261, DOI 10.1063/1.1746492; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Gao YQ, 2001, SCIENCE, V293, P259, DOI 10.1126/science.1058528; Hathorn BC, 2000, J CHEM PHYS, V113, P9497, DOI 10.1063/1.1321045; Hathorn BC, 1999, J CHEM PHYS, V111, P4087, DOI 10.1063/1.480267; Janssen C, 1999, J CHEM PHYS, V111, P7179, DOI 10.1063/1.480045; Mauersberger K, 1999, SCIENCE, V283, P370, DOI 10.1126/science.283.5400.370; MORTON J, 1990, J GEOPHYS RES-ATMOS, V95, P901, DOI 10.1029/JD095iD01p00901; Sehested J, 1998, J GEOPHYS RES-ATMOS, V103, P3545, DOI 10.1029/97JD03124; THIEMENS MH, 1988, GEOPHYS RES LETT, V15, P639, DOI 10.1029/GL015i007p00639; THIEMENS MH, 1983, SCIENCE, V219, P1073, DOI 10.1126/science.219.4588.1073; Thiemens MH, 1999, SCIENCE, V283, P341, DOI 10.1126/science.283.5400.341; THIEMENS MH, IN PRESS ACC CHEM RE; UREY HC, 1947, J CHEM SOC, P562, DOI 10.1039/jr9470000562; Weston RE, 1999, CHEM REV, V99, P2115, DOI 10.1021/cr9800154	17	31	33	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2001	293	5528					226	226		10.1126/science.1063648	http://dx.doi.org/10.1126/science.1063648			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452104				2022-12-28	WOS:000169875200034
J	Steere, AC				Steere, AC			Medical progress: Lyme disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BURGDORFERI SENSU-STRICTO; POLYMERASE CHAIN-REACTION; SURFACE PROTEIN-A; BORRELIA-BURGDORFERI; NERVOUS-SYSTEM; NEUROLOGIC MANIFESTATIONS; COST-EFFECTIVENESS; ANTIBODY-RESPONSE; SYNOVIAL-FLUID; PENICILLIN-G		Tufts Univ, Sch Med, Div Rheumatol & Immunol, Boston, MA 02111 USA	Tufts University	Steere, AC (corresponding author), New England Med Ctr 406, Div Rheumatol & Immunol, 750 Washington St, Boston, MA 02111 USA.			Steere, Allen/0000-0002-5268-9853	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR020358] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-20358] Funding Source: Medline; PHS HHS [CCU110291] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		*ADV COMM IMM PRAC, 1999, MMWR-MORBID MORTAL W, V48, P833; Akin E, 1999, INFECT IMMUN, V67, P173, DOI 10.1128/IAI.67.1.173-181.1999; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; ASBRINK E, 1985, ACTA PATH MICRO IM B, V93, P161; BARANTON G, 1992, INT J SYST BACTERIOL, V42, P378, DOI 10.1099/00207713-42-3-378; BARBOUR AG, 1986, MICROBIOL REV, V50, P381, DOI 10.1128/MMBR.50.4.381-400.1986; Barthold SW, 1997, CLIN INFECT DIS, V25, pS9, DOI 10.1086/516166; BARTHOLD SW, 1995, J INFECT DIS, V172, P778, DOI 10.1093/infdis/172.3.778; BARTHOLD SW, 1990, J INFECT DIS, V162, P133, DOI 10.1093/infdis/162.1.133; BERGER BW, 1992, J CLIN MICROBIOL, V30, P359, DOI 10.1128/JCM.30.2.359-361.1992; BROWN EL, 1995, EUR J IMMUNOL, V25, P3017, DOI 10.1002/eji.1830251105; Brown EL, 2001, J CLIN INVEST, V107, P845, DOI 10.1172/JCI11692; BROWN RN, 1992, SCIENCE, V256, P1439, DOI 10.1126/science.1604318; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Cadavid D, 2000, LAB INVEST, V80, P1043, DOI 10.1038/labinvest.3780109; CAMPBELL GL, 1995, J INFECT DIS, V172, P470, DOI 10.1093/infdis/172.2.470; Carlson D, 1999, ARTHRITIS RHEUM, V42, P2705, DOI 10.1002/1529-0131(199912)42:12&lt;2705::AID-ANR29&gt;3.0.CO;2-H; CDC, 1999, MMWR-MORBID MORTAL W, V48, P1; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590; Chen J, 1999, ARTHRITIS RHEUM, V42, P1813, DOI 10.1002/1529-0131(199909)42:9&lt;1813::AID-ANR4&gt;3.0.CO;2-0; COBURN J, 1993, P NATL ACAD SCI USA, V90, P7059, DOI 10.1073/pnas.90.15.7059; Coburn J, 1998, INFECT IMMUN, V66, P1946, DOI 10.1128/IAI.66.5.1946-1952.1998; Coleman JL, 1997, CELL, V89, P1111, DOI 10.1016/S0092-8674(00)80298-6; COYLE PK, 1999, LYME DIS CONTINUUM A, V5; DATTWYLER RJ, 1988, LANCET, V1, P1191; Dattwyler RJ, 1997, NEW ENGL J MED, V337, P289, DOI 10.1056/NEJM199707313370501; DATTWYLER RJ, 1990, LANCET, V336, P1404, DOI 10.1016/0140-6736(90)93103-V; deSilva AM, 1997, J CLIN INVEST, V99, P377, DOI 10.1172/JCI119169; DINERMAN H, 1992, ANN INTERN MED, V117, P281, DOI 10.7326/0003-4819-117-4-281; Doyle MK, 1998, J INFECT DIS, V177, P242, DOI 10.1086/517364; DRESSLER F, 1993, J INFECT DIS, V167, P392, DOI 10.1093/infdis/167.2.392; Eckman MH, 1997, NEW ENGL J MED, V337, P357, DOI 10.1056/NEJM199707313370525; ENGSTROM SM, 1995, J CLIN MICROBIOL, V33, P419, DOI 10.1128/JCM.33.2.419-427.1995; ETTESTAD PJ, 1995, J INFECT DIS, V171, P356, DOI 10.1093/infdis/171.2.356; Feng SL, 2000, INFECT IMMUN, V68, P4169, DOI 10.1128/IAI.68.7.4169-4173.2000; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gomes-Solecki MJC, 2000, J CLIN MICROBIOL, V38, P2530; Gross DM, 1998, J IMMUNOL, V160, P1022; Gross DM, 1998, SCIENCE, V281, P703, DOI 10.1126/science.281.5377.703; Guo BP, 1998, MOL MICROBIOL, V30, P711, DOI 10.1046/j.1365-2958.1998.01103.x; GUSTAFSON R, 1990, SCAND J INFECT DIS, V22, P297, DOI 10.3109/00365549009027051; HALPERIN JJ, 1989, NEUROLOGY, V39, P753, DOI 10.1212/WNL.39.6.753; Hemmer B, 1999, NAT MED, V5, P1375; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Kalish RA, 2001, J INFECT DIS, V183, P453, DOI 10.1086/318082; KALISH RA, 1993, INFECT IMMUN, V61, P2774, DOI 10.1128/IAI.61.7.2774-2779.1993; KALISH RA, IN PRESS CLIN INFECT; Kang IS, 1997, INFECT IMMUN, V65, P3107, DOI 10.1128/IAI.65.8.3107-3111.1997; KARLSSON M, 1994, NEUROLOGY, V44, P1203, DOI 10.1212/WNL.44.7.1203; Klempner MS, 2001, AM J MED, V110, P217, DOI 10.1016/S0002-9343(00)00701-4; Klempner MS, 2001, NEW ENGL J MED, V345, P85, DOI 10.1056/NEJM200107123450202; KRAUSE A, 1991, ARTHRITIS RHEUM-US, V34, P393, DOI 10.1002/art.1780340404; LANE RS, 1991, ANNU REV ENTOMOL, V36, P587, DOI 10.1146/annurev.en.36.010191.003103; LARDIERI G, 1993, LANCET, V342, P490, DOI 10.1016/0140-6736(93)91612-P; Liang FT, 1999, J CLIN MICROBIOL, V37, P3990, DOI 10.1128/JCM.37.12.3990-3996.1999; LOGIGIAN EL, 1990, NEW ENGL J MED, V323, P1438, DOI 10.1056/NEJM199011223232102; Logigian EL, 1999, J INFECT DIS, V180, P377, DOI 10.1086/314860; LOGIGIAN EL, 1992, NEUROLOGY, V42, P303, DOI 10.1212/WNL.42.2.303; Meyer AL, 2000, P NATL ACAD SCI USA, V97, P11433, DOI 10.1073/pnas.190335897; Mullegger RR, 2000, J INVEST DERMATOL, V115, P1115, DOI 10.1046/j.1523-1747.2000.00198.x; NADELMAN RB, 1992, ANN INTERN MED, V117, P273, DOI 10.7326/0003-4819-117-4-273; NADELMAN RB, 1908, NEW ENGL J MED, V345, P79; Nichol G, 1998, ANN INTERN MED, V128, P37, DOI 10.7326/0003-4819-128-1-199801010-00007; Nocton JJ, 1996, J INFECT DIS, V174, P623, DOI 10.1093/infdis/174.3.623; NOCTON JJ, 1994, NEW ENGL J MED, V330, P229, DOI 10.1056/NEJM199401273300401; Nowakowski J, 2000, ARCH FAM MED, V9, P563, DOI 10.1001/archfami.9.6.563; Orloski K A, 2000, MMWR CDC Surveill Summ, V49, P1; Oschmann P, 1998, J NEUROL, V245, P262, DOI 10.1007/s004150050216; Patel R, 2000, CLIN INFECT DIS, V31, P1107, DOI 10.1086/318138; PFISTER HW, 1989, ARCH NEUROL-CHICAGO, V46, P1190, DOI 10.1001/archneur.1989.00520470044025; PIESMAN J, 1993, J INFECT DIS, V167, P1082, DOI 10.1093/infdis/167.5.1082; Probert WS, 1998, MOL MICROBIOL, V30, P1003, DOI 10.1046/j.1365-2958.1998.01127.x; Protection against viral hepatitis, 1990, MMWR RECOMM REP, V39, P1; Roberts ED, 1998, J INFECT DIS, V178, P722, DOI 10.1086/515357; Robertson J, 2000, J CLIN MICROBIOL, V38, P2097; ROTHERMEL H, IN PRESS PEDIATRICS; Schoen RT, 2000, CLIN THER, V22, P315, DOI 10.1016/S0149-2918(00)80035-1; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; Seltzer EG, 2000, JAMA-J AM MED ASSOC, V283, P609, DOI 10.1001/jama.283.5.609; Shadick NA, 1999, ANN INTERN MED, V131, P919, DOI 10.7326/0003-4819-131-12-199912210-00003; SHAPIRO ED, 1992, NEW ENGL J MED, V327, P1769, DOI 10.1056/NEJM199212173272501; SONNESYN SW, 1995, AM J CARDIOL, V76, P97, DOI 10.1016/S0002-9149(99)80814-5; SPIELMAN A, 1994, ANN NY ACAD SCI, V740, P146, DOI 10.1111/j.1749-6632.1994.tb19865.x; Stanek G., 1993, P358; STANEK G, 1990, NEW ENGL J MED, V322, P249, DOI 10.1056/NEJM199001253220407; STEERE AC, 1990, J INFECT DIS, V161, P1203, DOI 10.1093/infdis/161.6.1203; STEERE AC, 1989, NEW ENGL J MED, V321, P586, DOI 10.1056/NEJM198908313210906; Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401; STEERE AC, 1983, NEW ENGL J MED, V308, P733, DOI 10.1056/NEJM198303313081301; STEERE AC, 1977, ARTHRITIS RHEUM, V20, P7, DOI 10.1002/art.1780200102; Steere AC, 1998, ARTHRITIS RHEUM, V41, pS81; STEERE AC, 1994, ARTHRITIS RHEUM-US, V37, P878, DOI 10.1002/art.1780370616; STEERE AC, 1988, ARTHRITIS RHEUM, V31, P487, DOI 10.1002/art.1780310405; Strle F, 1999, ANN INTERN MED, V130, P32, DOI 10.7326/0003-4819-130-1-199901050-00006; Trollmo C, 2001, J IMMUNOL, V166, P5286, DOI 10.4049/jimmunol.166.8.5286; Vincent MS, 1998, J IMMUNOL, V161, P5762; Weis JJ, 1999, J IMMUNOL, V162, P948; WILLIAMS CL, 1995, PAEDIATR PERINAT EP, V9, P320, DOI 10.1111/j.1365-3016.1995.tb00148.x; Wormser GP, 2000, J CLIN MICROBIOL, V38, P1648, DOI 10.1128/JCM.38.4.1648-1650.2000; Wormser GP, 2000, CLIN INFECT DIS, V31, pS1, DOI 10.1086/314053; Yin ZN, 1997, ARTHRITIS RHEUM, V40, P69, DOI 10.1002/art.1780400111; Zhang JR, 1998, INFECT IMMUN, V66, P3698, DOI 10.1128/IAI.66.8.3698-3704.1998	102	849	895	1	107	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 12	2001	345	2					115	125		10.1056/NEJM200107123450207	http://dx.doi.org/10.1056/NEJM200107123450207			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451AH	11450660				2022-12-28	WOS:000169776900007
J	Dann, CE; Hsieh, JC; Rattner, A; Sharma, D; Nathans, J; Leahy, DJ				Dann, CE; Hsieh, JC; Rattner, A; Sharma, D; Nathans, J; Leahy, DJ			Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains	NATURE			English	Article							PROTEIN-PROTEIN INTERFACES; RECEPTOR TYROSINE KINASES; SECRETED PROTEINS; CRD DOMAIN; CLASSIFICATION; PURIFICATION; DIFFRACTION; ANTAGONIST; FAMILY	Members of the Frizzled family of seven-pass transmembrane proteins serve as receptors for Wnt signalling proteins(1). Wnt proteins have important roles in the differentiation and patterning of diverse tissues during animal development(2,3), and inappropriate activation of Wnt signalling pathways is a key feature of many cancers(4). An extracellular cysteine-rich domain (CRD) at the amino terminus of Frizzled proteins binds Wnt proteins(1), as do homologous domains in soluble proteins-termed secreted Frizzled-related proteins(5) - that function as antagonists of Wnt signalling(6-8). Recently, an LDL-receptor-related protein has been shown to function as a co-receptor for Wnt proteins and to bind to a Frizzled CRD in a Wnt-dependent manner(9-11). To investigate the molecular nature of the Wnt signalling complex, we determined the crystal structures of the CRDs from mouse Frizzled 8 and secreted Frizzled-related protein 3. Here we show a previously unknown protein fold, and the design and interpretation of CRD mutations that identify a Wnt-binding site. CRDs exhibit a conserved dimer interface that may be a feature of Wnt signalling. This work provides a framework for studies of homologous CRDs in proteins including muscle-specific kinase and Smoothened, a component of the Hedgehog signalling pathway(12,13).	Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Leahy, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	leahy@groucho.med.jhmi.edu	Dann, Charles E/C-2747-2018	Rattner, Amir/0000-0001-9542-6212; Nathans, Jeremy/0000-0001-8106-5460				Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leahy DJ, 2000, PROTEIN EXPRES PURIF, V20, P500, DOI 10.1006/prep.2000.1331; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Masiakowski P, 1998, CURR BIOL, V8, pR407, DOI 10.1016/S0960-9822(98)70263-5; Moon RT, 1997, CELL, V88, P725, DOI 10.1016/S0092-8674(00)81915-7; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Sparks AB, 1998, CANCER RES, V58, P1130; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Xu YK, 1998, CURR BIOL, V8, pR405, DOI 10.1016/S0960-9822(98)70262-3; YONG K, 1990, ACTA CRYSTALLOGR A, V46, P41	30	362	419	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					86	90		10.1038/35083601	http://dx.doi.org/10.1038/35083601			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452312				2022-12-28	WOS:000169644900049
J	Hengartner, MO				Hengartner, MO			Apoptosis - DNA destroyers	NATURE			English	Editorial Material									Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland	University of Zurich	Hengartner, MO (corresponding author), Univ Zurich, Inst Mol Biol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.		Hengartner, Michael O/E-6235-2011; Hengartner, Michael O/A-7058-2008	Hengartner, Michael/0000-0002-7584-596X				Chen FL, 2000, SCIENCE, V287, P1485, DOI 10.1126/science.287.5457.1485; COTE J, 1993, SCIENCE, V261, P765, DOI 10.1126/science.7688144; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Lorenzo HK, 1999, CELL DEATH DIFFER, V6, P516, DOI 10.1038/sj.cdd.4400527; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Wu YC, 2000, GENE DEV, V14, P536; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0	9	55	59	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					27	29		10.1038/35083663	http://dx.doi.org/10.1038/35083663			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452284				2022-12-28	WOS:000169644900023
J	Loope, DB; Rowe, CM; Joeckel, RM				Loope, DB; Rowe, CM; Joeckel, RM			Annual monsoon rains recorded by Jurassic dunes	NATURE			English	Article							UNITED-STATES	Pangaea, the largest landmass in the Earth's history, was nearly bisected by the Equator during the late Palaeozoic and early Mesozoic eras. Modelling experiments and stratigraphic studies have suggested that the supercontinent generated a monsoonal atmospheric circulation that led to extreme seasonality(1-3), but direct evidence for annual rainfall periodicity has been lacking(4). In the Mesozoic era, about 190 million years ago, thick deposits of wind-blown sand accumulated in dunes of a vast, low-latitude desert at Pangaea's western margin(5-7). These deposits are now situated in the southwestern USA. Here we analyse slump masses in the annual depositional cycles within these deposits, which have been described for some outcrops of the Navajo Sandstone(8). Twenty-four slumps, which were generated by heavy rainfall, appear within one interval representing 36 years of dune migration. We interpret the positions of 20 of these masses to indicate slumping during summer monsoon rains, with the other four having been the result of winter storms. The slumped lee faces of these Jurassic dunes therefore represent a prehistoric record of yearly rain events.	Univ Nebraska, Dept Geosci, Lincoln, NE 68588 USA; Univ Nebraska, Div Conservat & Survey, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Loope, DB (corresponding author), Univ Nebraska, Dept Geosci, Lincoln, NE 68588 USA.							[Anonymous], [No title captured]; BIGARELL.JJ, 1969, MAR GEOL, V7, P5, DOI 10.1016/0025-3227(69)90002-4; BLAKEY RC, 1988, SEDIMENT GEOL, V56, P3, DOI 10.1016/0037-0738(88)90050-4; CHANDLER MA, 1992, GEOL SOC AM BULL, V104, P543, DOI 10.1130/0016-7606(1992)104<0543:PCDTEJ>2.3.CO;2; Chang CS, 1999, BIOCHEM ENG J, V3, P239, DOI 10.1016/S1369-703X(99)00022-4; COOKE R, 1993, DESERT GEOMORPHOLOGY, P338; Hunter R.E., 1983, EOLIAN SEDIMENTS PRO, V38, P429; HUNTER RE, 1983, GEOL SOC AM BULL, V94, P1450, DOI 10.1130/0016-7606(1983)94<1450:SODOTO>2.0.CO;2; HUNTER RE, 1977, SEDIMENTOLOGY, V24, P361, DOI 10.1111/j.1365-3091.1977.tb00128.x; KUTZBACH JE, 1989, J GEOPHYS RES-ATMOS, V94, P3341, DOI 10.1029/JD094iD03p03341; KVALE EP, 1994, GEOLOGY, V22, P331, DOI 10.1130/0091-7613(1994)022<0331:EOSPIP>2.3.CO;2; LOOPE DB, 2000, GEOL SOC AM PROGM, V32, pA308; PARRISH JT, 1982, PALAEOGEOGR PALAEOCL, V40, P67, DOI 10.1016/0031-0182(82)90085-2; PARRISH JT, 1988, SEDIMENT GEOL, V56, P261, DOI 10.1016/0037-0738(88)90056-5	14	95	103	0	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					64	66		10.1038/35083554	http://dx.doi.org/10.1038/35083554			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452305				2022-12-28	WOS:000169644900042
J	Silver, LM				Silver, LM			What are clones? They're not what you think they are.	NATURE			English	Editorial Material									Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA	Princeton University; Princeton University	Silver, LM (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.							GURDON JB, 1968, SCI AM, V219, P24, DOI 10.1038/scientificamerican1268-24; Jaenisch R, 2001, SCIENCE, V291, P2552, DOI 10.1126/science.1060463; ROY R, 2001, WHO CLONED PRESIDENT; THOMAS TL, 1965, CLONE; Toffler A., 1980, 3 WAVE; WEBBER HJ, 1903, SCIENCE, V28, P501; Weiss Rick, 2001, WASHINGTON POST 1014, pA10	7	6	6	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					21	21		10.1038/35083650	http://dx.doi.org/10.1038/35083650			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452280				2022-12-28	WOS:000169644900019
J	Dong, YH; Wang, LH; Xu, JL; Zhang, HB; Zhang, XF; Zhang, LH				Dong, YH; Wang, LH; Xu, JL; Zhang, HB; Zhang, XF; Zhang, LH			Quenching quorum-sensing-dependent bacterial infection by an N-acyl homoserine lactonase	NATURE			English	Article							AERUGINOSA VIRULENCE GENES; PSEUDOMONAS-AERUGINOSA; ERWINIA-CAROTOVORA; EXOENZYME PRODUCTION; AUTOINDUCER; SIGNAL; EXPRESSION; BINDING; DETERMINANTS; SPECIFICITY	Bacterial cells sense their population density through a sophisticated cell-cell communication system and trigger expression of particular genes when the density reaches a threshold. This type of gene regulation, which controls diverse biological functions including virulence, is known as quorum sensing(1,2). Quorum-sensing signals, such as acyl-homoserine lactones (AHLs), are the essential components of the communication system. AHLs regulate virulence gene expression in a range of plant and animal (including human) bacterial pathogens(3-9). AHL-producing tobacco restored the pathogenicity of an AHL-negative mutant of Erwinia carotovora(10). Different bacterial species may produce different AHLs, which vary in the length and substitution of the acyl chain but contain the same homoserine lactone moiety. Here we show that the acyl-homoserine lactonase (AHL-lactonase), a new enzyme from Bacillus sp.(11), inactivates AHL activity by hydrolysing the lactone bond of AHLs. Plants expressing AHL-lactonase quenched pathogen quorum-sensing signalling and showed significantly enhanced resistance to E. carotovora infection. Our results highlight a promising potential to use quorum-sensing signals as molecular targets for disease control, thereby broadening current approaches for prevention of bacterial infections.	Natl Univ Singapore, Inst Mol Agrobiol, Lab Biosignals & Bioengn, Singapore 117604, Singapore	National University of Singapore	Zhang, LH (corresponding author), Natl Univ Singapore, Inst Mol Agrobiol, Lab Biosignals & Bioengn, 1 Res Link, Singapore 117604, Singapore.		Wang, Lianhui/D-6826-2016					Beaujean A, 1998, J EXP BOT, V49, P1589, DOI 10.1093/jexbot/49.326.1589; Borisjuk N, 1998, PLANTA, V206, P504, DOI 10.1007/s004250050427; Borisjuk NV, 1999, NAT BIOTECHNOL, V17, P466, DOI 10.1038/8643; Costa JM, 1997, CAN J MICROBIOL, V43, P1164, DOI 10.1139/m97-165; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; Dunphy G, 1997, J BACTERIOL, V179, P5288, DOI 10.1128/jb.179.17.5288-5291.1997; Fray RG, 1999, NAT BIOTECHNOL, V17, P1017, DOI 10.1038/13717; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; Gallois P., 1995, PLANT GENE TRANSFER, P39, DOI 10.1385/0-89603-321-X:39; Givskov M, 1996, J BACTERIOL, V178, P6618, DOI 10.1128/jb.178.22.6618-6622.1996; Hoang TT, 1999, J BACTERIOL, V181, P5489, DOI 10.1128/JB.181.17.5489-5497.1999; JONES S, 1993, EMBO J, V12, P2477, DOI 10.1002/j.1460-2075.1993.tb05902.x; Leadbetter JR, 2000, J BACTERIOL, V182, P6921, DOI 10.1128/JB.182.24.6921-6926.2000; Lewenza S, 1999, J BACTERIOL, V181, P748, DOI 10.1128/JB.181.3.748-756.1999; Manefield M, 2000, APPL ENVIRON MICROB, V66, P2079, DOI 10.1128/AEM.66.5.2079-2084.2000; Manefield M, 1999, MICROBIOL-SGM, V145, P283, DOI 10.1099/13500872-145-2-283; PASSADOR L, 1993, SCIENCE, V260, P1127, DOI 10.1126/science.8493556; Pearson JP, 1999, J BACTERIOL, V181, P1203, DOI 10.1128/JB.181.4.1203-1210.1999; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; PIRHONEN M, 1993, EMBO J, V12, P2467, DOI 10.1002/j.1460-2075.1993.tb05901.x; Qin YP, 2000, EMBO J, V19, P5212, DOI 10.1093/emboj/19.19.5212; Robson ND, 1997, TRENDS BIOTECHNOL, V15, P458, DOI 10.1016/S0167-7799(97)01102-5; von Bodman SB, 1998, P NATL ACAD SCI USA, V95, P7687, DOI 10.1073/pnas.95.13.7687; VONBODMAN SB, 1995, J BACTERIOL, V177, P5000, DOI 10.1128/JB.177.17.5000-5008.1995; Welch M, 2000, EMBO J, V19, P631, DOI 10.1093/emboj/19.4.631; WINSON MK, 1995, P NATL ACAD SCI USA, V92, P9427, DOI 10.1073/pnas.92.20.9427; ZHANG LH, 1993, NATURE, V362, P446, DOI 10.1038/362446a0; Zhu J, 1999, P NATL ACAD SCI USA, V96, P4832, DOI 10.1073/pnas.96.9.4832	28	718	828	19	274	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					813	817		10.1038/35081101	http://dx.doi.org/10.1038/35081101			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459062				2022-12-28	WOS:000169246400053
J	Reichhardt, T				Reichhardt, T			Airborne telescope delayed as plane is made ready	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					729	729		10.1038/35081269	http://dx.doi.org/10.1038/35081269			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11460101	Bronze			2022-12-28	WOS:000169246400012
J	Ramos-Remus, C; Galvan-Villegas, F				Ramos-Remus, C; Galvan-Villegas, F			A hair-on-end skull	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Inst Mexicano Seguro Social, Guadalajara 44340, Jalisco, Mexico	Instituto Mexicano del Seguro Social	Ramos-Remus, C (corresponding author), Inst Mexicano Seguro Social, Guadalajara 44340, Jalisco, Mexico.			Ramos-Remus, Cesar/0000-0002-4898-4219					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2001	345	5					E1	E1		10.1056/ENEJM200108023450524	http://dx.doi.org/10.1056/ENEJM200108023450524			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458KM	11484712				2022-12-28	WOS:000170193600006
J	Schwetz, BA				Schwetz, BA			New device for procedures on diseased bypass grafts	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2001	286	5					527	527		10.1001/jama.286.5.527	http://dx.doi.org/10.1001/jama.286.5.527			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458HE	11476645				2022-12-28	WOS:000170188300004
J	Mabey, D; Fraser-Hurt, N				Mabey, D; Fraser-Hurt, N			Extracts from "Clinical Evidence" - Trachoma	BRITISH MEDICAL JOURNAL			English	Review							AZITHROMYCIN; BLINDNESS; TANZANIA; TRICHIASIS; SURGERY; TRIAL		Guys & St Thomas Hosp Trust, London SE1 9RT, England; Epiconsult Ltd, Nhlangano, Swaziland	Guy's & St Thomas' NHS Foundation Trust	Mabey, D (corresponding author), Guys & St Thomas Hosp Trust, London SE1 9RT, England.			Mabey, David/0000-0002-0031-8276				Attiah M A, 1973, Rev Int Trach, V50, P11; BAILEY R, 1989, INT J EPIDEMIOL, V18, P944, DOI 10.1093/ije/18.4.944; BOBO L, 1991, LANCET, V338, P847, DOI 10.1016/0140-6736(91)91502-L; COURTRIGHT P, 1989, BRIT J OPHTHALMOL, V73, P536, DOI 10.1136/bjo.73.7.536; DAROUGAR S, 1980, BRIT J OPHTHALMOL, V64, P291, DOI 10.1136/bjo.64.4.291; Dawson CR, 1997, CLIN INFECT DIS, V24, P363, DOI 10.1093/clinids/24.3.363; DAWSON CR, 1969, J INFECT DIS, V119, P581, DOI 10.1093/infdis/119.6.581; Emerson PM, 1999, LANCET, V353, P1401, DOI 10.1016/S0140-6736(98)09158-2; FOSTER SO, 1966, AM J OPHTHALMOL, V61, P451, DOI 10.1016/0002-9394(66)91050-6; HOSHIWARA I, 1973, JAMA-J AM MED ASSOC, V224, P220, DOI 10.1001/jama.224.2.220; MABEY D, 2000, COCHRANE LIB; Munoz B, 1997, EPIDEMIOL REV, V19, P205, DOI 10.1093/oxfordjournals.epirev.a017953; Reacher M H, 1990, Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique, V67, P233; REACHER MH, 1992, ARCH OPHTHALMOL-CHIC, V110, P667, DOI 10.1001/archopht.1992.01080170089030; REACHER MH, 1990, BRIT J OPHTHALMOL, V74, P109, DOI 10.1136/bjo.74.2.109; Schachter J, 1999, LANCET, V354, P630, DOI 10.1016/S0140-6736(98)12387-5; SHUKLA BR, 1966, BRIT J OPHTHALMOL, V50, P218, DOI 10.1136/bjo.50.4.218; TABBARA KF, 1988, INT OPHTHALMOL, V12, P59, DOI 10.1007/BF00133783; Tabbara KF, 1996, OPHTHALMOLOGY, V103, P842; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; WEST S, 1995, LANCET, V345, P155, DOI 10.1016/S0140-6736(95)90167-1; WEST SK, 1991, INT J EPIDEMIOL, V20, P1088, DOI 10.1093/ije/20.4.1088; WOOLRIDGE RL, 1967, AM J OPHTHALMOL, V63, P1577	23	10	10	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2001	323	7306					218	221		10.1136/bmj.323.7306.218	http://dx.doi.org/10.1136/bmj.323.7306.218			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459UQ	11473918	Green Published			2022-12-28	WOS:000170270200023
J	McLeod, A				McLeod, A			Changing patterns of teenage pregnancy: population based study of small areas	BRITISH MEDICAL JOURNAL			English	Article								Objectives To measure the impact of socioeconomic deprivation on rates of teenage pregnancy and the extent of local variation in pregnancy rates in Scotland, and to examine how both have changed over time. Design Population study using routine data from hospital records, aggregated for small areas. Subjects Female teenagers resident in Scotland who were treated for pregnancy in an NHS hospital mi either 1981-5 (62 338 teenagers) or 1991-5 (48 514) and who were aged 13-19 at the time of conception. Main outcome measures Pregnancy rates per 1000 in age group and the proportions of pregnancies resulting in a maternity (live birth or stillbirth) in teenagers aged 13-15, 16-17, and 18-19. Results From the 1980s to the 1990s pregnancy rates increased differentially according to levels of local deprivation, as measured by the Carstairs index. Among teenagers aged less than 18 the annual pregnancy rate increased in the most deprived areas (from 7.0 to 12.5 pregnancies per 1000 13-15 year olds and from 67.6 to 84.6 per 1000 16-17 year olds), but there was no change, on average, among teenagers in the most affluent areas (3.8 per 1000 13-15 year olds and 28.9 per 1000 16-17 year olds). Among 18-19 year olds the pregnancy rate decreased in the most affluent areas (from 60.0 to 46.3 per 1000) and increased in the most deprived areas (from 112.4 to 116.0 per 1000). The amount of local variation explained by deprivation more than doubled from the 1980s to the 1990s. The proportion of pregnancies resulting in a maternity was positively associated with level of deprivation, but the effect remained similar over time. Conclusion From the 1980s to the 1990s the difference in rates of teenage pregnancy between more affluent and more deprived areas widened. This has implications for allocating resources to achieve government targets and points to important social processes behind the general increase in the number of teenage pregnancies in Scotland.	Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	McLeod, A (corresponding author), Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland.							Carstairs V., 1991, DEPRIVATION HLTH SCO; Churchill D, 2000, BRIT MED J, V321, P486, DOI 10.1136/bmj.321.7259.486; Coory M, 1998, STAT MED, V17, P2625, DOI 10.1002/(SICI)1097-0258(19981130)17:22<2625::AID-SIM957>3.0.CO;2-4; *DEP HLTH, 1992, HLTH NAT; Diamond I, 1999, J ROY STAT SOC A STA, V162, P273, DOI 10.1111/1467-985X.00135; *INF STAT DIV, 1995, SCOTT HLTH STAT 1995; *INF STAT DIV, 1984, SCOTT HLTH STAT 1984; *ISD, 1998, TEEN PREGN SCOTL 15; Rigsby D C, 1998, J Pediatr Adolesc Gynecol, V11, P115; *SCOTT OFF, 1999, TOW HLTH SCOTL; SMITH T, 1993, BRIT MED J, V306, P1232, DOI 10.1136/bmj.306.6887.1232; *SOC EXCL UN, 1999, TEEN PREGN; StevensSimon C, 1996, J ADOLESCENT HEALTH, V19, P48, DOI 10.1016/1054-139X(95)00281-V	13	46	48	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2001	323	7306					199	203		10.1136/bmj.323.7306.199	http://dx.doi.org/10.1136/bmj.323.7306.199			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459UQ	11473910	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000170270200017
J	Brooks, CL; Onuchic, JN; Wales, DJ				Brooks, CL; Onuchic, JN; Wales, DJ			Statistical thermodynamics - Taking a walk on a landscape	SCIENCE			English	Editorial Material							TRANSITION-STATE; KINETICS; LIQUIDS; MECHANISMS; PROTEINS; GLASSES		Scripps Res Inst, Dept Mol Biol, Glebe, NSW 2037, Australia; Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of California System; University of California San Diego; University of Cambridge	Brooks, CL (corresponding author), Scripps Res Inst, Dept Mol Biol, Glebe, NSW 2037, Australia.	brooks@scripps.edu						ANGELL CA, 1995, SCIENCE, V267, P1924, DOI 10.1126/science.267.5206.1924; Becker OM, 1997, J CHEM PHYS, V106, P1495, DOI 10.1063/1.473299; BERRY RS, 1987, NATO ASI SER B, V158, P185; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Dugourd P, 1997, CHEM PHYS LETT, V267, P186, DOI 10.1016/S0009-2614(97)00062-6; Eaton WA, 2000, ANNU REV BIOPH BIOM, V29, P327, DOI 10.1146/annurev.biophys.29.1.327; Finke JM, 2000, BIOCHEMISTRY-US, V39, P15633, DOI 10.1021/bi001307d; Gruebele M, 1999, ANNU REV PHYS CHEM, V50, P485, DOI 10.1146/annurev.physchem.50.1.485; Hardin C, 2000, P NATL ACAD SCI USA, V97, P14235, DOI 10.1073/pnas.230432197; Hirst JD, 1999, PROTEIN ENG, V12, P721, DOI 10.1093/protein/12.9.721; Hummer G, 2001, PROTEINS, V42, P77, DOI 10.1002/1097-0134(20010101)42:1<77::AID-PROT80>3.3.CO;2-R; Klimov DK, 2000, P NATL ACAD SCI USA, V97, P2544, DOI 10.1073/pnas.97.6.2544; Kono H, 2001, J MOL BIOL, V306, P607, DOI 10.1006/jmbi.2000.4422; Lacroix E, 1999, CURR OPIN STRUC BIOL, V9, P487, DOI 10.1016/S0959-440X(99)80069-4; Pillardy A, 2001, P NATL ACAD SCI USA, V98, P2329, DOI 10.1073/pnas.041609598; Sastry S, 1998, NATURE, V393, P554, DOI 10.1038/31146; Sciortino F, 2000, J PHYS-CONDENS MAT, V12, P6525, DOI 10.1088/0953-8984/12/29/324; Shea JE, 2000, J CHEM PHYS, V113, P7663, DOI 10.1063/1.1313792; Shea JE, 2001, ANNU REV PHYS CHEM, V52, P499, DOI 10.1146/annurev.physchem.52.1.499; Shimada J, 2001, J MOL BIOL, V308, P79, DOI 10.1006/jmbi.2001.4586; Shirts M, 2000, SCIENCE, V290, P1903, DOI 10.1126/science.290.5498.1903; Skolnick J, 2000, NAT BIOTECHNOL, V18, P283, DOI 10.1038/73723; STILLINGER FH, 1995, SCIENCE, V267, P1935, DOI 10.1126/science.267.5206.1935; Wales DJ, 2000, ADV CHEM PHYS, V115, P1, DOI 10.1002/9780470141748.ch1; Wong KB, 2000, J MOL BIOL, V296, P1257, DOI 10.1006/jmbi.2000.3523; Xia XY, 2000, P NATL ACAD SCI USA, V97, P2990, DOI 10.1073/pnas.97.7.2990	27	154	156	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2001	293	5530					612	613		10.1126/science.1062559	http://dx.doi.org/10.1126/science.1062559			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474087				2022-12-28	WOS:000170204600029
J	Sanderson, SL; Cheer, AY; Goodrich, JS; Graziano, JD; Callan, WT				Sanderson, SL; Cheer, AY; Goodrich, JS; Graziano, JD; Callan, WT			Crossflow filtration in suspension-feeding fishes	NATURE			English	Article							FLOW MICROFILTRATION; MEMBRANE FILTRATION; PARTICLE RETENTION; PERMEATE FLUX; MECHANISMS; FILTER; ULTRAFILTRATION; DEPOSITION; TRANSPORT; MIGRATION	Rows of comb-like or tufted gill rakers in the oral cavity of suspension-feeding fishes (for example, herring, anchovies and tilapia) have been thought to serve as (1) non-porous barriers that direct particle-laden water to the sticky oral roof, where particles are retained as water exits from the oral cavity, (2) conventional dead-end filters that sieve particles from water exiting between rakers, or (3) sticky filters that retain particles encountered by a hydrosol filtration mechanism(1-6). Here we present data from computational fluid dynamics and video endoscopy in suspension-feeding fish indicating that the rakers of three distantly related species function instead as a crossflow filter(7,8.) Particles are concentrated inside the oral cavity as filtrate exits between the rakers, but particles are not retained on the rakers. Instead, the high-velocity crossflow along the rakers carries particles away from the raker surfaces and transports the particles towards the oesophagus. This crossflow prevents particles from clogging the gaps between the rakers, and solves the mystery of particle transport from the rakers to the oesophagus.	Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA; Univ Calif Davis, Dept Math, Davis, CA 95616 USA; Univ Calif Davis, Inst Theoret Dynam, Davis, CA 95616 USA	William & Mary; University of California System; University of California Davis; University of California System; University of California Davis	Sanderson, SL (corresponding author), Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA.	slsand@wm.edu						BELFORT G, 1994, J MEMBRANE SCI, V96, P1, DOI 10.1016/0376-7388(94)00119-7; BOWEN WR, 1995, ADV COLLOID INTERFAC, V56, P141, DOI 10.1016/0001-8686(94)00232-2; CHEER AYL, 1987, J THEOR BIOL, V129, P17, DOI 10.1016/S0022-5193(87)80201-1; Chellam S, 1997, ENVIRON SCI TECHNOL, V31, P819, DOI 10.1021/es9605228; Cheryan M, 1998, ULTRAFILTRATION MICR; DREW DA, 1991, CHEM ENG SCI, V46, P3219, DOI 10.1016/0009-2509(91)85023-Q; Gerking SD., 2014, FEEDING ECOLOGY FISH; GIBSON RN, 1988, J FISH BIOL, V32, P949, DOI 10.1111/j.1095-8649.1988.tb05438.x; Goodrich JS, 2000, J FISH BIOL, V56, P858; GREEN G, 1980, DESALINATION, V35, P129, DOI 10.1016/S0011-9164(00)88607-5; HOOGENBOEZEM W, 1991, CAN J FISH AQUAT SCI, V48, P7, DOI 10.1139/f91-002; Kardong K.V., 2009, VERTEBRATES COMP ANA, V6th; Koehl M.A.R., 1995, Symposia of the Society for Experimental Biology, V49, P157; LABARBERA M, 1984, AM ZOOL, V24, P71; LANGELAND A, 1995, J FISH BIOL, V47, P719, DOI 10.1006/jfbi.1995.0174; LAUDER GV, 1980, J EXP BIOL, V88, P49; Li H, 1998, J MEMBRANE SCI, V149, P83, DOI 10.1016/S0376-7388(98)00181-1; MUMMERT JR, 1986, T AM FISH SOC, V115, P522, DOI 10.1577/1548-8659(1986)115<522:EOFSOT>2.0.CO;2; NORTON SF, 1993, J EXP BIOL, V176, P11; PORTER MC, 1972, IND ENG CHEM PROD RD, V11, P234, DOI 10.1021/i360043a002; SANDERSON SL, 1991, SCIENCE, V251, P1346, DOI 10.1126/science.251.4999.1346; SANDERSON SL, 1996, J EXP BIOL, V199, P1743; SANDERSON SL, 1993, FLUID DYNAMICS BIOL, P135; Sethi S, 1997, J MEMBRANE SCI, V136, P191, DOI 10.1016/S0376-7388(97)00168-3; SHIMETA J, 1991, OCEANOGR MAR BIOL, V29, P191; Tardieu E, 1998, J MEMBRANE SCI, V147, P1, DOI 10.1016/S0376-7388(98)00091-X; Vogel S., 1994, LIFE MOVING FLUIDS P; Wiesner MR, 1999, J ENVIRON ENG-ASCE, V125, P1124, DOI 10.1061/(ASCE)0733-9372(1999)125:12(1124); Zeman L. J., 1996, MICROFILTRATION ULTR	29	105	107	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2001	412	6845					439	441		10.1038/35086574	http://dx.doi.org/10.1038/35086574			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473318				2022-12-28	WOS:000170068200048
J	Bardeen, C				Bardeen, C			Electron transfer - Sometimes you can go home again	SCIENCE			English	Editorial Material							DYNAMICS; FEMTOSECOND		Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Bardeen, C (corresponding author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.	bardeen@scs.uiuc.edu						Assel M, 1999, J CHEM PHYS, V111, P6869, DOI 10.1063/1.479979; Baltuska A, 1999, J PHYS CHEM A, V103, P10065, DOI 10.1021/jp992482a; GAUDUEL Y, 1990, J OPT SOC AM B, V7, P1528, DOI 10.1364/JOSAB.7.001528; KEE TW, IN PRESS J PHYS CHEM; Levis RJ, 2001, SCIENCE, V292, P709, DOI 10.1126/science.1059133; LU H, 1990, J OPT SOC AM B, V7, P1511, DOI 10.1364/JOSAB.7.001511; Lukas AS, 2000, J PHYS CHEM B, V104, P931, DOI 10.1021/jp993774e; Martini IB, 2001, SCIENCE, V293, P462, DOI 10.1126/science.1061612; Peon J, 1999, J PHYS CHEM A, V103, P2460, DOI 10.1021/jp9840782; ROSSKY PJ, 1994, NATURE, V370, P263, DOI 10.1038/370263a0; SON DH, IN PRESS CHEM PHYS L; Vilchiz VH, 2001, J PHYS CHEM A, V105, P1711, DOI 10.1021/jp003974m	12	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2001	293	5529					444	445		10.1126/science.1063373	http://dx.doi.org/10.1126/science.1063373			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463903				2022-12-28	WOS:000169966700033
J	Gachet, Y; Tournier, S; Millar, JBA; Hyams, JS				Gachet, Y; Tournier, S; Millar, JBA; Hyams, JS			A MAP kinase-dependent actin checkpoint ensures proper spindle orientation in fission yeast	NATURE			English	Article							ANAPHASE-PROMOTING COMPLEX; ATF1 TRANSCRIPTION FACTOR; ASYMMETRIC CELL-DIVISION; SCHIZOSACCHAROMYCES-POMBE; BIPOLAR SPINDLE; PROTEIN-KINASE; CYCLE; PROTEOLYSIS; PATHWAY; LOCALIZATION	The accurate segregation of chromosomes at mitosis depends on a correctly assembled bipolar spindle that exerts balanced forces on each sister chromatid(1,2). The integrity of mitotic chromosome segregation is ensured by the spindle assembly checkpoint (SAC) that delays mitosis in response to defective spindle organisation or failure of chromosome attachment(2,3). Here we describe a distinct mitotic checkpoint in the fission yeast, Schizosaccharomyces pombe, that monitors the integrity of the actin cytoskeleton and delays sister chromatid separation, spindle elongation and cytokinesis until spindle poles have been properly oriented. This mitotic delay is imposed by a stress-activated mitogen-activated protein (MAP) kinase pathway but is independent of the anaphase-promoting complex (APC)(4,5).	Natl Inst Med Res, Div Yeast Genet, London NW7 1AA, England; UCL, Dept Biol, London WC1E 6B, England	MRC National Institute for Medical Research; University of London; University College London	Millar, JBA (corresponding author), Natl Inst Med Res, Div Yeast Genet, Ridgeway,Mill Hill, London NW7 1AA, England.	jmillar@nimr.mrc.ac.uk	Gachet, Yannick/AAK-5363-2021	Millar, Jonathan/0000-0002-9930-3989	Medical Research Council [MC_U117531948] Funding Source: Medline; MRC [MC_U117531948] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALFA CE, 1990, NATURE, V347, P680, DOI 10.1038/347680a0; Amon A, 1999, CURR OPIN GENET DEV, V9, P69, DOI 10.1016/S0959-437X(99)80010-0; BIRKENBIHL RP, 1995, J BIOL CHEM, V270, P7703, DOI 10.1074/jbc.270.13.7703; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; Hagan IM, 1996, CELL MOTIL CYTOSKEL, V34, P69; Hardwick KG, 1999, GENETICS, V152, P509; He XW, 1997, P NATL ACAD SCI USA, V94, P7965, DOI 10.1073/pnas.94.15.7965; Ishiguro J, 1996, FEBS LETT, V392, P237, DOI 10.1016/0014-5793(96)00819-8; Knoblich JA, 1997, CURR OPIN CELL BIOL, V9, P833, DOI 10.1016/S0955-0674(97)80085-3; Lu BW, 1998, CURR OPIN GENET DEV, V8, P392, DOI 10.1016/S0959-437X(98)80108-1; Mallavarapu A, 1999, CURR BIOL, V9, P1423, DOI 10.1016/S0960-9822(00)80090-1; MARKS J, 1985, EUR J CELL BIOL, V39, P27; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; OHKURA H, 1995, GENE DEV, V9, P1059, DOI 10.1101/gad.9.9.1059; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Tanaka K, 2001, EMBO J, V20, P1259, DOI 10.1093/emboj/20.6.1259; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; YAMASHITA M, 1991, DEV GROWTH DIFFER, V33, P617; Yanagida M, 1999, PHILOS T R SOC B, V354, P1559, DOI 10.1098/rstb.1999.0499; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039	28	135	139	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					352	355		10.1038/35085604	http://dx.doi.org/10.1038/35085604			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460168				2022-12-28	WOS:000169918200051
J	Fearon, DT; Manders, P; Wagner, SD				Fearon, DT; Manders, P; Wagner, SD			Arrested differentiation, the self-renewing memory lymphocyte, and vaccination	SCIENCE			English	Editorial Material							GERMINAL-CENTER FORMATION; CD8(+) T-CELLS; TRANSCRIPTIONAL REPRESSOR; BCL-6; INFLAMMATION; INDUCTION; PERSISTENCE; EXHAUSTION; MATURATION; MELANOMA	Vaccination for persistent viral or bacterial infections must program the immune system for a Lifelong need to generate antigen-specific effector Lymphocytes. Wow file immune system does this is not known, but recent studies have shown that a subset of B Lymphocytes, the germinal center B cell, is capable of self-renewal because it expresses a transcriptional repressor, BCL6, that blocks terminal differentiation. If a similar mechanism for arresting differentiation exists for long-lived, antigen-selected Lymphocytes, a stem cell-like capacity for serf-renewal could be the basis for the continual generation of effector Lymphocytes from the memory pool. Understanding how to regulate the terminal differentiation of lymphocytes will improve immunotherapeutic approaches for chronic infectious diseases and cancer.	Univ Cambridge, MRC Ctr, Sch Clin Med, Wellcome Trust Immunol Unit, Cambridge CB2 2SP, England; Addenbrookes Hosp, Dept Haematol, Cambridge CB2 2SP, England	MRC Laboratory Molecular Biology; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Fearon, DT (corresponding author), Univ Cambridge, MRC Ctr, Sch Clin Med, Wellcome Trust Immunol Unit, Cambridge CB2 2SP, England.			Wagner, Simon/0000-0002-8914-0370				Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; AZUMA M, 1993, J IMMUNOL, V150, P1147; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; DEWEINDT C, 1995, CELL GROWTH DIFFER, V6, P1495; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; MILSTEIN C, 1991, IMMUNOL TODAY, V12, P93, DOI 10.1016/0167-5699(91)90164-O; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Okabe S, 1998, MOL CELL BIOL, V18, P4235, DOI 10.1128/MCB.18.7.4235; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; Sale JE, 2001, PHILOS T R SOC B, V356, P21, DOI 10.1098/rstb.2000.0744; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schneider J, 1999, IMMUNOL REV, V170, P29, DOI 10.1111/j.1600-065X.1999.tb01326.x; Seyfert VL, 1996, ONCOGENE, V12, P2331; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shimizu J, 1999, J IMMUNOL, V163, P5211; Spiegel HML, 2000, J VIROL, V74, P1018, DOI 10.1128/JVI.74.2.1018-1022.2000; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Wagner S, UNPUB; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Yee C, 2000, J EXP MED, V192, P1637, DOI 10.1084/jem.192.11.1637; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	32	209	225	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					248	250		10.1126/science.1062589	http://dx.doi.org/10.1126/science.1062589			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452114				2022-12-28	WOS:000169875200044
J	Lu, QX; Lemke, G				Lu, QX; Lemke, G			Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family	SCIENCE			English	Article							EXPRESSION ANALYSIS; PROTEIN-S; C-MER; LIGANDS; AXL; ANTIBODIES; SELECTION; CLONING; GAS6	Receptor tyrosine kinases and their Ligands mediate cell-cell communication and interaction in many organ systems, but have not been known to actin this capacity in the mature immune system. We now provide genetic evidence that three closely related receptor tyrosine kinases, Tyro 3, Axl, and Mer, play an essential immunoregulatory role. Mutant mice that lack these receptors develop a severe Lymphoproliferative disorder accompanied by broad-spectrum autoimmunity. These phenotypes are cell nonautonomous with respect to Lymphocytes and result from the hyperactivation of antigen-presenting cells in which the three receptors are normally expressed.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Lemke, G (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.							Bokarewa MI, 1997, SEMIN HEMATOL, V34, P235; Camenisch TD, 1999, J IMMUNOL, V162, P3498; Daeron M, 1999, CURR TOP MICROBIOL, V244, P1; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; GODOWSKI PJ, 1995, CELL, V82, P355, DOI 10.1016/0092-8674(95)90424-7; GRAHAM DK, 1994, CELL GROWTH DIFFER, V5, P647; GRAHAM DK, 1995, ONCOGENE, V10, P2349; GREVES M, 1999, HAEMATOLOGICA, V84, P32; Hahn BH, 1997, DUBOIS LUPUS ERYTHEM, P69; HESS DC, 1993, J RHEUMATOL, V20, P610; LAI C, 1994, ONCOGENE, V9, P2567; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; LU Q, UNPUB; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.immunol.10.1.295; NEUBAUER A, 1994, BLOOD, V84, P1931; Neubauer A, 1997, LEUKEMIA LYMPHOMA, V25, P91, DOI 10.3109/10428199709042499; Nousari HC, 1999, LANCET, V354, P667, DOI 10.1016/S0140-6736(99)03007-X; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; STUART JM, 1984, ANNU REV IMMUNOL, V2, P199, DOI 10.1146/annurev.iy.02.040184.001215	25	506	554	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					306	311		10.1126/science.1061663	http://dx.doi.org/10.1126/science.1061663			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452127				2022-12-28	WOS:000169875200061
J	Waelti, P; Dickinson, A; Schultz, W				Waelti, P; Dickinson, A; Schultz, W			Dopamine responses comply with basic assumptions of formal learning theory	NATURE			English	Article							LONG-TERM DEPRESSION; RAT PREFRONTAL CORTEX; BEHAVIORAL REACTIONS; CONDITIONED-STIMULI; MONKEY MIDBRAIN; NEURONS; REWARD; PREDICTION; MECHANISMS; MODEL	According to contemporary learning theories, the discrepancy, or error, between the actual and predicted reward determines whether learning occurs when a stimulus is paired with a reward. The role of prediction errors is directly demonstrated by the observation that learning is blocked when the stimulus is paired with a fully predicted reward. By using this blocking procedure, we show that the responses of dopamine neurons to conditioned stimuli was governed differentially by the occurrence of reward prediction errors rather than stimulus-reward associations alone, as was the learning of behavioural reactions. Both behavioural and neuronal learning occurred predominantly when dopamine neurons registered a reward prediction error at the time of the reward. Our data indicate that the use of analytical tests derived from formal behavioural learning theory provides a powerful approach for studying the role of single neurons in learning.	Univ Fribourg, Inst Physiol, CH-1700 Fribourg, Switzerland; Univ Fribourg, Program Neurosci, CH-1700 Fribourg, Switzerland; Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Fribourg; University of Fribourg; University of Cambridge	Schultz, W (corresponding author), Univ Fribourg, Inst Physiol, CH-1700 Fribourg, Switzerland.		schultz, wolfram/H-8958-2016	schultz, wolfram/0000-0002-8530-4518				CALABRESI P, 1992, J NEUROSCI, V12, P4224; Calabresi P, 1997, J NEUROSCI, V17, P4536; Centonze D, 1999, J NEUROPHYSIOL, V82, P3575, DOI 10.1152/jn.1999.82.6.3575; Dickinson A, 2001, Q J EXP PSYCHOL-B, V54, P3, DOI 10.1080/02724990042000010; Dickinson A., 1980, CONT ANIMAL LEARNING; FRISTON KJ, 1994, NEUROSCIENCE, V59, P229, DOI 10.1016/0306-4522(94)90592-4; GARCIAMUNOZ M, 1992, NEUROREPORT, V3, P357, DOI 10.1097/00001756-199204000-00017; Holland PC, 1997, ANIM LEARN BEHAV, V25, P373, DOI 10.3758/BF03209846; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Houk JC, 1995, MODELS INFORMATION P, P249; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Kalman R.E., 1960, T ASME J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Kamin L. J., 1969, FUNDAMENTAL ISSUES A, P42; KAWATO M, 1992, TRENDS NEUROSCI, V15, P445, DOI 10.1016/0166-2236(92)90008-V; Kim JJ, 1998, SCIENCE, V279, P570, DOI 10.1126/science.279.5350.570; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Mackintosh N. J, 1983, CONDITIONING ASS LEA; MACKINTOSH NJ, 1975, PSYCHOL REV, V82, P276, DOI 10.1037/h0076778; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MARTIN I, 1991, Q J EXP PSYCHOL-B, V43, P233; MINSKY M, 1961, P IRE, V49, P8, DOI 10.1109/JRPROC.1961.287775; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Otani S, 1998, NEUROSCIENCE, V85, P669, DOI 10.1016/S0306-4522(97)00677-5; Otani S, 1999, J NEUROSCI, V19, P9788; Pavlov IP, 1927, CONDITIONAL REFLEXES; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Rauhut AS, 1999, J EXP PSYCHOL ANIM B, V25, P45, DOI 10.1037/0097-7403.25.1.45; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; ROMO R, 1990, J NEUROPHYSIOL, V63, P592, DOI 10.1152/jn.1990.63.3.592; SALAMONE JD, 1994, BEHAV BRAIN RES, V61, P117, DOI 10.1016/0166-4328(94)90153-8; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHULTZ W, 1990, J NEUROPHYSIOL, V63, P607, DOI 10.1152/jn.1990.63.3.607; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SCHULTZ W, 1987, J NEUROPHYSIOL, V57, P201, DOI 10.1152/jn.1987.57.1.201; Suri RE, 1999, NEUROSCIENCE, V91, P871, DOI 10.1016/S0306-4522(98)00697-6; Sutton R.S., 1990, LEARNING COMPUTATION, P497; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; THOMPSON RF, 1991, PERSPECTIVES COGNITI, P25; Thorndike EL., 1911, ANIMAL INTELLIGENCE, DOI DOI 10.4324/9781351321044; Wickens JR, 1996, NEUROSCIENCE, V70, P1, DOI 10.1016/0306-4522(95)00436-M; WIDROW G, 1985, ADAPTIVE SIGNAL PROC; WIDROW G, 1960, I RADIO ENG W ELEC 4, P96; WISE RA, 1992, SYNAPSE, V10, P247, DOI 10.1002/syn.890100307; [No title captured]	50	693	701	2	55	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					43	48		10.1038/35083500	http://dx.doi.org/10.1038/35083500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	448TB	11452299	Green Submitted			2022-12-28	WOS:000169644900036
J	Patrick, GN; Zukerbert, L; Nikolic, M; de la Monte, S; Dikkes, P; Tsai, LH				Patrick, GN; Zukerbert, L; Nikolic, M; de la Monte, S; Dikkes, P; Tsai, LH			Neurobiology - p25 protein in neurodegeneration - Reply	NATURE			English	Editorial Material							DISEASE		Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Univ London Kings Coll, Mol Neurobiol Grp, London SE1 9RT, England; Rhode Isl Hosp, Providence, RI 02903 USA; Brown Univ, Sch Med, Providence, RI 02903 USA; Childrens Hosp, Dept Neurol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of London; King's College London; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Harvard University; Boston Children's Hospital	Patrick, GN (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 200 Longwood Ave, Boston, MA 02115 USA.		de la monte, suzanne/L-7670-2019	de la monte, suzanne/0000-0001-5886-2306				Grynspan F, 1997, BRAIN RES, V763, P145, DOI 10.1016/S0006-8993(97)00384-3; Lee KY, 1999, NEUROSCI RES, V34, P21, DOI 10.1016/S0168-0102(99)00026-7; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159	4	17	18	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					764	765		10.1038/35081149	http://dx.doi.org/10.1038/35081149			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11460109				2022-12-28	WOS:000169246400035
J	de Gennes, PG				de Gennes, PG			Ultradivided matter	NATURE			English	Editorial Material									Ecole Super Phys & Chim Ind, F-75231 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	de Gennes, PG (corresponding author), Ecole Super Phys & Chim Ind, 10 Rue Vauquelin, F-75231 Paris 05, France.							CABANE B, 2001, COLLECTION ECOLE PHY; ISRAELASHVILI J, 1985, INTERMOLECULAR SURFA; Morawetz H., 1985, POLYM ORIGIN GROWTH; 2001, P 1 LAV SEM COLL EC	4	24	24	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					385	385		10.1038/35086662	http://dx.doi.org/10.1038/35086662			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473291				2022-12-28	WOS:000170068200023
J	Erickson, GM; Rogers, KC; Yerby, SA				Erickson, GM; Rogers, KC; Yerby, SA			Dinosaurian growth patterns and rapid avian growth rates	NATURE			English	Article							HISTOLOGY; BIRDS	Did dinosaurs grow in a manner similar to extant reptiles, mammals or birds, or were they unique(1)? Are rapid avian growth rates an innovation unique to birds, or were they inherited from dinosaurian precursors(2)? We quantified growth rates for a group of dinosaurs spanning the phylogenetic and size diversity for the clade and used regression analysis to characterize the results. Here we show that dinosaurs exhibited sigmoidal growth curves similar to those of other vertebrates, but had unique growth rates with respect to body mass. All dinosaurs grew at accelerated rates relative to the primitive condition seen in extant reptiles. Small dinosaurs grew at moderately rapid rates, similar to those of marsupials, but large species attained rates comparable to those of eutherian mammals and precocial birds. Growth in giant sauropods was similar to that of whales of comparable size. Non-avian dinosaurs did not attain rates like those of altricial birds. Avian growth rates were attained in a stepwise fashion after birds diverged from theropod ancestors in the Jurassic period.	Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; Florida State Univ, Coll Med, Tallahassee, FL 32306 USA; Sci Museum Minnesota, St Paul, MN 55102 USA; Macalester Coll, St Paul, MN 55102 USA; Stanford Univ, Dept Biomech Engn, Stanford, CA 94305 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; Macalester College; Stanford University	Erickson, GM (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.							ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; APPENZELLER T, 1994, SCIENCE, V266, P1805, DOI 10.1126/science.266.5192.1805; Bakker RT., 1986, DINOSAUR HERESIES; Calder WA., 1984, SIZE FUNCTION LIFE H; CASE TJ, 1978, PALEOBIOLOGY, V4, P320, DOI 10.1017/S0094837300006023; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; CASTANET J, 1990, ANN SCI NAT ZOOL, V11, P191; Castanet J, 2000, CR ACAD SCI III-VIE, V323, P543, DOI 10.1016/S0764-4469(00)00181-5; Chiappe LM, 1998, NATURE, V392, P275, DOI 10.1038/32642; CHINSAMY A, 1994, NATURE, V368, P196, DOI 10.1038/368196a0; CHINSAMY A, 1990, Palaeontologia Africana, V27, P77; Chinsamy Anusuya, 1993, Modern Geology, V18, P319; Curry KA, 1999, J VERTEBR PALEONTOL, V19, P654, DOI 10.1080/02724634.1999.10011179; DERICQLES A, 1983, COLD LOOK WARM BLOOD, P103; DERICQLES A, 1990, MOD GEOL, V15, P19; Erickson GM, 2000, ZOOL J LINN SOC-LOND, V130, P551, DOI 10.1006/zjls.2000.0243; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; NORELL MA, IN PRESS SPECIAL PUB; Reid R.E.H., 1997, P449; RICQLES A, 1991, BONE MATRIX BONE SPE, V3, P1; Rimblot-Baly Frederique, 1995, Annales de Paleontologie, V81, P49; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Seebacher F, 2001, J VERTEBR PALEONTOL, V21, P51, DOI 10.1671/0272-4634(2001)021[0051:ANMTCA]2.0.CO;2; Sussman M., 1964, GROWTH DEV; Thompson D.W., 1943, GROWTH FORM; Varricchio D. J., 1997, ENCY DINOSAURS, P282, DOI DOI 10.1016/J.CUB.2016.10.043; Varricchio David J., 1993, Journal of Vertebrate Paleontology, V13, P99; WELLS JW, 1963, NATURE, V197, P948, DOI 10.1038/197948a0; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056	29	194	200	0	69	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					429	433		10.1038/35086558	http://dx.doi.org/10.1038/35086558			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473315				2022-12-28	WOS:000170068200045
J	Gill, JA; Norris, K; Potts, PM; Gunnarsson, TG; Atkinson, PW; Sutherland, WJ				Gill, JA; Norris, K; Potts, PM; Gunnarsson, TG; Atkinson, PW; Sutherland, WJ			The buffer effect and large-scale population regulation in migratory birds	NATURE			English	Article							CONSEQUENCES; NUMBERS; COMPETITION; FECUNDITY; ARRIVAL	Buffer effects occur when sites vary in quality and fluctuations in population size are mirrored by large changes in animal numbers in poor-quality sites but only small changes in good-quality sites. Hence, the poor sites `buffer' the good sites(1,2,) a mechanism that can potentially drive population regulation if there are demographic costs of inhabiting poor sites. Here we show that for a migratory bird this process can apply on a country-wide scale with consequences for both survival and timing of arrival on the breeding grounds (an indicator of reproductive success(3,4)). The Icelandic population of the black-tailed godwit, Limosa limosa islandica, wintering in Britain has increased fourfold since the 1970s (ref. 5) but rates of change within individual estuaries have varied from zero to sixfold increases. In accordance with the buffer effect, rates of increase are greater on estuaries with low initial numbers, and godwits on these sites have lower prey-intake rates, lower survival rates and arrive later in Iceland than godwits on sites with stable populations. The buffer effect can therefore be a major process influencing large-scale population regulation of migratory species.	Univ E Anglia, Sch Biol Sci, Tyndall Ctr, Norwich NR4 7TJ, Norfolk, England; Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England; Univ Iceland, Inst Biol, IS-108 Reykjavik, Iceland; Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England; British Trust Ornithol, Thetford IP24 2PU, England	University of East Anglia; University of Reading; University of Iceland; University of East Anglia; British Trust for Ornithology	Gill, JA (corresponding author), Univ E Anglia, Sch Biol Sci, Tyndall Ctr, Norwich NR4 7TJ, Norfolk, England.	j.gill@uea.ac.uk	Gunnarsson, Tomas G/L-9783-2015; Gill, Jennifer A/A-7759-2008; Sutherland, William/B-1291-2013; Atkinson, Philip/B-8975-2009	Sutherland, William/0000-0002-6498-0437; Gunnarsson, Tomas Gretar/0000-0001-7692-0637; Atkinson, Philip/0000-0002-0838-557X				BROWN JL, 1969, AM NAT, V103, P347, DOI 10.1086/282607; Currie D, 2000, IBIS, V142, P389, DOI 10.1111/j.1474-919X.2000.tb04435.x; Ferrer M, 1996, ECOLOGY, V77, P69, DOI 10.2307/2265655; FRASER DF, 1980, ECOLOGY, V61, P790, DOI 10.2307/1936749; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gill JA, 2001, P ROY SOC B-BIOL SCI, V268, P369, DOI 10.1098/rspb.2000.1386; GOSSCUSTARD JD, 1980, ARDEA, V68, P31; HALAMA KJ, 1994, OIKOS, V69, P107, DOI 10.2307/3545289; KAY DG, 1975, J MAR BIOL ASSOC UK, V55, P811, DOI 10.1017/S0025315400017732; KLUYVER H. N., 1953, ARCH NEERLAND ZOOL, V10, P265; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; KREBS JR, 1970, J ZOOL, V162, P317; Lepage D, 2000, J ANIM ECOL, V69, P414, DOI 10.1046/j.1365-2656.2000.00404.x; MOLLER AP, 1994, BEHAV ECOL SOCIOBIOL, V35, P115, DOI 10.1007/BF00171501; MOSER ME, 1988, J APPL ECOL, V25, P473, DOI 10.2307/2403838; POLLITT MS, 2000, WETLAND BIRD SURVEY; Sandercock BK, 1999, J AVIAN BIOL, V30, P460, DOI 10.2307/3677018; Sutherland W.J., 1996, INDIVIDUAL BEHAV POP; UNDERHILL LG, 1994, J APPL ECOL, V31, P463, DOI 10.2307/2404443; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239	20	237	248	1	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2001	412	6845					436	438		10.1038/35086568	http://dx.doi.org/10.1038/35086568			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473317				2022-12-28	WOS:000170068200047
J	Knight, J				Knight, J			US rejects bioweapon inspections	NATURE			English	News Item																			0	1	2	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					365	365		10.1038/35086726	http://dx.doi.org/10.1038/35086726			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473272	Bronze			2022-12-28	WOS:000170068200007
J	Brugha, R; Walt, G				Brugha, R; Walt, G			A global health fund: a leap of faith?	BRITISH MEDICAL JOURNAL			English	Article									Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Policy Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Brugha, R (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Policy Unit, London WC1E 7HT, England.		Brugha, Ruairi/C-8420-2012	Brugha, Ruairi/0000-0003-0729-0197				Buse K, 2000, B WORLD HEALTH ORGAN, V78, P699; Cassels A, 1998, LANCET, V352, P1777, DOI 10.1016/S0140-6736(98)05350-1; Hardon A., 2001, HAI EUROPE, V6; *MIN FOR AFF JAP, 2000, G8 COMM OK; *PERF INN UN, 2001, TACKL DIS POV M OK M, P46; *PERF INN UN, 2001, TACKL DIS POV M OK M, P25; SACHS J, 2001, OFF HLTH EC 8 ANN LE; Shretta R, 2001, HEALTH POLICY PLANN, V16, P161, DOI 10.1093/heapol/16.2.161; Smith E, 2001, WORKING PRIVATE SECT; 2001, DEV TODAY, V11	10	39	39	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2001	323	7305					152	154		10.1136/bmj.323.7305.152	http://dx.doi.org/10.1136/bmj.323.7305.152			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456WR	11463689	Green Published, Green Accepted			2022-12-28	WOS:000170106200023
J	Kemmeren, JM; Algra, A; Grobbee, DE				Kemmeren, JM; Algra, A; Grobbee, DE			Third generation oral contraceptives and risk of venous thrombosis: meta-analysis	BRITISH MEDICAL JOURNAL			English	Article							DEEP-VEIN THROMBOSIS; THROMBOEMBOLIC DISEASE; MEDIPLUS DATABASE; USERS; IMPACT; PROGESTAGEN; MUTATION; TRIALS	Objective To evaluate quantitatively articles that compared effects of second and third generation oral contraceptives on risk of venous thrombosis. Design Meta-analysis. Studies Cohort and case-control studies assessing risk of venous thromboembolism among women using oral contraceptives before October 1995. Main outcome measures Pooled adjusted odds ratios calculated by a general variance based random effects method. When possible, two tay two tables were extracted and combined by the Mantel-Haenszel method. Results The overall adjusted odds ratio for third versus second generation oral contraceptives was 1.7 (95%, confidence interval 1.4 to 2.0; seven studies). Similar-risks were found when oral contraceptives containing desogestrel or gestodene were compared with those containing levonorgestrel. Among first time users, the odds ratio for third versus second generation preparations was 3.1 (2.0 to 4.6; four studies). The odds ratio was 2.5 (1.6 to 4.1; five studies) for short term users compared with 2.0 (1.4 to 2.'7; five studies) for longer term users. The odds ratio was 1.3 (1.0 to 1.7) in studies funded by the pharmaceutical industry and 2.3 (1.7 to 3.2) in other studies. Differences in age and certainty of diagnosis of venous thrombosis did not affect the results. Conclusions This meta-analysis supports the view that third generation oral contraceptives are associated with an increased risk of venous thrombosis compared with secund generation oral contraceptives. The increase cannot be explained by several potential biases.	Univ Med Ctr Utrecht, Julius Ctr Gen Practice & Patient Oriented Res, NL-3508 GA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Algra, A (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Gen Practice & Patient Oriented Res, POB 85500, NL-3508 GA Utrecht, Netherlands.		Grobbee, Diederick/C-7651-2014	Grobbee, Diederick/0000-0003-4472-4468				Andersen BS, 1998, THROMB HAEMOSTASIS, V79, P28, DOI 10.1055/s-0037-1614213; Bennet L, 1998, J INTERN MED, V244, P27, DOI 10.1046/j.1365-2796.1998.00310.x; Bloemenkamp KWM, 1999, ARCH INTERN MED, V159, P65, DOI 10.1001/archinte.159.1.65; BLOEMENKAMP KWM, 1995, LANCET, V346, P1593, DOI 10.1016/S0140-6736(95)91929-5; Farley TMM, 1999, HUM REPROD UPDATE, V5, P721, DOI 10.1093/humupd/5.6.721; Farley TMM, 1996, CONTRACEPTION, V54, P193, DOI 10.1016/S0010-7824(96)00166-7; FARLEY TMM, 1995, LANCET, V346, P1582; Farmer RDT, 2000, BRIT J CLIN PHARMACO, V49, P580, DOI 10.1046/j.1365-2125.2000.00198.x; Farmer RDT, 1999, HUM REPROD UPDATE, V5, P688, DOI 10.1093/humupd/5.6.688; Farmer RDT, 1997, LANCET, V349, P83, DOI 10.1016/S0140-6736(96)07496-X; Farmer RDT, 1998, CONTRACEPTION, V57, P67, DOI 10.1016/S0010-7824(98)00002-X; Grobbee DE, 1997, BRIT MED J, V315, P1151; Herings RMC, 1999, LANCET, V354, P127, DOI 10.1016/S0140-6736(99)01257-X; Jamin C, 1996, CONTRACEPTION, V54, P55, DOI 10.1016/0010-7824(96)00120-5; Jick H, 2000, BMJ-BRIT MED J, V321, P1190, DOI 10.1136/bmj.321.7270.1190; JICK H, 1995, LANCET, V346, P1589, DOI 10.1016/S0140-6736(95)91928-7; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Lewis MA, 1999, HUM REPROD, V14, P1493, DOI 10.1093/humrep/14.6.1493; Lidegaard O, 1998, CONTRACEPTION, V57, P291, DOI 10.1016/S0010-7824(98)00033-X; Lidegaard O, 1996, CONTRACEPTION, V53, P135, DOI 10.1016/0010-7824(96)00035-2; Lidegaard O, 1997, ACTA OBSTET GYN SCAN, V76, P252; Martinelli I, 1999, ARTERIOSCL THROM VAS, V19, P700, DOI 10.1161/01.ATV.19.3.700; PETITTI DB, 1994, METAANALYSIS DECISIO, P106; POULTER NR, 1995, LANCET, V346, P1575; ROCHON PA, 1994, ARCH INTERN MED, V154, P157, DOI 10.1001/archinte.154.2.157; Spitzer WO, 1996, BRIT MED J, V312, P83; Spitzer WO, 1999, HUM REPROD UPDATE, V5, P736, DOI 10.1093/humupd/5.6.736; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; Suissa S, 2000, HUM REPROD, V15, P817, DOI 10.1093/humrep/15.4.817; Suissa S, 1997, CONTRACEPTION, V56, P141, DOI 10.1016/S0010-7824(97)00119-4; Todd JC, 1999, HUM REPROD, V14, P1500, DOI 10.1093/humrep/14.6.1500; van Lunsen H W, 1996, Eur J Contracept Reprod Health Care, V1, P39, DOI 10.3109/13625189609150654; Vandenbroucke JP, 2000, JAMA-J AM MED ASSOC, V283, P1422; Vandenbroucke JP, 1997, AM J OBSTET GYNECOL, V177, P887, DOI 10.1016/S0002-9378(97)70289-8; Vasilakis C, 1999, CONTRACEPTION, V59, P79, DOI 10.1016/S0010-7824(99)00011-6; Walker AM, 1998, CONTRACEPTION, V57, P169, DOI 10.1016/S0010-7824(98)00014-6; Weber W, 2001, LANCET, V357, P779, DOI 10.1016/S0140-6736(05)71212-5	37	258	265	0	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2001	323	7305					131	U13		10.1136/bmj.323.7305.131	http://dx.doi.org/10.1136/bmj.323.7305.131			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456WR	11463678	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000170106200012
J	Hale, P; Makgoba, MW; Merson, MH; Quinn, TC; Richman, DD; Vella, S; Wabwire-Mangen, F; Wain-Hobson, S; Weiss, RA				Hale, P; Makgoba, MW; Merson, MH; Quinn, TC; Richman, DD; Vella, S; Wabwire-Mangen, F; Wain-Hobson, S; Weiss, RA			Success hinges on support for treatment	NATURE			English	Editorial Material									Fac Med Necker Enfants Malad, Inst Necker, F-75015 Paris, France; MRC S Africa, Congella, South Africa; Yale Univ, Sch Med, New Haven, CT 06520 USA; Johns Hopkins Univ, Baltimore, MD USA; Univ Calif San Diego, San Diego, CA 92103 USA; Ist Super Sanita, Int AIDS Soc, I-00161 Rome, Italy; Makerere Univ, Inst Publ Hlth, Kampala, Uganda; Inst Pasteur, Paris, France; UCL, London WC1E 6BT, England	UDICE-French Research Universities; Universite Paris Cite; Yale University; Johns Hopkins University; University of California System; University of California San Diego; Istituto Superiore di Sanita (ISS); Makerere University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of London; University College London	Hale, P (corresponding author), Fac Med Necker Enfants Malad, Inst Necker, 156 Rue Vaugirard, F-75015 Paris, France.		VELLA, STEFANO/ABI-3368-2020; Vella, Stefano/GZM-0519-2022; VELLA, STEFANO/V-8440-2019	VELLA, STEFANO/0000-0003-2347-5984	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000361, Z01AI000361] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					272	272		10.1038/35085656	http://dx.doi.org/10.1038/35085656			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460135	Bronze			2022-12-28	WOS:000169918200020
J	Perrier, A; Howarth, N; Didier, D; Loubeyre, P; Unger, PF; de Moerloose, P; Slosman, D; Junod, A; Bounameaux, H				Perrier, A; Howarth, N; Didier, D; Loubeyre, P; Unger, PF; de Moerloose, P; Slosman, D; Junod, A; Bounameaux, H			Performance of helical computed tomography in unselected outpatients with suspected pulmonary embolism	ANNALS OF INTERNAL MEDICINE			English	Article							DEEP VENOUS THROMBOSIS; VENTILATION-PERFUSION SCINTIGRAPHY; SPIRAL CT; D-DIMER; MEDICAL LITERATURE; VEIN THROMBOSIS; DIAGNOSTIC-TEST; USERS GUIDES; LUNG-SCAN; ANGIOGRAPHY	Background: Helical computed tomography (CT) is commonly used to diagnose pulmonary embolism, although its operating characteristics have been insufficiently evaluated. Objective: To assess the sensitivity and specificity of helical CT in suspected pulmonary embolism. Design: observational study. Setting: Emergency department of a teaching and community hospital. Patients: 299 patients with clinically suspected pulmonary embolism and a plasma D-dimer level greater than 500 mug/L. Intervention: Pulmonary embolism was established by using a validated algorithm that included clinical assessment, lower-limb compression ultrasonography, lung scanning, and pulmonary angiography. Measurements: Sensitivity, specificity, and likelihood ratios of helical CT and interobserver agreement. Helical CT scans were withheld from clinicians and were read 3 months after acquisition by radiologists blinded to all clinical data. Results: 118 patients (39%) had pulmonary embolism, In 12 patients (4%), 2 of whom had pulmonary embolism, results of helical CT were inconclusive, For patients with conclusive results, sensitivity of helical CT was 70% (95% CI, 62% to 78%) and specificity was 91% (CI, 86% to 95%), Interobserver agreement was high (kappa = 0.823 to 0,902). The false-negative rate was lower for helical CT used after initial negative results on ultrasonography than for helical CT alone (21% vs, 30%). Use of helical CT after normal results on initial ultrasonography and nondiagnostic results on lung scanning had a false-negative rate of only 5% and a false-positive rate of only 7%. Conclusion: Helical CT should not be used alone for suspected pulmonary embolism but could replace angiography in combined strategies that include ultrasonography and lung scanning.	Univ Hosp Geneva, Dept Internal Med, Med Clin 1, CH-1211 Geneva 14, Switzerland	University of Geneva	Perrier, A (corresponding author), Univ Hosp Geneva, Dept Internal Med, Med Clin 1, Rue Micheli Du Crest 24, CH-1211 Geneva 14, Switzerland.	Arnaud.Perrier@medecine.unige.ch	Perrier, Arnaud/M-2263-2014					BECKER DM, 1989, ARCH INTERN MED, V149, P1731, DOI 10.1001/archinte.149.8.1731; Becker DM, 1996, ARCH INTERN MED, V156, P939, DOI 10.1001/archinte.156.9.939; BOUNAMEAUX H, 1991, LANCET, V337, P196, DOI 10.1016/0140-6736(91)92158-X; Bounameaux H, 1997, QJM-INT J MED, V90, P437, DOI 10.1093/qjmed/90.7.437; Cham MD, 2000, RADIOLOGY, V216, P744, DOI 10.1148/radiology.216.3.r00se44744; deMoerloose P, 1996, THROMB HAEMOSTASIS, V75, P11; Drucker EA, 1998, RADIOLOGY, V209, P235, DOI 10.1148/radiology.209.1.9769837; Garg K, 1998, RADIOLOGY, V208, P201, DOI 10.1148/radiology.208.1.9646814; GOODMAN LR, 1995, AM J ROENTGENOL, V164, P1369, DOI 10.2214/ajr.164.6.7754875; HULL RD, 1994, ARCH INTERN MED, V154, P289, DOI 10.1001/archinte.154.3.289; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P389, DOI 10.1001/jama.271.5.389; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Kearon C, 1998, ANN INTERN MED, V129, P1044, DOI 10.7326/0003-4819-129-12-199812150-00009; Kim KI, 1999, RADIOLOGY, V210, P693, DOI 10.1148/radiology.210.3.r99mr01693; LENSING AWA, 1989, NEW ENGL J MED, V320, P342, DOI 10.1056/NEJM198902093200602; Loud PA, 2000, AM J ROENTGENOL, V174, P61, DOI 10.2214/ajr.174.1.1740061; Mayo JR, 1997, RADIOLOGY, V205, P447, DOI 10.1148/radiology.205.2.9356627; Mullins MD, 2000, ARCH INTERN MED, V160, P293, DOI 10.1001/archinte.160.3.293; Perrier A, 2000, ARCH INTERN MED, V160, P512, DOI 10.1001/archinte.160.4.512; Perrier A, 1996, ARCH INTERN MED, V156, P531, DOI 10.1001/archinte.156.5.531; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Rathbun SW, 2000, ANN INTERN MED, V132, P227, DOI 10.7326/0003-4819-132-3-200002010-00009; RemyJardin M, 1996, RADIOLOGY, V200, P699, DOI 10.1148/radiology.200.3.8756918; RemyJardin M, 1997, RADIOLOGY, V204, P157, DOI 10.1148/radiology.204.1.9205239; REMYJARDIN M, 1992, RADIOLOGY, V185, P381, DOI 10.1148/radiology.185.2.1410342; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Sostman HD, 1996, JMRI-J MAGN RESON IM, V6, P275, DOI 10.1002/jmri.1880060203; SOSTMAN HD, 1994, RADIOLOGY, V193, P103, DOI 10.1148/radiology.193.1.8090877; Turkstra F, 1997, ANN INTERN MED, V126, P775, DOI 10.7326/0003-4819-126-10-199705150-00005; vanRossum AB, 1996, THORAX, V51, P23, DOI 10.1136/thx.51.1.23; vanRossum AB, 1996, RADIOLOGY, V201, P467, DOI 10.1148/radiology.201.2.8888242; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002; Woodard PK, 2000, RADIOLOGY, V215, P325, DOI 10.1148/radiology.215.2.r00ma48325; 1990, JAMA, V263, P2753	34	232	238	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2001	135	2					88	97		10.7326/0003-4819-135-2-200107170-00008	http://dx.doi.org/10.7326/0003-4819-135-2-200107170-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452DR	11453707				2022-12-28	WOS:000169842300002
J	Rajagopal, MR; Joranson, DE; Gilson, AM				Rajagopal, MR; Joranson, DE; Gilson, AM			Medical use, misuse, and diversion of opioids in India	LANCET			English	Article							TRENDS; CANCER; CARE	In less-developed countries, opioids such as morphine are often not available for pain relief because of excessive regulations imposed to prevent their misuse and diversion. We describe the effect that these draconian measures have had on the availability of drugs for medical use in Kerala, India, and present results of a study, which we did to ascertain whether or not the misuse and diversion of opioids is as prevalent as the government reaction would suggest. We followed 1723 patients in Calicut, India, who were being treated for pain with oral morphine on an -outpatient home-care basis. Over 2 years, we did not identify any instances of misuse or diversion. These results suggest that, in the context of India as a less-developed country, oral morphine can be dispensed safely to patients for use at home. We recommend that palliative care programmes talk to concerned governmental authorities, to make them aware of the medical need for opioids, and communicate with local news media to increase awareness of palliative care and the use of these analgesics. Our project has overcome regulatory barriers that had interrupted availability of morphine and Its use in pain relief in India.	Coll Med, Pain & Palliative Care Clin, Calicut, Kerala, India; Pain & Policy Studies Grp, Madison, WI USA; Univ Wisconsin, Ctr Comprehens Canc, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Rajagopal, MR (corresponding author), Coll Med, Pain & Palliative Care Clin, Calicut, Kerala, India.	pain@vsnl.com						Ajithakumari K, 1997, PALLIATIVE MED, V11, P451, DOI 10.1177/026921639701100604; [Anonymous], [No title captured]; [Anonymous], 2000, ACH BAL NAT OP CONTR; *I MED, 1997, APPR DEATH IMPR CAR; *INT NARC CONTR BO, 2000, NARC DRUGS EST WORLD; *INT NARC CONTR BO, 1999, NARC DRUGS EST WORLD; *INT NARC CONTR BO, 2000, REP INT NARC CONTR B; *INT NARC CONTR BO, 1989, NARC DRUGS EST WORLD; International Narcotics Control Board, 1996, REP INT NARC CONTR B; International Narcotics Control Board, 1999, REP INT NARC CONTR B; *JAP MIN HLTH WELF, 1999, REP ADM MEAS NARC ST; JORANSON DE, 1993, J PAIN SYMPTOM MANAG, V8, P353, DOI 10.1016/0885-3924(93)90052-W; Joranson DE, 2000, JAMA-J AM MED ASSOC, V283, P1710, DOI 10.1001/jama.283.13.1710; Kumar KS, 2000, PALLIATIVE MED, V14, P183, DOI 10.1191/026921600670697351; SIKORA K, 1998, WHO PROGRAMME CANC C; Sureshkumar K, 1996, PALLIATIVE MED, V10, P293, DOI 10.1177/026921639601000404; TEOH N, 1991, Palliative Medicine, V5, P185, DOI 10.1177/026921639100500302; *WHO, 1990, TECHN REP SER WHO, V804; *WHO, 1998, TECHN REP SER WHO, V882; *WHO COLL CTR POL, 2000, IMPR CANC PAIN REL W; World Health Organization, 1996, CANC PAIN REL GUID O	21	57	59	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 14	2001	358	9276					139	143		10.1016/S0140-6736(01)05322-3	http://dx.doi.org/10.1016/S0140-6736(01)05322-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452BR	11463435				2022-12-28	WOS:000169837700033
J	Wang, XL; Mahaney, MC				Wang, XL; Mahaney, MC			Genotype-specific effects of smoking on risk of CHD	LANCET			English	Editorial Material							CORONARY-ARTERY DISEASE; OXIDE SYNTHASE GENE; NITRIC-OXIDE; POLYMORPHISMS; CYP1A1; WOMEN		SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78227 USA	Texas Biomedical Research Institute	Wang, XL (corresponding author), SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78227 USA.							Bartsch H, 2000, CANCER EPIDEM BIOMAR, V9, P3; Ishibe N, 1997, CANCER EPIDEM BIOMAR, V6, P1075; KAMBOH MI, 1995, ATHEROSCLEROSIS, V117, P73, DOI 10.1016/0021-9150(95)05559-F; Kroncke KD, 1997, NITRIC OXIDE-BIOL CH, V1, P107, DOI 10.1006/niox.1997.0118; Lazarus P, 1998, CARCINOGENESIS, V19, P509, DOI 10.1093/carcin/19.3.509; Wang J, 2001, ARTERIOSCL THROM VAS, V21, P680; Wang XL, 2000, FEBS LETT, V471, P45, DOI 10.1016/S0014-5793(00)01356-9; Wang XL, 1996, NAT MED, V2, P41, DOI 10.1038/nm0196-41; WANG XL, 1994, CIRCULATION, V89, P1974, DOI 10.1161/01.CIR.89.5.1974; Wilson MH, 2000, FASEB J, V14, P791, DOI 10.1096/fasebj.14.5.791	10	10	11	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 14	2001	358	9276					87	88						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452BR	11463406				2022-12-28	WOS:000169837700005
J	Facinelli, B; Spinaci, C; Magi, G; Giovanetti, E; Varaldo, PE				Facinelli, B; Spinaci, C; Magi, G; Giovanetti, E; Varaldo, PE			Association between erythromycin resistance and ability to enter human respiratory cells in group A streptococci	LANCET			English	Article							GROUP-A STREPTOCOCCI; FIBRONECTIN-BINDING-PROTEIN; EPITHELIAL-CELLS; PYOGENES; INVASION; INTERNALIZATION; PHENOTYPES; STRAINS; GENE	Background An increase in erythromycin resistance rates among group A streptococci has been reported in some European countries. These bacteria, long thought to be extracellular pathogens, can be efficiently internalised by, and survive within, human cells of respiratory-tract origin. Macrolide antibiotics enter eukaryotic cells, whereas beta -lactams are essentially confined to the extracellular fluid. A protein encoded by gene prtF1 is required for efficient entry of group A streptococci into epithelial cells. We investigated isolates of group A streptococci from children with pharyngitis in Italy for the presence of prtF1 and cell-invasion efficiency. Methods We investigated 74 erythromycin-resistant and 52 erythromycin-susceptible isolates collected throughout Italy in 1997-98 from children with pharyngitis. Erythromycin-resistance phenotypes (constitutive, inducible, and M) were assessed by the triple-disc test and resistance determinants (ermB, ermTR, and mefA) by PCR. All strains were examined for the presence of prtF1 by PCR and for their ability to enter cultured human respiratory cells. Findings The proportion of prtF1-positive strains was significantly higher among erythromycin-resistant than susceptible strains (66 [89%] vs 11 [21%]; difference 68% [95% CI 52-84]). All erythromycin-resistant strains without prtF1 were of the M phenotype. The proportion of highly cell-invasive isolates (invasion efficiency >10%) was significantly higher among erythromycin-resistant than among susceptible strains (59 [80%] vs five [10%]; difference 70% [57-83]). Interpretations The unsuspected association between erythromycin resistance and cell invasiveness in group A streptococci raises serious concern. Strains combining erythromycin resistance and ability to enter human respiratory-tract cells may be able to escape both p-lactams by virtue of intracellular location and macrolides by virtue of resistance.	Univ Ancona, Sch Med, Inst Microbiol, I-60131 Ancona, Italy	Marche Polytechnic University	Facinelli, B (corresponding author), Univ Ancona, Sch Med, Inst Microbiol, Via Ranieri, I-60131 Ancona, Italy.			GIOVANETTI, Eleonora/0000-0002-9427-8091; VARALDO, Pietro/0000-0002-4131-487X				Cue DR, 1997, INFECT IMMUN, V65, P2759, DOI 10.1128/IAI.65.7.2759-2764.1997; Gillespie SH, 1998, LANCET, V352, P1954, DOI 10.1016/S0140-6736(05)61327-X; Giovanetti E, 1999, ANTIMICROB AGENTS CH, V43, P1935, DOI 10.1128/AAC.43.8.1935; HSUEH PR, 1995, ANTIMICROB AGENTS CH, V39, P2239, DOI 10.1128/AAC.39.10.2239; KAPLAN EL, 1997, CLIN INFECT DIS    S, V24, P89; LAPENTA D, 1994, P NATL ACAD SCI USA, V91, P12115, DOI 10.1073/pnas.91.25.12115; Medina E, 1999, J IMMUNOL, V163, P3396; MITSUHASHI S, 1982, MICROBIOLOGY 1982, P151; Molinari G, 1998, J INFECT DIS, V177, P1600, DOI 10.1086/515310; Molinari G, 1999, CURR OPIN MICROBIOL, V2, P56, DOI 10.1016/S1369-5274(99)80010-1; Molinari G, 1997, INFECT IMMUN, V65, P1357, DOI 10.1128/IAI.65.4.1357-1363.1997; NATANSON S, 1995, J INFECT DIS, V171, P871, DOI 10.1093/infdis/171.4.871; National Committee for Clinical Laboratory Standards, 1997, METH DIL ANT SUSC TE; Neeman R, 1998, LANCET, V352, P1974, DOI 10.1016/S0140-6736(97)12452-7; Osterlund A, 1997, LARYNGOSCOPE, V107, P640; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; SCHITO GC, 1998, 39 INT C ANT AG CHEM; SEPPALA H, 1993, J ANTIMICROB CHEMOTH, V32, P885, DOI 10.1093/jac/32.6.885; SEPPALA H, 1992, NEW ENGL J MED, V326, P292, DOI 10.1056/NEJM199201303260503; Seppala H, 1998, ANTIMICROB AGENTS CH, V42, P257; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P2562, DOI 10.1128/AAC.40.11.2562; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P1817, DOI 10.1128/AAC.40.8.1817; Varaldo PE, 1999, CLIN INFECT DIS, V29, P869, DOI 10.1086/520451; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577	24	78	78	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 7	2001	358	9275					30	33		10.1016/S0140-6736(00)05253-3	http://dx.doi.org/10.1016/S0140-6736(00)05253-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11454374				2022-12-28	WOS:000169710900013
J	Downward, J				Downward, J			The ins and outs of signalling	NATURE			English	Editorial Material							TYROSINE PHOSPHORYLATION; PROTEINS; SCAFFOLD; MODULES; YEAST; MODEL		Imperial Canc Res Fund, Signal Transduct Lab, London WC2A 3PX, England	Cancer Research UK	Downward, J (corresponding author), Imperial Canc Res Fund, Signal Transduct Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	downward@icrf.icnet.uk	Downward, Julian/A-3251-2012	Downward, Julian/0000-0002-2331-4729				Christophe D, 2000, CELL SIGNAL, V12, P337, DOI 10.1016/S0898-6568(00)00077-2; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Daniel JM, 1997, BIOESSAYS, V19, P883, DOI 10.1002/bies.950191008; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Endy D, 2001, NATURE, V409, P391, DOI 10.1038/35053181; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hunter T, 1998, PHILOS T R SOC B, V353, P583, DOI 10.1098/rstb.1998.0228; Kornberg Roger D., 1999, Trends in Cell Biology, V9, pM46, DOI 10.1016/S0962-8924(99)01679-7; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Massague J, 2000, GENE DEV, V14, P627; Mauro MJ, 2001, CURR OPIN ONCOL, V13, P3, DOI 10.1097/00001622-200101000-00002; Oliver SG, 1998, TRENDS BIOTECHNOL, V16, P373, DOI 10.1016/S0167-7799(98)01214-1; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Plowman GD, 1999, P NATL ACAD SCI USA, V96, P13603, DOI 10.1073/pnas.96.24.13603; Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schulze A, 2000, J CELL SCI, V113, P4151; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Walhout AJM, 2001, NAT REV MOL CELL BIO, V2, P55, DOI 10.1038/35048107; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Withers DJ, 2000, ENDOCRINOLOGY, V141, P1917, DOI 10.1210/en.141.6.1917	25	148	154	0	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 14	2001	411	6839					759	762		10.1038/35081138	http://dx.doi.org/10.1038/35081138			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459043				2022-12-28	WOS:000169246400032
J	Tattersall, DB; Bak, S; Jones, PR; Olsen, CE; Nielsen, JK; Hansen, ML; Hoj, PB; Moller, BL				Tattersall, DB; Bak, S; Jones, PR; Olsen, CE; Nielsen, JK; Hansen, ML; Hoj, PB; Moller, BL			Resistance to an herbivore through engineered cyanogenic glucoside synthesis	SCIENCE			English	Article							BICOLOR L MOENCH; P-HYDROXYPHENYLACETALDEHYDE OXIME; SORGHUM-BICOLOR; CYTOCHROME P-450(TYR); ESCHERICHIA-COLI; L-TYROSINE; DHURRIN; BIOSYNTHESIS; EXPRESSION; PURIFICATION	The entire pathway for synthesis of the tyrosine-derived cyanogenic glucoside dhurrin has been transferred from Sorghum bicolor to Arabidopsis thaliana. Here, we document that genetically engineered plants are able to synthesize and store large amounts of new natural products. The presence of dhurrin in the transgenic A. thaliana plants confers resistance to the flea beetle Phyllotreta nemorum, which is a natural pest of other members of the crucifer group, demonstrating the potential utility of cyanogenic glucosides in plant defense.	Royal Vet & Agr Univ, Dept Plant Biol, Plant Biochem Lab, DK-1871 Frederiksberg C, Denmark; Royal Vet & Agr Univ, Ctr Mol Plant Physiol, DK-1871 Frederiksberg C, Denmark; Royal Vet & Agr Univ, Dept Chem, DK-1871 Frederiksberg C, Denmark; Univ Adelaide, Dept Hort Viticulture & Oenol, Glen Osmond, SA 5064, Australia; Australian Wine Res Inst, Glen Osmond, SA 5064, Australia	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Adelaide; Australian Wine Research Institute	Moller, BL (corresponding author), Royal Vet & Agr Univ, Dept Plant Biol, Plant Biochem Lab, 40 Thorvaldsensvej, DK-1871 Frederiksberg C, Denmark.	blm@kvl.dk	Bak, Soren/H-4404-2014; Møller, Birger Lindberg/H-2657-2014; Møller, Birger Lindberg/GQI-1792-2022; Olsen, Carl E/H-3031-2014; Hoj, Peter B/E-8526-2011	Bak, Soren/0000-0003-4100-115X; Møller, Birger Lindberg/0000-0002-3252-3119; Møller, Birger Lindberg/0000-0002-3252-3119; Olsen, Carl E/0000-0002-2275-0596; 				Bak S, 1999, PLANT J, V20, P663, DOI 10.1046/j.1365-313X.1999.00642.x; Bak S, 1998, PLANT MOL BIOL, V36, P393, DOI 10.1023/A:1005915507497; Bak S, 2000, PLANT PHYSIOL, V123, P1437, DOI 10.1104/pp.123.4.1437; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Engler HS, 2000, NATURE, V406, P144, DOI 10.1038/35018159; FRANZL S, 1985, TISSUE CELL, V17, P267, DOI 10.1016/0040-8166(85)90093-X; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; HALKIER BA, 1989, PLANT PHYSIOL, V90, P1552, DOI 10.1104/pp.90.4.1552; HALKIER BA, 1995, ARCH BIOCHEM BIOPHYS, V322, P369, DOI 10.1006/abbi.1995.1477; Jones DA, 1998, PHYTOCHEMISTRY, V47, P155, DOI 10.1016/S0031-9422(97)00425-1; Jones PR, 1999, J BIOL CHEM, V274, P35483, DOI 10.1074/jbc.274.50.35483; KOCH BM, 1995, ARCH BIOCHEM BIOPHYS, V323, P177; Li Y, 2001, J BIOL CHEM, V276, P4338, DOI 10.1074/jbc.M007447200; NAHRSTEDT A, 1986, PHYTOCHEMISTRY, V25, P2299, DOI 10.1016/S0031-9422(00)81683-0; Nielsen JK, 1997, ENTOMOL EXP APPL, V82, P25, DOI 10.1023/A:1002990929647; Nielsen JK, 2001, CHEMOECOLOGY, V11, P75, DOI 10.1007/PL00001835; Schappert PJ, 1999, ECOSCIENCE, V6, P511, DOI 10.1080/11956860.1999.11682560; Seigler D.S, 1991, HERBIVORES THEIR INT, V1; SIBBESEN O, 1995, J BIOL CHEM, V270, P3506, DOI 10.1074/jbc.270.8.3506; SIBBESEN O, 1994, P NATL ACAD SCI USA, V91, P9740, DOI 10.1073/pnas.91.21.9740; TOPFER R, 1987, NUCLEIC ACIDS RES, V15, P5890, DOI 10.1093/nar/15.14.5890; WANG P, 1992, ARCH BIOCHEM BIOPHYS, V298, P569, DOI 10.1016/0003-9861(92)90451-2	22	193	210	1	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1826	1828		10.1126/science.1062249	http://dx.doi.org/10.1126/science.1062249			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11474068				2022-12-28	WOS:000170894400046
J	Komura, Y; Tamura, R; Uwano, T; Nishijo, H; Kaga, K; Ono, T				Komura, Y; Tamura, R; Uwano, T; Nishijo, H; Kaga, K; Ono, T			Retrospective and prospective coding for predicted reward in the sensory thalamus	NATURE			English	Article							ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; AUDITORY THALAMUS; RECEPTIVE-FIELDS; BASAL GANGLIA; SINGLE UNITS; AMYGDALA; NEURONS; BRAIN; RAT	Reward is important for shaping goal-directed behaviour(1-4). After stimulus-reward associative learning, an organism can assess the motivational value of the incoming stimuli on the basis of past experience (retrospective processing), and predict forthcoming rewarding events (prospective processing)(1-5). The traditional role of the sensory thalamus is to relay current sensory information to cortex. Here we rnd that non-primary thalamic neurons respond to reward-related events in two ways. The early, phasic responses occurred shortly after the onset of the stimuli and depended on the sensory modality. Their magnitudes resisted extinction and correlated with the learning experience. The late responses gradually increased during the cue and delay periods, and peaked just before delivery of the reward. These responses were independent of sensory modality and were modulated by the value and timing of the reward. These observations provide new evidence that single thalamic neurons can code for the acquired significance of sensory stimuli in the early responses (retrospective coding) and predict upcoming reward value in the late responses (prospective coding).	Toyama Med & Pharmaceut Univ, Dept Physiol, Fac Med, Toyama 9300194, Japan; Univ Tokyo, Sch Med, Dept Otorhinolaryngol, Tokyo 1130033, Japan	University of Toyama; University of Tokyo	Ono, T (corresponding author), Toyama Med & Pharmaceut Univ, Dept Physiol, Fac Med, Toyama 9300194, Japan.							[Anonymous], [No title captured]; Bechara A, 1998, J NEUROSCI, V18, P428; BORDI F, 1994, EXP BRAIN RES, V98, P261, DOI 10.1007/BF00228414; BOUTON ME, 1994, CURR DIR PSYCHOL SCI, V3, P49, DOI 10.1111/1467-8721.ep10769943; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Dolan R.J., 2000, NEW COGNITIVE NEUROS; Edeline JM, 1999, HEARING RES, V131, P135, DOI 10.1016/S0378-5955(99)00026-X; GALLISTEL CR, 1991, BEHAV NEUROSCI, V105, P901, DOI 10.1037/0735-7044.105.6.901; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Laberge D, 1990, J Cogn Neurosci, V2, P358, DOI 10.1162/jocn.1990.2.4.358; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1991, NEUROSCI LETT, V134, P139, DOI 10.1016/0304-3940(91)90526-Y; Linke R, 1999, J COMP NEUROL, V403, P158; Liu Z, 2000, NAT NEUROSCI, V3, P1307, DOI 10.1038/81841; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; NAKAMURA K, 1987, J NEUROPHYSIOL, V58, P1123, DOI 10.1152/jn.1987.58.5.1123; ONO T, 1995, PROG NEUROBIOL, V46, P401, DOI 10.1016/0301-0082(95)00008-J; Rainer G, 1999, J NEUROSCI, V19, P5493; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P147, DOI 10.1152/jn.1987.57.1.147; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; ROLLS ET, 1999, BRAIN EMOTION; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Sefton Ann Jervie, 1995, P833; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Weinberger N M, 1993, Curr Opin Neurobiol, V3, P570, DOI 10.1016/0959-4388(93)90058-7; WINER JA, 1983, J NEUROSCI, V3, P2629; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; [No title captured]	30	183	186	0	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					546	549		10.1038/35087595	http://dx.doi.org/10.1038/35087595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	458PC	11484055				2022-12-28	WOS:000170202900047
J	Rogers, KC; Forster, CA				Rogers, KC; Forster, CA			The last of the dinosaur titans: a new sauropod from Madagascar	NATURE			English	Article							PHYLOGENETIC-RELATIONSHIPS	The Titanosauria, the last surviving group of the giant sauropod dinosaurs, attained a near-global distribution by the close of the Cretaceous period (65 Myr ago). With the exception of a few new discoveries in Argentina(1-3), most titanosaurs are known only from fragmentary postcranial skeletons and rare, isolated skull elements(4-9). Here we describe the most complete titanosaur yet discovered. Rapetosaurus krausei gen. et sp. nov., from the Maevarano Formation of Madagascar, provides a view of titanosaur anatomy from head to tail. A total-evidence phylogenetic analysis supports a close relationship between brachiosaurids and titanosaurs (Titanosauriformes(10-13)). The inclusion of cranial data from Rapetosaurus also lays to rest questions concerning the phylogeny of the enigmatic Mongolian genera Nemegtosaurus and Quaesitosaurus(14,15). In spite of their elongated, diplodocoid-like skulls, all three taxa are now firmly nested within Titanosauria.	SUNY Stony Brook, Hlth Sci Ctr, Dept Anat Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Rogers, KC (corresponding author), SUNY Stony Brook, Hlth Sci Ctr, Dept Anat Sci, Stony Brook, NY 11794 USA.							BERMAN DS, 1982, CARNEGIE MUSEUM ANN, V51, P405; Buckley GA, 2000, NATURE, V405, P941, DOI 10.1038/35016061; Calvo J.O., 1997, AMEGHINIANA, V34, P534; CALVO JO, 1998, ACTA GEOL LILLOANA, V13, P156; Chatterjee Sankar, 1996, Memoirs of the Queensland Museum, V39, P489; Coria RA, 1999, AMEGHINIANA, V36, P98; Coria Rodolfo A., 1999, National Science Museum Monographs, V15, P47; Curry Rogers K., 1999, 7 INT S MES TERR EC, P20; Deperet C, 1896, B SOC GEOLOGIQUE FRA, V21, P176; Gauthier J.A., 1986, ORIGIN BIRDS EVOLUTI, V8, P1; Gomani Elizabeth M., 1998, Journal of Vertebrate Paleontology, V18, p46A; HUENE F, 1929, CENTRALBLATT MINER B, P493; KRAUSE DW, 1999, GSA TODAY, V9, P1; KURZANOV SM, 1983, PALEONTOL J, V2, P90; Martinez Ruben, 1998, Journal of Vertebrate Paleontology, V18, p61A; McIntosh J.S., 1990, P345; Nowinski A., 1971, Palaeontologia Polonica, VNo. 25, P57; Powell J.E., 1992, DINOSAURIOS ENTORNO, P165; POWELL JE, 1986, THESIS U NACIONALE T; Ravoavy F, 1991, U ANTANANARIVO MEMOI, VII, P55; ROGERS KC, 1999, J VERT PALEONTOL, V19, pA41; Rogers RR, 2000, J GEOL, V108, P275, DOI 10.1086/314403; Romer A, 1956, OSTEOLOGY REPTILES; Salgado Leonardo, 1997, Ameghiniana, V34, P33; Salgado Leonardo, 1997, Ameghiniana, V34, P3; SWOFFORD DL, 1999, PAUP STAR PHYLOGENET; Upchurch P, 1999, J VERTEBR PALEONTOL, V19, P106, DOI 10.1080/02724634.1999.10011127; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; UPCHURCH P, 1995, PHILOS T R SOC B, V349, P365, DOI 10.1098/rstb.1995.0125; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; WILSON JA, 1999, EVOLUTIONARY HIST SA	31	164	173	1	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					530	534		10.1038/35087566	http://dx.doi.org/10.1038/35087566			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484051				2022-12-28	WOS:000170202900043
J	Gustafson, P; Gomes, VF; Vieira, CS; Jensen, H; Seng, R; Norberg, R; Samb, B; Naucler, A; Aaby, P				Gustafson, P; Gomes, VF; Vieira, CS; Jensen, H; Seng, R; Norberg, R; Samb, B; Naucler, A; Aaby, P			Tuberculosis mortality during a civil war in Guinea-Bissau	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IMPACT; INFECTIONS; DIAGNOSIS; DISTRICT; ABIDJAN; AFRICA; MALAWI	Context Tuberculosis (TB) is an increasing global problem, despite effective drug therapies. Access to TB therapy during conflict situations has not been studied. Objective To determine the effect of irregular TB treatment due to an armed conflict in Guinea-Bissau, West Africa. Design, Setting, and Patients Ongoing retrospective cohort study conducted in the capital city of Bissau among 101 patients with TB who received irregular or no treatment during the civil war (war cohort; June 7-December 6, 1998) and 108 patients with TB who received treatment 12 months earlier (peace cohort; June 7-December 6,1997) and comparison of an additional 42 patients who had completed treatment before June 6, 1998, and 69 patients who had completed treatment before June 6, 1997. Main Outcome Measure Mortality rates, compared by irregular (war cohort) vs regular (peace cohort) access to treatment, by intensive vs continuation phase of treatment, and by those who had previously completed treatment for TB. Results Irregular treatment was associated with an increased mortality rate among patients with TB. The mortality rate ratio (MR) was 3.12 (95% confidence interval [CI], 1.20-8.12) in the war cohort, adjusting for age, sex, human immunodeficiency virus (HIV) infection, residence, and length of treatment. Each additional week of treatment before the war started increased probability of survival by 5% (95% CI, 0%-10%). In the intensive phase of treatment, the adjusted MR was 3.30 (95% CI, 1.04-10.50) and in the continuation phase it was 2.26 (95% CI, 0.33-15.34). Increased mortality among the war cohort was most marked in HIV-positive patients, who had an adjusted MR of 8.19 (95% CI, 1.62-41.25). Mortality was not increased in HIV-positive or HIV-negative patients who had completed TB treatment when the war started. Conclusions Interruption of treatment had a profound impact on mortality among patients with TB during the war in Guinea-Bissau. Regular treatment for TB was associated with significantly improved survival for HIV-infected individuals. In emergencies, it is crucial to ensure availability of TB drugs.	Malmo Univ Hosp, Dept Infect Dis, S-20502 Malmo, Sweden; Hosp Raoul Follereau, Bissau, Guinea Bissau; State Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, Copenhagen, Denmark; IMEA, INSERM, U88, Paris, France; Karolinska Inst, Swedish Inst Infect Dis Control, Stockholm, Sweden	Lund University; Skane University Hospital; Aarhus University; Statens Serum Institut; Institut National de la Sante et de la Recherche Medicale (Inserm); Karolinska Institutet; Swedish Institute for Infectious Disease Control	Gustafson, P (corresponding author), Malmo Univ Hosp, Dept Infect Dis, S-20502 Malmo, Sweden.	Per.Gustafson@inf.mas.lu.se		Aaby, Peter/0000-0001-8331-1389				Aaby P, 1999, BRIT MED J, V319, P878, DOI 10.1136/bmj.319.7214.878; AABY P, 1997, PROSPECTIVE COMMUNIT, P276; ACKAH AN, 1995, LANCET, V345, P607, DOI 10.1016/S0140-6736(95)90519-7; Andersson S, 1997, AIDS, V11, P1815, DOI 10.1097/00002030-199715000-00005; Borgdorff MW, 1998, EUR RESPIR J, V11, P816, DOI 10.1183/09031936.98.11040816; Connolly C, 1998, INT J TUBERC LUNG D, V2, P919; DATTA M, 1993, TUBERCLE LUNG DIS, V74, P180, DOI 10.1016/0962-8479(93)90008-L; DECOCK KM, 1991, BMJ-BRIT MED J, V302, P496, DOI 10.1136/bmj.302.6775.496; DUNN PL, 1995, INFECT IMMUN, V63, P3428, DOI 10.1128/IAI.63.9.3428-3437.1995; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Glynn JR, 1998, B WORLD HEALTH ORGAN, V76, P295; Harries AD, 1998, T ROY SOC TROP MED H, V92, P343, DOI 10.1016/S0035-9203(98)91036-7; KREBS W, 1930, BEITR KLIN TUBERK, P345; LINCOLN EM, 1947, AM REV TUBERC PULM, V56, P95; LINCOLN EM, 1947, AM REV TUBERC PULM, V56, P75; Murray C J, 1990, Bull Int Union Tuberc Lung Dis, V65, P6; NAUCLER A, 1991, AIDS, V5, P301, DOI 10.1097/00002030-199103000-00009; OBrien JK, 1997, CHEST, V112, P387, DOI 10.1378/chest.112.2.387; PablosMendez A, 1997, AM J MED, V102, P164, DOI 10.1016/S0002-9343(96)00402-0; PablosMendez A, 1996, JAMA-J AM MED ASSOC, V276, P1223, DOI 10.1001/jama.276.15.1223; Rao VK, 1998, CHEST, V114, P1244, DOI 10.1378/chest.114.5.1244; Thompson BC, 1943, BRIT MED J, V1943, P721, DOI 10.1136/bmj.2.4326.721; THOMPSON BC, 1940, TUBERCLE, P217; van den Broek J, 1998, INT J TUBERC LUNG D, V2, P547; Walther-Jallow L, 1999, AIDS RES HUM RETROV, V15, P957, DOI 10.1089/088922299310467; WHO, 1997, MID IMP US ANT FOOD; Zellweger JP, 1998, INT J TUBERC LUNG D, V2, P372	27	44	47	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2001	286	5					599	603		10.1001/jama.286.5.599	http://dx.doi.org/10.1001/jama.286.5.599			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458HE	11476664				2022-12-28	WOS:000170188300025
J	Schwetz, BA				Schwetz, BA			New oral contraceptive	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2001	286	5					527	527		10.1001/jama.286.5.527	http://dx.doi.org/10.1001/jama.286.5.527			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458HE	11476645				2022-12-28	WOS:000170188300003
J	Ellis, CN; Krueger, GG				Ellis, CN; Krueger, GG		Alefacept Clin Study Grp	Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TOXIN DAB(389)IL-2; CELL RESPONSES; THERAPY; CD2; ACTIVATION; CYCLOSPORINE; KERATINOCYTE; REMISSION; DURATION; IMMUNE	Background Psoriatic plaques are characterized by infiltration with CD45RO+ memory effector T lymphocytes. The recombinant protein alefacept binds to CD2 on memory effector T lymphocytes, inhibiting their activation. Methods In a multicenter, randomized, placebo-controlled, double-blind study, we evaluated alefacept as a treatment for psoriasis. Two hundred twenty-nine patients with chronic psoriasis received intravenous alefacept (0.025, 0.075, or 0.150 mg per kilogram of body weight) or placebo weekly for 12 weeks, with follow-up for 12 additional weeks. Before treatment, the median scores on the psoriasis area-and-severity index were between 14 and 20 in all groups (0 denotes no psoriasis and 72 the most severe disease possible). Results Alefacept was well tolerated and nonimmunogenic. The mean reduction in the score on the psoriasis area-and-severity index two weeks after treatment was greater in the alefacept groups (38, 53, and 53 percent in the groups receiving 0.025, 0.075, and 0.150 mg per kilogram, respectively) than in the placebo group (21 percent, P<0.001). Twelve weeks after treatment, 28 patients who had received alefacept alone were clear or almost clear of psoriasis. Three patients in the placebo group were clear or almost clear; all three had received additional systemic therapy for psoriasis. Alefacept reduced peripheral-blood memory effector T-lymphocyte ( CD45RO+) counts, and the reduction in the number of memory effector T lymphocytes was correlated with the improvement in psoriasis. Conclusions Treatment with alefacept for 12 weeks is associated with improvement in chronic plaque psoriasis; some patients have a sustained clinical response after the cessation of treatment. Alefacept selectively targets CD45RO+ memory effector T lymphocytes, suggesting that they have a role in the pathogenesis of psoriasis. (N Engl Med 2001; 345: 248-55.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Utah, Hlth Sci Ctr, Dept Dermatol, Sch Med, Salt Lake City, UT 84132 USA; Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI USA; Vet Affairs Med Ctr, Dermatol Serv, Ann Arbor, MI USA; Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah	Ellis, CN (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Dermatol, Sch Med, 50 N Med Dr, Salt Lake City, UT 84132 USA.		Ellis, Charles/ABA-7264-2021	Ellis, Charles/0000-0001-9436-7628	NCRR NIH HHS [MO1-RR00064] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BATACSORGO Z, 1995, J INVEST DERMATOL, V105, pS89, DOI 10.1111/1523-1747.ep12316121; BOS JD, 1989, ARCH DERMATOL RES, V281, P24, DOI 10.1007/BF00424268; BROTTIER P, 1985, J IMMUNOL, V135, P1624; Chisholm P L, 1994, Ther Immunol, V1, P205; DANIELIAN S, 1991, EUR J IMMUNOL, V21, P1967, DOI 10.1002/eji.1830210828; DOBSON AJ, 1990, INTRO GEN LINEAR MOD, P84; ELLIS CN, 1991, NEW ENGL J MED, V324, P277, DOI 10.1056/NEJM199101313240501; ELLIS CN, 1995, ARCH DERMATOL, V131, P791, DOI 10.1001/archderm.131.7.791; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; GOTTLIEB SL, 1995, NAT MED, V1, P442, DOI 10.1038/nm0595-442; Gottlieb SL, 1997, J AM ACAD DERMATOL, V36, P272; GREAVES MW, 1995, NEW ENGL J MED, V332, P581, DOI 10.1056/NEJM199503023320907; JUNE CH, 1990, J IMMUNOL, V144, P1591; Kaplon RJ, 1996, TRANSPLANTATION, V61, P356, DOI 10.1097/00007890-199602150-00004; Koo J, 1999, J AM ACAD DERMATOL, V41, P51, DOI 10.1016/S0190-9622(99)70406-8; KRUEGER JG, 1995, J EXP MED, V182, P2057, DOI 10.1084/jem.182.6.2057; MAJEAU GR, 1994, J IMMUNOL, V152, P2753; Meier W, 1995, Ther Immunol, V2, P159; MILLER GT, 1993, J EXP MED, V178, P211, DOI 10.1084/jem.178.1.211; MORGANROTH GS, 1991, J INVEST DERMATOL, V96, P333, DOI 10.1111/1523-1747.ep12465237; Robert C, 1999, NEW ENGL J MED, V341, P1817, DOI 10.1056/NEJM199912093412407; VALLAT VP, 1994, J EXP MED, V180, P283, DOI 10.1084/jem.180.1.283; Weinstein GD, 1993, THERAPY OF MODERATE-TO-SEVERE PSORIASIS, P1	23	460	491	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2001	345	4					248	255		10.1056/NEJM200107263450403	http://dx.doi.org/10.1056/NEJM200107263450403			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455XZ	11474662				2022-12-28	WOS:000170054200003
J	Verstreken, P; Bellen, HJ				Verstreken, P; Bellen, HJ			Neuroscience - The meaning of a mini	SCIENCE			English	Editorial Material							NEUROMUSCULAR-JUNCTION FORMATION; NEUROTRANSMITTER RELEASE; DROSOPHILA; SYNAPTOGENESIS; RECEPTORS		Baylor Coll Med, Howard Hughes Med Inst, Program Dev Biol, Dept Mol & Human Genet,Div Neurosci, Houston, TX 77030 USA	Baylor College of Medicine; Howard Hughes Medical Institute	Verstreken, P (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, Program Dev Biol, Dept Mol & Human Genet,Div Neurosci, Houston, TX 77030 USA.		Verstreken, Patrik/AAC-7591-2022	Verstreken, Patrik/0000-0002-5073-5393; Bellen, Hugo/0000-0001-5992-5989				BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; BROADIE K, 1993, NEURON, V11, P607, DOI 10.1016/0896-6273(93)90073-Z; BROADIE K, 1993, NATURE, V361, P350, DOI 10.1038/361350a0; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; OKANE CJ, 1999, FR MOLEC B, V23, P208; PENNETTA G, 1999, FR MOLEC B, V23, P304; Saitoe M, 1997, DEV BIOL, V184, P48, DOI 10.1006/dbio.1996.8480; Saitoe M, 2001, SCIENCE, V293, P514, DOI 10.1126/science.1061270; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864	12	5	5	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2001	293	5529					443	444		10.1126/science.1063293	http://dx.doi.org/10.1126/science.1063293			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463902				2022-12-28	WOS:000169966700032
J	Wells, PS; Anderson, DR; Rodger, M; Stiell, I; Dreyer, JF; Barnes, D; Forgie, M; Kovacs, G; Ward, J; Kovacs, MJ				Wells, PS; Anderson, DR; Rodger, M; Stiell, I; Dreyer, JF; Barnes, D; Forgie, M; Kovacs, G; Ward, J; Kovacs, MJ			Excluding pulmonary embolism at the bedside without diagnostic imaging: Management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and D-dimer	ANNALS OF INTERNAL MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; ANGIOGRAPHY; ULTRASONOGRAPHY; SCINTIGRAPHY; PROBABILITY; UTILITY; SCAN; CT	Background: The limitations of the current diagnostic standard, ventilation-perfusion lung scanning, complicate the management of patients with suspected pulmonary embolism. We previously demonstrated that determining the pretest probability can assist with management and that the high negative predictive value of certain D-dimer assays may simplify the diagnostic process. Objective: To determine the safety of using a simple clinical model combined with D-dimer assay to manage patients presenting to the emergency department with suspected pulmonary embolism. Design: Prospective cohort study. Setting: Emergency departments at four tertiary care hospitals in Canada. Patients: 930 consecutive patients with suspected pulmonary embolism. Interventions: Physicians first used a clinical model to determine patients' pretest probability of pulmonary embolism and then performed a D-dimer test. Patients with low pretest probability and a negative D-dimer result had no further tests and were considered to have a diagnosis of pulmonary embolism excluded. All other patients underwent ventilation-perfusion lung scanning. If the scan was nondiagnostic, bilateral deep venous ultrasonography was done. Whether further testing (by serial ultrasonography or angiography) was done depended on the patients' pretest probability and the lung scanning results. Measurements: Patients received a diagnosis of pulmonary embolism if they had a high-probability ventilation-perfusion scan, an abnormal result on ultrasonography or pulmonary angiography, or a venous thromboembolic event during follow-up. Patients for whom the diagnosis was considered excluded were followed up for 3 months for the development of thromboembolic events. Results: The pretest probability of pulmonary embolism was low, moderate, and high in 527, 339, and 64 patients (1.3%, 16.2%, and 37.5% had pulmonary embolism), respectively. Of 849 patients in whom a diagnosis of pulmonary-embolism had initially been excluded, 5 (0.6% [95% CI, 0.2% to 1.4%]) developed pulmonary embolism or deep venous thrombosis during followup. However, 4 of these patients had not undergone the proper diagnostic testing protocol. In 7 of the patients who received a diagnosis of pulmonary embolism, the physician had performed more diagnostic tests than were called for by the algorithm. In 759 of the 849 patients in whom pulmonary embolism was not found on initial evaluation, the diagnostic protocol was followed correctly. Only 1 (0.1% [CI, 0.0% to 0.7%]) of these 759 patients developed thromboembolic events during follow-up. Of the 437 patients with a negative D-dimer result and low clinical probability, only 1 developed pulmonary embolism during follow-up; thus, the negative predictive value for the combined strategy of using the clinical model with D-dimer testing in these patients was 99.5% (CI, 99.1% to 100%). Conclusion: Managing patients for suspected pulmonary embolism on the basis of pretest probability and sigma -dimer result is safe and decreases the need for diagnostic imaging.	Univ Ottawa, Ottawa, ON K1N 6N5, Canada; Univ Western Ontario, London, ON N6A 3K7, Canada; Dalhousie Univ, Halifax, NS B3H 3J5, Canada; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	University of Ottawa; Western University (University of Western Ontario); Dalhousie University; University of British Columbia	Wells, PS (corresponding author), Suite 452,737 Parkdale Ave, Ottawa, ON K1Y 1J8, Canada.		Kovacs, Michael/G-3315-2011	Rodger, Marc/0000-0001-8166-3487; Anderson, David/0000-0003-0845-1722; Stiell, Ian/0000-0002-2583-6408				Anderson DR, 1999, ARCH INTERN MED, V159, P477, DOI 10.1001/archinte.159.5.477; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Bauld DL, 1999, AM J EMERG MED, V17, P11, DOI 10.1016/S0735-6757(99)90004-9; CARSON JL, 1992, NEW ENGL J MED, V326, P1240, DOI 10.1056/NEJM199205073261902; de Groot MR, 1999, THROMB HAEMOSTASIS, V82, P1588; Farrell S, 2000, ANN EMERG MED, V35, P121, DOI 10.1016/S0196-0644(00)70130-2; Ferretti GR, 1997, RADIOLOGY, V205, P453, DOI 10.1148/radiology.205.2.9356628; FRANKEL N, 1986, J NUCL MED, V27, P366; Gupta A, 1999, RADIOLOGY, V210, P353, DOI 10.1148/radiology.210.2.r99fe53353; HEIJBOER H, 1992, ACTA RADIOL, V33, P297; HULL RD, 1983, ANN INTERN MED, V98, P891, DOI 10.7326/0003-4819-98-6-891; Kember PG, 1997, BRIT J RADIOL, V70, P1109, DOI 10.1259/bjr.70.839.9536900; LENSING AWA, 1992, THROMB HAEMOSTASIS, V68, P245; LENSING AWA, 1989, NEW ENGL J MED, V320, P342, DOI 10.1056/NEJM198902093200602; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; RemyJardin M, 1996, RADIOLOGY, V200, P699, DOI 10.1148/radiology.200.3.8756918; Schluger N, 1994, J Thorac Imaging, V9, P180, DOI 10.1097/00005382-199422000-00013; STEIN PD, 1992, CIRCULATION, V85, P462, DOI 10.1161/01.CIR.85.2.462; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; 1990, JAMA, V263, P2753	21	932	971	0	27	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2001	135	2					98	107		10.7326/0003-4819-135-2-200107170-00010	http://dx.doi.org/10.7326/0003-4819-135-2-200107170-00010			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452DR	11453709				2022-12-28	WOS:000169842300003
J	Morley, P				Morley, P			Vasopressin or epinephrine: which initial vasopressor for cardiac arrests?	LANCET			English	Editorial Material							VENTRICULAR-FIBRILLATION; RESUSCITATION		Royal Melbourne Hosp, Intens Care Unit, Melbourne, Vic 3050, Australia	Royal Melbourne Hospital	Morley, P (corresponding author), Royal Melbourne Hosp, Intens Care Unit, Melbourne, Vic 3050, Australia.	peter.morley@mh.org.au	Morley, Peter/G-5280-2017	Morley, Peter/0000-0003-2653-090X				*AM HEART ASS COLL, 2000, RESUSCITATION, V46, P3; *AM HEART ASS INT, 2000, RESUSCITATION, V46, P155; American Heart Association, 2000, RESUSCITATION, V46, P169; Babbs CF, 2001, ANN EMERG MED, V37, pS152, DOI 10.1067/mem.2001.114122; *EUR RES COUNC, 2001, RESUSCITATION, V48, P211; Kudenchuk PJ, 1999, NEW ENGL J MED, V341, P871, DOI 10.1056/NEJM199909163411203; Lindner KH, 1997, LANCET, V349, P535, DOI 10.1016/S0140-6736(97)80087-6; Lindner KH, 1996, ANN INTERN MED, V124, P1061, DOI 10.7326/0003-4819-124-12-199606150-00006; Morris DC, 1997, ACAD EMERG MED, V4, P878, DOI 10.1111/j.1553-2712.1997.tb03813.x; Vandycke C, 2000, RESUSCITATION, V45, P161, DOI 10.1016/S0300-9572(00)00188-X	10	3	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 14	2001	358	9276					85	86		10.1016/S0140-6736(01)05375-2	http://dx.doi.org/10.1016/S0140-6736(01)05375-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452BR	11463404				2022-12-28	WOS:000169837700003
J	Zubieta, JK; Smith, YR; Bueller, JA; Xu, YJ; Kilbourn, MR; Jewett, DM; Meyer, CR; Koeppe, RA; Stohler, CS				Zubieta, JK; Smith, YR; Bueller, JA; Xu, YJ; Kilbourn, MR; Jewett, DM; Meyer, CR; Koeppe, RA; Stohler, CS			Regional mu opioid receptor regulation of sensory and affective dimensions of pain	SCIENCE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; STRESS-INDUCED ANALGESIA; MORPHINE-INDUCED ANALGESIA; HUMAN BRAIN; MICE LACKING; PERIAQUEDUCTAL GRAY; C-11 DIPRENORPHINE; BINDING; ANTINOCICEPTION; MECHANISMS	The endogenous opioid system is involved in stress responses, in the regulation of the experience of pain, and in the action of analgesic opiate drugs. We examined the function of the opioid system and mu -opioid receptors in the brains of healthy human subjects undergoing sustained pain. Sustained pain induced the regional release of endogenous opioids interacting with mu -opioid receptors in a number of cortical and subcortical brain regions. The activation of the mu -opioid receptor system was associated with reductions in the sensory and affective ratings of the pain experience, with distinct neuroanatomical involvements. These data demonstrate the central role of the mu -opioid receptors and their endogenous Ligands in the regulation of sensory and affective components of the pain experience.	Univ Michigan, Sch Med, Dept Psychiat, Ann Arbor, MI 48104 USA; Univ Michigan, Sch Med, Mental Hlth Res Inst, Ann Arbor, MI 48104 USA; Univ Michigan, Sch Med, Dept Radiol, Ann Arbor, MI 48104 USA; Univ Michigan, Sch Med, Dept Obstet & Gynecol, Ann Arbor, MI 48104 USA; Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48104 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Zubieta, JK (corresponding author), Univ Michigan, Sch Med, Dept Psychiat, Ann Arbor, MI 48104 USA.	zubieta@umich.edu	STOHLER, CHRISTIAN/AAQ-7539-2020; Zubieta, Jon-Kar/AAB-5565-2022	Stohler, Christian S/0000-0003-0443-6146	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012059, R01DE012743] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01 DE 12743, R01 DE 12059] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Adler LJ, 1997, ANESTH ANALG, V84, P120, DOI 10.1097/00000539-199701000-00023; AKIL H, 1984, ANNU REV NEUROSCI, V7, P223, DOI 10.1146/annurev.ne.07.030184.001255; ALBEFESSARD D, 1985, BRAIN RES REV, V9, P217, DOI 10.1016/0165-0173(85)90013-X; Aziz Q, 1997, GASTROENTEROLOGY, V113, P50, DOI 10.1016/S0016-5085(97)70079-9; BUSHNELL MC, 1989, EXP BRAIN RES, V78, P415; CARR KD, 1988, BRAIN RES, V441, P173, DOI 10.1016/0006-8993(88)91396-0; Casey KL, 2000, J NEUROPHYSIOL, V84, P525, DOI 10.1152/jn.2000.84.1.525; Casey KL, 1996, J NEUROPHYSIOL, V76, P571, DOI 10.1152/jn.1996.76.1.571; Casey KL, 1999, P NATL ACAD SCI USA, V96, P7668, DOI 10.1073/pnas.96.14.7668; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; COGHILL RC, 1994, J NEUROSCI, V14, P4095; Craig AD, 1996, NATURE, V384, P258, DOI 10.1038/384258a0; DANNALS RF, 1985, INT J APPL RADIAT IS, V36, P303, DOI 10.1016/0020-708X(85)90089-4; Derbyshire SWG, 1998, PAIN, V76, P127, DOI 10.1016/S0304-3959(98)00034-7; FIELDS HL, 1991, ANNU REV NEUROSCI, V14, P219, DOI 10.1146/annurev.neuro.14.1.219; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; FROST JJ, 1985, J COMPUT ASSIST TOMO, V9, P231, DOI 10.1097/00004728-198503000-00001; GEAR RW, 1995, J NEUROSCI, V15, P3154; Gear RW, 1999, J NEUROSCI, V19, P7175, DOI 10.1523/JNEUROSCI.19-16-07175.1999; Harte SE, 2000, BRAIN RES, V874, P78, DOI 10.1016/S0006-8993(00)02583-X; HELMSTETTER FJ, 1995, J PHARMACOL EXP THER, V275, P381; JONES AKP, 1994, BRIT J RHEUMATOL, V33, P909; JONES AKP, 1991, P ROY SOC B-BIOL SCI, V244, P39, DOI 10.1098/rspb.1991.0048; Jones AKP, 1999, J CEREBR BLOOD F MET, V19, P803, DOI 10.1097/00004647-199907000-00011; LaBuda CJ, 2000, BRAIN RES, V869, P1, DOI 10.1016/S0006-8993(00)02196-X; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; Manning BH, 1998, J NEUROSCI, V18, P9453; Mantyh PW, 1997, SCIENCE, V278, P275, DOI 10.1126/science.278.5336.275; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Melzack R, 2000, HDB PAIN ASSESSMENT, P152; Meyer C R, 1997, Med Image Anal, V1, P195, DOI 10.1016/S1361-8415(97)85010-4; MINOSHIMA S, 1993, J NUCL MED, V34, P322; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Rubinstein M, 1996, P NATL ACAD SCI USA, V93, P3995, DOI 10.1073/pnas.93.9.3995; Schlaepfer TE, 1998, AM J PSYCHIAT, V155, P470, DOI 10.1176/ajp.155.4.470; Silverman DHS, 1997, GASTROENTEROLOGY, V112, P64, DOI 10.1016/S0016-5085(97)70220-8; Smith YR, 1998, J CLIN ENDOCR METAB, V83, P4498, DOI 10.1210/jc.83.12.4498; Sora I, 1997, P NATL ACAD SCI USA, V94, P1544, DOI 10.1073/pnas.94.4.1544; TALBOT JD, 1991, SCIENCE, V251, P1355, DOI 10.1126/science.2003220; Tershner SA, 2000, BRAIN RES, V865, P17, DOI 10.1016/S0006-8993(00)02179-X; Tershner SA, 2000, PAIN, V85, P153, DOI 10.1016/S0304-3959(99)00257-2; TITELER M, 1989, EUR J PHARMACOL, V167, P221, DOI 10.1016/0014-2999(89)90582-7; Tolle TR, 1999, ANN NEUROL, V45, P40, DOI 10.1002/1531-8249(199901)45:1<40::AID-ART8>3.0.CO;2-L; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Wiedenmayer CP, 2000, BEHAV NEUROSCI, V114, P125, DOI 10.1037/0735-7044.114.1.125; Willoch F, 1999, AM J NEURORADIOL, V20, P686; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; ZHANG X, 1993, IEEE T BIO-MED ENG, V40, P344, DOI 10.1109/10.222327; Zubieta JK, 1999, AM J PSYCHIAT, V156, P842, DOI 10.1176/ajp.156.6.842	54	588	606	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2001	293	5528					311	315		10.1126/science.1060952	http://dx.doi.org/10.1126/science.1060952			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452128				2022-12-28	WOS:000169875200062
J	Eggenschwiler, JT; Espinoza, E; Anderson, KV				Eggenschwiler, JT; Espinoza, E; Anderson, KV			Rab23 is an essential negative regulator of the mouse Sonic hedgehog signalling pathway	NATURE			English	Article							NEURAL-TUBE; OPEN BRAIN; GENE; MICE; CHOLESTEROL; SPECIFICITY; MUTATION; DEFECTS; FAMILY; DORSAL	The mouse open brain (opb) and Sonic hedgehog (Shh) genes have opposing roles in neural patterning: opb is required for dorsal cell types and Shh is required for ventral cell types in the spinal cord(1-3). Here we show that opb acts downstream of Shh. Ventral cell types that are absent in Shh mutants, including the floor plate, are present in Shh opb double mutants. The organization of ventral cell types in Shh opb double mutants reveals that Shh-independent mechanisms can pattern the neural tube along its dorsal-ventral axis. We cloned opb by a map-based approach and found that it encodes Rab23, a member of the Rab family of vesicle transport proteins. The data indicate that dorsalizing signals activate transcription of Rab23 in order to silence the Shh pathway in dorsal neural cells.	Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Anderson, KV (corresponding author), Sloan Kettering Inst, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.	k-anderson@ski.mskcc.org		Anderson, Kathryn/0000-0003-1657-2161				Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; CAPDEVILA J, 1994, DEVELOPMENT, V120, P987; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Eggenschwiler JT, 2000, DEV BIOL, V227, P648, DOI 10.1006/dbio.2000.9918; FORBES AJ, 1993, DEVELOPMENT, P115; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Goodrich LV, 1998, NEURON, V21, P1243, DOI 10.1016/S0896-6273(00)80645-5; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; GUNTHER T, 1994, DEVELOPMENT, V120, P3119; Holtta-Vuori M, 2000, CURR BIOL, V10, P95, DOI 10.1016/S0960-9822(99)99991-8; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Incardona JP, 2000, P NATL ACAD SCI USA, V97, P12044, DOI 10.1073/pnas.220251997; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Liem KF, 2000, DEVELOPMENT, V127, P4855; LITINGTUNG Y, 2000, NAT NEUROSCI, V10, P979; Matise MP, 1999, ONCOGENE, V18, P7852, DOI 10.1038/sj.onc.1203243; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Methot N, 2001, DEVELOPMENT, V128, P733; Milenkovic L, 1999, DEVELOPMENT, V126, P4431; Mo R, 1997, DEVELOPMENT, V124, P113; OLKKONEN VM, 1994, GENE, V138, P207, DOI 10.1016/0378-1119(94)90809-5; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797	30	284	296	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2001	412	6843					194	198		10.1038/35084089	http://dx.doi.org/10.1038/35084089			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449277				2022-12-28	WOS:000169778700055
J	van der Pluijm, BA; Hall, CM; Vrolijk, PJ; Pevear, DR; Covey, MC				van der Pluijm, BA; Hall, CM; Vrolijk, PJ; Pevear, DR; Covey, MC			The dating of shallow faults in the Earth's crust	NATURE			English	Article							ILLITE; FORELAND; CLAYS; BELT	Direct dating of ductile shear zones and calculation of uplift/exhumation rates can be done using various radiometric dating techniques. But radiometric dating of shallow crustal faulting, which occurs in the crust's brittle regime, has remained difficult(1-4) because the low temperatures typical of shallow crusted faults prevent the complete syntectonic mineral recrystallization that occurs in deeper faults. Both old (detrital) and newly grown (authigenic) fine-grained phyllosilicates are thus preserved in shallow fault zones and therefore their radiometric ages reflect a mixture of both mineral populations. Also, the loss of Ar-39 during neutron irradiation in dating of clay minerals can produce erroneously old ages. Here we present a method of characterizing the clay populations in fault gouge, using X-ray modelling, combined with sample encapsulation, and show how it can be used to date near-surface fault activity reliably. We examine fault gouge from the Lewis thrust of the southern Canadian Rockies, which we determine to be similar to 52 Myr old. This result requires the western North America stress regime to have changed from contraction to extension in only a few million years during the Eocene. We also estimate the uplift/exhumation age and sedimentary source of these rocks to be similar to 172 Myr.	Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA; ExxonMobil Upstream Res Co, Houston, TX 77252 USA	University of Michigan System; University of Michigan; Exxon Mobil Corporation	van der Pluijm, BA (corresponding author), Univ Michigan, Dept Geol Sci, 1006 CC Little Bldg, Ann Arbor, MI 48109 USA.		van der Pluijm, Ben/A-8985-2008; van der Pluijm, Ben/M-3155-2019	van der Pluijm, Ben/0000-0001-7737-2791; van der Pluijm, Ben/0000-0001-7737-2791				BIRD P, 1988, SCIENCE, V239, P1501, DOI 10.1126/science.239.4847.1501; Constenius KN, 1996, GEOL SOC AM BULL, V108, P20, DOI 10.1130/0016-7606(1996)108<0020:LPECOT>2.3.CO;2; DONG HL, 1995, SCIENCE, V267, P355, DOI 10.1126/science.267.5196.355; Dong HL, 2000, EARTH PLANET SC LETT, V175, P309, DOI 10.1016/S0012-821X(99)00294-0; Eide EA, 1997, TERRA NOVA, V9, P135, DOI 10.1046/j.1365-3121.1997.d01-21.x; Fermor P, 1999, GEOL SOC AM BULL, V111, P317, DOI 10.1130/0016-7606(1999)111<0317:AOTTDS>2.3.CO;2; FOLAND KA, 1992, CHEM GEOL, V102, P269, DOI 10.1016/0009-2541(92)90161-W; Gibbons W, 1996, GEOLOGY, V24, P411, DOI 10.1130/0091-7613(1996)024<0411:MTMTFE>2.3.CO;2; Grathoff GH, 1996, CLAY CLAY MINER, V44, P835, DOI 10.1346/CCMN.1996.0440615; Hall CM, 1997, EARTH PLANET SC LETT, V148, P287, DOI 10.1016/S0012-821X(97)00041-1; Jaboyedoff M, 1999, CONTRIB MINERAL PETR, V135, P93, DOI 10.1007/s004100050500; KRALIK M, 1987, NATURE, V327, P315, DOI 10.1038/327315a0; Murphy P.J., 1979, REV ENG GEOL, V4, P153; Onstott TC, 1997, GEOCHIM COSMOCHIM AC, V61, P3851, DOI 10.1016/S0016-7037(97)00288-3; PEAVER DR, 1992, P 7 INT S WAT ROCK I, P1251; Pevear DR, 1999, P NATL ACAD SCI USA, V96, P3440, DOI 10.1073/pnas.96.7.3440; PEVEAR DR, 1993, COMPUTER APPL XRAY P, P19; PRICE RA, 1981, THRUST NAPPE TECTONI, P427; REYNOLDS RC, 1994, WILDFIRE COMPUTER PR; REYNOLDS RC, 1996, NEWMOD COMPUTER PROG; SMITH S, 1993, SOC PROBL, V40, P39, DOI 10.1525/sp.1993.40.1.03x0071s; SRODON J, 1984, REV MINERAL, V13, P495; Vrolijk P, 1999, J STRUCT GEOL, V21, P1039, DOI 10.1016/S0191-8141(99)00103-0; VROLIJK P, 1994, GEOL SOC AM, V26, P466; WILTSCHKO DV, 1983, AAPG BULL, V67, P1304; YAN Y, IN PRESS GEOL SOC SP	26	177	177	2	19	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					172	175		10.1038/35084053	http://dx.doi.org/10.1038/35084053			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449270	Green Published			2022-12-28	WOS:000169778700048
J	Floyd, JS; Mutter, JC; Goodliffe, AM; Taylor, B				Floyd, JS; Mutter, JC; Goodliffe, AM; Taylor, B			Evidence for fault weakness and fluid flow within an active low-angle normal fault	NATURE			English	Article							PAPUA-NEW-GUINEA; WOODLARK BASIN; FRICTION; MODEL; RIDGE	Determining the composition and physical properties of shallow-dipping, active normal faults (dips, <35<degrees> with respect to the horizontal) is important for understanding how such faults slip under low resolved shear stress and accommodate significant extension of the crust and lithosphere. Seismic reflection images(1) and earthquake source parameters(2) show that a magnitude 6.2 earthquake occurred at about 5 km depth on or close to a normal fault with a dip of 25-30 degrees located ahead of a propagating spreading centre in the Woodlark basin. Here we present results from a genetic algorithm inversion of seismic reflection data, which shows that the fault at 4-5 km depth contains a 33-m-thick layer with seismic velocities of about 4.3 km s(-1), which we interpret to be composed of serpentinite fault gouge. Isolated zones exhibit velocities as low as similar to1.7 km s(-1) with high porosities, which we suggest are maintained by high fluid pressures. We propose that hydrothermal fluid flow, possibly driven by a deep magmatic heat source, and high extensional stresses ahead of the ridge tip have created conditions for fault weakness and strain localization on the low-angle normal fault.	Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Columbia Univ, Dept Earth & Environm Sci, New York, NY 10027 USA; Columbia Univ, Columbia Earth Inst, New York, NY 10027 USA; Univ Hawaii, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA	Columbia University; Columbia University; Columbia University; University of Hawaii System	Floyd, JS (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.							Abers GA, 1997, J GEOPHYS RES-SOL EA, V102, P15301, DOI 10.1029/97JB00787; Anderson E. M., 1942, DYNAMICS FAULTING DY; BYERLEE J, 1990, GEOPHYS RES LETT, V17, P2109, DOI 10.1029/GL017i012p02109; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; DAVIES HL, 1971, GEOL SOC AM BULL, V82, P3299, DOI 10.1130/0016-7606(1971)82[3299:GOEP]2.0.CO;2; GANLEY DC, 1981, GEOPHYSICS, V46, P1100, DOI 10.1190/1.1441250; Goldberg D.E., 1989, GENETIC ALGORITHMS S; MARONE C, 1990, J GEOPHYS RES-SOLID, V95, P7007, DOI 10.1029/JB095iB05p07007; MUTTER JC, 1992, SCIENCE, V257, P627, DOI 10.1126/science.257.5070.627; Mutter JC, 1996, NATURE, V380, P333, DOI 10.1038/380333a0; MUTTER JC, 1993, EOS, V74, P412; OSTRANDER WJ, 1984, GEOPHYSICS, V49, P1637, DOI 10.1190/1.1441571; Rice J., 1992, FAULT MECH TRANSPORT, P475, DOI DOI 10.1016/S0074-6142(08)62835-1; SEN MK, 1992, GEOPHYS J INT, V108, P281, DOI 10.1111/j.1365-246X.1992.tb00857.x; SHUEY RT, 1985, GEOPHYSICS, V50, P609, DOI 10.1190/1.1441936; TAYLOR B, 1995, NATURE, V374, P534, DOI 10.1038/374534a0; Taylor B, 1999, J GEOPHYS RES-SOL EA, V104, P7497, DOI 10.1029/1998JB900115; TAYLOR B, 1996, JOI USSAC NEWSL, V9, P1; Taylor B., 1999, P ODP INIT REP, V180; Tucholke BE, 1998, J GEOPHYS RES-SOL EA, V103, P9857, DOI 10.1029/98JB00167; TUCHOLKE BE, 1994, J GEOPHYS RES-SOL EA, V99, P11937, DOI 10.1029/94JB00338; WIDESS MB, 1984, GEOPHYSICS, V49, P1637; Wyllie M.R.J., 1958, GEOPHYSICS, V23, P459, DOI 10.1190/1.1438493	23	64	65	0	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					779	783		10.1038/35081040	http://dx.doi.org/10.1038/35081040			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459052				2022-12-28	WOS:000169246400043
J	Gerstein, HC; Mann, JFE; Yi, QL; Zinman, B; Dinneen, SF; Hoogwerf, B; Halle, JP; Young, J; Rashkow, A; Joyce, C; Nawaz, S; Yusuf, S				Gerstein, HC; Mann, JFE; Yi, QL; Zinman, B; Dinneen, SF; Hoogwerf, B; Halle, JP; Young, J; Rashkow, A; Joyce, C; Nawaz, S; Yusuf, S		HOPE Study Investigators	Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOLLOW-UP; BLOOD-PRESSURE; REGRESSION DILUTION; ALL-CAUSE; MICROALBUMINURIA; MORTALITY; DISEASE; EXCRETION; PREDICTORS; ASSOCIATION	Context Microalbuminuria is a risk factor for cardiovascular (CV) events. The relationship between the degree of albuminuria and CV risk is unclear. Objectives To estimate the risk of CV events in high-risk individuals with diabetes mellitus (DM) and without DM who have microalbuminuria and to determine whether levels of albuminuria below the microalbuminuria threshold increase CV risk. Design The Heart Outcomes Prevention Evaluation study, a cohort study conducted between 1994 and 1999 with a median 4.5 years of follow-up. Setting Community and academic practices in North and South America and Europe. Participants Individuals aged 55 years or more with a history of CV disease (n=5545) or DM and at least 1 CV risk factor (n =3498) and a baseline urine albumin/creatinine ratio (ACR) measurement. Main Outcome Measures Cardiovascular events (myocardial infarction, stroke, or CV death); all-cause death; and hospitalization for congestive heart failure. Results Microalbuminuria was detected in 1140 (32.6%) of those with DM and 823 (14.8%) of those without DM at baseline. Microalbuminuria increased the adjusted relative risk (RR) of major CV events (RR, 1.83; 95% confidence interval [CI], 1.64-2.05), all-cause death (RR, 2.09; 95% CI, 1.84-2.38), and hospitalization for congestive heart failure (RR, 3.23; 95% CI, 2.54-4.10). Similar RRs were seen for participants with or without DM, even after adjusting for other CV risk factors (eg, the adjusted RR of the primary aggregate end point was 1.97 [95% CI, 1.68-2.31] in those with DM and 1.61 [95% CI, 1.36-1.90] in those without DM). Compared with the lowest quartile of ACR (<0.22 mg/mmol), the RRs of the primary aggregate end point in the second quartile (ie, ACR range, 0.22-0.57 mg/mmol) was 1.11 (95 % CI, 0.95-1.30); third quartile, 1.38 (95 % CI, 1.19-1.60; ACR range, 0.58-1.62 mg/mmol); and fourth quartile, 1.97 (95% CI, 1.73-2.25; ACR range, >1.62 mg/mmol) (P for trend <.001, even after excluding those with microalbuminuria). For every 0.4-mg/mmol increase in ACR level, the adjusted hazard of major CV events increased by 5.9% (95% CI, 4.9%-7.0%). Conclusions Our results indicate that any degree of albuminuria is a risk factor for CV events in individuals with or without DM; the risk increases with the ACR, starting well below the microalbuminuria cutoff. Screening for albuminuria identifies people at high risk for CV events.	McMaster Univ, Hamilton, ON, Canada; LMU, Klinikum Schwabing, Munich, Germany; Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Addenbrookes Hosp, Cambridge, England; Cleveland Clin Fdn, Cleveland, OH 44195 USA; Univ Montreal, Montreal, PQ, Canada; Griffin Hosp, Derby, CT USA; Mem Univ Newfoundland, St John, NF, Canada; Sudbury Reg Hosp, Sudbury, ON, Canada	McMaster University; Munchen Klinik; University of Munich; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cleveland Clinic Foundation; Universite de Montreal; Memorial University Newfoundland; Health Sciences North	Gerstein, HC (corresponding author), Dept Med, Room 3V38,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	gerstein@mcmaster.ca	Arnold, Malcolm/G-2869-2011; Gerstein, Hertzel/ABB-8781-2020; Zinman, Bernard/E-7266-2013; Gerstein, Hertzel C/B-1235-2013; Mann, Johannes/AAI-8803-2020	Gerstein, Hertzel/0000-0001-8072-2836; Gerstein, Hertzel C/0000-0001-8072-2836; Dinneen, Sean/0000-0002-6636-0493; Yusuf, Salim/0000-0003-4776-5601				Agewall S, 1997, AM J CARDIOL, V80, P164, DOI 10.1016/S0002-9149(97)00312-3; Agrawal B, 1996, J HYPERTENS, V14, P223, DOI 10.1097/00004872-199602000-00011; ANDERSSON DKG, 1995, DIABETES CARE, V18, P1534, DOI 10.2337/diacare.18.12.1534; Berton G, 1995, G Ital Cardiol, V25, P999; Berton G, 1997, CIRCULATION, V96, P3338; Borch-Johnsen K, 1999, ARTERIOSCL THROM VAS, V19, P1992, DOI 10.1161/01.ATV.19.8.1992; Capes SE, 2000, DIABETES CARE, V23, P377, DOI 10.2337/diacare.23.3.377; Chaiken RL, 1997, DIABETES CARE, V20, P709, DOI 10.2337/diacare.20.5.709; Cirillo M, 1998, ARCH INTERN MED, V158, P1933, DOI 10.1001/archinte.158.17.1933; DAMSGAARD EM, 1990, BRIT MED J, V300, P297, DOI 10.1136/bmj.300.6720.297; Dinneen SF, 1997, ARCH INTERN MED, V157, P1413, DOI 10.1001/archinte.157.13.1413; EISKJAER H, 1992, SCAND J CLIN LAB INV, V52, P193, DOI 10.3109/00365519209088785; Forsblom CM, 1998, DIABETES CARE, V21, P1932, DOI 10.2337/diacare.21.11.1932; Gerstein HC, 1996, DIABETES CARE, V19, P1225, DOI 10.2337/diacare.19.11.1225; Gerstein HC, 2000, DIABETES CARE, V23, pB35; GIACONI S, 1989, AM J HYPERTENS, V2, P259, DOI 10.1093/ajh/2.4.259; GOLDBOURT U, 1993, CARDIOLOGY, V82, P100, DOI 10.1159/000175862; HAFFNER SM, 1993, DIABETOLOGIA, V36, P1002, DOI 10.1007/BF02374491; HARRISON NA, 1989, BRIT J UROL, V63, P202, DOI 10.1111/j.1464-410X.1989.tb05166.x; *HEART OUTC PREV E, 2000, LANCET, V255, P253; HOFMANN W, 1989, J CLIN CHEM CLIN BIO, V27, P589; Hoogeveen EK, 1998, KIDNEY INT, V54, P203, DOI 10.1038/sj.ki.4495353; Jager A, 1999, ARTERIOSCL THROM VAS, V19, P617, DOI 10.1161/01.ATV.19.3.617; Jensen JS, 1997, NEPHROL DIAL TRANSPL, V12, P6; KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035; Knuiman MW, 1998, ANN EPIDEMIOL, V8, P56, DOI 10.1016/S1047-2797(97)00107-5; KUUSISTO J, 1994, DIABETES, V43, P960, DOI 10.2337/diabetes.43.8.960; Ljungman S, 1996, AM J HYPERTENS, V9, P770, DOI 10.1016/0895-7061(96)00102-1; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MELTZER S, 1998, CMAJ S8, V159, pS29; Mindlen F, 1996, CAN J CARDIOL, V12, P127; MOSS SE, 1994, ARCH INTERN MED, V154, P2473; Mudrikova T, 1999, WIEN KLIN WOCHENSCHR, V111, P66; Mykkanen L, 1998, DIABETES, V47, P793, DOI 10.2337/diabetes.47.5.793; MYKKANEN L, 1994, DIABETES, V43, P552, DOI 10.2337/diabetes.43.4.552; Niskanen L, 1998, DIABETES CARE, V21, P1861, DOI 10.2337/diacare.21.11.1861; Pickup JC, 1997, DIABETOLOGIA, V40, P1286, DOI 10.1007/s001250050822; SHULMAN N B, 1989, Hypertension (Dallas), V13, pI80; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; STEHOUWER CDA, 1992, LANCET, V340, P319, DOI 10.1016/0140-6736(92)91401-S; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823; VESTBO E, 1995, DIABETIC MED, V12, P488, DOI 10.1111/j.1464-5491.1995.tb00529.x; Wei M, 1998, DIABETES CARE, V21, P1167, DOI 10.2337/diacare.21.7.1167; Wingard DL., 1995, DIABETES AM, P429; YUDKIN JS, 1988, LANCET, V2, P530; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zelmanovitz T, 1997, DIABETES CARE, V20, P516, DOI 10.2337/diacare.20.4.516	47	1794	1887	3	49	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2001	286	4					421	426		10.1001/jama.286.4.421	http://dx.doi.org/10.1001/jama.286.4.421			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456DZ	11466120	Bronze			2022-12-28	WOS:000170069000013
J	Reilly, J; Stone, PH; Forest, CE; Webster, MD; Jacoby, HD; Prinn, RG				Reilly, J; Stone, PH; Forest, CE; Webster, MD; Jacoby, HD; Prinn, RG			Climate change - Uncertainty and climate change assessments	SCIENCE			English	Editorial Material							EXPERT		MIT, Joint Program Sci & Policy Global Change, Cambridge, MA 02139 USA; Univ N Carolina, Dept Publ Policy, Chapel Hill, NC 27599 USA	Massachusetts Institute of Technology (MIT); University of North Carolina; University of North Carolina Chapel Hill	Reilly, J (corresponding author), MIT, Joint Program Sci & Policy Global Change, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Forest, Chris E/M-1993-2014	Forest, Chris E/0000-0002-2643-0186				Australian Academy of Sciences, 2001, SCIENCE, V292, P1261; FOREST CE, IN PRESS CLIM DYN; Houghton J. T., 2001, CLIMATE CHANGE 2001; Kerr RA, 2001, SCIENCE, V292, P192, DOI 10.1126/science.292.5515.192; MANNE AS, 1994, ENERGY J, V15, P31; McCarthy J.J., 2001, CLIMATE CHANGE 2001; Metz B., 2001, CLIMATE CHANGE 2001; Morgan MG, 1995, ENVIRON SCI TECHNOL, V29, P468, DOI DOI 10.1021/ES00010A003; MORGAN MG, 1990, UNCERTAINTY GUIDE DE; Moss R. H., 2000, GUIDANCE PAPERS CROS, P33; Nakienovi N, 2000, SPECIAL REPORT EMISS; NORDHAUS WD, 1994, AM SCI, V82, P45; NORDHAUS WD, 1983, CHANGING CLIMATE, P87; PRINN R, 1999, CLIMATIC CHANGE, V41, P496; Reilly J., 1987, ENERGY J, V8, P1; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; WEBSTER MD, 2001, 73 MIT; Wigley TML, 2001, SCIENCE, V293, P451, DOI 10.1126/science.1061604	18	129	135	7	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2001	293	5529					430	+						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463897				2022-12-28	WOS:000169966700025
J	Rexrode, KM; Buring, JE; Glynn, RJ; Stampfer, MJ; Youngman, LD; Gaziano, JM				Rexrode, KM; Buring, JE; Glynn, RJ; Stampfer, MJ; Youngman, LD; Gaziano, JM			Analgesic use and renal function in men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; NONNARCOTIC ANALGESICS; COLORECTAL-CANCER; FAILURE; DISEASE; RISK; ASPIRIN; ACETAMINOPHEN; ABUSE	Context Several case-control studies suggest an association between analgesic use and increased risk of chronic renal disease, but few cohort studies have examined this association. Objective To determine whether analgesic use is associated with risk of renal dysfunction. Design and Setting Cohort study of analgesic use data from the Physicians' Health Study, which lasted 14 years from September 1982 to December 1995 with annual follow-up. Participants A total of 11 032 initially healthy men who provided blood samples and self-report of analgesic use. Main Outcome Measures Elevated creatinine level defined as 1.5 mg/dL (133 mu mol/L) or higher and a reduced creatinine clearance defined as 55 mL/min (0.9 mL/s) or less, and self-reported use of acetaminophen, aspirin, and other nonsteroidal antiinflammatory drugs (never [<12 pills]; 12-1499 pills; 1500-2499 pills; and <greater than or equal to>2500 pills). Results PI total of 460 men had elevated creatinine levels (4.2%) and 1258 had reduced creatinine clearance (11.4%). Mean creatinine levels and creatinine clearances were similar among men who did not use analgesics and those who did, even at total intakes of 2500 or more pills. In multivariable analyses adjusted for age; body mass index; history of hypertension, elevated cholesterol, and diabetes; occurrence of cardiovascular disease; physical activity; and use of other analgesics, the relative risks of elevated creatinine level associated with intake of 2500 or more pills were 0.83 (95% confidence interval [CI], 0.50-1.39, P for trend =.05) for acetaminophen, 0.98 (95% CI, 0.53-1.81; P for trend =.96) for aspirin, and 1.07 (95% CI, 0.71-1.64; P for trend =.86) for other nonsteroidal anti-inflammatory drugs. Ho association was observed be tween analgesic use and reduced creatinine clearance. Conclusions Moderate analgesic use in this cohort study of initially healthy men was not associated with increased risk of renal dysfunction.	Brigham & Womens Hosp, Dept Med, Div Prevent Med, Channing Lab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; US FDA, Res Off, Laurel, MD USA; Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA USA; VA Boston Healthcare Syst, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; US Food & Drug Administration (FDA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Gaziano, JM (corresponding author), Brigham & Womens Hosp, Dept Med, Div Prevent Med, Channing Lab, 900 Commonwealth Ave, Boston, MA 02215 USA.		Rexrode, Kathryn M/I-1177-2018	Rexrode, Kathryn/0000-0003-3387-8429	NATIONAL CANCER INSTITUTE [R01CA040360] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034595] Funding Source: NIH RePORTER; NCI NIH HHS [CA-40360, CA-34944] Funding Source: Medline; NHLBI NIH HHS [HL-34595, HL-26490] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BLAKELY P, 1995, J AM SOC NEPHROL, V6, P48; CHRISCHILLES EA, 1992, J GERONTOL, V47, pM137, DOI 10.1093/geronj/47.5.M137; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; DAgati V, 1996, AM J KIDNEY DIS, V28, pS24, DOI 10.1016/S0272-6386(96)90565-X; Delzell E, 1998, MEDICINE, V77, P102, DOI 10.1097/00005792-199803000-00003; DUBACH UC, 1991, NEW ENGL J MED, V324, P155, DOI 10.1056/NEJM199101173240304; ELSEVIERS MM, 1995, KIDNEY INT, V48, P1912, DOI 10.1038/ki.1995.491; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; Griffin MR, 2000, AM J EPIDEMIOL, V151, P488; Gutthann SP, 1996, ARCH INTERN MED, V156, P2433, DOI 10.1001/archinte.1996.00440200041005; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; MCCREDIE M, 1988, NEPHRON, V49, P26; McLaughlin JK, 1998, KIDNEY INT, V54, P679, DOI 10.1046/j.1523-1755.1998.00043.x; MORLANS M, 1990, BRIT J CLIN PHARMACO, V30, P717, DOI 10.1111/j.1365-2125.1990.tb03841.x; MURRAY TG, 1983, ARCH INTERN MED, V143, P1687, DOI 10.1001/archinte.143.9.1687; PERNEGER TV, 1994, NEW ENGL J MED, V331, P1675, DOI 10.1056/NEJM199412223312502; POMMER W, 1989, AM J NEPHROL, V9, P403, DOI 10.1159/000168002; ROSNER B, 1977, AM J EPIDEMIOL, V106, P306, DOI 10.1093/oxfordjournals.aje.a112466; SANDLER DP, 1989, NEW ENGL J MED, V320, P1238, DOI 10.1056/NEJM198905113201903; SANDLER DP, 1991, ANN INTERN MED, V115, P165, DOI 10.7326/0003-4819-115-3-165; SHEKELLE RB, 1981, NEW ENGL J MED, V304, P65, DOI 10.1056/NEJM198101083040201; SPUHLER O, 1953, Z KLIN MED, V151, P1; STEENLAND NK, 1990, AM J PUBLIC HEALTH, V80, P153, DOI 10.2105/AJPH.80.2.153; YOUNGMAN LD, 1993, FASEB J, V1, P377; 1988, N ENGL J MED, V318, P262; 1983, FED REG         1005, V48, P45466	27	78	80	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2001	286	3					315	321		10.1001/jama.286.3.315	http://dx.doi.org/10.1001/jama.286.3.315			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452QA	11466097	Bronze			2022-12-28	WOS:000169869200022
J	Chan, SY; Empig, CJ; Welte, FJ; Speck, RF; Schmaljohn, A; Kreisberg, JF; Goldsmith, MA				Chan, SY; Empig, CJ; Welte, FJ; Speck, RF; Schmaljohn, A; Kreisberg, JF; Goldsmith, MA			Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses	CELL			English	Article							BINDING-PROTEIN; GLYCOPROTEIN; MEMBRANE; IDENTIFICATION; SEQUESTRATION; INFECTIONS	Human infections by Marburg (MBG) and Ebola (EBO) viruses result in lethal hemorrhagic fever. To identify cellular entry factors employed by MBG virus, noninfectible cells transduced with an expression library were challenged with a selectable pseudotype virus packaged by MBG glycoproteins (GP). A cDNA encoding the folate receptor-alpha (FR-alpha) was recovered from cells exhibiting reconstitution of viral entry. A FR-alpha cDNA was recovered in a similar strategy employing EBO pseudotypes. FR-alpha expression in Jurkat cells facilitated MBG or EBO entry, and FR-blocking reagents inhibited infection by MBG or EBO. Finally, FR-alpha bound cells expressing MBG or EBO GP and mediated syncytia formation triggered by MBG GP. Thus, FR-alpha is a significant cofactor for cellular entry for MBG and EBO viruses.	Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA; Univ Calif San Francisco, Sch Med, San Francisco, CA 94141 USA; USA, Med Res Inst Infect Dis, Div Virol, Frederick, MD 21702 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Goldsmith, MA (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA.	mgoldsmith@gladstone.ucsf.edu	Speck, Roberto F/O-2433-2016	Kreisberg, Jason/0000-0002-3616-079X; Speck, Roberto/0000-0002-8453-1137				Allan VJ, 2000, PRACT APPROACH SER, V218, P1; ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; Antony AC, 1996, ANNU REV NUTR, V16, P501, DOI 10.1146/annurev.nu.16.070196.002441; BECKER S, 1995, J GEN VIROL, V76, P393, DOI 10.1099/0022-1317-76-2-393; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bray M, 1999, J INFECT DIS, V179, pS248, DOI 10.1086/514292; Chan SY, 2000, J GEN VIROL, V81, P2155, DOI 10.1099/0022-1317-81-9-2155; Chan SY, 2000, J VIROL, V74, P4933, DOI 10.1128/JVI.74.10.4933-4937.2000; Connolly BM, 1999, J INFECT DIS, V179, pS203, DOI 10.1086/514305; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Da Costa M, 2000, AM J PHYSIOL-CELL PH, V278, pC812, DOI 10.1152/ajpcell.2000.278.4.C812; FRA AM, 1994, J BIOL CHEM, V269, P30745; FRANKLIN WA, 1994, INT J CANCER, P89; Geisbert TW, 2000, LAB INVEST, V80, P171, DOI 10.1038/labinvest.3780021; Geisbert TW, 1998, ULTRASTRUCT PATHOL, V22, P3, DOI 10.3109/01913129809032253; Hevey M, 1997, VIROLOGY, V239, P206, DOI 10.1006/viro.1997.8883; JOHNSON E, 1995, INT J EXP PATHOL, V76, P227; KAMEN BA, 1988, J BIOL CHEM, V263, P13602; Lee RJ, 1996, BBA-MOL CELL RES, V1312, P237, DOI 10.1016/0167-4889(96)00041-9; MAYOR S, 1994, SCIENCE, V264, P1948, DOI 10.1126/science.7516582; Maziarz KM, 1999, J BIOL CHEM, V274, P11086, DOI 10.1074/jbc.274.16.11086; Peters C.J., 1996, FIELDS VIROLOGY, P1161; Rijnboutt S, 1996, J CELL BIOL, V132, P35, DOI 10.1083/jcb.132.1.35; Ross JF, 1999, CANCER-AM CANCER SOC, V85, P348, DOI 10.1002/(SICI)1097-0142(19990115)85:2<348::AID-CNCR12>3.0.CO;2-4; ROSS JF, 1994, CANCER-AM CANCER SOC, V73, P2432, DOI 10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; SCHMALJOHN AL, 1995, VIROLOGY, V206, P963, DOI 10.1006/viro.1995.1019; SVENDSEN IB, 1982, CARLSBERG RES COMMUN, V47, P371, DOI 10.1007/BF02907775; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; VEY M, 1992, VIROLOGY, V188, P408, DOI 10.1016/0042-6822(92)90775-K; Villanueva J, 1998, AM J PHYSIOL-REG I, V275, pR1503, DOI 10.1152/ajpregu.1998.275.5.R1503; Volchkov VE, 2000, VIROLOGY, V268, P1, DOI 10.1006/viro.1999.0110; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; WEITMAN SD, 1992, CANCER RES, V52, P3396; WEITMAN SD, 1992, CANCER RES, V52, P6708; Wool-Lewis RJ, 1998, J VIROL, V72, P3155, DOI 10.1128/JVI.72.4.3155-3160.1998; Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654; Yang ZY, 1998, SCIENCE, V279, P1034, DOI 10.1126/science.279.5353.1034; Zaki SR, 1999, CURR TOP MICROBIOL, V235, P97	40	165	178	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2001	106	1					117	126		10.1016/S0092-8674(01)00418-4	http://dx.doi.org/10.1016/S0092-8674(01)00418-4			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461707	Bronze			2022-12-28	WOS:000169870300014
J	McBride, AE; Silver, PA				McBride, AE; Silver, PA			State of the Arg: Protein methylation at arginine comes of age	CELL			English	Review							N-METHYLTRANSFERASE; SUBSTRATE-SPECIFICITY; BINDING; OLIGOMERIZATION; DOMAIN; PRMT3		Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Dept Canc Biol,Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	McBride, AE (corresponding author), Bowdoin Coll, Dept Biol, Brunswick, ME 04011 USA.							Abramovich C, 1997, EMBO J, V16, P260, DOI 10.1093/emboj/16.2.260; Bedford MT, 2000, J BIOL CHEM, V275, P16030, DOI 10.1074/jbc.M909368199; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; BRANSCOMBE TL, 2001, IN PRESS J BIOL CHEM, V18; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Frankel A, 2000, J BIOL CHEM, V275, P32974, DOI 10.1074/jbc.M006445200; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; RAJPUROHIT R, 1994, BIOCHEM J, V304, P903, DOI 10.1042/bj3040903; Shen EC, 1998, GENE DEV, V12, P679, DOI 10.1101/gad.12.5.679; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Valentini SR, 1999, RNA, V5, P272, DOI 10.1017/S1355838299981633; WAN GH, 2001, SCIENCE, V31, P31; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; Yun CY, 2000, J CELL BIOL, V150, P707, DOI 10.1083/jcb.150.4.707; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509	20	382	390	2	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2001	106	1					5	8		10.1016/S0092-8674(01)00423-8	http://dx.doi.org/10.1016/S0092-8674(01)00423-8			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461695	Bronze			2022-12-28	WOS:000169870300002
J	Reddien, PW; Cameron, S; Horvitz, HR				Reddien, PW; Cameron, S; Horvitz, HR			Phagocytosis promotes programmed cell death in C-elegans	NATURE			English	Article							CAENORHABDITIS-ELEGANS; APOPTOTIC CELLS; PROTEIN CED-9; GENE; ENGULFMENT; ENCODES; NEMATODE; MACROPHAGES; ACTIVATION; MIGRATION	In the nematode Caenorhabditis elegans programmed cell death requires the killer genes egl-1, ced-4 and ced-3 (refs 1 and 2), and the engulfment of dying cells requires the genes ced-1, ced-2, ced-5, ced-6, ced-7, ced-10 and ced-12 (refs 3-5). Here we show that engulfment promotes programmed cell death. Mutations that cause partial loss of function of killer genes allow the survival of some cells that are programmed to die, and mutations in engulfment genes enhance the frequency of this cell survival. Furthermore, mutations in engulfment genes alone allow the survival and differentiation of some cells that would normally die. Engulfment genes probably act in engulfing cells to promote death, as the expression in engulfing cells of ced-1, which encodes a receptor that recognizes cell corpses(6), rescues the cell-killing defects of ced-1 mutants. We propose that engulfing cells act to ensure that cells triggered to undergo programmed cell death by the CED-3 caspase(7) die rather than recover after the initial stages of death.	MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; Childrens Hosp, Dana Farber Canc Inst, Div Pediat Hematol Oncol, Boston, MA 02115 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute	Horvitz, HR (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, 68-425,77 Massachusetts Ave, Cambridge, MA 02139 USA.							Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Chung SB, 2000, NAT CELL BIOL, V2, P931, DOI 10.1038/35046585; CLARK SG, 1994, GENETICS, V137, P987; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Conradt B, 1999, CELL, V98, P317, DOI 10.1016/S0092-8674(00)81961-3; DiezRoux G, 1997, DEVELOPMENT, V124, P3633; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; ELLIS RE, 1991, GENETICS, V129, P79; FREYD G, 1990, NATURE, V344, P876, DOI 10.1038/344876a0; HEDGECOCK EM, 1983, SCIENCE, V220, P1277, DOI 10.1126/science.6857247; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; HENGARTNER MO, 1994, NATURE, V369, P318, DOI 10.1038/369318a0; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I; LITTLE GH, 1993, COMP BIOCHEM PHYS A, V105, P79, DOI 10.1016/0300-9629(93)90176-5; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; ROBERTSON AMG, 1982, J EMBRYOL EXP MORPH, V67, P89; Shah A, 1999, AGING MENT HEALTH, V3, P153, DOI 10.1080/13607869956316; Stanfield GM, 2000, MOL CELL, V5, P423, DOI 10.1016/S1097-2765(00)80437-2; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Wu YC, 2000, GENE DEV, V14, P536; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	30	268	285	1	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					198	202		10.1038/35084096	http://dx.doi.org/10.1038/35084096			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449278				2022-12-28	WOS:000169778700056
J	Audet, AM; Hartman, EE				Audet, AM; Hartman, EE			A 47-year-old woman with severe asthma, 1 year later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Commonwealth Fund, New York, NY 10021 USA	Commonwealth Fund	Audet, AM (corresponding author), Commonwealth Fund, New York, NY 10021 USA.							Busse WW, 2000, JAMA-J AM MED ASSOC, V284, P2225, DOI 10.1001/jama.284.17.2225	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2001	286	4					457	457		10.1001/jama.286.4.457	http://dx.doi.org/10.1001/jama.286.4.457			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456DZ	11466125				2022-12-28	WOS:000170069000018
J	Achara, S; Adeyemi, B; Dosekun, E; Kelleher, S; Lansley, M; Male, I; Muhialdin, N; Reynolds, L; Roberts, I; Smailbegovic, M; van der Spek, N				Achara, S; Adeyemi, B; Dosekun, E; Kelleher, S; Lansley, M; Male, I; Muhialdin, N; Reynolds, L; Roberts, I; Smailbegovic, M; van der Spek, N		Cochrane Injuries Grp Driver Educ	Evidence based road safety: the Driving Standards Agency's schools programme	LANCET			English	Article									Inst Child Hlth, Dept Paediat Epidemiol & Biostat, London WC1N 1EH, England	University of London; University College London	Roberts, I (corresponding author), London Sch Hyg & Trop Med, Publ Hlth Intervent Res Unit, London WC1B 3DP, England.			Male, Ian/0000-0001-5426-6646				CLAYTON AB, 1998, EVALUATION DSA SCH I; DETR, 2000, TOM ROADS SAF EV GOV; Stock J.R., 1983, 806568 DOTHS NAT HIG; STRANG PM, 1982, COMP ON ROAD OFF ROA; Vernick JS, 1999, AM J PREV MED, V16, P40, DOI 10.1016/S0749-3797(98)00115-9; Wynne-Jones JD, 1984, 33 MIN TRANSP ROAD T	6	21	22	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 21	2001	358	9277					230	232		10.1016/S0140-6736(01)05416-2	http://dx.doi.org/10.1016/S0140-6736(01)05416-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454HL	11476859	Green Submitted			2022-12-28	WOS:000169967100034
J	Custovic, A; Simpson, BM; Simpson, A; Kissen, P; Woodcock, A				Custovic, A; Simpson, BM; Simpson, A; Kissen, P; Woodcock, A		NAC Manchester Asthma Allergy Stud	Effect of environmental manipulation in pregnancy and early life on respiratory symptoms and atopy during first year of life: a randomised trial	LANCET			English	Article							ALLERGEN AVOIDANCE; CONFIDENCE-INTERVALS; EARLY EXPOSURE; RISK FACTOR; ASTHMA; SENSITIZATION; CHILDREN; INFANCY; CAT; MITE	Background Asthma places huge demands on healthcare services, and its prevalence is increasing. Reduction of exposure to environmental allergens could offer a realistic chance for primary prevention. Our aim was to ascertain whether or not living in a low-allergen environment reduces the risk of asthma and atopic diseases in infants. Methods We assigned infants to four risk groups according to parental atopic status. We enrolled 291 high-risk couples (both parents atopic, no pets) into a prospective, prenatally randomised, cohort study, and allocated them to environmental manipulation, in which measures to reduce prenatal and postnatal allergen exposure were undertaken (active HRA) (n=145) or no intervention (control HRC) (n=146). Two further prospective groups were studied: 161 high-risk infants with pets in the home (HRP group) and 168 low-risk infants, whose parents were both non-atopic (LR group). The main outcome measures were signs and symptoms of atopic disease at 1 year of age. Findings 103 families dropped out or were lost to follow up. At age 1 year we followed-up 133 HRA, 118 HRC, 140 HRP, and 126 LR infants. Children in the HRA group were less likely to have respiratory symptoms during the first year of life than those in the HRC group. The most pronounced differences were in the relative risks for severe wheeze with shortness of breath (relative risk 0.44 [95% CI 0.20-1.00]), prescribed medication for the treatment of wheezy attacks (0.58 [0.36-0.95]), and wheezing after vigorous playing, crying, or exertion (0.18 [0.04-0.79]). Probability of respiratory symptoms in HRC and HRP infants was similar, whereas it was much lower in the LR than in the HRC group. Cat ownership was significantly associated with sensitisation to cats (24.6 [3.04-199.05]; p=0.003). Interpretation Environmental manipulation reduces some respiratory symptoms in the first year of life in high-risk infants. Further follow up is needed, however, to ascertain whether living in a low-allergen environment reduces allergy and asthma in later life.	Wythenshawe Hosp, NW Lung Ctr, Manchester M23 9LT, Lancs, England	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Woodcock, A (corresponding author), Wythenshawe Hosp, NW Lung Ctr, Manchester M23 9LT, Lancs, England.		Custovic, Adnan/A-2435-2012	Custovic, Adnan/0000-0001-5218-7071; Simpson, Angela/0000-0003-2733-6666; Woodcock, Ashley/0000-0002-5428-8578				ARSHAD SH, 1992, LANCET, V339, P1493, DOI 10.1016/0140-6736(92)91260-F; BULPITT CJ, 1987, LANCET, V1, P494; Burr ML, 1997, CLIN EXP ALLERGY, V27, P1247; Custovic A, 2000, J ALLERGY CLIN IMMUN, V105, P252, DOI 10.1016/S0091-6749(00)90073-3; GARDNER MJ, 1989, STAT CONFIDENCE CONF; Hesselmar B, 1999, CLIN EXP ALLERGY, V29, P611; HIDE DW, 1994, J ALLERGY CLIN IMMUN, V93, P842, DOI 10.1016/0091-6749(94)90375-1; Hide DW, 1996, ALLERGY, V51, P89, DOI 10.1111/j.1398-9995.1996.tb04563.x; KUEHR J, 1994, J ALLERGY CLIN IMMUN, V94, P44, DOI 10.1016/0091-6749(94)90070-1; LANGMAN MJS, 1986, BRIT MED J, V292, P716, DOI 10.1136/bmj.292.6522.716; Lau S, 2000, LANCET, V356, P1392, DOI 10.1016/S0140-6736(00)02842-7; Martin YC, 1998, PERSPECT DRUG DISCOV, V12, P3, DOI 10.1023/A:1017037831628; Martinez FD, 1999, J ALLERGY CLIN IMMUN, V104, pS169, DOI 10.1016/S0091-6749(99)70058-8; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Peat JK, 1999, J ALLERGY CLIN IMMUN, V103, P1, DOI 10.1016/S0091-6749(99)70517-8; Platts-Mills T, 2001, LANCET, V357, P752, DOI 10.1016/S0140-6736(00)04168-4; Roost HP, 1999, J ALLERGY CLIN IMMUN, V104, P941, DOI 10.1016/S0091-6749(99)70072-2; Simpson BM, 2001, CLIN EXP ALLERGY, V31, P391, DOI 10.1046/j.1365-2222.2001.01050.x; Squillace SP, 1997, AM J RESP CRIT CARE, V156, P1760, DOI 10.1164/ajrccm.156.6.9704026; Tovey E, 1999, J ALLERGY CLIN IMMUN, V103, P179, DOI 10.1016/S0091-6749(99)70488-4; VANTO T, 1983, ACTA PAEDIATR SCAND, V72, P571, DOI 10.1111/j.1651-2227.1983.tb09773.x; Wahn U, 1997, J ALLERGY CLIN IMMUN, V99, P763, DOI 10.1016/S0091-6749(97)80009-7; Warner JA, 1991, PEDIATR ALLERGY IMMU, V1, P79; 1978, AM REV RESP DIS S, V118, P7	24	218	222	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 21	2001	358	9277					188	193		10.1016/S0140-6736(01)05406-X	http://dx.doi.org/10.1016/S0140-6736(01)05406-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454HL	11476835				2022-12-28	WOS:000169967100011
J	Minor, PD				Minor, PD			Biosafety consequences of eradication of wild-type polioviruses	LANCET			English	Editorial Material									Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England	National Institute for Biological Standards & Control	Minor, PD (corresponding author), Natl Inst Biol Stand & Controls, Blanche Lane S Mimms, Potters Bar EN6 3QG, Herts, England.							Dove AW, 1997, SCIENCE, V277, P779, DOI 10.1126/science.277.5327.779; DOWDLE WR, 1997, J INFECT DIS S1, V109, P1; *HOUS COMM, 1980, REP INV CAUS 1978 BI; Kelly H, 2000, Commun Dis Intell, V24, P207; Mulders MN, 1997, J INFECT DIS, V176, P617, DOI 10.1086/514081; *WHO, 1999, WER, V74, P165; *WHO VACC ASS MON, 1999, WHOVB9932 VAC ASS MO; Wood D. J., 2000, Biologicals, V28, P199, DOI 10.1006/biol.2000.0257; Wood DJ, 2000, B WORLD HEALTH ORGAN, V78, P347	9	10	10	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 21	2001	358	9277					166	168		10.1016/S0140-6736(01)05399-5	http://dx.doi.org/10.1016/S0140-6736(01)05399-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454HL	11476828				2022-12-28	WOS:000169967100004
J	Stephens, JC; Schneider, JA; Tanguay, DA; Choi, J; Acharya, T; Stanley, SE; Jiang, RH; Messer, CJ; Chew, A; Han, JH; Duan, JC; Carr, JL; Lee, MS; Koshy, B; Kumar, AM; Zhang, G; Newell, WR; Windemuth, A; Xu, CB; Kalbfleisch, TS; Shaner, SL; Arnold, K; Schulz, V; Drysdale, CM; Nandabalan, K; Judson, RS; Ruano, G; Vovis, GF				Stephens, JC; Schneider, JA; Tanguay, DA; Choi, J; Acharya, T; Stanley, SE; Jiang, RH; Messer, CJ; Chew, A; Han, JH; Duan, JC; Carr, JL; Lee, MS; Koshy, B; Kumar, AM; Zhang, G; Newell, WR; Windemuth, A; Xu, CB; Kalbfleisch, TS; Shaner, SL; Arnold, K; Schulz, V; Drysdale, CM; Nandabalan, K; Judson, RS; Ruano, G; Vovis, GF			Haplotype variation and linkage disequilibrium in 313 human genes	SCIENCE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; HUMAN LIPOPROTEIN-LIPASE; DNA POLYMORPHISM; ADMIXTURE; ALLELES; SUBSTITUTIONS; POPULATIONS; DIVERSITY; MUTATION; AFRICAN	Variation within genes has important implications for all biological traits. We identified 3899 single nucleotide polymorphisms (SNPs) that were present within 313 genes from 82 unrelated individuals of diverse ancestry, and we organized the SNPs into 4304 different haplotypes. Each gene had several variable SNPs and haplotypes that were present in all populations, as well as a number that were population-specific. Pairs of SNPs exhibited variability in the degree of Linkage disequilibrium that was a function of their Location within a gene, distance from each other, population distribution, and population frequency. Haplotypes generally had more information content (heterozygosity) than did individual SNPs. Our analysis of the pattern of variation strongly supports the recent expansion of the human population.	Genaissance Pharmaceut Inc, New Haven, CT 06511 USA		Stephens, JC (corresponding author), Genaissance Pharmaceut Inc, 5 Sci Pk, New Haven, CT 06511 USA.		Schneider, Julie/F-4785-2010; Kalbfleisch, Theodore/AAN-5407-2021; Newell, William/C-7995-2011; Schulz, Volkmar/AFS-7612-2022	Schulz, Volkmar/0000-0003-1341-9356; Judson, Richard/0000-0002-2348-9633; Kalbfleisch, Theodore/0000-0002-2370-8189; Schneider, Julie/0000-0003-0756-5007				ACHARYA T, UNPUB; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; CERDAFLORES RM, 1992, ANN HUM BIOL, V19, P347, DOI 10.1080/03014469200002222; Chakravarti A, 1998, NAT GENET, V19, P216, DOI 10.1038/885; Clark AG, 1999, NAT GENET, V22, P119, DOI 10.1038/9619; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hacia JG, 1999, NAT GENET, V22, P164, DOI 10.1038/9674; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Harding RM, 1997, AM J HUM GENET, V60, P772; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; LEWONTIN RC, 1995, GENETICS, V140, P377; Li W. H, 1997, MOL EVOLUTION; LI WH, 1991, GENETICS, V129, P513; LI WH, 1984, J MOL EVOL, V21, P58, DOI 10.1007/BF02100628; MU ZQ, UNPUB; NEI M, 1981, GENETICS, V97, P145; Nei M., 1987, MOL EVOLUTIONARY GEN; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHNEIDER JA, UNPUB; Shriver MD, 1997, AM J HUM GENET, V60, P957; SLATKIN M, 1985, EVOLUTION, V39, P53, DOI 10.2307/2408516; STEPHENS J, UNPUB; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; TAJIMA F, 1989, GENETICS, V123, P585; Templeton AR, 2000, AM J HUM GENET, V66, P69, DOI 10.1086/302699; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; WATTERSON GA, 1977, THEOR POPUL BIOL, V11, P141, DOI 10.1016/0040-5809(77)90023-5; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9	39	648	704	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2001	293	5529					489	493		10.1126/science.1059431	http://dx.doi.org/10.1126/science.1059431			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11452081				2022-12-28	WOS:000169966700047
J	Hahn, S; Kim, Y; Garner, P				Hahn, S; Kim, Y; Garner, P			Reduced osmolarity oral rehydration solution for treating dehydration due to diarrhoea in children: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DOUBLE-BLIND; PERSISTENT DIARRHEA; STANDARD; SODIUM; ABSORPTION; EFFICACY; THERAPY; CHOLERA; INFANTS	Objectives To compare reduced osmolarity oral rehydration solution with standard World Health Organization oral rehydration solution in children with acute diarrhoea, Design Systematic review of randomised controlled trials, Studies 15 randomised controlled trials including 2397 randomised patients. Outcomes The primary outcome was unscheduled intravenous infusion; secondary outcomes were stool output, vomiting, and hyponatraemia. Results In a meta-analysis of nine trials for the primary outcome, reduced osmolarity rehydration solution was associated with fewer unscheduled intravenous infusions compared with standard WHO rehydration solution (odds ratio 0.61, 95% confidence interval 0.47 to 0.81). Three trials reported that no patients required unscheduled intravenous infusion, Trials reporting secondary outcomes suggested that in the reduced osmolarity rehydration solution group, stool output was lower (standardised mean difference in the log scale - 0.214 (95%, confidence interval - 0.305 to - 0.123; 13 trials) and vomiting was less frequent (odds ratio 0.71, 0.55 to 0.92; six trials). Six trials sought presence of hyponatraemia, with events in three studies, but no significant difference between the two arms. Conclusion In children admitted to hospital with dehydration associated with diarrhoea, reduced osmolarity rehydration solution is associated with reduced need for unscheduled intravenous infusions, lower stool volume, and less vomiting compared with standard WHO rehydration solution.	Univ Reading, Med & Pharmaceut Stat Res Unit, Reading RG6 6FN, Berks, England; Seoul Natl Univ, Childrens Hosp, Dept Paediat, Seoul 110774, South Korea; Univ Liverpool, Liverpool Sch Trop Med, Effect Hlth Care Alliance Programme, Int Hlth Div, Liverpool L3 5QA, Merseyside, England	University of Reading; Seoul National University (SNU); Seoul National University Hospital; Liverpool School of Tropical Medicine; University of Liverpool	Hahn, S (corresponding author), Univ York, Dept Hlth Sci & Clin Evaluat, York YO10 5DD, N Yorkshire, England.	s.hahn@rdg.ac.uk	Garner, Paul/Y-8385-2019; Hahn, Seokyung/J-5705-2012; Garner, Paul/HII-5856-2022	Garner, Paul/0000-0002-0607-6941; Hahn, Seokyung/0000-0002-4684-4917				Alam NH, 1999, LANCET, V354, P296, DOI 10.1016/S0140-6736(98)09332-5; Alam NH, 2001, PEDIATRICS, V107, P613, DOI 10.1542/peds.107.4.613; Alam S, 2000, Indian Pediatr, V37, P952; ALMROTH S, 1995, LANCET, V345, P709, DOI 10.1016/S0140-6736(95)90873-0; BERNAL C, 2000, SALUDARTE, V1, P6; BHAN MK, 1995, LANCET, V345, P282, DOI 10.1016/S0140-6736(95)90275-9; BHARGAVA SK, 1984, J PEDIATR GASTR NUTR, V3, P500, DOI 10.1097/00005176-198409000-00004; Dutta P, 2000, ACTA PAEDIATR, V89, P411, DOI 10.1080/080352500750028104; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ElMougi M, 1996, B WORLD HEALTH ORGAN, V74, P471; ELMOUGI M, 1994, J PEDIATR GASTR NUTR, V19, P83, DOI 10.1097/00005176-199407000-00013; FARTHING MJG, 1988, DRUGS, V36, P80, DOI 10.2165/00003495-198800364-00011; Faruque ASG, 1996, ACTA PAEDIATR, V85, P1247, DOI 10.1111/j.1651-2227.1996.tb18240.x; Faruque ASG, 1996, SCAND J INFECT DIS, V28, P87, DOI 10.3109/00365549609027156; FINBERG L, 1973, NEW ENGL J MED, V289, P196, DOI 10.1056/NEJM197307262890407; FONTAINE O, 2000, CD001264 COCHR DAT; FORDTRAN JS, 1968, J CLIN INVEST, V47, P884, DOI 10.1172/JCI105781; GRANT JP, 1983, STATE WORLDS CHILDRE; HUNT JB, 1992, GUT, V33, P479, DOI 10.1136/gut.33.4.479; KIM Y, 2000, COCHRANE LIB; MAHALANABIS D, 1995, ACTA PAEDIATR, V84, P289, DOI 10.1111/j.1651-2227.1995.tb13630.x; MAHALANABIS D, 1973, JOHNS HOPKINS MED J, V132, P197; MARTINEZPANTALE.O, 1998, B MED HOSP INFANT M, V45, P817; Moreno-Sanchez H, 1990, Bol Med Hosp Infant Mex, V47, P630; SANTOSHAM M, 1982, NEW ENGL J MED, V306, P1070, DOI 10.1056/NEJM198205063061802; Santosham M, 1996, J PEDIATR-US, V128, P45, DOI 10.1016/S0022-3476(96)70426-2; SARKER SA, 1995, ACTA PAEDIATR, V84, P775, DOI 10.1111/j.1651-2227.1995.tb13755.x; Sutton AJ, 2000, METHODS METANALYSIS; VELASQUEZJONES L, 1990, CLIN THER, V12, P95	29	73	86	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2001	323	7304					81	85		10.1136/bmj.323.7304.81	http://dx.doi.org/10.1136/bmj.323.7304.81			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454GD	11451782	Bronze, Green Published			2022-12-28	WOS:000169964100016
J	Grimes, DA				Grimes, DA			Intrauterine devices and infertility: sifting through the evidence	LANCET			English	Editorial Material							PELVIC INFLAMMATORY DISEASE		Family Hlth Int, Res Triangle Pk, NC 27709 USA		Grimes, DA (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.							Bastianelli C, 1998, Minerva Ginecol, V50, P231; BUCHAN H, 1990, BRIT J OBSTET GYNAEC, V97, P780, DOI 10.1111/j.1471-0528.1990.tb02571.x; Cates W, 2000, WOMEN HEALTH, P381; Doll H, 2001, BRIT J OBSTET GYNAEC, V108, P304, DOI 10.1111/j.1471-0528.2001.00075.x; Grimes DA, 2000, LANCET, V356, P1013, DOI 10.1016/S0140-6736(00)02699-4; HUBACHER D, 2000, INT J GYNECOL OBSTET; *ROYAL COLL OBST G, INT INV MAN INF COUP; VESSEY MP, 1981, BRIT MED J, V282, P855, DOI 10.1136/bmj.282.6267.855; *WHO, 2001, IMPR ACC QUAL CAR FA; World Health Organization (Who), 1987, 753 WHO	10	16	16	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 7	2001	358	9275					6	7		10.1016/S0140-6736(00)05299-5	http://dx.doi.org/10.1016/S0140-6736(00)05299-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11454367				2022-12-28	WOS:000169710900006
J	Merila, J; Kruuk, LEB; Sheldon, BC				Merila, J; Kruuk, LEB; Sheldon, BC			Cryptic evolution in a wild bird population	NATURE			English	Article							NESTLING COLLARED FLYCATCHERS; DIRECTIONAL SELECTION; NATURAL-SELECTION; BODY-SIZE; VARIANCE; MASS	Microevolution is expected to be commonplace, yet there are few thoroughly documented cases of microevolution in wild populations(1,2). In contrast, it is often observed that apparently heritable traits under strong and consistent directional selection fail to show the expected evolutionary response(3,4). One explanation proposed for this paradox is that a genetic response to selection may be masked by opposing changes in the environment(5,6). We used data from a 20-year study of collared flycatchers (Ficedula albicollis) to explore selection on, and evolution of, a heritable trait: relative body weight at fledging ('condition'). Despite consistent positive directional selection, on both the phenotypic and the additive genetic component (breeding values, estimated from an animal model) of condition, the mean phenotypic value of this trait in the population has declined, rather than increased, over time. Here we show that, despite this decline, the mean breeding value for condition has increased over time. The mismatch between response to selection at the levels of genotype and phenotype can be explained by environmental deterioration, concealing underlying evolution. This form of cryptic evolution may be common in natural environments.	Uppsala Univ, Evolutionary Biol Ctr, Dept Populat Biol, SE-75236 Uppsala, Sweden; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Uppsala Univ, Evolutionary Biol Ctr, Dept Anim Ecol, SE-75236 Uppsala, Sweden	Uppsala University; University of Edinburgh; University of Oxford; Uppsala University	Merila, J (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Dept Populat Biol, Norbyvagen 18d, SE-75236 Uppsala, Sweden.		Merila, Juha/A-4061-2008; Sheldon, Ben C/A-8056-2010; Kruuk, Loeske/AAB-8714-2019; Kruuk, Loeske E. B./J-3295-2012	Merila, Juha/0000-0001-9614-0072; Sheldon, Ben C/0000-0002-5240-7828; Kruuk, Loeske/0000-0001-8588-1123; Kruuk, Loeske E. B./0000-0001-8588-1123				ALATALO RV, 1990, AM NAT, V135, P464, DOI 10.1086/285056; ALATALO RV, 1984, J ANIM ECOL, V53, P969, DOI 10.2307/4671; BLAIR HT, 1984, J ANIM SCI, V58, P878, DOI 10.2527/jas1984.584878x; Boltnev AI, 1998, CAN J ZOOL, V76, P843, DOI 10.1139/cjz-76-5-843; Both C, 1999, P ROY SOC B-BIOL SCI, V266, P465, DOI 10.1098/rspb.1999.0660; CONOVER DO, 1995, TRENDS ECOL EVOL, V10, P248, DOI 10.1016/S0169-5347(00)89081-3; COOKE F, 1990, AM NAT, V136, P261, DOI 10.1086/285095; Doligez B, 1999, J ANIM ECOL, V68, P1193, DOI 10.1046/j.1365-2656.1999.00362.x; FRANK SA, 1992, TRENDS ECOL EVOL, V7, P92, DOI 10.1016/0169-5347(92)90248-A; *GENST, 1998, GENST 5 REL 4 1; Gilchrist AS, 1999, GENETICS, V153, P1775; GRANT PR, 1995, EVOLUTION, V49, P241, DOI 10.1111/j.1558-5646.1995.tb02236.x; GROENEVELD E, 1992, ARCH ANIM BREED, V15, P399; GROENEVELD E, 1995, REML VCE MULTIVARIAT; GUSTAFSSON L, 1988, IBIS, V130, P11, DOI 10.1111/j.1474-919X.1988.tb00951.x; HOCHACHKA W, 1991, J ANIM ECOL, V60, P995, DOI 10.2307/5427; LEWONTIN RC, 1978, SCI AM, V239, P212, DOI 10.1038/scientificamerican0978-212; LINDEN M, 1992, ECOLOGY, V73, P336, DOI 10.2307/1938745; Lynch M., 1998, GENETICS ANAL QUANTI; Merila J, 1996, FUNCT ECOL, V10, P465, DOI 10.2307/2389939; Merila J, 1997, MOL ECOL, V6, P1167, DOI 10.1046/j.1365-294X.1997.00295.x; MERILA J, UNPUB J EVOL BIOL; MEYER K, 1989, GENET SEL EVOL, V21, P317, DOI 10.1051/gse:19890308; PRICE T, 1988, SCIENCE, V240, P798, DOI 10.1126/science.3363360; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; Roff D.A., 1997, EVOLUTIONARY QUANTIT; Sheldon BC, 1998, ECOLOGY, V79, P1939, DOI 10.1890/0012-9658(1998)079[1939:GAESIN]2.0.CO;2; Sorci G, 1999, EVOL ECOL RES, V1, P303; SOUTHWOOD OI, 1991, J ANIM SCI, V69, P3177; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P289, DOI 10.1098/rspb.2000.1363	30	169	172	0	61	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					76	79		10.1038/35083580	http://dx.doi.org/10.1038/35083580			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452309				2022-12-28	WOS:000169644900046
J	Parrish, J; Li, LL; Klotz, K; Ledwich, D; Wang, XD; Xue, D				Parrish, J; Li, LL; Klotz, K; Ledwich, D; Wang, XD; Xue, D			Mitochondrial endonuclease G is important for apoptosis in C-elegans	NATURE			English	Article							PROGRAMMED CELL DEATHS; DNA FRAGMENTATION; PROTEIN; INTERFERENCE; GENE; RNA	Programmed cell death (apoptosis) is a tightly regulated process of cell disassembly in which dying cells and their nuclei shrink and fragment and the chromosomal DNA is degraded into internucleosomal repeats(1-3). Here we report the characterization of the cps-6 gene, which appears to function downstream of, or in parallel to, the cell-death protease CED-3 of Caenorhabditis elegans in the DNA degradation process during apoptosis. cps-6 encodes a homologue of human mitochondrial endonuclease G(4,5), and its protein product similarly localizes to mitochondria in C. elegans. Reduction of cps-6 activity caused by a genetic mutation or RNA-mediated interference (RNAi) affects normal DNA degradation, as revealed by increased staining in a TUNEL assay, and results in delayed appearance of cell corpses during development in C. elegans. This observation provides in vivo evidence that the DNA degradation process is important for proper progression of apoptosis. CPS-6 is the first mitochondrial protein identified to be involved in programmed cell death in C. elegans, underscoring the conserved and important role of mitochondria in the execution of apoptosis.	Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Xue, D (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	ding.xue@colorado.edu		XUE, DING/0000-0002-8429-8136; Wang, Xiaodong/0000-0001-9885-356X				BRENNER S, 1974, GENETICS, V77, P71; Chalfie M, 1995, PROG BRAIN RES, V105, P179; Chen FL, 2000, SCIENCE, V287, P1485, DOI 10.1126/science.287.5457.1485; CLARK SG, 1994, GENETICS, V137, P987; COTE J, 1993, SCIENCE, V261, P765, DOI 10.1126/science.7688144; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gu T, 1998, MOL CELL BIOL, V18, P4556, DOI 10.1128/MCB.18.8.4556; HEDGECOCK EM, 1983, SCIENCE, V220, P1277, DOI 10.1126/science.6857247; Horvitz HR, 1999, CANCER RES, V59, p1701S; HSU DR, 1995, DEVELOPMENT, V121, P3323; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; McIlroy D, 2000, GENE DEV, V14, P549; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Riddle DL, 1997, C ELEGANS; RUIZCARRILLO A, 1987, EMBO J, V6, P401, DOI 10.1002/j.1460-2075.1987.tb04769.x; Shah A, 1999, AGING MENT HEALTH, V3, P153, DOI 10.1080/13607869956316; Stanfield GM, 2000, MOL CELL, V5, P423, DOI 10.1016/S1097-2765(00)80437-2; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; SULSTON JE, 1976, PHILOS T ROY SOC B, V275, P287, DOI 10.1098/rstb.1976.0084; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wu YC, 2000, GENE DEV, V14, P536; Zhang JH, 1998, P NATL ACAD SCI USA, V95, P12480, DOI 10.1073/pnas.95.21.12480	30	331	345	10	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					90	94		10.1038/35083608	http://dx.doi.org/10.1038/35083608			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452313				2022-12-28	WOS:000169644900050
J	Surridge, C; Anson, L				Surridge, C; Anson, L			Plant defence	NATURE			English	Editorial Material																			0	4	4	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					825	825						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11460112				2022-12-28	WOS:000169246400058
J	Mollica, RH; Sarajlic, N; Chernoff, M; Lavelle, J; Vukovic, IS; Massagli, MP				Mollica, RH; Sarajlic, N; Chernoff, M; Lavelle, J; Vukovic, IS; Massagli, MP			Longitudinal study of psychiatric symptoms, disability, mortality, and emigration among Bosnian refugees	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTTRAUMATIC-STRESS-DISORDER; HARVARD TRAUMA QUESTIONNAIRE; PRIMARY-CARE; MAJOR DEPRESSION; MYOCARDIAL-INFARCTION; MENTAL-HEALTH; FOLLOW-UP; WAR; CHECKLIST-25; INSTRUMENT	Context Evidence is emerging that psychiatric disorders are common in populations affected by mass violence. Previously, we found associations among depression, posttraumatic stress disorder (PTSD), and disability in a Bosnian refugee cohort. Objective To investigate whether previously observed associations continue over, time and are associated with mortality emigration to another region. Design, Setting, and Participants Three-year follow-up study conducted in 1999 among 534 adult Bosnian refugees originally living in a refugee camp in Croatia. At follow-up, 376 (70.4%) remained living in the region, 39 (7.3%) were deceased, 114 (21.3%) had emigrated, and 5 (1%) were lost to follow-up. Those still living in the region and the families of the deceased were reinterviewed (77.7% of the original participants). Main Outcome Measures Depression and PTSD diagnoses, based on Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria and measured by the Hopkins Symptom Checklist-25 and the Harvard Trauma Questionnaire, respectively; disability, measured by the Medical Outcomes Study Short-Form 20; and cause of death, determined by family interviews with review of death certificates, if available. Results In 1999, 45% of the original respondents who met the DSM-IV criteria for depression, PTSD, or both continued to have these disorders and 16% of respondents who were asymptomatic in 1996 developed 1 or both disorders. Forty-six percent of those who initially met disability criteria remained disabled. Log-linear analysis revealed that disability and psychiatric disorder were related at both times. Male sex, isolation from family, and older age were associated with increased mortality after adjusting for demographic characteristics, trauma history, and health status (for male sex, adjusted odds ratio [OR], 2.63; 95% confidence interval [CI], 1.17-5.92; living alone, OR, 2.40; 95% Cf, 1.07-5.38; and each 10-year increase in age, OR, 1.91; 95% Cl, 1.34-2.71). Depression was associated with higher mortality in unadjusted analysis but was not after statistical adjustment (unadjusted OR, 3.12; 95% Cl, 1.55-6.26; adjusted OR, 1.85; 95% Cl, 0.82-4.16). Posttraumatic stress disorder was not associated with mortality or emigration. Spending less than 12 months in the refugee camp (OR, 11.30 95% CI, 6.55-19.50), experiencing 6 or more trauma events (OR, 3.34 95% CI, 1.89-5.91), having higher education (OR, 1.90; 95% Cl, 1.10-3.29), and not having an observed handicap (OR, 0.11; 95% CI, 0.02-0.52) were associated with higher likelihood of emigration. Depression was not associated with emigration status. Conclusions Former Bosnian refugees who remained living in the region continued to exhibit psychiatric disorder and disability 3 years after initial assessment. Social isolation, male sex, and older age were associated with mortality. Healthier, better educated refugees were more likely to emigrate. Further research is necessary to understand the associations among depression, emigration status, and mortality over time.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Harvard Program Refugee Trauma, Boston, MA USA; Univ Zagreb, Sch Med, Zagreb 41001, Croatia	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Zagreb	Mollica, RH (corresponding author), Harvard Program Refugee Trauma, 8 Story St,3rd Floor, Cambridge, MA 02138 USA.	rmollica@hprt.harvard.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057806] Funding Source: NIH RePORTER; NIMH NIH HHS [MH5780602] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Agresti A., 1996, INTRO CATEGORICAL DA; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Angst J, 1997, BMJ-BRIT MED J, V315, P1143; [Anonymous], 1993, AM J PSYCHIAT, V150, P1; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Beiser M, 1999, STRANGERS GATEBOAT P; Bleich A, 1997, BRIT J PSYCHIAT, V170, P479, DOI 10.1192/bjp.170.5.479; Cardozo BL, 2000, JAMA-J AM MED ASSOC, V284, P569, DOI 10.1001/jama.284.5.569; CASE RB, 1992, JAMA-J AM MED ASSOC, V267, P515, DOI 10.1001/jama.267.4.515; Coulehan JL, 1997, ARCH INTERN MED, V157, P1113, DOI 10.1001/archinte.157.10.1113; Covinsky KE, 1999, ANN INTERN MED, V130, P563, DOI 10.7326/0003-4819-130-7-199904060-00004; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; de Girolamo G., 1996, ETHNOCULTURAL ASPECT, P33, DOI [DOI 10.1037/10555-002, 10.1037/10555-002]; DEWEY ME, 1993, AGE AGEING, V22, P109, DOI 10.1093/ageing/22.2.109; Drozdek B, 1997, J NERV MENT DIS, V185, P690, DOI 10.1097/00005053-199711000-00007; ENGEL GL, 1968, ANN INTERN MED, V69, P293, DOI 10.7326/0003-4819-69-2-293; Fawzi MCS, 1997, ACTA PSYCHIAT SCAND, V95, P87, DOI 10.1111/j.1600-0447.1997.tb00379.x; FIENBERG SE, 1980, ANAL CROSS CLASS CAT; FLAHERTY JA, 1988, J NERV MENT DIS, V176, P257; Ganzini L, 1997, J AM GERIATR SOC, V45, P307, DOI 10.1111/j.1532-5415.1997.tb00945.x; Havelka Mladen, 1995, Croatian Medical Journal, V36, P262; HORWATH E, 1992, ARCH GEN PSYCHIAT, V49, P817; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Kleijn WC, 2001, PSYCHOL REP, V88, P527, DOI 10.2466/PR0.88.2.527-532; Lesperance F, 1996, PSYCHOSOM MED, V58, P99, DOI 10.1097/00006842-199603000-00001; Loga S, 1999, Med Arh, V53, P139; Mehic-Basara N, 1999, Med Arh, V53, P39; MELLINGER GD, 1983, PSYCHOL MED, V13, P607, DOI 10.1017/S0033291700048029; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P497; Mollica RF, 2000, SCI AM, V282, P54, DOI 10.1038/scientificamerican0600-54; Mollica RF, 1999, JAMA-J AM MED ASSOC, V282, P433, DOI 10.1001/jama.282.5.433; MOLLICA RF, 1993, JAMA-J AM MED ASSOC, V270, P581, DOI 10.1001/jama.270.5.581; MORRIS PLP, 1993, AM J PSYCHIAT, V150, P124; Pulska T, 1998, ACTA PSYCHIAT SCAND, V97, P408, DOI 10.1111/j.1600-0447.1998.tb10023.x; RASMUSSEN OV, 1990, DAN MED BULL, V37, P1; SAS Institute Inc, 1999, SAS STAT US GUID; Shrestha NM, 1998, JAMA-J AM MED ASSOC, V280, P443, DOI 10.1001/jama.280.5.443; Smith E. M., 1993, INT HDB TRAUMATIC ST, P405; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; Summerfield D, 1999, SOC SCI MED, V48, P1449, DOI 10.1016/S0277-9536(98)00450-X; UHLENHUTH EH, 1983, ARCH GEN PSYCHIAT, V40, P1167; *UN HIGH COMM REF, 1988, HDB PROC CRIT DET RE; *US COMM REF, 1997, WORLD REF SURV 1997; VONKORFF M, 1992, ARCH GEN PSYCHIAT, V49, P91; VonKorff M, 1996, J CLIN EPIDEMIOL, V49, P297, DOI 10.1016/0895-4356(95)00512-9; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; WELLS KB, 1992, ARCH GEN PSYCHIAT, V49, P788; WESTERMEYER J, 1985, AM J PSYCHIAT, V142, P798; Westermeyer J, 2000, JAMA-J AM MED ASSOC, V284, P615, DOI 10.1001/jama.284.5.615; Whooley MA, 2000, NEW ENGL J MED, V343, P1942, DOI 10.1056/NEJM200012283432607; Williams JW, 2000, JAMA-J AM MED ASSOC, V284, P1519, DOI 10.1001/jama.284.12.1519	53	253	258	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2001	286	5					546	554		10.1001/jama.286.5.546	http://dx.doi.org/10.1001/jama.286.5.546			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	458HE	11476656				2022-12-28	WOS:000170188300017
J	Doyle, Y				Doyle, Y			Equity in the new NHS: hard lessons from implementing a local healthcare policy on donepezil	BRITISH MEDICAL JOURNAL			English	Article									Merton Sutton & Wandsworth Hlth Author, London, England		Doyle, Y (corresponding author), The Wilson, Surrey CR4 4TP, England.							BIRKS J, 2000, COCHRANE DATABASE SY; *DEP HLTH, 2000, NHS PLAN; Melzer D, 1998, BMJ-BRIT MED J, V316, P762, DOI 10.1136/bmj.316.7133.762; *NAT I CLIN EXC, 2001, DON RIV GAL TREATM; Rosen R, 1998, HEALTH POLICY, V43, P103, DOI 10.1016/S0168-8510(97)00091-2; *STAND MED ADV COM, 1998, US DON ALZH DIS; 1998, DRUG THER B, V36, P60	7	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2001	323	7306					222	224		10.1136/bmj.323.7306.222	http://dx.doi.org/10.1136/bmj.323.7306.222			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459UQ	11473920	Green Published			2022-12-28	WOS:000170270200024
J	Edlin, BR; Seal, KH; Lorvick, J; Kral, AH; Ciccarone, DH; Moore, LD; Lo, B				Edlin, BR; Seal, KH; Lorvick, J; Kral, AH; Ciccarone, DH; Moore, LD; Lo, B			Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DIRECTLY OBSERVED THERAPY; INTERFERON-ALPHA; ADHERENCE; TUBERCULOSIS; PROPHYLAXIS; COMBINATION; INFECTION; EQUIPMENT; EXCHANGE; SYRINGE		Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Edlin, BR (corresponding author), Univ Calif San Francisco, Inst Hlth Policy Studies, Urban Hlth Study, 3180 18th St,Suite 302, San Francisco, CA 94110 USA.	bredlin@itsa.ucsf.edu	Edlin, Brian R/F-2966-2018; Ciccarone, Daniel/I-5404-2013	Edlin, Brian R/0000-0001-8172-8797; Lorvick, Jennifer/0000-0002-2836-3028; Kral, Alex/0000-0002-9092-3671; Ciccarone, Daniel/0000-0002-2355-5477	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013245] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		[Anonymous], 1998, MMWR Recomm Rep, V47, P43; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; Bamberger JD, 2000, AM J PUBLIC HEALTH, V90, P699, DOI 10.2105/AJPH.90.5.699; Bangsberg DR, 1999, J GEN INTERN MED, V14, P446, DOI 10.1046/j.1525-1497.1999.05109.x; Beauchamp TL, 2009, PRINCIPLES BIOMEDICA; Bluthenthal RN, 2000, AIDS, V14, P605, DOI 10.1097/00002030-200003310-00015; BROERS B, 1994, ARCH INTERN MED, V154, P1121, DOI 10.1001/archinte.154.10.1121; Burris S, 2000, ANN INTERN MED, V133, P218, DOI 10.7326/0003-4819-133-3-200008010-00015; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Dieperink E, 2000, AM J PSYCHIAT, V157, P867, DOI 10.1176/appi.ajp.157.6.867; *EASL, 1999, J HEPATOL S1, V31, P3; Gerstein D., 1990, TREATING DRUG PROBLE; Gostin Lawrence O., 1999, HLTH HUMAN RIGHTS RE, P54; Gourevitch MN, 1996, J ADDICT DIS, V15, P93, DOI 10.1300/J069v15n01_07; Hagan H, 2001, AM J PUBLIC HEALTH, V91, P42, DOI 10.2105/AJPH.91.1.42; HARRISON K, 1995, J ACQ IMMUN DEF SYND, V10, P386; Haynes R. B., 1979, COMPLIANCE HLTH CARE; JANSSEN HLA, 1994, J HEPATOL, V21, P241, DOI 10.1016/S0168-8278(05)80402-7; King VL, 1999, METHADONE TREATMENT FOR OPIOID DEPENDENCE, P141; Lerner BH, 1998, ANN INTERN MED, V129, P573, DOI 10.7326/0003-4819-129-7-199810010-00012; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Lorvick J, 1999, J URBAN HEALTH, V76, P461, DOI 10.1007/BF02351503; Lorvick J, 2001, AM J PUBLIC HEALTH, V91, P46, DOI 10.2105/AJPH.91.1.46; Maddrey WC, 1999, SEMIN LIVER DIS, V19, P67; Marco A, 1998, EUR RESPIR J, V12, P967, DOI 10.1183/09031936.98.12040967; Marlatt G. A, 2012, HARM REDUCTION PRAGM; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Moatti JP, 2000, AIDS, V14, P151, DOI 10.1097/00002030-200001280-00010; *NIH, 1997, MAN HAP C, V15; *NIH, 1997, INT PREV HIV RISK BE, V15; NORMAND J, 1995, PREVENTING HIV TRANS; OCONNOR PG, 1994, NEW ENGL J MED, V331, P450, DOI 10.1056/NEJM199408183310707; *PAN CLIN PRACT TR, 2001, GUID US ANT AG HIV I; Pariante CM, 1999, LANCET, V354, P131, DOI 10.1016/S0140-6736(98)04793-X; *PUBL HLTH SERV, 1997, HIV PREV B MED ADV P; Quin JW, 1997, AUST NZ J MED, V27, P611, DOI 10.1111/j.1445-5994.1997.tb00985.x; RENAULT PF, 1987, ARCH INTERN MED, V147, P1577, DOI 10.1001/archinte.147.9.1577; ROBERTSON R, 1998, MANAGEMENT DRUG USER; Salomon N, 1997, INT J TUBERC LUNG D, V1, P397; Smirnoff M, 1998, INT J TUBERC LUNG D, V2, P134; Sorensen JL, 1998, AIDS CARE, V10, P297, DOI 10.1080/713612419; SYLVESTRE DL, 2000, ELIMINATING HLTH DIS, P422; THOMAS DL, 1995, MEDICINE, V74, P212, DOI 10.1097/00005792-199507000-00005; *US PREV SERV TASK, 1996, GUID CLIN PREV SERV, P591; Van Thiel DH, 1998, HEPATO-GASTROENTEROL, V45, P328; WARTENBERG AA, 1991, J GEN INTERN MED, V6, pS35, DOI 10.1007/BF02599256; WATTERS JK, 1994, JAMA-J AM MED ASSOC, V271, P115, DOI 10.1001/jama.271.2.115; WILLIAMS I, 1999, AM J MED S, V107, P2, DOI DOI 10.1016/S0002-9343(99)00373-3; Yano M, 1996, HEPATOLOGY, V23, P1334, DOI 10.1002/hep.510230607; Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301	50	172	172	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2001	345	3					211	214		10.1056/NEJM200107193450311	http://dx.doi.org/10.1056/NEJM200107193450311			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453JM	11463019	Green Accepted			2022-12-28	WOS:000169912800011
J	Giese, B; Amaudrut, J; Kohler, AK; Spormann, M; Wessely, S				Giese, B; Amaudrut, J; Kohler, AK; Spormann, M; Wessely, S			Direct observation of hole transfer through DNA by hopping between adenine bases and by tunnelling	NATURE			English	Article							RANGE ELECTRON-TRANSFER; DISTANCE DEPENDENCE; CHARGE-TRANSPORT; AQUEOUS-SOLUTION; MECHANISM; MOLECULES; MIGRATION; TRAP	The function of DNA during oxidative stress(1) and its suitability as a potential building block for molecular devices(2-4) depend on long-distance transfer of electrons and holes through the molecule, yet many conflicting measurements of the efficiency of this process have been reported(5,6). It is accepted that charges are transported over long distances through a multistep hopping reaction(7-11); this 'G-hopping'(8) involves positive charges moving between guanines (Gs), the DNA bases with the lowest ionization potential. But the mechanism fails to explain the persistence of efficient charge transfer when the guanine sites are distant(7,12), where transfer rates do not, as expected, decrease rapidly with transfer distance. Here we show experimentally that the rate of charge transfer between two guanine bases decreases with increasing separation only if the guanines are separated by no more than three base pairs; if more bridging base pairs are present, the transfer rates exhibit only a weak distance dependence. We attribute this distinct change in the distance dependence of the rate of charge transfer through DNA to a shift from coherent superexchange charge transfer (tunnelling) at short distances to a process mediated by thermally induced hopping of charges between adenine bases (A-hopping) at long distances. Our results confirm theoretical predictions of this behaviour(13-17), emphasizing that seemingly contradictory observations of a strong(8,9) as well as a weak(7,12) influence of distance on DNA charge transfer are readily explained by a change in the transfer mechanism.	Univ Basel, Dept Chem, CH-4056 Basel, Switzerland	University of Basel	Giese, B (corresponding author), Univ Basel, Dept Chem, St Johanns Ring 19, CH-4056 Basel, Switzerland.			Amaudrut, Jerome/0000-0003-0498-4089				Berlin YA, 2001, J AM CHEM SOC, V123, P260, DOI 10.1021/ja001496n; FELTS AK, 1995, J PHYS CHEM-US, V99, P2929, DOI 10.1021/j100009a057; Fink HW, 1999, NATURE, V398, P407, DOI 10.1038/18855; Giese B, 2000, ACCOUNTS CHEM RES, V33, P631, DOI 10.1021/ar990040b; Giese B, 2000, CHEMPHYSCHEM, V1, P195, DOI 10.1002/1439-7641(20001215)1:4<195::AID-CPHC195>3.0.CO;2-B; Giese B, 1999, ANGEW CHEM INT EDIT, V38, P996, DOI 10.1002/(SICI)1521-3773(19990401)38:7<996::AID-ANIE996>3.0.CO;2-4; Grozema FC, 2000, J AM CHEM SOC, V122, P10903, DOI 10.1021/ja001497f; Heller A, 2000, FARADAY DISCUSS, V116, P1, DOI 10.1039/b006196o; Jortner J, 1998, P NATL ACAD SCI USA, V95, P12759, DOI 10.1073/pnas.95.22.12759; Kasumov AY, 2001, SCIENCE, V291, P280, DOI 10.1126/science.291.5502.280; Lewis FD, 2001, ACCOUNTS CHEM RES, V34, P159, DOI 10.1021/ar0000197; Lewis FD, 1997, SCIENCE, V277, P673, DOI 10.1126/science.277.5326.673; MURPHY CJ, 1993, SCIENCE, V262, P1025, DOI 10.1126/science.7802858; Okada A, 1998, J PHYS CHEM A, V102, P1241, DOI 10.1021/jp972918r; Porath D, 2000, NATURE, V403, P635, DOI 10.1038/35001029; Saito I, 1998, J AM CHEM SOC, V120, P12686, DOI 10.1021/ja981888i; Schuster GB, 2000, ACCOUNTS CHEM RES, V33, P253, DOI 10.1021/ar980059z; Segal D, 2000, J PHYS CHEM B, V104, P3817, DOI 10.1021/jp993260f; Steenken S, 1997, J AM CHEM SOC, V119, P617, DOI 10.1021/ja962255b; Steenken S, 2000, J AM CHEM SOC, V122, P2373, DOI 10.1021/ja993508e; Williams TT, 2000, J AM CHEM SOC, V122, P9048, DOI 10.1021/ja001552k	21	712	725	8	149	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					318	320		10.1038/35085542	http://dx.doi.org/10.1038/35085542			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460159				2022-12-28	WOS:000169918200042
J	Hale, P				Hale, P			Mission now possible for AIDS fund - Adequate support by the G8 countries is needed to defeat this global killer.	NATURE			English	Editorial Material									Fac Med Necker Enfants Malad, Inst Necker, F-75015 Paris, France; MRC S Africa, Congella, South Africa; Yale Univ, Sch Med, New Haven, CT 06520 USA; Johns Hopkins Univ, Baltimore, MD USA; Univ Calif San Diego, San Diego, CA 92103 USA; Ist Super Sanita, Int AIDS Soc, I-00161 Rome, Italy; Makerere Univ, Inst Publ Hlth, Kampala, Uganda; Inst Pasteur, Paris, France; UCL, London WC1E 6BT, England	UDICE-French Research Universities; Universite Paris Cite; Yale University; Johns Hopkins University; University of California System; University of California San Diego; Istituto Superiore di Sanita (ISS); Makerere University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of London; University College London	Hale, P (corresponding author), Fac Med Necker Enfants Malad, Inst Necker, 156 Rue Vaugirard, F-75015 Paris, France.		VELLA, STEFANO/V-8440-2019	VELLA, STEFANO/0000-0003-2347-5984	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000361, ZIAAI000361] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Sachs JD, 2001, NAT MED, V7, P521, DOI 10.1038/87830; Schwartlander B, 2001, SCIENCE, V292, P2434, DOI 10.1126/science.1062876	2	6	7	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					271	272		10.1038/35085650	http://dx.doi.org/10.1038/35085650			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460133				2022-12-28	WOS:000169918200019
J	Stanley, JD; Goddio, F; Schnepp, G				Stanley, JD; Goddio, F; Schnepp, G			Nile flooding sank two ancient cities - Sediment failure caused these riverbank sites to drown over 1,200 years ago.	NATURE			English	Article									Smithsonian Inst, Natl Museum Nat Hist, Deltas Global Change Program, Washington, DC 20560 USA; Inst European Archeol Sous Marine, F-70005 Paris, France	Smithsonian Institution; Smithsonian National Museum of Natural History	Stanley, JD (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Deltas Global Change Program, Washington, DC 20560 USA.							BERNAND A, 1970, DELTA EGYPTIAN APRES, V1; Coleman J. M., 1982, DELTAS PROCESSES DEP; GODDIO F, 2000, EOS T AM GEOPHYS UN, V81, pF20; Guidoboni E., 1994, CATALOGUE ANCIENT EA, V1; Jones H. L., 1917, GEOGRAPHY STRABO; NUR AM, 2000, EOS T AM GEOPHYS UN, V81, pF21; Popper W., 1951, CAIRO NILOMETER; SALOVIEV SL, 2000, TSUNAMIS MEDITERRANE; Toussoun O., 1934, B SOC R ARCHEOL ALEX, V29, P342; TOUSSOUN O, 1922, MEM I EGYPT, V4, P1; WARNE AG, 1993, J COASTAL RES, V9, P26	11	18	18	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					293	294		10.1038/35085628	http://dx.doi.org/10.1038/35085628			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460151				2022-12-28	WOS:000169918200034
J	Ratnayaka, BDM; Dhaliwal, H; Watkin, S				Ratnayaka, BDM; Dhaliwal, H; Watkin, S			Neonatal convulsions after withdrawal of baclofen	BRITISH MEDICAL JOURNAL			English	Article																		BARKER I, 1982, LANCET, V2, P556; HYSER CL, 1984, J NATL MED ASSOC, V76, P533; KOFLER M, 1992, NEUROLOGY, V42, P697; LIPSCOMB DJ, 1980, POSTGRAD MED J, V56, P108, DOI 10.1136/pgmj.56.652.108; TERENCE CF, 1981, ARCH NEUROL-CHICAGO, V38, P588	5	23	23	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 14	2001	323	7304					85	85		10.1136/bmj.323.7304.85	http://dx.doi.org/10.1136/bmj.323.7304.85			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454GD	11451783	Green Published, Bronze			2022-12-28	WOS:000169964100017
J	Geballe, TH				Geballe, TH			Superconductivity - Super boron	SCIENCE			English	Editorial Material							DOPED C-60		Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Stanford University	Geballe, TH (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.							CHU CW, 1993, NATURE, V365, P323, DOI 10.1038/365323a0; Eremets MI, 2001, SCIENCE, V293, P272, DOI 10.1126/science.1062286; HANNAY NB, 1965, PHYS REV LETT, V14, P225, DOI 10.1103/PhysRevLett.14.225; MATTHIAS BT, 1963, REV MOD PHYS, V35, P1, DOI 10.1103/RevModPhys.35.1; Nagamatsu J, 2001, NATURE, V410, P63, DOI 10.1038/35065039; PALSTRA TTM, 1995, SOLID STATE COMMUN, V93, P327, DOI 10.1016/0038-1098(94)00786-1; Richardson CF, 1997, PHYS REV B, V55, P15130, DOI 10.1103/PhysRevB.55.15130; Schon JH, 2000, NATURE, V408, P549, DOI 10.1038/35046008; WEIR JT, 1995, PHYS REV LETT, V76, P1860; WHITE RM, 1979, LONG RANGE ORDER SOL, pCH3	10	7	10	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					223	224		10.1126/science.1063372	http://dx.doi.org/10.1126/science.1063372			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452102				2022-12-28	WOS:000169875200032
J	Kim, M; Canio, W; Kessler, S; Sinha, N				Kim, M; Canio, W; Kessler, S; Sinha, N			Developmental changes due to long-distance movement of a homeobox fusion transcript in tomato	SCIENCE			English	Article							MESSENGER-RNA; VIRAL MOVEMENT; GENE; TRAFFICKING; PROTEIN; LEAF; PLASMODESMATA; LOCALIZATION; TRANSPORT; PLANTS	Long-distance movement of RNA through the phloem is known to occur, but the functional importance of these transported RNAs has remained unclear. Crafting experiments with a naturally occurring dominant gain-of-function Leaf mutation in tomato were used to demonstrate long-distance movement of mutant messenger RNA (mRNA) into wild-type scions. The stock-specific pattern of mRNA expression was graft transmissible, indicating that the mRNA accumulation pattern is inherent to the transcript and not attributable to the promoter. The translocated mRNA caused changes in Leaf morphology of the wild-type scions, suggesting that the translocated RNA is functional.	Univ Calif Davis, Div Biol Sci, Plant Biol Sect, Davis, CA 95616 USA	University of California System; University of California Davis	Sinha, N (corresponding author), Univ Calif Davis, Div Biol Sci, Plant Biol Sect, 1 Shields Ave, Davis, CA 95616 USA.		Kessler, Sharon A/T-4784-2017	Kessler, Sharon A/0000-0002-7964-0451; Sinha, Neelima/0000-0002-1494-7065				BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; Chen JJ, 1997, PLANT CELL, V9, P1289, DOI 10.1105/tpc.9.8.1289; Choi SB, 2000, NATURE, V407, P765, DOI 10.1038/35037633; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; Gisel A, 1999, DEVELOPMENT, V126, P1879; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Janssen BJ, 1998, PLANT PHYSIOL, V117, P771, DOI 10.1104/pp.117.3.771; Kuehn Christina, 1997, Science (Washington D C), V275, P1298; LUCAS WJ, 1995, SCIENCE, V270, P1980, DOI 10.1126/science.270.5244.1980; LUCAS WJ, 1994, ANNU REV PHYTOPATHOL, V32, P387, DOI 10.1146/annurev.py.32.090194.002131; Parnis A, 1997, PLANT CELL, V9, P2143, DOI 10.1105/tpc.9.12.2143; Perbal MC, 1996, DEVELOPMENT, V122, P3433; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Ruiz-Medrano R, 1999, DEVELOPMENT, V126, P4405; Sessions A, 2000, SCIENCE, V289, P779, DOI 10.1126/science.289.5480.779; Xoconostle-Cazares B, 1999, SCIENCE, V283, P94, DOI 10.1126/science.283.5398.94	17	295	319	8	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					287	289		10.1126/science.1059805	http://dx.doi.org/10.1126/science.1059805			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452121				2022-12-28	WOS:000169875200055
J	Madhani, HD				Madhani, HD			Accounting for specificity in receptor tyrosine kinase signaling	CELL			English	Review							PHOSPHATIDYLINOSITOL 3'-KINASE; TRANSDUCTION; ACTIVATION; MET		Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Madhani, HD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	hiten@biochem.ucsf.edu		Madhani, Hiten/0000-0001-7400-6657				Blume-Jensen P, 2000, NAT GENET, V24, P157, DOI 10.1038/72814; Clandinin TR, 1998, CELL, V92, P523, DOI 10.1016/S0092-8674(00)80945-9; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Furge KA, 2000, ONCOGENE, V19, P5582, DOI 10.1038/sj.onc.1203859; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Heuchel R, 1999, P NATL ACAD SCI USA, V96, P11410, DOI 10.1073/pnas.96.20.11410; Kissel H, 2000, EMBO J, V19, P1312, DOI 10.1093/emboj/19.6.1312; Klinghoffer RA, 2001, MOL CELL, V7, P343, DOI 10.1016/S1097-2765(01)00182-4; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lesa GM, 1997, MOL BIOL CELL, V8, P779, DOI 10.1091/mbc.8.5.779; Luschnig S, 2000, MOL CELL, V5, P231, DOI 10.1016/S1097-2765(00)80419-0; Maina F, 2001, MOL CELL, V7, P1293, DOI 10.1016/S1097-2765(01)00261-1; Partanen J, 1998, GENE DEV, V12, P2332, DOI 10.1101/gad.12.15.2332; Pawson T, 1999, CELL, V97, P675, DOI 10.1016/S0092-8674(00)80779-5; STERNBERG PW, 1995, MOL REPROD DEV, V42, P523, DOI 10.1002/mrd.1080420422; Tallquist MD, 2000, GENE DEV, V14, P3179, DOI 10.1101/gad.844700; Tan PB, 1998, CELL, V93, P569, DOI 10.1016/S0092-8674(00)81186-1; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	19	26	27	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2001	106	1					9	11		10.1016/S0092-8674(01)00422-6	http://dx.doi.org/10.1016/S0092-8674(01)00422-6			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461696	Bronze			2022-12-28	WOS:000169870300003
J	Paris, F; Fuks, Z; Kang, A; Capodieci, P; Juan, G; Ehleiter, D; Haimovitz-Friedman, A; Cordon-Cardo, C; Kolesnick, R				Paris, F; Fuks, Z; Kang, A; Capodieci, P; Juan, G; Ehleiter, D; Haimovitz-Friedman, A; Cordon-Cardo, C; Kolesnick, R			Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice	SCIENCE			English	Article							FIBROBLAST-GROWTH-FACTOR; STEM-CELL SURVIVAL; SPHINGOMYELINASE; IRRADIATION; EXPRESSION; TISSUES	Gastrointestinal (GI) tract damage by chemotherapy or radiation Limits their efficacy in cancer treatment. Radiation has been postulated to target epithelial stem cells within the crypts of Lieberkuhn to initiate the Lethal CII syndrome. Here, we show in mouse models that microvascular endothelial apoptosis is the primary Lesion Leading to stem cell dysfunction. Radiation-induced crypt damage, organ failure, and death from the CI syndrome were prevented when endothelial apoptosis was inhibited pharmacologically by intravenous basic fibroblast growth factor (bFGF) or genetically by deletion of the acid sphingomyelinase gene. Endothelial but not crypt, cells express FGF receptor transcripts, suggesting that the endothelial Lesion occurs before crypt stem cell damage in the evolution of the GI syndrome. This study provides a basis for new approaches to prevent radiation damage to the bowel.	Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Kolesnick, R (corresponding author), Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, 1275 York Ave, New York, NY 10021 USA.	r-kolesnick@ski.mskcc.org	Paris, francois E/L-4915-2015	Paris, francois E/0000-0002-0176-7348	NCI NIH HHS [CA52462, CA85704] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085704] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Booth C, 2000, J CLIN INVEST, V105, P1493, DOI 10.1172/JCI10229; Bronckers ALJJ, 2000, HISTOCHEM CELL BIOL, V113, P293, DOI 10.1007/s004180000137; Capodieci P, 1998, DIAGN MOL PATHOL, V7, P69, DOI 10.1097/00019606-199804000-00002; CORDONCARDO C, 1990, LAB INVEST, V63, P832; CORDONCARDO C, UNPUB; Dobrowsky RT, 2000, METHOD ENZYMOL, V311, P184; Fahimi HD, 1999, J HISTOCHEM CYTOCHEM, V47, P1219, DOI 10.1177/002215549904701001; FUKS Z, 1992, EUR J CANCER, V28A, P725, DOI 10.1016/0959-8049(92)90104-A; HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831; Houchen CW, 1999, AM J PHYSIOL-GASTR L, V276, pG249, DOI 10.1152/ajpgi.1999.276.1.G249; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Khan WB, 1997, RADIAT RES, V148, P248, DOI 10.2307/3579609; MagiGalluzzi C, 1997, LAB INVEST, V76, P37; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Marathe S, 1998, J BIOL CHEM, V273, P4081, DOI 10.1074/jbc.273.7.4081; Merritt AJ, 1997, ONCOGENE, V14, P2759, DOI 10.1038/sj.onc.1201126; Merritt Anita J., 1996, P269; Okunieff P, 1996, BRIT J CANCER, V74, pS105; Okunieff P, 1998, RADIAT RES, V150, P204, DOI 10.2307/3579856; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; PARIS F, UNPUB; Pena LA, 2000, CANCER RES, V60, P321; POTTEN CS, 1990, INT J RADIAT BIOL, V58, P925, DOI 10.1080/09553009014552281; Potten CS, 1998, BRIT J CANCER, V78, P993, DOI 10.1038/bjc.1998.618; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Schissel SL, 1998, J BIOL CHEM, V273, P18250, DOI 10.1074/jbc.273.29.18250; TERRY NHA, 1989, INT J RADIAT ONCOL, V17, P569, DOI 10.1016/0360-3016(89)90108-9; [No title captured]	29	982	1037	2	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2001	293	5528					293	297		10.1126/science.1060191	http://dx.doi.org/10.1126/science.1060191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452123				2022-12-28	WOS:000169875200057
J	Joo, SH; Choi, SJ; Oh, I; Kwak, J; Liu, Z; Terasaki, O; Ryoo, R				Joo, SH; Choi, SJ; Oh, I; Kwak, J; Liu, Z; Terasaki, O; Ryoo, R			Ordered nanoporous arrays of carbon supporting high dispersions of platinum nanoparticles	NATURE			English	Article							MESOPOROUS SILICA; XENON-ADSORPTION; MOLECULAR-SIEVES; OXYGEN REDUCTION; NANOTUBES; ZEOLITE; NANOSTRUCTURES; PARTICLES; CATALYSIS; HYDROGEN	Nanostructured carbon materials are potentially of great technological interest for the development of electronic(1,2), catalytic(3,4) and hydrogen-storage systems(5,6). Here we describe a general strategy for the synthesis of highly ordered, rigid arrays of nanoporous carbon having uniform but tunable diameters (typically 6 nanometres inside and 9 nanometres outside). These structures are formed by using ordered mesoporous silicas as templates, the removal of which leaves a partially ordered graphitic framework. The resulting material supports a high dispersion of platinum nanoparticles, exceeding that of other common microporous carbon materials (such as carbon black, charcoal and activated carbon fibres). The platinum cluster diameter can be controlled to below 3 nanometres, and the high dispersion of these metal clusters gives rise to promising electrocatalytic activity for oxygen reduction, which could prove to be practically relevant for fuel-cell technologies. These nanomaterials can also be prepared in the form of free-standing films by using ordered silica films as the templates.	Korea Adv Inst Sci & Technol, Natl Craet Res Initiat Ctr Funct Nanomat, Taejon 305701, South Korea; Korea Adv Inst Sci & Technol, Dept Chem, Electrochem Lab, Taejon 305701, South Korea; Tohoku Univ, Japan Sci & Technol Corp, CREST, Dept Phys, Sendai, Miyagi 9808578, Japan; Tohoku Univ, Interdisciplinary Res Ctr, Sendai, Miyagi 9808578, Japan	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Japan Science & Technology Agency (JST); Tohoku University; Tohoku University	Ryoo, R (corresponding author), Korea Adv Inst Sci & Technol, Natl Craet Res Initiat Ctr Funct Nanomat, Taejon 305701, South Korea.		Oh, Ilwhan/G-8868-2011; Joo, Sang Hoon/E-5898-2010; Liu, Zheng/E-6119-2018; Kwak, Juhyoun/G-1079-2010; Ryoo, Ryong/B-1090-2009; Terasaki, Osamu/Y-1137-2018	Joo, Sang Hoon/0000-0002-8941-9662; Liu, Zheng/0000-0001-9095-7647; Kwak, Juhyoun/0000-0001-8937-6212; Terasaki, Osamu/0000-0001-5803-0817; Ryoo, Ryong/0000-0003-0047-3329				[Anonymous], 1988, CARBON ELECTROCHEMIC, DOI DOI 10.1016/j.jpowsour.2007.12.091; Cho SJ, 1996, J PHYS CHEM-US, V100, P4996, DOI 10.1021/jp952594b; Dillon AC, 1997, NATURE, V386, P377, DOI 10.1038/386377a0; Doshi DA, 2000, SCIENCE, V290, P107, DOI 10.1126/science.290.5489.107; Dresselhaus M.S., 1996, SCI FULLERENES CARBO; Fan HY, 2000, NATURE, V405, P56, DOI 10.1038/35011026; Fan SS, 1999, SCIENCE, V283, P512, DOI 10.1126/science.283.5401.512; Huang LM, 2000, J AM CHEM SOC, V122, P3530, DOI 10.1021/ja994240u; Jun S, 2000, J AM CHEM SOC, V122, P10712, DOI 10.1021/ja002261e; Kageyama K, 1999, SCIENCE, V285, P2113, DOI 10.1126/science.285.5436.2113; KORDESCH K, 1996, FUEL CELLS THEIR ELE; Kruk M, 2000, CHEM MATER, V12, P1961, DOI 10.1021/cm000164e; Kruk M, 1997, LANGMUIR, V13, P6267, DOI 10.1021/la970776m; KYOTANI T, 1995, CHEM MATER, V7, P1427, DOI 10.1021/cm00056a001; Lettow JS, 2000, LANGMUIR, V16, P8291, DOI 10.1021/la000660h; Lin JY, 2000, SCIENCE, V287, P1929; PEUCKERT M, 1986, J ELECTROCHEM SOC, V133, P944, DOI 10.1149/1.2108769; PLANEIX JM, 1994, J AM CHEM SOC, V116, P7935, DOI 10.1021/ja00096a076; POIRIER JA, 1994, J ELECTROCHEM SOC, V141, P425, DOI 10.1149/1.2054743; Radovic LR, 1997, CHEM PHYS CARBON, V25, P243; RODRIGUEZ NM, 1995, LANGMUIR, V11, P3862, DOI 10.1021/la00010a042; Rueckes T, 2000, SCIENCE, V289, P94, DOI 10.1126/science.289.5476.94; Ryoo R, 1997, CHEM COMMUN, P2225, DOI 10.1039/a704745b; Ryoo R, 1999, J PHYS CHEM B, V103, P7743, DOI 10.1021/jp991673a; RYOO R, 1992, J AM CHEM SOC, V114, P76, DOI 10.1021/ja00027a011; Takasu Y, 1996, ELECTROCHIM ACTA, V41, P2595, DOI 10.1016/0013-4686(96)00081-3; Thess A, 1996, SCIENCE, V273, P483, DOI 10.1126/science.273.5274.483; Wasmus S, 1999, J ELECTROANAL CHEM, V461, P14, DOI 10.1016/S0022-0728(98)00197-1; Yang PD, 1998, CHEM MATER, V10, P2033, DOI 10.1021/cm980201q	29	2308	2378	30	1780	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					169	172		10.1038/35084046	http://dx.doi.org/10.1038/35084046			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449269				2022-12-28	WOS:000169778700047
J	Bradstock, K				Bradstock, K			Wanderings of the bone-marrow stem cell	LANCET			English	Editorial Material							HEMATOPOIETIC PROGENITOR CELLS; CHEMOKINE SDF-1; PERIPHERAL-BLOOD; CD34(+) CELLS; MOBILIZATION; ENGRAFTMENT; MIGRATION		Westmead Hosp, Dept Haematol, Blood & Marrow Transplant Serv, Westmead, NSW 2145, Australia	University of Sydney	Bradstock, K (corresponding author), Westmead Hosp, Dept Haematol, Blood & Marrow Transplant Serv, Westmead, NSW 2145, Australia.	bradstok@icpmr.wsahs.nsw.gov.au						Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Gupta P, 1998, BLOOD, V91, P3724, DOI 10.1182/blood.V91.10.3724.3724_3724_3733; Kollet O, 2001, BLOOD, V97, P3283, DOI 10.1182/blood.V97.10.3283; Levesque JP, 2000, BLOOD, V96, p221A; LORD BI, 1975, BLOOD, V46, P65; Mohle R, 1998, BLOOD, V91, P4523, DOI 10.1182/blood.V91.12.4523.412k04_4523_4530; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; PAPAYANNOPOULOU T, 1995, P NATL ACAD SCI USA, V92, P9647, DOI 10.1073/pnas.92.21.9647; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Peled A, 1999, J CLIN INVEST, V104, P1199, DOI 10.1172/JCI7615; SHERIDAN WP, 1992, LANCET, V339, P640, DOI 10.1016/0140-6736(92)90795-5	12	2	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 7	2001	358	9275					5	6		10.1016/S0140-6736(00)05298-3	http://dx.doi.org/10.1016/S0140-6736(00)05298-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11454366				2022-12-28	WOS:000169710900005
J	Cyranoski, D				Cyranoski, D			Referendum stalls Japanese nuclear power strategy	NATURE			English	News Item																		1999, NATURE, V401, P736; 2001, NATURE, V411, P401	2	2	2	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					729	729		10.1038/35081266	http://dx.doi.org/10.1038/35081266			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11460100	Bronze			2022-12-28	WOS:000169246400011
J	Rausher, MD				Rausher, MD			Co-evolution and plant resistance to natural enemies	NATURE			English	Review							HESSIAN FLY DIPTERA; BACILLUS-THURINGIENSIS; ARABIDOPSIS-THALIANA; EVOLUTIONARY ECOLOGY; PLUTELLA-XYLOSTELLA; FIELD POPULATIONS; IPOMOEA-PURPUREA; TRANSGENIC CROPS; MORNING GLORY; RNA EVOLUTION	Co-evolution between plants and their natural enemies is generally believed to have generated much of the Earth's biological diversity. A process analogous to co-evolution occurs in agricultural systems, in which natural enemies adapt to crop resistance introduced by breeding or genetic engineering. Because of this similarity, the investigation of resistance mechanisms in crops is helping to elucidate the workings of co-evolution in nature, while evolutionary principles, including those derived from investigation of co-evolution in nature, are being applied in the management of resistance in genetically engineered crops.	Duke Univ, Dept Biol, Evolut Ecol & Organismal Biol Grp, Durham, NC 27708 USA	Duke University	Rausher, MD (corresponding author), Duke Univ, Dept Biol, Evolut Ecol & Organismal Biol Grp, Durham, NC 27708 USA.	mrausher@duke.edu						Agrawal AA, 2000, TRENDS PLANT SCI, V5, P309, DOI 10.1016/S1360-1385(00)01679-4; BERENBAUM M, 1983, EVOLUTION, V37, P163, DOI 10.1111/j.1558-5646.1983.tb05524.x; Berenbaum M.R., 1988, P113; Berenbaum MR, 1998, P NATL ACAD SCI USA, V95, P13743, DOI 10.1073/pnas.95.23.13743; BERENBAUM MR, 1986, EVOLUTION, V40, P1215, DOI 10.1111/j.1558-5646.1986.tb05746.x; BERGELSON J, 1994, AM NAT, V143, P349, DOI 10.1086/285607; Bergelson J, 1996, AM NAT, V148, P536, DOI 10.1086/285938; Bergelson J, 1996, P ROY SOC B-BIOL SCI, V263, P1659, DOI 10.1098/rspb.1996.0242; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Biere A, 1996, EVOLUTION, V50, P1098, DOI [10.1111/j.1558-5646.1996.tb02350.x, 10.2307/2410650]; Bishop JG, 2000, P NATL ACAD SCI USA, V97, P5322, DOI 10.1073/pnas.97.10.5322; CARROLL SP, 1992, EVOLUTION, V46, P1052, DOI 10.1111/j.1558-5646.1992.tb00619.x; CARROLL SP, 1987, ANN ENTOMOL SOC AM, V80, P373, DOI 10.1093/aesa/80.3.373; CASTILLOCHAVEZ C, 1988, EVOLUTION, V42, P986, DOI [10.2307/2408914, 10.1111/j.1558-5646.1988.tb02517.x]; COHEN MB, 1992, P NATL ACAD SCI USA, V89, P10920, DOI 10.1073/pnas.89.22.10920; COX TS, 1986, ENVIRON ENTOMOL, V15, P24, DOI 10.1093/ee/15.1.24; DeWit PJGM, 1997, TRENDS PLANT SCI, V2, P452, DOI 10.1016/S1360-1385(97)01139-4; DUSSOURD DE, 1987, SCIENCE, V237, P898, DOI 10.1126/science.3616620; EGGERSSCHUMACHER HA, 1983, ENTOMOL EXP APPL, V34, P301, DOI 10.1007/BF00186930; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Eubanks MD, 1997, OECOLOGIA, V109, P454, DOI 10.1007/s004420050105; Ewald PW, 1994, EVOLUTION INFECT DIS; Fagerstrom T, 1987, FUNCT ECOL, V1, P73, DOI 10.2307/2389708; Feeny Paul, 1992, P1; FINEBLUM WL, 1995, NATURE, V377, P517, DOI 10.1038/377517a0; FISCHHOFF DA, 1992, P 1992 BELTW COTT PR, P751; Fischhoff David A., 1996, V15, P214; FOSTER JE, 1991, ENVIRON ENTOMOL, V20, P964, DOI 10.1093/ee/20.4.964; Fry JD, 1996, AM NAT, V148, pS84, DOI 10.1086/285904; FRY JD, 1990, AM NAT, V136, P569, DOI 10.1086/285116; FUTUYMA DJ, 1979, ECOL MONOGR, V49, P33, DOI 10.2307/1942571; GALLUN RL, 1977, ANN NY ACAD SCI, V287, P223, DOI 10.1111/j.1749-6632.1977.tb34241.x; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; GOULD F, 1991, AM SCI, V79, P496; Gould F., 1988, P13; GROETERS FR, 1994, EVOLUTION, V48, P197, DOI 10.2307/2410015; HAMMA H, 1992, APPL ENTOMOL ZOOL, V27, P355; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Hartl D., 1989, PRINCIPLES POPULATIO; HATCHETT JH, 1968, ANN ENTOMOL SOC AM, V61, P1446, DOI 10.1093/aesa/61.6.1446; HAUGHN GW, 1988, MOL GEN GENET, V211, P266, DOI 10.1007/BF00330603; HAUGHN GW, 1986, MOL GEN GENET, V204, P430, DOI 10.1007/BF00331020; Heino M, 1998, CAN J FISH AQUAT SCI, V55, P1971, DOI 10.1139/cjfas-55-8-1971; Hoffmann A.A., 1991, EVOLUTIONARY GENETIC; International Conference on Harmonization, 1997, FED REG, V62, P27463; JANZEN DH, 1966, EVOLUTION, V20, P249, DOI 10.1111/j.1558-5646.1966.tb03364.x; JANZEN DH, 1980, EVOLUTION, V34, P611, DOI 10.1111/j.1558-5646.1980.tb04849.x; JERMY T, 1984, AM NAT, V124, P609, DOI 10.1086/284302; Jermy T., 1976, Symposia Biologica Hungarica, V16, P109; KOES RE, 1994, BIOESSAYS, V16, P123, DOI 10.1002/bies.950160209; Landweber LF, 1999, P NATL ACAD SCI USA, V96, P173, DOI 10.1073/pnas.96.1.173; Landweber LF, 1999, TRENDS ECOL EVOL, V14, P353, DOI 10.1016/S0169-5347(99)01680-8; LAW R, 1989, EVOL ECOL, V3, P343, DOI 10.1007/BF02285264; Levin BR, 1999, SCIENCE, V283, P806, DOI 10.1126/science.283.5403.806; Li W. H, 1997, MOL EVOLUTION; Liu YB, 1997, P ROY SOC B-BIOL SCI, V264, P605, DOI 10.1098/rspb.1997.0086; Mauricio R, 1998, AM NAT, V151, P20, DOI 10.1086/286099; Mauricio R, 1997, EVOLUTION, V51, P1435, DOI [10.2307/2411196, 10.1111/j.1558-5646.1997.tb01467.x]; McDowell JM, 1998, PLANT CELL, V10, P1861, DOI 10.1105/tpc.10.11.1861; MEFFE G. K., 1997, PRINCIPLES CONSERVAT; Meyers BC, 1998, PLANT CELL, V10, P1833, DOI 10.1105/tpc.10.11.1833; MULLER CH, 1969, SCIENCE, V164, P197, DOI 10.1126/science.164.3876.197; Murphy EJ, 1999, EVOL ECOL, V13, P517, DOI 10.1023/A:1006783902331; PAIGE KN, 1994, AM NAT, V143, P739, DOI 10.1086/285630; Painter RH, 1951, INSECT RESISTANCE CR; Parker JE, 1997, TRENDS BIOCHEM SCI, V22, P291, DOI 10.1016/S0968-0004(97)01089-X; Parniske M, 1997, CELL, V91, P821, DOI 10.1016/S0092-8674(00)80470-5; Perez CJ, 1997, J ECON ENTOMOL, V90, P1462, DOI 10.1093/jee/90.6.1462; PRYOR T, 1987, TRENDS GENET, V3, P157, DOI 10.1016/0168-9525(87)90217-4; Purrington CB, 1999, AM NAT, V154, pS82, DOI 10.1086/303285; RATHCKE BJ, 1975, SCIENCE, V187, P175, DOI 10.1126/science.187.4172.175; Rausher Mark D., 1993, P259; Rausher MD, 1996, TRENDS GENET, V12, P212, DOI 10.1016/0168-9525(96)10020-2; ROBINSON T, 1974, SCIENCE, V184, P430, DOI 10.1126/science.184.4135.430; ROSENTHAL GA, 1976, SCIENCE, V192, P256, DOI 10.1126/science.1257764; ROSENTHAL JP, 1994, TRENDS ECOL EVOL, V9, P145, DOI 10.1016/0169-5347(94)90180-5; Roush R. T., 1997, ADV INSECT CONTROL R, P271; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Roush RT, 1997, PESTIC SCI, V51, P328, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;328::AID-PS650&gt;3.0.CO;2-B; ROUSH RT, 1982, J ECON ENTOMOL, V75, P708, DOI 10.1093/jee/75.4.708; SCHAFER JF, 1971, ANNU REV PHYTOPATHOL, V9, P235, DOI 10.1146/annurev.py.09.090171.001315; SEIGLER D, 1976, AM NAT, V110, P101, DOI 10.1086/283050; SEIGLER DS, BIOCH SYSTEM ECOL, V5, P195; Shelton AM, 2000, NAT BIOTECHNOL, V18, P339, DOI 10.1038/73804; Shirley BW, 1996, TRENDS PLANT SCI, V1, P377, DOI 10.1016/1360-1385(96)10040-6; Shonle I, 2000, EVOLUTION, V54, P778, DOI 10.1111/j.0014-3820.2000.tb00079.x; Simms E. L., 1992, Plant resistance to herbivores and pathogens: ecology, evolution, and genetics., P392; SIMMS EL, 1989, EVOLUTION, V43, P573, DOI 10.1111/j.1558-5646.1989.tb04253.x; SIMMS EL, 1987, AM NAT, V130, P70; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; STRONG DR, 1984, INSECTS PLANTS; TABASHNIK BE, 1994, P NATL ACAD SCI USA, V91, P4120, DOI 10.1073/pnas.91.10.4120; Thompson J. N., 1982, INTERACTION COEVOLUT; Thompson JD., 1994, COEVOLUTIONARY PROCE; Tiffin P, 1999, AM NAT, V154, P700, DOI 10.1086/303271; Tiffin P, 2000, AM NAT, V155, P128, DOI 10.1086/303301; Van EMDEN H. F., 1966, WORLD REV PEST CONTR, V5, P115; Wang GL, 1998, PLANT CELL, V10, P765, DOI 10.1105/tpc.10.5.765; WHITTAKER RH, 1971, SCIENCE, V171, P757, DOI 10.1126/science.171.3973.757; Wood R. J., 1981, GENETIC CONSEQUENCES, P53; 1999, BIOSYSTEMS, V52; [No title captured]	103	311	350	6	162	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2001	411	6839					857	864		10.1038/35081193	http://dx.doi.org/10.1038/35081193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459070				2022-12-28	WOS:000169246400064
J	Davidson, A; Diamond, B				Davidson, A; Diamond, B			Advances in immunology - Autoimmune diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TUMOR-NECROSIS-FACTOR; STEM-CELL TRANSPLANTATION; INTERLEUKIN-1 RECEPTOR ANTAGONIST; SYSTEMIC-LUPUS-ERYTHEMATOSUS; INFLAMMATORY-BOWEL-DISEASE; SHARED EPITOPE HYPOTHESIS; CTLA-4 GENE POLYMORPHISM; ALTERED PEPTIDE LIGAND; CONGENITAL HEART-BLOCK; MYELIN BASIC-PROTEIN		Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Diamond, B (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	diamond@accom.yu.edu		Davidson, Anne/0000-0002-4081-6464	NIAID NIH HHS [AI31229] Funding Source: Medline; NIAMS NIH HHS [AR32371] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI031229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR032371, R01AR032371] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abrams JR, 1999, J CLIN INVEST, V103, P1243, DOI 10.1172/JCI5857; Agarwal K, 2000, J HEPATOL, V32, P538, DOI 10.1016/S0168-8278(00)80213-5; Arndt PA, 1999, TRANSFUSION, V39, P1239, DOI 10.1046/j.1537-2995.1999.39111239.x; Asadullah K, 2000, EXPERT OPIN INV DRUG, V9, P95, DOI 10.1517/13543784.9.1.95; Austrup F, 1997, NATURE, V385, P81, DOI 10.1038/385081a0; Awata T, 1998, DIABETES, V47, P128, DOI 10.2337/diab.47.1.128; Balasa B, 2000, IMMUNOL TODAY, V21, P19, DOI 10.1016/S0167-5699(99)01553-4; Balomenos D, 2000, NAT MED, V6, P171, DOI 10.1038/72272; Becker KG, 1999, DIABETES, V48, P1353, DOI 10.2337/diabetes.48.7.1353; Bell S, 2000, LANCET, V355, P858, DOI 10.1016/S0140-6736(99)00442-0; Bhan AK, 1999, IMMUNOL REV, V169, P195, DOI 10.1111/j.1600-065X.1999.tb01316.x; Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; Blumberg RS, 1999, CURR OPIN IMMUNOL, V11, P648, DOI 10.1016/S0952-7915(99)00032-1; Blumberg RS, 2000, CURR OPIN IMMUNOL, V12, P226, DOI 10.1016/S0952-7915(99)00079-5; Boismenu R, 2000, J LEUKOCYTE BIOL, V67, P267, DOI 10.1002/jlb.67.3.267; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Botto M, 1998, EXP CLIN IMMUNOGENET, V15, P231, DOI 10.1159/000019076; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Brandt J, 2000, ARTHRITIS RHEUM-US, V43, P1346, DOI 10.1002/1529-0131(200006)43:6<1346::AID-ANR18>3.0.CO;2-E; Brown PD, 2000, EXPERT OPIN INV DRUG, V9, P2167, DOI 10.1517/13543784.9.9.2167; Burt R K, 1999, Cancer Treat Res, V101, P157; Buyon JP, 1998, J AM COLL CARDIOL, V31, P1658, DOI 10.1016/S0735-1097(98)00161-2; Buyon JP, 1997, ARTHRITIS RHEUM-US, V40, P655, DOI 10.1002/art.1780400410; Bynoe MS, 2000, P NATL ACAD SCI USA, V97, P2703, DOI 10.1073/pnas.040577497; Charles PJ, 2000, ARTHRITIS RHEUM, V43, P2383, DOI 10.1002/1529-0131(200011)43:11<2383::AID-ANR2>3.3.CO;2-4; Chavany C, 1998, P NATL ACAD SCI USA, V95, P11354, DOI 10.1073/pnas.95.19.11354; Chen ZB, 2000, J EXP MED, V192, P1339, DOI 10.1084/jem.192.9.1339; Coelho SN, 1997, KIDNEY INT, V51, P646, DOI 10.1038/ki.1997.94; Comi G, 2000, J NEUROL, V247, P376, DOI 10.1007/s004150050605; Cope AP, 1997, J EXP MED, V185, P1573, DOI 10.1084/jem.185.9.1573; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Dahlquist G, 1998, ACTA PAEDIATR, V87, P5, DOI 10.1080/080352598750030537; Daikh DI, 2001, J IMMUNOL, V166, P2913, DOI 10.4049/jimmunol.166.5.2913; DANG H, 1995, J IMMUNOL, V155, P3205; Denham W, 1997, AM SURGEON, V63, P1045; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Dighiero G, 1999, IMMUNOL TODAY, V20, P423, DOI 10.1016/S0167-5699(99)01509-1; Dinarello CA, 2000, NEW ENGL J MED, V343, P732, DOI 10.1056/NEJM200009073431011; Drappa J, 1996, NEW ENGL J MED, V335, P1643, DOI 10.1056/NEJM199611283352204; Duda PW, 2000, J CLIN INVEST, V105, P967, DOI 10.1172/JCI8970; Edelson RL, 2000, NEW ENGL J MED, V343, P60, DOI 10.1056/NEJM200007063430111; Emery P, 2000, RHEUMATOLOGY, V39, P655, DOI 10.1093/rheumatology/39.6.655; Encinas JA, 2000, CURR OPIN IMMUNOL, V12, P691, DOI 10.1016/S0952-7915(00)00164-3; Falk K, 2000, J EXP MED, V191, P717, DOI 10.1084/jem.191.4.717; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Fridkis-Hareli M, 1999, J IMMUNOL, V162, P4697; Galvin JE, 2000, J CLIN INVEST, V106, P217, DOI 10.1172/JCI7132; Genain CP, 1996, SCIENCE, V274, P2054, DOI 10.1126/science.274.5295.2054; Ginn LR, 1998, ARTHRITIS RHEUM, V41, P400, DOI 10.1002/1529-0131(199803)41:3<400::AID-ART4>3.0.CO;2-5; Gold DP, 1997, CRIT REV IMMUNOL, V17, P507; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Gorus FK, 1997, DIABETES METAB REV, V13, P247, DOI 10.1002/(SICI)1099-0895(199712)13:4<247::AID-DMR196>3.0.CO;2-V; Gottlieb A, 2000, J AM ACAD DERMATOL, V42, P428, DOI 10.1016/S0190-9622(00)90214-7; Gottlieb AB, 2000, J AM ACAD DERMATOL, V43, P595, DOI 10.1067/mjd.2000.107945; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; GREGERSEN PK, 1997, TXB RHEUMATOLOGY, V1, P209; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; GU H, 1991, J EXP MED, V173, P1357, DOI 10.1084/jem.173.6.1357; GUILHERME L, 1995, CIRCULATION, V92, P415, DOI 10.1161/01.CIR.92.3.415; Henderson RD, 2000, J CLIN NEUROSCI, V7, P434, DOI 10.1054/jocn.2000.0693; Hill NJ, 2000, DIABETES, V49, P1744, DOI 10.2337/diabetes.49.10.1744; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Horwitz MS, 1998, NAT MED, V4, P781, DOI 10.1038/nm0798-781; Iizuka J, 1998, LAB INVEST, V78, P1523; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Juedes AE, 2000, J IMMUNOL, V164, P419, DOI 10.4049/jimmunol.164.1.419; Kalunian KC, 2000, ARTHRITIS RHEUM, V43, pS271; Kappos L, 2000, NAT MED, V6, P1176, DOI 10.1038/80525; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; Kawai T, 2000, NAT MED, V6, P114, DOI 10.1038/72162; Khare SD, 1998, RHEUM DIS CLIN N AM, V24, P883, DOI 10.1016/S0889-857X(05)70047-8; Khare SD, 1999, RHEUM DIS CLIN N AM, V25, pX; Klein J, 2000, NEW ENGL J MED, V343, P782, DOI 10.1056/NEJM200009143431106; Kontoyiannis D, 2000, EUR J IMMUNOL, V30, P2038, DOI 10.1002/1521-4141(200007)30:7<2038::AID-IMMU2038>3.0.CO;2-K; Kouki T, 2000, J IMMUNOL, V165, P6606, DOI 10.4049/jimmunol.165.11.6606; Kremer JM, 2001, ANN INTERN MED, V134, P695, DOI 10.7326/0003-4819-134-8-200104170-00013; Krueger J, 2000, J INVEST DERMATOL, V115, P333, DOI 10.1046/j.1523-1747.2000.00abs-8.x; Krueger JG, 2000, J AM ACAD DERMATOL, V43, P448, DOI 10.1067/mjd.2000.106515; Kukreja A, 1999, J CLIN ENDOCR METAB, V84, P4371, DOI 10.1210/jc.84.12.4371; Kukreja A, 2000, CELL MOL LIFE SCI, V57, P534, DOI 10.1007/PL00000715; LANZAVECCHIA A, 1995, J EXP MED, V181, P1945, DOI 10.1084/jem.181.6.1945; Liang B, 2000, CELL MOL LIFE SCI, V57, P561, DOI 10.1007/PL00000718; LIAO L, 1995, J EXP MED, V181, P1123, DOI 10.1084/jem.181.3.1123; Llorente L, 2000, ARTHRITIS RHEUM, V43, P1790, DOI 10.1002/1529-0131(200008)43:8<1790::AID-ANR15>3.0.CO;2-2; LopezHoyos M, 1996, J EXP MED, V183, P2523, DOI 10.1084/jem.183.6.2523; Madaio MP, 1998, J AUTOIMMUN, V11, P535, DOI 10.1006/jaut.1998.0217; Maini RN, 2000, ANNU REV MED, V51, P207, DOI 10.1146/annurev.med.51.1.207; Maisel A, 1998, CIRC RES, V82, P458, DOI 10.1161/01.RES.82.4.458; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; Malkiel S, 2000, INFECT IMMUN, V68, P5803, DOI 10.1128/IAI.68.10.5803-5808.2000; Mandik-Nayak L, 2000, INT IMMUNOL, V12, P353, DOI 10.1093/intimm/12.3.353; Marmont AM, 2000, ANNU REV MED, V51, P115, DOI 10.1146/annurev.med.51.1.115; Matsumoto Y, 2000, J IMMUNOL, V164, P2248, DOI 10.4049/jimmunol.164.4.2248; McCartney-Francis N L, 1998, Int Rev Immunol, V16, P553, DOI 10.3109/08830189809043009; MCDANIEL DO, 1995, ANN INTERN MED, V123, P181, DOI 10.7326/0003-4819-123-3-199508010-00004; Mease PJ, 2000, LANCET, V356, P385, DOI 10.1016/S0140-6736(00)02530-7; Merrill JT, 1999, THROMB HAEMOSTASIS, V81, P748; Miller SD, 1997, NAT MED, V3, P1133, DOI 10.1038/nm1097-1133; Mire-Sluis AR, 2000, DIABETOLOGIA, V43, P1282, DOI 10.1007/s001250051524; Mizuno M, 2000, CLIN EXP IMMUNOL, V119, P368; MOHAN C, 1995, J IMMUNOL, V154, P1470; Mohan N, 2000, ARTHRITIS RHEUM, V43, pS228; MOUDGIL KD, 1994, CLIN IMMUNOL IMMUNOP, V73, P283, DOI 10.1006/clin.1994.1200; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Nash RA, 2000, J CLIN IMMUNOL, V20, P38, DOI 10.1023/A:1006690526998; Neuhaus O, 2000, P NATL ACAD SCI USA, V97, P7452, DOI 10.1073/pnas.97.13.7452; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; O'Garra A, 1997, CURR OPIN IMMUNOL, V9, P872, DOI 10.1016/S0952-7915(97)80192-6; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Ortonne JP, 1999, BRIT J DERMATOL, V140, P1; Papadakis KA, 2000, INFLAMM BOWEL DIS, V6, P303, DOI 10.1002/ibd.3780060408; Paul-Clark MJ, 2001, J IMMUNOL, V166, P1169, DOI 10.4049/jimmunol.166.2.1169; Peterson JD, 1996, DIABETES, V45, P328, DOI 10.2337/diabetes.45.3.328; Pisetsky DS, 2000, NEW ENGL J MED, V342, P810, DOI 10.1056/NEJM200003163421110; PITKANEN J, IN PRESS J BIOL CHEM; Pozzilli P, 2000, DIABETOLOGIA, V43, P1000, DOI 10.1007/s001250051482; Prud'homme GJ, 2000, J AUTOIMMUN, V14, P23, DOI 10.1006/jaut.1999.0339; Ramiya VK, 1997, AUTOIMMUNITY, V26, P139, DOI 10.3109/08916939708994736; Reichlin M, 1998, J AUTOIMMUN, V11, P557, DOI 10.1006/jaut.1998.0219; Roep BO, 1999, J AUTOIMMUN, V13, P267, DOI 10.1006/jaut.1999.0312; Rook GAW, 1998, IMMUNOL TODAY, V19, P113, DOI 10.1016/S0167-5699(97)01204-8; Salemink I, 2000, THROMB HAEMOSTASIS, V84, P653, DOI 10.1055/s-0037-1614082; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Salvetti M, 2000, IMMUNOL TODAY, V21, P342, DOI 10.1016/S0167-5699(00)01658-3; Saoudi A, 1999, J IMMUNOL, V162, P7189; Sato S, 1996, J IMMUNOL, V157, P4371; Seddon B, 1999, J EXP MED, V189, P279, DOI 10.1084/jem.189.2.279; Seery JP, 1997, J EXP MED, V186, P1451, DOI 10.1084/jem.186.9.1451; Seishima M, 1999, ARCH DERMATOL RES, V291, P606, DOI 10.1007/s004030050462; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Silverstein AM, 2000, SEMIN IMMUNOL, V12, P173, DOI 10.1006/smim.2000.0228; SINHA AA, 1990, SCIENCE, V248, P1380, DOI 10.1126/science.1972595; Suzuki T, 1987, IMMUNE DEFICIENT ANI; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Takasu N, 1997, J ENDOCRINOL INVEST, V20, P452, DOI 10.1007/BF03348001; Taneja V, 1999, IMMUNOL REV, V169, P67, DOI 10.1111/j.1600-065X.1999.tb01307.x; Targoff IN, 2000, CURR OPIN RHEUMATOL, V12, P475, DOI 10.1097/00002281-200011000-00001; Teller K, 1996, J RHEUMATOL, V23, P1363; Thomas HE, 2000, DIABETES-METAB RES, V16, P251, DOI 10.1002/1520-7560(200007/08)16:4<251::AID-DMRR126>3.3.CO;2-3; Toyoda H, 1998, BIOESSAYS, V20, P750, DOI 10.1002/(SICI)1521-1878(199809)20:9<750::AID-BIES8>3.3.CO;2-8; Vanderlugt CL, 2000, J IMMUNOL, V164, P670, DOI 10.4049/jimmunol.164.2.670; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wakeland EK, 1997, J CLIN IMMUNOL, V17, P272, DOI 10.1023/A:1027370514198; Wallace DJ, 2001, EXPERT OPIN INV DRUG, V10, P111, DOI 10.1517/13543784.10.1.111; Wang CY, 1998, HUM GENET, V103, P681, DOI 10.1007/s004390050891; Warren SJP, 2000, NEW ENGL J MED, V343, P23, DOI 10.1056/NEJM200007063430104; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Weinblatt ME, 1999, ARTHRITIS RHEUM-US, V42, P1322, DOI 10.1002/1529-0131(199907)42:7<1322::AID-ANR4>3.0.CO;2-P; WEINER HL, 1993, SCIENCE, V259, P1321, DOI 10.1126/science.7680493; Weiner HL, 1997, ANNU REV MED, V48, P341; Welch TR, 1998, J CLIN IMMUNOL, V18, P48, DOI 10.1023/A:1023287820786; Westhoff CM, 1997, J IMMUNOL, V159, P3024; Wildbaum G, 2000, J CLIN INVEST, V106, P671, DOI 10.1172/JCI8759; Wilson SB, 1999, NATURE, V399, P84, DOI 10.1038/20007; Wilson SB, 1998, NATURE, V391, P177, DOI 10.1038/34419; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Yuki N, 1999, JPN J INFECT DIS, V52, P99; Zack DJ, 1996, J IMMUNOL, V157, P2082; Zhao ZS, 1998, SCIENCE, V279, P1344, DOI 10.1126/science.279.5355.1344; Zhou T, 1996, J IMMUNOL, V156, P2661	166	663	754	3	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2001	345	5					340	350		10.1056/NEJM200108023450506	http://dx.doi.org/10.1056/NEJM200108023450506			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458KM	11484692				2022-12-28	WOS:000170193600007
J	Plous, S; Herzog, H				Plous, S; Herzog, H			Animal research - Reliability of protocol reviews for animal research	SCIENCE			English	Editorial Material							MANUSCRIPT		Wesleyan Univ, Dept Psychol, Middletown, CT 06459 USA; Western Carolina Univ, Dept Psychol, Cullowhee, NC 28723 USA	Wesleyan University; University of North Carolina; Western Carolina University	Plous, S (corresponding author), Wesleyan Univ, Dept Psychol, Middletown, CT 06459 USA.							*AM PSYCH ASS, 1992, GUID ETH COND CAR US; BARTKO JJ, 1976, J NERV MENT DIS, V163, P307, DOI 10.1097/00005053-197611000-00003; CICCHETI DV, 1988, EDUC PSYCHOL MEAS, V48, P717, DOI 10.1177/0013164488483020; CICCHETTI DV, 1991, BEHAV BRAIN SCI, V14, P119, DOI 10.1017/S0140525X00065675; DRESSER R, 1989, J AM VET MED ASSOC, V194, P1184; GOLDMAN J, 1982, JAMA-J AM MED ASSOC, V248, P197, DOI 10.1001/jama.248.2.197; JAKO RA, 1990, J APPL PSYCHOL, V75, P500, DOI 10.1037/0021-9010.75.5.500; *NAT RES COUNC, 1996, GUID CAR US LAB; Plous S, 1996, AM PSYCHOL, V51, P1167, DOI 10.1037/0003-066X.51.11.1167; PRENTICE ED, 1990, INVEST RADIOL, V25, P271, DOI 10.1097/00004424-199003000-00012; STRAYHORN J, 1993, AM J PSYCHIAT, V150, P947	11	45	46	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					608	609		10.1126/science.1061621	http://dx.doi.org/10.1126/science.1061621			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	458PW	11474086				2022-12-28	WOS:000170204600026
J	Scherer, E; Munker, C; Mezger, K				Scherer, E; Munker, C; Mezger, K			Calibration of the lutetium-hafnium clock	SCIENCE			English	Article							LU-HF; HALF-LIFE; EVOLUTION; CONSTRAINTS; MANTLE; SYSTEMATICS; MONAZITE; LU-176; CRUST; DIFFERENTIATION	Well-defined constants of radioactive decay are the cornerstone of geochronology and the use of radiogenic isotopes to constrain the time scales and mechanisms of planetary differentiation. Four new determinations of the lutetium-176 decay constant (lambda Lu-176) made by calibration against the uranium-lead decay schemes yield a mean value of 1.865 +/- 0.015 x 10(-11) year(-1), in agreement with the two most recent decay-counting experiments. Lutetium-hafnium ages that are based on the previously used lambda Lu-176 of 1.93 x 10(-11) to 1.94 x 10(-11) year(-1) are thus similar to4% too young, and the initial hafnium isotope compositions of some of Earth's oldest minerals and rocks become less radiogenic relative to bulk undifferentiated Earth when calculated using the new decay constant. The existence of strongly unradiogenic hafnium in Early Archean and Hadean zircons implies that enriched crustal reservoirs existed on Earth by 4.3 billion years ago and persisted for 200 million years or more. Hence, current models of early terrestrial differentiation need revision.	Univ Munster, Inst Mineral, D-48149 Munster, Germany	University of Munster	Scherer, E (corresponding author), Univ Munster, Inst Mineral, Corrensstr 24, D-48149 Munster, Germany.		Mezger, Klaus/D-9502-2011; Munker, Carsten/O-7606-2015; Scherer, Erik E/P-3388-2017	Mezger, Klaus/0000-0002-2443-8539; Scherer, Erik E/0000-0001-6049-6202; Munker, Carsten/0000-0001-6406-559X				ALEINIKOFF JN, 1990, AM J SCI, V290, P522, DOI 10.2475/ajs.290.5.522; Amelin Y, 2000, GEOCHIM COSMOCHIM AC, V64, P4205, DOI 10.1016/S0016-7037(00)00493-2; Amelin Y, 1999, NATURE, V399, P252, DOI 10.1038/20426; Blichert-Toft J, 1999, EARTH PLANET SC LETT, V171, P439, DOI 10.1016/S0012-821X(99)00151-X; BlichertToft J, 1997, EARTH PLANET SC LETT, V148, P243, DOI 10.1016/S0012-821X(97)00040-X; BOUDIN A, 1970, SCIENCE, V168, P1219, DOI 10.1126/science.168.3936.1219; CHILDE F, 1993, CAN J EARTH SCI, V30, P1056, DOI 10.1139/e93-089; Cosca MA, 1998, J GEOL, V106, P539, DOI 10.1086/516040; DALMASSO J, 1992, APPL RADIAT ISOTOPES, V43, P69, DOI 10.1016/0883-2889(92)90078-S; DIXON D, 1954, PHILOS MAG, V45, P683; GEHRKE RJ, 1990, PHYS REV C, V41, P2878, DOI 10.1103/PhysRevC.41.2878; GLOVER RN, 1957, PHILOS MAG, V2, P699, DOI 10.1080/14786435708242713; Goldstein S. L., 1992, EOS T AM GEOPHYS UN, V73, P323; GOPEL C, 1991, METEORITICS, V26, P338; HARPER CL, 1992, NATURE, V360, P728, DOI 10.1038/360728a0; HEAMAN LM, 1993, CHEM GEOL, V110, P95, DOI 10.1016/0009-2541(93)90249-I; Horn I, 2000, CHEM GEOL, V164, P281, DOI 10.1016/S0009-2541(99)00168-0; JAFFEY AH, 1971, PHYS REV C, V4, P1889, DOI 10.1103/PhysRevC.4.1889; Kamber BS, 1998, PRECAMBRIAN RES, V91, P269, DOI 10.1016/S0301-9268(98)00053-9; Ludwig KR, 1998, GEOCHIM COSMOCHIM AC, V62, P665, DOI 10.1016/S0016-7037(98)00059-3; Ludwig KR, 2000, CHEM GEOL, V166, P315, DOI 10.1016/S0009-2541(99)00219-3; MCCULLOCH MT, 1993, LITHOS, V30, P237, DOI 10.1016/0024-4937(93)90038-E; Mojzsis SJ, 2001, NATURE, V409, P178, DOI 10.1038/35051557; Munker C, 2000, SCIENCE, V289, P1538, DOI 10.1126/science.289.5484.1538; Nir-El Y, 1998, APPL RADIAT ISOTOPES, V49, P1653, DOI 10.1016/S0969-8043(97)10007-0; NORMAN EB, 1980, PHYS REV C, V21, P1109, DOI 10.1103/PhysRevC.21.1109; ONIONS RK, 1971, CONTRIB MINERAL PETR, V34, P1, DOI 10.1007/BF00376027; PARRISH RR, 1990, CAN J EARTH SCI, V27, P1431, DOI 10.1139/e90-152; PATCHETT PJ, 1980, NATURE, V288, P571, DOI 10.1038/288571a0; Reischmann T., 1995, S AFR J GEOL, V98, P1; Salters VJM, 1998, CHEM GEOL, V145, P447, DOI 10.1016/S0009-2541(97)00154-X; SATO J, 1983, RADIOCHEM RADIOA LET, V58, P263; SGUIGNA AP, 1982, CAN J PHYS, V60, P361, DOI 10.1139/p82-049; Sharma M, 1996, GEOCHIM COSMOCHIM AC, V60, P3751, DOI 10.1016/S0016-7037(96)90093-9; TATSUMOTO M, 1981, MEM NATL I POLAR RES, V20, P237; Vervoort JD, 1996, GEOCHIM COSMOCHIM AC, V60, P3717, DOI 10.1016/0016-7037(96)00201-3; Vervoort JD, 1999, EARTH PLANET SC LETT, V168, P79, DOI 10.1016/S0012-821X(99)00047-3; Vervoort JD, 1999, GEOCHIM COSMOCHIM AC, V63, P533, DOI 10.1016/S0016-7037(98)00274-9; Wilde SA, 2001, NATURE, V409, P175, DOI 10.1038/35051550	39	2068	2301	3	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					683	687		10.1126/science.1061372	http://dx.doi.org/10.1126/science.1061372			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474108				2022-12-28	WOS:000170204600051
J	Corma, A; Nemeth, LT; Renz, M; Valencia, S				Corma, A; Nemeth, LT; Renz, M; Valencia, S			Sn-zeolite beta as a heterogeneous chemoselective catalyst for Baeyer-Villiger oxidations	NATURE			English	Article							HYDROGEN-PEROXIDE; PLATINUM COMPLEXES; CYCLIC-KETONES	The Baeyer-Villiger oxidation, first reported more than 100 years ago(1), has evolved into a versatile reaction widely used(2) to convert ketones-readily available building blocks in organic chemistry-into more complex and valuable esters and lactones. Catalytic versions of the Baeyer-Villiger oxidation are particularly attractive for practical applications, because catalytic transformations simplify processing conditions while minimizing reactant use as well as waste production. Further benefits are expected from replacing peracids, the traditionally used oxidant, by cheaper and less polluting hydrogen peroxide(3). Dissolved platinum complexes(4) and solid acids, such as zeolites(5,6) or sulphonated resins(7), efficiently activate ketone oxidation by hydrogen peroxide. But these catalysts lack sufficient selectivity for the desired product if the starting material contains functional groups other than the ketone group; they perform especially poorly in the presence of carbon-carbon double bonds. Here we show that upon incorporation of 1.6 weight per cent tin into its framework, zeolite beta acts as an efficient and stable heterogeneous catalyst for the Baeyer-Villiger oxidation of saturated as well as unsaturated ketones by hydrogen peroxide, with the desired lactones forming more than 98% of the reaction products. We ascribe this high selectivity to direct activation of the ketone group, whereas other catalysts first activate hydrogen peroxide, which can then interact with the ketone group as well as other functional groups.	Univ Politecn Valencia, CSIC, Inst Tecnol Quim, Valencia 46022, Spain; Universal Oil Prod, UOP LLC, Des Plaines, IL 60017 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Tecnologia Quimica (ITQ)	Corma, A (corresponding author), Univ Politecn Valencia, CSIC, Inst Tecnol Quim, Avda Naranjos S-N, Valencia 46022, Spain.	acorma@itq.upv.es	CANOS, AVELINO CORMA/A-3040-2013; Renz, Michael/B-9361-2011; Valencia, Susana/I-4644-2015	CANOS, AVELINO CORMA/0000-0002-2232-3527; Renz, Michael/0000-0002-1101-9562; Valencia, Susana/0000-0001-7160-2795				Arends IWCE, 1997, ANGEW CHEM INT EDIT, V36, P1144, DOI 10.1002/anie.199711441; Baeyer A., 1899, CHEM BER, V32, P3625; Bhaumik A, 1996, CATAL LETT, V40, P47, DOI 10.1007/BF00807456; CAMBLOR MA, 1992, J CHEM SOC CHEM COMM, P589, DOI 10.1039/c39920000589; CHANG CD, 1996, Patent No. 4870192; Corma A., 1999, US Patent, Patent No. [5968473A, 5968473]; Fischer J, 1999, APPL CATAL A-GEN, V180, P435, DOI 10.1016/S0926-860X(98)00378-0; FRISONE MD, 1993, ORGANOMETALLICS, V12, P148; Gavagnin R, 1998, ORGANOMETALLICS, V17, P661, DOI 10.1021/om970756f; HERRMANN WA, 1994, J MOL CATAL, V94, P213, DOI 10.1016/S0304-5102(94)87043-8; HERRMANN WA, 1995, J ORGANOMET CHEM, V500, P149, DOI 10.1016/0022-328X(95)00518-U; HOELDERICH W, 1999, Patent No. 19745442; Huang HH, 2001, WATER RES, V35, P2291, DOI 10.1016/S0043-1354(00)00496-6; JACOBSON SE, 1978, J CHEM SOC CHEM COMM, P888, DOI 10.1039/c39780000888; Kelly D. R., 1998, BIOTRANSFORMATIONS A, V8a, P535; Palazzi C, 2000, J MOL CATAL A-CHEM, V151, P245, DOI 10.1016/S1381-1169(99)00249-6; Renz M, 1999, EUR J ORG CHEM, V1999, P737; SEN T, 1995, J CHEM SOC CHEM COMM, P207, DOI 10.1039/c39950000207; Shambayati S., 1991, COMPREHENSIVE ORGANI, V1, P283; Strukul G, 1998, ANGEW CHEM INT EDIT, V37, P1199, DOI 10.1002/(SICI)1521-3773(19980518)37:9<1198::AID-ANIE1198>3.0.CO;2-Y	20	790	827	19	537	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2001	412	6845					423	425		10.1038/35086546	http://dx.doi.org/10.1038/35086546			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473313				2022-12-28	WOS:000170068200043
J	Lifshitz, Y; Duan, XF; Shang, NG; Li, Q; Wan, L; Bello, I; Lee, ST				Lifshitz, Y; Duan, XF; Shang, NG; Li, Q; Wan, L; Bello, I; Lee, ST			Nanostructure - Epitaxial diamond polytypes on silicon	NATURE			English	Article							CARBON; GROWTH		City Univ Hong Kong, Ctr Super Diamond & Adv Films, Hong Kong, Hong Kong, Peoples R China; City Univ Hong Kong, Dept Phys & Mat Sci, Hong Kong, Hong Kong, Peoples R China; Chinese Acad Sci, Beijing Lab Electron Microscopy, Ctr Condensed Matter Phys, Inst Phys, Hong Kong, Hong Kong, Peoples R China	City University of Hong Kong; City University of Hong Kong; Chinese Academy of Sciences	Lifshitz, Y (corresponding author), City Univ Hong Kong, Ctr Super Diamond & Adv Films, Hong Kong, Hong Kong, Peoples R China.		Wan, Li/E-9379-2017; Lee, Shuit-Tong/Q-7552-2018; Li, Quan/G-5082-2013; Lifshitz, Yeshayahu/E-6043-2011	Wan, Li/0000-0001-6426-6498; Li, Quan/0000-0001-8563-1802; 				Banhart F, 1996, NATURE, V382, P433, DOI 10.1038/382433a0; Lee ST, 2000, SCIENCE, V287, P104, DOI 10.1126/science.287.5450.104; Lifshitz Y, 1999, DIAM RELAT MATER, V8, P1659, DOI 10.1016/S0925-9635(99)00087-4; LIFSHITZ Y, 1989, PHYS REV LETT, V62, P1290, DOI 10.1103/PhysRevLett.62.1290; MORKOC H, 1994, J APPL PHYS, V76, P1363, DOI 10.1063/1.358463; Peng HY, 2000, APPL PHYS LETT, V77, P2831, DOI 10.1063/1.1320869; RAMSDELL LS, 1947, AM MINERAL, V32, P64	7	43	46	3	49	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					404	404		10.1038/35086656	http://dx.doi.org/10.1038/35086656			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473306	Bronze			2022-12-28	WOS:000170068200036
J	Ramsay, S				Ramsay, S			Johns Hopkins takes responsibility for volunteer's death	LANCET			English	News Item																			0	10	10	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 21	2001	358	9277					213	213						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454HL	11476843				2022-12-28	WOS:000169967100019
J	Volkman, SK; Barry, AE; Lyons, EJ; Nielsen, KM; Thomas, SM; Choi, M; Thakore, SS; Day, KP; Wirth, DF; Hartl, DL				Volkman, SK; Barry, AE; Lyons, EJ; Nielsen, KM; Thomas, SM; Choi, M; Thakore, SS; Day, KP; Wirth, DF; Hartl, DL			Recent origin of Plasmodium falciparum from a single progenitor	SCIENCE			English	Article							CHLOROQUINE RESISTANCE; POPULATION-STRUCTURE; ANTIGENIC VARIATION; MALARIA; GENE; ERYTHROCYTES; MUTATIONS; SEQUENCE; SURFACE; PROTEIN	Genetic variability of Plasmodium falciparum underlies its transmission success and thwarts efforts to control disease caused by this parasite. Genetic variation in antigenic, drug resistance, and pathogenesis determinants is abundant, consistent with an ancient origin of P. falciparum, whereas DNA variation at silent (synonymous) sites in coding sequences appears virtually absent, consistent with a recent origin of the parasite. To resolve this paradox, we analyzed introns and demonstrated that these are deficient in single-nucleotide polymorphisms, as are synonymous sites in coding regions. These data establish the recent origin of P. falciparum and further provide an explanation for the abundant diversity observed in antigen and other selected genes.	Harvard Univ, Sch Publ Hlth, Harvard Oxford Genome Divers Project, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Norwegian Univ Sci & Technol, Dept Bot, N-7491 Trondheim, Norway	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford; Harvard University; Norwegian University of Science & Technology (NTNU)	Wirth, DF (corresponding author), Harvard Univ, Sch Publ Hlth, Harvard Oxford Genome Divers Project, 665 Huntington Ave, Boston, MA 02115 USA.	dfwirth@hsph.harvard.edu	Nielsen, Kaare Magne/G-8107-2018; Day, Karen/F-3697-2015	Nielsen, Kaare Magne/0000-0002-7217-2114; Day, Karen/0000-0002-6115-6135; Barry, Alyssa/0000-0002-1189-2310				Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; BIGGS BA, 1991, P NATL ACAD SCI USA, V88, P9171, DOI 10.1073/pnas.88.20.9171; Biswas S, 2000, TROP MED INT HEALTH, V5, P737, DOI 10.1046/j.1365-3156.2000.00632.x; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; BRUCECHWATT LJ, 1965, B WORLD HEALTH ORGAN, V32, P363; Coluzzi M, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P277; Conway DJ, 2000, MOL BIOCHEM PARASIT, V111, P163, DOI 10.1016/S0166-6851(00)00313-3; ESCALANTE AA, 1995, MOL BIOL EVOL, V12, P616; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Hughes AL, 1998, GENETICS, V150, P511; HUGHES AL, 1992, MOL BIOL EVOL, V9, P381; JARCHO S, 1964, B HIST MED, V37, P1; KEMP DJ, 1990, ADV PARASIT, V29, P75; KUNKEL TA, 1986, J BIOL CHEM, V261, P3581; Lehmann T, 2000, J PARASITOL, V86, P960, DOI 10.1645/0022-3395(2000)086[0960:STOTGC]2.0.CO;2; Li W. H, 1997, MOL EVOLUTION; LIVINGSTONE FB, 1958, AM ANTHROPOL, V60, P533, DOI 10.1525/aa.1958.60.3.02a00110; MCCUTCHAN TF, 1990, IMMUNOL LETT, V25, P23, DOI 10.1016/0165-2478(90)90085-5; Rich SM, 1998, P NATL ACAD SCI USA, V95, P4425, DOI 10.1073/pnas.95.8.4425; Rich SM, 2000, P NATL ACAD SCI USA, V97, P6994, DOI 10.1073/pnas.97.13.6994; Rich SM, 1998, GENETICS, V150, P515; Rich SM, 1997, P NATL ACAD SCI USA, V94, P13040, DOI 10.1073/pnas.94.24.13040; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Salzberg SL, 1999, GENOMICS, V59, P24, DOI 10.1006/geno.1999.5854; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; Su XZ, 1996, GENOMICS, V33, P430, DOI 10.1006/geno.1996.0218; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Su XZ, 1997, CELL, V91, P593, DOI 10.1016/S0092-8674(00)80447-X; 2000, WHO TECH REP SER, V892, P1	33	128	134	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2001	293	5529					482	484		10.1126/science.1059878	http://dx.doi.org/10.1126/science.1059878			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463913				2022-12-28	WOS:000169966700044
J	Martin, M; Tsai, TF; Cropp, B; Chang, GJJ; Holmes, DA; Tseng, J; Shieh, WJ; Zaki, SR; Al-Sanouri, I; Cutrona, AF; Ray, G; Weld, LH; Cetron, MS				Martin, M; Tsai, TF; Cropp, B; Chang, GJJ; Holmes, DA; Tseng, J; Shieh, WJ; Zaki, SR; Al-Sanouri, I; Cutrona, AF; Ray, G; Weld, LH; Cetron, MS			Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases	LANCET			English	Article							VIRUS; ENCEPHALITIS; PATHOGENESIS; 17DD	Background In 1998, the US Centers for Disease Control and Prevention was notified of three patients who developed severe illnesses days after yellow fever vaccination. A similar case occurred in 1996. All four patients were more than 63 years old. Methods Vaccine strains of yellow fever virus, isolated from the plasma of two patients and the cerebrospinal fluid of one, were characterised by genomic sequencing. Clinical samples were subjected to neutralisation assays, and an immunohistochemical analysis was done on one sample of liver obtained at biopsy. Findings The clinical presentations were characterised by fever, myalgia, headache, and confusion, followed by severe multisystemic illnesses. Three patients died. Vaccine-related variants of yellow fever virus were found in plasma and cerebrospinal fluid of one vaccinee. The convalescent serum samples of two vaccinees showed antibody responses of at least 1:10 240. Immunohistochemical assay of liver tissue showed yellow fever antigen in the Kuppfer cells of the liver sample. Interpretation The clinical features, their temporal association with vaccination. recovery of vaccine-related virus, antibody responses, and immunohistochemical assay collectively suggest a possible causal relation between the illnesses and yellow fever vaccination. Yellow fever remains an important cause of illness and death in South America and Africa; hence, vaccination should be maintained until the frequency of these events is quantified.	Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div Infect Dis Pathol, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Emory Sch Med, Div Infect Dis, Atlanta, GA USA; Western Reserve Care Syst, Dept Internal Med, Youngstown, OH USA; Western Reserve Care Syst, Family Med Ctr, Youngstown, OH USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University; Case Western Reserve University; Case Western Reserve University	Cetron, MS (corresponding author), Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Natl Ctr Infect Dis, MS E03,1600 Clifton Rd, Atlanta, GA 30333 USA.	MCetron@cdc.gov		Weld, Leisa/0000-0001-6550-0135				[Anonymous], 1966, J AMER MED ASSOC, V198, P671; Barros MLB, 1996, LANCET, V348, P969, DOI 10.1016/S0140-6736(05)65392-5; BEEUWKES Henry, 1936, Transactions of the Royal Society of Tropical Medicine and Hygiene, V30, P61, DOI 10.1016/S0035-9203(36)90014-7; Centers for Disease Control and Prevention, 1999, HLTH INF INT TRAV 19; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P303; DECOCK KM, 1988, LANCET, V1, P630; DOSSANTOS CND, 1995, VIRUS RES, V35, P35; GOULD EA, 1989, J GEN VIROL, V70, P1889, DOI 10.1099/0022-1317-70-7-1889; HANSON Henry, 1929, American Journal of Tropical Medicine, V9, P233; JENNINGS AD, 1994, J INFECT DIS, V169, P512, DOI 10.1093/infdis/169.3.512; Kirk R., 1941, ANN TROP MED AND PARASITOL, V35, P67; MARTIN M, IN PRESS EMERG INFEC; McFarland JM, 1997, CLIN INFECT DIS, V25, P1143, DOI 10.1086/516111; MERLO C, 1993, VACCINE, V11, P691, DOI 10.1016/0264-410X(93)90329-V; Monath TP, 1999, VACCINES, P815; *PAHO DIV VACC IMM, 2000, SER ADV EV ASS YELL; POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Ryman KD, 1998, VIROLOGY, V244, P59, DOI 10.1006/viro.1998.9057; SMITH H. H., 1938, AMER JOUR TROP MED, V18, P437; Teichmann D, 1999, LANCET, V354, P1608, DOI 10.1016/S0140-6736(99)09233-8; Thonnon J, 1998, TROP MED INT HEALTH, V3, P872; TSAI TF, 2000, MANDELL DOUGLAS BENN, P1714; Vasconcelos PFC, 2001, LANCET, V358, P91, DOI 10.1016/S0140-6736(01)05326-0; ZAKI SR, 1995, AM J PATHOL, V146, P552	25	186	196	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 14	2001	358	9276					98	104		10.1016/S0140-6736(01)05327-2	http://dx.doi.org/10.1016/S0140-6736(01)05327-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452BR	11463410				2022-12-28	WOS:000169837700009
J	Stewart, PS; Costerton, JW				Stewart, PS; Costerton, JW			Antibiotic resistance of bacteria in biofilms	LANCET			English	Review							PSEUDOMONAS-AERUGINOSA BIOFILMS; ESCHERICHIA-COLI; ANTIMICROBIAL AGENTS; OPERON MAR; IN-VITRO; DIFFUSION; SUSCEPTIBILITY; TOBRAMYCIN; MECHANISMS; EXPRESSION	Bacteria that adhere to implanted medical devices or damaged tissue can encase themselves in a hydrated matrix of polysaccharide and protein, and form a slimy layer known as a biofilm. Antibiotic resistance of bacteria in the biofilm mode of growth contributes to the chronicity of infections such as those associated with implanted medical devices. The mechanisms of resistance in biofilms are different from the now familiar plasmids, transposons, and mutations that confer innate resistance to individual bacterial cells. In biofilms, resistance seems to depend on multicellular strategies. We summarise the features of biofilm infections, review emerging mechanisms of resistance, and discuss potential therapies.	Montana State Univ, Ctr Biofilm Engn, Bozeman, MT 59717 USA; Montana State Univ, Dept Chem Engn, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Stewart, PS (corresponding author), Montana State Univ, Ctr Biofilm Engn, Bozeman, MT 59717 USA.	phil_s@erc.montana.edu		Stewart, Philip/0000-0001-7773-8570				Alekshun MN, 1999, TRENDS MICROBIOL, V7, P410, DOI 10.1016/S0966-842X(99)01589-9; Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000; ANWAR H, 1989, ANTIMICROB AGENTS CH, V33, P1824, DOI 10.1128/AAC.33.10.1824; Bagge N, 2000, APMIS, V108, P589, DOI 10.1034/j.1600-0463.2000.d01-102.x; Brooun A, 2000, ANTIMICROB AGENTS CH, V44, P640, DOI 10.1128/AAC.44.3.640-646.2000; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; Cochran WL, 2000, J APPL MICROBIOL, V88, P22, DOI 10.1046/j.1365-2672.2000.00825.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 2000, PERSISTENT BACTERIAL, P432; Darveau RP, 1997, PERIODONTOL 2000, V14, P12, DOI 10.1111/j.1600-0757.1997.tb00190.x; Das JR, 1998, J APPL MICROBIOL, V84, P852; DEBEER D, 1994, BIOTECHNOL BIOENG, V43, P1131, DOI 10.1002/bit.260431118; GORDON CA, 1988, J ANTIMICROB CHEMOTH, V22, P667, DOI 10.1093/jac/22.5.667; Goto T, 1999, UROLOGY, V53, P1058, DOI 10.1016/S0090-4295(98)00649-9; Gristina A G, 1994, Semin Arthroplasty, V5, P160; HOIBY N, 1995, MICROBIAL BIOFILMS, P233; Hyde JAJ, 1998, J HEART VALVE DIS, V7, P316; KUMON H, 1994, MICROBIOL IMMUNOL, V38, P615, DOI 10.1111/j.1348-0421.1994.tb01831.x; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Maira-Litran T, 2000, J ANTIMICROB CHEMOTH, V45, P789, DOI 10.1093/jac/45.6.789; Maira-Litran T, 2000, J APPL MICROBIOL, V88, P243, DOI 10.1046/j.1365-2672.2000.00963.x; MARRIE TJ, 1982, CIRCULATION, V66, P1339, DOI 10.1161/01.CIR.66.6.1339; Morris NS, 1999, WORLD J UROL, V17, P345, DOI 10.1007/s003450050159; Nemoto K, 2000, CHEMOTHERAPY, V46, P111, DOI 10.1159/000007264; NICHOLS WW, 1988, ANTIMICROB AGENTS CH, V32, P518, DOI 10.1128/AAC.32.4.518; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Parsek MR, 2000, P NATL ACAD SCI USA, V97, P8789, DOI 10.1073/pnas.97.16.8789; PASSERINI L, 1992, CRIT CARE MED, V20, P665, DOI 10.1097/00003246-199205000-00020; Prigent-Combaret C, 1999, J BACTERIOL, V181, P5993, DOI 10.1128/JB.181.19.5993-6002.1999; Shigeta M, 1997, CHEMOTHERAPY, V43, P340, DOI 10.1159/000239587; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Stewart PS, 1998, BIOTECHNOL BIOENG, V59, P261, DOI 10.1002/(SICI)1097-0290(19980805)59:3<261::AID-BIT1>3.0.CO;2-9; Stewart PS, 1996, ANTIMICROB AGENTS CH, V40, P2517, DOI 10.1128/AAC.40.11.2517; TACK KJ, 1985, CHEMOTHERAPY, V31, P204, DOI 10.1159/000238337; TUOMANEN E, 1986, J GEN MICROBIOL, V132, P1297; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Williams I, 1997, MICROBIOL-UK, V143, P2407, DOI 10.1099/00221287-143-7-2407; Xu KD, 2000, MICROBIOL-UK, V146, P547, DOI 10.1099/00221287-146-3-547; YASUDA H, 1993, ANTIMICROB AGENTS CH, V37, P1749, DOI 10.1128/AAC.37.9.1749; Zhang TC, 1996, WATER ENVIRON RES, V68, P1107, DOI 10.2175/106143096X128504	40	3002	3168	35	1424	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 14	2001	358	9276					135	138		10.1016/S0140-6736(01)05321-1	http://dx.doi.org/10.1016/S0140-6736(01)05321-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452BR	11463434	Green Submitted			2022-12-28	WOS:000169837700032
J	Stiell, IG; Hebert, PC; Wells, GA; Vandemheen, KL; Tang, ASL; Higginson, LAJ; Dreyer, JF; Clement, C; Battram, E; Watpool, I; Mason, S; Klassen, T; Weitzman, BN				Stiell, IG; Hebert, PC; Wells, GA; Vandemheen, KL; Tang, ASL; Higginson, LAJ; Dreyer, JF; Clement, C; Battram, E; Watpool, I; Mason, S; Klassen, T; Weitzman, BN			Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial	LANCET			English	Article							CORONARY PERFUSION-PRESSURE; HIGH-DOSE EPINEPHRINE; ORGAN BLOOD-FLOW; PROLONGED CARDIOPULMONARY-RESUSCITATION; RELEASE; MODEL	Background Survival rates for cardiac arrest patients, both in and out of hospital, are poor. Results of a previous study suggest better outcomes for patients treated with vasopressin than for those given epinephrine, in the out-of-hospital setting. Our aim was to compare the effectiveness and safety of these drugs for the treatment of in-patient cardiac arrest. Methods We did a triple-blind randomised trial in the emergency departments, critical care units, and wards of three Canadian teaching hospitals. We assigned adults who had cardiac arrest and required drug therapy to receive one dose of vasopressin 40 U or epinephrine 1 mg intravenously, as the initial vasopressor. Patients who failed to respond to the study intervention were given epinephrine as a rescue medication. The primary outcomes were survival to hospital discharge, survival to 1 h, and neurological function. Preplanned subgroup assessments included patients with myocardial ischaemia or infarction, initial cardiac rhythm, and age. Findings We assigned 104 patients to vasopressin and 96 to epinephrine. For patients receiving vasopressin or epinephrine survival did not differ for hospital discharge (12 [12%] vs 13 [14%], respectively; p=0.67; 95% CI for absolute increase in survival -11.8% to 7.8%) or for 1 h survival (40 [39%] vs 34 [35%]; p=0.66; -10.9% to 17.0%); survivors had closely similar median mini-mental state examination scores (36 [range 19-38] vs 35 [20-40]; p=0.75) and median cerebral performance category scores (1 vs 1). Interpretation We failed to detect any survival advantage for vasopressin over epjnephrine, We cannot recommend the routine use of vasopressin for inhospital cardiac arrest patients, and disagree with American Heart Association guidelines, which recommend vasopressin as therapy for cardiac arrest.	Univ Ottawa, Div Emergency Med, Ottawa, ON, Canada; Univ Ottawa, Dept Med, Ottawa, ON, Canada; Univ Ottawa, Dept Epidemiol, Ottawa, ON, Canada; Univ Ottawa, Clin Epidemiol Unit, Ottawa, ON, Canada; Univ Ottawa, Inst Heart, Ottawa, ON, Canada; Univ Western Ontario, Div Emergency Med, London, ON, Canada; Univ Alberta, Dept Paediat, Edmonton, AB, Canada	University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa Heart Institute; Western University (University of Western Ontario); University of Alberta	Stiell, IG (corresponding author), Ottawa Hlth Res Inst, Clin Epidemiol Unit, Ottawa, ON K1Y 4E9, Canada.	istiell@ohri.ca	Tang, Anthony S/E-6203-2014	Stiell, Ian/0000-0002-2583-6408				Babar SI, 1999, RESUSCITATION, V41, P185, DOI 10.1016/S0300-9572(99)00071-4; BROWN CG, 1992, NEW ENGL J MED, V327, P1051, DOI 10.1056/NEJM199210083271503; CALLAHAM M, 1992, JAMA-J AM MED ASSOC, V268, P2667, DOI 10.1001/jama.268.19.2667; FOX AW, 1988, GEN PHARMACOL, V19, P639, DOI 10.1016/0306-3623(88)90121-8; HAUCK WW, 1986, AM STAT, V40, P318, DOI 10.2307/2684618; ISHIKAWA S, 1984, MINER ELECTROL METAB, V10, P184; KELSEY SF, 1991, CONTROL CLIN TRIALS, V12, P525; Kornberger E, 2000, CRIT CARE MED, V28, P3517, DOI 10.1097/00003246-200010000-00028; LINDNER KH, 1993, ANESTH ANALG, V77, P427; Lindner KH, 1996, HEART, V75, P145, DOI 10.1136/hrt.75.2.145; LINDNER KH, 1992, ANESTHESIOLOGY, V77, P662, DOI 10.1097/00000542-199210000-00008; LINDNER KH, 1995, CIRCULATION, V91, P215, DOI 10.1161/01.CIR.91.1.215; Lindner KH, 1997, LANCET, V349, P535, DOI 10.1016/S0140-6736(97)80087-6; Lindner KH, 1996, ANN INTERN MED, V124, P1061, DOI 10.7326/0003-4819-124-12-199606150-00006; MCALPINE HM, 1988, BRIT HEART J, V60, P117; Morris DC, 1997, ACAD EMERG MED, V4, P878, DOI 10.1111/j.1553-2712.1997.tb03813.x; Mulligan KA, 1997, RESUSCITATION, V35, P265, DOI 10.1016/S0300-9572(97)00060-9; PARADIS NA, 1990, JAMA-J AM MED ASSOC, V263, P1106, DOI 10.1001/jama.263.8.1106; PARADIS NA, 1993, RESUSCITATION, V26, P261, DOI 10.1016/0300-9572(93)90147-I; Prengel AW, 1996, STROKE, V27, P1241, DOI 10.1161/01.STR.27.7.1241; SCHALLER MD, 1987, AM J CARDIOL, V60, P1178, DOI 10.1016/0002-9149(87)90416-4; SHARE L, 1967, ENDOCRINOLOGY, V81, P1140, DOI 10.1210/endo-81-5-1140; SHEN YT, 1991, CIRC RES, V68, P1422, DOI 10.1161/01.RES.68.5.1422; Stiell IG, 1996, JAMA-J AM MED ASSOC, V275, P1417, DOI 10.1001/jama.275.18.1417; STIELL IG, 1992, NEW ENGL J MED, V327, P1045, DOI 10.1056/NEJM199210083271502; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Voelckel WG, 2000, CRIT CARE MED, V28, P3777, DOI 10.1097/00003246-200012000-00001; Wenzel V, 2000, J AM COLL CARDIOL, V35, P527, DOI 10.1016/S0735-1097(99)00562-8; Wenzel V, 1999, CRIT CARE MED, V27, P486, DOI 10.1097/00003246-199903000-00022; Wenzel V, 2000, CRIT CARE MED, V28, P1096, DOI 10.1097/00003246-200004000-00031; Wenzel V, 1999, CIRCULATION, V99, P1379, DOI 10.1161/01.CIR.99.10.1379; Wenzel V, 1998, STROKE, V29, P1462, DOI 10.1161/01.STR.29.7.1462; Willerson JT, 2000, CIRCULATION, V102, P1; WILSON MF, 1981, SURG GYNECOL OBSTET, V153, P869; WU WH, 1982, B NEW YORK ACAD MED, V58, P427; 1992, JAMA, V268, P2171	36	213	225	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 14	2001	358	9276					105	109		10.1016/S0140-6736(01)05328-4	http://dx.doi.org/10.1016/S0140-6736(01)05328-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452BR	11463411				2022-12-28	WOS:000169837700010
J	Abrieu, A; Magnaghi-Jaulin, L; Kahana, JA; Peter, M; Castro, A; Vigneron, S; Lorca, T; Cleveland, DW; Labbe, JC				Abrieu, A; Magnaghi-Jaulin, L; Kahana, JA; Peter, M; Castro, A; Vigneron, S; Lorca, T; Cleveland, DW; Labbe, JC			Mps1 is a kinetochore-associated kinase essential for the vertebrate mitotic checkpoint	CELL			English	Article							SPINDLE ASSEMBLY CHECKPOINT; POLE BODY DUPLICATION; XENOPUS EGG EXTRACTS; DEPENDENT PROTEIN-KINASE; CENP-E; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; UNATTACHED KINETOCHORES; CHROMOSOME ALIGNMENT; ANAPHASE INITIATION	The mitotic checkpoint acts to inhibit entry into anaphase until all chromosomes have successfully attached to spindle microtubules. Unattached kinetochores are believed to release an activated form of Mad2 that inhibits APC/C-dependent ubiquitination and subsequent proteolysis of components needed for anaphase onset. Using Xenopus egg extracts, a vertebrate homolog of yeast Mps1p is shown here to be a kinetochore-associated kinase, whose activity is necessary to establish and maintain the checkpoint. Since high levels of Mad2 overcome checkpoint loss in Mps1-depleted extracts, Mps1 acts upstream of Mad2-mediated inhibition of APC/C. Mps1 is essential for the checkpoint because it is required for recruitment and retention of active CENP-E at kinetochores, which in turn is necessary for kinetochore association of Mad1 and Mad2.	Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; CNRS, UPR 1086, Ctr Rech Biochim Macromol, F-34293 Montpellier 5, France	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Abrieu, Ariane/P-3307-2019; CASTRO, ANNA/F-4350-2010; Abrieu, Ariane/G-6336-2013; labbe, jean-claude/B-2277-2009; Cleveland, Don/AAN-9783-2021; Peter, Marion/Y-5024-2019	CASTRO, ANNA/0000-0002-3655-1352; Abrieu, Ariane/0000-0002-0942-8877; Peter, Marion/0000-0002-5720-4798; Peter, Matthias/0000-0002-2160-6824; Lorca, Thierry/0000-0003-2007-8924; Cleveland, Don/0000-0002-1934-3682				Abrieu A, 2000, CELL, V102, P817, DOI 10.1016/S0092-8674(00)00070-2; Bloecher A, 2000, NAT CELL BIOL, V2, P556, DOI 10.1038/35019601; Brady DM, 2000, CURR BIOL, V10, P675, DOI 10.1016/S0960-9822(00)00515-7; Brown KD, 1996, J CELL SCI, V109, P961; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chen RH, 1997, METHOD ENZYMOL, V283, P572; Chen RH, 1999, MOL BIOL CELL, V10, P2607, DOI 10.1091/mbc.10.8.2607; Chen RH, 1998, J CELL BIOL, V143, P283, DOI 10.1083/jcb.143.2.283; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Cooke CA, 1997, CHROMOSOMA, V106, P446, DOI 10.1007/s004120050266; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; DOUVILLE EMJ, 1992, MOL CELL BIOL, V12, P2681, DOI 10.1128/MCB.12.6.2681; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Farr KA, 1998, MOL CELL BIOL, V18, P2738, DOI 10.1128/MCB.18.5.2738; Fesquet D, 1999, EMBO J, V18, P2424, DOI 10.1093/emboj/18.9.2424; Fisk HA, 2001, CELL, V106, P95, DOI 10.1016/S0092-8674(01)00411-1; HARDWICK KG, 1995, J CELL BIOL, V131, P709, DOI 10.1083/jcb.131.3.709; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; HOGG D, 1994, ONCOGENE, V9, P89; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Jablonski SA, 1998, CHROMOSOMA, V107, P386, DOI 10.1007/s004120050322; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; LAUZE E, 1995, EMBO J, V14, P1655, DOI 10.1002/j.1460-2075.1995.tb07154.x; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Lorca T, 1998, EMBO J, V17, P3565, DOI 10.1093/emboj/17.13.3565; LORCA T, 1994, BBA-MOL CELL RES, V1223, P325, DOI 10.1016/0167-4889(94)90091-4; Martinez-Exposito MJ, 1999, P NATL ACAD SCI USA, V96, P8493, DOI 10.1073/pnas.96.15.8493; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; MILLS GB, 1992, J BIOL CHEM, V267, P16000; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; MORIN N, 1994, EMBO J, V13, P4343, DOI 10.1002/j.1460-2075.1994.tb06754.x; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Pereira G, 2000, MOL CELL, V6, P1, DOI 10.1016/S1097-2765(05)00017-1; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; ROBERTS BT, 1994, MOL CELL BIOL, V14, P8282, DOI 10.1128/MCB.14.12.8282; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; Schutz AR, 1997, J CELL BIOL, V136, P969, DOI 10.1083/jcb.136.5.969; Shapiro PS, 1998, J CELL BIOL, V142, P1533, DOI 10.1083/jcb.142.6.1533; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Taylor SS, 1998, J CELL BIOL, V142, P1, DOI 10.1083/jcb.142.1.1; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0; Zachariae W, 1999, CURR OPIN CELL BIOL, V11, P708, DOI 10.1016/S0955-0674(99)00041-1; Zecevic M, 1998, J CELL BIOL, V142, P1547, DOI 10.1083/jcb.142.6.1547; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	55	264	283	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2001	106	1					83	93		10.1016/S0092-8674(01)00410-X	http://dx.doi.org/10.1016/S0092-8674(01)00410-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461704	Bronze			2022-12-28	WOS:000169870300011
J	Grishok, A; Pasquinelli, AE; Conte, D; Li, N; Parrish, S; Ha, I; Baillie, DL; Fire, A; Ruvkun, G; Mello, CC				Grishok, A; Pasquinelli, AE; Conte, D; Li, N; Parrish, S; Ha, I; Baillie, DL; Fire, A; Ruvkun, G; Mello, CC			Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C-elegans developmental timing	CELL			English	Article							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; CELL-DIFFERENTIATION; MESSENGER-RNA; LIN-4 RNA; PROTEINS; TRANSCRIPTION; TRANSLATION; HELICASE; SEQUENCE	RNAi is a gene-silencing phenomenon triggered by double-stranded (ds) RNA and involves the generation of 21 to 26 nt RNA segments that guide mRNA destruction. In Caenorhabditis elegans, lin-4 and let-7 encode small temporal RNAs (stRNAs) of 22 nt that regulate stage-specific development. Here we show that inactivation of genes related to RNAi pathway genes, a homolog of Drosophila Dicer (dcr-1), and two homologs of rde-1 (alg-1 and alg-2), cause heterochronic phenotypes similar to lin-4 and let-7 mutations. Further we show that dcr-1, alg-1, and alg-2 are necessary for the maturation and activity of the lin-4 and let-7 stRNAs. Our findings suggest that a common processing machinery generates guide RNAs that mediate both RNAi and endogenous gene regulation.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Johns Hopkins Univ, Biol Grad Program, Baltimore, MD 21218 USA; Simon Fraser Univ, Inst Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; Carnegie Inst Sci, Baltimore, MD 21210 USA; Hanwha Chem R&D Inst, Daejun 305345, South Korea	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; Simon Fraser University; Carnegie Institution for Science	Mello, CC (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	craig.mello@umassmed.edu	Pillay, Nischalan/F-9536-2012	Fire, Andrew/0000-0001-6217-8312; Grishok, Alla/0000-0001-8922-7575	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058800] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM07321, R01 GM037706, GM58800, GM37706] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMBROS V, 1989, CELL, V57, P49, DOI 10.1016/0092-8674(89)90171-2; Antebi A, 1998, DEVELOPMENT, V125, P1191; Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; Baulcombe D, 1999, ARCH VIROL, P189; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Cikaluk DE, 1999, MOL BIOL CELL, V10, P3357, DOI 10.1091/mbc.10.10.3357; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Feinbaum R, 1999, DEV BIOL, V210, P87, DOI 10.1006/dbio.1999.9272; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Kataoka Y, 2001, GENES CELLS, V6, P313, DOI 10.1046/j.1365-2443.2001.00427.x; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lynn K, 1999, DEVELOPMENT, V126, P469; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Moussian B, 1998, EMBO J, V17, P1799, DOI 10.1093/emboj/17.6.1799; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Schmidt A, 1999, GENETICS, V151, P749; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Stewart HI, 1998, MOL GEN GENET, V260, P280, DOI 10.1007/PL00013816; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wilson JE, 1996, DEVELOPMENT, V122, P1631; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	42	1437	1634	3	133	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2001	106	1					23	34		10.1016/S0092-8674(01)00431-7	http://dx.doi.org/10.1016/S0092-8674(01)00431-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461699	Bronze			2022-12-28	WOS:000169870300006
J	Nadelman, RB; Nowakowski, J; Fish, D; Falco, RC; Freeman, K; McKenna, D; Welch, P; Marcus, R; Aguero-Rosenfeld, ME; Dennis, DT; Wormser, GP				Nadelman, RB; Nowakowski, J; Fish, D; Falco, RC; Freeman, K; McKenna, D; Welch, P; Marcus, R; Aguero-Rosenfeld, ME; Dennis, DT; Wormser, GP		Tick Bite Study Grp	Prophylaxis with single-dose doxycycline for the prevention of lyme disease after an ixodes scapularis tick bite.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDEMIC AREA; BORRELIA-BURGDORFERI; ERYTHEMA MIGRANS; DURATION; EFFICACY; TRIAL; RISK	Background: It is unclear whether antimicrobial treatment after an Ixodes scapularis tick bite will prevent Lyme disease. Methods: In an area of New York where Lyme disease is hyperendemic, we conducted a randomized, double-blind, placebo-controlled trial of treatment with a single 200-mg dose of doxycycline in 482 subjects who had removed attached I. scapularis ticks from their bodies within the previous 72 hours. At base line, three weeks, and six weeks, subjects were interviewed and examined, and serum antibody tests were performed, along with blood cultures for Borrelia burgdorferi. Results: Erythema migrans developed at the site of the tick bite in a significantly smaller proportion of the subjects in the doxycycline group than of those in the placebo group (1 of 235 subjects [0.4 percent] vs. 8 of 247 subjects [3.2 percent], P<0.04). The efficacy of treatment was 87 percent (95 percent confidence interval, 25 to 98 percent). Objective extracutaneous signs of Lyme disease did not develop in any subject, and there were no asymptomatic seroconversions. Treatment with doxycycline was associated with more frequent adverse effects (in 30.1 percent of subjects, as compared with 11.1 percent of those assigned to placebo; P<0.001), primarily nausea (15.4 percent vs. 2.6 percent) and vomiting (5.8 percent vs. 1.3 percent). Erythema migrans developed more frequently after untreated bites from nymphal ticks than after bites from adult female ticks (8 of 142 bites [5.6 percent] vs. 0 of 97 bites [0 percent], P=0.02). Conclusions: A single 200-mg dose of doxycycline given within 72 hours after an I. scapularis tick bite can prevent the development of Lyme disease. (N Engl J Med 2001;345:79-84.) Copyright (C) 2001 Massachusetts Medical Society.	Westchester Cty Med Ctr, Div Infect Dis, Lyme Dis Diagnost Ctr, Valhalla, NY 10595 USA; New York Med Coll, Dept Med, Div Infect Dis, Valhalla, NY 10595 USA; New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; Fordham Univ, Louis Calder Ctr, Vector Ecol Lab, Armonk, NY USA; Albert Einstein Coll Med, Dept Epidemiol & Social Med, Bronx, NY 10467 USA; No Westchester Hosp, Mt Kisco, NY USA; Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Natl Ctr Infect Dis, Ft Collins, CO USA	Westchester Medical Center; New York Medical College; New York Medical College; Yale University; Fordham University; Yeshiva University; Albert Einstein College of Medicine; Centers for Disease Control & Prevention - USA	Nadelman, RB (corresponding author), Westchester Cty Med Ctr, Div Infect Dis, Lyme Dis Diagnost Ctr, Macy Pavil 209 SE, Valhalla, NY 10595 USA.		DeHaas, Keith/I-4957-2017		PHS HHS [U50/CCU 210286, U50/CCU 210280] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AGRE F, 1993, AM J DIS CHILD, V147, P945, DOI 10.1001/archpedi.1993.02160330035013; [Anonymous], 1999, MED LETT DRUGS THER, V41, P29; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590; COSTELLO CM, 1989, J INFECT DIS, V159, P136, DOI 10.1093/infdis/159.1.136; DEVIGNES F, 2001, J INFECT DIS, V183, P773; Falco RC, 1996, AM J EPIDEMIOL, V143, P187, DOI 10.1093/oxfordjournals.aje.a008728; Falco RC, 1999, AM J EPIDEMIOL, V149, P771, DOI 10.1093/oxfordjournals.aje.a009886; Falco RC, 1998, JAMA-J AM MED ASSOC, V280, P602, DOI 10.1001/jama.280.7.602-a; HENNEKENS CH, 1987, EPIDEMIOLOGY MED, P254; KENYON RH, 1978, J CLIN MICROBIOL, V8, P102; MAGID D, 1992, NEW ENGL J MED, V327, P534, DOI 10.1056/NEJM199208203270806; NADELMAN RB, 1990, AM J MED, V88, P21, DOI 10.1016/0002-9343(90)90122-T; Nadelman RB, 1996, AM J MED, V100, P502, DOI 10.1016/S0002-9343(95)99915-9; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Orloski K A, 2000, MMWR CDC Surveill Summ, V49, P1; SCHROETER AL, 1971, J AMER MED ASSOC, V218, P711, DOI 10.1001/jama.218.5.711; SHAPIRO ED, 1992, NEW ENGL J MED, V327, P1769, DOI 10.1056/NEJM199212173272501; Sood SK, 1997, J INFECT DIS, V175, P996, DOI 10.1086/514009; Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401; TAKAFUJI ET, 1984, NEW ENGL J MED, V310, P497, DOI 10.1056/NEJM198402233100805; Warshafsky S, 1996, J GEN INTERN MED, V11, P329, DOI 10.1007/BF02600042; Wormser GP, 2000, CLIN INFECT DIS, V31, pS1, DOI 10.1086/314053	22	259	272	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 12	2001	345	2					79	84		10.1056/NEJM200107123450201	http://dx.doi.org/10.1056/NEJM200107123450201			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451AH	11450675				2022-12-28	WOS:000169776900001
J	Zahnle, K				Zahnle, K			Decline and fall of the martian empire	NATURE			English	Editorial Material									NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Zahnle, K (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.							ANDERS E, 1977, SCIENCE, V198, P453, DOI 10.1126/science.198.4316.453; CAIDIN M, 1997, DESTINATION MARS; DEVAUCOULEURS G, 1954, PHYSICS PLANET MARS; FLAMMARION C, 1892, PLANETE MARS CONDITI; GLASSTONE S, 1968, BOOK MARS; HOROWITZ NH, 1986, UTOPIA BACK; Hoyt W. G., 1976, LOWELL MARS; KELLOGG WW, 1961, PUBLICATION NATL ACA, V944; Lowell P., 1908, MARS ABODE LIFE; Lowell P., 1906, MARS ITS CANALS; Lowell P., 1894, MARS; SALISBURY FB, 1962, SCIENCE, V136, P17, DOI 10.1126/science.136.3510.17; SHEEHAN W, 1996, PLANET MARS; SULLIVAN W, 1964, WE ARE NOT ALONE; WALLACE AR, 2000, MARS HABITABLE	15	7	8	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					209	213		10.1038/35084148	http://dx.doi.org/10.1038/35084148			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449281	Bronze			2022-12-28	WOS:000169778700059
J	Taylor, S; Coyle, E				Taylor, S; Coyle, E			For and against - Public health does not need to be led by doctors - Against	BRITISH MEDICAL JOURNAL			English	Article									Gwent Hlth Author, Pontypool NP4 0YP, Gwent, Wales; Shetland Hlth Board, Lerwick ZE1 0TG, Zetland, Scotland		Coyle, E (corresponding author), Gwent Hlth Author, Mamhilad Pk Estate, Pontypool NP4 0YP, Gwent, Wales.							[Anonymous], 1983, NHS MAN INQ; *CHART I ENV HLTH, 1995, ASS PROF COMP REG EX; *DEP HLTH SCOTT OF, 1998, GUID SPEC REG TRAIN; Department of Health and Social Security, 1976, PREV HLTH EV BUS REA; GREATOREX IF, 1999, PUBLIC HLTH MED, V1, P70; HART JT, 1987, BRIT MED J, V294, P871, DOI 10.1136/bmj.294.6576.871; Morris J N, 1969, Lancet, V2, P812; *SEC STAT HLTH, 1999, CM 4386; *SECR STAT SOC SER, 1988, PUBL HLTH ENGL ACH R; *STAND NURS MIDW A, 1995, MAK IT HAPP PUBL HLT; Walker R., 2000, PHARM J, V264, P340	11	1	1	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 30	2001	322	7302					1594	1596						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449QT	11458890				2022-12-28	WOS:000169699200034
J	Correia, ACM; Laskar, J				Correia, ACM; Laskar, J			The four final rotation states of Venus	NATURE			English	Article							ATMOSPHERIC TIDES; EVOLUTION; OBLIQUITY; SPIN; PLANETS; EARTH	Venus rotates very slowly on its axis in a retrograde direction, opposite to that of most other bodies in the Solar System(1). To explain this peculiar observation, it has been generally believed(2-6) that in the past its rotational axis was itself rotated to 180 degrees as a result of core-mantle friction inside the planet, together with atmospheric tides. But such a change has to assume a high initial obliquity (the angle between the planet's equator and the plane of the orbital motion). Chaotic evolution(7), however, allows the spin axis to flip for a large set of initial conditions(6,8). Here we show that independent of uncertainties in the models, terrestrial planets with dense atmosphere like Venus can evolve into one of only four possible rotation states. Moreover, we rnd that most initial conditions will drive the planet towards the configuration at present seen at Venus, albeit through two very different evolutionary paths. The first is the generally accepted view whereby the spin axis flips direction(2-6). But we have also found that it is possible for Venus to begin with prograde rotation (the same direction as the other planets) yet then develop retrograde rotation while the obliquity goes towards zero(9) : a rotation of the spin axis is not necessary in this case.	IMC, CNRS, UMR 8028, F-75014 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite	Laskar, J (corresponding author), IMC, CNRS, UMR 8028, 77 Av Denfert Rochereau, F-75014 Paris, France.	laskar@bdl.fr	Correia, Alexandre C. M./J-4315-2013; Laskar, Jacques/E-1098-2011	Correia, Alexandre C. M./0000-0002-8946-8579; Laskar, Jacques/0000-0003-2634-789X				AOKI S, 1969, ASTRON J, V74, P284, DOI 10.1086/110808; CARPENTER RL, 1970, ASTRON J, V75, P61, DOI 10.1086/110941; Chapman S., 1970, ATMOSPHERIC TIDES TH; DAVIES ME, 1992, J GEOPHYS RES-PLANET, V97, P13141, DOI 10.1029/92JE01166; deSurgy ON, 1997, ASTRON ASTROPHYS, V318, P975; DESURGY ON, 1996, INFLUENCE EFFECTS DI; DICKEY JO, 1994, SCIENCE, V265, P482, DOI 10.1126/science.265.5171.482; DOBROVOLSKIS AR, 1980, ICARUS, V41, P18, DOI 10.1016/0019-1035(80)90157-8; DOBROVOLSKIS AR, 1980, ICARUS, V41, P1, DOI 10.1016/0019-1035(80)90156-6; GOLD T, 1969, ICARUS, V11, P356, DOI 10.1016/0019-1035(69)90068-2; GOLDREICH P, 1966, ASTRON J, V71, P425, DOI 10.1086/109947; Goldreich P., 1970, Astronomical Journal, V75, P273, DOI 10.1086/110975; HUNTEN DM, 1993, SCIENCE, V259, P915, DOI 10.1126/science.259.5097.915; KASTING JF, 1993, SCIENCE, V259, P920, DOI 10.1126/science.11536547; KAULA WM, 1964, REV GEOPHYS, V2, P661, DOI 10.1029/RG002i004p00661; KONOPLIV AS, 1993, GEOPHYS RES LETT, V20, P2403, DOI 10.1029/93GL01890; KUNDT W, 1977, ASTRON ASTROPHYS, V60, P85; LAGO B, 1979, MOON PLANETS, V21, P127, DOI 10.1007/BF00897084; LASKAR J, 1993, NATURE, V361, P608, DOI 10.1038/361608a0; MCCUE J, 1993, EARTH MOON PLANETS, V63, P209, DOI 10.1007/BF00572469; Munk W. H., 1960, ROTATION EARTH GEOPH; Pais MA, 1999, EARTH PLANET SC LETT, V174, P155, DOI 10.1016/S0012-821X(99)00249-6; PEPIN RO, 1991, ICARUS, V92, P2, DOI 10.1016/0019-1035(91)90036-S; ROCHESTER MG, 1976, GEOPHYS J ROY ASTR S, V46, P109, DOI 10.1111/j.1365-246X.1976.tb01635.x; SHEN M, 1989, EARTH MOON PLANETS, V43, P275; WALKER JCG, 1975, J ATMOS SCI, V32, P1248, DOI 10.1175/1520-0469(1975)032<1248:EOTAOV>2.0.CO;2; YODER CF, 1995, ICARUS, V117, P250, DOI 10.1006/icar.1995.1156; YODER CF, 1997, GEOLOGY GEOPHYSICS A, V1087	29	80	82	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2001	411	6839					767	770		10.1038/35081000	http://dx.doi.org/10.1038/35081000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459048				2022-12-28	WOS:000169246400039
J	Lopes, M; Cotta-Ramusino, C; Pellicioli, A; Liberi, G; Plevani, P; Muzi-Falconi, M; Newlon, CS; Foiani, M				Lopes, M; Cotta-Ramusino, C; Pellicioli, A; Liberi, G; Plevani, P; Muzi-Falconi, M; Newlon, CS; Foiani, M			The DNA replication checkpoint response stabilizes stalled replication forks	NATURE			English	Article							S-PHASE; SACCHAROMYCES-CEREVISIAE; DAMAGE CHECKPOINTS; ORIGINS; PROGRESSION; PROTEIN; PHOSPHORYLATION; RECOMBINATION; ACTIVATION; PLASMIDS	In response to DNA damage and blocks to replication, eukaryotes activate the checkpoint pathways that prevent genomic instability and cancer by coordinating cell cycle progression with DNA repair(1-5). In budding yeast, the checkpoint response requires the Mec1-dependent activation of the Rad53 protein kinase(3,4,6). Active Rad53 slows DNA synthesis when DNA is damaged(7) and prevents firing of late origins of replication(8,9). Further, rad53 mutants are unable to recover from a replication block 10. Mec1 and Rad53 also modulate the phosphorylation state of different DNA replication and repair enzymes(6,11-13). Little is known of the mechanisms by which checkpoint pathways interact with the replication apparatus when DNA is damaged or replication blocked. We used the two-dimensional gel technique(14) to examine replication intermediates in response to hydroxyurea-induced replication blocks. Here we show that hydroxyurea-treated rad53 mutants accumulate unusual DNA structures at replication forks. The persistence of these abnormal molecules during recovery from the hydroxyurea block correlates with the inability to dephosphorylate Rad53. Further, Rad53 is required to properly maintain stable replication forks during the block. We propose that Rad53 prevents collapse of the fork when replication pauses.	Ist FIRC Oncol Mol, I-20141 Milan, Italy; Univ Milan, Dipartimento Genet & Biol Microorganismi, I-20133 Milan, Italy; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA	IFOM - FIRC Institute of Molecular Oncology; University of Milan; Rutgers State University New Brunswick; Rutgers State University Medical Center	Foiani, M (corresponding author), Ist FIRC Oncol Mol, Via Serio 21, I-20141 Milan, Italy.		Muzi-Falconi, Marco/A-6035-2012; Pellicioli, Achille/B-8765-2017; LIBERI, GIORDANO/AAY-7273-2020; Foiani, Marco/M-8234-2014; Lopes, Massimo/G-4300-2013	Muzi-Falconi, Marco/0000-0001-7046-6090; Pellicioli, Achille/0000-0002-1528-9009; LIBERI, GIORDANO/0000-0003-3160-2242; Foiani, Marco/0000-0003-4795-834X; Lopes, Massimo/0000-0003-3847-8133; PLEVANI, PAOLO/0000-0003-1869-2626	Telethon [E.1108] Funding Source: Medline	Telethon(Fondazione Telethon)		Bashkirov VI, 2000, MOL CELL BIOL, V20, P4393, DOI 10.1128/MCB.20.12.4393-4404.2000; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Brush GS, 1996, P NATL ACAD SCI USA, V93, P15075, DOI 10.1073/pnas.93.26.15075; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; Dimitrova DS, 2000, NAT CELL BIOL, V2, P686, DOI 10.1038/35036309; Edwards RJ, 1999, NAT CELL BIOL, V1, P393, DOI 10.1038/15623; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; FOIANI M, 2000, MUTAT RES, V21, P286; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; Kalejta RF, 1996, MOL CELL BIOL, V16, P4915; Liberi G, 2000, EMBO J, V19, P5027, DOI 10.1093/emboj/19.18.5027; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Lowndes NF, 2000, CURR OPIN GENET DEV, V10, P17, DOI 10.1016/S0959-437X(99)00050-7; Marini F, 1997, EMBO J, V16, P639, DOI 10.1093/emboj/16.3.639; MARTINPARRAS L, 1992, J BIOL CHEM, V267, P22496; NEWLON CS, 1993, COLD SPRING HARB SYM, V58, P415, DOI 10.1101/SQB.1993.058.01.048; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Rothstein R, 2000, GENE DEV, V14, P1; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Weinert T, 1997, CANCER SURV, V29, P109; Weinert T, 1998, CURR OPIN GENET DEV, V8, P185, DOI 10.1016/S0959-437X(98)80140-8; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	29	607	620	1	27	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					557	561		10.1038/35087613	http://dx.doi.org/10.1038/35087613			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484058				2022-12-28	WOS:000170202900050
J	Nielsen, SJ; Schneider, R; Bauer, UM; Bannister, AJ; Morrison, A; O'Carroll, D; Firestein, R; Cleary, M; Jenuwein, T; Herrera, RE; Kouzarides, T				Nielsen, SJ; Schneider, R; Bauer, UM; Bannister, AJ; Morrison, A; O'Carroll, D; Firestein, R; Cleary, M; Jenuwein, T; Herrera, RE; Kouzarides, T			Rb targets histone H3 methylation and HP1 to promoters	NATURE			English	Article							RETINOBLASTOMA PROTEIN; CHROMATIN-STRUCTURE; IN-VIVO; DEACETYLASE; EXPRESSION; DOMAIN	In eukaryotic cells the histone methylase SUV39H1 and the methyl-lysine binding protein HP1 functionally interact to repress transcription at heterochromatic sites(1). Lysine 9 of histone H3 is methylated by SUV39H1 (ref. 2), creating a binding site for the chromo domain of HP1 (refs 3, 4). Here we show that SUV39H1 and HP1 are both involved in the repressive functions of the retinoblastoma (Rb) protein. Rb associates with SUV39H1 and HP1 in vivo by means of its pocket domain. SUV39H1 cooperates with Rb to repress the cyclin E promoter, and in fibroblasts that are disrupted for SUV39, the activity of the cyclin E and cyclin A2 genes are specifically elevated. Chromatin immunoprecipitations show that Rb is necessary to direct methylation of histone H3, and is necessary for binding of HP1 to the cyclin E promoter. These results indicate that the SUV39H1-HP1 complex is not only involved in heterochromatic silencing but also has a role in repression of euchromatic genes by Rb and perhaps other co-repressor proteins.	Wellcome CRC Inst, Cambridge CB2 1QR, England; Dept Pathol, Cambridge CB2 1QR, England; Baylor Coll Med, Dept Mol & Cellular Biol, Breast Ctr, Houston, TX 77030 USA; Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA	Baylor College of Medicine; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Stanford University	Kouzarides, T (corresponding author), Wellcome CRC Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	tk106@mole.bio.cam.ac.uk		Morrison, Ashby/0000-0003-1228-5093; Bannister, Andrew/0000-0002-6312-4436; O'Carroll, Donal/0000-0002-8626-2217; Kouzarides, Tony/0000-0002-8918-4162	NIGMS NIH HHS [R25 GM056929] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056929] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; DEDON PC, 1991, ANAL BIOCHEM, V197, P83, DOI 10.1016/0003-2697(91)90359-2; Firestein R, 2000, MOL CELL BIOL, V20, P4900, DOI 10.1128/MCB.20.13.4900-4909.2000; HAGEMEIER C, 1993, NUCLEIC ACIDS RES, V21, P4998, DOI 10.1093/nar/21.22.4998; Herrera RE, 1996, MOL CELL BIOL, V16, P2402; Hurford RK, 1997, GENE DEV, V11, P1447, DOI 10.1101/gad.11.11.1447; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; Korner K, 2000, J BIOL CHEM, V275, P18676, DOI 10.1074/jbc.M001110200; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Williams L, 2000, TRENDS PLANT SCI, V5, P239, DOI 10.1016/S1360-1385(00)01653-8	19	704	741	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2001	412	6846					561	565		10.1038/35087620	http://dx.doi.org/10.1038/35087620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484059				2022-12-28	WOS:000170202900051
J	Clark, JS; Carpenter, SR; Barber, M; Collins, S; Dobson, A; Foley, JA; Lodge, DM; Pascual, M; Pielke, R; Pizer, W; Pringle, C; Reid, WV; Rose, KA; Sala, O; Schlesinger, WH; Wall, DH; Wear, D				Clark, JS; Carpenter, SR; Barber, M; Collins, S; Dobson, A; Foley, JA; Lodge, DM; Pascual, M; Pielke, R; Pizer, W; Pringle, C; Reid, WV; Rose, KA; Sala, O; Schlesinger, WH; Wall, DH; Wear, D			Ecological forecasts: An emerging imperative	SCIENCE			English	Editorial Material							SPREAD; AGRICULTURE; INVASION; MALARIA; MODELS; CARBON; CO2	Planning and decision-making can be improved by access to reliable forecasts of ecosystem state, ecosystem services, and natural capital. Availability of new data sets, together with progress in computation and statistics, will increase our ability to forecast ecosystem change. An agenda that would lead toward a capacity to produce, evaluate, and communicate forecasts of critical ecosystem services requires a process that engages scientists and decision-makers. interdisciplinary linkages are necessary because of the climate and societal controls on ecosystems, the feedbacks involving social change, and the decision-making relevance of forecasts.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; Ecol Soc Amer, Washington, DC 20006 USA; Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; Univ Wisconsin, Ctr Sustainabil & Global Environm, Madison, WI 53706 USA; Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; Natl Ctr Atmospher Res, Environm & Societal Impacts Grp, Boulder, CO 80301 USA; Resources Future Inc, Washington, DC 20036 USA; Univ Georgia, Dept Ecol, Athens, GA 30602 USA; Millennium Ecosyst Assessment, Seattle, WA 98103 USA; Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; Univ Buenos Aires, CONICET, Fac Agron, IFEVA,Dept Ecol, RA-1417 Buenos Aires, DF, Argentina; Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; US Forest Serv, USDA, Res Triangle Pk, NC 27709 USA	Duke University; University of Wisconsin System; University of Wisconsin Madison; Kansas State University; Princeton University; University of Wisconsin System; University of Wisconsin Madison; University of Notre Dame; University of Michigan System; University of Michigan; National Center Atmospheric Research (NCAR) - USA; Resources for the Future; University System of Georgia; University of Georgia; Louisiana State University System; Louisiana State University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Duke University; Colorado State University; United States Department of Agriculture (USDA); United States Forest Service	Clark, JS (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	jimclark@duke.edu	Collins, Scott L/P-7742-2014; Clark, James S./G-6331-2011; Wall, Diana H/F-5491-2011; Foley, Jonathan A/GRS-5522-2022; Lodge, David Michael/AAX-1781-2021; Rose, Kenneth/AAA-3534-2022; Carpenter, Stephen/AAQ-6404-2020; Pringle, Catherine M/I-1841-2012	Collins, Scott L/0000-0002-0193-2892; Rose, Kenneth/0000-0002-9310-8410; Sala, Osvaldo/0000-0003-0142-9450				[Anonymous], 2000, SPECIAL REPORT EMISS; Benstead JP, 1999, ECOL APPL, V9, P656, DOI 10.1890/1051-0761(1999)009[0656:EOALHD]2.0.CO;2; *BIO SERV, 1981, PRES IMPL FOR ORG SH, V2; *BIO SERV, 1981, PRES IMPL FOR ORG SH, V1; Brabets T. P, 1996, 964001 US GEOL SURV; Brook BW, 2000, NATURE, V404, P385, DOI 10.1038/35006050; CARLIN BP, 2000, C&H TEXT STAT SCI, P1; Carpenter SR, 1999, ECOL APPL, V9, P751, DOI 10.1890/1051-0761(1999)009[0751:MOEFLS]2.0.CO;2; Carpenter SR, 1996, ECOLOGY, V77, P677, DOI 10.2307/2265490; Carpenter SR, 2000, ECOSYSTEMS, V3, P495, DOI 10.1007/s100210000043; Clark J., UNPUB; Clark JS, 1999, AM J BOT, V86, P1, DOI 10.2307/2656950; Clark JS, 2001, AM NAT, V157, P537, DOI 10.1086/319934; Dye C, 2000, SCIENCE, V289, P1697; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Ellsworth DS, 2000, TREE PHYSIOL, V20, P435; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Glass GE, 2000, EMERG INFECT DIS, V6, P238, DOI 10.3201/eid0603.000303; HARRISON S, 1993, CONSERV BIOL, V7, P950, DOI 10.1046/j.1523-1739.1993.740950.x; JUDGE GG, 1982, THEORY PRACTICE ECON; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; LANDE R, 1987, AM NAT, V130, P624, DOI 10.1086/284734; Ludwig D, 1999, ECOLOGY, V80, P298, DOI 10.1890/0012-9658(1999)080[0298:IIMTEA]2.0.CO;2; Nalepa TF, 1995, J GREAT LAKES RES, V21, P411, DOI 10.1016/S0380-1330(95)71055-3; *NAT AC SCI, 2001, UND WEATH CLIM EC IN; *NAT AC SCI, 2000, GRAND CHALL ENV SCI; National Research Council, 1999, MAK CLIM FOR MATT; Pacala SW, 1996, ECOL MONOGR, V66, P1, DOI 10.2307/2963479; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; RASKIN P, 2000, 8 STOCKH ENV I POL S; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Richards J.F., 1990, EARTH TRANSFORMED HU, P163; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; SAREWITZ D, 2000, PREDICTION SCI POLIC; Schlesinger WH, 1999, SCIENCE, V284, P2095, DOI 10.1126/science.284.5423.2095; Shugart H.H., 1984, THEORY FOREST DYNAMI; Stokstad E, 1999, SCIENCE, V285, P1199, DOI 10.1126/science.285.5431.1199; Strayer DL, 1999, J N AM BENTHOL SOC, V18, P74, DOI 10.2307/1468010; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Wear DN, 1998, ECOSYSTEMS, V1, P575, DOI 10.1007/s100219900052; Wedin DA, 1996, SCIENCE, V274, P1720, DOI 10.1126/science.274.5293.1720; Wikle CK, 2001, J AM STAT ASSOC, V96, P382, DOI 10.1198/016214501753168109	45	622	658	7	241	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2001	293	5530					657	660		10.1126/science.293.5530.657	http://dx.doi.org/10.1126/science.293.5530.657			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474103				2022-12-28	WOS:000170204600045
J	Fernandez-Lopez, S; Kim, HS; Choi, EC; Delgado, M; Granja, JR; Khasanov, A; Kraehenbuehl, K; Long, G; Weinberger, DA; Wilcoxen, KM; Ghadiri, MR				Fernandez-Lopez, S; Kim, HS; Choi, EC; Delgado, M; Granja, JR; Khasanov, A; Kraehenbuehl, K; Long, G; Weinberger, DA; Wilcoxen, KM; Ghadiri, MR			Antibacterial agents based on the cyclic D,L-alpha-peptide architecture	NATURE			English	Article							TRANSMEMBRANE ION CHANNELS; ANTIMICROBIAL PEPTIDES; NANOTUBES; MEMBRANES; CELLS; DYES	The rapid emergence of bacterial infections that are resistant to many drugs underscores the need for new therapeutic agents(1-3). Here we report that six- and eight-residue cyclic D,L-alpha -peptides act preferentially on Gram-positive and/or Gram-negative bacterial membranes compared to mammalian cells, increase membrane permeability, collapse transmembrane ion potentials, and cause rapid cell death. The effectiveness of this class of materials as selective antibacterial agents is highlighted by the high efficacy observed against lethal methicillin-resistant Staphylococcus aureus infections in mice. Cyclic D,L-alpha -peptides are proteolytically stable, easy to synthesize, and can be derived from a potentially vast membrane-active sequence space. The unique abiotic structure of the cyclic peptides and their quick bactericidal action may also contribute to limit temporal acquirement of drug resistant bacteria. The low molecular weight D,L-alpha -peptides offer an attractive complement to the current arsenal of naturally derived antibiotics, and hold considerable potential in combating a variety of existing and emerging infectious diseases.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Ghadiri, MR (corresponding author), Scripps Res Inst, Dept Chem, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ghadiri@scripps.edu	Abrams, William R/A-5782-2008; Long, Georgina V/C-1771-2013; Granja, Juan R/P-7646-2014	Long, Georgina V/0000-0001-8894-3545; Granja, Juan R/0000-0002-5842-7504				AMSTERDAM D, 1991, ANTIBIOTICS LAB MED, P53; Andreu D, 1998, BIOPOLYMERS, V47, P415, DOI 10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Bong DT, 2001, ANGEW CHEM INT EDIT, V40, P988, DOI 10.1002/1521-3773(20010316)40:6<988::AID-ANIE9880>3.0.CO;2-N; Clark TD, 1998, J AM CHEM SOC, V120, P651, DOI 10.1021/ja972786f; Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000; GHADIRI MR, 1993, NATURE, V366, P324, DOI 10.1038/366324a0; GHADIRI MR, 1994, NATURE, V369, P301, DOI 10.1038/369301a0; GRANJA JR, 1994, J AM CHEM SOC, V116, P10785, DOI 10.1021/ja00102a054; Khurshid MA, 1999, MMWR-MORBID MORTAL W, V48, P1165; Kim HS, 1998, J AM CHEM SOC, V120, P4417, DOI 10.1021/ja9735315; KIM HS, 1999, SELF ASSEMBLING CYCL, pCH3; Koplan J. P, 1998, PREVENTING EMERGING; LOEW LM, 1994, ADV CHEM SER, V235, P151; National Committee for Clinical Laboratory Standards, 1997, METH DIL ANT SUSC TE; Oren Z, 2000, BIOCHEMISTRY-US, V39, P6103, DOI 10.1021/bi992408i; Oren Z, 1998, BIOPOLYMERS, V47, P451; Pinner RW, 1996, JAMA-J AM MED ASSOC, V275, P189, DOI 10.1001/jama.275.3.189; Seebach D, 1997, HELV CHIM ACTA, V80, P173, DOI 10.1002/hlca.19970800116; SIMS PJ, 1974, BIOCHEMISTRY-US, V13, P3315, DOI 10.1021/bi00713a022; TOSTESON MT, 1985, J MEMBRANE BIOL, V87, P35, DOI 10.1007/BF01870697; WAGGONER AS, 1979, ANNU REV BIOPHYS BIO, V8, P47, DOI 10.1146/annurev.bb.08.060179.000403	22	788	822	4	220	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2001	412	6845					452	455		10.1038/35086601	http://dx.doi.org/10.1038/35086601			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473322				2022-12-28	WOS:000170068200052
J	Crespo-Facorro, B; Paradiso, S; Andreasen, NC; O'Leary, DS; Watkins, GL; Ponto, LLB; Hichwa, RD				Crespo-Facorro, B; Paradiso, S; Andreasen, NC; O'Leary, DS; Watkins, GL; Ponto, LLB; Hichwa, RD			Neural mechanisms of anhedonia in schizophrenia - A PET study of response to unpleasant and pleasant odors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL BLOOD-FLOW; NUCLEUS-ACCUMBENS; BRAIN ACTIVITY; COGNITIVE DYSMETRIA; FUNCTIONAL-ANATOMY; FACIAL EXPRESSIONS; OLFACTORY FUNCTION; <O-15>WATER PET; CEREBELLAR	Context Loss of the capacity to experience pleasure (anhedonia) is a core clinical feature of schizophrenia. Although functional imaging techniques have been successful in identifying the neural basis of cognitive impairments in schizophrenia, no attempts to date have been made to investigate neural systems underlying emotional disturbances. Objective To study the neural basis of emotional processing in schizophrenia by exploring the pattern of brain responses to olfactory stimuli in patients and healthy volunteers. Design Positron emission tomographic study of patients with schizophrenia and healthy volunteers, Positron emission tomographic data were collected between July 21, 1995, and September 11, 1997, and data analyses were conducted in 1999-2001. Setting The Mental Health Clinical Research Center at the University of Iowa, Iowa City. Participants Sixteen healthy volunteers with a mean age of 29.5; years and 18 patients with schizophrenia and a mean age of 30.0 years. Main Outcome Measure Areas of relative increase or decrease in regional cerebral blood flow, measured using positron emission tomography and the [O-15]water method while participants performed an emotion-induction olfactory task to determine response to pleasant (vanillin) and unpleasant (4-methylvaleric acid) odors, compared between patients and healthy volunteers. Results Patients with schizophrenia subjectively experienced unpleasant odors in a manner similar to healthy volunteers but showed impairment in the experience of pleasant odors. The analysis of the regional cerebral blood flow revealed that patients failed to activate limbic/paralimbic regions (eg, insular cortex, nucleus accumbens, and parahippocampal gyrus) during the experience of unpleasant odors, recruiting a compensatory set of frontal cortical regions instead. Conclusion Abnormalities in the complex functional interactions between mesolimbic and frontal regions may underlie emotional disturbances in schizophrenia.	Univ Iowa Hosp & Clin, Mental Hlth Clin Res Ctr, Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; Hosp Univ Marques de Valdecilla, Santander, Spain; Univ Iowa Hosp & Clin, Dept Radiol, Positron Emiss Tomog Imaging Ctr, Iowa City, IA 52242 USA	University of Iowa; Hospital Universitario Marques de Valdecilla (HUMV); University of Iowa	Andreasen, NC (corresponding author), Univ Iowa Hosp & Clin, Mental Hlth Clin Res Ctr, Coll Med, Dept Psychiat, Room 2911 JPP,200 Hawkins Dr, Iowa City, IA 52242 USA.		Crespo-Facorro, BENEDICTO/GXZ-9830-2022; Crespo-Facorro, BENEDICTO/AAY-2238-2021; Paradiso, Sergio/H-9052-2012	Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; Ponto, Laura/0000-0003-1197-6714; O'Leary, Daniel/0000-0003-1959-6521; Andreasen, Nancy/0000-0001-5730-9744	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060990, P30MH043271, T32MH019113, P50MH043271] Funding Source: NIH RePORTER; NIMH NIH HHS [MH60990, MH19113, MHCRC43271] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Andreasen NC, 1999, BIOL PSYCHIAT, V46, P908, DOI 10.1016/S0006-3223(99)00152-3; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; Andreasen NC, 1999, ARCH GEN PSYCHIAT, V56, P781, DOI 10.1001/archpsyc.56.9.781; Andreasen NC, 1996, P NATL ACAD SCI USA, V93, P9985, DOI 10.1073/pnas.93.18.9985; Andreasen NC, 1996, J CEREBR BLOOD F MET, V16, P804, DOI 10.1097/00004647-199609000-00005; ANDREASEN NC, 1992, J NEUROPSYCH CLIN N, V4, P125; ANDREASEN NC, 1994, SCIENCE, V266, P294, DOI 10.1126/science.7939669; ANDREASEN NC, 1993, J NEUROPSYCH CLIN N, V5, P121; ANDREASEN NC, 1995, P NATL ACAD SCI USA, V92, P5111, DOI 10.1073/pnas.92.11.5111; Andreasen NC, 1995, NEUROIMAGE, V2, P296, DOI 10.1006/nimg.1995.1037; ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P754; Arndt S, 1996, J CEREBR BLOOD F MET, V16, P1271, DOI 10.1097/00004647-199611000-00023; Arnold SE, 1996, ACTA NEUROPATHOL, V92, P217, DOI 10.1007/s004010050512; BERENBAUM H, 1990, PSYCHOL MED, V20, P367, DOI 10.1017/S0033291700017682; BERTOLUCCIDANGIO M, 1990, J NEUROCHEM, V55, P1208, DOI 10.1111/j.1471-4159.1990.tb03126.x; Blanchard JJ, 1998, SCHIZOPHRENIA BULL, V24, P413, DOI 10.1093/oxfordjournals.schbul.a033336; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; BROWN SL, 1979, J NERV MENT DIS, V167, P410, DOI 10.1097/00005053-197907000-00003; Casey KL, 1999, P NATL ACAD SCI USA, V96, P7668, DOI 10.1073/pnas.96.14.7668; CHAPMAN LJ, 1994, J ABNORM PSYCHOL, V103, P171, DOI 10.1037/0021-843X.103.2.171; Chua P, 1999, NEUROIMAGE, V9, P563, DOI 10.1006/nimg.1999.0407; CIZADLO T, 1994, SPIE INT SOC OPTICAL, V2168, P423; CLARK DC, 1987, ANHEDONIA AFFECT DEF; Crespo-Facorro B, 2000, SCHIZOPHR RES, V46, P35, DOI 10.1016/S0920-9964(00)00028-1; CROW TJ, 1977, PSYCHOL MED, V7, P213, DOI 10.1017/S0033291700029287; Curtis VA, 1998, AM J PSYCHIAT, V155, P1056, DOI 10.1176/ajp.155.8.1056; Davis M, 1998, J CLIN NEUROPHYSIOL, V15, P378, DOI 10.1097/00004691-199809000-00002; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; DREVETS WC, 1992, J NEUROSCI, V12, P3628; Epstein J, 1999, ANN NY ACAD SCI, V877, P562, DOI 10.1111/j.1749-6632.1999.tb09289.x; Fulbright RK, 1998, AM J NEURORADIOL, V19, P1721; GEORGE MS, 1995, AM J PSYCHIAT, V152, P341; Goldstein JM, 1999, ARCH GEN PSYCHIAT, V56, P537, DOI 10.1001/archpsyc.56.6.537; GRAY JA, 1995, NEUROPSYCHOLOGIA, V33, P1143, DOI 10.1016/0028-3932(95)00054-7; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; HURTIG RR, 1994, J CEREBR BLOOD F MET, V14, P423, DOI 10.1038/jcbfm.1994.53; ITO M, 1993, TRENDS NEUROSCI, V16, P448, DOI 10.1016/0166-2236(93)90073-U; KIM SG, 1994, SCIENCE, V265, P949, DOI 10.1126/science.8052851; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Kopala LC, 1998, AM J PSYCHIAT, V155, P134, DOI 10.1176/ajp.155.1.134; Kosslyn SM, 1996, NEUROREPORT, V7, P1569, DOI 10.1097/00001756-199607080-00007; Kraepelin E., 1919, CUTTING SHEPHERD; Kwapil TR, 1998, J ABNORM PSYCHOL, V107, P558, DOI 10.1037/0021-843X.107.4.558; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; LeDoux J.E., 1996, EMOTIONAL BRAIN MYST; LEINER HC, 1989, BEHAV NEUROSCI, V103, P998, DOI 10.1037/0735-7044.103.5.998; Mandal MK, 1998, SCHIZOPHRENIA BULL, V24, P399, DOI 10.1093/oxfordjournals.schbul.a033335; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; MEEHL PE, 1962, AM PSYCHOL, V17, P827, DOI 10.1037/h0041029; Mega MS, 1997, J NEUROPSYCH CLIN N, V9, P315; MESULAM MM, 1982, J COMP NEUROL, V212, P1, DOI 10.1002/cne.902120102; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Moberg PJ, 1999, NEUROPSYCHOPHARMACOL, V21, P325, DOI 10.1016/S0893-133X(99)00019-6; Moberg PJ, 1997, AM J PSYCHIAT, V154, P1016; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Nakamura K, 1998, NEUROREPORT, V9, P753, DOI 10.1097/00001756-199803090-00035; Paradiso S, 1999, AM J PSYCHIAT, V156, P1618, DOI 10.1176/ajp.156.10.1618; Paradiso S, 1997, AM J PSYCHIAT, V154, P384; PARDO JV, 1993, AM J PSYCHIAT, V150, P713; Parent A., 1996, CARPENTERS HUMAN NEU, V9th. Edn; Qureshy A, 2000, J NEUROPHYSIOL, V84, P1656, DOI 10.1152/jn.2000.84.3.1656; RAICHLE ME, 1983, J NUCL MED, V24, P790; Reiman EM, 1997, J CLIN PSYCHIAT, V58, P4; Reiman EM, 1997, AM J PSYCHIAT, V154, P918; Rolls ET, 1996, PHILOS T ROY SOC B, V351, P1433, DOI 10.1098/rstb.1996.0128; Royet JP, 1999, J COGNITIVE NEUROSCI, V11, P94, DOI 10.1162/089892999563166; SALAMONE JD, 1994, BEHAV BRAIN RES, V61, P117, DOI 10.1016/0166-4328(94)90153-8; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; SCHMAHMANN JD, 1991, ARCH NEUROL-CHICAGO, V48, P1178, DOI 10.1001/archneur.1991.00530230086029; SERBY MJ, 1992, SCI OLFACTION, P410; Shin LM, 1999, AM J PSYCHIAT, V156, P575; Talairach J., 1988, COPLANAR STEREOTAXIC; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Whalen PJ, 1998, J NEUROSCI, V18, P411; Wollenweber SD, 1997, IEEE T NUCL SCI, V44, P1613, DOI 10.1109/23.632741; Wright IC, 1999, SCHIZOPHR RES, V35, P1, DOI 10.1016/S0920-9964(98)00094-2; YAKOVLEV PI, 1948, J NERV MENT DIS, V107, P313, DOI 10.1097/00005053-194810740-00001; Zatorre RJ, 2000, NEUROREPORT, V11, P2711, DOI 10.1097/00001756-200008210-00021	80	184	185	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2001	286	4					427	435		10.1001/jama.286.4.427	http://dx.doi.org/10.1001/jama.286.4.427			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	456DZ	11466121	Bronze			2022-12-28	WOS:000170069000014
J	Gill, G; Burrell, S; Brown, J				Gill, G; Burrell, S; Brown, J			Fear and frustration - the Liverpool cholera riots of 1832	LANCET			English	Review								Public mistrust in the medical profession is not new. We describe a series of street riots that took place in the city of Liverpool in north-west England in 1832 during a cholera epidemic. The disturbances were directed primarily against the local medical fraternity. The episode is of interest, since the same city recently experienced a similar crisis of confidence between doctors and public. On this occasion the cause was not cholera, but rather the reports from Alder Hey Children's Hospital that organ parts from deceased infants undergoing necropsy had been kept for several years without parental consent.	Univ Liverpool, Dept Med, Liverpool L9 1AE, Merseyside, England; Univ Liverpool, Dept Trop Med, Liverpool L9 1AE, Merseyside, England	University of Liverpool; Liverpool School of Tropical Medicine; University of Liverpool	Gill, G (corresponding author), Univ Liverpool, Dept Med, Liverpool L9 1AE, Merseyside, England.							[Anonymous], 1832, LIVERPOOL MERCU 0608; BICKERTON T, 1936, MED HIST LIVERPOOL E, P81; BOLD A, 1985, BOOK ROTTERS, P36; Bradbury J, 1999, LANCET, V354, P2055, DOI 10.1016/S0140-6736(99)99214-0; Brody H, 2000, LANCET, V356, P64, DOI 10.1016/S0140-6736(00)02442-9; BYNUM WF, 1994, SCI PRACTICE MED 19, P74; DUREY M, 1979, RETURN PLAGUE BRIT S, P155; Evans R., 1992, EPIDEMICS IDEAS ESSA, P149, DOI [10.1017/CBO9780511563645.008, DOI 10.1017/CBO9780511563645.008]; FRAZER WM, 1997, DUNCAN LIVERPOOL, P18; Gill G, 2000, HISTORIAN, V66, P10; LATTA T, 1831, LANCET, V2, P274; Longmate Norman, 1966, KING CHOLERA BIOGRAP; MORRIS LJ, 1970, CHOLERA SOCIAL RESPO; Morris R J, 1975, Med Hist, V19, P256; O'Shaughnessy WB, 1831, LANCET, V17, P366, DOI 10.1016/S0140-6736(02)94163-2; Pelling Margaret, 1978, CHOLERA FEVER ENGLIS; *PUBL REC OFF, 1832, PC1108 PUBL REC OFF; Redfern Michael, 2001, ROYAL LIVERPOOL CHIL; RICHARDSON R, 1987, DEATH DISSECTION DES; RUDE G, 1995, CROWD HIST STUDY POP, P149; TAYLOR RH, 1996, GASTROENTEROL INT, V9, P155; Wohl Anthony, 1983, ENDANGERED LIVES PUB; WOHL AS, 1983, ENDANGERED LIVES PUB, P121; 1832, LIVERPOOL COURI 0613; 1823, LIVERPOOL MERCU 0605; 1832, TIMES           0604; 1932, LIVERPOOL CHORN 0602; 1832, LIVERPOOL COURI 0606	28	19	20	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 21	2001	358	9277					233	237		10.1016/S0140-6736(01)05463-0	http://dx.doi.org/10.1016/S0140-6736(01)05463-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454HL	11476860				2022-12-28	WOS:000169967100035
J	Agnelli, G; Prandoni, P; Santamaria, MG; Bagatella, P; Iorio, A; Bazzan, M; Moia, M; Guazzaloca, G; Bertoldi, A; Tomasi, C; Scannapieco, G; Ageno, W; Ascani, A; Villalta, S; Frulla, M; Mosena, L; Girolami, A; Vaccarino, A; Alatri, A; Palareti, G; Marchesi, M; Ambrosio, GB; Parisi, R; Doria, S; Steidl, L; Ambrosini, F; Silingardi, M; Ghirarduzzi, A; Iori, I				Agnelli, G; Prandoni, P; Santamaria, MG; Bagatella, P; Iorio, A; Bazzan, M; Moia, M; Guazzaloca, G; Bertoldi, A; Tomasi, C; Scannapieco, G; Ageno, W; Ascani, A; Villalta, S; Frulla, M; Mosena, L; Girolami, A; Vaccarino, A; Alatri, A; Palareti, G; Marchesi, M; Ambrosio, GB; Parisi, R; Doria, S; Steidl, L; Ambrosini, F; Silingardi, M; Ghirarduzzi, A; Iori, I		Warfarin Optimal Duration Italian	Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Meeting of the International-Society-of-Thrombosis-and-Hemostasis	AUG 14-21, 1999	WASHINGTON, D.C.	Int Soc Thrombosis & Hemostasis			VEIN THROMBOSIS; EPISODE; RISK	Background: In patients with idiopathic deep venous thrombosis, continuing anticoagulant therapy beyond three months is associated with a reduced incidence of recurrent thrombosis during the period of therapy. Whether this benefit persists after anticoagulant therapy is discontinued is controversial. Methods: Patients with a first episode of idiopathic proximal deep venous thrombosis who had completed three months of oral anticoagulant therapy were randomly assigned to the discontinuation of oral anticoagulants or to their continuation for nine additional months. The primary study outcome was recurrence of symptomatic, objectively confirmed venous thromboembolism during at least two years of follow-up. Results: The primary intention-to-treat analysis showed that of 134 patients assigned to continued oral anticoagulant therapy, 21 had a recurrence of venous thromboembolism (15.7 percent; average follow-up, 37.8 months), as compared with 21 of 133 patients assigned to the discontinuation of oral anticoagulant therapy (15.8 percent; average follow-up, 37.2 months), resulting in a relative risk of 0.99 (95 percent confidence interval, 0.57 to 1.73). During the initial nine months after randomization (after all patients received three months of therapy), 1 patient had a recurrence while receiving oral anticoagulant therapy (0.7 percent), as compared with 11 of the patients assigned to the discontinuation of oral anticoagulant therapy (8.3 percent, P=0.003). The incidence of recurrence after the discontinuation of treatment was 5.1 percent per patient-year in patients in whom oral anticoagulant therapy was discontinued after 3 months and 5.0 percent per patient-year in patients who received an additional 9 months of oral anticoagulant therapy. None of the recurrences were fatal. Four patients had nonfatal major bleeding during the extended period of anticoagulant therapy (3.0 percent). Conclusions: In patients with idiopathic deep venous thrombosis, the clinical benefit associated with extending the duration of anticoagulant therapy to one year is not maintained after the therapy is discontinued. (N Engl J Med 2001;345:165-9.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Perugia, Dipartimento Med Interna, Sez Med Interna & Cardiovasc, I-06123 Perugia, Italy; Univ Padua, Ist Clin Med 2, Padua, Italy; Univ Turin, Ist Ematol, Turin, Italy; Osped Maggiore, Ist Ricovero & Cura Carattere Sci, Ctr Emofilia & Trombosi, Milan, Italy; St Orsola Marcello Malpighi Hosp, Div Angiol, Bologna, Italy; Osped S Chiara, Div Chirurg Vasc, Trento, Italy; Osped Civile, Div Med, Bolzano, Italy; Osped S Giovanni & Paolo, Div Med 1, Venice, Italy; Univ Varese, Dipartimento Med Interna & Terapia Med, Varese, Italy	University of Perugia; University of Padua; University of Turin; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Azienda Ospedaliero-Universitaria di Bologna; ULSS 3 Serenissima; Ospedale SS Giovanni Paolo Venezia; University of Insubria	Agnelli, G (corresponding author), Univ Perugia, Dipartimento Med Interna, Sez Med Interna & Cardiovasc, Via Enrico dal Pozzo, I-06123 Perugia, Italy.		Iorio, Alfonso/B-9478-2013; Moia, Marco/J-2888-2015	Iorio, Alfonso/0000-0002-3331-8766; Moia, Marco/0000-0002-7041-7755; ageno, walter/0000-0002-1922-8879				Ginsberg JS, 1996, NEW ENGL J MED, V335, P1816, DOI 10.1056/NEJM199612123352407; Hansson PO, 2000, ARCH INTERN MED, V160, P769, DOI 10.1001/archinte.160.6.769; Hyers TM, 2001, CHEST, V119, p176S, DOI 10.1378/chest.119.1_suppl.176S; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kearon C, 1999, NEW ENGL J MED, V341, P298; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Lensing AWA, 1999, LANCET, V353, P479, DOI 10.1016/S0140-6736(98)04298-6; Lindmarker P, 2000, J INTERN MED, V247, P601, DOI 10.1046/j.1365-2796.2000.t01-1-00662.x; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Schafer AI, 1999, NEW ENGL J MED, V340, P955, DOI 10.1056/NEJM199903253401209; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; SUDLOW MF, 1992, LANCET, V340, P873	13	483	493	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2001	345	3					165	169		10.1056/NEJM200107193450302	http://dx.doi.org/10.1056/NEJM200107193450302			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	453JM	11463010	Green Published			2022-12-28	WOS:000169912800002
J	Baron, M; Lewis, V				Baron, M; Lewis, V			Liver metastases from lung cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Wellmont Bristol Reg Med Ctr, Bristol, TN 37620 USA; Blue Ridge Med Specialists, Bristol, TN 37620 USA		Baron, M (corresponding author), Wellmont Bristol Reg Med Ctr, Bristol, TN 37620 USA.								0	3	3	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2001	345	3					180	180		10.1056/NEJM200107193450305	http://dx.doi.org/10.1056/NEJM200107193450305			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453JM	11463013				2022-12-28	WOS:000169912800005
J	Hoehler, TM; Bebout, BM; Des Marais, DJ				Hoehler, TM; Bebout, BM; Des Marais, DJ			The role of microbial mats in the production of reduced gases on the early Earth	NATURE			English	Article							OXYGEN; CYANOBACTERIA; FERMENTATION	The advent of oxygenic photosynthesis on Earth may have increased global biological productivity by a factor of 100-1,000 (ref. 1), profoundly affecting both geochemical and biological evolution. Much of this new productivity probably occurred in microbial mats, which incorporate a range of photosynthetic and anaerobic microorganisms in extremely close physical proximity(2,3). The potential contribution of these systems to global biogeochemical change would have depended on the nature of the interactions among these mat microorganisms. Here we report that in modern, cyanobacteria-dominated mats from hypersaline environments in Guerrero Negro, Mexico, photosynthetic microorganisms generate H-2 and CO-gases that provide a basis for direct chemical interactions with neighbouring chemotrophic and heterotrophic microbes(4). We also observe an unexpected flux of CH4, which is probably related to H-2-based alteration of the redox potential within the mats. These fluxes would have been most important during the nearly 2-billion-year period during which photosynthetic mats contributed substantially to biological productivity(5) -and hence, to biogeochemistry-on Earth. In particular, the large fluxes of H-2 that we observe could, with subsequent escape to space, represent a potentially important mechanism for oxidation of the primitive oceans and atmosphere.	NASA, Ames Res Ctr, Exobiol Branch, Moffett Field, CA 94035 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Hoehler, TM (corresponding author), NASA, Ames Res Ctr, Exobiol Branch, MS 239-4, Moffett Field, CA 94035 USA.	thoehler@mail.arc.nasa.gov						Bebout B.M., 1994, MICROBIAL MATS STRUC, P265; BERNER RA, 1989, AM J SCI, V289, P333, DOI 10.2475/ajs.289.4.333; CANFIELD DE, 1993, GEOCHIM COSMOCHIM AC, V57, P3971, DOI 10.1016/0016-7037(93)90347-Y; COHEN Y, 1984, ANCIENT STROMATOLITE; CONRAD R, 1988, ADV MICROB ECOL, V10, P231; Des Marais D.J., 1995, ADV MICROBIAL ECOL P, P251; DesMarais DJ, 1997, REV MINERAL, V35, P429; Dolfing J., 1988, BIOL ANAEROBIC MICRO, P417; Elderfield H, 1996, ANNU REV EARTH PL SC, V24, P191, DOI 10.1146/annurev.earth.24.1.191; FAY P, 1992, MICROBIOL REV, V56, P340, DOI 10.1128/MMBR.56.2.340-373.1992; Fenchel T., 1995, ECOLOGY EVOLUTION AN; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; Holland HD., 1984, CHEM EVOLUTION ATMOS; IANNOTTI EL, 1973, J BACTERIOL, V114, P1231, DOI 10.1128/JB.114.3.1231-1240.1973; Jorgensen BB., 1994, MICROBIAL MATS, P243; LOVLEY DR, 1983, APPL ENVIRON MICROB, V45, P187, DOI 10.1128/AEM.45.1.187-192.1983; MARAIS DJD, 1992, NATURE, V359, P605, DOI 10.1038/359605a0; NEWTON W, 1977, RECENT DEV NITROGEN; Nisbet EG, 1999, P ROY SOC B-BIOL SCI, V266, P2375, DOI 10.1098/rspb.1999.0934; Schink B., 1988, BIOL ANAEROBIC MICRO, P771; Skyring G. W., 1989, MICROBIAL MATS PHYSL, P170; Stal LJ, 1997, FEMS MICROBIOL REV, V21, P179, DOI 10.1016/S0168-6445(97)00056-9; Walker, 1977, EVOLUTION ATMOSPHERE, V32, P71; Walter M. R., 1976, STROMATOLITES; Wolin M.J., 1982, ASM NEWS, V48, P561; [No title captured]	27	176	187	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2001	412	6844					324	327		10.1038/35085554	http://dx.doi.org/10.1038/35085554			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460161				2022-12-28	WOS:000169918200044
J	Lok, C				Lok, C			Smithsonian head ruffled by inquiry	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					257	257		10.1038/35085693	http://dx.doi.org/10.1038/35085693			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460117	Bronze			2022-12-28	WOS:000169918200004
J	Zhu, XK; Guo, Y; O'Nions, RK; Young, ED; Ash, RD				Zhu, XK; Guo, Y; O'Nions, RK; Young, ED; Ash, RD			Isotopic homogeneity of iron in the early solar nebula	NATURE			English	Article							SOURCE-MASS-SPECTROMETRY; ANOMALOUS O-17 COMPOSITIONS; OXYGEN-ISOTOPE; METEORITES; CHROMIUM; FRACTIONATION; CHONDRITES; SULFATE; SYSTEM	The chemical and isotopic homogeneity of the early solar nebula, and the processes producing fractionation during its evolution, are central issues of cosmochemistry. Studies of the relative abundance variations of three or more isotopes of an element can in principle determine if the initial reservoir of material was a homogeneous mixture or if it contained several distinct sources of precursor material. For example, widespread anomalies(1-4) observed in the oxygen isotopes of meteorites have been interpreted as resulting from the mixing of a solid phase that was enriched in O-16 with a gas phase in which O-16 was depleted(1-3), or as an isotopic 'memory' of Galactic evolution(5). In either case, these anomalies are regarded as strong evidence that the early solar nebula was not initially homogeneous. Here we present measurements of the relative abundances of three iron isotopes in meteoritic and terrestrial samples. We show that significant variations of iron isotopes exist in both terrestrial and extraterrestrial materials. But when plotted in a three-isotope diagram, all of the data for these Solar System materials fall on a single mass-fractionation line, showing that homogenization of iron isotopes occurred in the solar nebula before both planetesimal accretion and chondrule formation.	Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England	University of Oxford	Zhu, XK (corresponding author), Univ Oxford, Dept Earth Sci, Parks Rd, Oxford OX1 3PR, England.	xiangz@earth.ox.ac.uk	Ash, Richard/AAD-4888-2021	Ash, Richard/0000-0003-2144-5917; Young, Edward/0000-0002-1299-0801				Arnett D., 1996, SUPERNOVAE NUCLEOSYN; Bao HM, 2000, NATURE, V407, P499, DOI 10.1038/35035054; Bao HM, 2000, NATURE, V406, P176, DOI 10.1038/35018052; Belshaw NS, 2000, INT J MASS SPECTROM, V197, P191, DOI 10.1016/S1387-3806(99)00245-6; BIRCK JL, 1988, EARTH PLANET SC LETT, V90, P131, DOI 10.1016/0012-821X(88)90096-9; CLAYTON DD, 1988, ASTROPHYS J, V334, P191, DOI 10.1086/166829; CLAYTON RN, 1991, GEOCHIM COSMOCHIM AC, V55, P2317, DOI 10.1016/0016-7037(91)90107-G; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.earth.21.1.115; CLAYTON RN, 1988, PHILOS T R SOC A, V325, P483, DOI 10.1098/rsta.1988.0062; CLAYTON RN, 1988, GEOCHIM COSMOCHIM AC, V52, P1313, DOI 10.1016/0016-7037(88)90286-4; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; Clayton RN, 1996, GEOCHIM COSMOCHIM AC, V60, P1999, DOI 10.1016/0016-7037(96)00074-9; Cliff SS, 1997, SCIENCE, V278, P1774, DOI 10.1126/science.278.5344.1774; Halliday AN, 1998, GEOCHIM COSMOCHIM AC, V62, P919, DOI 10.1016/S0016-7037(98)00057-X; Marechal CN, 1999, CHEM GEOL, V156, P251, DOI 10.1016/S0009-2541(98)00191-0; NIEMEYER S, 1984, GEOCHIM COSMOCHIM AC, V48, P1401, DOI 10.1016/0016-7037(84)90398-3; NIEMEYER S, 1981, EARTH PLANET SC LETT, V53, P211, DOI 10.1016/0012-821X(81)90155-2; PAPANASTASSIOU DA, 1986, ASTROPHYS J, V308, pL27, DOI 10.1086/184737; Podosek FA, 1997, METEORIT PLANET SCI, V32, P617, DOI 10.1111/j.1945-5100.1997.tb01547.x; Rockmann T, 1998, SCIENCE, V281, P544, DOI 10.1126/science.281.5376.544; ROTARU M, 1992, NATURE, V358, P465, DOI 10.1038/358465a0; THIEMENS MH, 1983, SCIENCE, V219, P1073, DOI 10.1126/science.219.4588.1073; Thiemens MH, 1999, SCIENCE, V283, P341, DOI 10.1126/science.283.5400.341; VOLKENING J, 1990, ASTROPHYS J, V358, pL29, DOI 10.1086/185772; VOLKENING J, 1989, ASTROPHYS J, V347, pL43, DOI 10.1086/185603; Young ED, 1998, SCIENCE, V282, P452, DOI 10.1126/science.282.5388.452; Zhu XK, 2000, SCIENCE, V287, P2000, DOI 10.1126/science.287.5460.2000; Zhu XK, 2000, CHEM GEOL, V163, P139, DOI 10.1016/S0009-2541(99)00076-5	28	131	163	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2001	412	6844					311	313		10.1038/35085525	http://dx.doi.org/10.1038/35085525			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460156				2022-12-28	WOS:000169918200039
J	Satcher, D				Satcher, D			International tobacco control: An update	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Satcher D, 1999, JAMA-J AM MED ASSOC, V281, P942, DOI 10.1001/jama.281.10.942	1	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2001	286	3					296	296		10.1001/jama.286.3.296	http://dx.doi.org/10.1001/jama.286.3.296			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452QA	11466085				2022-12-28	WOS:000169869200007
J	Localio, AR; Berlin, JA; Ten Have, TR; Kimmel, SE				Localio, AR; Berlin, JA; Ten Have, TR; Kimmel, SE			Adjustments for center in multicenter studies: An overview	ANNALS OF INTERNAL MEDICINE			English	Article							PERIODONTAL-DISEASE PROGRESSION; LOGISTIC-REGRESSION ANALYSIS; CLUSTERED BINARY DATA; LONGITUDINAL DATA; ASSOCIATION MODELS; MEDICAL JOURNALS; STATISTICS NOTES; CLINICAL-TRIALS; CORRELATED DATA; HEART-DISEASE	Increasingly, investigators rely on multicenter or multigroup studies to demonstrate effectiveness and generalizability. Authors too often overlook the analytic challenges in these study designs: the correlation of outcomes and exposures among patients within centers, confounding of associations by center, and effect modification of treatment or exposure across center. Correlation or clustering, resulting from the similarity of outcomes among patients within a center, requires an adjustment to confidence intervals and P values, especially in observational studies and in randomized multicenter studies in which treatment is allocated by center rather than by individual patient. Multicenter designs also warrant testing and adjustment for the potential bias of confounding by center, and for the presence of effect modification or interaction by center. This paper uses examples from the recent biomedical literature to highlight the issues and analytic options.	Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Localio, AR (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, 606 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	rlocalio@cceb.upenn.edu						Agresti A, 2000, STAT MED, V19, P1115, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1115::AID-SIM408>3.0.CO;2-X; Albert PS, 1999, STAT MED, V18, P1707, DOI 10.1002/(SICI)1097-0258(19990715)18:13<1707::AID-SIM138>3.0.CO;2-H; Andersen PK, 1999, STAT MED, V18, P1489, DOI 10.1002/(SICI)1097-0258(19990630)18:12<1489::AID-SIM140>3.0.CO;2-#; Anderson J. D, 1990, METHODOLOGICAL ERROR, V2e, p147~185; [Anonymous], 1999, STAT MED, V18, P1905; ASHBY M, 1992, STAT MED, V11, P67, DOI 10.1002/sim.4780110108; BAILAR JC, 1988, ANN INTERN MED, V108, P266, DOI 10.7326/0003-4819-108-2-266; Bassuk SS, 1999, ANN INTERN MED, V131, P165, DOI 10.7326/0003-4819-131-3-199908030-00002; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Berlin JA, 1999, BIOMETRICS, V55, P470, DOI 10.1111/j.0006-341X.1999.00470.x; Breslow N, 1980, STAT METHODS CANC RE, P248; Campbell MK, 1998, BMJ-BRIT MED J, V317, P1171, DOI 10.1136/bmj.317.7167.1171; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; CORNFIELD J, 1978, AM J EPIDEMIOL, V108, P100, DOI 10.1093/oxfordjournals.aje.a112592; COX DR, 1974, THEORETICAL STATISTI, P292; Daumit GL, 1999, ANN INTERN MED, V130, P173, DOI 10.7326/0003-4819-130-3-199902020-00002; Dexter PR, 1998, ANN INTERN MED, V128, P102, DOI 10.7326/0003-4819-128-2-199801150-00005; DIACONIS P, 1983, SCI AM, V248, P116, DOI 10.1038/scientificamerican0583-116; Diggle PJ, 1994, ANAL LONGITUDINAL DA; DONALD A, 1987, STAT MED, V6, P491, DOI 10.1002/sim.4780060408; DONNER A, 1994, AM J EPIDEMIOL, V140, P279, DOI 10.1093/oxfordjournals.aje.a117247; DONNER A, 1990, INT J EPIDEMIOL, V19, P795, DOI 10.1093/ije/19.4.795; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; Feldman HI, 1996, JAMA-J AM MED ASSOC, V276, P620, DOI 10.1001/jama.276.8.620; Fink JC, 2000, J CLIN EPIDEMIOL, V53, P79, DOI 10.1016/S0895-4356(99)00129-8; Fiscella K, 1999, ANN INTERN MED, V131, P745, DOI 10.7326/0003-4819-131-10-199911160-00005; FLETCHER RH, 1996, CLIN EPIDEMIOLOGY ES, P235; Goldstein H, 1995, MULTILEVEL STAT MODE, P1; Goodman SN, 1998, J GEN INTERN MED, V13, P753, DOI 10.1046/j.1525-1497.1998.00227.x; GOTZSCHE PC, 1989, CONTROL CLIN TRIALS, V10, P31, DOI 10.1016/0197-2456(89)90017-2; Gould AL, 1998, STAT MED, V17, P1779, DOI 10.1002/(SICI)1097-0258(19980815/30)17:15/16<1779::AID-SIM979>3.0.CO;2-7; GRAUBARD BI, 1994, STAT MED, V13, P509, DOI 10.1002/sim.4780130514; Greenland S, 2000, AM J EPIDEMIOL, V151, P531; Hansen M.H., 1953, SAMPLE SURVEY METHOD, VI; Hedeker D, 2000, STAT METHODS MED RES, V9, P161, DOI 10.1177/096228020000900206; Horton NJ, 1999, AM STAT, V53, P160, DOI 10.2307/2685737; Katz MH, 1999, MULTIVARIABLE ANAL P; Kerry SM, 1998, BRIT MED J, V316, P549, DOI 10.1136/bmj.316.7130.549; Kerry SM, 1998, BRIT MED J, V316, P1455, DOI 10.1136/bmj.316.7142.1455; Kinsinger LS, 1998, J GEN INTERN MED, V13, P507, DOI 10.1046/j.1525-1497.1998.00160.x; Kish L., 1965, SURVEY SAMPLING, P88; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Knox SS, 1998, AM J CARDIOL, V82, P1192, DOI 10.1016/S0002-9149(98)00599-2; KOM EL, 1999, ANAL HLTH SURVEYS; Laine C, 1998, AM J MED, V105, P373, DOI 10.1016/S0002-9343(98)00291-5; LIANG KY, 1993, ANNU REV PUBL HEALTH, V14, P43, DOI 10.1146/annurev.pu.14.050193.000355; Longford NT., 1993, RANDOM COEFFICIENT M; Marrazzo JM, 1997, ANN INTERN MED, V127, P796, DOI 10.7326/0003-4819-127-9-199711010-00004; Marshall EG, 1998, BRIT MED J, V316, P1701, DOI 10.1136/bmj.316.7146.1701; Murray DM, 1998, DESIGN ANAL GROUP RA; Neuhaus J M, 1992, Stat Methods Med Res, V1, P249, DOI 10.1177/096228029200100303; Neuhaus JM, 1998, BIOMETRICS, V54, P638, DOI 10.2307/3109770; NEUHAUS JM, 1993, STAT MED, V12, P1259, DOI 10.1002/sim.4780121107; NEUHAUS JM, 1991, INT STAT REV, V59, P25, DOI 10.2307/1403572; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pittet D, 1999, ANN INTERN MED, V130, P126, DOI 10.7326/0003-4819-130-2-199901190-00006; Pouyanne P, 2000, BRIT MED J, V320, P1036, DOI 10.1136/bmj.320.7241.1036; Robinson JW, 1999, J FAM PRACTICE, V48, P698; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P276; Selhub J, 1999, ANN INTERN MED, V131, P331, DOI 10.7326/0003-4819-131-5-199909070-00003; Shekelle PG, 1998, ANN INTERN MED, V129, P9, DOI 10.7326/0003-4819-129-1-199807010-00003; SIMPSON JM, 1995, AM J PUBLIC HEALTH, V85, P1378, DOI 10.2105/AJPH.85.10.1378; Smith MA, 1998, ANN INTERN MED, V129, P190, DOI 10.7326/0003-4819-129-3-199808010-00005; Sullivan LM, 1999, STAT MED, V18, P855, DOI 10.1002/(SICI)1097-0258(19990415)18:7<855::AID-SIM117>3.0.CO;2-7; Ten Have T R, 1998, J Biopharm Stat, V8, P131; TENHAVE TR, 1995, STAT MED, V14, P413; TenHave TR, 1996, STAT MED, V15, P1227; Ukoumunne OC, 1999, BRIT MED J, V319, P376, DOI 10.1136/bmj.319.7206.376; Wei LJ, 1997, STAT MED, V16, P833, DOI 10.1002/(SICI)1097-0258(19970430)16:8<833::AID-SIM538>3.0.CO;2-2; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Yamaguchi T, 1999, STAT MED, V18, P1961; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	73	360	361	1	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2001	135	2					112	123		10.7326/0003-4819-135-2-200107170-00012	http://dx.doi.org/10.7326/0003-4819-135-2-200107170-00012			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452DR	11453711				2022-12-28	WOS:000169842300005
J	Prentice, A				Prentice, A			Regular review - Endometriosis	BRITISH MEDICAL JOURNAL			English	Review							MILD ENDOMETRIOSIS; INFERTILE; WOMEN; TRIAL		Rosic Hosp, Univ Dept Obstet & Gynaecol, Cambridge CB2 2SW, England		Prentice, A (corresponding author), Rosic Hosp, Univ Dept Obstet & Gynaecol, Cambridge CB2 2SW, England.							Henderson AF, 1991, MODERN APPROACHES EN, P275; HUGHES E, 2000, CD000155; MAHMOOD TA, 1991, HUM REPROD, V6, P544, DOI 10.1093/oxfordjournals.humrep.a137377; Marcoux S, 1997, NEW ENGL J MED, V337, P217, DOI 10.1056/NEJM199707243370401; MOORE J, 2000, CD001019; Parazzini F, 1999, HUM REPROD, V14, P1332; PRENTICE A, 2000, CD000346; PRENTICE A, 2000, CD002122; *ROYAL COLL OBST G, 2000, INV MAN END; SELAK V, 2000, CD000068; SUTTON CJG, 1994, FERTIL STERIL, V62, P696; WILSON M, 2000, CLIN EVIDENCE, P1045	12	57	58	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 14	2001	323	7304					93	95		10.1136/bmj.323.7304.93	http://dx.doi.org/10.1136/bmj.323.7304.93			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454GD	11451786	Green Published			2022-12-28	WOS:000169964100020
J	Asahi, R; Morikawa, T; Ohwaki, T; Aoki, K; Taga, Y				Asahi, R; Morikawa, T; Ohwaki, T; Aoki, K; Taga, Y			Visible-light photocatalysis in nitrogen-doped titanium oxides	SCIENCE			English	Article							PLANE-WAVE METHOD; TIO2; SURFACES; CHEMISTRY; DEGRADATION; OXIDATION; ANATASE; WATER	To use solar irradiation or interior Lighting efficiently, we sought a photocatalyst with high reactivity under visible Light. Films and powders of TiO2-XNX have revealed an improvement over titanium dioxide (TiO2) under visible Light (wavelength < 500 nanometers) in optical absorption and photocatalytic activity such as photodegradations of methylene blue and gaseous acetaldehyde and hydrophilicity of the film surface, Nitrogen doped into substitutional sites of TiO2 has proven to be indispensable for band-gap narrowing and photocatalytic activity, as assessed by first-principles calculations and x-ray photoemission spectroscopy.	Toyota Cent Res & Dev Labs Inc, Aichi 4801192, Japan	Toyota Central R&D Labs Inc	Asahi, R (corresponding author), Toyota Cent Res & Dev Labs Inc, Aichi 4801192, Japan.			Morikawa, Takeshi/0000-0002-4985-0925				ANPO M, 1997, CATAL SURV JPN, V1, P169, DOI [DOI 10.1023/A:1019024913274, DOI 10.1023/A:1019024913274)]; Asahi R, 2000, PHYS REV B, V61, P7459, DOI 10.1103/PhysRevB.61.7459; BRECKENRIDGE RG, 1953, PHYS REV, V91, P793, DOI 10.1103/PhysRev.91.793; CHOI WY, 1994, J PHYS CHEM-US, V98, P13669, DOI 10.1021/j100102a038; CRONEMEYER DC, 1959, PHYS REV, V113, P1222, DOI 10.1103/PhysRev.113.1222; FOX MA, 1993, CHEM REV, V93, P341, DOI 10.1021/cr00017a016; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; GHOSH AK, 1977, J ELECTROCHEM SOC, V124, P1516, DOI 10.1149/1.2133104; Hadjiivanov KI, 1996, CHEM SOC REV, V25, P61, DOI 10.1039/cs9962500061; HEDIN L, 1971, J PHYS PART C SOLID, V4, P2064, DOI 10.1088/0022-3719/4/14/022; Heller A, 1995, ACCOUNTS CHEM RES, V28, P503, DOI 10.1021/ar00060a006; HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004; JANSEN HJF, 1984, PHYS REV B, V30, P561, DOI 10.1103/PhysRevB.30.561; Jansen M, 2000, NATURE, V404, P980, DOI 10.1038/35010082; Johnson NM, 2000, PHYS TODAY, V53, P31, DOI 10.1063/1.1325190; LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013; Machida M, 1999, J MATER SCI, V34, P2569, DOI 10.1023/A:1004644514653; Ollis D.F., 1993, PHOTOCATALYTIC PURIF; SAHA NC, 1992, J APPL PHYS, V72, P3072, DOI 10.1063/1.351465; Sakata T., 1983, ENERGY RESOURCES PHO, P332; Sopyan I, 1996, J PHOTOCH PHOTOBIO A, V98, P79, DOI 10.1016/1010-6030(96)04328-6; Vinodgopal K, 1996, ENVIRON SCI TECHNOL, V30, P1660, DOI 10.1021/es950655d; Wang R, 1997, NATURE, V388, P431, DOI 10.1038/41233; WIMMER E, 1981, PHYS REV B, V24, P864, DOI 10.1103/PhysRevB.24.864	24	10986	11806	240	8548	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					269	271		10.1126/science.1061051	http://dx.doi.org/10.1126/science.1061051			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452117				2022-12-28	WOS:000169875200049
J	Kamada, K; Shu, F; Chen, H; Malik, S; Stelzer, G; Roeder, RG; Meisterernst, M; Burley, SK				Kamada, K; Shu, F; Chen, H; Malik, S; Stelzer, G; Roeder, RG; Meisterernst, M; Burley, SK			Crystal structure of Negative Cofactor 2 recognizing the TBP-DNA transcription complex	CELL			English	Article							RNA-POLYMERASE-II; TATA-BINDING PROTEIN; YEAST TFIIA/TBP/DNA COMPLEX; HISTONE FOLD; IN-VIVO; PREINITIATION COMPLEX; GENE-TRANSCRIPTION; REPRESSOR COMPLEX; MINOR-GROOVE; BOX	The X-ray structure of a ternary complex of Negative Cofactor 2 (NC2), the TATA box binding protein (TBP), and DNA has been determined at 2.6 Angstrom resolution. The N termini of NC2 alpha and beta resemble histones H2A and H2B, respectively, and form a heterodimer that binds to the bent DNA double helix on the underside of the preformed TBP-DNA complex via electrostatic interactions. NC2 beta contributes to inhibition of TATA-dependent transcription through interactions of its C-terminal or helix with a conserved hydrophobic feature on the upper surface of TBP, which in turn positions the penultimate a helix of NC2 beta to block recognition of the TBP-DNA complex by transcription factor IIB. Further regulatory implications of the NC2 heterodimer structure are discussed.	Rockefeller Univ, Lab Mol Biophys, New York, NY 10021 USA; Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Natl Res Ctr Environm & Hlth, Inst Immunol, Dept Gene Express, D-81377 Munich, Germany; Univ Munich, Mol Biol Lab, D-81377 Munich, Germany	Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; University of Munich; University of Munich	Burley, SK (corresponding author), Rockefeller Univ, Lab Mol Biophys, 1230 York Ave, New York, NY 10021 USA.		Kamada, Katsuhiko/M-3666-2017	Kamada, Katsuhiko/0000-0001-8523-3417; Burley, Stephen K./0000-0002-2487-9713				ARENTS G, 1995, P NATL ACAD SCI USA, V92, P11170, DOI 10.1073/pnas.92.24.11170; BAXEVANIS AD, 1995, NUCLEIC ACIDS RES, V23, P2685, DOI 10.1093/nar/23.14.2685; Birck C, 1998, CELL, V94, P239, DOI 10.1016/S0092-8674(00)81423-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Cang Y, 1999, EMBO J, V18, P6662, DOI 10.1093/emboj/18.23.6662; Castano E, 2000, P NATL ACAD SCI USA, V97, P7184, DOI 10.1073/pnas.140202297; CHASMAN DI, 1993, P NATL ACAD SCI USA, V90, P8174, DOI 10.1073/pnas.90.17.8174; DeDecker BS, 1996, J MOL BIOL, V264, P1072, DOI 10.1006/jmbi.1996.0697; Gadbois EL, 1997, P NATL ACAD SCI USA, V94, P3145, DOI 10.1073/pnas.94.7.3145; Gangloff YG, 2001, TRENDS BIOCHEM SCI, V26, P250, DOI 10.1016/S0968-0004(00)01741-2; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Geisberg JV, 2001, MOL CELL BIOL, V21, P2736, DOI 10.1128/MCB.21.8.2736-2742.2001; Goppelt A, 1996, EMBO J, V15, P3105, DOI 10.1002/j.1460-2075.1996.tb00673.x; Green MR, 2000, TRENDS BIOCHEM SCI, V25, P59, DOI 10.1016/S0968-0004(99)01527-3; Hoffmann A, 1996, NATURE, V380, P356, DOI 10.1038/380356a0; INOSTROZA JA, 1992, CELL, V70, P477; Juo ZS, 1996, J MOL BIOL, V261, P239, DOI 10.1006/jmbi.1996.0456; Kaiser K, 1996, TRENDS BIOCHEM SCI, V21, P342, DOI 10.1016/S0968-0004(96)10043-8; Kim J, 1996, J BIOL CHEM, V271, P18405, DOI 10.1074/jbc.271.31.18405; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Kim S, 2000, MOL CELL BIOL, V20, P2455, DOI 10.1128/MCB.20.7.2455-2465.2000; Kim S, 1997, P NATL ACAD SCI USA, V94, P820, DOI 10.1073/pnas.94.3.820; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; Kosa PF, 1997, P NATL ACAD SCI USA, V94, P6042, DOI 10.1073/pnas.94.12.6042; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee TI, 1998, MOL CELL BIOL, V18, P4455, DOI 10.1128/MCB.18.8.4455; Lemaire M, 2000, MOL MICROBIOL, V36, P163, DOI 10.1046/j.1365-2958.2000.01839.x; Liu DJ, 1998, CELL, V94, P573, DOI 10.1016/S0092-8674(00)81599-8; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maldonado E, 1999, CELL, V99, P455, DOI 10.1016/S0092-8674(00)81533-0; Malik S, 1998, P NATL ACAD SCI USA, V95, P2192, DOI 10.1073/pnas.95.5.2192; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; MEISTERERNST M, 1991, CELL, V67, P557, DOI 10.1016/0092-8674(91)90530-C; Mermelstein F, 1996, GENE DEV, V10, P1033, DOI 10.1101/gad.10.8.1033; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; NIKOLOV DB, 1992, NATURE, V360, P40, DOI 10.1038/360040a0; NIKOLOV DB, 1996, P NATL ACAD SCI USA, V93, P4956; Oelgeschlager T, 1996, NATURE, V382, P735, DOI 10.1038/382735a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; Prelich G, 1997, MOL CELL BIOL, V17, P2057, DOI 10.1128/MCB.17.4.2057; PURNELL BA, 1994, GENE DEV, V8, P830, DOI 10.1101/gad.8.7.830; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Sekinger EA, 2001, CELL, V105, P403, DOI 10.1016/S0092-8674(01)00329-4; Sekinger EA, 1999, EMBO J, V18, P7041, DOI 10.1093/emboj/18.24.7041; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; Willy PJ, 2000, SCIENCE, V290, P982, DOI 10.1126/science.290.5493.982; Xie XL, 1996, NATURE, V380, P316, DOI 10.1038/380316a0; Yeung K, 1997, MOL CELL BIOL, V17, P36, DOI 10.1128/MCB.17.1.36	55	118	124	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2001	106	1					71	81		10.1016/S0092-8674(01)00417-2	http://dx.doi.org/10.1016/S0092-8674(01)00417-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461703	Bronze			2022-12-28	WOS:000169870300010
J	Schoener, TW; Spiller, DA; Losos, JB				Schoener, TW; Spiller, DA; Losos, JB			Predators increase the risk of catastrophic extinction of prey populations	NATURE			English	Article							TROPHIC CASCADES; COMPETITION; DIVERSITY	There has been considerable research on both top-down effects(1,2) and on disturbances(3-5) in ecological communities; however, the interaction between the two, when the disturbance is catastrophic, has rarely been examined(6). Predators may increase the probability of prey extinction resulting from a catastrophic disturbance both by reducing prey population size(7,8) and by changing ecological traits of prey individuals such as habitat characteristics(8,9) in a way that increases the vulnerability of prey species to extinction. We show that a major hurricane in the Bahamas led to the extinction of lizard populations on most islands onto which a predator had been experimentally introduced, whereas no populations became extinct on control islands. Before the hurricane, the predator had reduced prey populations to about half of those on control islands. Two months after the hurricane, we found only recently hatched individuals-apparently lizards survived the inundating storm surge only as eggs. On predator-introduction islands, those hatchling populations were a smaller fraction of pre-hurricane populations than on control islands. Egg survival allowed rapid recovery of prey populations to pre-hurricane levels on all control islands but on only a third of predator-introduction islands-the other two-thirds lost their prey populations. Thus climatic disturbance compounded by predation brought prey populations to extinction.	Univ Calif Davis, Sect Ecol & Evolut, Davis, CA 95616 USA; Washington Univ, Dept Biol, St Louis, MO 63130 USA	University of California System; University of California Davis; Washington University (WUSTL)	Schoener, TW (corresponding author), Univ Calif Davis, Sect Ecol & Evolut, Davis, CA 95616 USA.	twschoener@ucdavis.edu						Abrams PA, 1996, AM NAT, V148, P211, DOI 10.1086/285920; Ackerman J., 2000, NAT GEOGR MAG    OCT, V198, P86; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; DUNSON WA, 1991, AM NAT, V101, P97; EVANS EW, 1982, J NEW YORK ENTOMOL S, V90, P241; FIENBERG SE, 1972, BIOMETRIKA, V59, P591, DOI 10.1093/biomet/59.3.591; Gerber GP, 2000, OECOLOGIA, V124, P599, DOI 10.1007/s004420000414; HECKEL DG, 1979, ECOLOGY, V60, P966, DOI 10.2307/1936865; HOLT RD, 1994, ANNU REV ECOL SYST, V25, P495, DOI 10.1146/annurev.es.25.110194.002431; Kareiva P.M., 1993, BIOTIC INTERACTIONS; MENGE BA, 1976, AM NAT, V110, P351, DOI 10.1086/283073; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Pickett S. T. A., 1985, ECOLOGY NATURAL DIST; Power Mary E., 1996, P286; Roughgarden J, 1986, COMMUNITY ECOL, P333; Schmitz OJ, 1997, ECOLOGY, V78, P1388, DOI 10.1890/0012-9658(1997)078[1388:BMTCEO]2.0.CO;2; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Schoener T.W., 1987, P8; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Schoener TW, 1996, NATURE, V381, P691, DOI 10.1038/381691a0; SCHOENER TW, 1975, ECOL MONOGR, V45, P233, DOI 10.2307/1942423; SCHOENER TW, 1982, OECOLOGIA, V53, P160, DOI 10.1007/BF00545659; SCHOENER TW, UNPUB ECOL MONOGR; SCHWARTZ A, 1991, AMPHIBIANS REPTILES, P424; Siegel S., 1988, NONPARAMETRIC STAT B, P128; SIH A, 1985, ANNU REV ECOL SYST, V16, P269, DOI 10.1146/annurev.es.16.110185.001413; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Spiller DA, 1998, SCIENCE, V281, P695, DOI 10.1126/science.281.5377.695; WIENS JA, 1977, AM SCI, V65, P590	29	75	81	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2001	412	6843					183	186		10.1038/35084071	http://dx.doi.org/10.1038/35084071			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449274				2022-12-28	WOS:000169778700052
J	Nallamothu, BK; Saint, S; Kolias, TJ; Eagle, KA				Nallamothu, BK; Saint, S; Kolias, TJ; Eagle, KA			Of nicks and time	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							AORTIC DISSECTION; COCAINE ABUSE; MANAGEMENT		Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Vet Affairs Med Ctr, Hlth Serv Res & Dev Field Program, Ann Arbor, MI USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Nallamothu, BK (corresponding author), B1F245 Univ Hosp, Ann Arbor, MI 48109 USA.		Saint, Sanjay/AAF-5126-2019					CIGARROA JE, 1993, NEW ENGL J MED, V328, P35, DOI 10.1056/NEJM199301073280107; CREGLER LL, 1986, NEW ENGL J MED, V315, P1495, DOI 10.1056/NEJM198612043152327; EAGLE KA, 1989, CURR PROB CARDIOLOGY, V14, P225, DOI 10.1016/S0146-2806(89)80010-6; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; HOLLANDER JE, 1995, ACAD EMERG MED, V2, P179, DOI 10.1111/j.1553-2712.1995.tb03191.x; HOLLANDER JE, 1995, NEW ENGL J MED, V333, P1267, DOI 10.1056/NEJM199511093331907; ISNER JM, 1986, NEW ENGL J MED, V315, P1438, DOI 10.1056/NEJM198612043152302; ISSELBACHER EM, 1994, CIRCULATION, V90, P2375, DOI 10.1161/01.CIR.90.5.2375; KLONER RA, 1992, CIRCULATION, V85, P407, DOI 10.1161/01.CIR.85.2.407; Lange RA, 2001, NEW ENGL J MED, V345, P351, DOI 10.1056/NEJM200108023450507; Mendelson JH, 1996, NEW ENGL J MED, V334, P965, DOI 10.1056/NEJM199604113341507; Pretre R, 1997, LANCET, V349, P1461, DOI 10.1016/S0140-6736(96)09372-5; RICH JA, 1991, ANN EMERG MED, V20, P616, DOI 10.1016/S0196-0644(05)82378-9	13	12	12	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2001	345	5					359	363		10.1056/NEJM200108023450508	http://dx.doi.org/10.1056/NEJM200108023450508			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458KM	11484694				2022-12-28	WOS:000170193600009
J	Rodriguez, MA; McLoughlin, E; Nah, G; Campbell, JC				Rodriguez, MA; McLoughlin, E; Nah, G; Campbell, JC			Mandatory reporting of domestic violence injuries to the police - What do emergency department patients think?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WOMEN; CARE; LAWS	Context Laws requiring mandatory reporting of domestic violence to police exist in 4 states. Controversy exists about the risks and benefits of such laws. Objective To examine attitudes of female emergency department patients toward mandatory reporting of domestic violence injuries to police and how these attitudes may differ by abuse status. Design, Setting, and Participants Cross-sectional survey conducted in 1996 of 1218 women patients (72.8% response rate) in 12 emergency departments in California (a state with a mandatory reporting law) and Pennsylvania (without such a law). Main Outcome Measures Opposition to mandatory reporting to police and the characteristics associated with this belief. Results Twelve percent of respondents (n=140) reported physical or sexual abuse within the past year by a current or former partner. Of abused women, 55.7% supported mandatory reporting and 44.3% opposed mandatory reporting (7.9% preferred that physicians never report abuse to police and 36.4% preferred physicians report only with patient consent). Among nonabused women, 70.7% (n=728) supported mandatory reporting and 29.3% opposed mandatory reporting. Patients currently seeing/living with partners (odds ratio [OR], 1.5; 95% confidence interval [CPI, 1.1-2.0), non-English speakers (OR, 2.1; 95% Cl, 1.4-3.0), and those who had experienced physical or sexual abuse within the last year (OR, 2.2; 95% CI, 1.6-2.9) had higher odds of opposing mandatory reporting of domestic violence injuries. There were no differences in attitudes by location (California vs Pennsylvania). Conclusions The efficacy of mandatory reporting of domestic violence to police should be further assessed, and policymakers should consider options that include consent of patients before wider implementation.	Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA; Johns Hopkins Univ, Sch Nursing, Baltimore, MD USA; Trauma Fdn, Baltimore, MD USA	University of California System; University of California San Francisco; Johns Hopkins University	Rodriguez, MA (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Family & Community Med, San Francisco, CA 94110 USA.				PHS HHS [R49 CCR 903697.11, R49 CCR 310553] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bauer HM, 2000, J HEALTH CARE POOR U, V11, P33; CAMPBELL J, 1994, ASSESSING DANGEROUSN; Campbell JC, 2001, ACAD EMERG MED, V8, P131, DOI 10.1111/j.1553-2712.2001.tb01277.x; Chalk Rosemary, 1998, VIOLENCE FAMILIES; Coulter ML, 1997, J FAM VIOLENCE, V12, P349, DOI 10.1023/A:1022857022792; Dearwater SR, 1998, JAMA-J AM MED ASSOC, V280, P433, DOI 10.1001/jama.280.5.433; Gielen AC, 2000, AM J PREV MED, V19, P279, DOI 10.1016/S0749-3797(00)00234-8; GOLDMAN J, 2000, HLTH PRIVACY PRINCIP; Houry D, 1999, ANN EMERG MED, V34, P336, DOI 10.1016/S0196-0644(99)70127-7; HYMAN A, 1995, JAMA-J AM MED ASSOC, V273, P1781, DOI 10.1001/jama.273.22.1781; Larkin H, 1999, WESTERN J MED, V171, P119; Rodriguez MA, 1999, AM J PUBLIC HEALTH, V89, P575, DOI 10.2105/AJPH.89.4.575; Rodriguez MA, 1998, WESTERN J MED, V169, P337; SACHS CJ, IN PRESS WOMEN HLTH; Soeken K. L., 1998, EMPOWERING SURVIVORS, P195	15	53	53	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2001	286	5					580	583		10.1001/jama.286.5.580	http://dx.doi.org/10.1001/jama.286.5.580			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	458HE	11476660	Bronze			2022-12-28	WOS:000170188300021
J	Ghigo, JM				Ghigo, JM			Natural conjugative plasmids induce bacterial biofilm development	NATURE			English	Article								Horizontal gene transfer is a principal source of evolution leading to change in the ecological character of bacterial species(1). Bacterial conjugation(2), which promotes the horizontal transfer of genetic material between donor and recipient cells by physical contact, is a phenomenon of fundamental evolutionary consequence(3). Although conjugation has been studied primarily in liquid, most natural bacterial populations are found associated with environmental surfaces in complex multispecies communities called biofilms(4). Biofilms are ideally suited to the exchange of genetic material of various origins, and it has been shown that bacterial conjugation occurs within biofilms(5,6). Here I investigate the direct contribution of conjugative plasmids themselves to the capacity of the bacterial host to form a biofilm. Natural conjugative plasmids expressed factors that induced planktonic bacteria to form or enter biofilm communities, which favour the infectious transfer of the plasmid. This general connection between conjugation and biofilms suggests that medically relevant plasmid-bearing strains are more likely to form a biofilm. This may influence both the chances of biofilm-related infection risks and of conjugational spread of virulence factors.	Inst Pasteur, Unite Membranes Bacteriennes, CNRS, URA 2172, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ghigo, JM (corresponding author), Inst Pasteur, Unite Membranes Bacteriennes, CNRS, URA 2172, 25 Rue Dr Roux, F-75724 Paris 15, France.	jmghigo@pasteur.fr	GHIGO, Jean-Marc/AAP-4011-2021	GHIGO, Jean-Marc/0000-0001-6528-118X				Bergstrom CT, 2000, GENETICS, V155, P1505; BRADLEY DE, 1980, J BACTERIOL, V143, P1466, DOI 10.1128/JB.143.3.1466-1470.1980; BUKHARI AI, 1977, DNA INSERTION ELEMEN, P601; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Christensen BB, 1998, APPL ENVIRON MICROB, V64, P2247; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; COUTURIER M, 1988, MICROBIOL REV, V52, P375, DOI 10.1128/MMBR.52.3.375-395.1988; de la Cruz F, 2000, TRENDS MICROBIOL, V8, P128, DOI 10.1016/S0966-842X(00)01703-0; FROST LS, 1994, MICROBIOL REV, V58, P162, DOI 10.1128/MMBR.58.2.162-210.1994; Frost LS., 1993, BACTERIAL CONJUGATIO, P189; Hausner M, 1999, APPL ENVIRON MICROB, V65, P3710; LEDERBERG J, 1946, NATURE, V158, P558, DOI 10.1038/158558a0; LUNDQUIST PD, 1986, GENETICS, V113, P483; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pratt LA, 1999, CURR OPIN MICROBIOL, V2, P598, DOI 10.1016/S1369-5274(99)00028-4; RIED G, 1987, FEBS LETT, V223, P387, DOI 10.1016/0014-5793(87)80324-1; Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000	19	475	505	5	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2001	412	6845					442	445		10.1038/35086581	http://dx.doi.org/10.1038/35086581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473319				2022-12-28	WOS:000170068200049
J	Deeks, JJ				Deeks, JJ			Systematic reviews in health care - Systematic reviews of evaluations of diagnostic and screening	BRITISH MEDICAL JOURNAL			English	Article							TESTS; ACCURACY; METAANALYSES		Inst Hlth Sci, Imperial Canc Res Fund, NHS Ctr Stat Med, Oxford OX3 7LF, England	University of Oxford	Deeks, JJ (corresponding author), Inst Hlth Sci, Imperial Canc Res Fund, NHS Ctr Stat Med, Oxford OX3 7LF, England.		Deeks, Jon/AAV-5745-2020	Deeks, Jon/0000-0002-8850-1971				BLAND JM, 1994, BRIT MED J, V308, P1499, DOI 10.1136/bmj.308.6942.1499; *COCHR METH GROUP, 1996, REC METH; Deeks JJ, 1996, BAILLIERE CLIN OB GY, V10, P613, DOI 10.1016/S0950-3552(96)80008-3; Deeks JJ, 1999, ANN ONCOL, V10, P761, DOI 10.1023/A:1008359805260; Deeks~ JJ, 2001, SYSTEMATIC REV HLTH; DEVILLE W, 1999, P 2 S SYST REV BAS O; GUYATT GH, 1986, CAN MED ASSOC J, V134, P587; Ingelfinger JA, 1994, BIOSTATISTICS CLIN M, P26; IRWIG L, 1995, J CLIN EPIDEMIOL, V48, P119, DOI 10.1016/0895-4356(94)00099-C; IRWIG L, 1994, ANN INTERN MED, V120, P667, DOI 10.7326/0003-4819-120-8-199404150-00008; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P289; KARDAUN JWPF, 1990, METHOD INFORM MED, V29, P12; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; LITTENBERG B, 1993, MED DECIS MAKING, V13, P313, DOI 10.1177/0272989X9301300408; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; MULROW CD, 1989, J GEN INTERN MED, V4, P288, DOI 10.1007/BF02597398; Oosterhuis WP, 2000, CLIN CHEM LAB MED, V38, P577, DOI 10.1515/CCLM.2000.084; REID MC, 1995, JAMA-J AM MED ASSOC, V274, P645, DOI 10.1001/jama.274.8.645; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; Shapiro D E, 1995, Acad Radiol, V2 Suppl 1, pS37; Smith-Bindman R, 1998, JAMA-J AM MED ASSOC, V280, P1510, DOI 10.1001/jama.280.17.1510; Vamvakas EC, 1998, ARCH PATHOL LAB MED, V122, P675	23	875	904	0	26	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2001	323	7305					157	162		10.1136/bmj.323.7305.157	http://dx.doi.org/10.1136/bmj.323.7305.157			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456WR	11463691	Green Published			2022-12-28	WOS:000170106200025
J	Schucher, B; Brinkmann, G; Petermann, C; Lankisch, PG				Schucher, B; Brinkmann, G; Petermann, C; Lankisch, PG			The heavy smoking football fan who had an epileptic fit	LANCET			English	Editorial Material									Municipal Clin Luneburg, Dept Internal Med, Luneburg, Germany; Municipal Clin Luneburg, Dept Diagnost Radiol, Luneburg, Germany; Allgemeines Krankenhaus Hamburg, Dept Pulm Dis, Hamburg, Germany		Lankisch, PG (corresponding author), Staedt Klinikum, Med Klin, Boegelstr 1, D-21339 Luneburg, Germany.							ISRAEL J, 1879, VIRCHOWS ARCH PATHOL, V74, P15; Russo TA, 1998, HARRISONS PRINCIPLES, P989; SMEGO RA, 1987, REV INFECT DIS, V9, P855; SMITH DL, 1975, CHEST, V67, P242, DOI 10.1378/chest.67.2.242; [No title captured]	5	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 21	2001	358	9277					206	206		10.1016/S0140-6736(01)05409-5	http://dx.doi.org/10.1016/S0140-6736(01)05409-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454HL	11476838				2022-12-28	WOS:000169967100014
J	Trottier, Y; Mandel, JL				Trottier, Y; Mandel, JL			Biomedicine - Huntingtin - Profit and loss	SCIENCE			English	Editorial Material							NEUROTROPHIC FACTOR; BRAIN; MODEL; POLYGLUTAMINE; TRANSCRIPTION; NEURONS; DISEASE		ULP, INSERM, CNRS, IGBMC, F-67404 Illkirch Graffenstaden, CU Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Trottier, Y (corresponding author), ULP, INSERM, CNRS, IGBMC, F-67404 Illkirch Graffenstaden, CU Strasbourg, France.	yvon@titus.u-strasbg.fr	Trottier, Yvon/H-8852-2016; Mandel, Jean Louis/Q-2668-2016	Trottier, Yvon/0000-0001-7230-4810; Mandel, Jean Louis/0000-0002-0535-6589				Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; Cha JHJ, 2000, TRENDS NEUROSCI, V23, P387, DOI 10.1016/S0166-2236(00)01609-X; COYLE JT, 1976, NATURE, V263, P244, DOI 10.1038/263244a0; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Kennedy L, 2000, HUM MOL GENET, V9, P2539, DOI 10.1093/hmg/9.17.2539; McCampbell A, 2001, NAT MED, V7, P528, DOI 10.1038/87842; MCGEER EG, 1976, NATURE, V263, P517, DOI 10.1038/263517a0; Perez-Navarro E, 2000, J NEUROCHEM, V75, P2190, DOI 10.1046/j.1471-4159.2000.0752190.x; Rigamonti D, 2001, J BIOL CHEM, V276, P14545, DOI 10.1074/jbc.C100044200; Schuman EM, 1999, CURR OPIN NEUROBIOL, V9, P105, DOI 10.1016/S0959-4388(99)80013-0; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	16	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2001	293	5529					445	446		10.1126/science.1063429	http://dx.doi.org/10.1126/science.1063429			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463904				2022-12-28	WOS:000169966700034
J	Aldhous, P				Aldhous, P			Millennium Dome sees signs of a Wellcome break	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					258	258		10.1038/35085698	http://dx.doi.org/10.1038/35085698			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460118	Bronze			2022-12-28	WOS:000169918200005
J	Kramer, MS; Barr, RG; Dagenais, S; Yang, H; Jones, P; Ciofani, L; Jane, F				Kramer, MS; Barr, RG; Dagenais, S; Yang, H; Jones, P; Ciofani, L; Jane, F			Pacifier use, early weaning, and cry/fuss behavior - A randomized controlled	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONNUTRITIVE SUCKING; INFANTS; TERM; DURATION	Context The World Health Organization and the United Nations Children's Fund strongly discourage use of pacifiers because of their perceived interference with breastfeeding, Observational studies have reported a strong association between pacifier use and early weaning, but such studies are unable to determine whether the association is causal. Objectives To test whether regular pacifier use is causally related to weaning by 3 months postpartum and to examine differences in results according to randomized intervention allocation vs observational use or nonuse of pacifiers. Design Double-blind, randomized controlled trial conducted from January 1998 to August 1999. Setting Postpartum unit of a university teaching hospital in Montreal, Quebec. Participants A total of 281 healthy, breastfeeding women and their healthy, term singleton infants. Interventions Participants were randomly allocated to 1 of 2 counseling interventions provided by a research nurse trained in location counseling. The experimental intervention (n=140) differed from the control (n=141) by recommending avoidance of pacifier use and suggesting alternative ways to comfort a crying or fussing infant, Main Outcome Measures Early weaning, defined as weaning within the first 3 months, compared between groups; 24-hour infant behavior logs detailing frequency and duration of crying, fussing, and pacifier use at 4, 6, and 9 weeks. Results A total of 258 mother-infant pairs (91.8%) completed follow-up. The experimental intervention increased total avoidance of pacifier use (38.6% vs 16.0% in the control group), reduced daily use (40.8% vs 55.7%), and decreased the mean number of pacifier insertions per day (0.8 vs 2.4 at 4 weeks [P<.001]; 0.8 vs 3.0 at 6 weeks [P<.001]; and 1.3 vs 3.0 at 9 weeks [P=.004]). In the analysis based on randomized intervention allocation, the experimental intervention had no discernible effect on weaning at 3 months (18.9% vs 18.3% in the experimental vs control group; relative risk [RR], 1.0; 95% confidence interval [CI], 0.6-1.7), and no effect was observed on cry/ fuss behavior tin the experimental vs control groups, respectively, total daily duration, 143 vs 151 minutes at 4 weeks [P=.49]; 128 vs 131 minutes at 6 weeks [P=.81]; and 110 vs 104 minutes at 9 weeks [P=.58]). When randomized allocation was ignored, however, we observed a strong observational association between exposure to daily pacifier use and weaning by 3 months (25.0% vs 12.9% of the exposed vs unexposed groups; RR, 1.9, 95% CI, 1.1-3.3). Conclusions We found a strong observational association between pacifier use and early weaning. No such association was observed, however, when our data were analyzed by randomized allocation, strongly suggesting that pacifier use is a marker of breastfeeding difficulties or reduced motivation to breastfeed, rather than a true cause of early weaning.	McGill Univ, Dept Pediat, Fac Med, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Epidemiol & Stat, Fac Med, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Psychiat, Fac Med, Montreal, PQ H3A 2T5, Canada; McGill Univ, Hlth Ctr Res Inst, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University; McGill University; McGill University	Kramer, MS (corresponding author), 1020 Pine Ave W, Montreal, PQ H3A 1A2, Canada.	mkrame@po-box.mcgill.ca						Aarts C, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.4.e50; BARR RG, 1988, ARCH DIS CHILD, V63, P380, DOI 10.1136/adc.63.4.380; BARROS FC, 1995, PEDIATRICS, V95, P497; BOWENJONES A, 1982, DEV MED CHILD NEUROL, V24, P626; CAMPOS RG, 1989, CHILD DEV, V60, P781, DOI 10.1111/j.1467-8624.1989.tb03509.x; Clements MS, 1997, ACTA PAEDIATR, V86, P51, DOI 10.1111/j.1651-2227.1997.tb08831.x; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; FIELD T, 1984, PEDIATRICS, V74, P1012; FORD RPK, 1994, J PAEDIATR CHILD H, V30, P483, DOI 10.1111/j.1440-1754.1994.tb00717.x; GALE CR, 1995, SOC HIST MED, V8, P231, DOI 10.1093/shm/8.2.231; GENSON K, 2000, NEW ENGL J MED, V342, P1878; GORELICK L, 1955, NY ST DENT J, V21, P3; GRAYDONALD K, 1985, PEDIATRICS, V75, P514; GRAYDONALD K, 1988, AM J EPIDEMIOL, V127, P885, DOI 10.1093/oxfordjournals.aje.a114891; GUNNAR MR, 1984, J AM ACAD CHILD PSY, V23, P34, DOI 10.1097/00004583-198401000-00005; Howard CR, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.3.e33; HUNZIKER UA, 1986, PEDIATRICS, V77, P641; KING FT, 1923, FEEDING CARE BABY; Levin S, 1971, S Afr Med J, V45, P237; MATHEW OP, 1989, AM J DIS CHILD, V143, P588, DOI 10.1001/archpedi.1989.02150170090030; NEIFERT M, 1995, J PEDIATR-US, V126, pS125, DOI 10.1016/S0022-3476(95)90252-X; PEDLEY TF, 1907, DENT REC, V27, P176; Pritchard E, 1911, LANCET, V2, P851; RICHARD L, 1992, BIRTH-ISS PERINAT C, V19, P185; SELLEY WG, 1990, BRIT J DISORD COMMUN, V25, P311; SMITH BA, 1990, DEV PSYCHOL, V26, P731; STJAMESROBERTS I, 1993, ARCH DIS CHILD, V68, P82, DOI 10.1136/adc.68.1.82; VICTORA CG, 1993, LANCET, V341, P404, DOI 10.1016/0140-6736(93)92991-2; Victora CG, 1997, PEDIATRICS, V99, P445, DOI 10.1542/peds.99.3.445; WHO/UNICEF, 1989, PROT PROM SUPP BREAS; WOLFF PH, 1968, PEDIATRICS, V42, P943; WOODSON R, 1985, INFANT BEHAV DEV, V8, P435, DOI 10.1016/0163-6383(85)90007-4	32	134	150	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2001	286	3					322	326		10.1001/jama.286.3.322	http://dx.doi.org/10.1001/jama.286.3.322			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	452QA	11466098	Bronze			2022-12-28	WOS:000169869200023
J	Zinkernagel, RM; Hengartner, H				Zinkernagel, RM; Hengartner, H			Regulation of the immune response by antigen	SCIENCE			English	Editorial Material							T-CELL; TOLERANCE; VIRUS; INDUCTION; SPECIFICITY; AUTOIMMUNE; INFECTION; MICE	How, why, and when specific T and B Lymphocytes respond against infection follow explicit rules, but how this can be assessed experimentally depends crucially on the methodology used. In this Viewpoint, we discuss the parameters of receptor specificity and antigen that determine whether an immune response can be accurately measured against model antigens and how this relates to protection against a given pathogen. We suggest that antigen structure, Localization, dose, and time during which antigen is available are all decisive factors in regulating an immune response.	Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Zinkernagel, RM (corresponding author), Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland.							BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784; Bachmann MF, 1997, SCIENCE, V276, P2024, DOI 10.1126/science.276.5321.2024; Carbone FR, 1998, IMMUNOL TODAY, V19, P368, DOI 10.1016/S0167-5699(98)01301-2; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; COHN M, 1990, IMMUNOL REV, V115, P7, DOI 10.1111/j.1600-065X.1990.tb00783.x; COUTINHO A, 1975, TRANSPLANT REV, V23, P49; Ehl S, 1998, J EXP MED, V187, P763, DOI 10.1084/jem.187.5.763; GANSS R, 1999, IMMUNOL REV, V119, P203; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; HOTCHIN J, 1962, COLD SPRING HARB SYM, V27, P479, DOI 10.1101/SQB.1962.027.001.046; HUNIG T, 1981, NATURE, V294, P460, DOI 10.1038/294460a0; Karrer U, 1997, J EXP MED, V185, P2157, DOI 10.1084/jem.185.12.2157; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Klinkert WEF, 1997, J NEUROIMMUNOL, V72, P163, DOI 10.1016/S0165-5728(96)00183-X; Kundig TM, 1996, P NATL ACAD SCI USA, V93, P9716, DOI 10.1073/pnas.93.18.9716; KUNDIG TM, 1995, SCIENCE, V268, P1343, DOI 10.1126/science.7761853; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; MATZINGER P, 1977, CELL IMMUNOL, V29, P1, DOI 10.1016/0008-8749(77)90269-6; Mims C. A., 1987, PATHOGENESIS INFECT; MOLLER G, 1989, IMMUNOL REV, V110, P1; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; NEWMAN MA, 1992, J IMMUNOL, V149, P3260; Ochsenbein AF, 2001, NATURE, V411, P1058, DOI 10.1038/35082583; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; OHASHI PS, 1993, J IMMUNOL, V150, P5185; ROOST HP, 1995, P NATL ACAD SCI USA, V92, P1257, DOI 10.1073/pnas.92.5.1257; Shevach EM, 2001, J EXP MED, V193, pF41, DOI 10.1084/jem.193.11.F41; Simonsen M, 1969, Transplant Rev, V3, P22; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Weigle W O, 1973, Adv Immunol, V16, P61, DOI 10.1016/S0065-2776(08)60296-5; ZINKERNAGEL RM, 1991, IMMUNOL REV, V122, P133, DOI 10.1111/j.1600-065X.1991.tb00601.x; Zinkernagel RM, 1996, SCIENCE, V271, P173, DOI 10.1126/science.271.5246.173	32	171	177	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2001	293	5528					251	253		10.1126/science.1063005	http://dx.doi.org/10.1126/science.1063005			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452115				2022-12-28	WOS:000169875200045
J	Hackett, PH; Roach, RC				Hackett, PH; Roach, RC			Current concepts: High-altitude illness.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACUTE MOUNTAIN-SICKNESS; PULMONARY-EDEMA; NITRIC-OXIDE; DOUBLE-BLIND; PREVENTION; ACETAZOLAMIDE; HYPOXIA; DEXAMETHASONE; SUSCEPTIBILITY; HEADACHE		Univ Colorado, Hlth Sci Ctr, Dept Emergency Med, Denver, CO USA; St Marys Hosp, Dept Emergency Med, Grand Junction, CO USA; New Mexico Resonance, Albuquerque, NM USA	Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Hackett, PH (corresponding author), Int Soc Mt Med, 610 Sabeta Dr, Ridgway, CO 81432 USA.	hackett@ismmed.org	Roach, Robert/F-4729-2011	Roach, Robert/0000-0002-7998-8976				BARTSCH P, 1994, LANCET, V344, P1445, DOI 10.1016/S0140-6736(94)90617-3; BARTSCH P, 1991, NEW ENGL J MED, V325, P1284, DOI 10.1056/NEJM199110313251805; Bartsch P., 2001, HIGH ALTITUDE EXPLOR, P731; Basnyat B, 2000, High Alt Med Biol, V1, P167; Beaumont M, 1996, AM J RESP CRIT CARE, V153, P1864, DOI 10.1164/ajrccm.153.6.8665047; Bernhard WN, 1998, AVIAT SPACE ENVIR MD, V69, P883; BROOME JR, 1994, AVIAT SPACE ENVIR MD, V65, P19; BURTSCHER M, 1995, LANCET, V346, P254, DOI 10.1016/S0140-6736(95)91303-3; Burtscher M, 1998, BRIT MED J, V316, P1057; Busch T, 2001, AM J RESP CRIT CARE, V163, P368, DOI 10.1164/ajrccm.163.2.2001134; CLARK IA, 1999, ADV EXPT MED BIOL, V474, P373; DARMANANDA S, 1997, REDUCTION MOUNTAIN S; DEAN AG, 1990, J WILDERNESS MED, V1, P86, DOI 10.1580/0953-9859-1.2.86; del Rio MS, 1999, ADV EXP MED BIOL, V474, P145; Dietz T E, 2000, High Alt Med Biol, V1, P207, DOI 10.1089/15270290050144208; Dumont L, 2000, BRIT MED J, V321, P267, DOI 10.1136/bmj.321.7256.267; Duplain H, 1999, CIRCULATION, V99, P1713, DOI 10.1161/01.CIR.99.13.1713; Durmowicz AG, 1997, J PEDIATR-US, V130, P838, DOI 10.1016/S0022-3476(97)80033-9; ELLIOTT AR, 1992, J APPL PHYSIOL, V73, P1150, DOI 10.1152/jappl.1992.73.3.1150; ELLSWORTH AJ, 1991, WESTERN J MED, V154, P289; FERRAZZINI G, 1987, BRIT MED J, V294, P1380, DOI 10.1136/bmj.294.6584.1380; GREENE MK, 1981, BRIT MED J, V283, P811, DOI 10.1136/bmj.283.6295.811; GRISSOM CK, 1992, ANN INTERN MED, V116, P461, DOI 10.7326/0003-4819-116-6-461; Grunig E, 2000, J AM COLL CARDIOL, V35, P980, DOI 10.1016/S0735-1097(99)00633-6; HACKETT PH, 1980, NEW ENGL J MED, V302, P1070, DOI 10.1056/NEJM198005083021907; HACKETT PH, 1976, LANCET, V2, P1149; HACKETT PH, 1988, AVIAT SPACE ENVIR MD, V59, P950; HACKETT PH, 1988, J APPL PHYSIOL, V64, P1268, DOI 10.1152/jappl.1988.64.3.1268; HACKETT PH, 1992, INT J SPORTS MED, V13, pS68, DOI 10.1055/s-2007-1024599; Hackett PH, 1998, JAMA-J AM MED ASSOC, V280, P1920, DOI 10.1001/jama.280.22.1920; Hackett PH, 1999, ADV EXP MED BIOL, V474, P23; HACKETT PH, 2001, HIGH ALTITUDE EXPLOR, V8, P39; Hackett PH, 2001, WILDERNESS MED, P2; Hanaoka M, 1998, CIRCULATION, V97, P1124, DOI 10.1161/01.CIR.97.12.1124; Hartmann G, 2000, CYTOKINE, V12, P246, DOI 10.1006/cyto.1999.0533; HOHENHAUS E, 1995, EUR RESPIR J, V8, P1825, DOI 10.1183/09031936.95.08111825; HONIGMAN B, 1994, ANN INTERN MED, V120, P698, DOI 10.7326/0003-4819-120-8-199404150-00034; Hultgren HN, 1996, ANNU REV MED, V47, P267; HULTGREN HN, 1964, CIRCULATION, V29, P393, DOI 10.1161/01.CIR.29.3.393; Hultgren HN, 1996, WESTERN J MED, V164, P222; ICENOGLE M, 1999, ADV EXPT MED BIOL, V474, P392; ITUGER D, 1999, ADV EXPT MED BIOL, V474, P435; Jensen JB, 1996, J APPL PHYSIOL, V80, P1214, DOI 10.1152/jappl.1996.80.4.1214; JOHNSON TS, 1984, NEW ENGL J MED, V310, P683, DOI 10.1056/NEJM198403153101103; KAWASHIMA A, 1989, J APPL PHYSIOL, V67, P1982, DOI 10.1152/jappl.1989.67.5.1982; KELLER HR, 1995, BMJ-BRIT MED J, V310, P1232, DOI 10.1136/bmj.310.6989.1232; KILGORE D, 1999, ADV EXPT MED BIOL, V474, P396; KRASNEY JA, 1994, MED SCI SPORT EXER, V26, P195, DOI 10.1249/00005768-199402000-00010; Kubo K, 1998, RESP PHYSIOL, V111, P301, DOI 10.1016/S0034-5687(98)00006-1; Levine BD, 1999, ADV EXP MED BIOL, V474, P319; Maakestad K, 2001, WILDERNESS ENV MED, V12, P51; Maggiorini M, 2001, CIRCULATION, V103, P2078; Matsuzawa Y, 1992, HIGH ALTITUDE MED, P300; MILLEDGE JS, 1991, EUR RESPIR J, V4, P1000; Muza SR, 1999, ADV EXPT MED BIOL, V474, P414; Naeije R, 1996, CHEST, V110, P286, DOI 10.1378/chest.110.1.286; OELZ O, 1989, LANCET, V2, P1241; PURKAYASTHA SS, 1995, J APPL PHYSIOL, V79, P487, DOI 10.1152/jappl.1995.79.2.487; RADWELL AR, 1987, HYPOXIA COLD, P543; REEVES JT, 1993, HYPOXIA AND MOLECULAR MEDICINE, P275; RIED LD, 1994, J WILDERNESS MED, V5, P34; ROACH RC, 1995, WESTERN J MED, V162, P32; Roach RC, 2000, J APPL PHYSIOL, V88, P581, DOI 10.1152/jappl.2000.88.2.581; ROACH RC, 1993, HYPOXIA MOL MED, P372; Roncin JP, 1996, AVIAT SPACE ENVIR MD, V67, P445; ROSS RT, 1985, LANCET, V1, P990; Sartori C, 2000, AM J RESP CRIT CARE, V161, pA415; Scherrer U, 1999, ADV EXP MED BIOL, V474, P93; Scherrer U, 1996, NEW ENGL J MED, V334, P624, DOI 10.1056/NEJM199603073341003; Schilling L, 1999, ADV EXP MED BIOL, V474, P123; SEVERINGHAUS JW, 1995, J APPL PHYSIOL, V79, P375, DOI 10.1152/jappl.1995.79.2.375; SINGH I, 1969, NEW ENGL J MED, V280, P175, DOI 10.1056/NEJM196901232800402; Stenmark KR, 1999, ADV EXP MED BIOL, V474, P231; SWENSON ER, 2000, AM J RESP CRIT CARE, V161, pA418; WEST JB, 1992, LANCET, V340, P762, DOI 10.1016/0140-6736(92)92301-U; Yaron M, 1998, ARCH PEDIAT ADOL MED, V152, P683	76	880	922	9	119	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 12	2001	345	2					107	114		10.1056/NEJM200107123450206	http://dx.doi.org/10.1056/NEJM200107123450206			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451AH	11450659				2022-12-28	WOS:000169776900006
J	Baralle, D				Baralle, D			Chromosomal aberrations, subtelomeric defects, and mental retardation	LANCET			English	Editorial Material									Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 5AQ, England	Addenbrooke's Hospital; University of Cambridge	Baralle, D (corresponding author), Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 5AQ, England.			Baralle, Diana/0000-0003-3217-4833				Antonarakis SE, 2001, NAT GENET, V27, P230, DOI 10.1038/85769; Castellvi-Bel S, 2001, MOL GENET METAB, V72, P104, DOI 10.1006/mgme.2000.3128; De Vries BBA, 2001, J MED GENET, V38, P175, DOI 10.1136/jmg.38.3.175; de Vries BBA, 2001, J MED GENET, V38, P145, DOI 10.1136/jmg.38.3.145; Doheny KF, 1997, J MED GENET, V34, P640, DOI 10.1136/jmg.34.8.640; Hamerton JL, 1999, LANCET, V354, P1659, DOI 10.1016/S0140-6736(99)00246-9; Knight SJL, 1999, LANCET, V354, P1676, DOI 10.1016/S0140-6736(99)03070-6; Ning Y, 1996, NAT GENET, V14, P86, DOI 10.1038/ng0996-86; PHELAN MC, 1996, P GREENWOOD GENET CT, V15, P45; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; *WHO, 1968, 392 WHO; *WHO, 1986, WHO OFFS PUBL, V86; WINTER RM, 1998, LONDON DYSMORPHOLOGY	13	12	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 7	2001	358	9275					7	8		10.1016/S0140-6736(00)05300-9	http://dx.doi.org/10.1016/S0140-6736(00)05300-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	449WV	11454368				2022-12-28	WOS:000169710900007
J	Loreau, M; Hector, A				Loreau, M; Hector, A			Partitioning selection and complementarity in biodiversity experiments	NATURE			English	Article							GRASSLAND ECOSYSTEMS; SPECIES-DIVERSITY; PLANT DIVERSITY; PRODUCTIVITY; COVARIANCE	The impact of biodiversity loss on the functioning of ecosystems and their ability to provide ecological services has become a central issue in ecology. Several experiments have provided evidence that reduced species diversity may impair ecosystem processes such as plant biomass production(1-5). The interpretation of these experiments, however, has been controversial(6-12) because two types of mechanism may operate in combination(6,13-15). In the 'selection effect', dominance by species with particular traits affects ecosystem processes. In the 'complementarity effect', resource partitioning or positive interactions lead to increased total resource use. Here we present a new approach to separate the two effects on the basis of an additive partitioning analogous to the Price equation in evolutionary genetics(16-19). Applying this method to data from the pan-European BIODEPTH experiment(4) reveals that the selection effect is zero on average and varies from negative to positive in different localities, depending on whether species with lower- or higher-than-average biomass dominate communities. In contrast, the complementarity effect is positive overall, supporting the hypothesis that plant diversity influences primary production in European grasslands through niche differentiation or facilitation.	Ecole Normale Super, Ecol Lab, UMR 7625, F-75230 Paris 05, France; Imperial Coll, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Loreau, M (corresponding author), Ecole Normale Super, Ecol Lab, UMR 7625, 46 Rue Ulm, F-75230 Paris 05, France.		Hector, Andrew/H-4199-2011	Hector, Andrew/0000-0002-1309-7716				Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; Frank SA, 1997, EVOLUTION, V51, P1712, DOI [10.2307/2410995, 10.1111/j.1558-5646.1997.tb05096.x]; FRANK SA, 1995, J THEOR BIOL, V175, P373, DOI 10.1006/jtbi.1995.0148; Garnier E, 1997, ACTA OECOL, V18, P657, DOI 10.1016/S1146-609X(97)80049-5; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 1998, OIKOS, V82, P597, DOI 10.2307/3546380; HECTOR A, 2000, SCIENCE, V289, P1255; Huston M A, 2000, Science, V289, P1255; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Jolliffe PA, 2000, J ECOL, V88, P371, DOI 10.1046/j.1365-2745.2000.00470.x; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Loreau M, 1998, OIKOS, V82, P600, DOI 10.2307/3546381; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; PRICE GR, 1995, J THEOR BIOL, V175, P389, DOI 10.1006/jtbi.1995.0149; PRICE GR, 1972, ANN HUM GENET, V35, P485, DOI 10.1111/j.1469-1809.1957.tb01874.x; PRICE GR, 1970, NATURE, V227, P520, DOI 10.1038/227520a0; Schlapfer F, 1999, ECOL APPL, V9, P893, DOI 10.1890/1051-0761(1999)009[0893:EEOBAC]2.0.CO;2; Tilman D, 1997, OIKOS, V80, P185, DOI 10.2307/3546532; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Troumbis AY, 2000, OIKOS, V90, P549, DOI 10.1034/j.1600-0706.2000.900313.x; van der Heijden MGA, 1999, OIKOS, V87, P408, DOI 10.2307/3546758; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Wardle DA, 1999, OIKOS, V87, P403, DOI 10.2307/3546757	25	1869	1949	67	1109	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					72	76		10.1038/35083573	http://dx.doi.org/10.1038/35083573			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452308				2022-12-28	WOS:000169644900045
J	Dangl, JL; Jones, JDG				Dangl, JL; Jones, JDG			Plant pathogens and integrated defence responses to infection	NATURE			English	Review							DISEASE RESISTANCE GENE; RACE-SPECIFIC RESISTANCE; LEUCINE-RICH REPEATS; CLADOSPORIUM-FULVUM; ARABIDOPSIS-THALIANA; SALICYLIC-ACID; CONFER RESISTANCE; HYPERSENSITIVE RESPONSE; ACQUIRED-RESISTANCE; MILDEW RESISTANCE	Plants cannot move to escape environmental challenges. Biotic stresses result from a battery of potential pathogens: fungi, bacteria, nematodes and insects intercept the photosynthate produced by plants, and viruses use replication machinery at the host's expense. Plants, in turn, have evolved sophisticated mechanisms to perceive such attacks, and to translate that perception into an adaptive response. Here, we review the current knowledge of recognition-dependent disease resistance in plants. We include a few crucial concepts to compare and contrast plant innate immunity with that more commonly associated with animals. There are appreciable differences, but also surprising parallels.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet, Chapel Hill, NC 27599 USA; John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Dangl, JL (corresponding author), Univ N Carolina, Dept Biol, Coker Hall 108,CB 3280, Chapel Hill, NC 27599 USA.	dangl@email.unc.edu; jonathan.jones@bbsrc.ac.uk	Jones, Jonathan DG/J-5129-2012	Jones, Jonathan DG/0000-0002-4953-261X				Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P47, DOI 10.1016/S0968-0004(98)01341-3; Bent AF, 1996, PLANT CELL, V8, P1757, DOI 10.1105/tpc.8.10.1757; BISGROVE SR, 1994, PLANT CELL, V6, P927, DOI 10.1105/tpc.6.7.927; Botella MA, 1998, PLANT CELL, V10, P1847, DOI 10.1105/tpc.10.11.1847; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; Bryan GT, 2000, PLANT CELL, V12, P2033, DOI 10.1105/tpc.12.11.2033; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; CENTURY KS, 1995, P NATL ACAD SCI USA, V92, P6597, DOI 10.1073/pnas.92.14.6597; Chen ZY, 2000, MOL PLANT MICROBE IN, V13, P1312, DOI 10.1094/MPMI.2000.13.12.1312; Clarke JD, 2000, PLANT CELL, V12, P2175, DOI 10.1105/tpc.12.11.2175; Cooley MB, 2000, PLANT CELL, V12, P663, DOI 10.1105/tpc.12.5.663; Dangl J L, 1994, Curr Top Microbiol Immunol, V192, P99; Delaney TP, 1997, PLANT PHYSIOL, V113, P5, DOI 10.1104/pp.113.1.5; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; DELLEDONNE M, IN PRESS P NATL ACAD; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P1908, DOI 10.1073/pnas.020367497; Dixon MS, 2000, P NATL ACAD SCI USA, V97, P8807, DOI 10.1073/pnas.97.16.8807; DrogeLaser W, 1997, EMBO J, V16, P726, DOI 10.1093/emboj/16.4.726; Durner J, 1998, P NATL ACAD SCI USA, V95, P10328, DOI 10.1073/pnas.95.17.10328; Durrant WE, 2000, PLANT CELL, V12, P963, DOI 10.1105/tpc.12.6.963; Ellis J, 2000, CURR OPIN PLANT BIOL, V3, P278, DOI 10.1016/S1369-5266(00)00080-7; Ellis JG, 1999, PLANT CELL, V11, P495, DOI 10.1105/tpc.11.3.495; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; FREIALDENHOVEN A, 1994, PLANT CELL, V6, P983; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Glazebrook J, 1997, ANNU REV GENET, V31, P547, DOI 10.1146/annurev.genet.31.1.547; GLAZEBROOK J, IN PRESS CURR OPIN P; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gopalan S, 1996, PLANT CELL, V8, P1095, DOI 10.1105/tpc.8.7.1095; Grant M, 2000, PLANT J, V23, P441, DOI 10.1046/j.1365-313x.2000.00804.x; Grant MR, 1998, P NATL ACAD SCI USA, V95, P15843, DOI 10.1073/pnas.95.26.15843; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; HALTERMAN D, IN PRESS PLANT J; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; INITIATIVE TAG, 2000, NATURE, V408, P796, DOI DOI 10.1038/35048692; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Jabs T, 1997, P NATL ACAD SCI USA, V94, P4800, DOI 10.1073/pnas.94.9.4800; JONES DA, 1994, SCIENCE, V266, P789, DOI 10.1126/science.7973631; Jones DA, 1996, ADV BOT RES ADV PLAN, V24, P90; JONES JDG, IN PRESS CURR OPIN P; JORGENSEN JH, 1988, GENOME, V30, P129, DOI 10.1139/g88-022; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Kjemtrup S, 2000, CURR OPIN MICROBIOL, V3, P73, DOI 10.1016/S1369-5274(99)00054-5; KoomanGersmann M, 1996, PLANT CELL, V8, P929, DOI 10.1105/tpc.8.5.929; Lauge R, 2000, PLANT J, V23, P735, DOI 10.1046/j.1365-313x.2000.00843.x; Lauge R, 1997, MOL PLANT MICROBE IN, V10, P725, DOI 10.1094/MPMI.1997.10.6.725; Lauge R, 1998, P NATL ACAD SCI USA, V95, P9014, DOI 10.1073/pnas.95.15.9014; Lauge R, 1998, MOL PLANT MICROBE IN, V11, P301, DOI 10.1094/MPMI.1998.11.4.301; Leister RT, 2000, PLANT J, V22, P345, DOI 10.1046/j.1365-313x.2000.00744.x; Ligterink W, 1997, SCIENCE, V276, P2054, DOI 10.1126/science.276.5321.2054; Luck JE, 2000, PLANT CELL, V12, P1367, DOI 10.1105/tpc.12.8.1367; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; McDowell JM, 2000, TRENDS BIOCHEM SCI, V25, P79, DOI 10.1016/S0968-0004(99)01532-7; McDowell JM, 1998, PLANT CELL, V10, P1861, DOI 10.1105/tpc.10.11.1861; McDowell JM, 2000, PLANT J, V22, P523, DOI 10.1046/j.1365-313x.2000.00771.x; McNellis TW, 1998, PLANT J, V14, P247, DOI 10.1046/j.1365-313X.1998.00106.x; Medzhitov R, 2000, TRENDS MICROBIOL, V8, P452, DOI 10.1016/S0966-842X(00)01845-X; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Meyers BC, 1998, PLANT CELL, V10, P1817, DOI 10.1105/tpc.10.11.1817; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; Mudgett MB, 1999, MOL MICROBIOL, V32, P927, DOI 10.1046/j.1365-2958.1999.01403.x; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; NIMCHUK Z, IN PRESS CURR OPIN P; Noel L, 1999, PLANT CELL, V11, P2099, DOI 10.1105/tpc.11.11.2099; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Oldroyd GED, 1998, P NATL ACAD SCI USA, V95, P10300, DOI 10.1073/pnas.95.17.10300; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Parker JE, 1996, PLANT CELL, V8, P2033, DOI 10.1105/tpc.8.11.2033; Parniske M, 1997, CELL, V91, P821, DOI 10.1016/S0092-8674(00)80470-5; Piedras P, 1998, MOL PLANT MICROBE IN, V11, P1155, DOI 10.1094/MPMI.1998.11.12.1155; Ren T, 2000, PLANT CELL, V12, P1917, DOI 10.1105/tpc.12.10.1917; Reuber TL, 1998, PLANT J, V16, P473, DOI 10.1046/j.1365-313x.1998.00319.x; Reymond P, 1998, CURR OPIN PLANT BIOL, V1, P404, DOI 10.1016/S1369-5266(98)80264-1; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Riely BK, 2001, P NATL ACAD SCI USA, V98, P2059, DOI 10.1073/pnas.98.4.2059; Ritter C, 1996, PLANT CELL, V8, P251, DOI 10.1105/tpc.8.2.251; Romeis T, 1999, PLANT CELL, V11, P273, DOI 10.1105/tpc.11.2.273; Rossi M, 1998, P NATL ACAD SCI USA, V95, P9750, DOI 10.1073/pnas.95.17.9750; Ryals J, 1997, PLANT CELL, V9, P425, DOI 10.1105/tpc.9.3.425; Salmeron JM, 1996, CELL, V86, P123, DOI 10.1016/S0092-8674(00)80083-5; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Scheel D, 1998, CURR OPIN PLANT BIOL, V1, P305, DOI 10.1016/1369-5266(88)80051-7; Scofield SR, 1996, SCIENCE, V274, P2063, DOI 10.1126/science.274.5295.2063; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Swiderski MR, 2001, PLANT J, V26, P101, DOI 10.1046/j.1365-313x.2001.01014.x; Tang XY, 1996, SCIENCE, V274, P2060, DOI 10.1126/science.274.5295.2060; Trotochaud AE, 1999, PLANT CELL, V11, P393, DOI 10.1105/tpc.11.3.393; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Van der Hoorn RAL, 2001, PLANT CELL, V13, P273, DOI 10.1105/tpc.13.2.273; van der Vossen EAG, 2000, PLANT J, V23, P567, DOI 10.1046/j.1365-313x.2000.00814.x; Wang GL, 1998, PLANT CELL, V10, P765, DOI 10.1105/tpc.10.5.765; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Wulff BBH, 2001, PLANT CELL, V13, P255, DOI 10.1105/tpc.13.2.255; Xiao SY, 2001, SCIENCE, V291, P118, DOI 10.1126/science.291.5501.118; Yang YO, 1997, GENE DEV, V11, P1621, DOI 10.1101/gad.11.13.1621; Zhou FS, 2001, PLANT CELL, V13, P337, DOI 10.1105/tpc.13.2.337	110	2762	3025	35	1087	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 14	2001	411	6839					826	833		10.1038/35081161	http://dx.doi.org/10.1038/35081161			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459065				2022-12-28	WOS:000169246400059
J	Malajovich, I; Berry, JJ; Samarth, N; Awschalom, DD				Malajovich, I; Berry, JJ; Samarth, N; Awschalom, DD			Persistent sourcing of coherent spins for multifunctional semiconductor spintronics	NATURE			English	Article							INJECTION; AMPLIFICATION; INTERFACE	Recent studies of n-type semiconductors have demonstrated spin-coherent transport over macroscopic distances(1), with spin-coherence times exceeding 100 ns(2,3); such materials are therefore potentially useful building blocks for spin-polarized electronics ('spintronics'). Spin injection into a semiconductor (a necessary step for spin electronics(4)) has proved difficult(5,6); the only successful approach involves classical injection of spins from magnetic semiconductors(7,8). Other work has shown that optical excitation can provide a short (<500 ps) non-equilibrium burst of coherent spin transfer across a GaAs/ZnSe interface, but less than 10% of the total spin crosses into the ZnSe layer, leaving long-lived spins trapped in the GaAs layer (ref. 9). Here we report a 'persistent' spin-conduction mode in biased semiconductor heterostructures, in which the sourcing of coherent spin transfer lasts at least 1-2 orders of magnitude longer than in unbiased structures. We use time-resolved Kerr spectroscopy to distinguish several parallel channels of interlayer spin-coherent injection. The relative increase in spin-coherent injection is up to 500% in the biased structures, and up to 4,000% when p-n junctions are used to impose a built-in bias. These experiments reveal promising opportunities for multifunctional spin electronic devices (such as spin transistors that combine memory and logic functions), in which the amplitude and phase of the net spin current are controlled by either electrical or magnetic fields.	Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; Penn State Univ, Dept Phys, University Pk, PA 16802 USA	University of California System; University of California Santa Barbara; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Awschalom, DD (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.		Samarth, Nitin/C-4475-2014; Samarth, Nitin/AAV-2322-2020; Ma, Jun/D-8971-2011	Samarth, Nitin/0000-0003-2599-346X; Samarth, Nitin/0000-0003-2599-346X; berry, joseph/0000-0003-3874-3582				Fiederling R, 1999, NATURE, V402, P787, DOI 10.1038/45502; Filip AT, 2000, PHYS REV B, V62, P9996, DOI 10.1103/PhysRevB.62.9996; Kikkawa JM, 1999, NATURE, V397, P139, DOI 10.1038/16420; Kikkawa JM, 1997, SCIENCE, V277, P1284, DOI 10.1126/science.277.5330.1284; Kikkawa JM, 1998, PHYS REV LETT, V80, P4313, DOI 10.1103/PhysRevLett.80.4313; Malajovich I, 2000, PHYS REV LETT, V84, P1015, DOI 10.1103/PhysRevLett.84.1015; Malajovich I, 2000, J APPL PHYS, V87, P5073, DOI 10.1063/1.373252; Monzon FG, 1999, J MAGN MAGN MATER, V198-99, P632, DOI 10.1016/S0304-8853(98)01205-0; Ohno Y, 1999, NATURE, V402, P790, DOI 10.1038/45509; PRINZ GA, 1995, PHYS TODAY, V48, P58, DOI 10.1063/1.881459; Schull K, 1997, SEMICOND SCI TECH, V12, P485, DOI 10.1088/0268-1242/12/4/026; YEGANEH MS, 1992, PHYS REV LETT, V68, P3761, DOI 10.1103/PhysRevLett.68.3761	12	200	205	3	40	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					770	772		10.1038/35081014	http://dx.doi.org/10.1038/35081014			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459049				2022-12-28	WOS:000169246400040
J	Lee, C; Murray, MF; Miron, PM; Marsden, D; Irons, M; Wilkins-Haug, LE; Morton, CC				Lee, C; Murray, MF; Miron, PM; Marsden, D; Irons, M; Wilkins-Haug, LE; Morton, CC			Clinical picture: multicolour karyotyping	LANCET			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Lee, C (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.								0	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 21	2001	357	9264					1240	1240		10.1016/S0140-6736(00)04472-X	http://dx.doi.org/10.1016/S0140-6736(00)04472-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425YY	11458963	Bronze			2022-12-28	WOS:000168323300009
J	Abbott, A				Abbott, A			Hopes of biotech interest spur Latvian population genetics	NATURE			English	News Item																		Masood E, 1998, NATURE, V396, P395, DOI 10.1038/24667	1	2	2	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					468	468		10.1038/35087723	http://dx.doi.org/10.1038/35087723			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484011	Bronze			2022-12-28	WOS:000170202900008
J	Dubrovinsky, L; Annerstin, H; Dubrovinskaia, N; Westman, F; Harryson, H; Fabrichnaya, O; Carlson, S				Dubrovinsky, L; Annerstin, H; Dubrovinskaia, N; Westman, F; Harryson, H; Fabrichnaya, O; Carlson, S			Chemical interaction of Fe and Al2O3 as a source of heterogeneity at the Earth's core-mantle boundary	NATURE			English	Article							X-RAY-DIFFRACTION; HIGH-PRESSURE; LIQUID-IRON; INNER-CORE; PEROVSKITE; SPECTROSCOPY; MOSSBAUER; SILICATES	Seismological studies have revealed that a complex texture or heterogeneity exists in the Earth's inner core and at the boundary between core and mantle(1-4). These studies highlight the importance of understanding the properties of iron when modelling the composition and dynamics of the core and the interaction of the core with the lowermost mantle(5-7). One of the main problems in inferring the composition of the lowermost mantle is our lack of knowledge of the high-pressure and high-temperature chemical reactions that occur between iron and the complex Mg-Fe-Si-Al-oxides which are thought to form the bulk of the Earth's lower mantle. A number of studies(6,8-12) have demonstrated that iron can react with MgSiO3-perovskite at high pressures and high temperatures, and it was proposed(6,8) that the chemical nature of this process involves the reduction of silicon by the more electropositive iron. Here we present a study of the interaction between iron and corundum (Al2O3) in electrically- and laser-heated diamond anvil cells at 2,000-2,200 K and pressures up to 70 GPa, simulating conditions in the Earth's deep interior. We found that at pressures above 60 GPa and temperatures of 2,200 K, iron and corundum react to form iron oxide and an iron-aluminium alloy. Our results demonstrate that iron is able to reduce aluminium out of oxides at core-mantle boundary conditions, which could provide an additional source of light elements in the Earth's core and produce significant heterogeneity at the core-mantle boundary.	Uppsala Univ, Dept Earth Sci, S-75336 Uppsala, Sweden; Max Planck Inst Met Res, D-70569 Stuttgart, Germany; European Synchrotron Radiat Facil, F-38043 Grenoble, France	Uppsala University; Max Planck Society; European Synchrotron Radiation Facility (ESRF)	Dubrovinsky, L (corresponding author), Uppsala Univ, Dept Earth Sci, S-75336 Uppsala, Sweden.	Leonid.Dubrovinsky@geo.uu.se	Fabrichnaya, Olga B/N-1638-2015; Dubrovinskaia, Natalia/A-8013-2015	Fabrichnaya, Olga B/0000-0001-5750-3192; Dubrovinskaia, Natalia/0000-0002-8256-5675; Dubrovinsky, Leonid/0000-0002-3717-7585				ALLEGRE CJ, 1995, EARTH PLANET SC LETT, V134, P515, DOI 10.1016/0012-821X(95)00123-T; ANDERSON DL, 1989, THEORY EARTH; Breger L, 2000, GEOPHYS RES LETT, V27, P2781, DOI 10.1029/1999GL008467; CARNERO EJ, 2000, GEOPHYS RES LETT, V27, P2777; Dubrovinskaia NA, 1999, CALPHAD, V23, P69, DOI 10.1016/S0364-5916(99)00014-0; Dubrovinsky LS, 2000, SCIENCE, V289, P430, DOI 10.1126/science.289.5478.430; Dubrovinsky LS, 1998, PHYS CHEM MINER, V25, P434, DOI 10.1007/s002690050133; Dubrovinsky LS, 1999, HIGH TEMP-HIGH PRESS, V31, P393, DOI 10.1068/htrt146; DUBROVINSKY LS, 1998, SCIENCE, V281, P11; El Goresy A, 2000, SCIENCE, V288, P1632, DOI 10.1126/science.288.5471.1632; Fabrichnaya OB, 1997, GEOCHIM COSMOCHIM AC, V61, P4539, DOI 10.1016/S0016-7037(97)00256-1; GOARANT F, 1992, J GEOPHYS RES-SOL EA, V97, P4477, DOI 10.1029/92JB00018; HILLGREN VJ, 1994, SCIENCE, V264, P1442, DOI 10.1126/science.264.5164.1442; KNITTLE E, 1991, SCIENCE, V251, P1438, DOI 10.1126/science.251.5000.1438; KNITTLE E, 1989, GEOPHYS RES LETT, V16, P609, DOI 10.1029/GL016i007p00609; Lauterbach S, 2000, CONTRIB MINERAL PETR, V138, P17, DOI 10.1007/PL00007658; Li J, 1996, NATURE, V381, P686, DOI 10.1038/381686a0; MALAVERGNE V, 1996, THESIS U PARIS 7; MAO HK, 1987, HIGH PRESSURE RES MI, P135; McCammon C, 1997, NATURE, V387, P694, DOI 10.1038/42685; Pasternak MP, 1997, PHYS REV LETT, V79, P5046, DOI 10.1103/PhysRevLett.79.5046; Poirier JP, 1998, GEODYNAMICS, V28, P131; RUFF L, 1980, PHYS EARTH PLANET IN, V21, P181, DOI 10.1016/0031-9201(80)90069-2; SONG X, 1994, GEOPHYS RES LETT, V21, P153, DOI 10.1029/93GL03262; Stixrude L, 1998, REV MINERAL, V37, P261; Tschauner O, 1999, NATURE, V398, P604, DOI 10.1038/19287; Vidale JE, 2000, NATURE, V405, P445, DOI 10.1038/35013039; Vidale JE, 2000, NATURE, V404, P273, DOI 10.1038/35005059; YOO CS, 1995, SCIENCE, V270, P1473, DOI 10.1126/science.270.5241.1473	29	26	28	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2001	412	6846					527	529		10.1038/35087559	http://dx.doi.org/10.1038/35087559			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484050				2022-12-28	WOS:000170202900042
J	Howlett, R				Howlett, R			Population ecology - Birds in a buffer state	NATURE			English	Editorial Material																		Gill JA, 2001, NATURE, V412, P436, DOI 10.1038/35086568	1	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					396	396		10.1038/35086691	http://dx.doi.org/10.1038/35086691			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473300	Bronze			2022-12-28	WOS:000170068200031
J	Mustard, JF; Cooper, CD; Rifkin, MK				Mustard, JF; Cooper, CD; Rifkin, MK			Evidence for recent climate change on Mars from the identification of youthful near-surface ground ice	NATURE			English	Article							GLOBAL SURVEYOR; ORBITER CAMERA; WATER; BEHAVIOR; MODEL; VIEWS	Ground ice in the crust and soil may be one of the largest reservoirs of water on Mars(1-3). Near-surface ground ice is predicted to be stable at latitudes higher than 40 degrees (ref. 4), where a number of geomorphologic features indicative of viscous creep and hence ground ice have been observed(5). Mid-latitude soils have also been implicated as a water-ice reservoir(6), the capacity of which is predicted to vary on a 100,000-year timescale owing to orbitally driven variations in climate(7). It is uncertain, however, whether near-surface ground ice currently exists at these latitudes, and how it is changing with time. Here we report observational evidence for a mid-latitude reservoir of near-surface water ice occupying the pore space of soils. The thickness of the ice-occupied soil reservoir (1-10 m) and its distribution in the 30 degrees to 60 degrees latitude bands indicate a reservoir of (1.5-6.0) x 10(4) km(3), equivalent to a global layer of water 10-40 cm thick. We infer that the reservoir was created during the last phase of high orbital obliquity less than 100,000 years ago, and is now being diminished.	Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	Brown University	Mustard, JF (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.							Carr M.H, 1996, WATER MARS; Christensen, 1992, MARS, P686; CLIFFORD SM, 1993, J GEOPHYS RES-PLANET, V98, P10973, DOI 10.1029/93JE00225; COOPER CD, 2000, LUNAR PLANET SCI, V31, P1747; Edgett KS, 2000, J GEOPHYS RES-PLANET, V105, P1623, DOI 10.1029/1999JE001152; FANALE FP, 1986, ICARUS, V67, P1, DOI 10.1016/0019-1035(86)90170-3; Haberle RM, 1997, J GEOPHYS RES-PLANET, V102, P9051, DOI 10.1029/97JE00383; Herkenhoff KE, 2000, ICARUS, V144, P243, DOI 10.1006/icar.1999.6287; Houben H, 1997, J GEOPHYS RES-PLANET, V102, P9069, DOI 10.1029/97JE00046; Johnson JB, 2000, GEOPHYS RES LETT, V27, P2769, DOI 10.1029/1999GL011077; Kreslavsky MA, 2000, J GEOPHYS RES-PLANET, V105, P26695, DOI 10.1029/2000JE001259; Malin MC, 1998, SCIENCE, V279, P1681, DOI 10.1126/science.279.5357.1681; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; Metzger SM, 1999, GEOPHYS RES LETT, V26, P2781, DOI 10.1029/1999GL008341; MUSTARD JF, 2001, LUNAR PLANET SCI, V32, P1988; Renno NO, 2000, J GEOPHYS RES-PLANET, V105, P1859, DOI 10.1029/1999JE001037; Seibert NM, 2001, GEOPHYS RES LETT, V28, P899, DOI 10.1029/2000GL012093; SQURYES SW, 1986, SCIENCE, V231, P249; SQUYRES SW, 1989, ICARUS, V79, P229, DOI 10.1016/0019-1035(89)90078-X; STORRS AD, 1988, ICARUS, V76, P493, DOI 10.1016/0019-1035(88)90017-6	20	425	429	0	37	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					411	414		10.1038/35086515	http://dx.doi.org/10.1038/35086515			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473309				2022-12-28	WOS:000170068200039
J	Oieroset, M; Phan, TD; Fujimoto, M; Lin, RP; Lepping, RP				Oieroset, M; Phan, TD; Fujimoto, M; Lin, RP; Lepping, RP			In situ detection of collisionless reconnection in the Earth's magnetotail	NATURE			English	Article							MAGNETIC-FIELD RECONNECTION; GEOTAIL OBSERVATIONS; MAGNETOPAUSE; PLASMA; MAGNETOSPHERE; SIMULATION; FLOWS	Magnetic reconnection is the process by which magnetic field lines of opposite polarity reconfigure to a lower-energy state, with the release of magnetic energy to the surroundings. Reconnection at the Earth's dayside magnetopause and in the magnetotail allows the solar wind into the magnetosphere(1,2). It begins in a small `diffusion region', where a kink in the newly reconnected lines produces jets of plasma away from the region. Although plasma jets from reconnection have previously been reported(3-7), the physical processes that underlie jet formation have remained poorly understood because of the scarcity of in situ observations of the minuscule diffusion region. Theoretically, both resistive and collisionless processes can initiate reconnection(8-14), but which process dominates in the magnetosphere is still debated. Here we report the serendipitous encounter of the Wind spacecraft with an active reconnection diffusion region, in which are detected key processes predicted by models(8-13) of collisionless reconnection. The data therefore demonstrate that collisionless reconnection occurs in the magnetotail.	Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 152, Japan; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	University of California System; University of California Berkeley; Tokyo Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Oieroset, M (corresponding author), Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA.							Birn J, 2001, J GEOPHYS RES-SPACE, V106, P3715, DOI 10.1029/1999JA900449; CATTELL C, 1995, J GEOPHYS RES-SPACE, V100, P11823, DOI 10.1029/94JA03146; CORONITI FV, 1977, ASTROPHYS J SUPPL S, V33, P189, DOI 10.1086/190423; Cowley S. W. H., 1984, GEOPHYS MONOGR SER, V30, P375, DOI DOI 10.1029/GM030P0375; Deng XH, 2001, NATURE, V410, P557, DOI 10.1038/35069018; DUNGEY JW, 1961, PHYS REV LETT, V6, P47, DOI 10.1103/PhysRevLett.6.47; Fujimoto M, 1997, GEOPHYS RES LETT, V24, P2893, DOI 10.1029/97GL02821; Gombosi T.I., 1998, PHYS SPACE PLASMAS, V15, P121; Goodrich CC, 1998, GEOPHYS RES LETT, V25, P2537, DOI 10.1029/98GL01159; GOSLING JT, 1986, J GEOPHYS RES, V91, P3029, DOI 10.1029/JA091iA03p03029; Hesse M, 2001, J GEOPHYS RES-SPACE, V106, P3721, DOI 10.1029/1999JA001002; Hoshino M, 1998, J GEOPHYS RES-SPACE, V103, P4509, DOI 10.1029/97JA01785; Ma ZW, 2001, J GEOPHYS RES-SPACE, V106, P3773, DOI 10.1029/1999JA001004; NAGAI T, IN PRESS J GEOPHYS R; Oieroset M, 2000, J GEOPHYS RES-SPACE, V105, P25247, DOI 10.1029/2000JA900075; PASCHMANN G, 1979, NATURE, V282, P243, DOI 10.1038/282243a0; Phan TD, 2000, NATURE, V404, P848, DOI 10.1038/35009050; Pritchett PL, 2001, J GEOPHYS RES-SPACE, V106, P3783, DOI 10.1029/1999JA001006; Raeder J, 1999, J GEOPHYS RES-SPACE, V104, P17357, DOI 10.1029/1999JA900159; Shay MA, 1999, GEOPHYS RES LETT, V26, P2163, DOI 10.1029/1999GL900481; Shay MA, 2001, J GEOPHYS RES-SPACE, V106, P3759, DOI 10.1029/1999JA001007; Sibeck DG, 1999, SPACE SCI REV, V88, P207, DOI 10.1023/A:1005255801425; Sonnerup B. U. O., 1979, SOLAR SYSTEM PLASMA, P45; SONNERUP BU, 1967, J GEOPHYS RES, V72, P171, DOI 10.1029/JZ072i001p00171; SONNERUP BUO, 1981, J GEOPHYS RES-SPACE, V86, P49, DOI 10.1029/JA086iA12p10049; TERASAWA T, 1983, GEOPHYS RES LETT, V10, P475, DOI 10.1029/GL010i006p00475; VASYLIUNAS VM, 1975, REV GEOPHYS, V13, P303, DOI 10.1029/RG013i001p00303; Wang XG, 2000, J GEOPHYS RES-SPACE, V105, P27633, DOI 10.1029/1999JA000357	28	407	422	2	43	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					414	417		10.1038/35086520	http://dx.doi.org/10.1038/35086520			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473310				2022-12-28	WOS:000170068200040
J	Folkers, GK; Fauci, AS				Folkers, GK; Fauci, AS			The AIDS research model - Implications for other infectious diseases of global health importance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHALLENGES; PREVENTION; HIV/AIDS		NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, NIH, Bldg 31,Room 7A03,31 Ctr Dr,MSC 2520, Bethesda, MD 20892 USA.	afauci@nih.gov						[Anonymous], WHO REP INF DIS REM; [Anonymous], 2001, NIAID GLOB HLTH RES; Auerbach JD, 2000, AM J PUBLIC HEALTH, V90, P1029, DOI 10.2105/AJPH.90.7.1029; Binswanger HP, 2001, SCIENCE, V292, P221, DOI 10.1126/science.1057504; *CDCP, 1981, MMWR-MORBID MORTAL W, V30, P250; FAUCI AS, 1993, SCIENCE, V262, P1011, DOI 10.1126/science.8235617; Fauci AS, 1998, EMERG INFECT DIS, V4, P374, DOI 10.3201/eid0403.980308; GALLO RC, 1987, NATURE, V326, P435; Gellman Barton, 2000, WASH POST, pA01; GREENE WC, 1991, NEW ENGL J MED, V324, P308, DOI 10.1056/NEJM199101313240506; *I GLOB HLTH, 2000, GLOB HLTH FOR, V1; Institute of Medicine, 1997, AM VIT INT GLOB HLTH; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LAWRENCE C, 2001, HLTH FUNDING UPDATE; Mofenson LM, 2000, LANCET, V355, P2237, DOI 10.1016/S0140-6736(00)02415-6; Nabel GJ, 2001, NATURE, V410, P1002, DOI 10.1038/35073500; National Intelligence Council, 2000, GLOB INF DIS THREAT; Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639; SARNGADHARAN MG, 1984, SCIENCE, V224, P506, DOI 10.1126/science.6324345; SELIK RM, 1993, TRANSFUSION, V33, P890, DOI 10.1046/j.1537-2995.1993.331194082377.x; Shorter E, 1987, HLTH CENTURY; *UN GEN ASS SPEC S, 2001, GLOB CRIS GLOB ACT; *UNAIDS, 2000, REP GLOB HIV AIDS EP; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WACHTER RM, 1992, NEW ENGL J MED, V326, P128, DOI 10.1056/NEJM199201093260209; World Health Organization, 2000, WORLD HLTH REP 2000; 1998, MMWR MORB MORTAL WKL, V47, P43; 2000, HIV AIDS SURVEILLANC, V12, P1	28	15	15	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2001	286	4					458	461		10.1001/jama.286.4.458	http://dx.doi.org/10.1001/jama.286.4.458			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456DZ	11466126				2022-12-28	WOS:000170069000019
J	Sheikh, S; Williamson, K; Kearley, K; Bassindale, S; Lancaster, T				Sheikh, S; Williamson, K; Kearley, K; Bassindale, S; Lancaster, T			Lesson of the week - Danger of stereotyping in suspected osteomalacia	BRITISH MEDICAL JOURNAL			English	Review							RICKETS; ASIANS; MODEL; RISK		Inst Hlth Sci, Dept Primary Hlth Care, Oxford OX3 7LF, England; Jericho Hlth Ctr, Oxford OX2 6NW, England; Med Sch Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England	University of Oxford; University of Birmingham	Lancaster, T (corresponding author), Inst Hlth Sci, Dept Primary Hlth Care, Oxford OX3 7LF, England.							Awumey EMK, 1998, J CLIN ENDOCR METAB, V83, P169, DOI 10.1210/jc.83.1.169; Dunnigan MG, 1997, P NUTR SOC, V56, P939, DOI 10.1079/PNS19970100; FINCH PJ, 1992, Q J MED, V83, P439; FORD JA, 1972, BRIT MED J, V3, P446, DOI 10.1136/bmj.3.5824.446; FORD JA, 1972, BMJ-BRIT MED J, V2, P677, DOI 10.1136/bmj.2.5815.677; HENDERSON JB, 1990, Q J MED, V76, P923; MCKIBBON A, 1999, PDQ EVIDENCE BASED P, P95; NISBET JA, 1990, CLIN SCI, V78, P383, DOI 10.1042/cs0780383; SOLANKI T, 1995, AGE AGEING, V24, P103, DOI 10.1093/ageing/24.2.103	9	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2001	323	7305					149	151		10.1136/bmj.323.7305.149	http://dx.doi.org/10.1136/bmj.323.7305.149			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456WR	11463688	Green Published			2022-12-28	WOS:000170106200021
J	Saitoe, M; Schwarz, TL; Umbach, JA; Gundersen, CB; Kidokoro, Y				Saitoe, M; Schwarz, TL; Umbach, JA; Gundersen, CB; Kidokoro, Y			Absence of junctional glutamate receptor clusters in Drosophila mutants lacking spontaneous transmitter release	SCIENCE			English	Article							NEUROMUSCULAR-JUNCTION; NEURONAL-SYNAPTOBREVIN; EMBRYOS; SYNAPSE; NEUROTRANSMITTER; MELANOGASTER; MUTATIONS; SYNTAXIN; LARVAE; CSP	Little is known about the functional significance of spontaneous miniature synaptic potentials, which are the result of vesicular exocytosis at nerve terminals. Here, by using Drosophila mutants with specific defects in presynaptic function, we found that glutamate receptors clustered normally at neuromuscular junctions of mutants that retained spontaneous transmitter secretion but had Lost the ability to release transmitter in response to action potential. In contrast, receptor clustering was defective in mutants in which both spontaneous and evoked vesicle exocytosis were absent. Thus, spontaneous vesicle exocytosis appears to be tightly Linked to the clustering of glutamate receptors during development.	Gunma Univ, Sch Med, Inst Behav Sci, Gunma 3718511, Japan; Tokyo Metropolitan Inst Neurosci, Tokyo 1838526, Japan; Stanford Univ, Med Ctr, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Gunma University; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Saitoe, M (corresponding author), Gunma Univ, Sch Med, Inst Behav Sci, Gunma 3718511, Japan.			Gundersen, Cameron/0000-0002-1552-6086; Saitoe, Minoru/0000-0001-9731-4214				ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P757, DOI 10.1113/jphysiol.1977.sp011880; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; BROADIE K, 1993, NEURON, V11, P607, DOI 10.1016/0896-6273(93)90073-Z; BROADIE K, 1993, NATURE, V361, P350, DOI 10.1038/361350a0; BROADIE KS, 1993, J NEUROSCI, V13, P144; Burgess RW, 1997, J CELL BIOL, V138, P861, DOI 10.1083/jcb.138.4.861; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Deitcher DL, 1998, J NEUROSCI, V18, P2028; DIANTONIO A, 1993, J NEUROSCI, V13, P4924; DiAntonio A, 1999, J NEUROSCI, V19, P3023; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; KIDOKORO Y, 1994, NEUROSCI RES, V19, P143, DOI 10.1016/0168-0102(94)90137-6; KOENIG JH, 1983, J CELL BIOL, V96, P1517, DOI 10.1083/jcb.96.6.1517; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; MORR J, COMMUNICATION; Nishikawa K, 1995, J NEUROSCI, V15, P7905; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; PESTRONK A, 1976, NATURE, V264, P787, DOI 10.1038/264787a0; Saitoe M, 1997, DEV BIOL, V184, P48, DOI 10.1006/dbio.1996.8480; Schulze KL, 1996, GENETICS, V144, P1713; Umbach JA, 1998, J NEUROSCI, V18, P3233; UMBACH JA, 1994, NEURON, V13, P899, DOI 10.1016/0896-6273(94)90255-0; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Yoshihara M, 1999, J NEUROSCI, V19, P2432	25	94	96	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2001	293	5529					514	517		10.1126/science.1061270	http://dx.doi.org/10.1126/science.1061270			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463917				2022-12-28	WOS:000169966700052
J	Turk, D; McPhaden, MJ; Busalacchi, AJ; Lewis, MR				Turk, D; McPhaden, MJ; Busalacchi, AJ; Lewis, MR			Remotely sensed biological production in the equatorial Pacific	SCIENCE			English	Article							1997-98 EL-NINO; ATMOSPHERIC CO2; OCEAN; CARBON; EXPORT; MODEL; CYCLE	A combination of ship, buoy, and satellite observations in the tropical Pacific during the period from 1992 to 2000 provides a basin-scale perspective on the net effects of El Nino and La Nina on biogeochemical cycles. New biological production during the 1997-99 El Nino/La Nina period varied by more than a factor of 2, The resulting interannual changes in global carbon sequestration associated with the El Nino/La Nina cycle contributed to the Largest known natural perturbation of the global carbon cycle over these time scales.	Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 4J1, Canada; NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA	Dalhousie University; National Oceanic Atmospheric Admin (NOAA) - USA; University System of Maryland; University of Maryland College Park	Turk, D (corresponding author), Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 4J1, Canada.		McPhaden, Michael J/D-9799-2016	McPhaden, Michael J/0000-0002-8423-5805				BARBER RT, 1983, SCIENCE, V222, P1203, DOI 10.1126/science.222.4629.1203; BARBER RT, 1989, GLOBAL ECOLOGICAL CO, P21; BATTISTI DS, 1988, J ATMOS SCI, V45, P2889, DOI 10.1175/1520-0469(1988)045<2889:DATOAW>2.0.CO;2; Behrenfeld MJ, 2001, SCIENCE, V291, P2594, DOI 10.1126/science.1055071; Chavez FP, 1999, SCIENCE, V286, P2126, DOI 10.1126/science.286.5447.2126; CHAVEZ FP, 1987, DEEP-SEA RES, V34, P1229, DOI 10.1016/0198-0149(87)90073-2; Cullen JJ, 1995, LIMNOL OCEANOGR, V40, P1336, DOI 10.4319/lo.1995.40.7.1336; Dugdale RC, 1998, NATURE, V391, P270, DOI 10.1038/34630; EPPLEY RW, 1979, NATURE, V282, P677, DOI 10.1038/282677a0; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Feely RA, 1999, NATURE, V398, P597, DOI 10.1038/19273; Hackert EC, 2001, J GEOPHYS RES-OCEANS, V106, P2345, DOI 10.1029/1999JC000055; Leonard CL, 1996, INT J REMOTE SENS, V17, P721, DOI 10.1080/01431169608949040; McCarthy JJ, 1996, DEEP-SEA RES PT II, V43, P1065, DOI 10.1016/0967-0645(96)00022-7; McPhaden MJ, 1998, J GEOPHYS RES-OCEANS, V103, P14169, DOI 10.1029/97JC02906; McPhaden MJ, 1999, SCIENCE, V283, P950, DOI 10.1126/science.283.5404.950; Meinen CS, 2001, J PHYS OCEANOGR, V31, P1324, DOI 10.1175/1520-0485(2001)031<1324:IVIWWV>2.0.CO;2; MURRAY JW, 1989, DEEP-SEA RES, V36, P1471, DOI 10.1016/0198-0149(89)90052-6; MURRAY JW, 1994, SCIENCE, V266, P58, DOI 10.1126/science.266.5182.58; Murtugudde RG, 1999, J GEOPHYS RES-OCEANS, V104, P18351, DOI 10.1029/1999JC900135; PENA MA, 1992, MAR ECOL PROG SER, V80, P265, DOI 10.3354/meps080265; PICAUT J, IN PRESS RADAR ALTIM; Raimbault P, 1999, J GEOPHYS RES-OCEANS, V104, P3341, DOI 10.1029/1998JC900004; Rayner PJ, 1999, TELLUS B, V51, P213, DOI 10.1034/j.1600-0889.1999.t01-1-00008.x; Rodier M, 1997, DEEP-SEA RES PT II, V44, P2085, DOI 10.1016/S0967-0645(97)00092-1; SCHOPF PS, 1988, J ATMOS SCI, V45, P549, DOI 10.1175/1520-0469(1988)045<0549:VIACOM>2.0.CO;2; Siegel DA, 1999, J GEOPHYS RES-OCEANS, V104, P13359, DOI 10.1029/1999JC900051; Turk D, 2001, J GEOPHYS RES-OCEANS, V106, P4501, DOI 10.1029/1999JC000058; Uz BM, 2001, NATURE, V409, P597, DOI 10.1038/35054527; WHEELER P, UNPUB JOINT GLOBAL O; WILKERSON FP, 1992, J GEOPHYS RES-OCEANS, V97, P669, DOI 10.1029/91JC01534	31	58	73	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2001	293	5529					471	474		10.1126/science.1056449	http://dx.doi.org/10.1126/science.1056449			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463910				2022-12-28	WOS:000169966700041
J	Young, WR; Roberts, AJ; Stuhne, G				Young, WR; Roberts, AJ; Stuhne, G			Reproductive pair correlations and the clustering of organisms	NATURE			English	Article							PLANKTON PATCHINESS; INDIVIDUALS	Clustering of organisms can be a consequence of social behaviour, or of the response of individuals to chemical and physical cues(1). Environmental variability can also cause clustering: for example, marine turbulence transports plankton(2-8) and produces chlorophyll concentration patterns in the upper ocean(9-11). Even in a homogeneous environment, nonlinear interactions between species(12-14) can result in spontaneous pattern formation. Here we show that a population of independent, random-walking organisms ('brownian bugs'), reproducing by binary division and dying at constant rates, spontaneously aggregates. Using an individual-based model, we show that clusters form out of spatially homogeneous initial conditions without environmental variability, predator-prey interactions, kinesis or taxis. The clustering mechanism is reproductively driven-birth must always be adjacent to a living organism. This clustering can overwhelm diffusion and create non-poissonian correlations between pairs (parent and offspring) or organisms, leading to the emergence of patterns.	Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Univ So Queensland, Dept Math & Comp, Toowoomba, Qld 4352, Australia	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Southern Queensland	Young, WR (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.		Young, William R/B-1632-2009	Roberts, Anthony/0000-0001-8930-1552				Abraham ER, 2000, NATURE, V407, P727, DOI 10.1038/35037555; Abraham ER, 1998, NATURE, V391, P577, DOI 10.1038/35361; BATCHELOR GK, 1952, PROC R SOC LON SER-A, V213, P349, DOI 10.1098/rspa.1952.0130; BATCHELOR GK, 1959, J FLUID MECH, V5, P113, DOI 10.1017/S002211205900009X; DENMAN K, 1977, LIMNOL OCEANOGR, V22, P1033, DOI 10.4319/lo.1977.22.6.1033; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Flierl G, 1999, J THEOR BIOL, V196, P397, DOI 10.1006/jtbi.1998.0842; Franks PJS, 1997, LIMNOL OCEANOGR, V42, P1297, DOI 10.4319/lo.1997.42.5_part_2.1297; GOWER JFR, 1980, NATURE, V288, P157, DOI 10.1038/288157a0; HARRIS TE, 1963, THEORY BRANCHING PRO, pCH1; Keeling MJ, 1997, PHILOS T ROY SOC B, V352, P1589, DOI 10.1098/rstb.1997.0143; KIERSTEAD H, 1953, J MAR RES, V12, P141; Kraichnan R. H., 1974, Journal of Fluid Mechanics, V64, P737, DOI 10.1017/S0022112074001881; Legall JF, 1999, LECT MATH; LESIEUR M, 1980, NATURE, V294, P673; LEVIN SA, 1976, NATURE, V259, P659, DOI 10.1038/259659a0; Neufeld Z, 1999, PHYS REV LETT, V82, P2606, DOI 10.1103/PhysRevLett.82.2606; Pascual M, 1999, ECOLOGY, V80, P2225, DOI 10.1890/0012-9658(1999)080[2225:FITPDS]2.0.CO;2; PIERREHUMBERT RT, 1994, CHAOS SOLITON FRACT, V4, P1091, DOI 10.1016/0960-0779(94)90139-2; PIERREHUMBERT RT, 1991, NONLINEAR PHENOMENA; RAND DA, 1995, P ROY SOC B-BIOL SCI, V259, P55, DOI 10.1098/rspb.1995.0009; Robinson AR, 1997, P ROY SOC A-MATH PHY, V453, P2295, DOI 10.1098/rspa.1997.0123; SEGEL LA, 1972, J THEOR BIOL, V37, P545, DOI 10.1016/0022-5193(72)90090-2; SKELLAM JG, 1951, BIOMETRIKA, V38, P196, DOI 10.2307/2332328; STEELE JH, 1992, J PLANKTON RES, V14, P1397, DOI 10.1093/plankt/14.10.1397; van Kampen N. G., 1981, STOCHASTIC PROCESSES	26	152	153	0	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					328	331		10.1038/35085561	http://dx.doi.org/10.1038/35085561			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460162	Green Accepted			2022-12-28	WOS:000169918200045
J	Haass, C; Kahle, PJ				Haass, C; Kahle, PJ			Neuroscience - Parkin and its substrates	SCIENCE			English	Editorial Material							UBIQUITIN-PROTEIN LIGASE; ALPHA-SYNUCLEIN; JUVENILE PARKINSONISM; DISEASE; GENE; MUTATIONS		Univ Munich, Dept Biochem, Lab Alzheimers & Parkinsons Dis Res, D-80336 Munich, Germany	University of Munich	Haass, C (corresponding author), Univ Munich, Dept Biochem, Lab Alzheimers & Parkinsons Dis Res, D-80336 Munich, Germany.							Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Kahle PJ, 2000, TRENDS BIOCHEM SCI, V25, P524, DOI 10.1016/S0968-0004(00)01682-0; Kahle PJ, 2000, ANN NY ACAD SCI, V920, P33; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Steiner H, 2000, NAT REV MOL CELL BIO, V1, P217, DOI 10.1038/35043065; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	15	17	18	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					224	225		10.1126/science.1063286	http://dx.doi.org/10.1126/science.1063286			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452103				2022-12-28	WOS:000169875200033
J	Rose, EF; Shimizu, N; Layne, GD; Grove, TL				Rose, EF; Shimizu, N; Layne, GD; Grove, TL			Melt production beneath Mt. Shasta from boron data in primitive melt inclusions	SCIENCE			English	Article							ISOTOPIC COMPOSITION; METAMORPHIC ROCKS; ION MICROPROBE; OCEANIC-CRUST; ARC LAVAS; MANTLE; SYSTEMATICS; BASALTS; TEMPERATURE; COMPONENT	Most are magmas are thought to be generated by partial melting of the mantle wedge induced by infiltration of slab-derived fluids. However, partial melting of subducting oceanic crust has also been proposed to contribute to the melt generation process, especially when young and hot Lithosphere is being subducted. The isotopic composition of boron measured in situ in olivine-hosted primitive melt inclusions in a basaltic andesite from Mt. Shasta, California, is characterized by large negative values that are also highly variable (delta B-11 = = -21.3 to -0.9 per mil). The boron concentrations, from 0.7 to 1.6 parts per million, are Lower than in most other are Lavas. The relation between concentration and isotopic composition of boron observed here supports a hypothesis that materials Left after dehydration of the subducting slab may have contributed to the generation of basaltic andesite Lavas at Mt. Shasta.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution	Rose, EF (corresponding author), Okayama Univ Misasa, Inst Study Earths Interior PML, Tottori 6820193, Japan.		Rose-Koga, Estelle F./H-5372-2018; Facility, NENIMF/B-8811-2015; Rose-Koga, Estelle/AAM-5589-2021; Grove, Timothy/M-9638-2013	Rose-Koga, Estelle F./0000-0001-9704-5819; Rose-Koga, Estelle/0000-0001-9704-5819; Grove, Timothy/0000-0003-0628-1969				BAKER MB, 1994, CONTRIB MINERAL PETR, V118, P111, DOI 10.1007/BF01052863; BEBOUT GE, 1993, GEOCHIM COSMOCHIM AC, V57, P2227, DOI 10.1016/0016-7037(93)90565-E; CHAUSSIDON M, 1995, SCIENCE, V269, P383, DOI 10.1126/science.269.5222.383; CHAUSSIDON M, 1994, EARTH PLANET SC LETT, V121, P277, DOI 10.1016/0012-821X(94)90073-6; Chaussidon M, 1997, GEOSTANDARD NEWSLETT, V21, P7, DOI 10.1111/j.1751-908X.1997.tb00527.x; CHAUSSIDON M, 1993, GEOCHIM COSMOCHIM AC, V57, P5053, DOI 10.1016/0016-7037(93)90607-X; CHAUSSIDON M, 1992, EARTH PLANET SC LETT, V108, P229, DOI 10.1016/0012-821X(92)90025-Q; CHRISTIANSEN RL, 1977, 01961497 US GEOL SUR; DEFANT MJ, 1990, NATURE, V347, P662, DOI 10.1038/347662a0; GROVE TL, IN PRESS CONTRIB MIN; Hyndman RD, 1995, CAN J EARTH SCI, V32, P1611, DOI 10.1139/e95-129; Ishikawa T, 1997, EARTH PLANET SC LETT, V152, P123, DOI 10.1016/S0012-821X(97)00144-1; ISHIKAWA T, 1994, NATURE, V370, P205, DOI 10.1038/370205a0; LEEMAN WP, 1990, J GEOPHYS RES-SOLID, V95, P19561, DOI 10.1029/JB095iB12p19561; MORAN AE, 1992, EARTH PLANET SC LETT, V111, P331, DOI 10.1016/0012-821X(92)90188-2; NAKANO T, IN PRESS PHYS EARTH; PALMER MR, 1991, GEOLOGY, V19, P215, DOI 10.1130/0091-7613(1991)019<0215:BISOHA>2.3.CO;2; Palmer MR, 1996, GEOPHYS RES LETT, V23, P3479, DOI 10.1029/96GL02079; PALMER MR, 1987, GEOCHIM COSMOCHIM AC, V51, P2319, DOI 10.1016/0016-7037(87)90285-7; Peacock SM, 1999, CHEM GEOL, V160, P281, DOI 10.1016/S0009-2541(99)00103-5; RYAN JG, 1993, GEOCHIM COSMOCHIM AC, V57, P1489, DOI 10.1016/0016-7037(93)90008-K; SHIMIZU N, 1982, ANNU REV EARTH PL SC, V10, P483, DOI 10.1146/annurev.ea.10.050182.002411; SHIMIZU N, 1998, AGU FALL M AM GEOPH; Smith HJ, 1997, EARTH PLANET SC LETT, V146, P303, DOI 10.1016/S0012-821X(96)00209-9; SPIVACK AJ, 1987, GEOCHIM COSMOCHIM AC, V51, P1033, DOI 10.1016/0016-7037(87)90198-0; STOLPER E, 1994, EARTH PLANET SC LETT, V121, P293, DOI 10.1016/0012-821X(94)90074-4; TRUSCOTT MG, 1986, B GEOL SOC FINLAND, V58, P169; You CF, 1996, MAR GEOL, V129, P351, DOI 10.1016/0025-3227(96)83353-6	28	61	67	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					281	283		10.1126/science.1059663	http://dx.doi.org/10.1126/science.1059663			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452119				2022-12-28	WOS:000169875200053
J	Schiermeier, Q				Schiermeier, Q			Imported stem cells deepen Germany's ethical divide	NATURE			English	News Item																			0	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					4	4		10.1038/35083712	http://dx.doi.org/10.1038/35083712			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452264	Bronze			2022-12-28	WOS:000169644900004
J	Macilwain, C				Macilwain, C			Meeting hints at thaw in relations between genome rivals	NATURE			English	News Item																		Macilwain C, 2000, NATURE, V405, P983, DOI 10.1038/35016696	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					726	726		10.1038/35081251	http://dx.doi.org/10.1038/35081251			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11460096	Bronze			2022-12-28	WOS:000169246400005
J	Zhu, H; Bilgin, M; Bangham, R; Hall, D; Casamayor, A; Bertone, P; Lan, N; Jansen, R; Bidlingmaier, S; Houfek, T; Mitchell, T; Miller, P; Dean, RA; Gerstein, M; Snyder, M				Zhu, H; Bilgin, M; Bangham, R; Hall, D; Casamayor, A; Bertone, P; Lan, N; Jansen, R; Bidlingmaier, S; Houfek, T; Mitchell, T; Miller, P; Dean, RA; Gerstein, M; Snyder, M			Global analysis of protein activities using proteome chips	SCIENCE			English	Article							ASH1 MESSENGER-RNA; ARP2/3 COMPLEX; BUDDING YEAST; KINASES; CALMODULIN; SUBUNIT; GENOME; MOTOR	To facilitate studies of the yeast proteome, we cloned 5800 open reading frames and overexpressed and purified their corresponding proteins. The proteins were printed onto slides at high spatial density to form a yeast proteome microarray and screened for their ability to interact with proteins and phospholipids. We identified many new calmodulin- and phospholipid-interacting proteins; a common potential binding motif was identified for many of the calmodulin-binding proteins. Thus, microarrays of an entire eukaryotic proteome can be prepared and screened for diverse biochemical activities. The microarrays can also be used to screen protein-drug interactions and to detect posttranslational modifications.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; N Carolina State Univ, Fungal Genom Lab, Raleigh, NC 27695 USA; Yale Univ, Dept Anesthesiol, New Haven, CT 06520 USA	Yale University; Yale University; University of North Carolina; North Carolina State University; Yale University	Snyder, M (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	michael.snyder@yale.edu	Casamayor, Antonio/A-3190-2012; Bertone, Paul/A-6600-2013; Bertone, Paul/Z-3734-2019; Casamayor, Antonio/C-2509-2017	Casamayor, Antonio/0000-0003-2788-7329; Bertone, Paul/0000-0001-5059-4829; Bertone, Paul/0000-0001-5059-4829; Snyder, Michael/0000-0003-0784-7987				Ansari K, 1999, J BIOL CHEM, V274, P30052, DOI 10.1074/jbc.274.42.30052; Arenkov P, 2000, ANAL BIOCHEM, V278, P123, DOI 10.1006/abio.1999.4363; Arnold I, 1999, J BIOL CHEM, V274, P36, DOI 10.1074/jbc.274.1.36; Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bohl F, 2000, EMBO J, V19, P5514, DOI 10.1093/emboj/19.20.5514; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; CAVEMAN A, 2000, J CELL SCI, V113, P3543; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Costanzo MC, 2001, NUCLEIC ACIDS RES, V29, P75, DOI 10.1093/nar/29.1.75; CYERT MS, 1991, P NATL ACAD SCI USA, V88, P7376, DOI 10.1073/pnas.88.16.7376; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Fields S, 1999, P NATL ACAD SCI USA, V96, P8825, DOI 10.1073/pnas.96.16.8825; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Gerstein M, 1998, PROTEINS, V33, P518, DOI 10.1002/(SICI)1097-0134(19981201)33:4<518::AID-PROT5>3.0.CO;2-J; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Guerra R, 2000, BIOSCIENCE REP, V20, P41, DOI 10.1023/A:1005583117296; Homma K, 2000, J BIOL CHEM, V275, P34766, DOI 10.1074/jbc.M003132200; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Li Y, 1999, MOL CELL BIOL, V19, P3588; MacBeath G, 2000, SCIENCE, V289, P1760; MARTIN TF, 2000, ANNU REV CELL DEV BI, V14, P231; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Menendez J, 1998, YEAST, V14, P647; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; Pardo M, 1999, YEAST, V15, P459, DOI 10.1002/(SICI)1097-0061(199904)15:6<459::AID-YEA387>3.0.CO;2-L; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Schaerer-Brodbeck C, 2000, MOL BIOL CELL, V11, P1113, DOI 10.1091/mbc.11.4.1113; STIRLING DA, 1994, EMBO J, V13, P4329, DOI 10.1002/j.1460-2075.1994.tb06753.x; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wera S, 2001, FEMS YEAST RES, V1, P9, DOI 10.1111/j.1567-1364.2001.tb00008.x; Winter DC, 1999, P NATL ACAD SCI USA, V96, P7288, DOI 10.1073/pnas.96.13.7288; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576; Zhu H, 2001, CURR OPIN CHEM BIOL, V5, P40, DOI 10.1016/S1367-5931(00)00170-8	37	1711	1865	3	199	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2101	2105		10.1126/science.1062191	http://dx.doi.org/10.1126/science.1062191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11474067	Green Submitted			2022-12-28	WOS:000171028700077
J	Lanzara, A; Bogdanov, PV; Zhou, XJ; Kellar, SA; Feng, DL; Lu, ED; Yoshida, T; Eisaki, H; Fujimori, A; Kishio, K; Shimoyama, JI; Noda, T; Uchida, S; Hussain, Z; Shen, ZX				Lanzara, A; Bogdanov, PV; Zhou, XJ; Kellar, SA; Feng, DL; Lu, ED; Yoshida, T; Eisaki, H; Fujimori, A; Kishio, K; Shimoyama, JI; Noda, T; Uchida, S; Hussain, Z; Shen, ZX			Evidence for ubiquitous strong electron-phonon coupling in high-temperature superconductors	NATURE			English	Article							T-C SUPERCONDUCTORS; NORMAL-STATE; BI2SR2CACU2O8+DELTA; PHOTOEMISSION; LA1.85SR0.15CUO4; DISPERSION; PSEUDOGAP; SPECTRA; ENERGY	Coupling between electrons and phonons (lattice vibrations) drives the formation of the electron pairs responsible for conventional superconductivity(1). The lack of direct evidence for electron-phonon coupling in the electron dynamics of the high-transition-temperature superconductors has driven an intensive search for an alternative mechanism. A coupling of an electron with a phonon would result in an abrupt change of its velocity and scattering rate near the phonon energy. Here we use angle-resolved photoemission spectroscopy to probe electron dynamics-velocity and scattering rate-for three different families of copper oxide superconductors. We see in all of these materials an abrupt change of electron velocity at 50-80 meV, which we cannot explain by any known process other than to invoke coupling with the phonons associated with the movement of the oxygen atoms. This suggests that electron-phonon coupling strongly influences the electron dynamics in the high-temperature superconductors, and must therefore be included in any microscopic theory of superconductivity.	Stanford Univ, Dept Phys, Stanford, CA 94305 USA; Stanford Univ, Stanford Synchrotron Radiat Lab, Stanford, CA 94305 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA; Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1138656, Japan; Univ Tokyo, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan; Univ Tokyo, Dept Superconduct, Bunkyo Ku, Tokyo 133, Japan	Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Tokyo; University of Tokyo; University of Tokyo	Shen, ZX (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.		Fujimori, Atsushi/U-1971-2019; lanzara, alessandra/AAC-9535-2020; Feng, Donglai/R-1615-2018; Fujimori, Atsushi/G-5099-2014; Kishio, Kohji/AAL-2904-2020; Eisaki, Hiroshi/F-6317-2018	Feng, Donglai/0000-0001-9370-5357; Fujimori, Atsushi/0000-0003-4876-0634; Eisaki, Hiroshi/0000-0002-8299-6416; Kishio, Kohji/0000-0002-2759-8618				Allen P. B., 1992, Comments on Condensed Matter Physics, V15, P327; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; BATLOGG B, 1994, PHYSICA C, V235, P130, DOI 10.1016/0921-4534(94)91330-7; Bianconi A, 1996, PHYS REV LETT, V76, P3412, DOI 10.1103/PhysRevLett.76.3412; Bogdanov PV, 2000, PHYS REV LETT, V85, P2581, DOI 10.1103/PhysRevLett.85.2581; Campuzano JC, 1999, PHYS REV LETT, V83, P3709, DOI 10.1103/PhysRevLett.83.3709; Carbotte JP, 1999, NATURE, V401, P354, DOI 10.1038/43843; CHUANG YD, 2000, CONDMAT0102386; Cren T, 2000, PHYS REV LETT, V84, P147, DOI 10.1103/PhysRevLett.84.147; DeWilde Y, 1998, PHYS REV LETT, V80, P153, DOI 10.1103/PhysRevLett.80.153; Eschrig M, 2000, PHYS REV LETT, V85, P3261, DOI 10.1103/PhysRevLett.85.3261; Feng DL, 2001, PHYS REV LETT, V86, P5550, DOI 10.1103/PhysRevLett.86.5550; Fong HF, 1996, PHYS REV B, V54, P6708, DOI 10.1103/PhysRevB.54.6708; Gunnarsson O, 1997, REV MOD PHYS, V69, P575, DOI 10.1103/RevModPhys.69.575; HE H, 2000, CONDMAT0002013; Hengsberger M, 1999, PHYS REV LETT, V83, P592, DOI 10.1103/PhysRevLett.83.592; JOHNSON PD, 2001, CONDMAT0102260; KAMINSKI A, 2000, CONDMAT0004482; Kulic ML, 2000, PHYS REP, V338, P1, DOI 10.1016/S0370-1573(00)00008-9; LaShell S, 2000, PHYS REV B, V61, P2371, DOI 10.1103/PhysRevB.61.2371; McQueeney RJ, 1999, PHYS REV LETT, V82, P628, DOI 10.1103/PhysRevLett.82.628; PETROV Y, 2000, CONDMAT0003414; Puchkov AV, 1996, J PHYS-CONDENS MAT, V8, P10049, DOI 10.1088/0953-8984/8/48/023; Renner C, 1998, PHYS REV LETT, V80, P3606, DOI 10.1103/PhysRevLett.80.3606; Scalapino D. J., 1969, Superconductivity vol 1, P449; TAKAGI H, 1992, PHYS REV LETT, V69, P2975, DOI 10.1103/PhysRevLett.69.2975; Valla T, 1999, SCIENCE, V285, P2110, DOI 10.1126/science.285.5436.2110; VARMA CM, 1989, PHYS REV LETT, V63, P1996, DOI 10.1103/PhysRevLett.63.1996; Zhou XJ, 2001, PHYS REV LETT, V86, P5578, DOI 10.1103/PhysRevLett.86.5578	29	1153	1164	11	279	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					510	514		10.1038/35087518	http://dx.doi.org/10.1038/35087518			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484045	Green Submitted			2022-12-28	WOS:000170202900037
J	Trembath, RC; Thomson, JR; Machado, RD; Morgan, NV; Atkinson, C; Winship, I; Simonneau, G; Galie, N; Loyd, JE; Humbert, M; Nichols, WC; Morrell, NW; Berg, J; Manes, A; McGaughran, J; Pauciulo, M; Wheeler, L				Trembath, RC; Thomson, JR; Machado, RD; Morgan, NV; Atkinson, C; Winship, I; Simonneau, G; Galie, N; Loyd, JE; Humbert, M; Nichols, WC; Morrell, NW; Berg, J; Manes, A; McGaughran, J; Pauciulo, M; Wheeler, L			Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ARTERIOVENOUS-MALFORMATIONS; GERMLINE MUTATIONS; PENDRED SYNDROME; KINASE-1 GENE; RECEPTOR; BETA; ENDOGLIN; TYPE-2; GROWTH; PPH1	Background: Most patients with familial primary pulmonary hypertension have defects in the gene for bone morphogenetic protein receptor II (BMPR2), a member of the transforming growth factor beta (TGF-beta) superfamily of receptors. Because patients with hereditary hemorrhagic telangiectasia may have lung disease that is indistinguishable from primary pulmonary hypertension, we investigated the genetic basis of lung disease in these patients. Methods: We evaluated members of five kindreds plus one individual patient with hereditary hemorrhagic telangiectasia and identified 10 cases of pulmonary hypertension. In the two largest families, we used microsatellite markers to test for linkage to genes encoding TGF-beta -receptor proteins, including endoglin and activin-receptor-like kinase 1 (ALK1), and BMPR2. In subjects with hereditary hemorrhagic telangiectasia and pulmonary hypertension, we also scanned ALK1 and BMPR2 for mutations. Results: We identified suggestive linkage of pulmonary hypertension with hereditary hemorrhagic telangiectasia on chromosome 12q13, a region that includes ALK1. We identified amino acid changes in activin-receptor-like kinase 1 that were inherited in subjects who had a disorder with clinical and histologic features indistinguishable from those of primary pulmonary hypertension. Immunohistochemical analysis in four subjects and one control showed pulmonary vascular endothelial expression of activin-receptor-like kinase 1 in normal and diseased pulmonary arteries. Conclusions: Pulmonary hypertension in association with hereditary hemorrhagic telangiectasia can involve mutations in ALK1. These mutations are associated with diverse effects, including the vascular dilatation characteristic of hereditary hemorrhagic telangiectasia and the occlusion of small pulmonary arteries that is typical of primary pulmonary hypertension.	Univ Leicester, Dept Med, Div Med Genet, Leicester LE1 7RH, Leics, England; Univ Leicester, Dept Genet, Div Med Genet, Leicester LE1 7RH, Leics, England; Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Dept Med, Cambridge CB2 2QQ, England; Univ Cambridge, Papworth Hosp, Sch Clin Med, Dept Med, Cambridge CB2 2QQ, England; Univ Auckland, Sch Med, Dept Mol Med, Auckland, New Zealand; Univ Paris Sud, Assistance Publ Hop Paris, Hop Antoine Beclere, Serv Pneumol, Clamart, France; Univ Bologna, Inst Cardiol, Bologna, Italy; Vanderbilt Univ, Med Ctr, Nashville, TN USA; Childrens Hosp, Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA	University of Leicester; University of Leicester; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Papworth Hospital; University of Cambridge; University of Auckland; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; University of Bologna; Vanderbilt University; Cincinnati Children's Hospital Medical Center	Trembath, RC (corresponding author), Univ Leicester, Dept Med, Div Med Genet, Adrian Bldg, Leicester LE1 7RH, Leics, England.		Morgan, Neil V/A-5475-2009; Galie, Nazzareno/F-7004-2014; Winship, Ingrid M/D-7204-2016; wei, wei/HHR-8613-2022; Simonneau, Gerald/ABE-6614-2020; Machado, Rajiv D./AAD-7813-2019; McGaughran, Julie/A-2563-2012	Morgan, Neil V/0000-0001-6433-5692; Galie, Nazzareno/0000-0003-4271-8670; Machado, Rajiv D./0000-0001-9247-0744; Morrell, Nicholas/0000-0001-5700-9792; McGaughran, Julie/0000-0002-0926-7858; Trembath, Richard/0000-0003-0550-3400; Loyd, James/0000-0002-5042-7390; Winship, Ingrid/0000-0001-8535-6003; Humbert, Marc/0000-0003-0703-2892	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048164, R01HL061997] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL48164, HL61997] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abdalla SA, 2000, HUM MOL GENET, V9, P1227, DOI 10.1093/hmg/9.8.1227; Berg JN, 1997, AM J HUM GENET, V61, P60, DOI 10.1086/513903; Berg JN, 1996, J MED GENET, V33, P256, DOI 10.1136/jmg.33.3.256; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Cool CD, 1999, AM J PATHOL, V155, P411, DOI 10.1016/S0002-9440(10)65137-1; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Coyle B, 1996, NAT GENET, V12, P421, DOI 10.1038/ng0496-421; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Gausden E, 1997, J MED GENET, V34, P126, DOI 10.1136/jmg.34.2.126; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Klaus Daniel J., 1998, Human Mutation, V12, P137, DOI 10.1002/(SICI)1098-1004(1998)12:2<137::AID-HUMU15>3.0.CO;2-M; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; LOYD JE, 1984, AM REV RESPIR DIS, V129, P194; Machado RD, 2000, GENOMICS, V68, P220, DOI 10.1006/geno.2000.6291; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Makowski GS, 1998, ANN CLIN LAB SCI, V28, P254; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Morse JH, 1997, CIRCULATION, V95, P2603, DOI 10.1161/01.CIR.95.12.2603; Nichols WC, 1997, NAT GENET, V15, P277, DOI 10.1038/ng0397-277; PIETRA GG, 1989, CIRCULATION, V80, P1198, DOI 10.1161/01.CIR.80.5.1198; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; Rubin LJ, 1997, NEW ENGL J MED, V336, P111, DOI 10.1056/NEJM199701093360207; SAPRU RP, 1969, BRIT HEART J, V31, P559; Schulick AH, 1998, P NATL ACAD SCI USA, V95, P6983, DOI 10.1073/pnas.95.12.6983; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Shovlin CL, 1999, THORAX, V54, P714, DOI 10.1136/thx.54.8.714; Thomson JR, 2000, J CLIN PATHOL, V53, P899, DOI 10.1136/jcp.53.12.899; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; TRELL E, 1972, AM J MED, V53, P50, DOI 10.1016/0002-9343(72)90115-5; WHYTE MKB, 1993, J APPL PHYSIOL, V75, P321, DOI 10.1152/jappl.1993.75.1.321	33	506	539	1	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2001	345	5					325	334		10.1056/NEJM200108023450503	http://dx.doi.org/10.1056/NEJM200108023450503			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458KM	11484689	Green Published, Green Accepted			2022-12-28	WOS:000170193600003
J	Davidson, JRT				Davidson, JRT			Recognition and treatment of posttraumatic stress disorder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED TRIAL; PRIMARY-CARE; GASTROINTESTINAL DISORDERS; EXPOSURE THERAPY; COMORBIDITY; COMMUNITY; ABUSE; AMITRIPTYLINE; EXPERIENCES; PREVALENCE		Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA	Duke University	Davidson, JRT (corresponding author), Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Box 3812, Durham, NC 27710 USA.				NIMH NIH HHS [R01-MH 5665601, R01 MH 5834001] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058340] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amaya-Jackson L, 1999, J TRAUMA STRESS, V12, P709, DOI 10.1023/A:1024781504756; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Ballenger JC, 2000, J CLIN PSYCHIAT, V61, P60; BALLENGER JC, IN PRESS J CLIN PSYC; Beckham JC, 1997, ADDICT BEHAV, V22, P637, DOI 10.1016/S0306-4603(96)00071-8; Bisson JI, 2000, EFFECTIVE TREATMENTS FOR PTSD, P317; Boscarino JA, 1997, PSYCHOSOM MED, V59, P605, DOI 10.1097/00006842-199711000-00008; Brady K, 2000, JAMA-J AM MED ASSOC, V283, P1837, DOI 10.1001/jama.283.14.1837; BRAUN P, 1990, J CLIN PSYCHIAT, V51, P226; Breslau N, 1999, AM J PSYCHIAT, V156, P908, DOI 10.1176/ajp.156.6.908; BUTTERFIELD MI, IN PRESS INT CLIN PS; Canive JM, 1998, J CLIN PSYCHOPHARM, V18, P379, DOI 10.1097/00004714-199810000-00005; Cohen JA, 2000, EFFECTIVE TREATMENTS FOR PTSD, P330; Connor KM, 1999, BRIT J PSYCHIAT, V175, P17, DOI 10.1192/bjp.175.1.17; Connor KM, 1999, INT CLIN PSYCHOPHARM, V14, P29, DOI 10.1097/00004850-199901000-00003; CULPEPPER L, 2000, HIPPOCRATES, V14, P45; DAVIDSON J, 1990, ARCH GEN PSYCHIAT, V47, P259; Davidson J.R.T., 1990, J TRAUMA STRESS, V3, P459, DOI [10.1002/jts.2490030314, DOI 10.1002/JTS.2490030314]; Davidson JRT, 1998, J CLIN PSYCHOPHARM, V18, P93, DOI 10.1097/00004714-199802000-00020; Davidson JRT, 2001, ARCH GEN PSYCHIAT, V58, P485, DOI 10.1001/archpsyc.58.5.485; DAVIDSON JRT, 1991, PSYCHOL MED, V21, P713, DOI 10.1017/S0033291700022352; Davidson JRT, 2000, J CLIN PSYCHIAT, V61, P52; DAVIDSON JRT, 2000, EUR NEUROPSYCHOPHARM, pS349; Davison NR, 1998, TEXTUAL PRACT, V12, P291; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; Devilly GJ, 1999, J ANXIETY DISORD, V13, P131, DOI 10.1016/S0887-6185(98)00044-9; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; FESLER FA, 1991, J CLIN PSYCHIAT, V52, P361; FICHTNER CG, 1994, J CLIN PSYCHOPHARM, V14, P79; Foa EB, 1999, J CONSULT CLIN PSYCH, V67, P194, DOI 10.1037/0022-006X.67.2.194; Foa EB, 2000, EFFECTIVE TREATMENTS FOR PTSD, P1; Foa Edna B., 1999, Journal of Clinical Psychiatry, V60, P1; GEIPIN E, 1996, J CLIN PSYCHIAT, V57, P390; Greenberg PE, 1999, J CLIN PSYCHIAT, V60, P427, DOI 10.4088/JCP.v60n0702; Haug TT, 2000, FAM PRACT, V17, P114, DOI 10.1093/fampra/17.2.114; Hembree EA, 2000, J CLIN PSYCHIAT, V61, P33; Hertzberg MA, 1999, BIOL PSYCHIAT, V45, P1226, DOI 10.1016/S0006-3223(99)00011-6; Hertzberg MA, 1996, J CLIN PSYCHOPHARM, V16, P294, DOI 10.1097/00004714-199608000-00004; Hidalgo R, 1999, INT CLIN PSYCHOPHARM, V14, P61, DOI 10.1097/00004850-199903000-00001; Irwin C, 1996, J CLIN PSYCHIAT, V57, P576, DOI 10.4088/JCP.v57n1204; Kaplan Z, 1996, ANXIETY, V2, P51; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Kolb LC, 1984, POSTTRAUMATIC STRESS, P98; KOSTEN TR, 1991, J NERV MENT DIS, V179, P366, DOI 10.1097/00005053-199106000-00011; Krakow B, 2001, JAMA-J AM MED ASSOC, V286, P537, DOI 10.1001/jama.286.5.537; Lamberg L, 2000, JAMA-J AM MED ASSOC, V284, P554, DOI 10.1001/jama.284.5.554-a; Leserman J, 1998, PSYCHOL MED, V28, P417, DOI 10.1017/S0033291797006508; LIPPER S, 1986, PSYCHOSOMATICS, V27, P849, DOI 10.1016/S0033-3182(86)72590-5; Londborg PD, 2001, J CLIN PSYCHIAT, V62, P325, DOI 10.4088/JCP.v62n0503; Marks I, 1998, ARCH GEN PSYCHIAT, V55, P317, DOI 10.1001/archpsyc.55.4.317; Marshall RD, 1998, J CLIN PSYCHOPHARM, V18, P10, DOI 10.1097/00004714-199802000-00003; Mellman TA, 1998, J TRAUMA STRESS, V11, P563, DOI 10.1023/A:1024460814230; Meltzer-Brody S, 1999, PSYCHIAT RES, V88, P63, DOI 10.1016/S0165-1781(99)00070-0; Mollica RH, 2001, JAMA-J AM MED ASSOC, V286, P546, DOI 10.1001/jama.286.5.546; Murray CJL, 1996, GLOBAL BURDEN DIS, P5; MYNORSWALLIS LM, 1995, BMJ-BRIT MED J, V310, P441, DOI 10.1136/bmj.310.6977.441; Perkonigg A, 2000, ACTA PSYCHIAT SCAND, V101, P46, DOI 10.1034/j.1600-0447.2000.101001046.x; RISSE SC, 1990, J CLIN PSYCHIAT, V51, P206; SCARINCI IC, 1994, AM J MED, V97, P108, DOI 10.1016/0002-9343(94)90020-5; Seedat S, 2000, INT J NEUROPSYCHOPH, V3, P135, DOI 10.1017/S1461145700001899; Smyth JM, 1999, JAMA-J AM MED ASSOC, V281, P1304, DOI 10.1001/jama.281.14.1304; SPITZER RL, 1995, JAMA-J AM MED ASSOC, V274, P1511, DOI 10.1001/jama.274.19.1511; Stein MB, 2000, GEN HOSP PSYCHIAT, V22, P261, DOI 10.1016/S0163-8343(00)00080-3; Switzer GE, 1999, J TRAUMA STRESS, V12, P25, DOI 10.1023/A:1024738114428; Tarrier N, 1999, J CONSULT CLIN PSYCH, V67, P13, DOI 10.1037/0022-006X.67.1.13; Taubman-Ben-Ari O, 2001, PSYCHOL MED, V31, P555, DOI 10.1017/S0033291701003658; VANDERKOLK BA, 1994, J CLIN PSYCHIAT, V55, P517	70	64	73	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2001	286	5					584	588		10.1001/jama.286.5.584	http://dx.doi.org/10.1001/jama.286.5.584			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	458HE	11476661				2022-12-28	WOS:000170188300022
J	Schwetz, BA				Schwetz, BA			New weight-reduction system	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2001	286	5					527	527		10.1001/jama.286.5.527	http://dx.doi.org/10.1001/jama.286.5.527			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458HE	11476645				2022-12-28	WOS:000170188300005
J	Thompson, KM; Haninger, K				Thompson, KM; Haninger, K			Violence in E-rated video games	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context Children's exposure to violence, alcohol, tobacco and other substances, and sexual messages in the media are a source of public health concern; however, content in video games commonly played by children has not been quantified. Objectives To quantify and characterize the depiction of violence, alcohol, tobacco and other substances, and sex in video games rated E (for "Everyone"), analogous to the G rating of films, which suggests suitability for all audiences. Design We created a database of all existing E-rated video games available for rent or sale in the United States by April 1, 2001, to identify the distribution of games by genre and to characterize the distribution of content descriptors associated with these games. We played and assessed the content of a convenience sample of 55 E-rated video games released for major home video game consoles between 1985 and 2000. Main Outcome Measures Game genre; duration of violence; number of fatalities; types of weapons used; whether injuring characters or destroying objects is rewarded or is required to advance in the game; depiction of alcohol, tobacco and other substances; and sexual. content. Results Based on analysis of the 672 current E-rated video games played on home consoles, 77% were in sports, racing, or action genres and 57% did not receive any content descriptors. We found that 35 of the 55 games we played (64%) involved intentional violence for an average of 30.7% of game play (range, 1.5%-91.2%), and we noted significant differences in the amount of violence among game genres. Injuring characters was rewarded or required for advancement in 33 games (60%). The presence of any content descriptor for violence (n=23 games) was significantly correlated with the presence of intentional violence in the game (at a 5% significance level based on a 2-sided Wilcoxon rank-sum test, t(53)=2.59). Notably, 14 of 32 games (44%) that did not receive a content descriptor for violence contained acts of violence. Action and shooting games led to the largest numbers of deaths from violent acts, and we found a significant correlation between the proportion of violent game play and the number of deaths per minute of play. We noted potentially objectionable sexual content in 2 games and the presence of alcohol in 1 game. Conclusions Content analysis suggests a significant amount of violence in some E-rated video games. The content descriptors provide some information to parents and should be used along with the rating, but the game's genre also appears to play a role in the amount of violent play. Physicians and parents should understand that popular E-rated video games may be a source of exposure to violence and other unexpected content for children and that games may reward the players for violent actions.	Harvard Univ, Sch Publ Hlth, Harvard Ctr Risk Anal, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Thompson, KM (corresponding author), Harvard Univ, Sch Publ Hlth, Harvard Ctr Risk Anal, 718 Huntington Ave, Boston, MA 02115 USA.			Thompson, Kimberly/0000-0002-0849-9147				*AM AC PED AM MED, 2000, C PUBL HLTH SUMM JUL; Anderson CA, 2000, J PERS SOC PSYCHOL, V78, P772, DOI 10.1037//0022-3514.78.4.772; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; *DAD RAD, NEW RIDG RAC 5 BAB R; Dill KE, 1998, AGGRESS VIOLENT BEH, V3, P407, DOI 10.1016/S1359-1789(97)00001-3; Federal Trade Commission, 2009, MARK VIOL ENT CHILDR; Grossman D., 1999, STOP TEACHING OUR KI; HERMAN L, HIST VID GAMES; HUNTER W, DOT EATERS VIDEOGAME; *NAT I MED FAM, KIDSC; *NPD, NPD GROUP ESS MARK I; Roberts D. F., 1999, KIDS MEDIA NEW MILLE; Robinson TH, 2001, ARCH PEDIAT ADOL MED, V155, P17, DOI 10.1001/archpedi.155.1.17; SHELOV S, 1995, PEDIATRICS, V95, P949; Singer D. G., 2001, HDB CHILDREN MEDIA; Villani S, 2001, J AM ACAD CHILD PSY, V40, P392, DOI 10.1097/00004583-200104000-00007; Walsh DA, 2001, PEDIATRICS, V107, P1302, DOI 10.1542/peds.107.6.1302; WOLF MJP, 2000, MEDIUM VIDEO GAME; Yokota F, 2000, JAMA-J AM MED ASSOC, V283, P2716, DOI 10.1001/jama.283.20.2716	19	97	97	0	23	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2001	286	5					591	598		10.1001/jama.286.5.591	http://dx.doi.org/10.1001/jama.286.5.591			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	458HE	11476663	Bronze			2022-12-28	WOS:000170188300024
J	Bjornstad, ON; Grenfell, BT				Bjornstad, ON; Grenfell, BT			Noisy clockwork: Time series analysis of population fluctuations in animals	SCIENCE			English	Review							DENSITY-DEPENDENCE; COD POPULATIONS; SNOWSHOE HARE; DYNAMICS; MODELS; CHAOS; RODENT; CYCLES; STOCHASTICITY; CONSEQUENCES	Both biotic interactions and abiotic random forcing are crucial influences on population dynamics. This frequently leads to roughly equal importance of deterministic and stochastic forces. The resulting tension between noise and determinism makes ecological dynamics unique, with conceptual and methodological challenges distinctive from those in other dynamical systems. The theory for stochastic, nonlinear ecological dynamics has been developed alongside methods to test models. A range of dynamical components has been considered-density dependence, environmental and demographic stochasticity, and climatic forcing-as welt as their often complex interactions. We discuss recent advances in understanding ecological dynamics and testing theory using long-term data and review how dynamical forces interact to generate some central field and laboratory time series.	Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Cambridge	Bjornstad, ON (corresponding author), Penn State Univ, Dept Entomol, 501 ASI Bldg, University Pk, PA 16802 USA.		Bjornstad, Ottar N/I-4518-2012					ANDERSON RM, 1982, NATURE, V296, P245, DOI 10.1038/296245a0; BAILEY BA, 1997, NONLINEAR DYNAMICS T, P115; Bailey NTJ, 1957, MATH THEORY EPIDEMIC; BARTLETT MS, 1960, METHEUENS MONOGRAPHS; BARTZLI GO, 1992, WILDLIFE 2001 POPULA, P831; Benoit HP, 1998, ECOLOGY, V79, P2839, DOI 10.1890/0012-9658(1998)079[2839:TTDCOC]2.0.CO;2; Bjornstad ON, 2001, NATURE, V409, P1001, DOI 10.1038/35059003; BJORNSTAD ON, 1995, P ROY SOC B-BIOL SCI, V262, P127, DOI 10.1098/rspb.1995.0186; Bjornstad ON, 1999, P NATL ACAD SCI USA, V96, P5066, DOI 10.1073/pnas.96.9.5066; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; CluttonBrock TH, 1997, AM NAT, V149, P195, DOI 10.1086/285987; Costantino RF, 1997, SCIENCE, V275, P389, DOI 10.1126/science.275.5298.389; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Cushing JM, 1998, J THEOR BIOL, V194, P1, DOI 10.1006/jtbi.1998.0736; Cushing JM, 1998, J ANIM ECOL, V67, P298, DOI 10.1046/j.1365-2656.1998.00194.x; DENNIS B, 1988, ECOLOGY, V69, P1200, DOI 10.2307/1941275; Dennis B, 2001, ECOL MONOGR, V71, P277, DOI 10.1890/0012-9615(2001)071[0277:ECACDI]2.0.CO;2; DENNIS B, 1994, ECOL MONOGR, V64, P205, DOI 10.2307/2937041; DEVALPINE P, IN PRESS ECOLOGY; ELLNER S, 1995, AM NAT, V145, P343, DOI 10.1086/285744; ELLNER SP, IN PRESS J COMPUT GR; ELLNER SP, IN PRESS ECOLOGY; Engen S, 1998, BIOMETRICS, V54, P840, DOI 10.2307/2533838; Fromentin JM, 1996, MAR ECOL PROG SER, V134, P111, DOI 10.3354/meps134111; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; GRENFELL BT, 1992, NATURE, V355, P823, DOI 10.1038/355823a0; GRENFELL BT, IN PRESS ECOLOGY; GURNEY WSC, 1980, NATURE, V287, P17, DOI 10.1038/287017a0; HASSELL MP, 1976, J ANIM ECOL, V45, P471, DOI 10.2307/3886; HEWITT OH, 1954, J WILDLIFE MANAGE, V18, P1; Higgins K, 1997, SCIENCE, V276, P1431, DOI 10.1126/science.276.5317.1431; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; Keeling MJ, 2000, SCIENCE, V290, P1758, DOI 10.1126/science.290.5497.1758; Kendall BE, 1999, ECOLOGY, V80, P1789, DOI 10.1890/0012-9658(1999)080[1789:WDPCAS]2.0.CO;2; King AA, 2001, ECOLOGY, V82, P814, DOI 10.2307/2680200; Kingsland SE., 1985, MODELING NATURE; KREBS CJ, 1995, WILDLIFE RES, V22, P1, DOI 10.1071/WR9950001; KREBS CJ, 1995, SCIENCE, V269, P1112, DOI 10.1126/science.269.5227.1112; Leirs H, 1997, NATURE, V389, P176, DOI 10.1038/38271; Lima M, 1999, AM NAT, V153, P476, DOI 10.1086/303191; May R. M, 1974, STABILITY COMPLEXITY, V2nd; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; MCALLISTER MK, 1994, CAN J FISH AQUAT SCI, V51, P2673, DOI 10.1139/f94-267; McCauley E, 1999, NATURE, V402, P653, DOI 10.1038/45223; Millar RB, 2000, CAN J FISH AQUAT SCI, V57, P43, DOI 10.1139/f99-169; Nelson WA, 2001, P ROY SOC B-BIOL SCI, V268, P1223, DOI 10.1098/rspb.2001.1652; NISBET RM, 1994, J MATH BIOL, V32, P329, DOI 10.1007/BF00160164; Nisbet RM, 1982, MODELLING FLUCTUATIN; PERRY JN, 2000, POPULATION COMMUNITY; POLACHECK T, 1993, CAN J FISH AQUAT SCI, V50, P2597, DOI 10.1139/f93-284; Post E, 1999, ECOLOGY, V80, P1322, DOI 10.1890/0012-9658(1999)080[1322:CVPPAN]2.0.CO;2; RAND DA, 1991, P ROY SOC B-BIOL SCI, V246, P179, DOI 10.1098/rspb.1991.0142; Royama T., 1992, ANAL POPULATION ECOL; Saether BE, 2000, SCIENCE, V287, P854, DOI 10.1126/science.287.5454.854; Solow AR, 1997, ECOLOGY, V78, P2624; Stenseth NC, 1999, P ROY SOC B-BIOL SCI, V266, P1645, DOI 10.1098/rspb.1999.0827; Stenseth NC, 1996, P ROY SOC B-BIOL SCI, V263, P1117, DOI 10.1098/rspb.1996.0164; Stenseth NC, 1997, P NATL ACAD SCI USA, V94, P5147, DOI 10.1073/pnas.94.10.5147; Stenseth NC, 1996, P ROY SOC B-BIOL SCI, V263, P1423, DOI 10.1098/rspb.1996.0208; SUGIHARA G, 1990, NATURE, V344, P734, DOI 10.1038/344734a0; Turchin P, 2000, ECOLOGY, V81, P3099, DOI 10.1890/0012-9658(2000)081[3099:LOTEOC]2.0.CO;2; Turchin P, 2000, NATURE, V405, P562, DOI 10.1038/35014595; TURCHIN P, 1993, OIKOS, V68, P167, DOI 10.2307/3545323; Wilson HB, 1997, P ROY SOC B-BIOL SCI, V264, P1189, DOI 10.1098/rspb.1997.0164; Wood SN, 2001, ECOL MONOGR, V71, P1, DOI 10.1890/0012-9615(2001)071[0001:PSEM]2.0.CO;2; YAO QW, 1994, PHILOS T R SOC A, V348, P357, DOI 10.1098/rsta.1994.0096	67	450	463	2	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					638	643		10.1126/science.1062226	http://dx.doi.org/10.1126/science.1062226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474099				2022-12-28	WOS:000170204600041
J	Inchausti, P; Halley, J				Inchausti, P; Halley, J			Investigating long-term ecological variability using the global population dynamics database	SCIENCE			English	Editorial Material								The Global Population Dynamics Database (GPDD) is an important new source of information for ecologists, resource managers, and environmental scientists interested in the dynamics of natural populations. It comprises more than 4500 time series of population abundance for over 1800 animal species across many taxonomic groups and geographical locations. The GPDD offers great potential for asking comparative questions about the nature of population variability. We illustrate this by characterizing some critical features of ecological variability, variance growth, and spectral reddening.	Ecole Normale Super, Ecol Lab, F-75005 Paris, France; Aristotle Univ Thessaloniki, Sch Biol, Dept Ecol, GR-54006 Thessaloniki, Greece	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Aristotle University of Thessaloniki	Inchausti, P (corresponding author), Ecole Normale Super, Ecol Lab, 46 Rue Ulm, F-75005 Paris, France.	inchauss@biologie.ens.fr; jmax@bio.auth.gr	Halley, John M/AAP-3004-2020					Adler R., 1997, PRACTICAL GUIDE HEAV; ARINO A, 1995, EVOL ECOL, V9, P423; CYR H, 1996, OIKOS, V79, P54; Halley JM, 1996, TRENDS ECOL EVOL, V11, P33, DOI 10.1016/0169-5347(96)81067-6; Halley JM, 1999, THEOR POPUL BIOL, V56, P215, DOI 10.1006/tpbi.1999.1424; HALLEY JW, UNPUB; Kendall BE, 1998, ECOL LETT, V1, P160; LAWTON JH, 1988, NATURE, V334, P563, DOI 10.1038/334563a0; MACARDLE B, 1990, J ANIM ECOL, V59, P439; May R.M., 1975, P81; MURDOCH WW, 1994, ECOLOGY, V75, P271, DOI 10.2307/1939533; PIMM SL, 1988, NATURE, V334, P613, DOI 10.1038/334613a0; Pimm SL, 1991, BALANCE NATURE ECOLO; Royama T., 1992, ANAL POPULATION ECOL; STEELE J, 1986, NATURE, V313, P355; White A, 1996, NATURE, V381, P198, DOI 10.1038/381198a0	16	101	104	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2001	293	5530					655	657		10.1126/science.293.5530.655	http://dx.doi.org/10.1126/science.293.5530.655			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474102				2022-12-28	WOS:000170204600044
J	Rees, M; Condit, R; Crawley, M; Pacala, S; Tilman, D				Rees, M; Condit, R; Crawley, M; Pacala, S; Tilman, D			Long-term studies of vegetation dynamics	SCIENCE			English	Review							TROPICAL RAIN-FOREST; RECRUITMENT LIMITATION; PLANT DIVERSITY; SEED SIZE; INTERSPECIFIC VARIATION; LITTER DECOMPOSITION; GRAZING OPTIMIZATION; COMMUNITY STRUCTURE; FIELD-MEASUREMENTS; SAPLING MORTALITY	By integrating a wide range of experimental, comparative, and theoretical approaches, ecologists are starting to gain a detailed understanding of the long-term dynamics of vegetation. We explore how patterns of variation in demographic traits among species have provided insight into the processes that structure plant communities. We find a common set of mechanisms, derived from ecological and evolutionary principles, that underlie the main forces shaping systems as diverse as annual plant communities and tropical forests. Trait variation between species maintains diversity and has important implications for ecosystem processes. Hence, greater understanding of how Earth's vegetation functions wit[ likely require integration of ecosystem science with ideas from plant evolutionary, population, and community ecology.	Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Silwood Pk, Ascot SL5 7PY, Berks, England; Smithsonian Trop Res Inst, Ctr Trop Forest Sci, Unit 0948, APO, AA 34002 USA; Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Smithsonian Institution; Smithsonian Tropical Research Institute; Princeton University; University of Minnesota System; University of Minnesota Twin Cities	Rees, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Silwood Pk, Ascot SL5 7PY, Berks, England.	mrees@ic.ac.uk	Tilman, David/ABD-5309-2021					Agyeman VK, 1999, J ECOL, V87, P815, DOI 10.1046/j.1365-2745.1999.00400.x; ALVAREZBUYLLA ER, 1992, J ECOL, V80, P275, DOI 10.2307/2261011; Bolker BM, 1999, AM NAT, V153, P575, DOI 10.1086/303199; BROKAW NVL, 1985, ECOLOGY, V66, P682, DOI 10.2307/1940529; BROWN JH, 1990, SCIENCE, V250, P1705, DOI 10.1126/science.250.4988.1705; CARPENTER SR, 1987, ECOLOGY, V68, P1863, DOI 10.2307/1939878; Caspersen JP, 2001, OIKOS, V92, P160, DOI 10.1034/j.1600-0706.2001.920119.x; Chapin FS, 1998, BIOSCIENCE, V48, P45, DOI 10.2307/1313227; CHESSON PL, 1988, ANN ZOOL FENN, V25, P5; CHESSON PL, 1990, PHILOS T R SOC B, V330, P165, DOI 10.1098/rstb.1990.0190; Clark DA, 1999, ECOL APPL, V9, P981, DOI 10.1890/1051-0761(1999)009[0981:ATGOTR]2.0.CO;2; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; Clark JS, 1998, BIOSCIENCE, V48, P13, DOI 10.2307/1313224; Clark JS, 1998, ECOL MONOGR, V68, P213, DOI 10.1890/0012-9615(1998)068[0213:SASSOR]2.0.CO;2; Clark JS, 1999, AM J BOT, V86, P1, DOI 10.2307/2656950; Clark JS, 1998, AM NAT, V152, P204, DOI 10.1086/286162; CLARK JS, 1995, AM NAT, V146, P72, DOI 10.1086/285788; Clark JS, 1996, ECOLOGY, V77, P2148, DOI 10.2307/2265709; Clements F.E., 1928, PLANT SUCCESSION IND; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Condit R, 1996, J VEG SCI, V7, P405, DOI 10.2307/3236284; Condit R, 1999, PHILOS T R SOC B, V354, P1739, DOI 10.1098/rstb.1999.0517; CONDIT R, 1995, TRENDS ECOL EVOL, V10, P18, DOI 10.1016/S0169-5347(00)88955-7; CONNELL J H, 1971, P298; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; CONNELL JH, 1984, ECOL MONOGR, V54, P141, DOI 10.2307/1942659; CRAWLEY MJ, 1990, PHILOS T R SOC B, V330, P125, DOI 10.1098/rstb.1990.0187; CRAWLEY MJ, 1990, J APPL ECOL, V27, P803, DOI 10.2307/2404378; CRAWLEY MJ, 1983, STUDIES ECOLOGY, V10; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Davies SJ, 1998, J ECOL, V86, P662, DOI 10.1046/j.1365-2745.1998.00299.x; Davies SJ, 1999, AM J BOT, V86, P1786, DOI 10.2307/2656675; de Mazancourt C, 1999, ECOL APPL, V9, P784, DOI 10.1890/1051-0761(1999)009[0784:GOANCP]2.0.CO;2; De Mazancourt C, 1998, ECOLOGY, V79, P2242, DOI 10.1890/0012-9658(1998)079[2242:GOANCW]2.0.CO;2; de Mazancourt C, 2000, AM NAT, V155, P735, DOI 10.1086/303360; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Edwards GR, 1999, J ECOL, V87, P423, DOI 10.1046/j.1365-2745.1999.00363.x; Ehrlen J, 2000, ECOLOGY, V81, P1667, DOI 10.1890/0012-9658(2000)081[1667:DLAPOI]2.0.CO;2; Ericson L, 1999, J ECOL, V87, P649, DOI 10.1046/j.1365-2745.1999.00384.x; Eriksson O, 1997, ECOGRAPHY, V20, P559, DOI 10.1111/j.1600-0587.1997.tb00424.x; Eriksson O, 1998, J ECOL, V86, P922, DOI 10.1046/j.1365-2745.1998.00309.x; Finzi AC, 2000, FOREST ECOL MANAG, V131, P153, DOI 10.1016/S0378-1127(99)00206-6; Fraser LH, 1999, J ECOL, V87, P514, DOI 10.1046/j.1365-2745.1999.00373.x; Gleason HA, 1927, ECOLOGY, V8, P299, DOI 10.2307/1929332; Grime J. P., 1979, Plant strategies and vegetation processes.; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Grubb P. J., 1982, PLANT COMMUNITY WORK, P79; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; GUO QF, 1995, OIKOS, V73, P251, DOI 10.2307/3545915; Guo QF, 2000, ECOLOGY, V81, P2149, DOI 10.1890/0012-9658(2000)081[2149:COSSOP]2.0.CO;2; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; Hector A, 2000, OIKOS, V90, P357, DOI 10.1034/j.1600-0706.2000.900217.x; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Hubbell SP, 1997, CORAL REEFS, V16, pS9, DOI 10.1007/s003380050237; Hubbell Stephen P., 2001, V32, pi; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Jakobsson A, 2000, OIKOS, V88, P494, DOI 10.1034/j.1600-0706.2000.880304.x; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; KITAJIMA K, 1994, OECOLOGIA, V98, P419, DOI 10.1007/BF00324232; Kiviniemi K, 1999, OIKOS, V86, P241, DOI 10.2307/3546442; Kobe RK, 1997, OIKOS, V80, P226, DOI 10.2307/3546590; Kobe RK, 1996, ECOL MONOGR, V66, P181, DOI 10.2307/2963474; Latham Roger Earl, 1993, P294; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Loehle C, 2000, AM NAT, V156, P14, DOI 10.1086/303369; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; MacArthur R.H., 1967, THEORY ISLAND BIOGEO, DOI DOI 10.1080/00379271.2014.984955; May R. M., 1974, STABILITY COMPLEXITY, V6; MCKANE RB, 1990, ECOLOGY, V71, P1126, DOI 10.2307/1937380; McNaughton SJ., 1979, SERENGETI DYNAMICS E, P46; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; Morin P, 1999, ECOLOGY, V80, P752, DOI 10.2307/177014; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Naeem S, 1996, OIKOS, V76, P259, DOI 10.2307/3546198; Oksanen L, 2000, AM NAT, V155, P703, DOI 10.1086/303354; Okuda T, 1997, PLANT ECOL, V131, P155, DOI 10.1023/A:1009727109920; PACALA SW, 1993, CAN J FOREST RES, V23, P1980, DOI 10.1139/x93-249; Pacala SW, 1996, ECOL MONOGR, V66, P1, DOI 10.2307/2963479; Pacala SW, 1998, AM NAT, V152, P729, DOI 10.1086/286203; PACALA SW, 1992, AM NAT, V140, P243, DOI 10.1086/285411; PAKE CE, 1995, ECOLOGY, V76, P246, DOI 10.2307/1940646; Pake CE, 1996, ECOLOGY, V77, P1427, DOI 10.2307/2265540; Proulx M, 1998, ECOLOGY, V79, P2581, DOI 10.1890/0012-9658(1998)079[2581:ROGIOP]2.0.CO;2; Rees M, 1996, AM NAT, V147, P1, DOI 10.1086/285837; REES M, 1995, J ECOL, V83, P857, DOI 10.2307/2261422; REES M, 1993, NATURE, V366, P150, DOI 10.1038/366150a0; Ritchie ME, 1998, ECOLOGY, V79, P165, DOI 10.1890/0012-9658(1998)079[0165:HEOPAN]2.0.CO;2; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Silman M.R., 1996, THESIS DUKE U; SWAINE MD, 1988, VEGETATIO, V75, P81, DOI 10.1007/BF00044629; THOMPSON K, 1987, NEW PHYTOL, V106, P23; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D, 1997, SCIENCE, V278, P1866; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; TILMAN D, 1988; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Tilman David, 1993, P13; Turnbull LA, 1999, J ECOL, V87, P899, DOI 10.1046/j.1365-2745.1999.00405.x; Turnbull LA, 2000, OIKOS, V88, P225, DOI 10.1034/j.1600-0706.2000.880201.x; Venable D. Lawrence, 1993, Plant Species Biology, V8, P207, DOI 10.1111/j.1442-1984.1993.tb00071.x; VENABLE DL, 1988, AM NAT, V131, P360, DOI 10.1086/284795; VITOUSEK PM, 1989, ECOL MONOGR, V59, P247, DOI 10.2307/1942601; Wardle DA, 2000, OIKOS, V89, P11, DOI 10.1034/j.1600-0706.2000.890102.x; Watkinson AR, 1997, J ECOL, V85, P541, DOI 10.2307/2960576; WESTOBY M, 1992, TRENDS ECOL EVOL, V7, P368, DOI 10.1016/0169-5347(92)90006-W; Wills C, 1999, P ROY SOC B-BIOL SCI, V266, P1445, DOI 10.1098/rspb.1999.0799; WILSON AM, 1989, FUNCT ECOL, V3, P297, DOI 10.2307/2389369	111	422	483	3	233	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2001	293	5530					650	655		10.1126/science.1062586	http://dx.doi.org/10.1126/science.1062586			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474101				2022-12-28	WOS:000170204600043
J	Padian, K; de Ricqles, AJ; Horner, JR				Padian, K; de Ricqles, AJ; Horner, JR			Dinosaurian growth rates and bird origins	NATURE			English	Article							BONE MICROSTRUCTURE; PERIOSTEAL BONE; SKELETOCHRONOLOGY; HISTOLOGY; ONTOGENY	Dinosaurs, like other tetrapods, grew more quickly just after hatching than later in life. However, they did not grow like most other non-avian reptiles, which grow slowly and gradually through life. Rather, microscopic analyses of the long-bone tissues show that dinosaurs grew to their adult size relatively quickly, much as large birds and mammals do today. The first birds reduced their adult body size by shortening the phase of rapid growth common to their larger theropod dinosaur relatives. These changes in timing were primarily related not to physiological differences but to differences in growth strategy.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; Univ Paris 07, CNRS, UMR 8570, Equipe Format Squelett, F-75251 Paris 05, France; Coll France, F-75231 Paris, France; Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France; Montana State University System; Montana State University Bozeman	Padian, K (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	kpadian@socrates.berkeley.edu						ALBERCH P, 1979, PALEOBIOLOGY, V5, P296, DOI 10.1017/S0094837300006588; Amprino R., 1947, ARCH BIOL SCI, V58, P315; [Anonymous], 1980, COLD LOOK WARM BLOOD; Apanius V., 1998, AVIAN GROWTH DEV EVO; CASE TJ, 1978, PALEOBIOLOGY, V4, P320, DOI 10.1017/S0094837300006023; Castanet J, 2000, CR ACAD SCI III-VIE, V323, P543, DOI 10.1016/S0764-4469(00)00181-5; Castanet J, 1996, CR ACAD SCI III-VIE, V319, P301; Castanet J., 1993, BONE, P245; Chiappe LM, 1999, B AM MUS NAT HIST, P3; Chinsamy A, 1995, PALEOBIOLOGY, V21, P561, DOI 10.1017/S0094837300013543; Chinsamy A, 1998, J VERTEBR PALEONTOL, V18, P385, DOI 10.1080/02724634.1998.10011066; Chinsamy A, 1998, CRETACEOUS RES, V19, P225, DOI 10.1006/cres.1997.0102; Chinsamy Anusuya, 1993, Modern Geology, V18, P319; Curry KA, 1999, J VERTEBR PALEONTOL, V19, P654, DOI 10.1080/02724634.1999.10011179; De Buffrenil V, 2000, J HERPETOL, V34, P414, DOI 10.2307/1565365; de Ricqles AJ, 2000, ZOOL J LINN SOC-LOND, V129, P349, DOI 10.1006/zjls.1999.0239; de Ricqles Armand, 2000, Annee Biologique, V39, P69; DERICQLES A, 2001, IN PRESS PERSPECTIVE; DUNHAM AE, 1989, GEOL S AM S, V238, P1; Erickson GM, 2000, ZOOL J LINN SOC-LOND, V130, P551, DOI 10.1006/zjls.2000.0243; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 1999, NATURE, V398, P205, DOI 10.1038/18343; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; Horner JR, 2001, PALEOBIOLOGY, V27, P39, DOI 10.1666/0094-8373(2001)027<0039:COOSEA>2.0.CO;2; Horner JR, 1999, PALEOBIOLOGY, V25, P295, DOI 10.1017/S0094837300021308; HOUCK MA, 1990, SCIENCE, V247, P195, DOI 10.1126/science.247.4939.195; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Klevezal G., 1996, RECORDING STRUCTURES; KLEVEZAL G A, 1972, Zoologicheskii Zhurnal, V51, P1726; Padian K, 1997, ENCY DINOSAURS, P288; Reid R.E.H., 1997, P449; Reid R.E.H., 1997, P403; Ricqles A., 1991, BONE BONE MATRIX BON, V3, P1, DOI DOI 10.1111/J.0021-8782.2004.00275.X; Rimblot-Baly Frederique, 1995, Annales de Paleontologie, V81, P49; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Spotila J. R., 1980, COLD LOOK WARM BLOOD, P233; van Soest R. W. M, 1971, Bijdragen tot de Dierkunde, V41, P61; Varricchio D. J., 1997, ENCY DINOSAURS, P282, DOI DOI 10.1016/J.CUB.2016.10.043; Varricchio David J., 1993, Journal of Vertebrate Paleontology, V13, P99; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Zhang Fucheng, 1998, Vertebrata Palasiatica, V36, P126	41	207	216	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2001	412	6845					405	408		10.1038/35086500	http://dx.doi.org/10.1038/35086500			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473307				2022-12-28	WOS:000170068200037
J	Goulder, PJR; Brander, C; Tang, YH; Tremblay, C; Colbert, RA; Addo, MM; Rosenberg, ES; Nguyen, T; Allen, R; Trocha, A; Altfeld, M; He, SQ; Bunce, M; Funkhouser, R; Pelton, SI; Burchett, SK; McIntosh, K; Korber, BTM; Walker, BD				Goulder, PJR; Brander, C; Tang, YH; Tremblay, C; Colbert, RA; Addo, MM; Rosenberg, ES; Nguyen, T; Allen, R; Trocha, A; Altfeld, M; He, SQ; Bunce, M; Funkhouser, R; Pelton, SI; Burchett, SK; McIntosh, K; Korber, BTM; Walker, BD			Evolution and transmission of stable CTL escape mutations in HIV infection	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CYTOTOXIC T-LYMPHOCYTES; VIREMIA; IMMUNODOMINANT; PROGRESSION; SUPPRESSION; RESPONSES; VARIANTS; CHILDREN; DISEASE	Increasing evidence indicates that potent anti-HIV-1 activity is mediated by cytotoxic T lymphocytes (CTLs)(1-3); however, the effects of this immune pressure on viral transmission and evolution have not been determined. Here we investigate mother-child transmission in the setting of human leukocyte antigen (HLA)-B27 expression, selected for analysis because it is associated with prolonged immune containment in adult infection(4). In adults, mutations in a dominant and highly conserved B27-restricted Gag CTL epitope lead to loss of recognition and disease progression(4-6). In mothers expressing HLA-B27 who transmit HIV-1 perinatally, we document transmission of viruses encoding CTL escape variants in this dominant Gag epitope that no longer bind to B27. Their infected infants target an otherwise subdominant B27-restricted epitope and fail to contain HIV replication. These CTL escape variants remain stable without reversion in the absence of the evolutionary pressure that originally selected the mutation. These data suggest that CTL escape mutations in epitopes associated with suppression of viraemia will accumulate as the epidemic progresses, and therefore have important implications for vaccine design.	Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02114 USA; Harvard Univ, Sch Med, Div AIDS, Boston, MA 02114 USA; Childrens Hosp, Med Ctr, William S Rowe Div Rheumatol, Boston, MA 02115 USA; Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; Churchill Hosp, Oxford Transplant Ctr, Oxford OX3 7LJ, England; Univ Calif Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Boston Univ, Med Ctr, Sect Pediat Infect Dis, Boston, MA 02118 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Cambridge; University of Oxford; United States Department of Energy (DOE); Los Alamos National Laboratory; Boston University	Goulder, PJR (corresponding author), Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02114 USA.		Addo, Marylyn M./GNP-2548-2022; Altfeld, Marcus/AAE-7306-2019	Altfeld, Marcus/0000-0001-5972-2997; Brander, Christian/0000-0002-0548-5778; Addo, Marylyn/0000-0003-2836-9224; Allen, Rachel/0000-0001-9834-8475; Pelton, Stephen/0000-0003-4862-5344; Korber, Bette/0000-0002-2026-5757				Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Altfeld M, 2001, J EXP MED, V193, P169, DOI 10.1084/jem.193.2.169; Altfeld MA, 2000, J VIROL, V74, P8541, DOI 10.1128/JVI.74.18.8541-8549.2000; Barnhart HX, 1996, PEDIATRICS, V97, P710; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Brander C, 1998, J CLIN INVEST, V101, P2559, DOI 10.1172/JCI2405; BRANDER C, 1999, HIV MOL IMMUNOLOGY; Bunce M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/j.1399-0039.1995.tb03127.x; Ciurea A, 2001, J EXP MED, V193, P297, DOI 10.1084/jem.193.3.297; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; DECAMPOSLIMA PO, 1993, SCIENCE, V260, P98, DOI 10.1126/science.7682013; Goulder PJR, 2000, J VIROL, V74, P5679, DOI 10.1128/JVI.74.12.5679-5690.2000; Goulder PJR, 2001, J EXP MED, V193, P181, DOI 10.1084/jem.193.2.181; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2000, J EXP MED, V192, P1819, DOI 10.1084/jem.192.12.1819; GUO HC, 1993, P NATL ACAD SCI USA, V90, P8053, DOI 10.1073/pnas.90.17.8053; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; KUIKEN CL, 1999, HUMAN RETROVIRUSES A; LEWICKI HA, 1995, VIROLOGY, V211, P443, DOI 10.1006/viro.1995.1426; MOSKOPHIDIS D, 1995, J VIROL, V69, P2187, DOI 10.1128/JVI.69.4.2187-2193.1995; Nietfield W, 1995, J Immunol, V154, P2189; Pantaleo G, 1997, P NATL ACAD SCI USA, V94, P254, DOI 10.1073/pnas.94.1.254; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Wilson JDK, 2000, AIDS, V14, P225, DOI 10.1097/00002030-200002180-00003; Yang OO, 1997, J VIROL, V71, P3120, DOI 10.1128/JVI.71.4.3120-3128.1997	30	453	471	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					334	338		10.1038/35085576	http://dx.doi.org/10.1038/35085576			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460164				2022-12-28	WOS:000169918200047
J	Knee, LBG; Brunt, CM				Knee, LBG; Brunt, CM			A massive cloud of cold atomic hydrogen in the outer Galaxy	NATURE			English	Article							H-I; MOLECULAR CLOUDS; MILKY-WAY; TEMPERATURES; SUPERSHELLS; SHELLS	A large fraction of the mass of the interstellar medium in our Galaxy is in the form of warm (10(3)-10(4) K) and cool (50-100 K) atomic hydrogen (H I) gas(1). Cold (10-30 K) regions are thought to be dominated by dense clouds of molecular hydrogen(2). Cold H I is difficult to observe, and therefore our knowledge of its abundance and distribution in the interstellar medium is poor. The few known clouds of cold H I are much smaller in size and mass than typical molecular clouds 3-5. Here we report the discovery that the H I supershell GSH139-03-69 is very cold (10 K). It is about 2 kiloparsecs in size and as massive as the largest molecular complexes(6). The existence of such an immense structure composed of cold atomic hydrogen in the interstellar medium runs counter to the prevailing view that cold gas resides almost exclusively in clouds dominated by molecular hydrogen.	Natl Res Council Canada, Herzberg Inst Astrophys, Dominion Radio Astrophys Observ, Penticton, BC V2A 6K3, Canada; Univ Calgary, Dept Phys & Astron, Calgary, AB T2N 1N4, Canada	National Research Council Canada; University of Calgary	Knee, LBG (corresponding author), Natl Res Council Canada, Herzberg Inst Astrophys, Dominion Radio Astrophys Observ, POB 248, Penticton, BC V2A 6K3, Canada.	lewis.knee@nrc.ca		Knee, Lewis/0000-0002-9342-9003				BLITZ L, 1991, NATO ADV SCI I C-MAT, V342, P3; Burton W. B., 1988, GALACTIC EXTRAGALACT, V2nd, P295; CRUTCHER RM, 1974, ASTROPHYS J, V188, P481, DOI 10.1086/152738; Dame TM, 2001, ASTROPHYS J, V547, P792, DOI 10.1086/318388; Ehlerova S, 1997, ASTRON ASTROPHYS, V328, P121; ELMEGREEN BG, 1987, ASTROPHYS J, V320, P182, DOI 10.1086/165534; Gibson SJ, 2000, ASTROPHYS J, V540, P851, DOI 10.1086/309364; Hartmann D., 1997, ATLAS GALACTIC NEUTR; HEILES C, 1979, ASTROPHYS J, V229, P533, DOI 10.1086/156986; HEILES C, 1982, ASTROPHYS J, V262, P135, DOI 10.1086/160403; Heyer MH, 1998, ASTROPHYS J SUPPL S, V115, P241, DOI 10.1086/313086; Higgs LA, 2000, ASTRON J, V120, P2471, DOI 10.1086/316833; Higgs LA, 1999, ASTR SOC P, V168, P15; KERR FJ, 1986, MON NOT R ASTRON SOC, V221, P1023, DOI 10.1093/mnras/221.4.1023; Kulkarni S. R., INTERSTELLAR PROCESS, V134, P87, DOI [10.1007/978-94-009-3861-8_5, DOI 10.1007/978-94-009-3861-8_5]; KULKARNI SR, 1985, ASTROPHYS J, V291, P716, DOI 10.1086/163110; Landecker TL, 2000, ASTRON ASTROPHYS SUP, V145, P509, DOI 10.1051/aas:2000257; Perna R, 2000, ASTROPHYS J, V539, P706, DOI 10.1086/309282; SOLOMON PM, 1987, ASTROPHYS J, V319, P730, DOI 10.1086/165493; Spitzer L, 2008, JRASC; TAYLOR AR, UNPUB ASTRON J; TENORIOTAGLE G, 1988, ANNU REV ASTRON ASTR, V26, P145; TRAPERO J, 1995, ASTROPHYS J, V445, P231, DOI 10.1086/175690; VANDISHOECK EF, 1986, ASTROPHYS J SUPPL S, V62, P109, DOI 10.1086/191135; WANNIER PG, 1983, ASTROPHYS J, V268, P727, DOI 10.1086/160995	26	40	41	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					308	310		10.1038/35085519	http://dx.doi.org/10.1038/35085519			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460155				2022-12-28	WOS:000169918200038
J	Meijers-Heijboer, H; van Geel, B; van Putten, WLJ; Henzen-Logmans, SC; Seynaeve, C; Menke-Pluymers, MBE; Bartels, CCM; Verhoog, LC; van den Ouweland, AMW; Niermeijer, MF; Brekelmans, CTM; Klijn, JGM				Meijers-Heijboer, H; van Geel, B; van Putten, WLJ; Henzen-Logmans, SC; Seynaeve, C; Menke-Pluymers, MBE; Bartels, CCM; Verhoog, LC; van den Ouweland, AMW; Niermeijer, MF; Brekelmans, CTM; Klijn, JGM			Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OVARIAN-CANCER; SUSCEPTIBILITY GENE; GERMLINE MUTATIONS; HIGH-RISK; SURGERY; CARRIERS; SATISFACTION; TAMOXIFEN; SURVIVAL; FAMILIES	Background: Women with a BRCA1 or BRCA2 mutation have a high risk of breast cancer and may choose to undergo prophylactic bilateral total mastectomy. We investigated the efficacy of this procedure in such women. Methods: We conducted a prospective study of 139 women with a pathogenic BRCA1 or BRCA2 mutation who were enrolled in a breast-cancer surveillance program at the Rotterdam Family Cancer Clinic. At the time of enrollment, none of the women had a history of breast cancer. Seventy-six of these women eventually underwent prophylactic mastectomy, and the other 63 remained under regular surveillance. The effect of mastectomy on the incidence of breast cancer was analyzed by the Cox proportional-hazards method in which mastectomy was modeled as a time-dependent covariate. Results: No cases of breast cancer were observed after prophylactic mastectomy after a mean (+/-SE) follow-up of 2.9+/-1.4 years, whereas eight breast cancers developed in women under regular surveillance after a mean follow-up of 3.0+/-1.5 years (P=0.003; hazard ratio, 0; 95 percent confidence interval, 0 to 0.36). The actuarial mean five-year incidence of breast cancer among all women in the surveillance group was 17+/-7 percent. On the basis of an exponential model, the yearly incidence of breast cancer in this group was 2.5 percent. The observed number of breast cancers in the surveillance group was consistent with the expected number (ratio of observed to expected cases, 1.2; 95 percent confidence interval, 0.4 to 3.7; P=0.80). Conclusions: In women with a BRCA1 or BRCA2 mutation, prophylactic bilateral total mastectomy reduces the incidence of breast cancer at three years of follow-up. (N Engl J Med 2001;345:159-64.) Copyright (C) 2001 Massachusetts Medical Society.	Erasmus Univ, Med Ctr, Dr Daniel den Hoed Klin, Dept Med Oncol,Rotterdam Family Canc Clin, NL-3075 EA Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Surg, NL-3075 EA Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Stat, NL-3075 EA Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3075 EA Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Pathol, NL-3075 EA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Klijn, JGM (corresponding author), Erasmus Univ, Med Ctr, Dr Daniel den Hoed Klin, Dept Med Oncol,Rotterdam Family Canc Clin, Groene Hilledijk 301, NL-3075 EA Rotterdam, Netherlands.	bos@onch.azrl.nl						BERMAN L, 2000, LANCET, V356, P881; BILIMORIA MM, 1995, CA-CANCER J CLIN, V45, P263, DOI 10.3322/canjclin.45.5.263; Borgen PI, 1998, ANN SURG ONCOL, V5, P603, DOI 10.1007/BF02303829; Brekelmans CTM, 2001, J CLIN ONCOL, V19, P924, DOI 10.1200/JCO.2001.19.4.924; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; Eisen A, 2000, J CLIN ONCOL, V18, P1980, DOI 10.1200/JCO.2000.18.9.1980; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Frost MH, 2000, JAMA-J AM MED ASSOC, V284, P319, DOI 10.1001/jama.284.3.319; Gabriel SE, 1997, NEW ENGL J MED, V336, P677, DOI 10.1056/NEJM199703063361001; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; HARTMANN LC, 2000, P AM ASSOC CANC RES, V41, P222; Hatcher MB, 2001, BRIT MED J, V322, P76, DOI 10.1136/bmj.322.7278.76; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; Khurana KK, 2000, ARCH PATHOL LAB MED, V124, P378; Klijn JGM, 1997, EUR J CANCER, V33, P2149, DOI 10.1016/S0959-8049(97)00360-2; Kriege M., 2000, European Journal of Cancer, V36, pS137; Kuhl CK, 2000, RADIOLOGY, V215, P267, DOI 10.1148/radiology.215.1.r00ap01267; Lerman C, 1996, JAMA-J AM MED ASSOC, V275, P1885, DOI 10.1001/jama.275.24.1885; Meijers-Heijboer EJ, 2000, LANCET, V355, P2015, DOI 10.1016/S0140-6736(00)02347-3; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Narod SA, 2000, LANCET, V356, P1876, DOI 10.1016/S0140-6736(00)03258-X; Peelen T, 2000, BRIT J CANCER, V82, P151, DOI 10.1054/bjoc.1999.0892; PetrijBosch A, 1997, NAT GENET, V17, P341, DOI 10.1038/ng1197-341; PetrijBosch A, 1997, NAT GENET, V17, P503, DOI 10.1038/ng1297-503a; Rebbeck TR, 1999, J NATL CANCER I, V91, P1475, DOI 10.1093/jnci/91.17.1475; SKOLNICK MH, 1990, SCIENCE, V250, P1715, DOI 10.1126/science.2270486; STEFANEK ME, 1995, PREV MED, V24, P412, DOI 10.1006/pmed.1995.1066; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Verhoog LC, 1998, LANCET, V351, P316, DOI 10.1016/S0140-6736(97)07065-7; Verhoog LC, 1999, J CLIN ONCOL, V17, P3396, DOI 10.1200/JCO.1999.17.11.3396; Whittemore AS, 1997, AM J HUM GENET, V60, P496; Wooster R, 1996, NATURE, V379, P749, DOI 10.1038/379749a0; ZION SM, 2000, PROG P AM SOC CLIN O, V19, pA441	34	669	688	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2001	345	3					159	164		10.1056/NEJM200107193450301	http://dx.doi.org/10.1056/NEJM200107193450301			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453JM	11463009	Green Published			2022-12-28	WOS:000169912800001
J	Reimold, AM; Iwakoshi, NN; Manis, J; Vallabhajosyula, P; Szomolanyi-Tsuda, E; Gravallese, EM; Friend, D; Grusby, MJ; Alt, F; Glimcher, LH				Reimold, AM; Iwakoshi, NN; Manis, J; Vallabhajosyula, P; Szomolanyi-Tsuda, E; Gravallese, EM; Friend, D; Grusby, MJ; Alt, F; Glimcher, LH			Plasma cell differentiation requires the transcription factor XBP-1	NATURE			English	Article							B-CELL; GERMINAL CENTER; T-CELL; TERMINAL DIFFERENTIATION; BLIMP-1 EXPRESSION; DEFICIENT MICE; IGM SECRETION; PROTEIN; LYMPHOCYTES; MEMORY	Considerable progress has been made in identifying the transcription factors involved in the early specification of the B-lymphocyte lineage. However, little is known about factors that control the transition of mature activated B cells to antibody-secreting plasma cells. Here we report that the transcription factor XBP-1 is required for the generation of plasma cells. XBP-1 transcripts were rapidly upregulated in vitro by stimuli that induce plasma-cell differentiation, and were found at high levels in plasma cells from rheumatoid synovium. When introduced into B-lineage cells, XBP-1 initiated plasma-cell differentiation. Mouse lymphoid chimaeras deficient in XBP-1 possessed normal numbers of activated B lymphocytes that proliferated, secreted cytokines and formed normal germinal centres. However, they secreted very little immunoglobulin of any isotype and failed to control infection with the B-cell-dependent polyoma virus, because plasma cells were markedly absent. XBP-1 is the only transcription factor known to be selectively and specifically required for the terminal differentiation of B lymphocytes to plasma cells.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Beth Israel Deaconess Medical Center; University of Massachusetts System; University of Massachusetts Worcester	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.		Longo, Kenneth A/A-5631-2010					Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Altmeyer A, 1997, IMMUNITY, V7, P667, DOI 10.1016/S1074-7613(00)80387-8; Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; Bachmann MF, 1999, CURR OPIN IMMUNOL, V11, P332, DOI 10.1016/S0952-7915(99)80053-3; BLACKMAN MA, 1986, CELL, V47, P609, DOI 10.1016/0092-8674(86)90625-2; BROOKS K, 1983, NATURE, V302, P825, DOI 10.1038/302825a0; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Choe J, 1998, EUR J IMMUNOL, V28, P508, DOI 10.1002/(SICI)1521-4141(199802)28:02<508::AID-IMMU508>3.0.CO;2-I; CLAUSS IM, 1993, DEV DYNAM, V197, P146, DOI 10.1002/aja.1001970207; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Gartner F, 2000, J EXP MED, V192, P1745, DOI 10.1084/jem.192.12.1745; Glimcher LH, 1999, CELL, V96, P13, DOI 10.1016/S0092-8674(00)80955-1; GRAVALLESE EM, 1991, ARTHRITIS RHEUM-US, V34, P1076, DOI 10.1002/art.1780340903; Henderson A, 1998, ANNU REV IMMUNOL, V16, P163, DOI 10.1146/annurev.immunol.16.1.163; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; ILLERA VA, 1993, J IMMUNOL, V151, P2965; Kim HJ, 1999, J IMMUNOL, V162, P3053; Knodel M, 1999, EUR J IMMUNOL, V29, P2988; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Lin KI, 2000, MOL CELL BIOL, V20, P8684, DOI 10.1128/MCB.20.23.8684-8695.2000; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; Liu Y J, 1997, Semin Immunol, V9, P235, DOI 10.1006/smim.1997.0080; Manis JP, 1998, J EXP MED, V188, P1421, DOI 10.1084/jem.188.8.1421; McHeyzer-Williams MG, 1999, CURR OPIN IMMUNOL, V11, P172, DOI 10.1016/S0952-7915(99)80029-6; Melchers F, 1997, CURR TOP MICROBIOL, V224, P19; Messika EJ, 1998, J EXP MED, V188, P515, DOI 10.1084/jem.188.3.515; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Morrison AM, 1998, SEMIN IMMUNOL, V10, P133, DOI 10.1006/smim.1998.0115; Morse L, 1997, IMMUNITY, V6, P47, DOI 10.1016/S1074-7613(00)80241-1; Oliver AM, 1997, J IMMUNOL, V158, P1108; RANDALL TD, 1993, MOL CELL BIOL, V13, P3929, DOI 10.1128/MCB.13.7.3929; Reimold AM, 1996, J EXP MED, V183, P393, DOI 10.1084/jem.183.2.393; Reimold AM, 2000, GENE DEV, V14, P152; SANDERSON RD, 1989, CELL REGUL, V1, P27, DOI 10.1091/mbc.1.1.27; Schliephake DE, 1996, EUR J IMMUNOL, V26, P268, DOI 10.1002/eji.1830260142; Schwoon DR, 1997, EUR ADDICT RES, V3, P11, DOI 10.1159/000259142; Soro PG, 1999, J IMMUNOL, V163, P611; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; SzomolanyiTsuda E, 1996, J EXP MED, V183, P403, DOI 10.1084/jem.183.2.403; SZOMOLANYITSUDA.E, J IMMUNOL, V164, P5877; Takatsu K, 1997, P SOC EXP BIOL MED, V215, P121; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Wen XY, 1999, INT J ONCOL, V15, P173; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000	49	960	1007	1	35	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					300	307		10.1038/35085509	http://dx.doi.org/10.1038/35085509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460154				2022-12-28	WOS:000169918200037
J	Polanczyk, CA; Rohde, LE; Goldman, L; Cook, EF; Thomas, EJ; Marcantonio, ER; Mangione, CM; Lee, TH				Polanczyk, CA; Rohde, LE; Goldman, L; Cook, EF; Thomas, EJ; Marcantonio, ER; Mangione, CM; Lee, TH			Right heart catheterization and cardiac complications in patients undergoing noncardiac surgery - An observational study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PULMONARY-ARTERY CATHETERIZATION; MYOCARDIAL-INFARCTION; VENTRICULAR-ARRHYTHMIAS; RISK; ISCHEMIA; INDEX; CARE	Context Right heart catheterization (RHC) is commonly performed before high-risk noncardiac surgery, but the benefit: of this strategy remains unproven. Objective To evaluate the relationship between use of perioperative RHC and postoperative cardiac complication rates in patients undergoing major noncardiac surgery. Design Prospective, observational cohort study. Setting Tertiary care teaching hospital in the United States. Patients Patients (n=4059 aged greater than or equal to 50 years) who underwent major elective noncardiac procedures with an expected length of stay of 2 or more days between July 18, 1989, and February 28, 1994, Two hundred twenty one patients had RHC and 3838 did not. Main Outcome Measure Combined end point of major postoperative cardiac events, including myocardial infarction, unstable angina, cardiogenic pulmonary edema, ventricular fibrillation, documented ventricular tachycardia or primary cardiac arrest, and sustained complete heart block, classified by a reviewer blinded to preoperative data. Results Major cardiac events occurred in 171 patients (4.2%). Patients who underwent perioperative RHC had a 3-fold increase in incidence of major postoperative cardiac events (34 [15.4%] vs 137 [3.6%]; P<.001). In multivariate analyses, the adjusted odds ratios (ORs) for postoperative major cardiac and noncardiac events in patients undergoing RHC were 2.0 (95% confidence interval [CI], 1.3-3.2) and 2.1 (95% CI, 1.2-3.5), respectively. In a case-control analysis of a subset of 215 matched pairs of patients who did and did not undergo RHC, adjusted for propensity of RHC and type of procedure, patients who underwent perioperative RHC also had increased risk of postoperative congestive heart failure (OR, 2.9; 95% CI, 1.4-6.2) and major noncardiac events (OR, 2.2; 95% CI, 1.4-4.9). Conclusions No evidence was found of reduction in complication rates associated with use of perioperative RHC in this population. Because of the morbidity and the high costs associated with RHC, the impact of this intervention in perioperative care should be evaluated in randomized trials.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Sect Clin Epidemiol,Div Gen Med, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Cardiovasc, Boston, MA 02115 USA; Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA; Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90024 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lee, TH (corresponding author), Partners Community HealthCare Inc, Suite 1150,Prudential Tower,800 Boylston St, Boston, MA 02199 USA.	thlee@partners.org	Marcantonio, Edward R/U-3929-2017; Polanczyk, Carisi CAP/D-6208-2013; Rohde, Luis Eduardo/I-4216-2013	Marcantonio, Edward R/0000-0002-2911-4250; 	AHRQ HHS [R01-HS06573] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006573] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		BERLAUK JF, 1991, ANN SURG, V214, P289, DOI 10.1097/00000658-199109000-00011; BLAND RD, 1985, CRIT CARE MED, V13, P85, DOI 10.1097/00003246-198502000-00006; CHARLSON ME, 1989, ANN SURG, V210, P637, DOI 10.1097/00000658-198911000-00012; CONNORS AF, 1985, CHEST, V88, P567, DOI 10.1378/chest.88.4.567; Connors AF, 1996, JAMA-J AM MED ASSOC, V276, P889, DOI 10.1001/jama.276.11.889; CULPEPPER JA, 1982, CHEST, V82, P380, DOI 10.1378/chest.82.3.380; DETSKY AS, 1986, ARCH INTERN MED, V146, P2131, DOI 10.1001/archinte.146.11.2131; FOOTE GA, 1974, NEW ENGL J MED, V290, P927, DOI 10.1056/NEJM197404252901702; GOLDMAN L, 1981, CIRCULATION, V64, P1227, DOI 10.1161/01.CIR.64.6.1227; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; GORE JM, 1987, CHEST, V92, P721, DOI 10.1378/chest.92.4.721; GREENLAND P, 1991, CIRCULATION, V83, P484, DOI 10.1161/01.CIR.83.2.484; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; HERTZER NR, 1982, CLEVELAND CLIN Q, V49, P1; IBERTI TJ, 1985, AM J MED, V78, P451, DOI 10.1016/0002-9343(85)90337-7; IBERTI TJ, 1990, JAMA-J AM MED ASSOC, V264, P2928, DOI 10.1001/jama.264.22.2928; ISAACSON IJ, 1990, J VASC SURG, V12, P754, DOI 10.1067/mva.1990.24456; Joyce W P, 1990, Eur J Vasc Surg, V4, P633, DOI 10.1016/S0950-821X(05)80820-5; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Lee TH, 1996, AM J CARDIOL, V77, P1031, DOI 10.1016/S0002-9149(96)00126-9; Mangano DT, 1995, NEW ENGL J MED, V333, P1750, DOI 10.1056/NEJM199512283332607; MERMEL LA, 1994, AM J RESP CRIT CARE, V149, P1020, DOI 10.1164/ajrccm.149.4.8143037; NAYLOR CD, 1993, JAMA-J AM MED ASSOC, V269, P2407, DOI 10.1001/jama.269.18.2407; ROIZEN MF, 1993, ANESTHESIOLOGY, V78, P380; SECHZER PH, 1963, ANESTHESIOLOGY, V24, P779, DOI 10.1097/00000542-196311000-00005; SHAW TJI, 1979, ANAESTHESIA, V34, P651, DOI 10.1111/j.1365-2044.1979.tb06365.x; SHOEMAKER WC, 1988, CHEST, V94, P1176, DOI 10.1378/chest.94.6.1176; SPODICK DH, 1980, AM J CARDIOL, V46, P173, DOI 10.1016/0002-9149(80)90620-7; SPRUNG CL, 1983, AM J MED, V75, P906, DOI 10.1016/0002-9343(83)90862-8; WONG T, 1992, ANN INTERN MED, V116, P743, DOI 10.7326/0003-4819-116-9-743	30	147	159	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2001	286	3					309	314		10.1001/jama.286.3.309	http://dx.doi.org/10.1001/jama.286.3.309			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452QA	11466096	Bronze			2022-12-28	WOS:000169869200021
J	Baker, VR				Baker, VR			Water and the martian landscape	NATURE			English	Review							ORBITER LASER ALTIMETER; CHAOTIC OBLIQUITY; OUTFLOW CHANNELS; POLYGONAL TERRAIN; FLUVIAL VALLEYS; MARS; ICE; SURFACE; CRATER; CLIMATE	Over the past 30 years, the water-generated landforms and landscapes of Mars have been revealed in increasing detail by a succession of spacecraft missions. Recent data from the Mars Global Surveyor mission confirm the view that brief episodes of water-related activity, including glaciation, punctuated the geological history of Mars. The most recent of these episodes seems to have occurred within the past 10 million years. These new results are anomalous in regard to the prevailing view that the martian surface has been continuously extremely cold and dry, much as it is today, for the past 3.9 billion years. Interpretations of the new data are controversial, but explaining the anomalies in a consistent manner leads to potentially fruitful hypotheses for understanding the evolution of Mars in relation to Earth.	Univ Arizona, Dept Hydrol & Water Resources, Tucson, AZ 85721 USA	University of Arizona	Baker, VR (corresponding author), Univ Arizona, Dept Hydrol & Water Resources, Tucson, AZ 85721 USA.	baker@hwr.arizona.edu						Ackert RP, 1998, GEOGR ANN A, V80A, P267; ANDERSON RC, IN PRESS J GEOPHYS R; Baker V.R., 1992, CHANNELS VALLEY NETW, P493; Baker V.R., 1982, THE CHANNELS OF MARS, DOI [10.1029/EO063i045p00862, DOI 10.1029/EO063I045P00862]; BAKER VR, 1974, ICARUS, V23, P27, DOI 10.1016/0019-1035(74)90101-8; BAKER VR, 1991, NATURE, V352, P589, DOI 10.1038/352589a0; Baker VR, 1996, GEOMORPHOLOGY, V16, P197, DOI 10.1016/S0169-555X(96)80001-8; BAKER VR, 1986, J GEOPHYS RES-SOLID, V91, P3561, DOI 10.1029/JB091iB03p03561; BAKER VR, 1979, J GEOPHYS RES, V84, P7985, DOI 10.1029/JB084iB14p07985; Baker VR, 1996, BING SYMP G, P57; BAKER VR, FLOOD MEGAFLOOD DEPO; BAKER VR, 1993, RESOURCES NEAR EARTH, P765; Barlow NG, 2000, J GEOPHYS RES-PLANET, V105, P26733, DOI 10.1029/2000JE001258; Barsch D., 1996, ROCKGLACIERS; BROECKER WS, 1989, GEOCHIM COSMOCHIM AC, V53, P2465, DOI 10.1016/0016-7037(89)90123-3; BURR D, IN PRESS INT ASS SCI; BURR DM, UNPUB GEOPHYS RE LET; Cabrol NA, 1999, ICARUS, V142, P160, DOI 10.1006/icar.1999.6191; Cabrol NA, 2001, ICARUS, V149, P291, DOI 10.1006/icar.2000.6530; Cabrol NA, 1999, ICARUS, V139, P235, DOI 10.1006/icar.1999.6099; Carr M. H., 1977, Journal of Geophysical Research, V82, P4039, DOI 10.1029/JS082i028p04039; Carr M.H, 1996, WATER MARS; Carr MH, 1999, J GEOPHYS RES-PLANET, V104, P21897, DOI 10.1029/1999JE001048; CARR MH, 1981, ICARUS, V48, P91, DOI 10.1016/0019-1035(81)90156-1; CARR MH, 1990, ICARUS, V87, P210, DOI 10.1016/0019-1035(90)90031-4; Carr MH, 1997, J GEOPHYS RES-PLANET, V102, P9145, DOI 10.1029/97JE00113; Carr MH, 1996, PLANET SPACE SCI, V44, P1411, DOI 10.1016/S0032-0633(96)00053-0; Carr MH, 2000, ASTRON GEOPHYS, V41, P20, DOI 10.1046/j.1468-4004.2000.00320.x; Carr MH, 2000, ICARUS, V146, P366, DOI 10.1006/icar.2000.6428; CHAMBERLIN TC, 1904, POPULAR SCI MONTHLY, V66, P66; Chapman M.G., 2000, ENV EFFECTS VOLCANIC, P39, DOI DOI 10.1007/978-1-4615-4151-6_3; Clark DH, 1998, GEOGR ANN A, V80A, P175, DOI 10.1111/j.0435-3676.1998.00035.x; CLIFFORD SM, IN PRESS EVOLUTION M; Colaprete A, 1998, J GEOPHYS RES-PLANET, V103, P5897, DOI 10.1029/97JE03371; Costard F, 2001, GEOMORPHOLOGY, V37, P289, DOI 10.1016/S0169-555X(00)00088-X; COSTARD F, LUN PLAN SCI C, V32; CRADDOCK RA, 1993, J GEOPHYS RES-PLANET, V98, P3453, DOI 10.1029/92JE02508; CROWELL JC, 1999, GEOL SOC AM MEMOIR, V192; Davis WM, 1926, SCIENCE, V63, P463, DOI 10.1126/science.63.1636.463; Dohm JM, 2000, GEOPHYS RES LETT, V27, P3559, DOI 10.1029/2000GL011728; FRENCH HM, 1996, PERIGLACIAL ENV, V2nd; Gilbert G K, 1896, Science, V3, P1, DOI 10.1126/science.3.53.1; Golombek MP, 2000, J GEOPHYS RES-PLANET, V105, P1841, DOI 10.1029/1999JE001043; Greeley R., 1992, MARS, P730; Gulick VC, 1997, ICARUS, V130, P68, DOI 10.1006/icar.1997.5802; GULICK VC, 1989, NATURE, V341, P514, DOI 10.1038/341514a0; Gulick VC, 1998, J GEOPHYS RES-PLANET, V103, P19365, DOI 10.1029/98JE01321; Gulick VC, 2001, GEOMORPHOLOGY, V37, P241, DOI 10.1016/S0169-555X(00)00086-6; Hartmann WK, 2000, J GEOPHYS RES-PLANET, V105, P15011, DOI 10.1029/1999JE001189; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Head JW, 1999, SCIENCE, V286, P2134, DOI 10.1126/science.286.5447.2134; HEAD JW, 2001, LUN PLAN SCI C, V32; HEAD JW, IN PRESS J GEOPHYS R; HEAD JW, 2001, LUNAR PLANET SCI, V32; Hiesinger H, 2000, J GEOPHYS RES-PLANET, V105, P11999, DOI 10.1029/1999JE001193; HODGES CA, 1979, J GEOPHYS RES, V84, P8061, DOI 10.1029/JB084iB14p08061; Hoffman N, 2000, ICARUS, V146, P326, DOI 10.1006/icar.2000.6398; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; HOFFMAN PF, IN PRESS TERRA NOVA; Hynek BM, 2001, GEOLOGY, V29, P407, DOI 10.1130/0091-7613(2001)029<0407:EFEDOT>2.0.CO;2; Ivanov MA, 2001, J GEOPHYS RES-PLANET, V106, P3275, DOI 10.1029/2000JE001257; Jakosky B. M., 1992, MARS, P969; JAKOSKY BM, 1995, J GEOPHYS RES-PLANET, V100, P1579, DOI 10.1029/94JE02801; Jons H.-P, 1985, 16 LUNAR PLANET SCI, P414; KARGEL JS, 1995, J GEOPHYS RES-PLANET, V100, P5351, DOI 10.1029/94JE02447; KARGEL JS, 1992, GEOLOGY, V20, P3, DOI 10.1130/0091-7613(1992)020<0003:AGOM>2.3.CO;2; Keszthelyi L, 2000, J GEOPHYS RES-PLANET, V105, P15027, DOI 10.1029/1999JE001191; KOMAR PD, 1980, ICARUS, V42, P317, DOI 10.1016/0019-1035(80)90097-4; KOMATSU G, LUN PLAN SCI C, V31; LAITY JE, 1985, GEOL SOC AM BULL, V96, P203, DOI 10.1130/0016-7606(1985)96<203:SPATDO>2.0.CO;2; Lane MD, 2000, J GEOPHYS RES-PLANET, V105, P17617, DOI 10.1029/1999JE001197; LASKAR J, 1993, NATURE, V361, P608, DOI 10.1038/361608a0; LUCCHITTA BK, 1986, J GEOPHYS RES-SOLID, V91, pE166, DOI 10.1029/JB091iB13p0E166; Lucchitta BK, 2001, GEOPHYS RES LETT, V28, P403, DOI 10.1029/2000GL011924; LUCCHITTA BK, 1982, J GEOPHYS RES, V87, P9951, DOI 10.1029/JB087iB12p09951; LUCCHITTA BK, 1981, ICARUS, V45, P264, DOI 10.1016/0019-1035(81)90035-X; LUCCHITTA BK, 2001, LUNAR PLANET SCI, V32; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; Malin MC, 1998, SCIENCE, V279, P1681, DOI 10.1126/science.279.5357.1681; Malin MC, 1999, GEOPHYS RES LETT, V26, P3049, DOI 10.1029/1999GL002342; Mangold N, 2001, GEOPHYS RES LETT, V28, P407, DOI 10.1029/2000GL008491; MASURSKY H, 1973, J GEOPHYS RES, V78, P4009, DOI 10.1029/JB078i020p04009; Max MD, 2001, GEOPHYS RES LETT, V28, P1787, DOI 10.1029/2000GL011606; Max MD, 2000, J GEOPHYS RES-PLANET, V105, P4165, DOI 10.1029/1999JE001119; MOORE JG, 1989, J GEOPHYS RES-SOLID, V94, P17465, DOI 10.1029/JB094iB12p17465; MOUGINISMARK PJ, 1990, ICARUS, V84, P362, DOI 10.1016/0019-1035(90)90044-A; MOUGINISMARK PJ, 1993, LUNAR PLANET SCI, V24, P1021; Mulvaney R, 2000, GEOPHYS RES LETT, V27, P2673, DOI 10.1029/1999GL011254; Musselwhite DS, 2001, GEOPHYS RES LETT, V28, P1283, DOI 10.1029/2000GL012496; Nelson DM, 1999, J GEOPHYS RES-PLANET, V104, P8653, DOI 10.1029/98JE01900; NUMMEDAL D, 1981, ICARUS, V45, P77, DOI 10.1016/0019-1035(81)90007-5; Nummedal D., 1978, CHANNELED SCABLAND; Ori GG, 2000, J GEOPHYS RES-PLANET, V105, P17629, DOI 10.1029/1999JE001219; PARKER TJ, 1989, ICARUS, V82, P111, DOI 10.1016/0019-1035(89)90027-4; PARKER TJ, 1993, J GEOPHYS RES-PLANET, V98, P11061, DOI 10.1029/93JE00618; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; PIERI DC, 1980, TM81979 NASA; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; SCHULTZ PH, 1979, J GEOPHYS RES, V84, P7669, DOI 10.1029/JB084iB13p07669; Seibert NM, 2001, GEOPHYS RES LETT, V28, P899, DOI 10.1029/2000GL012093; SLEEP NH, IN PRESS P NATL ACAD; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Squyres S. W., 1992, MARS, P523; SQUYRES SW, 1989, ICARUS, V79, P229, DOI 10.1016/0019-1035(89)90078-X; Strom R.G., 1992, MARS, P383, DOI DOI 10.1016/S0032-0633(99)00016-1; SUGDEN DE, 1995, NATURE, V376, P412, DOI 10.1038/376412a0; Tanaka KL, 1999, J GEOPHYS RES-PLANET, V104, P8637, DOI 10.1029/98JE02552; TANAKA KL, 1990, J GEOPHYS RES-SOLID, V95, P14315, DOI 10.1029/JB095iB09p14315; TOUMA J, 1993, SCIENCE, V259, P1294, DOI 10.1126/science.259.5099.1294; WEITZ CM, 2001, LUNAR PLANET SCI, V32; Whewell W., 1847, PHILOS INDUCTIVE SCI; WILLIAMS GE, 1993, EARTH-SCI REV, V34, P1, DOI 10.1016/0012-8252(93)90004-Q; WILSON L, 1969, REV GEOGR PHYS GEOL, V11, P303; [No title captured]	117	424	434	3	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2001	412	6843					228	236		10.1038/35084172	http://dx.doi.org/10.1038/35084172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449284				2022-12-28	WOS:000169778700062
J	Hoeppner, DJ; Hengartner, MO; Schnabel, R				Hoeppner, DJ; Hengartner, MO; Schnabel, R			Engulfment genes cooperate with ced-3 to promote cell death in Caenorhabditis elegans	NATURE			English	Article							C-ELEGANS; APOPTOSIS; PROTEIN; GENETICS; NEMATODE; CORPSES	Genetic studies have identified over a dozen genes that function in programmed cell death (apoptosis) in the nematode Caenorhabditis elegans(1-3). Although the ultimate effects on cell survival or engulfment of mutations in each cell death gene have been extensively described, much less is known about how these mutations affect the kinetics of death and engulfment, or the interactions between these two processes. We have used four-dimensional-Nomarski time-lapse video microscopy to follow in detail how cell death genes regulate the extent and kinetics of apoptotic cell death and removal in the early C. elegans embryo. Here we show that blocking engulfment enhances cell survival when cells are subjected to weak pro-apoptotic signals. Thus, genes that mediate corpse removal can also function to actively kill cells.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Dept Mol Genet & Microbiol, Grad Program Genet, Stony Brook, NY 11794 USA; Tech Univ Braunschweig, Inst Genet, D-38106 Braunschweig, Germany	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Braunschweig University of Technology	Hengartner, MO (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.		Hengartner, Michael O/E-6235-2011; Hengartner, Michael O/A-7058-2008	Hengartner, Michael/0000-0002-7584-596X				BRENNER S, 1974, GENETICS, V77, P71; Chung SB, 2000, NAT CELL BIOL, V2, P931, DOI 10.1038/35046585; DiezRoux G, 1997, DEVELOPMENT, V124, P3633; Duffield JS, 2000, J IMMUNOL, V164, P2110, DOI 10.4049/jimmunol.164.4.2110; ELLIS RE, 1991, GENETICS, V129, P79; GUMIENNY TL, IN PRESS CELL DEATH; HENGARTNER MO, 1994, NATURE, V369, P318, DOI 10.1038/369318a0; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; Hodgkin J, 1997, C ELEGANS, P881; Knepper-Nicolai B, 1998, J BIOL CHEM, V273, P30530, DOI 10.1074/jbc.273.46.30530; LANG R, 1994, DEVELOPMENT, V120, P3395; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; ROBERTSON AMG, 1982, J EMBRYOL EXP MORPH, V67, P89; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Shah A, 1999, AGING MENT HEALTH, V3, P153, DOI 10.1080/13607869956316; Stanfield GM, 2000, MOL CELL, V5, P423, DOI 10.1016/S1097-2765(00)80437-2; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; XUE D, 1995, NATURE, V377, P248, DOI 10.1038/377248a0; [No title captured]	23	226	228	1	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					202	206		10.1038/35084103	http://dx.doi.org/10.1038/35084103			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449279				2022-12-28	WOS:000169778700057
J	Zuber, MT				Zuber, MT			The crust and mantle of Mars	NATURE			English	Review							THERMAL EMISSION SPECTROMETER; MARTIAN METEORITE ALH84001; SNC METEORITES; GLOBAL SURVEYOR; TERRESTRIAL PLANETS; TOPOGRAPHIC SIGNATURE; HEMISPHERIC DICHOTOMY; MAGNETIC-ANOMALIES; INTERNAL STRUCTURE; ACCRETION HISTORY	Clues to the history of Mars are recorded in the chemistry and structure of the planet's crust and mantle. The mantle is the rocky, interior region of the planet that transports heat generated during accretion and subsequent core formation. The crust formed by melting of the upper mantle, and has been shaped and re-distributed by impact, volcanism, mantle flow and erosion. Observations point to a dynamically active interior in the early phases of martian history, followed by a rapid fall-off in heat transport that significantly influenced the geological, geophysical and geochemical evolution of the planet, including the history of water and climate.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Zuber, MT (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.							Acuna MH, 1999, SCIENCE, V284, P790, DOI 10.1126/science.284.5415.790; ACUNA MH, IN PRESS J GEOPHYS R; Albee AL, 1998, SCIENCE, V279, P1671, DOI 10.1126/science.279.5357.1671; ANDERSON RC, IN PRESS J GEOPHYS R; Ash RD, 1996, NATURE, V380, P57, DOI 10.1038/380057a0; Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; BANERDT WB, 1982, J GEOPHYS RES, V87, P9723, DOI 10.1029/JB087iB12p09723; BANERDT WB, 1992, MARS, P249; Bell JF, 1999, ICARUS, V138, P25, DOI 10.1006/icar.1998.6057; Bertka CM, 1998, SCIENCE, V281, P1838, DOI 10.1126/science.281.5384.1838; BILLS BG, 1990, J GEOPHYS RES-SOLID, V95, P14131, DOI 10.1029/JB095iB09p14131; BILLS BG, 1995, J GEOPHYS RES, V100, P26314; Blichert-Toft J, 1999, EARTH PLANET SC LETT, V173, P25, DOI 10.1016/S0012-821X(99)00222-8; BOGARD DD, 1983, SCIENCE, V221, P651, DOI 10.1126/science.221.4611.651; BOGARD DD, 1984, GEOCHIM COSMOCHIM AC, V48, P1723, DOI 10.1016/0016-7037(84)90028-0; Borg LE, 1997, GEOCHIM COSMOCHIM AC, V61, P4915, DOI 10.1016/S0016-7037(97)00276-7; BRATT SR, 1985, J GEOPHYS RES-SOLID, V90, P3049, DOI 10.1029/JB090iB04p03049; Breuer D, 1996, J GEOPHYS RES-PLANET, V101, P7531, DOI 10.1029/96JE00117; Breuer D, 1997, EARTH PLANET SC LETT, V148, P457, DOI 10.1016/S0012-821X(97)00049-6; Breuer D, 1998, GEOPHYS RES LETT, V25, P229, DOI 10.1029/97GL03767; Carr M., 1981, SURFACE MARS; CHEN JH, 1986, GEOCHIM COSMOCHIM AC, V50, P955, DOI 10.1016/0016-7037(86)90376-5; CHOBLET G, 1999, LUN PLAN SCI C, V30; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9609, DOI 10.1029/1999JE001127; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; CHRISTENSEN PR, IN PRESS J GEOPHYS R; CISOWSKI SM, 1986, GEOCHIM COSMOCHIM AC, V50, P1043, DOI 10.1016/0016-7037(86)90386-8; Connerney JEP, 1999, SCIENCE, V284, P794, DOI 10.1126/science.284.5415.794; DREIBUS G, 1985, METEORITICS, V20, P367; Dunlop D, 1997, ROCK MAGNETISM; Fanale F.P., 1992, MARS, P1135; Folkner WM, 1997, SCIENCE, V278, P1749, DOI 10.1126/science.278.5344.1749; FORSYTH DW, 1993, J GEOPHYS RES-SOL EA, V98, P16073, DOI 10.1029/93JB01722; FREY H, 1988, GEOPHYS RES LETT, V15, P229, DOI 10.1029/GL015i003p00229; Frey H, 1998, GEOPHYS RES LETT, V25, P4409, DOI 10.1029/1998GL900095; FREY HV, 2001, LUN PLAN SCI C, V32; Garvin JB, 1998, GEOPHYS RES LETT, V25, P4405, DOI 10.1029/1998GL900177; Grasset O, 1998, J GEOPHYS RES-SOL EA, V103, P18171, DOI 10.1029/98JB01492; GREELEY R, 1981, REV GEOPHYS, V19, P13, DOI 10.1029/RG019i001p00013; Harder H, 1996, NATURE, V380, P507, DOI 10.1038/380507a0; Harder H, 2000, GEOPHYS RES LETT, V27, P301, DOI 10.1029/1999GL008418; Hargraves RB, 2000, J GEOPHYS RES-PLANET, V105, P1819, DOI 10.1029/1999JE001032; HARTMANN WK, IN PRESS SPACE SCI R; HEAD JW, IN PRESS J GEOPHYS R; HESS PC, 2000, LUN PLAN SCI C, V32; Hynek BM, 2001, GEOLOGY, V29, P407, DOI 10.1130/0091-7613(2001)029<0407:EFEDOT>2.0.CO;2; JAGOUTZ E, 1991, SPACE SCI REV, V56, P13, DOI 10.1007/BF00178386; JANLE P, 1983, MOON PLANETS, V28, P55, DOI 10.1007/BF01371673; King SD, 2000, SCIENCE, V290, P1137, DOI 10.1126/science.290.5494.1137; Kletetschka G, 2000, EARTH PLANET SC LETT, V176, P469, DOI 10.1016/S0012-821X(00)00016-9; Kletetschka G, 2000, METEORIT PLANET SCI, V35, P895, DOI 10.1111/j.1945-5100.2000.tb01478.x; LANGEL RA, 1982, GEOPHYS RES LETT, V9, P269, DOI 10.1029/GL009i004p00269; Lee DC, 1997, NATURE, V388, P854, DOI 10.1038/42206; LEMOINE FG, IN PRESS J GEOPHYS R; Lingenfelter R. E., 1973, Moon, V7, P172, DOI 10.1007/BF00578814; Longhi J., 1992, MARS, V1, P184, DOI [10.2307/j.ctt207g59v.10, DOI 10.2307/J.CTT207G59V.10]; McEwen AS, 1999, NATURE, V397, P584, DOI 10.1038/17539; MCGILL GE, 1989, J GEOPHYS RES-SOLID, V94, P2753, DOI 10.1029/JB094iB03p02753; MCGILL GE, 1991, ICARUS, V93, P386, DOI 10.1016/0019-1035(91)90221-E; MCGILL GE, 1990, J GEOPHYS RES-SOLID, V95, P12595, DOI 10.1029/JB095iB08p12595; MCGOVERN PJ, 2001, LUN PLAN SCI C, V32; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924; MCSWEEN HY, 1985, REV GEOPHYS, V23, P391, DOI 10.1029/RG023i004p00391; MCSWEEN HY, 1994, METEORITICS, V29, P757, DOI 10.1111/j.1945-5100.1994.tb01092.x; McSween HY, 1999, J GEOPHYS RES-PLANET, V104, P8679, DOI 10.1029/98JE02551; McSween HY, 2001, NATURE, V409, P487, DOI 10.1038/35054011; Minitti ME, 2000, GEOCHIM COSMOCHIM AC, V64, P2535, DOI 10.1016/S0016-7037(00)00366-5; MITTLEFEHLDT DW, 1994, METEORITICS, V29, P214, DOI 10.1111/j.1945-5100.1994.tb00673.x; Morris RV, 2000, J GEOPHYS RES-PLANET, V105, P1757, DOI 10.1029/1999JE001059; MUSTARD JF, 1993, J GEOPHYS RES-PLANET, V98, P3387, DOI 10.1029/92JE02682; MUSTARD JF, 1995, SCIENCE, V267, P1623, DOI 10.1126/science.7886449; Mutch T.A., 1976, GEOLOGY MARS; NEUMANN GA, IN PRESS J GEOPHYS R; Nimmo F, 2000, J GEOPHYS RES-PLANET, V105, P11969, DOI 10.1029/1999JE001216; Nimmo F, 2001, J GEOPHYS RES-PLANET, V106, P5085, DOI 10.1029/2000JE001331; NOBLE SK, 2001, LUN PLAN SCI C, V32; PARMENTIER EM, 2001, LUN PLAN SCI C, V32; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; Pike R. J., 1974, Geophysical Research Letters, V1, P291, DOI 10.1029/GL001i007p00291; Purucker M, 2000, GEOPHYS RES LETT, V27, P2449, DOI 10.1029/2000GL000072; SCHUBERT G, 1990, J GEOPHYS RES-SOLID, V95, P14095, DOI 10.1029/JB095iB09p14095; Schubert G, 2000, NATURE, V408, P666, DOI 10.1038/35047163; SCHUBERT G, 1990, J GEOPHYS RES-SOLID, V95, P14105, DOI 10.1029/JB095iB09p14105; Schubert G., 1992, MARS, P147, DOI [10.2307/j.ctt207g59v.9, DOI 10.2307/J.CTT207G59V.9]; SHARP RP, 1971, J GEOPHYS RES, V76, P331, DOI 10.1029/JB076i002p00331; SHARP RP, 1973, J GEOPHYS RES, V78, P4073, DOI 10.1029/JB078i020p04073; SHERMAN DM, 1982, J GEOPHYS RES, V87, P169, DOI 10.1029/JB087iB12p10169; Sleep NH, 2000, J GEOPHYS RES-PLANET, V105, P17563, DOI 10.1029/2000JE001240; SLEEP NH, 1994, J GEOPHYS RES-PLANET, V99, P5639, DOI 10.1029/94JE00216; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Smith DE, 1996, SCIENCE, V271, P184, DOI 10.1126/science.271.5246.184; Smith DE, 1999, SCIENCE, V286, P94, DOI 10.1126/science.286.5437.94; SMITH DE, IN PRESS J GEOPHYS R; SODERBLOM L. A., 1992, MARS, P557; Sohl F, 1997, J GEOPHYS RES-PLANET, V102, P1613, DOI 10.1029/96JE03419; SOLOMON SC, 1982, J GEOPHYS RES, V87, P9755, DOI 10.1029/JB087iB12p09755; SOLOMON SC, 2001, EOS T AM GEOPHYS UNI; Spohn T, 1998, ASTRON ASTROPHYS REV, V8, P181, DOI 10.1007/s001590050010; SPOHN T, 1999, EOS T AM GEOPHYS UNI, V80; SQUYRES SW, 1994, SCIENCE, V265, P744, DOI 10.1126/science.265.5173.744; SWINDLE TD, 1986, GEOCHIM COSMOCHIM AC, V50, P1001, DOI 10.1016/0016-7037(86)90381-9; Tanaka K. L., 1992, MARS, P345; TANAKA KL, 1986, J GEOPHYS RES-SOLID, V91, pE139, DOI 10.1029/JB091iB13p0E139; Treiman AH, 1998, METEORIT PLANET SCI, V33, P753, DOI 10.1111/j.1945-5100.1998.tb01681.x; TREIMAN AH, 1995, METEORITICS, V30, P294, DOI 10.1111/j.1945-5100.1995.tb01127.x; Wadhwa M, 2001, SCIENCE, V291, P1527, DOI 10.1126/science.1057594; WANKE H, 1988, PHILOS T R SOC A, V325, P545, DOI 10.1098/rsta.1988.0067; WEINSTEIN SA, 1995, J GEOPHYS RES-PLANET, V100, P11719, DOI 10.1029/95JE00710; WEISS BP, UNPUB NATURE; WIENS RC, 1986, EARTH PLANET SC LETT, V77, P149, DOI 10.1016/0012-821X(86)90156-1; WILHELMS DE, 1984, NATURE, V309, P138, DOI 10.1038/309138a0; WISE DU, 1979, J GEOPHYS RES, V84, P7934, DOI 10.1029/JB084iB14p07934; WISE DU, 1979, ICARUS, V38, P456, DOI 10.1016/0019-1035(79)90200-8; Withers P, 2001, NATURE, V410, P651, DOI 10.1038/35070640; WOOD JA, 1981, BASALTIC VOLCANISM T, P634; ZHONG S, 2001, LUN PLAN SCI C, V32; Zhong SJ, 2000, EARTH PLANET SC LETT, V177, P131, DOI 10.1016/S0012-821X(00)00041-8; Zhong SJ, 2001, EARTH PLANET SC LETT, V189, P75, DOI 10.1016/S0012-821X(01)00345-4; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788; ZUBER MT, 1994, SCIENCE, V266, P1839, DOI 10.1126/science.266.5192.1839; [No title captured]	121	194	198	7	46	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					220	227		10.1038/35084163	http://dx.doi.org/10.1038/35084163			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449283	Bronze			2022-12-28	WOS:000169778700061
J	McCarthy, M				McCarthy, M			Counselling can help to reduce second-hand smoke in the home	LANCET			English	News Item																		Emmons KM, 2001, PEDIATRICS, V108, P18, DOI 10.1542/peds.108.1.18	1	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 7	2001	358	9275					43	43		10.1016/S0140-6736(01)05307-7	http://dx.doi.org/10.1016/S0140-6736(01)05307-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11454386				2022-12-28	WOS:000169710900023
J	Podbielski, A; Kreikemeyer, B				Podbielski, A; Kreikemeyer, B			Persistence of group A streptococci in eukaryotic cells - a safe place?	LANCET			English	Editorial Material							ASYMPTOMATIC CARRIERS; PYOGENES		Univ Hosp Rostock, Dept Med Microbiol & Hosp Hyg, D-18057 Rostock, Germany	University of Rostock	Podbielski, A (corresponding author), Univ Hosp Rostock, Dept Med Microbiol & Hosp Hyg, Schillingallee 70, D-18057 Rostock, Germany.			Kreikemeyer, Bernd/0000-0001-9527-5098				Balaban N, 1998, SCIENCE, V280, P438, DOI 10.1126/science.280.5362.438; Beckert S, 2001, INFECT IMMUN, V69, P534, DOI 10.1128/IAI.69.1.534-537.2001; Brandt CM, 2001, J INFECT DIS, V183, P670, DOI 10.1086/318542; Cleary PP, 1998, MOL MICROBIOL, V28, P157, DOI 10.1046/j.1365-2958.1998.00786.x; Desaki M, 2000, BIOCHEM BIOPH RES CO, V267, P124, DOI 10.1006/bbrc.1999.1917; Goodfellow AM, 2000, J CLIN MICROBIOL, V38, P389; Kreikemeyer B, 2001, MOL MICROBIOL, V39, P392, DOI 10.1046/j.1365-2958.2001.02226.x; Molinari G, 2001, MOL MICROBIOL, V40, P99, DOI 10.1046/j.1365-2958.2001.02373.x; Neeman R, 1998, LANCET, V352, P1974, DOI 10.1016/S0140-6736(97)12452-7; Osterlund A, 1997, ACTA OTO-LARYNGOL, V117, P883, DOI 10.3109/00016489709114219; Ouadrhiri Y, 1999, ANTIMICROB AGENTS CH, V43, P1242, DOI 10.1128/AAC.43.5.1242; Talay SR, 2000, CELL MICROBIOL, V2, P521, DOI 10.1046/j.1462-5822.2000.00076.x	12	15	16	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 7	2001	358	9275					3	4		10.1016/S0140-6736(00)05296-X	http://dx.doi.org/10.1016/S0140-6736(00)05296-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11454364				2022-12-28	WOS:000169710900003
J	Pfleiderer, C; Uhlarz, M; Hayden, SM; Vollmer, R; von Lohneysen, H; Bernhoeft, NR; Lonzarich, GG				Pfleiderer, C; Uhlarz, M; Hayden, SM; Vollmer, R; von Lohneysen, H; Bernhoeft, NR; Lonzarich, GG			Coexistence of superconductivity and ferromagnetism in the d-band metal ZrZn2	NATURE			English	Article							HEAT	It has generally been believed that, within the context of the Bardeen-Cooper-Schrieffer (BCS) theory of superconductivity, the conduction electrons in a metal cannot be both ferromagnetically ordered and superconducting(1,2). Even when the superconductivity has been interpreted as arising from magnetic mediation of the paired electrons, it was thought that the superconducting state occurs in the paramagnetic phase(3,4). Here we report the observation of superconductivity in the ferromagnetically ordered phase of the d-electron compound ZrZn2. The specific heat anomaly associated with the superconducting transition in this material appears to be absent, and the superconducting state is very sensitive to defects, occurring only in very pure samples. Under hydrostatic pressure superconductivity and ferromagnetism disappear at the same pressure, so the ferromagnetic state appears to be a prerequisite for superconductivity. When combined with the recent observation of superconductivity in UGe2 (ref. 4), our results suggest that metallic ferromagnets may universally become superconducting when the magnetization is small.	Univ Karlsruhe, Inst Phys, D-76128 Karlsruhe, Germany; Univ Bristol, HH Wills Phys Lab, Bristol BS8 1TL, Avon, England; Forschungszentrum Karlsruhe, Inst Festkorperphys, D-76021 Karlsruhe, Germany; CEA Grenoble, DRFMC, SPSMS, F-38054 Grenoble 9, France; Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England	Helmholtz Association; Karlsruhe Institute of Technology; University of Bristol; Helmholtz Association; Karlsruhe Institute of Technology; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Cambridge	Pfleiderer, C (corresponding author), Univ Karlsruhe, Inst Phys, D-76128 Karlsruhe, Germany.		Hayden, Stephen M/F-4162-2011; Loehneysen, Hilbert/W-2490-2019; Pfleiderer, Christian/P-3575-2014	Hayden, Stephen M/0000-0002-3209-027X; Pfleiderer, Christian/0000-0001-7749-7965				BERK NF, 1966, PHYS REV LETT, V17, P433, DOI 10.1103/PhysRevLett.17.433; BERNHOEFT NR, 1988, PHYS SCRIPTA, V38, P191, DOI 10.1088/0031-8949/38/2/015; Blagoev KB, 1999, PHYS REV LETT, V82, P133, DOI 10.1103/PhysRevLett.82.133; ENZ CP, 1978, SCIENCE, V201, P828, DOI 10.1126/science.201.4358.828; FAY D, 1980, PHYS REV B, V22, P3173, DOI 10.1103/PhysRevB.22.3173; Felner I, 1997, PHYS REV B, V55, pR3374, DOI 10.1103/PhysRevB.55.R3374; Fischer O., 1982, SUPERCONDUCTIVITY TE; FULDE P, 1964, PHYS REV, V135, pA550, DOI 10.1103/PhysRev.135.A550; GINZBURG VL, 1957, SOV PHYS JETP-USSR, V4, P153; HUANG SZ, 1981, SOLID STATE COMMUN, V38, P1151, DOI 10.1016/0038-1098(81)90977-7; JARLBORG T, 1988, J MAGN MAGN MATER, V23, P291; Karchev NI, 2001, PHYS REV LETT, V86, P846, DOI 10.1103/PhysRevLett.86.846; LARKIN AI, 1965, SOV PHYS JETP-USSR, V20, P762; LORAM JW, 1994, J SUPERCOND, V7, P243, DOI 10.1007/BF00730405; Mackenzie AP, 1998, PHYS REV LETT, V80, P161, DOI 10.1103/PhysRevLett.80.161; Mathur ND, 1998, NATURE, V394, P39, DOI 10.1038/27838; MATTHIAS BT, 1958, PHYS REV, V109, P604, DOI 10.1103/PhysRev.109.604; SANCHEZ D, 1995, PHYSICA B, V204, P167, DOI 10.1016/0921-4526(94)00259-X; Saxena SS, 2000, NATURE, V406, P587, DOI 10.1038/35020500; SCHREURS LWM, 1989, MATER RES BULL, V24, P1141, DOI 10.1016/0025-5408(89)90072-X; SMITH TF, 1971, PHYS REV LETT, V27, P1732, DOI 10.1103/PhysRevLett.27.1732; Sonin EB, 1998, PHYS REV B, V57, pR14000, DOI 10.1103/PhysRevB.57.R14000; VANDEURSEN APJ, 1986, J MAGN MAGN MATER, V54-7, P1113, DOI 10.1016/0304-8853(86)90407-5	23	393	396	6	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					58	61		10.1038/35083531	http://dx.doi.org/10.1038/35083531			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452303				2022-12-28	WOS:000169644900040
J	Pichot, C; Maataoui, M; Raddi, S; Raddi, P				Pichot, C; Maataoui, M; Raddi, S; Raddi, P			Surrogate mother for endangered Cupressus	NATURE			English	Article									INRA, Unite Rech Forestieres Mediterraneennes, F-84000 Avignon, France; Fac Sci, Dept Biol, UMR INRA UAPV Ecol Invertebres, F-84000 Avignon, France; Univ Florence, DISTAF, I-50145 Florence, Italy; CNR, Inst Forest Tree Pathol, I-50144 Florence, Italy	INRAE; Avignon Universite; INRAE; University of Florence; Consiglio Nazionale delle Ricerche (CNR)	Pichot, C (corresponding author), INRA, Unite Rech Forestieres Mediterraneennes, Ave Vivaldi, F-84000 Avignon, France.		Raddi, Sabrina/U-5640-2019	Raddi, Sabrina/0000-0002-9796-1515				BARRY J P, 1970, Bulletin de la Societe d'Histoire Naturelle de l'Afrique du Nord, V61, P95; Den Nijs A. P. M., 1993, V1, P229; Frankham R, 1998, NATURE, V392, P441, DOI 10.1038/33022; GAUSSEN H., 1968, GYMNOSPERMES ACTUELL; Mogie M., 1992, EVOLUTION ASEXUAL RE; PAPAGEORGIOU AC, 1993, SILVAE GENET, V42, P109; Pichot C, 2000, ANN FOREST SCI, V57, P17; Pichot C, 2000, THEOR APPL GENET, V101, P574, DOI 10.1007/s001220051518; Pichot C, 1998, SEX PLANT REPROD, V11, P148, DOI 10.1007/s004970050132; Singh H., 1978, EMBRYOLOGY GYMNOSPER	10	59	66	2	18	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					39	39		10.1038/35083687	http://dx.doi.org/10.1038/35083687			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452293	Green Published, Bronze			2022-12-28	WOS:000169644900030
J	Waterhouse, PM; Wang, MB; Lough, T				Waterhouse, PM; Wang, MB; Lough, T			Gene silencing as an adaptive defence against viruses	NATURE			English	Review							DOUBLE-STRANDED-RNA; MESSENGER-RNA; TRANSPOSABLE ELEMENT; DNA METHYLATION; CYTOSINE METHYLATION; TRANSGENE EXPRESSION; VIRAL MOVEMENT; SINGLE-COPY; PLANT GENE; INTERFERENCE	Gene silencing was perceived initially as an unpredictable and inconvenient side effect of introducing transgenes into plants. It now seems that it is the consequence of accidentally triggering the plant's adaptive defence mechanism against viruses and transposable elements. This recently discovered mechanism, although mechanistically different, has a number of parallels with the immune system of mammals.	CSIRO Plant Ind, Canberra, ACT 2601, Australia; HortRes, Palmerston North, New Zealand	Commonwealth Scientific & Industrial Research Organisation (CSIRO); New Zealand Institute for Plant & Food Research Ltd	Waterhouse, PM (corresponding author), CSIRO Plant Ind, Canberra, ACT 2601, Australia.	peterw@pi.csiro.au		Waterhouse, Peter/0000-0002-2812-3753				Anandalakshmi R, 2000, SCIENCE, V290, P142, DOI 10.1126/science.290.5489.142; Baulcombe DC, 1999, CURR OPIN PLANT BIOL, V2, P109, DOI 10.1016/S1369-5266(99)80022-3; Bennetzen JL, 1996, CURR TOP MICROBIOL, V204, P195; Bennetzen JL, 1996, TRENDS MICROBIOL, V4, P347, DOI 10.1016/0966-842X(96)10042-1; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; BLUMENTHAL T, 1979, ANNU REV BIOCHEM, V48, P525, DOI 10.1146/annurev.bi.48.070179.002521; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; BRUTNELL TP, 1994, GENETICS, V138, P213; Buck KW, 1999, PHILOS T R SOC B, V354, P613, DOI 10.1098/rstb.1999.0413; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Covey SN, 1997, NATURE, V385, P781, DOI 10.1038/385781a0; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; DECARVALHO F, 1992, EMBO J, V11, P2595, DOI 10.1002/j.1460-2075.1992.tb05324.x; Ding B, 1997, PLANT J, V12, P931, DOI 10.1046/j.1365-313X.1997.12040931.x; Domeier ME, 2000, SCIENCE, V289, P1928, DOI 10.1126/science.289.5486.1928; DOUGHERTY WG, 1995, CURR OPIN CELL BIOL, V7, P399, DOI 10.1016/0955-0674(95)80096-4; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; English JJ, 1996, PLANT CELL, V8, P179, DOI 10.1105/tpc.8.2.179; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; HAMILTON AJ, 1990, NATURE, V346, P284, DOI 10.1038/346284a0; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; HERSHBERGER RJ, 1995, GENETICS, V140, P1087; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; Holtorf H, 1999, PLANT CELL, V11, P471; Hutvagner G, 2000, RNA, V6, P1445, DOI 10.1017/S1355838200001096; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Jones AL, 1998, EMBO J, V17, P6385, DOI 10.1093/emboj/17.21.6385; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kooter JM, 1999, TRENDS PLANT SCI, V4, P340, DOI 10.1016/S1360-1385(99)01467-3; Kuhn C, 1997, SCIENCE, V275, P1298, DOI 10.1126/science.275.5304.1298; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Kunze R, 1997, ADV BOT RES, V27, P331; Lee KY, 1997, PLANT J, V12, P1127, DOI 10.1046/j.1365-313X.1997.12051127.x; Li HW, 1999, EMBO J, V18, P2683, DOI 10.1093/emboj/18.10.2683; LINDBO JA, 1992, VIROLOGY, V189, P725, DOI 10.1016/0042-6822(92)90595-G; LIU WM, 1994, NUCLEIC ACIDS RES, V22, P1087, DOI 10.1093/nar/22.6.1087; Llave C, 2000, P NATL ACAD SCI USA, V97, P13401, DOI 10.1073/pnas.230334397; LUCAS WJ, 1995, SCIENCE, V270, P1980, DOI 10.1126/science.270.5244.1980; LUCAS WJ, 1994, ANNU REV PHYTOPATHOL, V32, P387, DOI 10.1146/annurev.py.32.090194.002131; Mallory AC, 2001, PLANT CELL, V13, P571, DOI 10.1105/tpc.13.3.571; Marathe R, 2000, PLANT J, V22, P51, DOI 10.1046/j.1365-313x.2000.00710.x; Martienssen R, 1998, TRENDS GENET, V14, P263, DOI 10.1016/S0168-9525(98)01518-2; Mayo MA, 1999, ARCH VIROL, V144, P1659, DOI 10.1007/s007050050620; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Metzlaff M, 1997, CELL, V88, P845, DOI 10.1016/S0092-8674(00)81930-3; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Morel JB, 2000, CURR BIOL, V10, P1591, DOI 10.1016/S0960-9822(00)00862-9; MORRIS TJ, 1979, PHYTOPATHOLOGY, V69, P854, DOI 10.1094/Phyto-69-854; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; NAPOLI C, 1990, PLANT CELL, V7, P599; Ogawa T, 1996, NAT BIOTECHNOL, V14, P1566, DOI 10.1038/nbt1196-1566; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; POWELLABEL P, 1986, SCIENCE, V232, P738, DOI DOI 10.1126/SCIENCE.3457472; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; Ratcliff FG, 1999, PLANT CELL, V11, P1207, DOI 10.1105/tpc.11.7.1207; ROTHSTEIN SJ, 1987, P NATL ACAD SCI USA, V84, P8439, DOI 10.1073/pnas.84.23.8439; Ruiz-Medrano R, 1999, DEVELOPMENT, V126, P4405; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Sasaki T, 1998, PLANT CELL PHYSIOL, V39, P895, DOI 10.1093/oxfordjournals.pcp.a029451; SCHLAPPI M, 1994, CELL, V77, P427, DOI 10.1016/0092-8674(94)90157-0; SIMONS RW, 1983, CELL, V34, P683, DOI 10.1016/0092-8674(83)90401-4; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; Stam M, 2000, PLANT J, V21, P27, DOI 10.1046/j.1365-313x.2000.00650.x; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tanzer MM, 1997, PLANT CELL, V9, P1411, DOI 10.1105/tpc.9.8.1411; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; VanHoudt H, 1997, PLANT J, V12, P379, DOI 10.1046/j.1365-313X.1997.12020379.x; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; Wang MB, 2001, RNA, V7, P16, DOI 10.1017/S1355838201001224; Wang MB, 2000, PLANT MOL BIOL, V43, P67, DOI 10.1023/A:1006490331303; Wang MB, 2000, MOL PLANT PATHOL, V1, P347, DOI 10.1046/j.1364-3703.2000.00038.x; Wassenegger M, 1998, PLANT MOL BIOL, V37, P349, DOI 10.1023/A:1005946720438; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Yang D, 2000, CURR BIOL, V10, P1191, DOI 10.1016/S0960-9822(00)00732-6; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zou C, 1998, GENE, V211, P187, DOI 10.1016/S0378-1119(98)00107-3	90	706	820	4	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2001	411	6839					834	842		10.1038/35081168	http://dx.doi.org/10.1038/35081168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459066				2022-12-28	WOS:000169246400060
J	Budd, G				Budd, G			Climbing life's tree	NATURE			English	Editorial Material									Uppsala Univ, Dept Earth Sci, SE-75236 Uppsala, Sweden	Uppsala University	Budd, G (corresponding author), Uppsala Univ, Dept Earth Sci, Norbyvagen 22, SE-75236 Uppsala, Sweden.			Budd, Graham/0000-0001-9007-4369				Budd GE, 2000, BIOL REV, V75, P253, DOI 10.1017/S000632310000548X; SMITH AB, 1994, SYSTEMATICS FOSSIL R	2	18	19	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					487	487		10.1038/35087679	http://dx.doi.org/10.1038/35087679			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484029				2022-12-28	WOS:000170202900023
J	Modan, B; Hartge, P; Hirsh-Yechezkel, G; Chetrit, A; Lubin, F; Beller, U; Ben-Baruch, G; Fishman, A; Menczer, J; Struewing, JP; Tucker, MA; Wacholder, S; Ebbers, SM; Friedman, E; Piura, B				Modan, B; Hartge, P; Hirsh-Yechezkel, G; Chetrit, A; Lubin, F; Beller, U; Ben-Baruch, G; Fishman, A; Menczer, J; Struewing, JP; Tucker, MA; Wacholder, S; Ebbers, SM; Friedman, E; Piura, B		Natl Israel Ovarian Canc Study Grp	Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BREAST-CANCER; DETERMINANTS; POPULATION; OVULATION; ISRAEL; WOMEN	Background Multiparity and the use of oral contraceptives reduce the risk of ovarian cancer, but their effects on this risk in women with a BRCA1 or BRCA2 mutation are unclear. Methods We conducted a population-based case control study of ovarian cancer among Jewish women in Israel. Women were tested for the two founder mutations in BRCA1 and the one founder mutation in BRCA2 that are known to be common among Jews. We estimated the effects of parity and oral-contraceptive use on the risk of ovarian cancer in carriers and noncarriers in separate analyses that included all control women, who did not have ovarian cancer. Results Of 751 controls who underwent mutation analysis, 13 (1.7 percent) had a BRCA1 or BRCA2 mutation, whereas 244 of 840 women with ovarian cancer (29.0 percent) had a BRCA1 or BRCA2 mutation. Overall, each additional birth and each additional year of use of oral contraceptives were found to lower the risk of ovarian cancer, as expected. Additional births were protective in separate analyses of carriers and non-carriers, but oral-contraceptive use appeared to reduce the risk only in noncarriers; among carriers, the reduction in the odds of ovarian cancer was 12 percent per birth (95 percent confidence interval, 2.3 to 21 percent) and 0..2 percent per year of oral-contraceptive use (-4.9 to 5.0 percent). Conclusions The risk of ovarian cancer among carriers of a BRCA1 or BRCA2 mutation decreases with each birth but not with increased duration of use of oral contraceptives. These data suggest that it is premature to use oral contraceptives for the chemoprevention of ovarian cancer in carriers of such mutations. (N Engl J Med 2001;345:235-40.) Copyright (C) 2001 Massachusetts Medical Society.	Chaim Sheba Med Ctr, Dept Clin Epidemiol, IL-52621 Tel Hashomer, Israel; NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; Shaare Zedek Med Ctr, Jerusalem, Israel; Sapir Med Ctr, Kefar Sava, Israel; Edith Wolfson Med Ctr, Holon, Israel	Chaim Sheba Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Hebrew University of Jerusalem; Shaare Zedek Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Modan, B (corresponding author), Chaim Sheba Med Ctr, Dept Clin Epidemiol, IL-52621 Tel Hashomer, Israel.	BModan@gcrtner.hcalth.gov.il	Tucker, Margaret A/B-4297-2015; Struewing, Jeffery P/I-7502-2013; Struewing, Jeffery P/C-3221-2008	Struewing, Jeffery P/0000-0002-4848-3334; 	DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [Z01CP010171] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA061126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000732] Funding Source: NIH RePORTER; NCI NIH HHS [MS N02-CP-81005, N02-CP-60534, N02-CP-91026, R01 CA61126-01-03] Funding Source: Medline	DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMI HO, 1994, LANCET, V344, P1250, DOI 10.1016/S0140-6736(94)90749-8; ALBERT P, IN PRESS AM J EPIDEM; BOOTH M, 1989, BRIT J CANCER, V60, P592, DOI 10.1038/bjc.1989.320; CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P711; CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P717; Eeles RA, 2000, BRIT J CANCER, V83, P25; FATHALLA MF, 1971, LANCET, V2, P163; Gabrick DM, 2000, JAMA-J AM MED ASSOC, V284, P1791, DOI 10.1001/jama.284.14.1791; Godard B, 1998, AM J OBSTET GYNECOL, V179, P403, DOI 10.1016/S0002-9378(98)70372-2; GWINN ML, 1990, J CLIN EPIDEMIOL, V43, P559, DOI 10.1016/0895-4356(90)90160-Q; HARTGE P, 1989, AM J OBSTET GYNECOL, V161, P10, DOI 10.1016/0002-9378(89)90221-4; HARTGE P, 1995, BRIT J CANCER, V71, P642, DOI 10.1038/bjc.1995.126; MCGOWAN L, 1988, European Journal of Gynaecological Oncology, V9, P195; Modan B, 1996, JAMA-J AM MED ASSOC, V276, P1823, DOI 10.1001/jama.276.22.1823; Modan B, 1998, AM J EPIDEMIOL, V147, P1038; MORI M, 1988, AM J EPIDEMIOL, V128, P771, DOI 10.1093/oxfordjournals.aje.a115030; Narod SA, 1998, NEW ENGL J MED, V339, P424, DOI 10.1056/NEJM199808133390702; PARAZZINI F, 1991, EUR J CANCER, V27, P594, DOI 10.1016/0277-5379(91)90226-4; PIEGORSCH WW, 1994, STAT MED, V13, P153, DOI 10.1002/sim.4780130206; Riman T, 1998, CLIN ENDOCRINOL, V49, P695, DOI 10.1046/j.1365-2265.1998.00577.x; Rodriguez C, 2001, JAMA-J AM MED ASSOC, V285, P1460, DOI 10.1001/jama.285.11.1460; Rodriguez GC, 1998, J SOC GYNECOL INVEST, V5, P271, DOI 10.1016/S1071-5576(98)00017-3; Salazar-Martinez E, 1999, CANCER RES, V59, P3658; Schildkraut Joellen M., 2001, Gynecologic Oncology, V80, P275; Struewing JP, 1999, AM J HUM GENET, V65, P1800, DOI 10.1086/302678; Ursin G, 1997, CANCER RES, V57, P3678; WEISS NS, 1981, INT J CANCER, V28, P669, DOI 10.1002/ijc.2910280602; WEISS NS, 1988, AM J EPIDEMIOL, V128, P451, DOI 10.1093/oxfordjournals.aje.a114993; WU ML, 1988, AM J EPIDEMIOL, V128, P1216, DOI 10.1093/oxfordjournals.aje.a115076	29	261	264	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2001	345	4					235	240		10.1056/NEJM200107263450401	http://dx.doi.org/10.1056/NEJM200107263450401			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455XZ	11474660	Bronze			2022-12-28	WOS:000170054200001
J	Shelton, JD; Johnston, B				Shelton, JD; Johnston, B			Condom gap in Africa: evidence from donor agencies and key informants	BRITISH MEDICAL JOURNAL			English	Article									US Agcy Int Dev, Ctr Populat Hlth & Nutr, Washington, DC 20523 USA; Futures Grp Int, Populat Hlth & Nutr Informat Project, Washington, DC 20005 USA	United States Agency for International Development (USAID)	Shelton, JD (corresponding author), US Agcy Int Dev, Ctr Populat Hlth & Nutr, Washington, DC 20523 USA.							Gardner R, 1999, POPULATION REPORTS H, V9; HANENBERG RS, 1994, LANCET, V344, P243, DOI 10.1016/S0140-6736(94)93004-X; Sidley P, 2001, BRIT MED J, V322, P635, DOI 10.1136/bmj.322.7287.635	3	35	35	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2001	323	7305					139	139		10.1136/bmj.323.7305.139	http://dx.doi.org/10.1136/bmj.323.7305.139			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456WR	11463681	Bronze, Green Published			2022-12-28	WOS:000170106200015
J	Ellis, DA; Mabury, SA; Martin, JW; Muir, DCG				Ellis, DA; Mabury, SA; Martin, JW; Muir, DCG			Thermolysis of fluoropolymers as a potential source of halogenated organic acids in the environment	NATURE			English	Article							TRIFLUOROACETIC-ACID; SURFACE WATERS; PRECIPITATION; RADICALS; DEGRADATION; MECHANISM; PYROLYSIS; KINETICS; OZONE; RAIN	Following the introduction of hydrochlorofluorocarbon (HCFCs) and hydrofluorocarbon (HFCs) gases as replacements for the ozone-destroying chlorofluorocarbons (CFCs), it has been discovered that HCFCs/HFCs can degrade in the atmosphere to produce trifluoroacetic acid(1), a compound with no known loss mechanisms in the environment(2,3), and higher concentrations in natural waters(4) have been shown to be mildly phytotoxic(5). Present environmental levels of trifluooracetic acid are not accounted by HCFC/HFC degradation alone(8-10). Here we report that thermolysis of fluorinated polymers, such as the commercial polymers Teflon and Kel-F, can also produce trifluoroacetate and the similar compound chlorodifluoroacetate. This can occur either directly, or indirectly via products that are known to degrade to these haloacetates in the atmosphere(11). The environmental significance of these findings is confirmed by modelling, which indicates that the thermolysis of fluoropolymers in industrial and consumer high-temperature applications (ovens, nonstick cooking utensils and combustion engines) is likely to be a significant source of trifluoroacetate in urban rain water (similar to 25 ng l(-1), as estimated for Toronto). Thermolysis also leads to longer chain polyfluoro- and/or polychlorofluoro- (C3-C14) carboxylic acids which may be equally persistent. Some of these products have recently been linked with possible adverse health(6) and environmental impacts and are being phased out of the US market(7). Furthermore, we detected CFCs and fluorocarbons- groups that can destroy ozone and act as greenhouse gases, respectively-among the other thermal degradation products, suggesting that continued use of fluoropolymers may also exacerbate stratospheric ozone-depletion and global warming.	Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; Univ Guelph, Dept Environm Biol, Guelph, ON N1G 2W1, Canada; Environm Canada, Natl Water Res Inst, Burlington, ON L7R 4A6, Canada	University of Toronto; University of Guelph; Environment & Climate Change Canada; National Water Research Institute	Mabury, SA (corresponding author), Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada.		Martin, Jonathan W/J-3824-2013; Muir, Derek/AAD-7526-2021	Martin, Jonathan W/0000-0001-6265-4294; Muir, Derek/0000-0001-6631-9776				Acerboni G, 1999, CHEM PHYS LETT, V309, P364, DOI 10.1016/S0009-2614(99)00698-3; ARITO H, 1977, Annals of Occupational Hygiene, V20, P247, DOI 10.1093/annhyg/20.3.247; ATKINSON B, 1957, J CHEM SOC, P2086, DOI 10.1039/jr9570002086; Berends AG, 1999, ENVIRON TOXICOL CHEM, V18, P1053, DOI [10.1002/etc.5620180533, 10.1897/1551-5028(1999)018&lt;1053:TOTTAO&gt;2.3.CO;2]; Berg M, 2000, ENVIRON SCI TECHNOL, V34, P2675, DOI 10.1021/es990855f; Boutonnet JC, 1999, HUM ECOL RISK ASSESS, V5, P59, DOI 10.1080/10807039991289644; BROWN D, 2000, WASH POST       0517; Buravtsev NN, 1999, J FLUORINE CHEM, V96, P35, DOI 10.1016/S0022-1139(98)00325-X; Cahill TM, 2000, ENVIRON SCI TECHNOL, V34, P2909, DOI 10.1021/es991435t; Cahill TM, 2001, ENVIRON SCI TECHNOL, V35, P820, DOI 10.1021/es0013982; Ellis DA, 2000, ENVIRON SCI TECHNOL, V34, P632, DOI 10.1021/es990422c; FEIRING AE, 1994, ORGANOFLUORINE CHEM, P348; FRANKLIN J, 1993, CHEMOSPHERE, V27, P1565, DOI 10.1016/0045-6535(93)90251-Y; Holloway JH, 2000, J FLUORINE CHEM, V104, P3, DOI 10.1016/S0022-1139(00)00222-0; Hynes RG, 1999, J PHYS CHEM A, V103, P5967, DOI 10.1021/jp991065v; Imbalzano J.F, 1991, CHEM ENG PROG, V30, P69; Johns K, 2000, J FLUORINE CHEM, V104, P5, DOI 10.1016/S0022-1139(00)00251-7; Jordan A, 1999, ENVIRON SCI TECHNOL, V33, P522, DOI 10.1021/es980674y; Lemieux PM, 2000, ENVIRON SCI TECHNOL, V34, P377, DOI 10.1021/es990465t; Martin JW, 2000, ENVIRON SCI TECHNOL, V34, P274, DOI 10.1021/es990935j; Mashino M, 2000, J PHYS CHEM A, V104, P7255, DOI 10.1021/jp000498r; Paleta O, 1997, J FLUORINE CHEM, V86, P155, DOI 10.1016/S0022-1139(97)00083-3; RAVISHANKARA AR, 1993, SCIENCE, V259, P194, DOI 10.1126/science.259.5092.194; Rizvi M, 1995, J THERM ANAL, V45, P1597, DOI 10.1007/BF02547453; Schneider WF, 1996, J PHYS CHEM-US, V100, P6097, DOI 10.1021/jp952703m; Scott BF, 2000, ENVIRON SCI TECHNOL, V34, P4266, DOI 10.1021/es9908523; Simon CM, 1998, POLYM DEGRAD STABIL, V62, P1, DOI 10.1016/S0141-3910(97)00097-9; Teruel MA, 1999, INT J CHEM KINET, V31, P867, DOI 10.1002/(SICI)1097-4601(1999)31:12<867::AID-KIN5>3.0.CO;2-R; Upham BL, 1998, INT J CANCER, V78, P491, DOI 10.1002/(SICI)1097-0215(19981109)78:4<491::AID-IJC16>3.0.CO;2-9; Von Sydow LM, 2000, ENVIRON SCI TECHNOL, V34, P3115, DOI 10.1021/es9913683; Wujcik CE, 1999, ENVIRON SCI TECHNOL, V33, P1747, DOI 10.1021/es980697c	31	223	232	7	118	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					321	324		10.1038/35085548	http://dx.doi.org/10.1038/35085548			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460160				2022-12-28	WOS:000169918200043
J	Wang, C; Deng, L; Hong, M; Akkaraju, GR; Inoue, J; Chen, ZJJ				Wang, C; Deng, L; Hong, M; Akkaraju, GR; Inoue, J; Chen, ZJJ			TAK1 is a ubiquitin-dependent kinase of MKK and IKK	NATURE			English	Article							I-KAPPA-B; SIGNAL-TRANSDUCTION PATHWAY; DEFECTIVE INTERLEUKIN-1; ACTIVATION; PROTEIN; TRAF6; INDUCTION; ALPHA; IL-1; JNK	TRAF6 is a signal transducer that activates I kappaB kinase (IKK) and Jun amino-terminal kinase (JNK) in response to pro-inflammatory mediators such as interleukin-1 (IL-1) and lipopolysaccharides (LPS)(1-4). IKK activation by TRAF6 requires two intermediary factors, TRAF6-regulated IKK activator 1 (TRIKA1) and TRIKA2 (ref. 5). TRIKA1 is a dimeric ubiquitin-conjugating enzyme complex composed of Ubc13 and Uev1A (or the functionally equivalent Mms2). This Ubc complex, together with TRAF6, catalyses the formation of a Lys 63 (K63)-linked polyubiquitin chain that mediates IKK activation through a unique proteasome-independent mechanism(5). Here we report the purification and identification of TRIKA2, which is composed of TAK1, TAB1 and TAB2, a protein kinase complex previously implicated in IKK activation through an unknown mechanism(6,7). We find that the TAK1 kinase complex phosphorylates and activates IKK in a manner that depends on TRAF6 and Ubc13-Uev1A. Moreover, the activity of TAK1 to phosphorylate MKK6, which activates the JNK-p38 kinase pathway, is directly regulated by K63-linked polyubiquitination. We also provide evidence that TRAF6 is conjugated by the K63 polyubiquitin chains. These results indicate that ubiquitination has an important regulatory role in stress response pathways, including those of IKK and JNK.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Keio Univ, Dept Appl Chem, Kouhoku Ku, Kanagawa 2238522, Japan	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Keio University	Chen, ZJJ (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA.		Chen, Zhijian/C-6039-2012	Chen, Zhijian/0000-0002-8475-8251; Akkaraju, Giridhar/0000-0003-2977-2744				Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837; Zhao Q, 1999, J BIOL CHEM, V274, P8355, DOI 10.1074/jbc.274.13.8355	24	1565	1648	4	129	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					346	351		10.1038/35085597	http://dx.doi.org/10.1038/35085597			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460167				2022-12-28	WOS:000169918200050
J	Humphries, SE; Talmud, PJ; Hawe, E; Bolla, M; Day, INM; Miller, GJ				Humphries, SE; Talmud, PJ; Hawe, E; Bolla, M; Day, INM; Miller, GJ			Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study	LANCET			English	Article							DIAGONAL GEL-ELECTROPHORESIS; APOE-DEFICIENT MICE; ALZHEIMERS-DISEASE; E POLYMORPHISM; MYOCARDIAL-INFARCTION; RISK; LIPOPROTEIN; ATHEROSCLEROSIS; AUTOANTIBODIES; ACTIVATION	Background The common isoforms of apolipoprotein E (apoE), E2, E3, and E4, are important determinants of plasma lipid concentrations, and the epsilon4 allele is associated with raised risk of coronary heart disease. We investigated whether the effect of smoking on coronary heart disease risk is affected by APOE genotype. Methods We enrolled 3052 middle-aged men who were free of coronary heart disease for prospective cardiovascular surveillance in the second Northwick Park Heart Study (NPHSII). Smoking habit was ascertained at baseline and yearly by questionnaire. APOE genotype was identified by PCR and restriction enzyme digestion. Endpoints were fatal coronary heart disease, non-fatal myocardial infarction, and coronary artery surgery and silent myocardial infarction at follow-up. Findings During 18 836 person years of surveillance, 96 men had an acute myocardial infarction, 26 needed coronary artery surgery, and 14 had silent myocardial infarctions. Compared with never-smokers, risk of coronary heart disease in ex-smokers was 1.34 (95% CI 0.86-2.08) and in smokers it was 1.94 (1.25-3.01). This risk was independent of other classic risk factors. In never-smokers, risk was closely similar in men with different genotypes. Risk in men homozygous for the epsilon3 allele was 1.74 (1.10-2.77) in ex-smokers and 1.68 (1.01-2.83) in smokers, whereas in men carrying the epsilon4 allele risk was 0.84 (0.40-1.75) and 3.17 (1.82-5.50), respectively, with no significant differences in risk in the epsilon2 carriers. For the epsilon3 group, the genotype effect on risk was no longer significant after adjustment for classic risk factors (including plasma lipids). However. even after adjustment. smokers who were carriers of the epsilon4 allele, showed significantly raised risk of coronary heart disease compared with the non-smoking group (2.79, 1.59-4.91, epsilon4-smoking interaction p=0.007). Interpretation Smoking increases the risk of coronary heart disease in men of all genotypes but particularly in men carrying the epsilon4 allele.	Royal Free & UCL, Sch Med, Rayne Inst, Dept Med,Ctr Cardiovasc Genet, London WC1E 6JJ, England; St Bartholomews Hosp, Coll Med, Wolfson Inst Prevent Med, MRC Epidemiol & Med Care Unit, London, England; Southampton Univ Hosp NHS Trust & Sch Med, Human Genet Res Div, Southampton, Hants, England	University of London; King's College London; University College London; UCL Medical School; University of London; Queen Mary University London; University of Southampton	Humphries, SE (corresponding author), Royal Free & UCL, Sch Med, Rayne Inst, Dept Med,Ctr Cardiovasc Genet, London WC1E 6JJ, England.	rmhaseh@ucl.ac.uk	Talmud, Philippa J/C-4402-2008; Humphries, Stephen E/C-5075-2008	Talmud, Philippa/0000-0002-5560-1933; Humphries, Stephen E/0000-0002-8221-6547	NHLBI NIH HHS [HL 33014] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL033014] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLEN DR, 1988, J VASC SURG, V7, P139, DOI 10.1067/mva.1988.avs0070139; BLANN AD, 1992, ATHEROSCLEROSIS, V96, P249, DOI 10.1016/0021-9150(92)90072-O; BOLLA MK, 1995, CLIN CHEM, V41, P1599; CHAIT A, 1993, AM J MED, V94, P350, DOI 10.1016/0002-9343(93)90144-E; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DALMON J, 1993, MOL CELL BIOL, V13, P1183, DOI 10.1128/MCB.13.2.1183; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; DAY INM, 1994, ANAL BIOCHEM, V222, P389, DOI 10.1006/abio.1994.1507; Desurmont C, 2000, ARTERIOSCL THROM VAS, V20, P435, DOI 10.1161/01.ATV.20.2.435; Doll R, 2000, BRIT MED J, V320, P1097, DOI 10.1136/bmj.320.7242.1097; DOLL RICHARD, 1966, NAT CANCER INST MONOGR, V19, P205; Eliasson B, 1997, ATHEROSCLEROSIS, V129, P79, DOI 10.1016/S0021-9150(96)06028-5; Fickl H, 1996, ATHEROSCLEROSIS, V124, P75, DOI 10.1016/0021-9150(96)05820-0; Gerdes LU, 2000, CIRCULATION, V101, P1366, DOI 10.1161/01.CIR.101.12.1366; GREEN MS, 1986, AM HEART J, V111, P932, DOI 10.1016/0002-8703(86)90645-9; Haffer S., 1996, ARTERIOSCLER THROMB, V58, P585; HIXSON JE, 1991, ARTERIOSCLER THROMB, V11, P1237, DOI 10.1161/01.ATV.11.5.1237; Ishigami M, 2000, ARTERIOSCL THROM VAS, V20, P1020, DOI 10.1161/01.ATV.20.4.1020; Kessler C, 1997, ARTERIOSCL THROM VAS, V17, P2880, DOI 10.1161/01.ATV.17.11.2880; Lowe Gordon D. O., 1993, Current Opinion in Lipidology, V4, P283, DOI 10.1097/00041433-199308000-00004; MILLER GJ, 1995, THROMB HAEMOSTASIS, V73, P82; Miller GJ, 1996, THROMB HAEMOSTASIS, V75, P767; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; *MRC COMM RES CHRO, 1976, QUEST RESP SYMPT; Ott A, 1998, LANCET, V351, P1840, DOI 10.1016/S0140-6736(97)07541-7; PALINSKI W, 1994, ARTERIOSCLER THROMB, V14, P605, DOI 10.1161/01.ATV.14.4.605; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; Pratico D, 1998, NAT MED, V4, P1189, DOI 10.1038/2685; Prineas R., 1982, MINNESOTA CODE MANUA; Seed M, 2001, AM J MED, V110, P22, DOI 10.1016/S0002-9343(00)00652-5; Smith JD, 1998, INT J CLIN LAB RES, V28, P116, DOI 10.1007/s005990050030; Stengard JH, 1999, CLIN GENET, V56, P367; Talmud PJ, 2000, ATHEROSCLEROSIS, V149, P75, DOI 10.1016/S0021-9150(99)00309-3; Terry JG, 1996, STROKE, V27, P1755, DOI 10.1161/01.STR.27.10.1755; *WHO REG OFF EUR, 1976, MYOC INF COMM REG; Wilson PWF, 1996, ARTERIOSCL THROM VAS, V16, P1250, DOI 10.1161/01.ATV.16.10.1250	36	197	211	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 14	2001	358	9276					115	119		10.1016/S0140-6736(01)05330-2	http://dx.doi.org/10.1016/S0140-6736(01)05330-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452BR	11463413				2022-12-28	WOS:000169837700012
J	Inwald, D; Roland, M; Kuitert, L; McKenzie, SA; Petros, A				Inwald, D; Roland, M; Kuitert, L; McKenzie, SA; Petros, A			Oxygen treatment for acute severe asthma	BRITISH MEDICAL JOURNAL			English	Article							NEBULIZED SALBUTAMOL; 100-PERCENT OXYGEN; DRIVING GAS; VENTILATION; PERFUSION; PHENYLEPHRINE; HYPOXEMIA; SAFE		Inst Child Hlth, Portex Dept Anaesthesia Intens Care & Resp Med, London WC1N 1EH, England; St Bartholomews & Royal London Sch Med & Dent, Dept Resp Med, London EC1A 7BE, England; Royal London Hosp, Queen Elizabeth Childrens Serv, London E1 1BB, England; Great Ormond St Hosp Children, Paediat Intens Care Unit, London WC1N 3JF, England	University of London; University College London; University of London; Queen Mary University London; Barts Health NHS Trust; Royal London Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Inwald, D (corresponding author), Inst Child Hlth, Portex Dept Anaesthesia Intens Care & Resp Med, 30 Guilford St, London WC1N 1EH, England.			Inwald, David/0000-0001-9518-7821				ALLIOTT RJ, 1972, BMJ-BRIT MED J, V1, P539, DOI 10.1136/bmj.1.5799.539; BALLESTER E, 1989, THORAX, V44, P258, DOI 10.1136/thx.44.4.258; BALLESTER E, 1990, AM REV RESPIR DIS, V141, P558, DOI 10.1164/ajrccm/141.3.558; BASS BH, 1969, LANCET, V2, P438; Campbell MJ, 1997, BRIT MED J, V314, P1439, DOI 10.1136/bmj.314.7092.1439; CATES CJ, 2000, COCHRANE DATABASE SY; CHOOKANG YE, 1974, SCOT MED J, V19, P191, DOI 10.1177/003693307401900407; CONNETT G, 1993, THORAX, V48, P574, DOI 10.1136/thx.48.5.574; CRANE J, 1987, NEW ZEAL MED J, V100, P309; DOUGLAS JG, 1985, THORAX, V40, P180, DOI 10.1136/thx.40.3.180; FIELD GB, 1967, CLIN SCI, V32, P279; GLEESON JGA, 1988, ARCH DIS CHILD, V63, P900, DOI 10.1136/adc.63.8.900; GUNAWARDENA KA, 1984, BRIT MED J, V288, P272, DOI 10.1136/bmj.288.6413.272; HARRIS L, 1972, J ALLERGY CLIN IMMUN, V49, P63, DOI 10.1016/0091-6749(72)90057-7; Kotani Y, 1999, J ASTHMA, V36, P583, DOI 10.3109/02770909909087295; MCFADDEN ER, 1968, NEW ENGL J MED, V278, P1027, DOI 10.1056/NEJM196805092781901; MOLFINO NA, 1991, NEW ENGL J MED, V324, P285, DOI 10.1056/NEJM199101313240502; PALMER KNV, 1969, BRIT MED J, V1, P31, DOI 10.1136/bmj.1.5635.31; RODRIGUEZROISIN R, 1989, AM REV RESPIR DIS, V139, P732, DOI 10.1164/ajrccm/139.3.732; Somerville M, 1995, J PUBLIC HEALTH MED, V17, P397; TAL A, 1984, CHEST, V86, P868, DOI 10.1378/chest.86.6.868; WAGNER PD, 1978, AM REV RESPIR DIS, V118, P511; WILLIAMS AJ, 1994, PULM PHARMACOL, V7, P235, DOI 10.1006/pulp.1994.1026; [No title captured], DOI DOI 10.1136/THX.52.2008.S1]	24	23	23	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 14	2001	323	7304					98	100		10.1136/bmj.323.7304.98	http://dx.doi.org/10.1136/bmj.323.7304.98			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454GD	11451788	Green Published			2022-12-28	WOS:000169964100022
J	Sterne, JAC; Egger, M; Smith, GD				Sterne, JAC; Egger, M; Smith, GD			Systematic reviews in health care - Investigating and dealing with publication and other biases in meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DATA-AUGMENTATION APPROACH; PASSIVE SMOKING DEBATE; CLINICAL RESEARCH; CONTROLLED TRIALS; DRUG TRIALS; METAANALYSIS; ACCOUNT		Univ Bristol, Dept Social Med, MRC, Hlth Serv Res Collaborat, Bristol BS8 2PR, Avon, England	University of Bristol	Sterne, JAC (corresponding author), Univ Bristol, Dept Social Med, MRC, Hlth Serv Res Collaborat, Bristol BS8 2PR, Avon, England.	jonathan.sterne@bristol.ac.uk	Davey Smith, George/A-7407-2013; Sterne, Jonathan/Z-3106-2019	Davey Smith, George/0000-0002-1407-8314; Sterne, Jonathan/0000-0001-8496-6053; Egger, Matthias/0000-0001-7462-5132				BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Begg CB, 1997, STAT SCI, V12, P241; Copas J, 1999, J R STAT SOC A STAT, V162, P95, DOI 10.1111/1467-985X.00123; Copas JB, 2000, BRIT MED J, V320, P417, DOI 10.1136/bmj.320.7232.417; Daniels MJ, 1997, STAT MED, V16, P1965, DOI 10.1002/(SICI)1097-0258(19970915)16:17<1965::AID-SIM630>3.3.CO;2-D; Dear K.B.G., 1992, STAT SCI, V7, P237, DOI DOI 10.1214/SS/1177011363; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; DUVAL SJ, 2001, IN PRESS J AM STAT A; DUVAL SJ, 2001, IN PRES BIOMETRICS; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M, 2001, SYSTEMATIC REV HLTH; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Givens GH, 1997, STAT SCI, V12, P221; GLASZIOU PP, 1995, BMJ-BRIT MED J, V311, P1356, DOI 10.1136/bmj.311.7016.1356; GOTZSCHE PC, 1989, EUR J CLIN PHARMACOL, V36, P429, DOI 10.1007/BF00558064; GOTZSCHE PC, 1993, LANCET, V341, P1533; GOTZSCHE PC, 1987, BRIT MED J, V295, P654, DOI 10.1136/bmj.295.6599.654; Hedges LV, 1992, STAT SCI, V7, P246, DOI DOI 10.1214/SS/1177011364; Hughes MD, 1998, AIDS, V12, P1823, DOI 10.1097/00002030-199814000-00014; Iyengar S., 1988, STAT SCI, V3, P109, DOI DOI 10.1214/SS/1177013012; JUNI P, 2001, BMJ, V322; Lefebvre C, 2001, SYSTEMATIC REV HLTH; LIGHT RJ, 1981, SUMMING UP SCI REV R; Linde K, 1997, LANCET, V350, P834, DOI 10.1016/S0140-6736(97)02293-9; MADDOX J, 1988, NATURE, V334, P287, DOI 10.1038/334287a0; Midgley JP, 1996, JAMA-J AM MED ASSOC, V275, P1590, DOI 10.1001/jama.275.20.1590; MOHER D, 2001, IN PRESS LANCET; MORGENSTERN H, 1982, AM J PUBLIC HEALTH, V72, P1336, DOI 10.2105/AJPH.72.12.1336; RAVNSKOV U, 1992, BMJ-BRIT MED J, V305, P15, DOI 10.1136/bmj.305.6844.15; SMITH GD, 1994, BMJ-BRIT MED J, V308, P72, DOI 10.1136/bmj.308.6921.72; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Sterne J, 2001, SYSTEMATIC REV HLTH; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; STERNE JAC, 2001, HIGH FALSE POSITIVE; STERNE JAC, 2001, IN PRESS J CLIN EPID; STUCK AE, 1993, LANCET, V342, P1032, DOI 10.1016/0140-6736(93)92884-V; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Taylor S, 1998, AUSTRALASIAN EPIDEMI, V5, P14; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; THOMPSON SG, 2001, SYSTEMATIC REV HLTH; Tramer MR, 1997, BMJ-BRIT MED J, V315, P635, DOI 10.1136/bmj.315.7109.635; Vandenbroucke JP, 1997, LANCET, V350, P824, DOI 10.1016/S0140-6736(97)22038-6; VEVEA JL, 1995, PSYCHOMETRIKA, V60, P419, DOI 10.1007/BF02294384; Villar J, 1997, J CLIN EPIDEMIOL, V50, P997, DOI 10.1016/S0895-4356(97)00148-0	46	1405	1439	2	69	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2001	323	7304					101	105		10.1136/bmj.323.7304.101	http://dx.doi.org/10.1136/bmj.323.7304.101			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454GD	11451790	Green Published			2022-12-28	WOS:000169964100023
J	Sprent, J; Tough, DF				Sprent, J; Tough, DF			T cell death and memory	SCIENCE			English	Editorial Material							IN-VIVO; LYMPHOCYTES; PHENOTYPE; DIFFERENTIATION; STIMULATION; PERSISTENCE; EXPRESSION; INDUCTION; RESPONSES; EFFECTORS	In typical immune responses, contact with antigen causes naive T cells to proliferate and differentiate into effector cells. After the pathogen is destroyed, most effector T cells are eliminated-thereby preserving the primary T cell repertoire-but some cells survive and form long-lived memory cells. During each stage of this process, the Life or death fate of T cells is strictly regulated.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Sprent, J (corresponding author), Scripps Res Inst, Dept Immunol, IMM4,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jsprent@scripps.edu			NATIONAL CANCER INSTITUTE [R37CA038355, R01CA038355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021487, R01AI046710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG001743] Funding Source: NIH RePORTER; NCI NIH HHS [CA38355] Funding Source: Medline; NIAID NIH HHS [AI46710, AI21487] Funding Source: Medline; NIA NIH HHS [AG01743] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahmed R, 1999, FUNDAMENTAL IMMUNOLO, P1295; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; GOWANS JL, 1964, PROC R SOC SER B-BIO, V159, P257, DOI 10.1098/rspb.1964.0001; Huang LR, 2000, P NATL ACAD SCI USA, V97, P3406, DOI 10.1073/pnas.060026497; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; JUDGE A, UNPUB; Kaufman SHE., 1999, FUNDAMENTAL IMMUNOLO, P1335; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Picker L.J., 1999, FUNDAMENTAL IMMUNOLO, P479; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Saparov A, 1999, IMMUNITY, V11, P271, DOI 10.1016/S1074-7613(00)80102-8; Sourdive DJD, 1998, J EXP MED, V188, P71, DOI 10.1084/jem.188.1.71; SPRENT J, 1973, CELL IMMUNOL, V7, P10, DOI 10.1016/0008-8749(73)90180-9; SPRENT J, 1978, IMMUNOL REV, V42, P108, DOI 10.1111/j.1600-065X.1978.tb00260.x; Sprent J, 1997, CURR OPIN IMMUNOL, V9, P371, DOI 10.1016/S0952-7915(97)80084-2; Sprent J, 2001, CURR OPIN IMMUNOL, V13, P248, DOI 10.1016/S0952-7915(00)00211-9; SPRENT J, 1976, CELL IMMUNOL, V21, P278, DOI 10.1016/0008-8749(76)90057-5; Steinman R. M, 1999, FUNDAMENTAL IMMUNOLO, P547; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Tough DF, 2001, J IMMUNOL, V166, P6007, DOI 10.4049/jimmunol.166.10.6007; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; Whitmire JK, 2000, CURR OPIN IMMUNOL, V12, P448, DOI 10.1016/S0952-7915(00)00119-9; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; Zinkernagel RM, 1996, ANNU REV IMMUNOL, V14, P333, DOI 10.1146/annurev.immunol.14.1.333	33	162	177	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2001	293	5528					245	248		10.1126/science.1062416	http://dx.doi.org/10.1126/science.1062416			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452113				2022-12-28	WOS:000169875200043
J	Hogberg, P; Nordgren, A; Buchmann, N; Taylor, AFS; Ekblad, A; Hogberg, MN; Nyberg, G; Ottosson-Lofvenius, M; Read, DJ				Hogberg, P; Nordgren, A; Buchmann, N; Taylor, AFS; Ekblad, A; Hogberg, MN; Nyberg, G; Ottosson-Lofvenius, M; Read, DJ			Large-scale forest girdling shows that current photosynthesis drives soil respiration	NATURE			English	Article							CARBON BALANCE; TEMPERATURE SENSITIVITY; ROOTS	The respiratory activities of plant roots, of their mycorrhizal fungi and of the free-living microbial heterotrophs (decomposers) in soils are significant components of the global carbon balance, but their relative contributions remain uncertain(1,2). To separate mycorrhizal root respiration from heterotrophic respiration in a boreal pine forest, we conducted a large-scale tree-girdling experiment, comprising 9 plots each containing about 120 trees. Tree-girdling involves stripping the stem bark to the depth of the current xylem at breast height terminating the supply of current photosynthates to roots and their mycorrhizal fungi without physically disturbing the delicate root-microbe-soil system. Here we report that girdling reduced soil respiration within 1-2 months by about 54% relative to respiration on ungirdled control plots, and that decreases of up to 37% were detected within 5 days. These values clearly show that the flux of current assimilates to roots is a key driver of soil respiration; they are conservative estimates of root respiration, however, because girdling increased the use of starch reserves in the roots. Our results indicate that models of soil respiration should incorporate measures of photosynthesis and of seasonal patterns of photosynthate allocation to roots.	SLU, Depr Forest Ecol, Sect Soil Sci, SE-90183 Umea, Sweden; Max Planck Inst Biogeochem, D-07701 Jena, Germany; SLU, Dept Forest Mycol & Pathol, SE-75007 Uppsala, Sweden; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Swedish University of Agricultural Sciences; Max Planck Society; Swedish University of Agricultural Sciences; University of Sheffield	Hogberg, P (corresponding author), SLU, Depr Forest Ecol, Sect Soil Sci, SE-90183 Umea, Sweden.		Högberg, Mona N./L-9635-2014; Ekblad, Alf/AAG-2632-2019; Read, David/C-2454-2013; Högberg, Peter/B-2916-2012; Buchmann, Nina/E-6095-2011	Högberg, Mona N./0000-0003-1258-7630; Högberg, Peter/0000-0002-2849-2719; Buchmann, Nina/0000-0003-0826-2980; Nyberg, Gert/0000-0003-1979-8772				Agren G. I., 1980, Ecological Bulletins, V32, P307; Boone RD, 1998, NATURE, V396, P570, DOI 10.1038/25119; Craine JM, 1999, PLANT SOIL, V207, P77, DOI 10.1023/A:1004417419288; EDWARDS NT, 1979, OECOLOGIA, V40, P247, DOI 10.1007/BF00345322; Ericsson A., 1980, Ecological Bulletins, V32, P239; Goulden ML, 1998, SCIENCE, V279, P214, DOI 10.1126/science.279.5348.214; Grace J, 2000, NATURE, V404, P819, DOI 10.1038/35009170; Hansen J., 1997, P97; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Hogberg P, 1996, SOIL BIOL BIOCHEM, V28, P1131, DOI 10.1016/0038-0717(96)00124-1; Lindroth A, 1998, GLOBAL CHANGE BIOL, V4, P443, DOI 10.1046/j.1365-2486.1998.00165.x; Malhi Y, 1999, PLANT CELL ENVIRON, V22, P715, DOI 10.1046/j.1365-3040.1999.00453.x; Plamboeck AH, 1999, OECOLOGIA, V119, P452, DOI 10.1007/s004420050807; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Smith SE, 1997, MYCORRHIZAL SYMBIOSE; SODERSTROM B, 1987, SOIL BIOL BIOCHEM, V19, P231, DOI 10.1016/0038-0717(87)90002-2; STEEN E, 1986, NEW PHYTOL, V104, P339, DOI 10.1111/j.1469-8137.1986.tb02901.x; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084	18	1394	1539	22	694	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					789	792		10.1038/35081058	http://dx.doi.org/10.1038/35081058			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459055				2022-12-28	WOS:000169246400046
J	Webb, E; Shankleman, W; Evans, MR; Brooks, R				Webb, E; Shankleman, W; Evans, MR; Brooks, R			The health of children in refuges for women victims of domestic violence: cross sectional descriptive survey	BRITISH MEDICAL JOURNAL			English	Article								Objectives To describe the health and developmental status of children living in refuges for women victims of domestic violence and to investigate their access to primary healthcare services. Design Cross sectional survey. Setting Women's refuges in Cardiff. Participants 148 resident children aged under 16 years and their mothers. Main outcome measures Completeness of records on the child health system (register of all children that includes data on the child's health) for named health visitor, named general practitioner, and immunisation uptake; satisfactory completion of child health surveillance; Denver test results for developmental status; Rutter test scores for behavioural and emotional problems; reports of maternal concerns. Results 148/257 (58%) children living in refuges between April 1999 and January 2000 were assessed. Child health system data were incorrect (general practitioner and/or address) or unavailable for 85/148 (57%) children. Uptake of all assessments and immunisations was low 13/68 (19%) children aged <5 years had delayed or questionable development on the Denver test, and 49/101 (49%) children aged 3-15 years had a Rutter score of >10 (indicating probable mental health problems). Concerns were expressed by mothers of 113/148 (76%) children. After leaving the refuge, 22 children were untraceable and 36 returned home to the perpetrator from whom the families had fled. Conclusions The children had a high level of need, as well as poor access to sei vices. Time spent in a refuge provides a window of opportunity to review health and developmental status. Specialist health visitors could facilitate and provide support, liaison, and follow up.	Univ Wales Coll Med, Dept Child Hlth, Cardiff CF14 4XW, S Glam, Wales; Univ Wales Coll Med, Dept Epidemiol & Publ Hlth, Cardiff CF14 4XW, S Glam, Wales; Cardiff & Vale NHS Trust, Primary Care Directorate, Sure Start, Lansdowne Hosp, Cardiff CF11 8UL, S Glam, Wales	Cardiff University; Cardiff University; Cardiff University	Webb, E (corresponding author), Univ Wales Coll Med, Dept Child Hlth, Cardiff CF14 4XW, S Glam, Wales.		Evans, Meirion/C-2990-2008	Evans, Meirion/0000-0003-3578-1866				[Anonymous], 1990, DENVER 2 TECHNICAL M; *BRIT PAED ASS, 1990, OUTC MEAS CHILD HLTH; Brooks R. M., 1998, AMBULATORY CHILD HLT, V4, P369; *DEP HLTH HOM OFF, 1999, WORK SAF CHILDR GUID; Department of Health, 1998, QUAL PROT PROGR TRAN; Department of Health, 1995, TOG WE STAND COMM RO; Elander J, 1996, INT J METHOD PSYCH, V6, P63, DOI 10.1002/(SICI)1234-988X(199607)6:2<63::AID-MPR151>3.3.CO;2-M; ERICKSEN JR, 1992, J ADV NURS, V17, P1200, DOI 10.1111/j.1365-2648.1992.tb01836.x; Hall D, 1998, BRIT MED J, V316, P1551, DOI 10.1136/bmj.316.7144.1551; HALL D, 1996, HLTH ALL; Hiew C. C., 1994, CHILDREN WORLDWIDE, V21, P27; Hogg C, 1997, EMOTIONAL BEHAV PROB; KEROUAC S, 1986, HLTH CARE WOMEN INT, V7, P412; Meltzer H, 1999, MENTAL HLTH CHILDREN; OHARA M, 1995, DOMESTIC VIOLENCE CH; SHANKLEMAN J, 2000, ARCH DIS CHILD, V82, pA55; Webb E, 1998, BRIT MED J, V316, P1588, DOI 10.1136/bmj.316.7144.1588; *WELCH OFF, 1999, 2099 WELSH OFF; *WELCH OFF, 1997, HLTH CHILDR WAL	19	19	19	0	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2001	323	7306					210	213		10.1136/bmj.323.7306.210	http://dx.doi.org/10.1136/bmj.323.7306.210			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459UQ	11473915	Green Published, Bronze			2022-12-28	WOS:000170270200021
J	Carson, MJ; Lo, D				Carson, MJ; Lo, D			Immunology - The push-me pull-you of T cell activation	SCIENCE			English	Editorial Material									Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Digital Gene Technol Inc, La Jolla, CA 92037 USA	Scripps Research Institute	Carson, MJ (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.							Gran B, 1999, ANN NEUROL, V45, P559, DOI 10.1002/1531-8249(199905)45:5<559::AID-ANA3>3.0.CO;2-Q; Kabarowski JHS, 2001, SCIENCE, V293, P702, DOI 10.1126/science.1061781; Le LQ, 2001, IMMUNITY, V14, P561, DOI 10.1016/S1074-7613(01)00145-5; Lo D, 1999, IMMUNOL REV, V169, P225, DOI 10.1111/j.1600-065X.1999.tb01318.x; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MCMURRAY HF, 1993, J CLIN INVEST, V92, P1004, DOI 10.1172/JCI116605; QUINN MT, 1988, P NATL ACAD SCI USA, V85, P2805, DOI 10.1073/pnas.85.8.2805; Weng ZG, 1998, P NATL ACAD SCI USA, V95, P12334, DOI 10.1073/pnas.95.21.12334	8	14	16	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					618	619		10.1126/science.1063516	http://dx.doi.org/10.1126/science.1063516			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474091				2022-12-28	WOS:000170204600033
J	Kuroda, A; Nomura, K; Ohtomo, R; Kato, J; Ikeda, T; Takiguchi, N; Ohtake, H; Kornberg, A				Kuroda, A; Nomura, K; Ohtomo, R; Kato, J; Ikeda, T; Takiguchi, N; Ohtake, H; Kornberg, A			Role of inorganic polyphosphate in promoting ribosomal, protein degradation by the ion protease in E-coli	SCIENCE			English	Article							ESCHERICHIA-COLI; LON PROTEASE; SULA; PURIFICATION; SYSTEM	Inorganic polyphosphate (polyp), a polymer of hundreds of phosphate (P-i) residues, accumulates in Escherichia coli in response to stresses, including amino acid starvation. Here we show that the adenosine 5'-triphosphate-dependent protease Lon formed a complex with polyp and degraded most of the ribosomal proteins, including S2, L9, and L13. Purified S2 also bound to polyp and formed a complex with Lon in the presence of polyP. Thus, polyP may promote ribosomal. protein degradation by the Lon protease, thereby supplying the amino acids needed to respond to starvation.	Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Hiroshima 7398527, Japan; Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	Hiroshima University; Stanford University	Kuroda, A (corresponding author), Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, 1-4-1 Kagamiyama, Hiroshima 7398527, Japan.		Kato, Junichi/S-1469-2018; Takiguchi, Noboru/F-3419-2014	Kato, Junichi/0000-0003-0279-8813; Takiguchi, Noboru/0000-0001-7266-0276				Ault-Riche D, 1998, J BACTERIOL, V180, P1841; CACHIA C, 1991, J CHROMATOGR, V539, P343, DOI 10.1016/S0021-9673(01)83943-1; CHUNG CH, 1982, P NATL ACAD SCI-BIOL, V79, P795, DOI 10.1073/pnas.79.3.795; GOLDBERG AL, 1992, EUR J BIOCHEM, V203, P9, DOI 10.1111/j.1432-1033.1992.tb19822.x; Ishii Y, 2000, J BIOCHEM-TOKYO, V127, P837, DOI 10.1093/oxfordjournals.jbchem.a022677; Kanemori M, 1999, J BACTERIOL, V181, P3674, DOI 10.1128/JB.181.12.3674-3680.1999; KORNBERG A, 1995, J BACTERIOL, V177, P491, DOI 10.1128/jb.177.3.491-496.1995; Kuroda A, 1997, J BIOL CHEM, V272, P21240, DOI 10.1074/jbc.272.34.21240; Kuroda A, 1999, P NATL ACAD SCI USA, V96, P14264, DOI 10.1073/pnas.96.25.14264; MAURIZI MR, 1992, EXPERIENTIA, V48, P178, DOI 10.1007/BF01923511; Miller C. G., 1996, ESCHERICHIA COLI SAL, P938; MIZUSAWA S, 1983, P NATL ACAD SCI-BIOL, V80, P358, DOI 10.1073/pnas.80.2.358; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; NISHI K, 1988, MOL GEN GENET, V212, P177, DOI 10.1007/BF00322462; SONEZAKI S, 1994, APPL MICROBIOL BIOT, V42, P313; ULBRICH B, 1975, EUR J BIOCHEM, V57, P49, DOI 10.1111/j.1432-1033.1975.tb02275.x; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006	17	285	295	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					705	708		10.1126/science.1061315	http://dx.doi.org/10.1126/science.1061315			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474114				2022-12-28	WOS:000170204600057
J	Cooper, DS				Cooper, DS			Subclinical hypothyroidism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MATERNAL THYROID-DEFICIENCY; 20-YEAR FOLLOW-UP; NEUROPSYCHOLOGICAL DEVELOPMENT; COST-EFFECTIVENESS; DOUBLE-BLIND; THYROXINE; DISEASE; THYROTROPIN; COMMUNITY; PREVALENCE		Sinai Hosp, Div Endocrinol, Baltimore, MD 21215 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Sinai Hospital of Baltimore; Johns Hopkins University	Cooper, DS (corresponding author), Sinai Hosp, Div Endocrinol, 2401 W Belvedere Ave, Baltimore, MD 21215 USA.	dcooper@lifebridgehealth.org						Allan WC, 2000, J MED SCREEN, V7, P127, DOI 10.1136/jms.7.3.127; *AM COLL OBST GYN, 1998, PREC UPD OBST GYN PR, P3; American Academy of Family Physicians, 2000, PER HLTH EX SUMM AAF; Ayala AR, 2000, ENDOCRIN METAB CLIN, V29, P399, DOI 10.1016/S0889-8529(05)70139-0; Baldini IM, 1997, PROG NEURO-PSYCHOPH, V21, P925, DOI 10.1016/S0278-5846(97)00089-4; Biondi B, 1999, J CLIN ENDOCR METAB, V84, P2064, DOI 10.1210/jc.84.6.2064; Bona M, 1998, PHARMACOECONOMICS, V14, P209, DOI 10.2165/00019053-199814020-00009; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Centanni M, 1997, EUR J ENDOCRINOL, V136, P595, DOI 10.1530/eje.0.1360595; COOPER DS, 1984, ANN INTERN MED, V101, P18, DOI 10.7326/0003-4819-101-1-18; Danese MD, 1996, JAMA-J AM MED ASSOC, V276, P285, DOI 10.1001/jama.276.4.285; Danese ND, 2000, J CLIN ENDOCR METAB, V85, P2993, DOI 10.1210/jcem.85.9.6841; de Escobar GM, 2000, J CLIN ENDOCR METAB, V85, P3975, DOI 10.1210/jc.85.11.3975; DIEKMAN T, 1995, ARCH INTERN MED, V155, P1490, DOI 10.1001/archinte.155.14.1490; ELDER J, 1990, ANN CLIN BIOCHEM, V27, P110, DOI 10.1177/000456329002700204; Glenn GC, 1996, ARCH PATHOL LAB MED, V120, P929; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Hak AE, 2000, ANN INTERN MED, V132, P270, DOI 10.7326/0003-4819-132-4-200002150-00004; Helfand M, 1998, ANN INTERN MED, V129, P141, DOI 10.7326/0003-4819-129-2-199807150-00020; Helfand M, 1999, ANN INTERN MED, V130, P246, DOI 10.7326/0003-4819-130-2-199901190-00018; Helfand M, 1998, ANN INTERN MED, V129, P144, DOI 10.7326/0003-4819-129-2-199807150-00020; Jaeschke R, 1996, J GEN INTERN MED, V11, P744, DOI 10.1007/BF02598988; KONG WM, 2000, END SOC 82 ANN M TOR; Kumana CR, 1999, JAMA-J AM MED ASSOC, V282, P1899, DOI 10.1001/jama.282.20.1899; Ladenson PW, 2000, ARCH INTERN MED, V160, P1573, DOI 10.1001/archinte.160.11.1573; LEUNG AS, 1993, OBSTET GYNECOL, V81, P349; Lincoln SR, 1999, J REPROD MED, V44, P455; Lindeman RD, 1999, J AM GERIATR SOC, V47, P703, DOI 10.1111/j.1532-5415.1999.tb01593.x; MANCIET G, 1995, AGE AGEING, V24, P235, DOI 10.1093/ageing/24.3.235; Marqusee E, 1998, ENDOCRIN METAB CLIN, V27, P37, DOI 10.1016/S0889-8529(05)70296-6; MEIER C, 2000, END SOC 82 ANN M TOR; MISIUNAS A, 1995, THYROID, V5, P283, DOI 10.1089/thy.1995.5.283; MONZANI F, 1993, CLIN INVESTIGATOR, V71, P367; NYSTROM E, 1988, CLIN ENDOCRINOL, V29, P63, DOI 10.1111/j.1365-2265.1988.tb00250.x; PARLE JV, 1991, CLIN ENDOCRINOL, V34, P77; *PREV SERV TASK FO, 1996, GUID CLIN PREV SERV, P209; SINGER PA, 1995, JAMA-J AM MED ASSOC, V273, P808, DOI 10.1001/jama.273.10.808; STAUB JJ, 1992, AM J MED, V92, P631, DOI 10.1016/0002-9343(92)90782-7; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Vanderpump MPJ, 1996, BMJ-BRIT MED J, V313, P539; Vanderpump MPJ, 1996, THYROID, V6, P155; Weetman AP, 1997, BRIT MED J, V314, P1175, DOI 10.1136/bmj.314.7088.1175; Zulewski H, 1997, J CLIN ENDOCR METAB, V82, P771, DOI 10.1210/jc.82.3.771	44	381	423	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2001	345	4					260	265		10.1056/NEJM200107263450406	http://dx.doi.org/10.1056/NEJM200107263450406			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455XZ	11474665				2022-12-28	WOS:000170054200006
J	Ruiz, J				Ruiz, J			The stability against freezing of an internal liquid-water ocean in Callisto	NATURE			English	Article							GALILEAN SATELLITES; SUBSURFACE OCEANS; ICY SATELLITES; OUTER PLANETS; EVOLUTION; CONVECTION; GANYMEDE; EUROPA; MODELS; SHELL	The discovery of the induced magnetic field of Callisto-one of Jupiter's moons-has been interpreted(1,2) as evidence for a subsurface ocean, even though the presence of such an ocean is difficult to understand in the context of existing theoretical models(3-5). Tidal heating should not be significant for Callisto, and, in the absence of such heating, it is difficult to see how this internal ocean could have survived until today without freezing(1,6). Previous work(3,4) indicated that an outer ice layer on the ocean would be unstable against solid-state convection, which once begun would lead to total freezing of liquid water in about 10(8) years. Here I show that when a methodology(7) for more physically reasonable water ice viscosities (that is, stress-dependent non-newtonian viscosities, rather than the stress-independent newtonian viscosities considered previously) is adopted, the outer ice shell becomes stable against convection. This implies that a subsurface ocean could have survived up to the present, without the need for invoking antifreeze substances or other special conditions.	Univ Complutense Madrid, Fac Ciencias Geol, Dept Geodinam, E-28040 Madrid, Spain; Univ Complutense Madrid, Seminar Planetary Sci, E-28040 Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Ruiz, J (corresponding author), Univ Complutense Madrid, Fac Ciencias Geol, Dept Geodinam, E-28040 Madrid, Spain.	jaruiz@eucmax.sim.ucm.es	Ruiz, Javier/P-3975-2015	Ruiz, Javier/0000-0002-3937-8380				Anderson JD, 1998, SCIENCE, V280, P1573, DOI 10.1126/science.280.5369.1573; CASSEN PM, 1982, SATELLITES JUPITER, P93; CONSOLMAGNO GJ, 1978, ICARUS, V34, P280, DOI 10.1016/0019-1035(78)90168-9; Davies ME, 1998, ICARUS, V135, P372, DOI 10.1006/icar.1998.5982; Durham WB, 1997, J GEOPHYS RES-PLANET, V102, P16293, DOI 10.1029/97JE00916; DURHAM WB, IN PRESS J GEOPHYS; Goldsby DL, 1997, SCRIPTA MATER, V37, P1399, DOI 10.1016/S1359-6462(97)00246-7; GOLDSBY DL, IN PRESS J GEOPHYS; GOLDSBY DL, 1997, LUNAR PLANET SCI, V28, P429; Kamb B., 1972, FLOW FRACTURE ROCKS, P211, DOI [10.1029/GM016p0211, DOI 10.1029/GM016P0211]; KARGEL JS, 1992, ICARUS, V100, P556, DOI 10.1016/0019-1035(92)90118-Q; Kargel JS, 2000, ICARUS, V148, P226, DOI 10.1006/icar.2000.6471; Khurana KK, 1998, NATURE, V395, P777, DOI 10.1038/27394; KIRK RL, 1987, ICARUS, V69, P91, DOI 10.1016/0019-1035(87)90009-1; KLINGER J, 1980, SCIENCE, V209, P271, DOI 10.1126/science.209.4453.271; LEWIS JS, 1971, SCIENCE, V172, P1127, DOI 10.1126/science.172.3988.1127; LUPO MJ, 1979, ICARUS, V40, P157, DOI 10.1016/0019-1035(79)90061-7; McKinnon WB, 1999, GEOPHYS RES LETT, V26, P951, DOI 10.1029/1999GL900125; McKinnon WB, 1998, ASTROPHYS SPACE SC L, V227, P525, DOI 10.1007/978-94-011-5252-5_22; MUELLER S, 1988, ICARUS, V76, P437, DOI 10.1016/0019-1035(88)90014-0; Pappalardo RT, 1998, NATURE, V391, P365, DOI 10.1038/34862; REYNOLDS RT, 1979, GEOPHYS RES LETT, V6, P121, DOI 10.1029/GL006i002p00121; Schubert G., 1986, SATELLITES, P224; Showman AP, 1999, SCIENCE, V286, P77, DOI 10.1126/science.286.5437.77; Showman AP, 1997, ICARUS, V127, P93, DOI 10.1006/icar.1996.5669; Solomatov VS, 1996, J GEOPHYS RES-PLANET, V101, P4737, DOI 10.1029/95JE03361; SOLOMATOV VS, 1995, PHYS FLUIDS, V7, P266, DOI 10.1063/1.868624; Sotin C, 1998, ASTROPHYS SPACE SC L, V227, P79, DOI 10.1007/978-94-011-5252-5_4; STEVENSON DJ, 1998, EOS T AGU S, V79, pF535; Zimmer C, 2000, ICARUS, V147, P329, DOI 10.1006/icar.2000.6456	30	35	37	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					409	411		10.1038/35086506	http://dx.doi.org/10.1038/35086506			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473308	Green Accepted			2022-12-28	WOS:000170068200038
J	Otsuka, R; Watanabe, H; Hirata, K; Tokai, K; Muro, T; Yoshiyama, M; Takeuchi, K; Yoshikawa, J				Otsuka, R; Watanabe, H; Hirata, K; Tokai, K; Muro, T; Yoshiyama, M; Takeuchi, K; Yoshikawa, J			Acute effects of passive smoking on the coronary circulation in healthy young adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITRON EMISSION TOMOGRAPHY; BLOOD-FLOW VELOCITY; ENVIRONMENTAL TOBACCO-SMOKE; AMERICAN-HEART-ASSOCIATION; DOPPLER-ECHOCARDIOGRAPHY; CIGARETTE-SMOKING; ARTERY STENOSIS; DISEASE; RESERVE; RISK	Context Recent studies have shown that passive smoking is a risk factor for ischemic heart disease and may be associated with vascular endothelial dysfunction, The acute effects of passive smoking on coronary circulation in nonsmokers are not known. Objective To determine the acute effects of passive smoking on coronary circulation using coronary flow velocity reserve (CFVR), assessed by noninvasive transthoracic Doppler echocardiography. Design, Setting, and Participants Cross-sectional study conducted from-September 2000 to November 2000 among 30 Japanese men (mean age, 27 years; 15 healthy nonsmokers and 15 asymptomatic active smokers) without history of hypertension, diabetes mellitus, or hyperlipidemia. Main Outcome Measures Coronary flow velocity reserve, calculated as the ratio of hyperemic to basal coronary flow velocity induced by intravenous infusion of adenosine triphosphate and measured in each participant before and after a 30-min ute exposure to environmental tobacco smoke. Results Heart rate and blood pressure responses to adenosine triphosphate infusion were not affected by passive smoking exposure in either group. Passive smoking exposure had no effect on basal coronary flow velocity in either group. Mean (SD) CFVR in nonsmokers was significantly higher than that in active smokers before passive smoking exposure (4.4 [0.91] vs 3.6 [0.88], respectively; P=.02), while CFVR after passive smoking exposure did not differ between groups (P=.83). Passive smoking exposure significantly reduced mean (SD) CFVR in nonsmokers (4.4 [0.91] vs 3.4 [0.73], respectively; P<.001). Conclusions Passive smoking substantially reduced CFVR in healthy nonsmokers. This finding provides direct evidence that passive smoking may cause endothelial dysfunction of the coronary circulation in nonsmokers.	Osaka City Univ, Sch Med, Dept Internal Med & Cardiol, Abeno Ku, Osaka 5458585, Japan	Osaka Metropolitan University	Watanabe, H (corresponding author), Osaka City Univ, Sch Med, Dept Internal Med & Cardiol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.							ALLRED EN, 1989, NEW ENGL J MED, V321, P1426, DOI 10.1056/NEJM198911233212102; CAMICI P, 1989, AM J PHYSIOL, V257, pE309, DOI 10.1152/ajpendo.1989.257.3.E309; Celermajer DS, 1996, NEW ENGL J MED, V334, P150, DOI 10.1056/NEJM199601183340303; DAYANIKLI F, 1994, CIRCULATION, V90, P808, DOI 10.1161/01.CIR.90.2.808; DESILVA R, 1994, CARDIOVASC RES, V28, P1595; FOLKOW B, 1990, HYPERTENSION, V16, P89, DOI 10.1161/01.HYP.16.1.89; Frielingsdorf J, 1996, CIRCULATION, V93, P1380, DOI 10.1161/01.CIR.93.7.1380; FUSEJIMA K, 1987, J AM COLL CARDIOL, V10, P1024, DOI 10.1016/S0735-1097(87)80342-X; GLANTZ SA, 1995, JAMA-J AM MED ASSOC, V273, P1047, DOI 10.1001/jama.273.13.1047; GLANTZ SA, 1991, CIRCULATION, V83, P1, DOI 10.1161/01.CIR.83.1.1; GOULD KL, 1974, AM J CARDIOL, V33, P87, DOI 10.1016/0002-9149(74)90743-7; HOLBROOK JH, 1984, CIRCULATION, V70, P1114; Hozumi T, 1998, CIRCULATION, V97, P1557, DOI 10.1161/01.CIR.97.16.1557; Kaufmann PA, 2000, CIRCULATION, V102, P1233, DOI 10.1161/01.CIR.102.11.1233; Kawachi I, 1997, CIRCULATION, V95, P2374, DOI 10.1161/01.CIR.95.10.2374; KENNY A, 1994, BRIT HEART J, V71, P57; KENNY A, 1992, AM J CARDIOL, V69, P1265, DOI 10.1016/0002-9149(92)91218-S; KENNY A, 1994, AM J CARDIOL, V73, P1021, DOI 10.1016/0002-9149(94)90164-3; KRITZ H, 1995, ARCH INTERN MED, V155, P1942, DOI 10.1001/archinte.155.18.1942; Miller DD, 1996, CIRCULATION, V94, P2447, DOI 10.1161/01.CIR.94.10.2447; Nagamachi S, 1996, J NUCL MED, V37, P1626; NITENBERG A, 1993, DIABETES, V42, P1017, DOI 10.2337/diabetes.42.7.1017; PENN A, 1993, CIRCULATION, V88, P1820, DOI 10.1161/01.CIR.88.4.1820; PENN A, 1994, CIRCULATION, V90, P1363, DOI 10.1161/01.CIR.90.3.1363; RAIJ L, 1994, CIRCULATION, V90, P575; ROSS JJ, 1990, J AM COLL CARDIOL, V15, P373, DOI 10.1016/S0735-1097(10)80065-8; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; SEILER C, 1993, CIRCULATION, V88, P2139, DOI 10.1161/01.CIR.88.5.2139; Sonoda S, 1998, AM HEART J, V135, P621, DOI 10.1016/S0002-8703(98)70277-7; Steenland K, 1996, CIRCULATION, V94, P622, DOI 10.1161/01.CIR.94.4.622; STEENLAND K, 1992, JAMA-J AM MED ASSOC, V267, P94, DOI 10.1001/jama.267.1.94; Sumida H, 1998, J AM COLL CARDIOL, V31, P811, DOI 10.1016/S0735-1097(98)00010-2; Tanaka T, 1998, AM J CARDIOL, V82, P1275, DOI 10.1016/S0002-9149(98)00614-6; TAYLOR AE, 1992, CIRCULATION, V86, P699, DOI 10.1161/01.CIR.86.2.699; Valkonen M, 1998, CIRCULATION, V97, P2012, DOI 10.1161/01.CIR.97.20.2012; Verberne HJ, 1999, HEART, V82, P509, DOI 10.1136/hrt.82.4.509; WELLS AJ, 1994, J AM COLL CARDIOL, V24, P546, DOI 10.1016/0735-1097(94)90315-8; WELLS AJ, 1988, ENVIRON INT, V14, P249; WILSON RF, 1985, CIRCULATION, V72, P82, DOI 10.1161/01.CIR.72.1.82; ZEIHER AM, 1995, CIRCULATION, V92, P1094, DOI 10.1161/01.CIR.92.5.1094; ZHU BQ, 1993, J AM COLL CARDIOL, V21, P225, DOI 10.1016/0735-1097(93)90741-I	41	260	272	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2001	286	4					436	441		10.1001/jama.286.4.436	http://dx.doi.org/10.1001/jama.286.4.436			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456DZ	11466122	Bronze			2022-12-28	WOS:000170069000015
J	Daniels, SR				Daniels, SR			Repair of coarctation of the aorta and hypertension: does age matter?	LANCET			English	Editorial Material							FOLLOW-UP; SYSTOLIC HYPERTENSION; EXERCISE; CHILDREN		Univ Cincinnati, Coll Med, Dept Pediat, Div Cardiol, Cincinnati, OH 45229 USA; Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA	University of Cincinnati; Cincinnati Children's Hospital Medical Center	Daniels, SR (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Div Cardiol, Cincinnati, OH 45229 USA.							BEEKMAN RH, 1983, AM J CARDIOL, V52, P112, DOI 10.1016/0002-9149(83)90080-2; Bhat MA, 2001, BRIT J SURG, V88, P536, DOI 10.1046/j.1365-2168.2001.01745.x; BROUWER RMHJ, 1994, J THORAC CARDIOV SUR, V108, P525, DOI 10.1016/S0022-5223(94)70264-0; CAMPBELL M, 1970, BRIT HEART J, V32, P633; COHEN M, 1989, CIRCULATION, V80, P840, DOI 10.1161/01.CIR.80.4.840; CRAFOORD C, 1945, J THORAC SURG, V14, P347; DANIELS SR, 1987, AM HEART J, V113, P349, DOI 10.1016/0002-8703(87)90277-8; FREED MD, 1979, AM J CARDIOL, V43, P253, DOI 10.1016/S0002-9149(79)80012-0; FYLER DC, 1980, PEDIATRICS, V65, P432; GIDDING SS, 1985, CIRCULATION, V71, P495, DOI 10.1161/01.CIR.71.3.495; MENDELSOHN AM, 1994, AM J CARDIOL, V74, P696, DOI 10.1016/0002-9149(94)90312-3; OLLEY PM, 1979, 1 CLIN C CONG HEART, P159; Rhodes J, 1997, J PEDIATR-US, V131, P210, DOI 10.1016/S0022-3476(97)70155-0; Wells WJ, 1996, ANN THORAC SURG, V61, P1168, DOI 10.1016/0003-4975(96)00008-2	14	58	61	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 14	2001	358	9276					89	89		10.1016/S0140-6736(01)05378-8	http://dx.doi.org/10.1016/S0140-6736(01)05378-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452BR	11463407				2022-12-28	WOS:000169837700006
J	Cha, BJ; Koppetsch, BS; Theurkauf, WE				Cha, BJ; Koppetsch, BS; Theurkauf, WE			In vivo analysis of Drosophila bicoid mRNA localization reveals a novel microtubule-dependent axis specification pathway	CELL			English	Article							MESSENGER-RNA LOCALIZATION; ALPHA-LIKE PROTEIN; ANTEROPOSTERIOR POLARITY; SPATIAL-DISTRIBUTION; ANTERIOR POLE; OOGENESIS; OOCYTES; POSTERIOR; TRANSPORT; CYTOSKELETON	Drosophila bicoid mRNA is synthesized in the nurse cells and transported to the oocyte where microtubules and Exuperantia protein mediate localization to the anterior pole. Fluorescent bicoid mRNA injected into the oocyte displays nonpolar microtubule-dependent transport to the closest cortical surface, and the oocyte microtubule cytoskeleton lacks clear axial asymmetry. Nonetheless, bicoid mRNA injected into the nurse cell cytoplasm, withdrawn, and injected into a second oocyte shows microtubule-dependent transport to the anterior cortex. Nurse cells require microtubules and Exuperantia to support anterior transport of bicoid mRNA, and microtubules are required for bicoid mRNA-Exuperantia particle coassembly. We propose that microtubule-dependent Exuperantia-bicoid mRNA complex formation in the nurse cell cytoplasm allows anterior-specific transport on a grossly nonpolar oocyte microtubule network.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Theurkauf, WE (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.			Theurkauf, William/0000-0001-7342-1912				BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; BULINSKI JC, 1991, BIOESSAYS, V13, P285, DOI 10.1002/bies.950130605; CHAO YC, 1991, DEV GENET, V12, P333, DOI 10.1002/dvg.1020120502; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Clark IE, 1997, DEVELOPMENT, V124, P461; COOLEY L, 1994, SCIENCE, V266, P590, DOI 10.1126/science.7939713; DURONIO RJ, 1995, GENE DEV, V9, P1445, DOI 10.1101/gad.9.12.1445; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; Glotzer JB, 1997, CURR BIOL, V7, P326, DOI 10.1016/S0960-9822(06)00156-4; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; Grieder NC, 2000, DEVELOPMENT, V127, P4253; HAY B, 1990, DEVELOPMENT, V109, P425; Hays T, 2000, NAT CELL BIOL, V2, pE60, DOI 10.1038/35008687; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; King R. C., 1970, OVARIAN DEV DROSOPHI; Lasko P, 1999, FASEB J, V13, P421, DOI 10.1096/fasebj.13.3.421; MACDONALD PM, 1993, DEVELOPMENT, V118, P1233; MARCEY D, 1991, EMBO J, V10, P4259, DOI 10.1002/j.1460-2075.1991.tb05004.x; NeumanSilberberg FS, 1996, MECH DEVELOP, V59, P105, DOI 10.1016/0925-4773(96)00567-9; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Pokrywka NJ, 1995, CURR TOP DEV BIOL, V31, P139; POKRYWKA NJ, 1995, DEV BIOL, V167, P363, DOI 10.1006/dbio.1995.1030; POKRYWKA NJ, 1991, DEVELOPMENT, V113, P55; Rickard JE, 1996, TRENDS CELL BIOL, V6, P178, DOI 10.1016/0962-8924(96)10017-9; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; SALLES FJ, 1994, SCIENCE, V266, P1996, DOI 10.1126/science.7801127; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; Spradling Allan C., 1993, P1; STJOHNSTON D, 1989, DEVELOPMENT, V107, P13; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THEURKAUF WE, 1994, SCIENCE, V265, P2093, DOI 10.1126/science.8091233; THEURKAUF WE, 1992, DEVELOPMENT, V115, P923; THEURKAUF WE, 1994, METHOD CELL BIOL, V44, P489, DOI 10.1016/S0091-679X(08)60928-0; Theurkauf WE, 1998, DEVELOPMENT, V125, P3655; WANG SX, 1994, NATURE, V369, P400, DOI 10.1038/369400a0; Waters JC, 1997, CURR OPIN CELL BIOL, V9, P37, DOI 10.1016/S0955-0674(97)80149-4; Wilhelm JE, 2000, J CELL BIOL, V148, P427, DOI 10.1083/jcb.148.3.427	41	153	155	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2001	106	1					35	46		10.1016/S0092-8674(01)00419-6	http://dx.doi.org/10.1016/S0092-8674(01)00419-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461700	Bronze			2022-12-28	WOS:000169870300007
J	Eremets, MI; Struzhkin, VW; Mao, HK; Hemley, RJ				Eremets, MI; Struzhkin, VW; Mao, HK; Hemley, RJ			Superconductivity in boron	SCIENCE			English	Article							TRANSITION-TEMPERATURE; PRESSURE-DEPENDENCE; METALLIC HYDROGEN	Metals formed from light elements are predicted to exhibit intriguing states of electronic order. Of these materials, those containing boron are of considerable current interest because of their relatively high superconducting temperatures. We have investigated elemental boron to very high pressure using diamond anvil cell electrical conductivity techniques. We find that boron transforms from a nonmetal to a superconductor at about 160 gigapascals (GPa). The critical temperature of the transition increases from 6 kelvin (K) at 175 GPa to 11.2 K at 250 GPa, giving a positive pressure derivative of 0.05 K/GPa. Although the observed metallization pressure is compatible with the predictions of first-principles calculations, superconductivity in boron remains to be explored theoreticalty. The present results constitute a record pressure for both electrical conductivity studies and investigations of superconductivity in dense matter.	Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; Carnegie Inst Sci, Ctr High Pressure Res, Washington, DC 20015 USA; Max Planck Inst Chem, D-55020 Mainz, Germany	Carnegie Institution for Science; Carnegie Institution for Science; Max Planck Society	Hemley, RJ (corresponding author), Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.	hemley@gl.ciw.edu	Struzhkin, Viktor V/J-9847-2013	Struzhkin, Viktor V/0000-0002-3468-0548				Ashcroft N.W, 1976, SOLID STATE PHYS; ASHCROFT NW, 1968, PHYS REV LETT, V21, P1748, DOI 10.1103/PhysRevLett.21.1748; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; CAVA RJ, 1994, NATURE, V367, P146, DOI 10.1038/367146a0; CAVA RJ, 1994, NATURE, V367, P252, DOI 10.1038/367252a0; Christensen NE, 2001, PHYS REV LETT, V86, P1861, DOI 10.1103/PhysRevLett.86.1861; DACOROGNA MM, 1986, PHYS REV B, V34, P4865, DOI 10.1103/PhysRevB.34.4865; Eremets MI, 1998, SCIENCE, V281, P1333, DOI 10.1126/science.281.5381.1333; Eremets MI, 2000, PHYS REV LETT, V85, P2797, DOI 10.1103/PhysRevLett.85.2797; ERERNETS MI, 1996, HIGH PRESSURE EXPT M; Fujimori M, 1999, PHYS REV LETT, V82, P4452, DOI 10.1103/PhysRevLett.82.4452; GUBSER DU, 1975, PHYS REV LETT, V35, P104, DOI 10.1103/PhysRevLett.35.104; Huber K.P., 1979, MOL SPECTRA MOL STRU, DOI DOI 10.1007/978-1-4757-0961-2; Johnson KA, 2000, NATURE, V403, P632, DOI 10.1038/35001024; Kortus J, 2001, PHYS REV LETT, V86, P4656, DOI 10.1103/PhysRevLett.86.4656; Lang KM, 1999, J LOW TEMP PHYS, V114, P445, DOI 10.1023/A:1021854204812; Loa I, 2001, SOLID STATE COMMUN, V118, P279, DOI 10.1016/S0038-1098(01)00095-3; Lorenz B, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.012507; MA Y, 2000, T AM GEOPHYS UNION, V81, pS39; MADELUNG O, 1983, LANDOLTBORNSTEIN E, V17; MAILHIOT C, 1990, PHYS REV B, V42, P9033, DOI 10.1103/PhysRevB.42.9033; MAO HK, 1986, J GEOPHYS RES-SOLID, V91, P4673, DOI 10.1029/JB091iB05p04673; MCMILLAN WL, 1968, PHYS REV, V167, P331, DOI 10.1103/PhysRev.167.331; Monteverde M, 2001, SCIENCE, V292, P75, DOI 10.1126/science.1059775; Mott N.F., 1990, METAL INSULATOR TRAN; Nagamatsu J, 2001, NATURE, V410, P63, DOI 10.1038/35065039; Neaton JB, 1999, NATURE, V400, P141, DOI 10.1038/22067; PAPACONSTANTOPOULOS DA, 1977, PHYS REV B, V15, P4221, DOI 10.1103/PhysRevB.15.4221; Richardson CF, 1997, PHYS REV LETT, V78, P118, DOI 10.1103/PhysRevLett.78.118; Richardson CF, 1997, PHYS REV B, V55, P15130, DOI 10.1103/PhysRevB.55.15130; Stadele M, 2000, PHYS REV LETT, V84, P6070, DOI 10.1103/PhysRevLett.84.6070; Struzhkin VV, 1997, NATURE, V390, P382, DOI 10.1038/37074; TAKEI K, 1985, J APPL PHYS, V57, P5093, DOI 10.1063/1.335294; Vast N, 1997, PHYS REV LETT, V78, P693, DOI 10.1103/PhysRevLett.78.693; VOT T, 2001, PHYS REV B, V6322, P505; Young DA, 1991, PHASE DIAGRAMS ELEME	37	259	271	5	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2001	293	5528					272	274		10.1126/science.1062286	http://dx.doi.org/10.1126/science.1062286			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452118				2022-12-28	WOS:000169875200050
J	Eikelboom, JW; Quinlan, DJ; Douketis, JD				Eikelboom, JW; Quinlan, DJ; Douketis, JD			Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a metaanalysis of the randomised trials	LANCET			English	Article							MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; DOUBLE-BLIND; PROLONGED PROPHYLAXIS; HOSPITAL DISCHARGE; ARTHROPLASTY; ENOXAPARIN; PLACEBO; DALTEPARIN; PREVENTION	Background The optimum duration of prophylaxis against venous thromboembolism after total hip or knee replacement is uncertain, Our primary objective was to establish the efficacy of extended-duration prophylaxis on symptomatic venous thromboembolic events. Methods We identified randomised trials comparing extended-duration prophylaxis using heparin or warfarin with placebo or untreated control in patients undergoing elective total hip or knee replacement by searching electronic databases (MEDLINE, EMBASE), references from retrieved articles, and abstracts from conference proceedings, and by contact with pharmaceutical companies and investigators. Two reviewers independently extracted data on study design, symptomatic and symptomless venographic venous thromboembolism, death, and bleeding outcomes. Results from individual trials were combined with the Mantel-Haenszel method. Findings Nine studies met our inclusion criteria (3999 patients), eight with low molecular weight heparin, and one with unfractionated heparin. Extended-duration prophylaxis for 30-42 days significantly reduced the frequency of symptomatic venous thromboembolism (1.3% vs 3.3%, OR 0.38; 95% CI 0.24-0.61, numbers needed to treat [NNT]=50), with no statistical evidence of heterogeneity (chi (2) test, p=0.69). There was a greater risk reduction in patients undergoing hip replacement (1.4% vs 4.3%, 0.33; 0.19-0.56, 34) compared with knee replacement (1.0% vs 1.4%, 0.74; 0.26-2.15, 250), A significant reduction in symptomless venographic deep vein thrombosis was also observed (9.6% vs 19.6%, 0.48; 0.36-0.63, 10). There was no increase in major bleeding bur extended-duration prophylaxis was associated with excess minor bleeding (3.7% vs 2.5%, 1.56; 1.08-2.26, numbers needed to harm [NNH]=83). Interpretation Among patients undergoing total hip or knee replacement, extended-duration prophylaxis significantly reduces the frequency of symptomatic venous thromboembolism. The reduction in risk is equivalent to about 20 symptomatic events per 1000 patients treated.	Kings Coll Hosp London, Dept Radiol, London SE5 9RS, England; Royal Perth Hosp, Dept Haematol, Thrombosis Unit, Perth, WA, Australia; McMaster Univ, Dept Med, Hamilton, ON, Canada; St Josephs Hosp, Hamilton, ON, Canada	King's College Hospital NHS Foundation Trust; King's College Hospital; Royal Perth Hospital; University of Western Australia; McMaster University; McGill University; McMaster University	Quinlan, DJ (corresponding author), Kings Coll Hosp London, Dept Radiol, London SE5 9RS, England.	dan.quinlan@kcl.ac.uk	Eikelboom, John/AAG-6117-2019; Douketis, James/AAO-5659-2021	Eikelboom, John/0000-0003-4126-1285; 				Bergqvist D, 1996, NEW ENGL J MED, V335, P696, DOI 10.1056/NEJM199609053351002; Caprini JA, 1999, J VASC SURG, V30, P813, DOI 10.1016/S0741-5214(99)70005-4; Comp PC, 2001, J BONE JOINT SURG AM, V83A, P336, DOI 10.2106/00004623-200103000-00004; Dahl OE, 1997, THROMB HAEMOSTASIS, V77, P26; Davidson BL, 1998, CHEST, V114, P1239, DOI 10.1378/chest.114.5.1239; Davidson BL, 2000, ANN INTERN MED, V132, P914, DOI 10.7326/0003-4819-132-11-200006060-00011; Douketis JD, 1998, JAMA-J AM MED ASSOC, V279, P458, DOI 10.1001/jama.279.6.458; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Geerts WH, 2001, CHEST, V119, p132S, DOI 10.1378/chest.119.1_suppl.132S; Haentjens P, 2000, ACTA ORTHOP BELG, V66, P1; Heit JA, 2000, ANN INTERN MED, V132, P853, DOI 10.7326/0003-4819-132-11-200006060-00002; HIRSH J, 1998, CHEST, V114, P1135; Hull RD, 2000, ARCH INTERN MED, V160, P2208, DOI 10.1001/archinte.160.14.2208; Lassen MR, 1998, THROMB RES, V89, P281, DOI 10.1016/S0049-3848(98)00018-8; Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7; Leclerc JR, 1998, ARCH INTERN MED, V158, P873, DOI 10.1001/archinte.158.8.873; MADHOK R, 1993, MAYO CLIN PROC, V68, P11, DOI 10.1016/S0025-6196(12)60013-5; Manganelli D, 1998, RESPIRATION, V65, P369, DOI 10.1159/000029297; MANTEL N, 1959, J NATL CANCER I, V22, P719; Nicolaides AN, 2001, INT ANGIOL, V20, P1; Nilsson PE, 1997, ORTHOPEDICS, V20, P22; O'Brien J, 2000, LANCET, V355, P1295; Planes A, 1996, LANCET, V348, P224, DOI 10.1016/S0140-6736(96)01453-5; Planes A, 1996, DRUGS, V52, P47, DOI 10.2165/00003495-199600527-00009; Planes A, 1997, ORTHOPEDICS, V20, P18; PLANES A, 1998, CHEST, V114, P125; RAJARATNAM G, 1990, J PUBLIC HEALTH MED, V12, P56, DOI 10.1093/oxfordjournals.pubmed.a042507; Ricotta S, 1996, THROMB HAEMOSTASIS, V76, P887; Robinson KS, 1997, ANN INTERN MED, V127, P439, DOI 10.7326/0003-4819-127-6-199709150-00004; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; SHARROCK NE, 1995, J ARTHROPLASTY, V10, P523, DOI 10.1016/S0883-5403(05)80155-X; Spiro Theodore E., 1997, Blood, V90, p295A; THOMPSON SG, 1994, BMJ-BRIT MED J, V309, P1351, DOI 10.1136/bmj.309.6965.1351; White RH, 2000, NEW ENGL J MED, V343, P1758, DOI 10.1056/NEJM200012143432403; 2000, BRIT NATL FORMULARYD	35	387	404	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 7	2001	358	9275					9	15		10.1016/S0140-6736(00)05249-1	http://dx.doi.org/10.1016/S0140-6736(00)05249-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11454370				2022-12-28	WOS:000169710900009
J	Gillmore, JD; Lovat, LB; Persey, MR; Pepys, MB; Hawkins, PN				Gillmore, JD; Lovat, LB; Persey, MR; Pepys, MB; Hawkins, PN			Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein	LANCET			English	Article							P COMPONENT SCINTIGRAPHY; JUVENILE RHEUMATOID-ARTHRITIS; C-REACTIVE PROTEIN; SYSTEMIC AMYLOIDOSIS; LIVER-TRANSPLANTATION; ALZHEIMER-DISEASE; REGRESSION; DEPOSITS; IMMUNOASSAY; TURNOVER	Background Reactive systemic (AA, secondary) amyloidosis occurs in chronic inflammatory diseases, and most patients present with nephropathy. The amyloid fibrils are derived from the circulating acute-phase reactant serum amyloid A protein (SAA), but the relation between production of fib,il precursor protein, amyloid load, and clinical outcome in AA and other types of amyloidosis is unclear. Methods We studied amyloidotic organ function and survival prospectively for 12-117 months in 80 patients with systemic AA amyloidosis in whom serum SAA concentration was measured monthly and visceral amyloid deposits were assessed annually by serum amyloid P component scintigraphy. Underlying inflammatory diseases were treated as vigorously as possible. Findings Amyloid deposits regressed in 25 of 42 patients whose median SAA values were within the reference range (<10 mg/L) throughout follow-up, and amyloidotic organ function stabilised or improved in 39 of these cases. Outcome varied substantially among patients whose median SAA concentration exceeded 10 mg/L, but amyloid load increased and organ function deteriorated in most of those whose SAA was persistently above 50 mg/L, Estimated survival at 10 years was 90% in patients whose median SAA was under 10 mg/L, and 40% among those whose median SAA exceeded this value (p=0.0009). Interpretation Although isolated amyloid fibrils are stable in vitro, AA amyloid deposits exist in a state of dynamic turnover, and outcome is favourable in AA amyloidosis when the SAA concentration is maintained below 10 mg/L. The potential for amyloid to regress and for the function of amyloidotic organs to recover support therapeutic strategies to decrease the supply of amyloid fibril precursor proteins in amyloidosis generally.	UCL Royal Free & Univ Coll Med Sch, Dept Med, Ctr Amyloidosis & Acute Phase Prot, London NW3 2PF, England	University of London; University College London; UCL Medical School	Gillmore, JD (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Med, Ctr Amyloidosis & Acute Phase Prot, Royal Free Campus, London NW3 2PF, England.	j.gillmore@rfc.ucl.ac.uk	Hawkins, Philip N/C-5573-2008; Lovat, Laurence/C-1986-2009	Lovat, Laurence/0000-0003-4542-3915				Akpolat T, 2000, AM J NEPHROL, V20, P68, DOI 10.1159/000013559; Baum J, 1977, ARTHRITIS RHEUM, V20, P253; BERGLUND K, 1993, J RHEUMATOL, V20, P2051; GERTZ MA, 1991, MEDICINE, V70, P246, DOI 10.1097/00005792-199107000-00002; Gillmore JD, 2000, QJM-INT J MED, V93, P269, DOI 10.1093/qjmed/93.5.269; Goldsmith DJA, 1996, NEPHRON, V74, P572, DOI 10.1159/000189454; HAWKINS PN, 1990, CLIN EXP IMMUNOL, V81, P325; HAWKINS PN, 1993, ARTHRITIS RHEUM, V36, P842, DOI 10.1002/art.1780360616; HAWKINS PN, 1988, J EXP MED, V167, P903, DOI 10.1084/jem.167.3.903; HAWKINS PN, 1988, LANCET, V1, P1413; HAWKINS PN, 1990, J CLIN INVEST, V86, P1862, DOI 10.1172/JCI114917; HAWKINS PN, 1993, Q J MED, V86, P365; HAWKINS PN, 1990, NEW ENGL J MED, V323, P508, DOI 10.1056/NEJM199008233230803; HAWKINS PN, 1995, MYELOMA, P477; HAZENBERG BPC, 1994, BAILLIERE CLIN RHEUM, V8, P661, DOI 10.1016/S0950-3579(05)80121-9; HOLMGREN G, 1993, LANCET, V341, P1113, DOI 10.1016/0140-6736(93)93127-M; Husby G, 1998, SCAND J RHEUMATOL, V27, P161, DOI 10.1080/030097498440750; HUTCHINSON WL, 1994, J CLIN INVEST, V94, P1390, DOI 10.1172/JCI117474; Jager PL, 1998, J NUCL MED, V39, P699; Kraul D., 1997, Clinical Chemistry, V43, pS150; Kyle RA, 1997, NEW ENGL J MED, V336, P1202, DOI 10.1056/NEJM199704243361702; Ledue TB, 1998, ANN CLIN BIOCHEM, V35, P745, DOI 10.1177/000456329803500607; Lovat LB, 1998, GUT, V42, P727, DOI 10.1136/gut.42.5.727; MORONI G, 1992, CLIN NEPHROL, V38, P81; Pepys MB, 1999, HORIZONS MED, P397; PEPYS MB, 1996, OXFORD TXB MED, P1512; Poole S, 1998, J IMMUNOL METHODS, V214, P1, DOI 10.1016/S0022-1759(98)00057-X; Rydh A, 1998, EUR J NUCL MED, V25, P709; SAVOLAINEN HA, 1993, J RHEUMATOL, V20, P1201; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schnitzer T J, 1977, Arthritis Rheum, V20, P245; Tan SY, 1996, KIDNEY INT, V50, P282, DOI 10.1038/ki.1996.313; TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299; VIGUSHIN DM, 1994, AMYLOID AMYLOIDOSIS, P685; WILKINS J, 1994, CLIN CHEM, V40, P1284; YAMADA T, 1993, ANN CLIN BIOCHEM, V30, P72, DOI 10.1177/000456329303000112	36	407	432	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 7	2001	358	9275					24	29		10.1016/S0140-6736(00)05252-1	http://dx.doi.org/10.1016/S0140-6736(00)05252-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11454373				2022-12-28	WOS:000169710900012
J	Thornton, JG; Capogna, G				Thornton, JG; Capogna, G			Reducing likelihood of instrumental delivery with epidural anaesthesia	LANCET			English	Editorial Material							ANALGESIA; LABOR		Univ Leeds, Leeds Gen Infirm, Acad Unit Paediat Obstet & Gynaecol, Leeds LS2 9NS, W Yorkshire, England; Fatebenefratelli Hosp 38, Dept Obstet Anaesthesia, I-00186 Rome, Italy	Leeds General Infirmary; University of Leeds	Thornton, JG (corresponding author), Univ Leeds, Leeds Gen Infirm, Acad Unit Paediat Obstet & Gynaecol, Leeds LS2 9NS, W Yorkshire, England.		Thornton, Jim/B-8336-2008	Thornton, Jim/0000-0001-9764-6876				Burnstein R, 1999, ANAESTHESIA, V54, P634, DOI 10.1046/j.1365-2044.1999.00894.x; Howell CJ, 2001, BRIT J OBSTET GYNAEC, V108, P27, DOI 10.1016/S0306-5456(00)00012-7; HOWELL CJ, 2001, COCHRANE LIB; Nageotte MP, 1997, NEW ENGL J MED, V337, P1715, DOI 10.1056/NEJM199712113372402; REYNOLDS F, 1992, LANCET, V339, P1234, DOI 10.1016/0140-6736(92)91177-A	5	31	33	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 7	2001	358	9275					2	2		10.1016/S0140-6736(00)05295-8	http://dx.doi.org/10.1016/S0140-6736(00)05295-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11454363				2022-12-28	WOS:000169710900002
J	Bonneh, YS; Cooperman, A; Sagi, D				Bonneh, YS; Cooperman, A; Sagi, D			Motion-induced blindness in normal observers	NATURE			English	Article							STABILIZED RETINAL IMAGE; BINOCULAR-RIVALRY; PERCEPTION; ATTENTION; FRAGMENTATION; MOVEMENT; MASKING; VISION	Cases in which salient visual stimuli do not register consciously are known to occur in special conditions, such as the presentation of dissimilar stimuli to the two eyes(1) or when images are stabilized on the retina(2). Here, we report a striking phenomenon of 'visual disappearance' observed with normal-sighted observers under natural conditions. When a global moving pattern is superimposed on high-contrast stationary or slowly moving stimuli, the latter disappear and reappear alternately for periods of several seconds. We show that this motion-induced blindness (MIB) phenomenon is unlikely to reflect retinal suppression, sensory masking or adaptation. The phenomenology observed includes perceptual grouping effects, object rivalry and visual field anisotropy. This is very similar to that found in other types of visual disappearance, as well as in clinical cases of attention deficits, in which partial invisibility might occur despite the primary visual areas being intact(3). Disappearance might reflect a disruption of attentional processing, which shifts the system into a winner-takes-all mode, uncovering the dynamics of competition between object representations within the human visual system.	Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA; Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	The Smith-Kettlewell Eye Research Institute; Weizmann Institute of Science	Bonneh, YS (corresponding author), Smith Kettlewell Eye Res Inst, 2318 Fillmore St, San Francisco, CA 94115 USA.	yoram@ski.org	Sagi, Dov/A-5454-2008	Sagi, Dov/0000-0002-8446-9230; Bonneh, Yoram/0000-0003-1091-639X				Andrews TJ, 1997, P NATL ACAD SCI USA, V94, P9905, DOI 10.1073/pnas.94.18.9905; BENNETTCLARK HC, 1963, NATURE, V199, P1215, DOI 10.1038/1991215a0; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; Bonneh Y, 1999, VISION RES, V39, P271, DOI 10.1016/S0042-6989(98)00112-6; BONNEH Y, 1999, INVEST OPHTHALMOL  S, V40, P4253; Breese BB., 1899, PSYCHOL REV-MONOGR S, V3, DOI [10.1037/h0092990, DOI 10.1037/H0092990]; BURBECK CA, 1984, J OPT SOC AM A, V1, P216, DOI 10.1364/JOSAA.1.000216; CAMPBELL FW, 1973, PERCEPTION, V2, P123, DOI 10.1068/p020123; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Driver J, 2001, COGNITION, V79, P39, DOI 10.1016/S0010-0277(00)00124-4; Duncan J, 1997, CURR OPIN NEUROBIOL, V7, P255, DOI 10.1016/S0959-4388(97)80014-1; EVANS CR, 1965, BRIT J PSYCHOL, V56, P121, DOI 10.1111/j.2044-8295.1965.tb00951.x; FUKUDA H, 1992, J EXP PSYCHOL HUMAN, V18, P362, DOI 10.1037/0096-1523.18.2.362; GRINDLEY GC, 1965, Q J EXP PSYCHOL, V17, P97, DOI 10.1080/17470216508416418; GRINDLEY GC, 1966, Q J EXP PSYCHOL, V18, P319, DOI 10.1080/14640746608400049; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; Logothetis NK, 1998, PHILOS T R SOC B, V353, P1801, DOI 10.1098/rstb.1998.0333; LURIA AR, 1959, BRAIN, V82, P437, DOI 10.1093/brain/82.3.437; Mackay D., 1986, VISUAL NEUROSCI, P365; O'Regan JK, 1999, NATURE, V398, P34, DOI 10.1038/17953; PETTIGREW JD, IN PRESS SOC NEUR AB; RIZZO M, 1990, NEUROLOGY, V40, P447, DOI 10.1212/WNL.40.3_Part_1.447; Troxler D, 1804, OPHTHALMOLOGISCHES B, P51; WALKER P, 1976, Q J EXP PSYCHOL, V28, P35, DOI 10.1080/14640747608400537	26	222	227	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2001	411	6839					798	801		10.1038/35081073	http://dx.doi.org/10.1038/35081073			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	441TV	11459058				2022-12-28	WOS:000169246400049
J	Smetacek, V				Smetacek, V			A watery arms race	NATURE			English	Editorial Material									Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Smetacek, V (corresponding author), Alfred Wegener Inst Polar & Marine Res, Handelshafen 12, D-27570 Bremerhaven, Germany.							Dawkins R., 1982, pi; MARGULI SL, 2000, ENV EVOLUTION; Raven JA, 1997, LIMNOL OCEANOGR, V42, P198, DOI 10.4319/lo.1997.42.1.0198; Verity PG, 1996, MAR ECOL PROG SER, V130, P277, DOI 10.3354/meps130277	4	148	158	0	44	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					745	745		10.1038/35081210	http://dx.doi.org/10.1038/35081210			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459035	Bronze			2022-12-28	WOS:000169246400024
J	Walsh, C				Walsh, C			Enabling the chemistry of life (vol 409, pg 226, 2001)	NATURE			English	Correction							CATALYSIS; ENZYMES; DNA; SYNTHETASE; EVOLUTION; BIOSYNTHESIS; POLYKETIDE; SYNTHASE; PATHWAYS; PROTEINS	Enzymes are the subset of proteins that catalyse the chemistry of life, transforming both macromolecular substrates and small molecules. The precise three-dimensional architecture of enzymes permits almost unerring selectivity in physical and chemical steps to impose remarkable rate accelerations and specificity in product-determining reactions. Many enzymes are members of families that carry out related chemical transformations and offer opportunities for directed in vitro evolution, to tailor catalytic properties to particular functions.										Atkins J.F, 1999, RNA WORLD; Babbitt PC, 1996, BIOCHEMISTRY-US, V35, P16489, DOI 10.1021/bi9616413; BERTINO I, 1994, BIOINORGANIC CHEM; Bizily SP, 1999, P NATL ACAD SCI USA, V96, P6808, DOI 10.1073/pnas.96.12.6808; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; Cane DE, 1997, CHEM REV, V97, P2463, DOI 10.1021/cr970097g; Cech TR, 1999, RNA WORLD, P321; Gehring AM, 1998, BIOCHEMISTRY-US, V37, P11637, DOI 10.1021/bi9812571; Gerlt JA, 1998, CURR OPIN CHEM BIOL, V2, P607, DOI 10.1016/S1367-5931(98)80091-4; HUBBARD BK, 2000, THESIS U ILLINOIS; Konz D, 1999, CHEM BIOL, V6, pR39, DOI 10.1016/S1074-5521(99)80002-7; Lewis RJ, 1996, BIOESSAYS, V18, P661, DOI 10.1002/bies.950180810; Lippard S. J., 1994, PRINCIPLES BIOINORGA; Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21, DOI 10.1128/MMBR.63.1.21-53.1999; MCDANIEL R, 1995, NATURE, V375, P549, DOI 10.1038/375549a0; Narlikar GJ, 1997, ANNU REV BIOCHEM, V66, P19, DOI 10.1146/annurev.biochem.66.1.19; Patten PA, 1996, SCIENCE, V271, P1086, DOI 10.1126/science.271.5252.1086; PEISER GD, 1984, P NATL ACAD SCI-BIOL, V81, P3059, DOI 10.1073/pnas.81.10.3059; Quadri LEN, 1999, BIOCHEMISTRY-US, V38, P14941, DOI 10.1021/bi991787c; Que L, 2000, NAT STRUCT BIOL, V7, P182, DOI 10.1038/73270; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; ROACH PL, 1995, NATURE, V375, P700, DOI 10.1038/375700a0; SANCAR A, 1994, BIOCHEMISTRY-US, V33, P2, DOI 10.1021/bi00167a001; Schmidt-Dannert C, 2000, NAT BIOTECHNOL, V18, P750, DOI 10.1038/77319; Schofield CJ, 1997, CURR OPIN STRUC BIOL, V7, P857, DOI 10.1016/S0959-440X(97)80158-3; Sheppard TL, 2000, P NATL ACAD SCI USA, V97, P7802, DOI 10.1073/pnas.97.14.7802; SINHA RR, 1999, NAT PROD REP, V16, P249; Smithrud DB, 1997, CURR OPIN BIOTECH, V8, P459, DOI 10.1016/S0958-1669(97)80069-9; Stryer L., 1995, BIOCHEMISTRY-US, V4th ed.; Tobin MB, 2000, CURR OPIN STRUC BIOL, V10, P421, DOI 10.1016/S0959-440X(00)00109-3; Trauger JW, 2000, NATURE, V407, P215, DOI 10.1038/35025116; Valegard K, 1998, NATURE, V394, P805, DOI 10.1038/29575; Wackett LP, 1999, ASM NEWS, V65, P87; WAGNER J, 1995, SCIENCE, V270, P1797, DOI 10.1126/science.270.5243.1797; Walsh C, 2001, NATURE, V409, P226, DOI 10.1038/35051697; WALSH CT, 1987, BIOCHEMISTRY-US, V26, P4901, DOI 10.1021/bi00390a001; Watt RK, 1999, CELL MOL LIFE SCI, V56, P604, DOI 10.1007/s000180050456; WONG CH, 1994, ENZYMES SYNTHETIC OR; Zhang BL, 1997, NATURE, V390, P96, DOI 10.1038/36375	39	1	3	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2001	411	6839					824	+		10.1038/35081124	http://dx.doi.org/10.1038/35081124			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11460111	Bronze			2022-12-28	WOS:000169246400057
J	Merritt, D; Ferrarese, L; Joseph, CL				Merritt, D; Ferrarese, L; Joseph, CL			No supermassive black hole in M33?	SCIENCE			English	Article							MASS; BULGE; GALAXIES; NUCLEUS	We observed the nucleus of M33, the third-brightest galaxy in the Local Group, with the Space Telescope Imaging Spectrograph at a resolution at least a factor of 10 higher than previously obtained. Rather than the steep rise expected within the radius of gravitational influence of a supermassive black hole, the random stellar velocities showed a decrease within a parsec of the center of the galaxy. The implied upper limit on the mass of the central black hole is only 3000 solar masses, about three orders of magnitude lower than the dynamically inferred mass of any other supermassive black hole. Detecting black holes of only a few thousand solar masses is observationally challenging, but it is critical to establish how supermassive black holes relate to their host galaxies, and which mechanisms influence the formation and evolution of both.	Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Merritt, D (corresponding author), Rutgers State Univ, Dept Phys & Astron, POB 849, Piscataway, NJ 08854 USA.	merritt@physics.rutgers.edu		Ferrarese, Laura/0000-0002-8224-1128				Cattaneo A, 1999, MON NOT R ASTRON SOC, V308, P77, DOI 10.1046/j.1365-8711.1999.02693.x; CIOTTI L, IN PRESS ASTROPHYS J; EBISUZAKI T, UNPUB; FABBIANO G, IN PRESS ASTROPHYS J; Ferrarese L, 2000, ASTROPHYS J, V539, pL9, DOI 10.1086/312838; Gebhardt K, 2000, ASTROPHYS J, V539, pL13, DOI 10.1086/312840; GEBHARDT K, UNPUB; Haehnelt MG, 2000, MON NOT R ASTRON SOC, V318, pL35, DOI 10.1046/j.1365-8711.2000.03989.x; Joseph CL, 2001, ASTROPHYS J, V550, P668, DOI 10.1086/319781; KORMENDY J, 1993, ASTRON J, V105, P1793, DOI 10.1086/116555; Lauer TR, 1998, ASTRON J, V116, P2263, DOI 10.1086/300617; LONG KS, 1981, ASTROPHYS J, V246, pL61, DOI 10.1086/183553; Matsumoto H, 2001, ASTROPHYS J, V547, pL25, DOI 10.1086/318878; MERRITT D, 1993, ASTROPHYS J, V413, P79, DOI 10.1086/172979; Merritt D, 1997, ASTRON J, V114, P228, DOI 10.1086/118467; Merritt D, 2001, MON NOT R ASTRON SOC, V320, pL30, DOI 10.1046/j.1365-8711.2001.04165.x; Miller M. M., UNPUB; MINNITI D, 1993, ASTROPHYS J, V410, pL79, DOI 10.1086/186884; Minniti D, 1996, ASTRON ASTROPHYS, V306, P715; REGAN MW, 1994, ASTROPHYS J, V434, P536, DOI 10.1086/174755; Takamiya T, 2000, ASTROPHYS J, V534, P670, DOI 10.1086/308770; VALLURI M, UNPUB; van den Bergh S, 1999, ASTRON ASTROPHYS REV, V9, P273, DOI 10.1007/s001590050019; van der Marel RP, 1999, ASTRON J, V117, P744, DOI 10.1086/300730; VANDENBERGH S, 1991, PUBL ASTRON SOC PAC, V103, P609, DOI 10.1086/132860; VANDERMAREL RP, 1993, ASTROPHYS J, V407, P525, DOI 10.1086/172534	26	109	109	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1116	1118		10.1126/science.1063896	http://dx.doi.org/10.1126/science.1063896			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11463879				2022-12-28	WOS:000170432600053
J	Goodman, S				Goodman, S			Pressure grows over US blood ban	NATURE			English	News Item																		2001, NATURE, V412, P7	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					467	467		10.1038/35087718	http://dx.doi.org/10.1038/35087718			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484010	Bronze			2022-12-28	WOS:000170202900007
J	Waldman, RJ				Waldman, RJ			Public health in times of war and famine - What can be done? What should be done?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORTALITY; REFUGEE		Columbia Univ, Mailman Sch Publ Hlth, Heilbrunn Ctr Populat & Family Hlth, Program Forced Migrat & Hlth, New York, NY 10032 USA	Columbia University	Waldman, RJ (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Heilbrunn Ctr Populat & Family Hlth, Program Forced Migrat & Hlth, 60 Haven Ave,B-2, New York, NY 10032 USA.	rw178@columbia.edu						Aaby P, 1999, BRIT MED J, V319, P878, DOI 10.1136/bmj.319.7214.878; COLLINS S, 1993, JAMA-J AM MED ASSOC, V270, P637; DROUART E, 1999, ACTION CONTRE FAIM A; Gostelow L, 1999, DISASTERS, V23, P316, DOI 10.1111/1467-7717.00121; Gustafson P, 2001, JAMA-J AM MED ASSOC, V286, P599, DOI 10.1001/jama.286.5.599; Leaning J, 2001, LANCET, V357, P1432, DOI 10.1016/S0140-6736(00)04572-4; MARTIN JP, 1994, 25 HUMAN RIGHTS DOCU, P57; *MED SANS FRONT, 1977, REF HLTH APPR EM SIT; NOJI EK, 1999, HUMANITARIAN CRISES; Perrin P., 1996, HDB WAR PUBLIC HLTH; ROBERTS L, 2001, MORTALITY E REPUBLIC; Salama P, 2001, JAMA-J AM MED ASSOC, V286, P531, DOI 10.1001/jama.286.5.531; Salama P, 2001, JAMA-J AM MED ASSOC, V286, P563, DOI 10.1001/jama.286.5.563; TANGUY J, 1999, ETHICS INT AFF, P13; TERRY F, 2000, HUMINTARIAN EXCH OCT; The Sphere Project, 2000, HUM CHART MIN STAND; TOOLE M J, 1989, Bulletin of the World Health Organization, V67, P381; TOOLE MJ, 1990, JAMA-J AM MED ASSOC, V263, P3296, DOI 10.1001/jama.263.24.3296; TOOLE MJ, 1993, LANCET, V341, P1193, DOI 10.1016/0140-6736(93)91013-C; Waldman RJ, 2001, LANCET, V357, P1427, DOI 10.1016/S0140-6736(00)04568-2	20	13	13	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2001	286	5					588	590		10.1001/jama.286.5.588	http://dx.doi.org/10.1001/jama.286.5.588			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458HE	11476662				2022-12-28	WOS:000170188300023
J	De La Cruz, EM; Pollard, TD				De La Cruz, EM; Pollard, TD			Structural biology - Actin' up	SCIENCE			English	Editorial Material							ADP-ACTIN; ATP-ACTIN; POLYMERIZATION; FILAMENTS; DYNAMICS; BINDING		Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University; Yale University	De La Cruz, EM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.							Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; CARLIER MF, 1988, J BIOL CHEM, V263, P817; De La Cruz EM, 2000, BIOPHYS J, V78, P2516, DOI 10.1016/S0006-3495(00)76797-X; Oosawa F., 1975, THERMODYNAMICS POLYM; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1994, ANNU REV CELL BIOL, V10, P207, DOI 10.1146/annurev.cellbio.10.1.207; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; POLLLARD TD, 2001, CELL BIOL; STRAUB FB, 1950, BIOCHIM BIOPHYS ACTA, V4, P455, DOI 10.1016/0006-3002(50)90052-7; WEGNER A, 1976, J MOL BIOL, V108, P139, DOI 10.1016/S0022-2836(76)80100-3	11	15	16	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					616	618		10.1126/science.1063558	http://dx.doi.org/10.1126/science.1063558			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474090				2022-12-28	WOS:000170204600032
J	Kumagai, H; Ohminato, T; Nakano, M; Ooi, M; Kubo, A; Inoue, H; Oikawa, J				Kumagai, H; Ohminato, T; Nakano, M; Ooi, M; Kubo, A; Inoue, H; Oikawa, J			Very-long-period seismic signals and caldera formation at Miyake Island, Japan	SCIENCE			English	Article								Over a period of roughly 40 days, starting on 8 July 2000, a caldera structure 1.7 kilometers in diameter developed by means of gradual depression and expansion of the summit crater at Miyake Island, Japan. At the same time, very-long-period (VLP) seismic signals were observed once or twice a day. Source mechanism analyses of the VLP signals show that the moment tensor solutions are smooth step functions over a time scale of 50 seconds, with dominant volumetric change components. We developed a model to explain the caldera and the VLP signals, in which a vertical piston of solid materials in the conduit is intermittently sucked into the magma chamber by lateral magma outflow. This model offers potential for making quantitative estimations of the characteristic physical properties of magma systems.	Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki 305, Japan; Univ Tokyo, Earthquake Res Inst, Tokyo 113, Japan; Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi, Japan	National Research Institute for Earth Science & Disaster Resilience; University of Tokyo; Nagoya University	Kumagai, H (corresponding author), Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki 305, Japan.		Ohminato, Takao/L-1562-2014					Eaton J., 1987, US GEOL SURV PROF PA, V1350, P1307; EATON JP, 1960, SCIENCE, V132, P925, DOI 10.1126/science.132.3432.925; HAYAKAWA Y, 2000, PROGRAMS ABSTR VOLCA, V2, P20; Isshiki N, 1964, B VOLCANOL, V27, P29, DOI [10.1007/BF02597505, DOI 10.1007/BF02597505]; KAZAHAYA K, 2000, PROGRAMS ABSTR VOLCA, V81, pF1259; KAZAHAYA K, 2000, EOS, V81, pF1259; KIKUCHI M, 2001, J GEOGR, V110, P145; Miyazaki T., 1984, B VOLCANOL SOC JPN, V29, pS1, DOI [10.18940/kazanc.29.TOKUBE_S1, DOI 10.18940/KAZANC.29.TOKUBE_S1]; NISHIZAWA A, 1990, PROGRAMS ABSTR SEISM, V2, pA79; Ohminato T, 1998, J GEOPHYS RES-SOL EA, V103, P23839, DOI 10.1029/98JB01122; SAKAI S, 2000, PROGRAMS ABSTR SEISM, V1, pA1; Tsukui M, 1998, B VOLCANOL SOC JPN, V43, P149; Turcotte D., 2014, GEODYNAMICS, V3rd edn.; Ukawa M, 2000, EARTH PLANETS SPACE, V52, pXIX, DOI 10.1186/BF03351659; WILLIAMS H, 1941, U CALIF PUBLS GEOL S, V25, P239	15	129	129	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					687	690		10.1126/science.1062136	http://dx.doi.org/10.1126/science.1062136			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474109				2022-12-28	WOS:000170204600052
J	Fox, NC; Crum, WR; Scahill, RI; Stevens, JM; Janssen, JC; Rossor, MN				Fox, NC; Crum, WR; Scahill, RI; Stevens, JM; Janssen, JC; Rossor, MN			Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images	LANCET			English	Article							PRECLINICAL PHASE; APOLIPOPROTEIN-E; ATROPHY; RISK; MRI; REGISTRATION; MICROSCOPY; PATTERNS; ALLELE	Background Early diagnosis and monitoring of the progression of Alzheimer's disease is important for the development of therapeutic strategies. To detect the earliest structural brain changes, individuals need to be studied before symptom onset. We used an imaging technique known as voxel-compression mapping to localise progressive atrophy in patients with preclinical Alzheimer's disease. Methods Four symptom-free individuals from families with early-onset Alzheimer's disease with known autosomal dominant mutations underwent serial magnetic resonance imaging (MRI) over 5-8 years. All four became symptomatic during follow-up. 20 individuals with a clinical diagnosis of probable Alzheimer's disease and 20 control participants also underwent serial MR imaging. A non-linear fluid matching algorithm was applied to register repeat scans onto baseline imaging. Jacobian determinants were used to create the voxel-compression maps. Findings Progressive atrophy was revealed in presymptomatic individuals, with posterior cingulate and neocortical temporoparietal cortical losses, and medial temporal-lobe atrophy. In patients with known Alzheimer's disease, atrophy was widespread apart from in the primary motor and sensory cortices and cerebellum, reflecting the clinical phenomenology. Interpretation Voxel-compression maps confirmed early involvement of the medial temporal lobes, but also showed posterior cingulate and temporoparietal cortical losses at presymptomatic stage. This technique could be applied diagnostically and used to monitor the effects of therapeutic intervention.	UCL, Inst Neurol, Dept Clin Neurol, Dementia Res Grp, London, England; Imperial Coll Sch Med, Div Neurosci, London, England	University of London; University College London; Imperial College London	Fox, NC (corresponding author), Natl Hosp Neurol & Neurosurg, Dementia Res Grp, 8-11 Queen Sq, London WC1N 3BG, England.	nfox@dementia.ionl.ucl.ac.uk	Rossor, Martin/C-1598-2008; Fox, Nick C/B-1319-2009; Crum, William R/C-4891-2008; Fox, Nick C/AAE-1849-2021	Fox, Nick C/0000-0002-6660-657X; Crum, William R/0000-0001-9369-2197; Fox, Nick C/0000-0002-6660-657X; Scahill, Rachael/0000-0002-1832-106X; Rossor, Martin/0000-0001-8215-3120				Benveniste H, 1999, P NATL ACAD SCI USA, V96, P14079, DOI 10.1073/pnas.96.24.14079; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; DELEON MJ, 1993, AM J NEURORADIOL, V14, P897; Fabrigoule C, 1998, BRAIN, V121, P135, DOI 10.1093/brain/121.1.135; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox NC, 1999, LANCET, V353, P2125, DOI 10.1016/S0140-6736(99)00496-1; Fox NC, 1997, J MAGN RESON IMAGING, V7, P1069, DOI 10.1002/jmri.1880070620; Fox NC, 1998, BRAIN, V121, P1631, DOI 10.1093/brain/121.9.1631; Fox NC, 2000, NAT MED, V6, P20, DOI 10.1038/71481; Freeborough PA, 1997, COMPUT METH PROG BIO, V53, P15, DOI 10.1016/S0169-2607(97)01803-8; Freeborough PA, 1998, J COMPUT ASSIST TOMO, V22, P838, DOI 10.1097/00004728-199809000-00031; Freeborough PA, 1996, J COMPUT ASSIST TOMO, V20, P1012, DOI 10.1097/00004728-199611000-00030; Jack CR, 1997, NEUROLOGY, V49, P786, DOI 10.1212/WNL.49.3.786; LINN RT, 1995, ARCH NEUROL-CHICAGO, V52, P485, DOI 10.1001/archneur.1995.00540290075020; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; NEWMAN SK, 1994, J NEUROL NEUROSUR PS, V57, P967, DOI 10.1136/jnnp.57.8.967; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SMALL GW, 1995, JAMA-J AM MED ASSOC, V273, P942, DOI 10.1001/jama.273.12.942; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Thompson PM, 2000, NATURE, V404, P190, DOI 10.1038/35004593; Warrington E.K., 1984, RECOGNITION MEMORY T; WHITWELL JL, IN PRESS AM J NEUROR	24	341	349	0	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 21	2001	358	9277					201	205		10.1016/S0140-6736(01)05408-3	http://dx.doi.org/10.1016/S0140-6736(01)05408-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454HL	11476837				2022-12-28	WOS:000169967100013
J	Martinovic, J; Benachi, A; Laurent, N; Daikha-Dahmane, F; Gubler, MC				Martinovic, J; Benachi, A; Laurent, N; Daikha-Dahmane, F; Gubler, MC			Fetal toxic effects and angiotensin-II-receptor antagonists	LANCET			English	Letter									Univ Paris 05, Hosp Necker Enfants Malad, INSERM, U423, F-75743 Paris, France; Univ Paris 05, Dept Histoembryol, F-75743 Paris, France; Univ Paris 05, Dept Obstet, F-75743 Paris, France; Hosp Bocage, Dept Pathol, Dijon, France; Hosp Bocage, Dept Obstet, Dijon, France; Hosp Robert Debre, Dept Histoembryol, Paris, France; Hop Ambroise Pare, Dept Biochem, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Gubler, MC (corresponding author), Univ Paris 05, Hosp Necker Enfants Malad, INSERM, U423, F-75743 Paris, France.			Gubler, Marie-Claire/0000-0002-3526-5661				HINCHLIFFE SA, 1992, PATHOL RES PRACT, V188, P775; PRYDE PG, 1993, J AM SOC NEPHROL, V3, P1575; Saji H, 2001, LANCET, V357, P363, DOI 10.1016/S0140-6736(00)03648-5; Sorensen A M, 1998, Ugeskr Laeger, V160, P1460; SPENCE SG, 1995, TERATOLOGY, V51, P367, DOI 10.1002/tera.1420510603	5	66	74	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 21	2001	358	9277					241	242		10.1016/S0140-6736(01)05426-5	http://dx.doi.org/10.1016/S0140-6736(01)05426-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454HL	11480433	Bronze			2022-12-28	WOS:000169967100045
J	Bengtsson, L				Bengtsson, L			Weather - Hurricane threats	SCIENCE			English	Editorial Material							WEST-AFRICAN RAINFALL; TROPICAL CYCLONES; UNITED-STATES; EL-NINO; INTENSITY; CLIMATE; ASSOCIATION; FREQUENCY		Max Planck Inst Meteorol, D-20146 Hamburg, Germany; Univ Reading, Environm Syst Sci Ctr, Reading RG6 6AL, Berks, England	Max Planck Society; University of Reading	Bengtsson, L (corresponding author), Max Planck Inst Meteorol, Bundesstr 55, D-20146 Hamburg, Germany.							AMS, 2000, B AM METEOROL SOC, V81, P1341, DOI [10.1175/1520-0477(2000)0812.3.CO;2, DOI 10.1175/1520-0477(2000)0812.3.CO;2]; Bengtsson L, 1996, TELLUS A, V48, P57, DOI 10.1034/j.1600-0870.1996.00004.x; BENGTSSON L, 1995, TELLUS A, V47, P175, DOI 10.1034/j.1600-0870.1995.t01-1-00003.x; BENGTSSON L, IN PRESS 50 ANNIVERS, P83; EMANUEL KA, 1991, ANNU REV FLUID MECH, V23, P179, DOI 10.1146/annurev.fluid.23.1.179; EMANUEL KA, 1987, NATURE, V326, P483, DOI 10.1038/326483a0; Goldenberg SB, 1996, J CLIMATE, V9, P1169, DOI 10.1175/1520-0442(1996)009<1169:PMFTAO>2.0.CO;2; Goldenberg SB, 2001, SCIENCE, V293, P474, DOI 10.1126/science.1060040; GRAY WM, 1984, MON WEATHER REV, V112, P1649, DOI 10.1175/1520-0493(1984)112<1649:ASHFPI>2.0.CO;2; GRAY WM, 1990, SCIENCE, V249, P1251, DOI 10.1126/science.249.4974.1251; Gray WM., 1979, METEOROLOGY TROPICAL, P155, DOI DOI 10.1175/1520-0450; Henderson-Sellers A, 1998, B AM METEOROL SOC, V79, P19, DOI 10.1175/1520-0477(1998)079<0019:TCAGCC>2.0.CO;2; Holland GJ, 1997, J ATMOS SCI, V54, P2519, DOI 10.1175/1520-0469(1997)054<2519:TMPIOT>2.0.CO;2; Kleinschmidt E., 1951, ARCH METEOROL GEOPHY, V4, P53, DOI [10.1007/BF02246793, DOI 10.1007/BF02246793]; Knutson TR, 1998, SCIENCE, V279, P1018, DOI 10.1126/science.279.5353.1018; Pielke RA, 1997, HURRICANES, P147; Pielke RA, 1998, WEATHER FORECAST, V13, P621, DOI 10.1175/1520-0434(1998)013<0621:NHDITU>2.0.CO;2; SCHADE LR, 1994, THESIS MIT CAMBRIDGE; Vitart F, 2001, J CLIMATE, V14, P533, DOI 10.1175/1520-0442(2001)014<0533:SOATSF>2.0.CO;2	19	37	41	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2001	293	5529					440	441		10.1126/science.1062047	http://dx.doi.org/10.1126/science.1062047			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463900				2022-12-28	WOS:000169966700030
J	McKee, RA; Walker, FJ; Chisholm, MF				McKee, RA; Walker, FJ; Chisholm, MF			Physical structure and inversion charge at a semiconductor interface with a crystalline oxide	SCIENCE			English	Article							SCHOTTKY-BARRIER HEIGHTS; MOLECULAR-BEAM EPITAXY; SILICON; TRANSISTORS; DIELECTRICS; CONSTRAINTS; STABILITY; TITANATE; DEVICES; SRTIO3	We show that the physical and electrical structure and hence the inversion charge for crystalline oxides on semiconductors can be understood and systematically manipulated at the atomic Level. Heterojunction band offset and alignment are adjusted by atomic-level structural and chemical changes, resulting in the demonstration of an electrical interface between a polar oxide and a semiconductor free of interface charge. In a broader sense, we take the metal oxide semiconductor device to a new and prominent position in the solid-state electronics timeline, It can now be extensively developed using an entirely new physical system: the crystalline oxides-on-semiconductors interface.	Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory	McKee, RA (corresponding author), Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA.		Chisholm, Matthew F./F-7198-2017	Chisholm, Matthew F./0000-0003-0546-5109; Walker, Frederick/0000-0002-8094-249X				Arora N, 1993, MOSFET MODELS VLSI C; BREWS JR, 1975, J APPL PHYS, V46, P2181, DOI 10.1063/1.321863; Campbell SA, 1997, IEEE T ELECTRON DEV, V44, P104, DOI 10.1109/16.554800; Chambers SA, 2000, APPL PHYS LETT, V77, P1662, DOI 10.1063/1.1310209; Copel M, 2000, APPL PHYS LETT, V76, P436, DOI 10.1063/1.125779; Eisenbeiser K, 2000, APPL PHYS LETT, V76, P1324, DOI 10.1063/1.126023; JELLISON GE, 1994, APPL OPTICS, V33, P6053, DOI 10.1364/AO.33.006053; KAHNG D, 1960, SILICON SILICON DIOX; Kane BE, 2000, FORTSCHR PHYS, V48, P1023, DOI 10.1002/1521-3978(200009)48:9/11<1023::AID-PROP1023>3.0.CO;2-J; LEVY JA, UNPUB; Lin A, 2001, APPL PHYS LETT, V78, P2034, DOI 10.1063/1.1358848; LOONEY DH, 1957, Patent No. 2791758; Lucovsky G, 1999, APPL PHYS LETT, V74, P2005, DOI 10.1063/1.123728; Lucovsky G, 2000, APPL SURF SCI, V166, P497, DOI 10.1016/S0169-4332(00)00482-7; McKee R A, 1998, U.S. Patent, Patent No. [5 830 270, 5830270]; MCKEE RA, 1994, PHYS REV LETT, V72, P2741, DOI 10.1103/PhysRevLett.72.2741; MCKEE RA, 1993, APPL PHYS LETT, V63, P2818, DOI 10.1063/1.110297; MCKEE RA, 1991, APPL PHYS LETT, V59, P782, DOI 10.1063/1.105341; McKee RA, 1998, PHYS REV LETT, V81, P3014, DOI 10.1103/PhysRevLett.81.3014; MCKEE RW, UNPUB; Melloch MR, 1996, CRIT REV SOLID STATE, V21, P189, DOI 10.1080/10408439608241256; MERZ WJ, 1954, PHYS REV, V95, P690, DOI 10.1103/PhysRev.95.690; Nicollian EH., 1982, MOS METAL OXIDE SEMI; Robertson J, 1999, APPL PHYS LETT, V74, P1168, DOI 10.1063/1.123476; Robertson J, 2000, J VAC SCI TECHNOL B, V18, P1785, DOI 10.1116/1.591472; TERSOFF J, 1984, PHYS REV LETT, V52, P465, DOI 10.1103/PhysRevLett.52.465; WALKER FJ, UNPUB; WYCKOFF RWG, 1951, CRYSTAL STRUCTURE 6A, V1, pCH7; [No title captured]	29	264	293	1	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2001	293	5529					468	471		10.1126/science.293.5529.468	http://dx.doi.org/10.1126/science.293.5529.468			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463909				2022-12-28	WOS:000169966700040
J	Dalton, R				Dalton, R			Action urged to combat killer algae	NATURE			English	News Item																			0	4	4	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					260	260		10.1038/35085712	http://dx.doi.org/10.1038/35085712			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460123	Bronze			2022-12-28	WOS:000169918200010
J	Pasqualucci, L; Neumeister, P; Goossens, T; Nanjangud, G; Chaganti, RSK; Kuppers, R; Dalla-Favera, R				Pasqualucci, L; Neumeister, P; Goossens, T; Nanjangud, G; Chaganti, RSK; Kuppers, R; Dalla-Favera, R			Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas	NATURE			English	Article							DOUBLE-STRAND BREAKS; SOMATIC HYPERMUTATION; C-MYC; IMMUNOGLOBULIN GENES; HODGKINS-LYMPHOMA; BURKITT-LYMPHOMA; BCL-6 MUTATIONS; BINDING PROTEIN; IG GENES; TRANSLOCATIONS	Genomic instability promotes tumorigenesis and can occur through various mechanisms, including defective segregation of chromosomes or inactivation of DNA mismatch repair(1). Although B-cell lymphomas are associated with chromosomal translocations that deregulate oncogene expression(2), a mechanism for genome-wide instability during lymphomagenesis has not been described. During B-cell development, the immunoglobulin variable (V) region genes are subject to somatic hypermutation in germinal-centre B cells(3). Here we report that an aberrant hypermutation activity targets multiple loci, including the proto-oncogenes PIM1, MYC, RhoH/TTF (ARHH) and PAX5, in more than 50% of diffuse large-cell lymphomas (DLCLs), which are tumours derived from germinal centres. Mutations are distributed in the 5' untranslated or coding sequences, are independent of chromosomal translocations, and share features typical of V-region-associated somatic hypermutation. In contrast to mutations in V regions, however, these mutations are not detectable in normal germinal-centre B cells or in other germinal-centre-derived lymphomas, suggesting a DLCL-associated malfunction of somatic hypermutation. Intriguingly, the four hypermutable genes are susceptible to chromosomal translocations in the same region, consistent with a role for hypermutation in generating translocations by DNA double-strand breaks(4-6). By mutating multiple genes, and possibly by favouring chromosomal translocations, aberrant hypermutation may represent the major contributor to lymphomagenesis.	Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA; Univ Cologne, Inst Genet, D-50931 Cologne, Germany; Mem Sloan Kettering Canc Ctr, Canc Genet Lab, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA	Columbia University; Columbia University; University of Cologne; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Dalla-Favera, R (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10032 USA.			Kuppers, Ralf/0000-0002-6691-7191				Akasaka H, 2000, CANCER RES, V60, P2335; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; CESARMAN E, 1987, SCIENCE, V238, P1272, DOI 10.1126/science.3685977; Cigudosa JC, 1999, GENE CHROMOSOME CANC, V25, P123, DOI 10.1002/(SICI)1098-2264(199906)25:2<123::AID-GCC8>3.0.CO;2-4; CUYPERS HT, 1984, CELL, V37, P141; DALLAFAVERA R, 2001, CANC PRINCIPLES PRAC, P2215; Dang CV, 1999, MOL CELL BIOL, V19, P1; Gamberi B, 1997, BLOOD, V89, P975; Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463; GU W, 1994, SCIENCE, V264, P251, DOI 10.1126/science.8146655; HOOVER D, 1991, J BIOL CHEM, V266, P14018; Jungnickel B, 2000, J EXP MED, V191, P395, DOI 10.1084/jem.191.2.395; Klein U, 1998, IMMUNOL REV, V162, P261; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Migliazza A, 1995, P NATL ACAD SCI USA, V92, P12520, DOI 10.1073/pnas.92.26.12520; Morrison AM, 1998, SEMIN IMMUNOL, V10, P133, DOI 10.1006/smim.1998.0115; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muschen M, 2000, J EXP MED, V192, P1833, DOI 10.1084/jem.192.12.1833; Neuberger MS, 1998, IMMUNOL REV, V162, P107, DOI 10.1111/j.1600-065X.1998.tb01434.x; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Pasqualucci L, 2000, CANCER RES, V60, P5644; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Preudhomme C, 2000, ONCOGENE, V19, P2023, DOI 10.1038/sj.onc.1203521; RABBITTS TH, 1983, NATURE, V306, P760, DOI 10.1038/306760a0; Raffeld M, 1995, Curr Top Microbiol Immunol, V194, P265; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Shen HM, 2000, INT IMMUNOL, V12, P1085, DOI 10.1093/intimm/12.7.1085; Shirogane T, 1999, IMMUNITY, V11, P709, DOI 10.1016/S1074-7613(00)80145-4; Storb U, 1998, IMMUNOL REV, V162, P153; Zan H, 1999, J IMMUNOL, V162, P3437	30	740	770	0	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					341	346		10.1038/35085588	http://dx.doi.org/10.1038/35085588			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460166				2022-12-28	WOS:000169918200049
J	Richmond, JE; Weimer, RM; Jorgensen, EM				Richmond, JE; Weimer, RM; Jorgensen, EM			An open form of syntaxin bypasses the requirement for UNC-13 in vesicle priming	NATURE			English	Article							MUNC13-1; EXPRESSION; FUSION; FAMILY; GENE	The priming step of synaptic vesicle exocytosis is thought to require the formation of the SNARE complex, which comprises the proteins synaptobrevin, SNAP-25 and syntaxin(1-3). In solution syntaxin adopts a default, closed configuration that is incompatible with formation of the SNARE complex(4). Specifically, the amino terminus of syntaxin binds the SNARE motif and occludes interactions with the other SNARE proteins. The N terminus of syntaxin also binds the presynaptic protein UNC-13 (ref. 5). Studies in mouse, Drosophila and Caenorhabditis elegans suggest that UNC-13 functions at a post-docking step of exocytosis, most likely during synaptic vesicle priming(6-8). Therefore, UNC-13 binding to the N terminus of syntaxin may promote the open configuration of syntaxin(9). To test this model, we engineered mutations into C. elegans syntaxin that cause the protein to adopt the open configuration constitutively(4). Here we demonstrate that the open form of syntaxin can bypass the requirement for UNC-13 in synaptic vesicle priming. Thus, it is likely that UNC-13 primes synaptic vesicles for fusion by promoting the open configuration of syntaxin.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Jorgensen, EM (corresponding author), Univ Utah, Dept Biol, 257 S 1400 E, Salt Lake City, UT 84112 USA.	jorgensen@biology.utah.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH059820] Funding Source: NIH RePORTER; NIMH NIH HHS [R03 MH059820-02, R03 MH059820-01] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Betz A, 1997, J BIOL CHEM, V272, P2520; BRENNER S, 1974, GENETICS, V77, P71; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Kohn RE, 2000, MOL BIOL CELL, V11, P3441, DOI 10.1091/mbc.11.10.3441; MARUYAMA IN, 1991, P NATL ACAD SCI USA, V88, P5729, DOI 10.1073/pnas.88.13.5729; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Miyabayashi T, 1999, DEV BIOL, V215, P314, DOI 10.1006/dbio.1999.9470; Nonet ML, 1998, J NEUROSCI, V18, P70; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; THOMAS JH, 1990, GENETICS, V124, P855; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4	21	306	316	1	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 19	2001	412	6844					338	341		10.1038/35085583	http://dx.doi.org/10.1038/35085583			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460165	Green Accepted			2022-12-28	WOS:000169918200048
J	Tahaoglu, K; Torun, T; Sevim, T; Atac, G; Kir, A; Karasulu, L; Ozmen, I; Kapakli, N				Tahaoglu, K; Torun, T; Sevim, T; Atac, G; Kir, A; Karasulu, L; Ozmen, I; Kapakli, N			The treatment of multidrug-resistant tuberculosis in Turkey	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MDR-TB; CHEMOTHERAPY; RIFAMPIN	Background: We evaluated the results of treatment in 158 consecutive patients with multidrug-resistant tuberculosis who were treated at our center in Istanbul, Turkey. Methods: A total of 21 female patients and 137 male patients (age range, 15 to 68 years) received treatment for multidrug-resistant tuberculosis between March 1992 and October 1999. The patients had previously received a mean of 5.7 antituberculosis drugs and were infected with organisms that were resistant to a mean of 4.4 drugs. All patients received at least three drugs thought to be active; the treatment was continued for at least 18 months after the conversion to a negative culture and for at least 24 months in the absence of first-line drugs. Results: The mean number of drugs given during the study was 5.5 (range, 3 to 9). Surgical resection was performed in 36 patients. Adverse effects led to discontinuation of one or more drugs in 62 patients (39 percent). Cultures became negative in 150 patients (95 percent) after a mean of 1.9 months (range, 1 to 9). The overall success rate of treatment was 77 percent, with cures in 78 patients (49 percent) and probable cures in 43 (27 percent). Treatment failed in 13 patients (8 percent). Seven patients died (4 percent). Seventeen patients (11 percent) did not complete the treatment regimen. Thirty-eight percent of the patients with unsuccessful outcomes were infected with organisms that were resistant to more than five drugs. In a step-down logistic-regression analysis, a successful outcome was independently associated with a younger age (P=0.013) and the absence of previous treatment with ofloxacin (P=0.005). Conclusions: Most patients with multidrug-resistant tuberculosis can be cured with the use of appropriate, intensive treatment regimens. (N Engl J Med 2001;345:170-4.) Copyright (C) 2001 Massachusetts Medical Society.	Sureyyapasa Ctr Chest Dis & Thorac Surg, Dept Pulm Dis, Istanbul, Turkey; Sureyyapasa Ctr Chest Dis & Thorac Surg, Dept Thorac Surg, Istanbul, Turkey; Univ Istanbul, Istanbul Fac Med, Dept Chest Dis, Istanbul, Turkey	Istanbul Sureyyapasa Chest Diseases & Thoracic Surgery Training & Research Hospital; Istanbul Sureyyapasa Chest Diseases & Thoracic Surgery Training & Research Hospital; Istanbul University	Tahaoglu, K (corresponding author), Ekin Tibbi Yayincilik, Osmanaga Mah Nuzhet Efendi Sok 49-3, TR-81320 Istanbul, Turkey.		Ozmen, Ipek/I-3449-2018	Ozmen, Ipek/0000-0002-3448-3675				Espinal MA, 1999, INT J TUBERC LUNG D, V3, P561; Farmer P, 1999, INT J TUBERC LUNG D, V3, P643; Farmer P, 1998, INT J TUBERC LUNG D, V2, P869; Farmer P, 1999, MULTIDRUG RESISTAN 5; GOBLE M, 1993, NEW ENGL J MED, V328, P527, DOI 10.1056/NEJM199302253280802; ISEMAN MD, 1990, AM REV RESPIR DIS, V141, P623, DOI 10.1164/ajrccm/141.3.623; ISEMAN MD, 1993, NEW ENGL J MED, V329, P784, DOI 10.1056/NEJM199309093291108; ISEMAN MD, 1991, AM REV RESPIR DIS, V143, P697, DOI 10.1164/ajrccm/143.4_Pt_1.697; Park SK, 1998, INT J TUBERC LUNG D, V2, P877; RIEDER HL, 1994, TUBERCLE LUNG DIS, V75, P321, DOI 10.1016/0962-8479(94)90075-2; TAHAOGLU K, 1994, TUBERCLE LUNG DIS, V75, P324, DOI 10.1016/0962-8479(94)90076-0; TELZAK EE, 1995, NEW ENGL J MED, V333, P907, DOI 10.1056/NEJM199510053331404	12	205	216	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2001	345	3					170	174		10.1056/NEJM200107193450303	http://dx.doi.org/10.1056/NEJM200107193450303			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453JM	11463011				2022-12-28	WOS:000169912800003
J	Binder, GK; Griffin, DE				Binder, GK; Griffin, DE			Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; VIRAL-INFECTIONS; VIRUS-INFECTION; EXPRESSION; MICE; NEUROVIRULENCE; ENCEPHALITIS; CYTOKINES; MOUSE	Recovery from viral encephalomyelitis requires immune-mediated noncytolytic clearance from neurons by mechanisms assumed to be the same for all neurons. In alphavirus encephalomyelitis, antibody clears infectious virus from neurons in all regions of the central nervous system (CNS), but CD8 T cells contribute to elimination of viral RNA. To understand the role of T cells in clearance, we infected antibody knockout mice with Sindbis virus. Virus was cleared from spinal cord and brain stem neurons, but not from cortical neurons, and required both CD4 and CD8 T cells. Infection with cytokine-expressing recombinant viruses suggested that T cells used interferon-gamma, but not tumor necrosis factor alpha, in clearing virus and that populations of neurons differ in responsiveness to this effector pathway.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Griffin, DE (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.				NINDS NIH HHS [R01 NS038932] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038932] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BINDER GK, UNPUB; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; GRIFFIN DE, 1977, J IMMUNOL, V118, P1070; Guidotti LG, 2000, VIROLOGY, V273, P221, DOI 10.1006/viro.2000.0442; Guidotti LG, 1996, IMMUNITY, V4, P25, DOI 10.1016/S1074-7613(00)80295-2; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; JACKSON AC, 1988, LAB INVEST, V58, P503; JOLY E, 1991, SCIENCE, V253, P1283, DOI 10.1126/science.1891717; Kelly J. P., 1991, PRINCIPLES NEURAL SC, P273; Kelly JP., 1991, PRINC NEURAL SCI, V1, P283; Kimura T, 2000, J VIROL, V74, P6117, DOI 10.1128/JVI.74.13.6117-6125.2000; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KUNDIG TM, 1993, J IMMUNOL, V150, P2316; LEVINE B, 1991, SCIENCE, V254, P856, DOI 10.1126/science.1658936; Lin MT, 1998, ADV EXP MED BIOL, V440, P431; McCluskey LP, 2000, J NEUROPATH EXP NEUR, V59, P177, DOI 10.1093/jnen/59.3.177; OLDSTONE MBA, 1986, NATURE, V321, P239, DOI 10.1038/321239a0; PEARCE BD, 1994, J VIROL, V68, P5483, DOI 10.1128/JVI.68.9.5483-5495.1994; RAMSAY AJ, 1993, IMMUNOL TODAY, V14, P155, DOI 10.1016/0167-5699(93)90277-R; Ramshaw IA, 1997, IMMUNOL REV, V159, P119, DOI 10.1111/j.1600-065X.1997.tb01011.x; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; TUCKER PC, 1991, J VIROL, V65, P1551, DOI 10.1128/JVI.65.3.1551-1557.1991; WESSELINGH SL, 1994, J IMMUNOL, V152, P1289; Will A, 1996, J IMMUNOL, V157, P4576; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	25	200	204	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					303	306		10.1126/science.1059742	http://dx.doi.org/10.1126/science.1059742			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452126				2022-12-28	WOS:000169875200060
J	Germain, RN				Germain, RN			The art of the probable: System control in the adaptive immune system	SCIENCE			English	Review							CD4(+) T-CELLS; IN-VIVO; LYMPHOCYTE-RESPONSES; DENDRITIC CELLS; GENE-EXPRESSION; SELF-TOLERANCE; MEMORY CELLS; ANTIGEN; CYTOKINES; SIGNAL	The immune system provides very effective hose defense against infectious agents. Although many details are known about the cells and molecules involved, a broader "systems engineering" view of this complex system is just beginning to emerge. Here the argument is put forward that stochastic events, potent amplification mechanisms, feedback controls, and heterogeneity arising from spatially dispersed cell interactions give rise to many of the gross properties of the immune system. A better appreciation of these underlying features will not only add to our basic understanding of how immunity develops or goes awry, but also illuminate new directions far manipulating the system in prophylactic and therapeutic settings.	NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Germain, RN (corresponding author), NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bldg 10,Room 11N311,10 Ctr Dr MSC-1892, Bethesda, MD 20892 USA.	rgermain@nih.gov	Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000403, Z01AI000757, ZIAAI000403] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Biron CA, 1998, SEMIN IMMUNOL, V10, P383, DOI 10.1006/smim.1998.0138; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; BUCY RP, 1994, J EXP MED, V180, P1251, DOI 10.1084/jem.180.4.1251; Callard R, 1999, IMMUNITY, V11, P507, DOI 10.1016/S1074-7613(00)80125-9; CANTRELL DA, 1984, SCIENCE, V224, P1312, DOI 10.1126/science.6427923; CARSON DA, 1992, FASEB J, V6, P2800, DOI 10.1096/fasebj.6.10.1634042; COHN M, 1990, IMMUNOL REV, V115, P7, DOI 10.1111/j.1600-065X.1990.tb00783.x; Cook DL, 1998, P NATL ACAD SCI USA, V95, P15641, DOI 10.1073/pnas.95.26.15641; CROFT M, 1994, J IMMUNOL, V152, P2675; Curtsinger JM, 1998, J IMMUNOL, V160, P3236; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Gett AV, 2000, NAT IMMUNOL, V1, P239, DOI 10.1038/79782; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Grossman Z, 2000, SEMIN IMMUNOL, V12, P197, DOI 10.1006/smim.2000.0232; Hartl D., 1989, PRINCIPLES POPULATIO; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoffmann KF, 2000, J IMMUNOL, V164, P6406, DOI 10.4049/jimmunol.164.12.6406; Hu-Li J, 2001, IMMUNITY, V14, P1, DOI 10.1016/S1074-7613(01)00084-X; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; Janeway C.A., 1999, IMMUNOBIOLOGY IMMUNE; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; KELSO A, 1995, EUR J IMMUNOL, V25, P1168, DOI 10.1002/eji.1830250506; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; LAPORTE DC, 1984, J BIOL CHEM, V259, P4068; LEHMANN PV, 1992, NATURE, V358, P155, DOI 10.1038/358155a0; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Paul W., 1999, FUNDAMENTAL IMMUNOLO; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Pihlgren M, 1996, J EXP MED, V184, P2141, DOI 10.1084/jem.184.6.2141; Reiner SL, 1999, IMMUNITY, V11, P1, DOI 10.1016/S1074-7613(00)80076-X; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Rogers PR, 2000, J IMMUNOL, V164, P2338, DOI 10.4049/jimmunol.164.5.2338; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schulz O, 2000, IMMUNITY, V13, P453, DOI 10.1016/S1074-7613(00)00045-5; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; SNAPPER CM, 1988, IMMUNOL REV, V102, P51, DOI 10.1111/j.1600-065X.1988.tb00741.x; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; THOMPSON CB, 1989, P NATL ACAD SCI USA, V86, P1333, DOI 10.1073/pnas.86.4.1333; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Wenner CA, 1996, J IMMUNOL, V156, P1442; Whitmire JK, 2000, PHILOS T R SOC B, V355, P373, DOI 10.1098/rstb.2000.0577; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664	59	143	145	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2001	293	5528					240	245		10.1126/science.1062946	http://dx.doi.org/10.1126/science.1062946			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452112				2022-12-28	WOS:000169875200042
J	Rothfield, LI; Shih, YL; King, G				Rothfield, LI; Shih, YL; King, G			Polar explorers: Membrane proteins that determine division site placement	CELL			English	Review							ESCHERICHIA-COLI; CELL-DIVISION; TOPOLOGICAL REGULATION; INHIBITOR MINC; RAPID POLE; OSCILLATION; ATPASE; LOCALIZATION; SELECTION; RING		Univ Connecticut, Ctr Hlth, Dept Microbiol, Farmington, CT 06030 USA; Univ Connecticut, Ctr Hlth, Dept Biochem, Farmington, CT 06030 USA	University of Connecticut; University of Connecticut	Rothfield, LI (corresponding author), Univ Connecticut, Ctr Hlth, Dept Microbiol, Farmington, CT 06030 USA.	lroth@neuron.uchc.edu	Shih, Yu-Ling/F-8396-2011; King, Glenn F/J-5059-2012	Shih, Yu-Ling/0000-0002-8232-2569; King, Glenn F/0000-0002-2308-2200				Cook WR, 1999, J BACTERIOL, V181, P1900, DOI 10.1128/JB.181.6.1900-1905.1999; DEBOER PAJ, 1991, EMBO J, V10, P4371, DOI 10.1002/j.1460-2075.1991.tb05015.x; Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298; Hale CA, 2001, EMBO J, V20, P1563, DOI 10.1093/emboj/20.7.1563; Hayashi I, 2001, EMBO J, V20, P1819, DOI 10.1093/emboj/20.8.1819; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Marston AL, 1999, MOL MICROBIOL, V33, P84, DOI 10.1046/j.1365-2958.1999.01450.x; Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999; Raskin DM, 1997, CELL, V91, P685, DOI 10.1016/S0092-8674(00)80455-9; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Rothfield L, 1999, ANNU REV GENET, V33, P423, DOI 10.1146/annurev.genet.33.1.423; Rowland SL, 2000, J BACTERIOL, V182, P613, DOI 10.1128/JB.182.3.613-619.2000	15	50	55	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2001	106	1					13	16		10.1016/S0092-8674(01)00432-9	http://dx.doi.org/10.1016/S0092-8674(01)00432-9			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461697	Bronze			2022-12-28	WOS:000169870300004
J	Shapiro, HT; Meslin, EM				Shapiro, HT; Meslin, EM			Ethical issues in the design and conduct of clinical trials in developing countries.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; TRANSMISSION		Natl Bioeth Advisory Commiss, Bethesda, MD 20892 USA		Shapiro, HT (corresponding author), Natl Bioeth Advisory Commiss, Bethesda, MD 20892 USA.							Angell M, 2000, NEW ENGL J MED, V342, P967, DOI 10.1056/NEJM200003303421309; Angell M, 1997, NEW ENGL J MED, V337, P847, DOI 10.1056/NEJM199709183371209; Benatar SR, 2000, BMJ-BRIT MED J, V321, P824, DOI 10.1136/bmj.321.7264.824; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; *COUNC INT ORG MED, 1993, INT ETH GUID BIOM RE; Del Rio C, 1998, BIOETHICS, V12, P328, DOI 10.1111/1467-8519.00122; Flaherty M.P., 2000, WASH POST; Flaherty Mary Pat, 2001, WASHINGTON POST 0223, pA3; *GAMB GOV, 1998, LANCET, V51, P286; Glantz LH, 1998, HASTINGS CENT REP, V28, P38, DOI 10.2307/3528268; Global Forum for Health Research, 2000, 10 90 REP HLTH RES 2; IJSSELMUIDEN CB, 1992, NEW ENGL J MED, V326, P830, DOI 10.1056/NEJM199203193261212; Loue S, 2000, J LAW MED ETHICS, V28, P165, DOI 10.1111/j.1748-720X.2000.tb00006.x; Lurie P, 1997, NEW ENGL J MED, V337, P853, DOI 10.1056/NEJM199709183371212; National Bioethics Advisory Commission, 2001, ETH POL ISS INT RES; Stephens Joe, 2000, WASHINGTON POST 1217, pA1; Varmus H, 1997, NEW ENGL J MED, V337, P1003, DOI 10.1056/NEJM199710023371411; World Health Organization, 2000, TDRPRDETHICS20001 WH; *WORLD MED ASS DEC, 2001, ETH PRINC MED RES IN; 2000, WASHINGTON POST 1224, pB6	20	134	139	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 12	2001	345	2					139	142		10.1056/NEJM200107123450212	http://dx.doi.org/10.1056/NEJM200107123450212			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	451AH	11450665				2022-12-28	WOS:000169776900012
J	Bao, SW; Chan, WT; Merzenich, MM				Bao, SW; Chan, WT; Merzenich, MM			Cortical remodelling induced by activity of ventral tegmental dopamine neurons	NATURE			English	Article							AUDITORY-CORTEX; SOMATOSENSORY CORTEX; BASAL FOREBRAIN; CEREBRAL-CORTEX; PLASTICITY; RECEPTORS; SYSTEMS; REORGANIZATION; PREDICTION; INDUCTION	Representations of sensory stimuli in the cerebral cortex can undergo progressive remodelling according to the behavioural importance of the stimuli(1,2). The cortex receives widespread projections from dopamine neurons in the ventral tegmental area (VTA)(3-5), which are activated by new stimuli or unpredicted rewards(6,7), and are believed to provide a reinforcement signal for such learning-related cortical reorganization(8). In the primary auditory cortex (AI) dopamine release has been observed during auditory learning that remodels the sound-frequency representations(9,10). Furthermore, dopamine modulates longterm potentiation(11,12), a putative cellular mechanism underlying plasticity(13). Here we show that stimulating the VTA together with an auditory stimulus of a particular tone increases the cortical area and selectivity of the neural responses to that sound stimulus in AI. Conversely, the AI representations of nearby sound frequencies are selectively decreased. Strong, sharply tuned responses to the paired tones also emerge in a second cortical area, whereas the same stimuli evoke only poor or non-selective responses in this second cortical field in naive animals. In addition, we found that strong long-range coherence of neuronal discharge emerges between AI and this secondary auditory cortical area.	Univ Calif San Francisco, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Merzenich, MM (corresponding author), Univ Calif San Francisco, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	merz@phy.ucsf.edu						Bakin JS, 1996, BEHAV NEUROSCI, V110, P905, DOI 10.1037/0735-7044.110.5.905; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; DIAMOND DM, 1986, BRAIN RES, V372, P357, DOI 10.1016/0006-8993(86)91144-3; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; FOOTE SL, 1987, ANNU REV NEUROSCI, V10, P67, DOI 10.1146/annurev.ne.10.030187.000435; Goldsmith SK, 1996, NEUROSCIENCE, V74, P435, DOI 10.1016/0306-4522(96)00132-7; Gurden H, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0003.2000; HARING JH, 1986, BRAIN RES, V366, P152, DOI 10.1016/0006-8993(86)91290-4; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; LIDOW MS, 1991, NEUROSCIENCE, V40, P657, DOI 10.1016/0306-4522(91)90003-7; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; Otmakhova NA, 1998, J NEUROSCI, V18, P1270; PANDYA DN, 1982, TRENDS NEUROSCI, V5, P386, DOI 10.1016/0166-2236(82)90219-3; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Sachdev RNS, 1998, J NEUROPHYSIOL, V79, P3216, DOI 10.1152/jn.1998.79.6.3216; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Stark H, 1997, J NEUROCHEM, V68, P691; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; TREMBLAY N, 1990, J NEUROPHYSIOL, V64, P1212, DOI 10.1152/jn.1990.64.4.1212; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; ZILLES K, 1990, CEREBRAL CORTEX RAT, P77	30	426	447	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					79	83		10.1038/35083586	http://dx.doi.org/10.1038/35083586			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452310				2022-12-28	WOS:000169644900047
J	Alford, RA; Dixon, PM; Pechmann, JHK				Alford, RA; Dixon, PM; Pechmann, JHK			Ecology - Global amphibian population declines	NATURE			English	Article									James Cook Univ N Queensland, Sch Trop Biol, Townsville, Qld 4811, Australia; Iowa State Univ, Dept Stat, Ames, IA 50011 USA; Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA	James Cook University; Iowa State University; University of Louisiana System; University of New Orleans	Alford, RA (corresponding author), James Cook Univ N Queensland, Sch Trop Biol, Townsville, Qld 4811, Australia.		Dixon, Philip Michael/I-4843-2019; Alford, Ross A/H-1577-2011; Wrbka, Thomas/A-5699-2010	Dixon, Philip Michael/0000-0002-1778-0686; Alford, Ross A/0000-0002-3010-6768; Wrbka, Thomas/0000-0002-1451-9108				Alford RA, 1999, ANNU REV ECOL SYST, V30, P133, DOI 10.1146/annurev.ecolsys.30.1.133; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Chambers J. M., 1983, GRAPHICAL METHODS DA, DOI DOI 10.1201/9781351072304; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Pounds JA, 1997, CONSERV BIOL, V11, P1307, DOI 10.1046/j.1523-1739.1997.95485.x; WAKE D B, 1991, Alytes (Paris), V9, P33; Waldman B, 1998, BEHAVIORAL ECOLOGY AND CONSERVATION BIOLOGY, P394	8	141	187	4	50	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					499	500		10.1038/35087658	http://dx.doi.org/10.1038/35087658			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484041				2022-12-28	WOS:000170202900033
J	de Leon, MSP; Zollikofer, CPE				de Leon, MSP; Zollikofer, CPE			Neanderthal cranial ontogeny and its implications for late hominid diversity	NATURE			English	Article							PALEOANTHROPOLOGY; MORPHOLOGY; MANDIBLES; GROWTH; SHAPE; BASE; FACE	Homo neanderthalensis has a unique combination of craniofacial features that are distinct from fossil and extant anatomically modern' Homo sapiens (modern humans). Morphological evidence, direct isotopic dates(1) and fossil mitochondrial DNA from three Neanderthals(2,3) indicate that the Neanderthals were a separate evolutionary lineage for at least 500,000 yr. However, it is unknown when and how Neanderthal craniofacial autapomorphies (unique, derived characters) emerged during ontogeny. Here we use computerized fossil reconstruction(4) and geometric morphometrics (5,6) to show that characteristic differences in cranial and mandibular shape between Neanderthals and modern humans arose very early during development, possibly prenatally, and were maintained throughout postnatal ontogeny. Postnatal differences in cranial ontogeny between the two taxa are characterized primarily by heterochronic modifications of a common spatial pattern of development. Evidence for early ontogenetic divergence together with evolutionary stasis of taxon-specific patterns of ontogeny is consistent with separation of Neanderthals and modern humans at the species level.	Univ Zurich Irchel, Inst Anthropol, CH-8057 Zurich, Switzerland; Univ Zurich Irchel, Inst Informat MultiMedia Lab, CH-8057 Zurich, Switzerland	University of Zurich; University of Zurich	Zollikofer, CPE (corresponding author), Univ Zurich Irchel, Inst Anthropol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	zolli@ir.unizh.ch						Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; De Leon MSP, 1999, ANAT REC, V254, P474; DEAN MC, 1986, AM J PHYS ANTHROPOL, V70, P301, DOI 10.1002/ajpa.1330700305; DELEON MSP, 2000, THESIS U ZURICH; Enlow D. H., 1990, FACIAL GROWTH; FRANCISCUS RG, 1995, J HUM EVOL, V28, P577, DOI 10.1006/jhev.1995.1043; Krings M, 2000, NAT GENET, V26, P144, DOI 10.1038/79855; Lieberman Daniel E., 2000, Linnean Society Symposium Series, V20, P85; Lieberman DE, 2000, J HUM EVOL, V38, P291, DOI 10.1006/jhev.1999.0335; Lieberman DE, 1999, J HUM EVOL, V36, P487, DOI 10.1006/jhev.1998.0287; Lieberman DE, 2000, YEARB PHYS ANTHROPOL, V43, P117; Lieberman DE, 1998, NATURE, V393, P158, DOI 10.1038/30227; Maureille B, 1999, J HUM EVOL, V37, P137, DOI 10.1006/jhev.1999.0312; O'Higgins P, 1998, J ANAT, V193, P251, DOI 10.1046/j.1469-7580.1998.19320251.x; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; RAK Y, 1986, J HUM EVOL, V15, P151, DOI 10.1016/S0047-2484(86)80042-2; RAK Y, 1994, J HUM EVOL, V26, P313, DOI 10.1006/jhev.1994.1019; Rohlf F.J., 1993, CONTRIBUTIONS MORPHO, P131; Rosas A, 2001, AM J PHYS ANTHROPOL, V114, P74, DOI 10.1002/1096-8644(200101)114:1<74::AID-AJPA1007>3.3.CO;2-L; Schwartz JH, 1996, P NATL ACAD SCI USA, V93, P10852, DOI 10.1073/pnas.93.20.10852; STRINGER CB, 1990, MG PRIMATOL, V14, P115; Stringer Christopher, 1993, SEARCH NEANDERTHALS; Tattersall I, 1998, ANAT RECORD, V253, P113; TILLIER AM, 1989, HUMAN REVOLUTION, P286; TRINKAUS E, 1987, J HUM EVOL, V16, P429, DOI 10.1016/0047-2484(87)90071-6; Ubelaker DH, 1978, HUMAN SKELETAL REMAI; WILLIAMS FL, 2000, NEANDERTHALS EDGE, P257; Zollikofer CPE, 1998, EVOL ANTHROPOL, V6, P41, DOI 10.1002/(SICI)1520-6505(1998)6:2<41::AID-EVAN2>3.0.CO;2-Z; ZOLLIKOFER CPE, 1995, IEEE COMPUT GRAPH, V15, P48, DOI 10.1109/38.469515; ZOLLIKOFER CPE, 1995, NATURE, V375, P283, DOI 10.1038/375283b0	30	226	236	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2001	412	6846					534	538		10.1038/35087573	http://dx.doi.org/10.1038/35087573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	458PC	11484052				2022-12-28	WOS:000170202900044
J	Ellner, SP; McCauley, E; Kendall, BE; Briggs, CJ; Hosseini, PR; Wood, SN; Janssen, A; Sabelis, MW; Turchin, P; Nisbet, RM; Murdoch, WW				Ellner, SP; McCauley, E; Kendall, BE; Briggs, CJ; Hosseini, PR; Wood, SN; Janssen, A; Sabelis, MW; Turchin, P; Nisbet, RM; Murdoch, WW			Habitat structure and population persistence in an experimental community	NATURE			English	Article							PREDATOR-PREY SYSTEM; METAPOPULATION PERSISTENCE; LOCAL EXTINCTION; DYNAMICS; MODELS; STABILITY; DISPERSAL	Understanding spatial population dynamics is fundamental for many questions in ecology and conservation(1-4). Many theoretical mechanisms have been proposed whereby spatial structure can promote population persistence, in particular for exploiter-victim systems (host-parasite/pathogen, predator-prey) whose interactions are inherently oscillatory and therefore prone to extinction of local populations(5-11). Experiments have confirmed that spatial structure can extend persistence(11-16), but it has rarely been possible to identify the specific mechanisms involved. Here we use a model-based approach to identify the effects of spatial population processes in experimental systems of bean plants (Phaseolus lunatus), herbivorous mites (Tetranychus urticae) and predatory mites (Phytoseiulus persimilis). On isolated plants, and in a spatially undivided experimental system of 90 plants, prey and predator populations collapsed; however, introducing habitat structure allowed long-term persistence. Using mechanistic models, we determine that spatial population structure did not contribute to persistence, and spatially explicit models are not needed. Rather, habitat structure reduced the success of predators at locating prey outbreaks, allowing between-plant asynchrony of local population cycles due to random colonization events.	Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; Univ Calgary, Dept Biol Sci, Div Ecol, Calgary, AB T2N 1N4, Canada; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ St Andrews, Sch Math & Comp Sci, St Andrews KY16 9SS, Fife, Scotland; Inst Biodivers & Ecosyst Dynam, NL-1090 GB Amsterdam, Netherlands; Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA	Cornell University; University of Calgary; University of California System; University of California Santa Barbara; University of California System; University of California Berkeley; University of St Andrews; University of Amsterdam; University of Connecticut	Ellner, SP (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	spe2@cornell.edu	Briggs, Cheryl/F-7456-2013; Wood, Simon N/B-3058-2010; Janssen, Arne/B-2657-2009; Kendall, Bruce/C-1871-2008; Nisbet, Roger M/B-6951-2014; Hosseini, Parviez/F-8439-2010	Wood, Simon N/0000-0002-2034-7453; Janssen, Arne/0000-0001-5075-5303; Kendall, Bruce/0000-0003-1782-8106; 				Caswell, 2000, MATRIX POPULATION MO; de Roos AM, 1998, THEOR POPUL BIOL, V53, P108, DOI 10.1006/tpbi.1997.1345; DEROOS AM, 1991, P ROY SOC B-BIOL SCI, V246, P117, DOI 10.1098/rspb.1991.0132; Dieckmann U., 2000, GEOMETRY ECOLOGICAL; GURNEY WSC, 1983, J ANIM ECOL, V52, P479, DOI 10.2307/4567; HANSKI I, 1997, METAPOPULATION BIOL; HASSELL MP, 1991, NATURE, V353, P255, DOI 10.1038/353255a0; HASSELL MP, 1988, ANN ZOOL FENN, V25, P55; HASTINGS A, 1977, THEOR POPUL BIOL, V12, P37, DOI 10.1016/0040-5809(77)90034-X; Helle W., 1985, SPIDER MITES THEIR B; Holyoak M, 2000, AM NAT, V156, P378, DOI 10.1086/303395; Holyoak M, 1996, ECOLOGY, V77, P1867, DOI 10.2307/2265790; HUFFAKER C. B., 1963, HILGARDIA, V34, P305; Janssen A, 1997, EXP APPL ACAROL, V21, P415, DOI 10.1023/A:1018479828913; Levin SA, 1997, SCIENCE, V275, P334, DOI 10.1126/science.275.5298.334; MAY RM, 1978, J ANIM ECOL, V47, P833, DOI 10.2307/3674; MCCAULEY E, 1993, AM NAT, V142, P412, DOI 10.1086/285547; McCauley E, 2000, ECOLOGY, V81, P3350, DOI 10.1890/0012-9658(2000)081[3350:ICPFPD]2.0.CO;2; MURDOCH WW, 1994, ECOLOGY, V75, P271, DOI 10.2307/1939533; NISBET RM, 1982, MODELLING FLUCTUATIN, pCH10; Pels B, 1999, OIKOS, V86, P573, DOI 10.2307/3546662; SABELIS MW, 1991, BIOL J LINN SOC, V42, P267, DOI 10.1111/j.1095-8312.1991.tb00563.x; SABELIS MW, 1990, OECOLOGIA, V82, P289, DOI 10.1007/BF00317473; SABELIS MW, 1988, THEOR POPUL BIOL, V34, P169, DOI 10.1016/0040-5809(88)90040-8; SABELIS MW, 1987, NETH J ZOOL, V37, P117; Tilman D, 1997, SPATIAL ECOLOGY ROLE; VANDEKLASHORST G, 1992, EXP APPL ACAROL, V14, P185, DOI 10.1007/BF01200563; Wright S, 1943, GENETICS, V28, P114; [No title captured]	29	163	181	1	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2001	412	6846					538	543		10.1038/35087580	http://dx.doi.org/10.1038/35087580			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484053				2022-12-28	WOS:000170202900045
J	Helffrich, GR; Wood, BJ				Helffrich, GR; Wood, BJ			The Earth's mantle	NATURE			English	Review							BONIN SUBDUCTION ZONE; LOW-VELOCITY LAYER; BENEATH IZU-BONIN; SEISMIC DISCONTINUITIES; OCEANIC-CRUST; PHASE-TRANSFORMATIONS; CONTINENTAL-CRUST; PARTIAL MELT; CONSTRAINTS; EVOLUTION		Tokyo Inst Technol, Meguro Ku, Tokyo 1528551, Japan; Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England	Tokyo Institute of Technology; University of Bristol	Helffrich, GR (corresponding author), Tokyo Inst Technol, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528551, Japan.		Wood, Bernard J/E-8173-2010	Wood, Bernard J/0000-0003-1038-7301; Helffrich, George/0000-0002-7363-4552				AKAOGI M, 1977, PHYS EARTH PLANET IN, V15, P90, DOI 10.1016/0031-9201(77)90013-9; ALLEGRE CJ, 1982, TECTONOPHYSICS, V81, P109, DOI 10.1016/0040-1951(82)90125-1; ALLEGRE CJ, 1995, GEOCHIM COSMOCHIM AC, V59, P1445, DOI 10.1016/0016-7037(95)00054-4; ALLEGRE CJ, 1987, EARTH PLANET SC LETT, V81, P127, DOI 10.1016/0012-821X(87)90151-8; Allegre CJ, 1996, GEOPHYS RES LETT, V23, P3555, DOI 10.1029/96GL03373; ALLEGRE CJ, 1986, NATURE, V323, P123, DOI 10.1038/323123a0; ANDERSON DL, 1986, NATURE, V320, P321, DOI 10.1038/320321a0; Bernal J.D., 1936, OBSERVATORY, V59, P265; Bijwaard H, 1998, J GEOPHYS RES-SOL EA, V103, P30055, DOI 10.1029/98JB02467; BINA CR, 1994, J GEOPHYS RES-SOL EA, V99, P15853, DOI 10.1029/94JB00462; BlichertToft J, 1997, EARTH PLANET SC LETT, V148, P243, DOI 10.1016/S0012-821X(97)00040-X; BROADHURST CL, 1990, GEOCHIM COSMOCHIM AC, V54, P299, DOI 10.1016/0016-7037(90)90319-G; Castle JC, 1998, J GEOPHYS RES-SOL EA, V103, P12511, DOI 10.1029/98JB00503; Castle JC, 1997, GEOPHYS RES LETT, V24, P241, DOI 10.1029/96GL03829; Chai M, 1996, PHYS CHEM MINER, V23, P470, DOI 10.1007/BF00202033; CHASE CG, 1972, GEOPHYS J ROY ASTR S, V29, P117, DOI 10.1111/j.1365-246X.1972.tb02202.x; Chernov L. A. L. A., 1960, WAVE PROPAGATION RAN; CHRISTENSEN UR, 1994, J GEOPHYS RES-SOL EA, V99, P19867, DOI 10.1029/93JB03403; CHRISTENSEN UR, 1985, J GEOPHYS RES-SOLID, V90, P2995, DOI 10.1029/JB090iB04p02995; CHRISTENSEN UR, 1984, J GEOPHYS RES, V89, P4389, DOI 10.1029/JB089iB06p04389; Collier JD, 1997, GEOPHYS RES LETT, V24, P1535, DOI 10.1029/97GL01383; DAVIES GF, 1992, J GEOL, V100, P151, DOI 10.1086/629582; DAVIES GF, 1981, NATURE, V290, P208, DOI 10.1038/290208a0; Earle PS, 1997, SCIENCE, V277, P667, DOI 10.1126/science.277.5326.667; Elliott T, 1999, EARTH PLANET SC LETT, V169, P129, DOI 10.1016/S0012-821X(99)00077-1; FEI YW, 1990, J GEOPHYS RES-SOLID, V95, P6915, DOI 10.1029/JB095iB05p06915; Fiquet G, 2000, GEOPHYS RES LETT, V27, P21, DOI 10.1029/1999GL008397; Flanagan MP, 1998, J GEOPHYS RES-SOL EA, V103, P2673, DOI 10.1029/97JB03212; Funamori N, 1996, J GEOPHYS RES-SOL EA, V101, P8257, DOI 10.1029/95JB03732; Garnero EJ, 1998, J GEOPHYS RES-SOL EA, V103, P12495, DOI 10.1029/98JB00700; GRAND SP, 1994, J GEOPHYS RES-SOL EA, V99, P11591, DOI 10.1029/94JB00042; Grand SP., 1997, GSA TODAY, V7, P1; GURNIS M, 1986, J GEOPHYS RES-SOLID, V91, P6375, DOI 10.1029/JB091iB06p06375; Halliday A, 1996, EARTH PLANET SC LETT, V142, P75, DOI 10.1016/0012-821X(96)00096-9; HART SR, 1986, CHEM GEOL, V57, P247, DOI 10.1016/0009-2541(86)90053-7; Hedlin MAH, 1997, NATURE, V387, P145, DOI 10.1038/387145a0; HELFFRICH G, 1994, GEOPHYS RES LETT, V21, P2613, DOI 10.1029/94GL02341; HOFMANN AW, 1988, EARTH PLANET SC LETT, V90, P297, DOI 10.1016/0012-821X(88)90132-X; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; HOFMANN AW, 1982, EARTH PLANET SC LETT, V57, P421, DOI 10.1016/0012-821X(82)90161-3; ITO E, 1989, J GEOPHYS RES-SOLID, V94, P10637, DOI 10.1029/JB094iB08p10637; JACKSON MJ, 1984, J GEOPHYS RES, V89, P103, DOI 10.1029/JB089iB12p10103; JEANLOZ R, 1989, PHILOS T R SOC A, V328, P377, DOI 10.1098/rsta.1989.0042; Jeffreys H, 1940, SEISMOLOGICAL TABLES; JOCHUM KP, 1983, NATURE, V306, P431, DOI 10.1038/306431a0; Kaneshima S, 1999, SCIENCE, V283, P1888, DOI 10.1126/science.283.5409.1888; Kellogg LH, 1999, SCIENCE, V283, P1881, DOI 10.1126/science.283.5409.1881; Kendall JM, 1996, NATURE, V381, P409, DOI 10.1038/381409a0; KENNETT BLN, 1995, GEOPHYS J INT, V122, P108, DOI 10.1111/j.1365-246X.1995.tb03540.x; KINCAID C, 1987, J GEOPHYS RES, V92, P13822; KINZLER RJ, 1992, J GEOPHYS RES-SOL EA, V97, P6907, DOI 10.1029/91JB02841; KLEIN EM, 1987, J GEOPHYS RES-SOLID, V92, P8089, DOI 10.1029/JB092iB08p08089; KORNPROBST J, 1969, CONTRIB MINERAL PETR, V23, P283, DOI 10.1007/BF00371425; Lay T, 1998, NATURE, V392, P461, DOI 10.1038/33083; LIU LG, 1976, NATURE, V262, P770, DOI 10.1038/262770a0; Major A., 1966, EARTH PLANET SC LETT, V1, P241, DOI [10.1016/0012-821X(66)90077-X, DOI 10.1016/0012-821X(66)90077-X]; Masters G, 1996, PHILOS T R SOC A, V354, P1385, DOI 10.1098/rsta.1996.0054; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; MCKENZIE DP, 1969, GEOPHYS J ROY ASTR S, V18, P1, DOI 10.1111/j.1365-246X.1969.tb00259.x; METCALFE G, 1995, GEOPHYS RES LETT, V22, P743, DOI 10.1029/95GL00056; Newsom H. E., 1995, GLOBAL EARTH PHYSICS, V1, P159; NICOLAS A, 1972, TECTONOPHYSICS, V14, P143, DOI 10.1016/0040-1951(72)90107-2; OLSON P, 1984, PHYS EARTH PLANET IN, V36, P291, DOI 10.1016/0031-9201(84)90053-0; ONIONS RK, 1983, NATURE, V306, P429, DOI 10.1038/306429a0; ONions RK, 1996, EARTH PLANET SC LETT, V139, P213, DOI 10.1016/0012-821X(96)00004-0; Plank T, 1998, CHEM GEOL, V145, P325, DOI 10.1016/S0009-2541(97)00150-2; POLLACK HN, 1993, REV GEOPHYS, V31, P267, DOI 10.1029/93RG01249; PORCELLI D, 1995, GEOCHIM COSMOCHIM AC, V59, P4921, DOI 10.1016/0016-7037(95)00336-3; Revenaugh J, 1997, SCIENCE, V277, P670, DOI 10.1126/science.277.5326.670; RINGWOOD AE, 1991, GEOCHIM COSMOCHIM AC, V55, P2083, DOI 10.1016/0016-7037(91)90090-R; RUDNICK RL, 1995, NATURE, V378, P571, DOI 10.1038/378571a0; Rudnick RL, 2000, SCIENCE, V287, P278, DOI 10.1126/science.287.5451.278; SCHILLING JG, 1973, NATURE, V242, P565, DOI 10.1038/242565a0; SHEARER PM, 1993, GEOPHYS J INT, V115, P878, DOI 10.1111/j.1365-246X.1993.tb01499.x; SLEEP NH, 1988, GEOPHYS J INT, V95, P437, DOI 10.1111/j.1365-246X.1988.tb06695.x; Stixrude L, 1997, J GEOPHYS RES-SOL EA, V102, P14835, DOI 10.1029/97JB00550; STIXRUDE L, 1992, SCIENCE, V257, P1099, DOI 10.1126/science.257.5073.1099; Su WJ, 1997, PHYS EARTH PLANET IN, V100, P135, DOI 10.1016/S0031-9201(96)03236-0; Thomas C, 1999, J GEOPHYS RES-SOL EA, V104, P15073, DOI 10.1029/1999JB900128; Van Schmus W.R., 1995, GLOBAL EARTH PHYS HD, p283~291, DOI DOI 10.1029/RF001; VANDERHILST R, 1991, NATURE, V353, P37, DOI 10.1038/353037a0; Vidale JE, 1998, NATURE, V391, P682, DOI 10.1038/35601; VIDALE JE, 1992, NATURE, V356, P678, DOI 10.1038/356678a0; WEBER M, 1990, GEOPHYS J INT, V102, P231, DOI 10.1111/j.1365-246X.1990.tb00544.x; WICKS CW, 1993, SCIENCE, V261, P1424, DOI 10.1126/science.261.5127.1424; Wood BJ, 2000, EARTH PLANET SC LETT, V174, P341, DOI 10.1016/S0012-821X(99)00273-3; Yamada A, 1998, GEOPHYS RES LETT, V25, P4545, DOI 10.1029/1998GL900188	87	239	255	1	66	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					501	507		10.1038/35087500	http://dx.doi.org/10.1038/35087500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484043				2022-12-28	WOS:000170202900035
J	Wiebe, S; Blume, WT; Girvin, JP; Eliasziw, M				Wiebe, S; Blume, WT; Girvin, JP; Eliasziw, M		Effectiveness Efficiency Surgery T	A randomized, controlled trial of surgery for temporal-lobe epilepsy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; FOLLOW-UP; SEIZURE CONTROL; LOBECTOMY; BURDEN	Background: Randomized trials of surgery for epilepsy have not been conducted, because of the difficulties involved in designing and implementing feasible studies. The lack of data supporting the therapeutic usefulness of surgery precludes making strong recommendations for patients with epilepsy. We conducted a randomized, controlled trial to assess the efficacy and safety of surgery for temporal-lobe epilepsy. Methods: Eighty patients with temporal-lobe epilepsy were randomly assigned to surgery (40 patients) or treatment with antiepileptic drugs for one year (40 patients). Optimal medical therapy and primary outcomes were assessed by epileptologists who were unaware of the patients' treatment assignments. The primary outcome was freedom from seizures that impair awareness of self and surroundings. Secondary outcomes were the frequency and severity of seizures, the quality of life, disability, and death. Results: At one year, the cumulative proportion of patients who were free of seizures impairing awareness was 58 percent in the surgical group and 8 percent in the medical group (P<0.001). The patients in the surgical group had fewer seizures impairing awareness and a significantly better quality of life (P<0.001 for both comparisons) than the patients in the medical group. Four patients (10 percent) had adverse effects of surgery. One patient in the medical group died. Conclusions: In temporal-lobe epilepsy, surgery is superior to prolonged medical therapy. Randomized trials of surgery for epilepsy are feasible and appear to yield precise estimates of treatment effects.	London Hlth Sci Ctr, London, ON N6A 5A5, Canada; Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada; Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; Robarts Res Inst, London, ON N6A 5C1, Canada	London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Wiebe, S (corresponding author), London Hlth Sci Ctr, Univ Campus,339 Windermere Rd, London, ON N6A 5A5, Canada.	swiebe@uwo.ca						[Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; BAKER GA, 1994, EPILEPSY AND QUALITY OF LIFE, P135; BLUME WT, 1993, ANN NEUROL, V34, P703, DOI 10.1002/ana.410340513; BLUME WT, 1994, J EPILEPSY, V7, P203, DOI 10.1016/0896-6974(94)90031-0; BLUME WT, 1986, INT ANESTHESIOL CLIN, V24, P47, DOI 10.1097/00004311-198602430-00008; Brodie MJ, 1996, NEW ENGL J MED, V334, P479; Dasheiff R M, 1994, Seizure, V3, P197, DOI 10.1016/S1059-1311(05)80189-X; DEVINSKY O, 1993, EPILEPSIA, V34, pS1, DOI 10.1111/j.1528-1157.1993.tb05910.x; Engel J, 1999, ARCH NEUROL-CHICAGO, V56, P1338, DOI 10.1001/archneur.56.11.1338; Engel J, 1999, EPILEPTIC DISORD, V1, P249; Engel Jerome Jr., 1993, P609; Engel Jerome Jr., 1993, P23; Ficker DM, 1999, EPILEPSIA, V40, P62, DOI 10.1111/j.1528-1157.1999.tb01989.x; Foldvary N, 2000, NEUROLOGY, V54, P630, DOI 10.1212/WNL.54.3.630; GIRVIN JP, 1986, INT ANESTHESIOL CLIN, V24, P133, DOI 10.1097/00004311-198602430-00012; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P729; Hauser WA, 1990, EPILEPSY FREQUENCY C, P1; Holmes MD, 1996, EPILEPSIA, V37, P748, DOI 10.1111/j.1528-1157.1996.tb00646.x; Kale R, 1997, BRIT MED J, V315, P2, DOI 10.1136/bmj.315.7099.2; KING DW, 1986, NEUROLOGY, V36, P334, DOI 10.1212/WNL.36.3.334; Kunz R, 1998, BRIT MED J, V317, P1185, DOI 10.1136/bmj.317.7167.1185; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; McLachlan RS, 1997, ANN NEUROL, V41, P482, DOI 10.1002/ana.410410411; MILLER LA, 1994, J NEUROL NEUROSUR PS, V57, P1099, DOI 10.1136/jnnp.57.9.1099; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P495; Pilcher Webster H., 1993, P565; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; SADLER RM, 1989, CAN J NEUROL SCI, V16, P326, DOI 10.1017/S0317167100029164; Salanova V, 1999, EPILEPSIA, V40, P1417, DOI 10.1111/j.1528-1157.1999.tb02014.x; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; So EL, 1997, EPILEPSY RES, V27, P119, DOI 10.1016/S0920-1211(97)01028-0; Sperling MR, 1996, JAMA-J AM MED ASSOC, V276, P470, DOI 10.1001/jama.276.6.470; TAYLOR DC, 1980, J NEUROL NEUROSUR PS, V43, P758, DOI 10.1136/jnnp.43.9.758; VICKREY BG, 1995, LANCET, V346, P1445, DOI 10.1016/S0140-6736(95)92470-1; WALCZAK TS, 1990, NEUROLOGY, V40, P413, DOI 10.1212/WNL.40.3_Part_1.413; Wiebe S, 1999, CAN J NEUROL SCI, V26, P263, DOI 10.1017/S0317167100000354; WIEBE S, 1995, J EPILEPSY, V8, P227, DOI 10.1016/0896-6974(95)00039-G; WIEBE S, 1997, EPILEPSIA S3, V38, P83	40	2236	2314	2	114	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2001	345	5					311	318		10.1056/NEJM200108023450501	http://dx.doi.org/10.1056/NEJM200108023450501			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458KM	11484687				2022-12-28	WOS:000170193600001
J	Krakow, B; Hollifield, M; Johnston, L; Koss, M; Schrader, R; Warner, TD; Tandberg, D; Lauriello, J; McBride, L; Cutchen, L; Cheng, D; Emmons, S; Germain, A; Melendrez, D; Sandoval, D; Prince, H				Krakow, B; Hollifield, M; Johnston, L; Koss, M; Schrader, R; Warner, TD; Tandberg, D; Lauriello, J; McBride, L; Cutchen, L; Cheng, D; Emmons, S; Germain, A; Melendrez, D; Sandoval, D; Prince, H			Imagery rehearsal therapy for chronic nightmares in sexual assault survivors with posttraumatic stress disorder - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SLEEP; DESENSITIZATION; PREVALENCE; INSTRUMENT; INSOMNIA; EFFICACY; SESSION; DREAMS; PTSD	Context Chronic nightmares occur frequently in patients with posttraumatic stress disorder (PTSD) but are not usually a primary target of treatment. Objective To determine if treating chronic nightmares with imagery rehearsal therapy (IRT) reduces the frequency of disturbing dreams, improves sleep quality, and decreases PTSD symptom severity. Design, Setting, and Participants Randomized controlled trial conducted from 1995 to 1999 among 168 women in New Mexico; 95% had moderate-to-severe PTSD, 97% had experienced rape or other sexual assault, 77% reported life-threatening sexual assault, and 58% reported repeated exposure to sexual abuse in childhood or adolescence. Intervention Participants were randomized to receive treatment (n=88) or to the wait-list control group (n=80). The treatment group received IRT in 3 sessions; controls received no additional intervention, but continued any ongoing treatment. Main Outcome Measures cores on the Nightmare Frequency Questionnaire (NFQ), Pittsburgh Sleep Quality Index (PSQI), PTSD Symptom Scale (PSS), and Clinician-Administered PTSD Scale (CAPS) at 3- and 6-month follow-up. Results A total of 114 participants completed follow-up at 3 and/or 6 months. Comparing baseline to follow-up (n=97-114), treatment significantly reduced nights per week with nightmares (Co hen d=1.24; P<.001) and number of nightmares per week (Cohen d=0.85; P<.001) on the NFQ and improved sleep (on the PSQI, Cohen d=0.67; P<.001) and PTSD symptoms (on the PSS, Cohen d=1.00; P<.001 and on the CAPS, Cohen d=1.53; P<.001). Control participants showed small, nonsignificant improvements for the same measures (mean Cohen d=0.21). In a 3-point analysis (n=66-77), improvements occurred in the treatment group at 3-month follow-up (treatment vs control group, Cohen d=1.15 vs 0.07 for nights per week with nightmares; 0.95 vs -0.06 for nightmares per week; 0.77 vs 0.31 on the PSQI, and 1.06 vs 0.31 on the PSS) and were sustained without further intervention or contact between 3 and 6 months. An intent-to-treat analysis (n=168) confirmed significant differences between treatment and control groups for nightmares, sleep, and PTSD (all P<.02) with moderate effect sizes for treatment (mean Cohen d=0.60) and small effect sizes for controls (mean Cohen d=0.14). Posttraumatic stress symptoms decreased by at least 1 level of clinical severity in 65% of the treatment group compared with symptoms worsening or not changing in 69% of controls (chi (2)(1)=12.80; P<.001). Conclusions Imagery rehearsal therapy is a brief, well-tolerated treatment that appears to decrease chronic nightmares, improve sleep quality, and decrease PTSD symptom severity.	Sleep & Human Hlth Inst, Albuquerque, NM 87110 USA; Univ New Mexico, Sch Med, Hlth Sci Ctr, Albuquerque, NM 87131 USA; Univ New Mexico, Sch Med, Dept Emergency Med, Albuquerque, NM 87131 USA; Univ New Mexico, Sch Med, Dept Psychiat, Albuquerque, NM 87131 USA; Univ New Mexico, Sch Med, Dept Family & Community Med, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA; Univ Arizona, Hlth Sci Ctr, Tucson, AZ USA; Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; Hop Sacre Coeur, Lab Reves & Cauchemars, Montreal, PQ H4J 1C5, Canada	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico; University of New Mexico; University of New Mexico; University of Arizona; University of Arizona Health Sciences; Universite de Montreal; Universite de Montreal	Krakow, B (corresponding author), Sleep & Human Hlth Inst, 4775 Indian Sch Rd NE,Suite 305, Albuquerque, NM 87110 USA.	bkrakow@salud.unm.edu	WARNER, TEDDY/AAI-6905-2020		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH053239] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		*AM AC SLEEP MED, 1997, INT CLASS SLEEP DIS, P162; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Ballenger JC, 2000, J CLIN PSYCHIAT, V61, P60; Belicki K, 1997, SLEEP RES, V26, P637; BERQUIER A, 1992, J ABNORM PSYCHOL, V101, P246, DOI 10.1037/0021-843X.101.2.246; BISHAY N, 1985, BRIT J PSYCHIAT, V147, P67, DOI 10.1192/bjp.147.1.67; BIXLER EO, 1979, AM J PSYCHIAT, V136, P1257; BLAKE D, 1990, CLIN ADM PTSD SCALE, P1; Bliwise DL, 1996, SLEEP, V19, P462, DOI 10.1093/sleep/19.6.462; Brady K, 2000, JAMA-J AM MED ASSOC, V283, P1837, DOI 10.1001/jama.283.14.1837; Buysse D J, 1989, Psychiatry Res, V28, P193; Cartwright R, 1998, PSYCHIAT RES, V80, P249, DOI 10.1016/S0165-1781(98)00071-7; CELLUCCI AJ, 1978, J BEHAV THER EXP PSY, V9, P109, DOI 10.1016/0005-7916(78)90054-X; Foa EB, 2000, J TRAUMA STRESS, V13, P539, DOI 10.1023/A:1007802031411; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1007/BF00974317; FOA EB, 1995, POSTTRAUMATIC STRESS, P46; HALLIDAY G, 1987, CLIN PSYCHOL REV, V7, P501, DOI 10.1016/0272-7358(87)90041-9; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Hamilton M, 1969, BRIT J PSYCHIAT, V3, P76, DOI DOI 10.1037/T04100-000; HAYNES SN, 1975, PSYCHOL REC, V25, P225, DOI 10.1007/BF03394308; HEDEKER D, 1994, J CONSULT CLIN PSYCH, V62, P757, DOI 10.1037/0022-006X.62.4.757; KALES A, 1980, AM J PSYCHIAT, V137, P1197; KELLNER R, 1992, AM J PSYCHIAT, V149, P659; Kellner R., 1991, ANN CLIN PSYCHIATRY, V3, P67, DOI [10.3109/10401239109147970, DOI 10.3109/10401239109147970]; Kilpatrick D, 1998, DSM 4 SOURCEBOOK, P803; KLINK M, 1987, CHEST, V91, P540, DOI 10.1378/chest.91.4.540; Krakow B, 2000, JAMA-J AM MED ASSOC, V284, P563, DOI 10.1001/jama.284.5.563; Krakow B, 2000, J TRAUMA STRESS, V13, P589, DOI 10.1023/A:1007854015481; KRAKOW B, 1995, BEHAV RES THER, V33, P837, DOI 10.1016/0005-7967(95)00009-M; Krakow B, 2000, Crisis, V21, P163, DOI 10.1027//0227-5910.21.4.163; Krakow B, 2000, J PSYCHOSOM RES, V49, P291, DOI 10.1016/S0022-3999(00)00147-1; Krakow B, 2001, BIOL PSYCHIAT, V49, P948, DOI 10.1016/S0006-3223(00)01087-8; KRAKOW B, 1995, J NERV MENT DIS, V183, P623, DOI 10.1097/00005053-199510000-00002; Krakow B, 2000, COMPR PSYCHIAT, V41, P49, DOI 10.1016/S0010-440X(00)90131-7; KRAKOW B, IN PRESS J TRAUMA ST; KRAKOW B, IN PRESS J ANXIETY D; LANSKY M, 1995, POST TRAUMATIC NIGHT; Levin R, 1998, PSYCHIATRY, V61, P206, DOI 10.1080/00332747.1998.11024832; Mack J.E, 1974, NIGHTMARES HUMAN CON; MARKS I, 1978, BRIT J PSYCHIAT, V133, P461, DOI 10.1192/bjp.133.5.461; MILLER WR, 1983, J CONSULT CLIN PSYCH, V51, P870, DOI 10.1037/0022-006X.51.6.870; MOSCARELLO R, 1991, J AM ACAD PSYCHOAN, V19, P235, DOI 10.1521/jaap.1.1991.19.2.235; NEIDHARDT EJ, 1992, SLEEP, V15, P470; Nielsen T. A., 2000, PRINCIPLES PRACTICE, V3, P753; ROTHBAUM BO, 1992, J TRAUMA STRESS, V5, P455, DOI 10.1007/BF00977239; *SAS I INC, 1997, SAS STAT SOFTW CHANG, P571; Sheehan DV., 1983, ANXIETY DIS; Ware J.E, 1994, PHYS MENTAL HLTH SUM; Wile IS, 1934, AM J ORTHOPSYCHIAT, V4, P449, DOI 10.1111/j.1939-0025.1934.tb06308.x; Youakim JM, 1998, PSYCHOSOMATICS, V39, P168, DOI 10.1016/S0033-3182(98)71365-9; Zadra A, 2000, J ABNORM PSYCHOL, V109, P273, DOI 10.1037/0021-843X.109.2.273	51	334	339	0	54	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2001	286	5					537	545		10.1001/jama.286.5.537	http://dx.doi.org/10.1001/jama.286.5.537			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	458HE	11476655				2022-12-28	WOS:000170188300016
J	Jackson, JBC; Kirby, MX; Berger, WH; Bjorndal, KA; Botsford, LW; Bourque, BJ; Bradbury, RH; Cooke, R; Erlandson, J; Estes, JA; Hughes, TP; Kidwell, S; Lange, CB; Lenihan, HS; Pandolfi, JM; Peterson, CH; Steneck, RS; Tegner, MJ; Warner, RR				Jackson, JBC; Kirby, MX; Berger, WH; Bjorndal, KA; Botsford, LW; Bourque, BJ; Bradbury, RH; Cooke, R; Erlandson, J; Estes, JA; Hughes, TP; Kidwell, S; Lange, CB; Lenihan, HS; Pandolfi, JM; Peterson, CH; Steneck, RS; Tegner, MJ; Warner, RR			Historical overfishing and the recent collapse of coastal ecosystems	SCIENCE			English	Review							CHESAPEAKE BAY; SEA OTTERS; SOUTHERN CALIFORNIA; TROPHIC CASCADES; GREEN TURTLE; MORETON BAY; SEAGRASS; REEF; EUTROPHICATION; DECLINE	Ecological extinction caused by overfishing precedes all other pervasive human disturbance to coastal ecosystems, including pollution, degradation of water quality, and anthropogenic climate change. Historical abundances of large consumer species were fantastically large in comparison with recent observations. Paleoecological, archaeological, and historical data show that time lags of decades to centuries occurred between the onset of overfishing and consequent changes in ecological communities, because unfished species of similar trophic level assumed the ecological roles of overfished species until they too were overfished or died of epidemic diseases related to overcrowding. Retrospective data not only help to clarify underlying causes and rates of ecological change, but they also demonstrate achievable goals for restoration and management of coastal ecosystems that could not even be contemplated based on the limited perspective of recent observations alone.	Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Smithsonian Trop Res Inst, Ctr Trop Paleoecol & Archeol, Balboa, Panama; Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; Univ Florida, Archie Carr Ctr Sea Turtle Res, Gainesville, FL 32611 USA; Univ Florida, Dept Zool, Gainesville, FL 32611 USA; Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; Bates Coll, Dept Anthropol, Lewiston, ME 04240 USA; Australian Natl Univ, Ctr Resource & Environm Studies, Canberra, ACT 0200, Australia; Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA; Univ Calif Santa Cruz, US Geol Survey, Santa Cruz, CA 95064 USA; James Cook Univ N Queensland, Dept Marine Biol, Ctr Coral Reef Biodivers, Townsville, Qld 4811, Australia; Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; Univ N Carolina, Inst Marine Sci, Morehead City, NC 28557 USA; Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; Univ Maine, Darling Marine Ctr, Sch Marine Sci, Walpole, ME 04573 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Smithsonian Institution; Smithsonian Tropical Research Institute; National Center for Ecological Analysis & Synthesis; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of California System; University of California Davis; Australian National University; University of Oregon; United States Department of the Interior; United States Geological Survey; University of California System; University of California Santa Cruz; James Cook University; University of Chicago; University of North Carolina; University of North Carolina Chapel Hill; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Maine System; University of Maine Orono; University of California System; University of California Santa Barbara	Jackson, JBC (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	jbcj@ucsd.edu	Hughes, Terry P/L-4721-2013; Pandolfi, John M/A-3121-2009; Warner, Robert R./M-5342-2013; Lange, Carina/AHC-2015-2022	Hughes, Terry P/0000-0002-5257-5063; Pandolfi, John M/0000-0003-3047-6694; Warner, Robert R./0000-0002-3299-5685; Lange, Carina/0000-0002-2916-4207; Bjorndal, Karen/0000-0002-6286-1901; Erlandson, Jon/0000-0002-4705-4319; Bradbury, Roger/0000-0002-0940-3493				Abal EG, 1996, MAR FRESHWATER RES, V47, P763, DOI 10.1071/MF9960763; Allen G. M., 1942, AM COMMITTEE INT WIL, V11, P1; ALLEN J, 1989, ANTIQUITY, V63, P548, DOI 10.1017/S0003598X00076547; Aronson RB, 1998, CORAL REEFS, V17, P223, DOI 10.1007/s003380050122; BERTRAM G C L, 1973, Biological Journal of the Linnean Society, V5, P297, DOI 10.1111/j.1095-8312.1973.tb00708.x; Bigelow H. B., 1954, Fishery Bulletin United States, V53, P1; BIRKELAND C, 1982, MAR BIOL, V69, P175, DOI 10.1007/BF00396897; Bjorndal KA, 2000, ECOL APPL, V10, P269, DOI 10.2307/2641001; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; BOURQUE BJ, 1995, DIVESITY COMPLEXITY; Bradley R. S., 1999, PALEOCLIMATOLOGY REC; Brown J.H., 1995, MACROECOLOGY; BURKHOLDER JM, 1992, NATURE, V358, P407, DOI 10.1038/358407a0; CARLTON JT, 1993, SCIENCE, V261, P78, DOI 10.1126/science.261.5117.78; Carpenter SR, 2001, ECOL MONOGR, V71, P163, DOI 10.1890/0012-9615(2001)071[0163:TCNALP]2.0.CO;2; Casey JM, 1998, SCIENCE, V281, P690, DOI 10.1126/science.281.5377.690; CLOERN JE, 1982, MAR ECOL PROG SER, V9, P191, DOI 10.3354/meps009191; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Cooper S. R., 2000, HIST WATER QUALITY N; COOPER SR, 1993, ESTUARIES, V16, P617, DOI 10.2307/1352799; Cranfield HJ, 1999, AQUAT CONSERV, V9, P461, DOI 10.1002/(SICI)1099-0755(199909/10)9:5<461::AID-AQC353>3.0.CO;2-Z; Crosby A.W., 1986, ECOLOGICAL IMPERIALI, DOI DOI 10.1017/CBO9780511805554; Cushing D. H., 1988, PROVIDENT SEA; DAMPLER W, 1968, NEW VOYAGE WORLD; Davis S.J.M., 1987, ARCHAEOLOGY ANIMALS; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.1890/1051-0761(1998)008[0309:SBGARE]2.0.CO;2; Duerden J. E, 1901, W INDIAN B, P121; ELMGREN R, 1989, AMBIO, V18, P326; Erlandson JM, 1996, RADIOCARBON, V38, P355, DOI 10.1017/S0033822200017689; ESTES JA, 1989, CONSERV BIOL, V3, P252, DOI 10.1111/j.1523-1739.1989.tb00085.x; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; FINKL CW, 1995, J COAST RES SPEC ISS, V17, P402; Fogarty Michael J., 1998, Canadian Special Publication of Fisheries and Aquatic Sciences, V125, P273; Francis Robert C., 1994, Fisheries Oceanography, V3, P279, DOI 10.1111/j.1365-2419.1994.tb00105.x; Ganter R, 1994, PEARL SHELLERS TORRE; GEISTER J, 1977, 3RD P INT COR REEF S, V1, P23; HACUNDA JS, 1981, FISH B-NOAA, V79, P775; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; HEINSOHN GE, 1978, ENVIRON CONSERV, V5, P91, DOI 10.1017/S0376892900005518; Hochachka WM, 2000, P NATL ACAD SCI USA, V97, P5303, DOI 10.1073/pnas.080551197; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hutchings JA, 2000, NATURE, V406, P882, DOI 10.1038/35022565; HUXLEY T. H., 1884, LITERATURE, V4, P1; INGERSOLL E, 1881, HIST PRESENT CONDITI, P1; Jackson J.B.C., 1983, BIOTIC INTERACTIONS, P39, DOI 10.2307/4196; JACKSON JBC, 1991, BIOSCIENCE, V41, P475, DOI 10.2307/1311805; Jackson JBC, 1997, CORAL REEFS, V16, pS23, DOI 10.1007/s003380050238; Jackson JBC, 2001, P NATL ACAD SCI USA, V98, P5411, DOI 10.1073/pnas.091092898; JANZEN DH, 1982, SCIENCE, V215, P19, DOI 10.1126/science.215.4528.19; Jonas RB, 1997, AM ZOOL, V37, P612; Jones D., 1980, WHALERS TANGALOOMA; Jones Douglas S., 1998, Paleontological Society Papers, V4, P37; JUSTIC D, 1991, MODERN ANCIENT CONTI, P95; Kenchington R.A, 1990, MANAGING MARINE ENV; KENYON KW, 1977, J MAMMAL, V58, P97, DOI 10.2307/1379738; KIDWELL SM, 1995, ANNU REV ECOL SYST, V26, P269, DOI 10.1146/annurev.es.26.110195.001413; KIRKMAN H, 1978, AQUAT BOT, V5, P63, DOI 10.1016/0304-3770(78)90047-5; KNOWLTON N, 1992, AM ZOOL, V32, P674; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; LANGE CB, 1990, CLIMATIC CHANGE, V16, P319, DOI 10.1007/BF00144507; Lenihan HS, 1999, ECOL MONOGR, V69, P251, DOI 10.1890/0012-9615(1999)069[0251:PBCOOR]2.0.CO;2; Lenihan HS, 1999, LIMNOL OCEANOGR, V44, P910, DOI 10.4319/lo.1999.44.3_part_2.0910; Lenihan HS, 1998, ECOL APPL, V8, P128, DOI 10.2307/2641316; LESSIOS HA, 1988, ANNU REV ECOL SYST, V19, P371, DOI 10.1146/annurev.es.19.110188.002103; LEWIS SM, 1986, ECOL MONOGR, V56, P183, DOI 10.2307/2937073; LIMPUS CJ, 1995, STAT GREAT BARR REEF, P258; Limpus Colin J., 1994, Memoirs of the Queensland Museum, V35, P139; MacCall AD, 1996, CAL COOP OCEAN FISH, V37, P100; MacKnight C. C., 1976, VOYAGE MAREGE MACASS; Marsh KN, 1996, J CHEM ENG DATA, V41, P1; Munro JL., 1983, CARIBBEAN CORAL REEF, V2, P1; Munro John L., 1996, V20, P1; MYERS N, 1995, SCIENCE, V269, P358, DOI 10.1126/science.269.5222.358; Naeem S, 1998, CONSERV BIOL, V12, P39, DOI 10.1046/j.1523-1739.1998.96379.x; Neil David T., 1998, P3; Newell RI, 1988, CHESAPEAKE RES CONSO, V129, P536; NIXON SW, 1995, OPHELIA, V41, P199, DOI 10.1080/00785236.1995.10422044; OFFICER CB, 1984, SCIENCE, V223, P22, DOI 10.1126/science.223.4631.22; OFFICER CB, 1982, MAR ECOL PROG SER, V9, P203, DOI 10.3354/meps009203; Ogden A., 1941, CALIFORNIA SEA OTTER; Ogden J.C., 1980, P173; OGDEN JC, 1983, J EXP MAR BIOL ECOL, V66, P199, DOI 10.1016/0022-0981(83)90160-0; OJEDA FP, 1987, THESIS U MAINE; Ormond R., 1990, Lecture Notes in Biomathematics, V88, P189; ORTH RJ, 1983, SCIENCE, V222, P51, DOI 10.1126/science.222.4619.51; PAINE RT, 1992, NATURE, V355, P73, DOI 10.1038/355073a0; Pandolfi JM, 2001, ECOL MONOGR, V71, P49, DOI 10.1890/0012-9615(2001)071[0049:CSOPCR]2.0.CO;2; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Persson J, 2000, MAR POLLUT BULL, V40, P122, DOI 10.1016/S0025-326X(99)00180-0; PREEN A, 1995, MAR ECOL PROG SER, V124, P201, DOI 10.3354/meps124201; QUINN RH, 1993, FISHERIES RESOURCES; ROTHSCHILD BJ, 1994, MAR ECOL PROG SER, V111, P29, DOI 10.3354/meps111029; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; Sapp J., 1999, WHAT IS NATURAL CORA; Seymour RM, 1999, MAR ECOL PROG SER, V176, P1, DOI 10.3354/meps176001; SHERMAN K, 1991, ECOL APPL, V1, P349, DOI 10.2307/1941896; SIMENSTAD CA, 1978, SCIENCE, V200, P403, DOI 10.1126/science.200.4340.403; SMAYDA TJ, 1990, TOXIC MARINE PHYTOPLANKTON, P29; Soulu M., 1999, CONTINENTAL CONSERVA; Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; Steneck RS, 1997, P GULF MAIN EC DYN S, P91; STEVEN A, 1988, ANAL FISHING ACTIVIT; TEGNER MJ, 1991, MAR ECOL PROG SER, V77, P49, DOI 10.3354/meps077049; Tegner MJ, 2000, ICES J MAR SCI, V57, P579, DOI 10.1006/jmsc.2000.0715; THAYER GW, 1984, ESTUARIES, V7, P351, DOI 10.2307/1351619; THAYER GW, 1982, J EXP MAR BIOL ECOL, V62, P173, DOI 10.1016/0022-0981(82)90090-9; THORNE E, 1876, QUEEN COLONIES; TURNER RE, 1994, NATURE, V368, P619, DOI 10.1038/368619a0; ULANOWICZ RE, 1992, ESTUARIES, V15, P298, DOI 10.2307/1352778; WEFER G, 1999, USE PROXIES PALEOCEA; Zieman JC, 1999, ESTUARIES, V22, P460, DOI 10.2307/1353211	113	4401	4599	99	3493	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2001	293	5530					629	638		10.1126/science.1059199	http://dx.doi.org/10.1126/science.1059199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474098				2022-12-28	WOS:000170204600040
J	Srinivasan, A; Kraus, CN; DeShazer, D; Becker, PM; Dick, JD; Spacek, L; Bartlett, JG; Byrne, WR; Thomas, DL				Srinivasan, A; Kraus, CN; DeShazer, D; Becker, PM; Dick, JD; Spacek, L; Bartlett, JG; Byrne, WR; Thomas, DL			Glanders in a military research microbiologist	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Johns Hopkins Med Inst, Div Infect Dis, Bethesda, MD USA; Johns Hopkins Med Inst, Div Pulm & Crit Care Med, Bethesda, MD USA; Johns Hopkins Med Inst, Dept Pathol, Bethesda, MD USA; NIAID, NIH, Bethesda, MD 20892 USA; USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Thomas, DL (corresponding author), 424 N Bond St, Baltimore, MD 21231 USA.							Batmanov V. P., 1993, Antibiotiki i Khimioterapiya, V38, P18; DUNLOP RH, 1996, VET MED ILLUSTRATED, P456; GORBACH SL, 1992, INFECT DIS, P1294; Kenny DJ, 1999, ANTIMICROB AGENTS CH, V43, P2773, DOI 10.1128/AAC.43.11.2773; McGilvray C. D., 1944, CANADIAN JOUR PUBL HEALTH, V35, P268; OBINS GD, 1906, STUD R VICTORIA HOSP, V2, P1; VESLEY D, 1988, AM J PUBLIC HEALTH, V78, P1213, DOI 10.2105/AJPH.78.9.1213; Wheelis M, 1998, NATURE, V395, P213, DOI 10.1038/26089; WILKINSON L, 1981, MED HIST, V25, P363, DOI 10.1017/S0025727300034876; WOMACK CR, 1949, AM J MED, V6, P267, DOI 10.1016/0002-9343(49)90022-4; 2000, MMWR MORB MORTAL WKL, V49, P1	11	157	165	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2001	345	4					256	258		10.1056/NEJM200107263450404	http://dx.doi.org/10.1056/NEJM200107263450404			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455XZ	11474663	Bronze			2022-12-28	WOS:000170054200004
J	Bolton, DC				Bolton, DC			Prions and proteins: distinguishing between conformations	LANCET			English	Editorial Material									New York State Inst Basic Res Mental Retardat & D, Dept Biol Mol, Staten Isl, NY 10314 USA		Bolton, DC (corresponding author), New York State Inst Basic Res Mental Retardat & D, Dept Biol Mol, Staten Isl, NY 10314 USA.							Fischer MB, 2000, NATURE, V408, P479, DOI 10.1038/35044100; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Maissen M, 2001, LANCET, V357, P2026, DOI 10.1016/S0140-6736(00)05110-2; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; SHAKED GM, 2001, UNPUB PROTEASE RESIS	5	5	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 21	2001	358	9277					164	165		10.1016/S0140-6736(01)05397-1	http://dx.doi.org/10.1016/S0140-6736(01)05397-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454HL	11476826				2022-12-28	WOS:000169967100002
J	Faergemann, J				Faergemann, J			Treatment of seborrhoeic dermatitis with oral terbinafine?	LANCET			English	Editorial Material							PITYROSPORUM-OVALE; MALASSEZIA-FURFUR		Sahlgrens Univ Hosp, Dept Dermatol, S-41345 Gothenburg, Sweden	Sahlgrenska University Hospital	Faergemann, J (corresponding author), Sahlgrens Univ Hosp, Dept Dermatol, S-41345 Gothenburg, Sweden.							Bergbrant I M, 1991, Acta Derm Venereol Suppl (Stockh), V167, P1; Camera E, 1999, BRIT J DERMATOL, V140, P640, DOI 10.1046/j.1365-2133.1999.02762.x; Faergemann J, 1996, BRIT J DERMATOL, V134, P12, DOI 10.1111/j.1365-2133.1996.tb15652.x; FAERGEMANN J, 1986, BRIT J DERMATOL, V114, P695, DOI 10.1111/j.1365-2133.1986.tb04878.x; Faergemann J, 2000, Am J Clin Dermatol, V1, P75, DOI 10.2165/00128071-200001020-00001; Faergemann J, 2001, BRIT J DERMATOL, V144, P549, DOI 10.1046/j.1365-2133.2001.04082.x; Faergemann J, 1999, ALLERGY, V54, P413, DOI 10.1034/j.1398-9995.1999.00089.x; Gueho E, 1996, ANTON LEEUW INT J G, V69, P337, DOI 10.1007/BF00399623; KESEVAN S, 1997, J INVEST DERMATOL, V108, pA389; Leeming JP, 1997, BRIT J DERMATOL, V137, P764, DOI 10.1111/j.1365-2133.1997.tb01115.x; Neuber K, 1996, ARCH DERMATOL RES, V288, P532, DOI 10.1007/s004030050098; Rosen T, 1997, INT J DERMATOL, V36, P788, DOI 10.1046/j.1365-4362.1997.00309.x; Scaparro E, 2001, BRIT J DERMATOL, V144, P854, DOI 10.1046/j.1365-2133.2001.04144.x; SHUSTER S, 1984, BRIT J DERMATOL, V111, P235, DOI 10.1111/j.1365-2133.1984.tb04050.x; VILLARS V, 1989, CLIN EXP DERMATOL, V14, P124, DOI 10.1111/j.1365-2230.1989.tb00908.x	15	11	11	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 21	2001	358	9277					170	170		10.1016/S0140-6736(01)05401-0	http://dx.doi.org/10.1016/S0140-6736(01)05401-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454HL	11476831				2022-12-28	WOS:000169967100006
J	Hassell, KE; Whittington, Z; Cantrill, J; Bates, F; Rogers, A; Noyce, P				Hassell, KE; Whittington, Z; Cantrill, J; Bates, F; Rogers, A; Noyce, P			Managing demand: transfer of management of self limiting conditions from general practice to community pharmacies	BRITISH MEDICAL JOURNAL			English	Article									Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester M16 9PL, Lancs, England; Sefton Hlth Author, Waterloo L22 0QB, Merseyside, England; Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M16 9PL, Lancs, England	University of Manchester; University of Manchester	Hassell, KE (corresponding author), Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester M16 9PL, Lancs, England.		Mounsey, Zoe/K-9790-2016	Mounsey, Zoe/0000-0003-3452-2694				Department of Health, 2000, NHS PLAN PLAN INV PL; Hassell K, 2000, HEALTH SOC CARE COMM, V8, P40, DOI 10.1046/j.1365-2524.2000.00222.x; Thomas DHV, 1996, BRIT MED J, V312, P688; WHITTINGTON Z, 2001, PHARM J, V266, P425; 1994, LANCET, V343, P1374	5	33	33	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2001	323	7305					146	147		10.1136/bmj.323.7305.146	http://dx.doi.org/10.1136/bmj.323.7305.146			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	456WR	11463686	Green Published, Bronze			2022-12-28	WOS:000170106200019
J	Davis, GL; Rodrigue, JR				Davis, GL; Rodrigue, JR			Treatment of chronic hepatitis C in active drug users	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VIRUS-INFECTION; UNITED-STATES; INTERFERON; RISK; PREVALENCE; MORTALITY; RIBAVIRIN; THERAPY; ALCOHOL; DISEASE		Univ Florida, Coll Med, Gainesville, FL 32610 USA; Univ Florida, Coll Hlth Profess, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Davis, GL (corresponding author), Univ Florida, Coll Med, Gainesville, FL 32610 USA.							Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; ALTER MJ, 1990, JAMA-J AM MED ASSOC, V264, P2231, DOI 10.1001/jama.264.17.2231; [Anonymous], 1999, J Hepatol, V30, P956; BELL J, 1990, MED J AUSTRALIA, V153, P274, DOI 10.5694/j.1326-5377.1990.tb136900.x; Brown K, 1998, AUST NZ J PUBL HEAL, V22, P384, DOI 10.1111/j.1467-842X.1998.tb01396.x; Crofts N, 1997, ADDICTION, V92, P999, DOI 10.1111/j.1360-0443.1997.tb02979.x; Darby SC, 1997, LANCET, V350, P1425, DOI 10.1016/S0140-6736(97)05413-5; Davis GL, 1998, HEPATOLOGY, V28, p390A; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; FARCI P, 1992, SCIENCE, V258, P135, DOI 10.1126/science.1279801; Fontana RJ, 2000, DIGEST DIS, V18, P107, DOI 10.1159/000051384; Garfein RS, 1996, AM J PUBLIC HEALTH, V86, P655, DOI 10.2105/AJPH.86.5.655; GONZALEZPERALTA RP, 1994, J HEPATOL, V21, P255, DOI 10.1016/S0168-8278(05)80405-2; Hagan H, 2001, AM J PUBLIC HEALTH, V91, P42, DOI 10.2105/AJPH.91.1.42; Ho SB, 2001, AM J GASTROENTEROL, V96, P157; Hser YI, 2001, ARCH GEN PSYCHIAT, V58, P503, DOI 10.1001/archpsyc.58.5.503; JOE GW, 1982, AM J PUBLIC HEALTH, V72, P703, DOI 10.2105/AJPH.72.7.703; Johnson ME, 1998, AM J GASTROENTEROL, V93, P785; LAI ME, 1994, LANCET, V343, P388, DOI 10.1016/S0140-6736(94)91224-6; Leal P, 1999, J MED SCREEN, V6, P124, DOI 10.1136/jms.6.3.124; Manns MP, 2000, HEPATOLOGY, V32, p297A; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; MEYER RA, 1991, AM J GASTROENTEROL, V86, P1224; Muir AJ, 1999, HEPATOLOGY, V30, p190A; *NIH CONS DEV C, 1997, HEPATOLOGY S, V1, pS2; Ohnishi K, 1996, AM J GASTROENTEROL, V91, P1374; Ono K, 1996, ALCOHOL CLIN EXP RES, V20, P1560, DOI 10.1111/j.1530-0277.1996.tb01699.x; Rosenthal RN, 1999, ADDICTIONS COMPREHEN, P439; Schiff Eugene R., 1999, American Journal of Medicine, V107, p95S; Sherman M, 1997, CAN J GASTROENTEROL, V11, P407, DOI 10.1155/1997/454278; Stein MD, 2001, DRUG ALCOHOL DEPEN, V61, P211, DOI 10.1016/S0376-8716(00)00144-7; Stephenson J, 2001, JAMA-J AM MED ASSOC, V285, P1003, DOI 10.1001/jama.285.8.1003; Szabo G, 1999, ALCOHOL ALCOHOLISM, V34, P830, DOI 10.1093/alcalc/34.6.830; Wiley TE, 1998, HEPATOLOGY, V28, P805, DOI 10.1002/hep.510280330; Wong JB, 2000, AM J PUBLIC HEALTH, V90, P1562, DOI 10.2105/AJPH.90.10.1562; Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301	36	95	96	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2001	345	3					215	217		10.1056/NEJM200107193450312	http://dx.doi.org/10.1056/NEJM200107193450312			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453JM	11463020				2022-12-28	WOS:000169912800012
J	Shimizu, K; Kimura, T; Furomoto, S; Takeda, K; Kontani, K; Onuki, Y; Amaya, K				Shimizu, K; Kimura, T; Furomoto, S; Takeda, K; Kontani, K; Onuki, Y; Amaya, K			Superconductivity in the nonmagnetic state of iron under pressure	NATURE			English	Article							HCP	Ferromagnetism and superconductivity are thought to compete in conventional superconductors, although in principle it is possible for any metal to become a superconductor in its non-magnetic state at a sufficiently low temperature. At pressures above 10GPa, iron is known to transform to a non-magnetic structure(1,2) and the possibility of superconductivity in this state has been predicted(3,4). Here we report that iron does indeed become superconducting at temperatures below 2 K at pressures between 15 and 30 GPa. The transition to the superconducting state is confirmed by both a drop in resistivity and observation of the Meissner effect.	Osaka Univ, Grad Sch Engn Sci, Dept Phys Sci, Osaka 5608531, Japan; Osaka Univ, Res Ctr Mat Sci Extreme Condit, Osaka 5608531, Japan; Osaka Univ, Grad Sch Sci, Dept Phys, Osaka 5600043, Japan	Osaka University; Osaka University; Osaka University	Shimizu, K (corresponding author), Osaka Univ, Grad Sch Engn Sci, Dept Phys Sci, Osaka 5608531, Japan.			Shimizu, Katsuya/0000-0003-0560-8325				CORT G, 1982, J APPL PHYS, V53, P2064, DOI 10.1063/1.330745; FREEMAN AJ, 1990, PHYSICA C, V166, P317, DOI 10.1016/0921-4534(90)90411-7; TAYLOR RD, 1991, J APPL PHYS, V69, P6126, DOI 10.1063/1.348779; WOHLFARTH EP, 1979, PHYS LETT A, V75, P141, DOI 10.1016/0375-9601(79)90305-0	4	224	225	1	72	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					316	318		10.1038/35085536	http://dx.doi.org/10.1038/35085536			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460158				2022-12-28	WOS:000169918200041
J	Broza, M; Halpern, M				Broza, M; Halpern, M			Pathogen reservoirs - Chironomid egg masses and Vibrio cholerae	NATURE			English	Article							CLIMATE		Univ Haifa, Fac Sci & Sci Educ, Dept Biol, IL-36006 Tivon, Israel	University of Haifa	Broza, M (corresponding author), Univ Haifa, Fac Sci & Sci Educ, Dept Biol, IL-36006 Tivon, Israel.	broza@research.haifa.ac.il	Halpern, Malka/AAH-1498-2019	Halpern, Malka/0000-0002-3407-2198				Armitage P., 1995, THE CHIRONOMIDAE, VXII, P572, DOI 10.1007/978-94-011-0715-0; Broza M, 2000, WATER SCI TECHNOL, V42, P71, DOI 10.2166/wst.2000.0293; Colwell Rita R., 1994, P117; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Colwell RR, 1999, J APPL MICROBIOL, V85, p134S, DOI 10.1111/j.1365-2672.1998.tb05292.x; ECHOLS H, 1961, J MOL BIOL, V3, P425, DOI 10.1016/S0022-2836(61)80055-7; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Lewin S. M., 1996, P228; NOLTE U, 1993, ENT SCAND S, V43, P5; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987	11	93	100	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					40	40		10.1038/35083691	http://dx.doi.org/10.1038/35083691			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452294	Bronze			2022-12-28	WOS:000169644900031
J	Corten, GP; Veldkamp, HF				Corten, GP; Veldkamp, HF			Aerodynamics - Insects can halve wind-turbine power	NATURE			English	Article									Energy Ctr Netherlands, Unit Wind Energy, NL-1755 ZG Petten, Netherlands; NEG Micon AS, DK-8900 Randers, Denmark	Vestas Wind Systems	Corten, GP (corresponding author), Energy Ctr Netherlands, Unit Wind Energy, POB 1, NL-1755 ZG Petten, Netherlands.							Bak C., 1999, WIND ENERGY, V2, P195; Corten G. P, 1999, 13 IEA EXP M AER WIN; Corten GP., 2001, THESIS U UTRECHT; DYRMOSE SZ, 1998, DOUBLE STALL PHENOME; Madsen H. A., 1991, AERODYNAMICS HORIZON; Snel H., 1999, PROGR JOULE PROJECT	6	76	84	2	43	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					41	42		10.1038/35083698	http://dx.doi.org/10.1038/35083698			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452297				2022-12-28	WOS:000169644900034
J	Bayer, KU; De Koninck, P; Leonard, AS; Hell, JW; Schulman, H				Bayer, KU; De Koninck, P; Leonard, AS; Hell, JW; Schulman, H			Interaction with the NMDA receptor locks CaMKII in an active conformation	NATURE			English	Article							PROTEIN-KINASE-II; NR2B SUBUNIT; CALMODULIN; AUTOPHOSPHORYLATION; PHOSPHORYLATION; TRANSLOCATION; NEUROSCIENCE; SYNAPSES; ISOFORM; DENSITY	Calcium- and calmodulin-dependent protein kinase II (CaMKII) and glutamate receptors are integrally involved in forms of synaptic plasticity that may underlie learning and memory. In the simplest model for long-term potentiation(1), CaMKII is activated by Ca2+ influx through NMDA (N-methyl-D-aspartate) receptors and then potentiates synaptic efficacy by inducing synaptic insertion(2,3) and increased single-channel conductance(4) of AMPA (alpha -amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptors. Here we show that regulated CaMKII interaction with two sites on the NMDA receptor subunit NR2B provides a mechanism for the glutamate-induced translocation of the kinase to the synapse in hippocampal neurons. This interaction can lead to additional forms of potentiation by: facilitated CaMKII response to synaptoc Ca2+; suppression of inhibitory autophosphorylation of CaMKII; and, most notably, direct generation of sustained Ca2+/calmodulin (CaM)-independent (autonomous) kinase activity by a mechanism that is independent of the phosphorylation state. Furthermore, the interaction leads to trapping of CaM that may reduce down-regulation of NMDA receptor activity(5). CaMKII-NR2B interaction may be prototypical for direct activation of a kinase by its targeting protein.	Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA; Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA	Stanford University; University of Wisconsin System; University of Wisconsin Madison	Bayer, KU (corresponding author), Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA.	ulli.bayer@stanford.edu; schulman@cmgm.stanford.edu	Hell, Johannes W./P-5085-2019					Bayer KU, 1998, EMBO J, V17, P5598, DOI 10.1093/emboj/17.19.5598; Bayer KU, 1996, MOL CELL BIOL, V16, P29; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; COLBRAN RJ, 1990, J BIOL CHEM, V265, P11213; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Gardoni F, 1998, J NEUROCHEM, V71, P1733; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HANSON PI, 1992, J BIOL CHEM, V267, P17216; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hisatsune C, 1997, J BIOL CHEM, V272, P20805, DOI 10.1074/jbc.272.33.20805; Kolodziej SJ, 2000, J BIOL CHEM, V275, P14354, DOI 10.1074/jbc.275.19.14354; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; Lisman J, 1997, SCIENCE, V276, P2001, DOI 10.1126/science.276.5321.2001; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Rich RC, 1998, J BIOL CHEM, V273, P28424, DOI 10.1074/jbc.273.43.28424; Rongo C, 1999, NATURE, V402, P195, DOI 10.1038/46065; Schulman H, 1999, CALCIUM AS A CELLULAR REGULATOR, P311; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shen K, 2000, NAT NEUROSCI, V3, P881, DOI 10.1038/78783; SMITH MK, 1992, J BIOL CHEM, V267, P1761; Strack S, 2000, J BIOL CHEM, V275, P25061, DOI 10.1074/jbc.C000319200; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Yang EY, 1999, J BIOL CHEM, V274, P26199, DOI 10.1074/jbc.274.37.26199	30	511	543	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2001	411	6839					801	805		10.1038/35081080	http://dx.doi.org/10.1038/35081080			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459059				2022-12-28	WOS:000169246400050
J	Dixon, RA				Dixon, RA			Natural products and plant disease resistance	NATURE			English	Article							PHYTOALEXIN-DEFICIENT MUTANTS; NECTRIA-HAEMATOCOCCA; ARABIDOPSIS-THALIANA; BIOSYNTHESIS; BIOCHEMISTRY; ENZYME; ENCODES; GENE; METHYLTRANSFERASES; ACYLTRANSFERASE	Plants elaborate a vast array of natural products, many of which have evolved to confer selective advantage against microbial attack. Recent advances in molecular technology, aided by the enormous power of large-scale genomics initiatives, are leading to a more complete understanding of the enzymatic machinery that underlies the often complex pathways of plant natural product biosynthesis. Meanwhile, genetic and reverse genetic approaches are providing evidence for the importance of natural products in host defence. Metabolic engineering of natural product pathways is now a feasible strategy for enhancement of plant disease resistance.	Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73401 USA	Noble Research Institute	Dixon, RA (corresponding author), Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73401 USA.		Bruening, Stefan/B-8505-2011					Bell CJ, 2001, NUCLEIC ACIDS RES, V29, P114, DOI 10.1093/nar/29.1.114; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; BOWYER P, 1995, SCIENCE, V267, P371, DOI 10.1126/science.7824933; Chapple C, 1998, ANNU REV PLANT PHYS, V49, P311, DOI 10.1146/annurev.arplant.49.1.311; Cooper RM, 1996, NATURE, V379, P159, DOI 10.1038/379159a0; Crock J, 1997, P NATL ACAD SCI USA, V94, P12833, DOI 10.1073/pnas.94.24.12833; DIXON RA, 1995, PHYSIOL PLANTARUM, V93, P385, DOI 10.1111/j.1399-3054.1995.tb02243.x; DIXON RA, 1994, ANNU REV PHYTOPATHOL, V32, P479, DOI 10.1146/annurev.py.32.090194.002403; Enkerli J, 1998, MOL PLANT MICROBE IN, V11, P317, DOI 10.1094/MPMI.1998.11.4.317; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Frey M, 1997, SCIENCE, V277, P696, DOI 10.1126/science.277.5326.696; Frick S, 2001, PHYTOCHEMISTRY, V56, P1, DOI 10.1016/S0031-9422(00)00378-2; GLAZEBROOK J, 1994, P NATL ACAD SCI USA, V91, P8955, DOI 10.1073/pnas.91.19.8955; Glazebrook J, 1997, GENETICS, V146, P381; GRAYER RJ, 1994, PHYTOCHEMISTRY, V37, P19, DOI 10.1016/0031-9422(94)85005-4; Hammerschmidt R, 1999, ANNU REV PHYTOPATHOL, V37, P285, DOI 10.1146/annurev.phyto.37.1.285; Harborne JB, 1999, BIOCHEM SYST ECOL, V27, P335, DOI 10.1016/S0305-1978(98)00095-7; He XZ, 2000, PLANT CELL, V12, P1689, DOI 10.1105/tpc.12.9.1689; Hipskind JD, 2000, MOL PLANT MICROBE IN, V13, P551, DOI 10.1094/MPMI.2000.13.5.551; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; HRAZDINA G, 1992, ANNU REV PLANT PHYS, V43, P241, DOI 10.1146/annurev.pp.43.060192.001325; Ibrahim RK, 1998, PLANT MOL BIOL, V36, P1, DOI 10.1023/A:1005939803300; Jez JM, 2000, NAT STRUCT BIOL, V7, P786, DOI 10.1038/79025; Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7; Jung W, 2000, NAT BIOTECHNOL, V18, P208, DOI 10.1038/72671; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kehoe DM, 1999, TRENDS PLANT SCI, V4, P38, DOI 10.1016/S1360-1385(98)01354-5; KODAMA O, 1988, AGR BIOL CHEM TOKYO, V52, P2469, DOI 10.1080/00021369.1988.10869067; Lange BM, 1998, P NATL ACAD SCI USA, V95, P2100, DOI 10.1073/pnas.95.5.2100; Lehfeldt C, 2000, PLANT CELL, V12, P1295, DOI 10.1105/tpc.12.8.1295; Li AX, 2000, P NATL ACAD SCI USA, V97, P6902, DOI 10.1073/pnas.110154197; Loon L.C.V., 2000, MECH RESISTANCE PLAN, P325, DOI DOI 10.1007/978-94-011-3937-3_10; MALONEY AP, 1994, MOL GEN GENET, V243, P506, DOI 10.1007/BF00284198; MULLER K. O., 1941, Arb. biol. Anst. (Reichsanst.) Berl., V23, P189; Nurnberger T, 1999, CELL MOL LIFE SCI, V55, P167, DOI 10.1007/s000180050283; Papadopoulou K, 1999, P NATL ACAD SCI USA, V96, P12923, DOI 10.1073/pnas.96.22.12923; Pichersky E, 2000, TRENDS PLANT SCI, V5, P439, DOI 10.1016/S1360-1385(00)01741-6; Pierce ML, 1996, PHYSIOL MOL PLANT P, V48, P305, DOI 10.1006/pmpp.1996.0025; Schroder J, 1997, TRENDS PLANT SCI, V2, P373, DOI 10.1016/S1360-1385(97)01104-7; Smith RD, 2000, NAT BIOTECHNOL, V18, P1041, DOI 10.1038/80226; SNYDER BA, 1990, SCIENCE, V248, P1637, DOI 10.1126/science.248.4963.1637; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; Steele CL, 1999, ARCH BIOCHEM BIOPHYS, V367, P146, DOI 10.1006/abbi.1999.1238; Thomma BPHJ, 1999, PLANT J, V19, P163, DOI 10.1046/j.1365-313X.1999.00513.x; Trethewey RN, 1999, CURR OPIN PLANT BIOL, V2, P83, DOI 10.1016/S1369-5266(99)80017-X; van der Fits L, 2000, SCIENCE, V289, P295, DOI 10.1126/science.289.5477.295; VANETTEN HD, 1994, PLANT CELL, V6, P1191; VANETTEN HD, 1989, ANNU REV PHYTOPATHOL, V27, P143, DOI 10.1146/annurev.py.27.090189.001043; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Winkel-Shirley B, 1999, PHYSIOL PLANTARUM, V107, P142, DOI 10.1034/j.1399-3054.1999.100119.x; Yates JR, 1998, J MASS SPECTROM, V33, P1; Zhou N, 1999, PLANT CELL, V11, P2419, DOI 10.1105/tpc.11.12.2419; Zubieta C, 2001, NAT STRUCT BIOL, V8, P271, DOI 10.1038/85029	54	1161	1295	13	286	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2001	411	6839					843	847		10.1038/35081178	http://dx.doi.org/10.1038/35081178			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459067				2022-12-28	WOS:000169246400061
J	Lange, RA; Hillis, LD				Lange, RA; Hillis, LD			Medical progress - Cardiovascular complications of cocaine use	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INDUCED CORONARY VASOCONSTRICTION; MYOCARDIAL-INFARCTION; CHEST-PAIN; ARTERY-DISEASE; COCAETHYLENE DEGRADATION; PROCAINAMIDE INHIBITION; INTRANASAL COCAINE; AORTIC DISSECTION; CLINICAL SAFETY; HUMAN PLATELETS		Univ Texas, SW Med Ctr, Dept Internal Med, Div Cardiovasc, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Hillis, LD (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Div Cardiovasc, Room CS7-102,5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Lange, Richard/AAM-9594-2021					AMIN M, 1990, AM J CARDIOL, V66, P1434, DOI 10.1016/0002-9149(90)90529-A; Bailey DN, 1999, THER DRUG MONIT, V21, P301, DOI 10.1097/00007691-199906000-00008; Bailey DN, 1999, J ANAL TOXICOL, V23, P99, DOI 10.1093/jat/23.2.99; Bailey DN, 1999, J ANAL TOXICOL, V23, P173, DOI 10.1093/jat/23.3.173; Baumann BM, 2000, ACAD EMERG MED, V7, P878, DOI 10.1111/j.1553-2712.2000.tb02065.x; Baumgartner FJ, 1997, ANN THORAC SURG, V64, P1518, DOI 10.1016/S0003-4975(97)00988-0; BERTOLET BD, 1990, CLIN CARDIOL, V13, P323, DOI 10.1002/clc.4960130505; Besse S, 1997, EUR J PHARMACOL, V338, P123, DOI 10.1016/S0014-2999(97)81939-5; BILLMAN GE, 1993, J CARDIOVASC PHARM, V22, P869, DOI 10.1097/00005344-199312000-00015; BOEHRER JD, 1993, AM J MED, V94, P608, DOI 10.1016/0002-9343(93)90212-8; BRICKNER ME, 1991, CIRCULATION, V84, P1130, DOI 10.1161/01.CIR.84.3.1130; BRODY SL, 1990, AM J MED, V88, P325, DOI 10.1016/0002-9343(90)90484-U; BROGAN WC, 1992, ANN INTERN MED, V116, P556, DOI 10.7326/0003-4819-116-7-556; BROGAN WC, 1991, J AM COLL CARDIOL, V18, P581, DOI 10.1016/0735-1097(91)90617-I; CHAMBERS HF, 1987, ANN INTERN MED, V106, P833, DOI 10.7326/0003-4819-106-6-833; CHOKSHI SK, 1989, ANN INTERN MED, V111, P1039, DOI 10.7326/0003-4819-111-12-1039; COLEMAN DL, 1982, WESTERN J MED, V136, P444; DANIEL WC, 1995, AM J CARDIOL, V76, P398, DOI 10.1016/S0002-9149(99)80109-X; DARAS M, 1994, ACTA NEUROL SCAND, V90, P124; ESCOBEDO LG, 1991, ARCH PATHOL LAB MED, V115, P900; Fendrich M, 1999, AM J EPIDEMIOL, V149, P955; FLORES ED, 1990, J AM COLL CARDIOL, V16, P74, DOI 10.1016/0735-1097(90)90459-3; Gan XH, 1999, CLIN IMMUNOL, V91, P68, DOI 10.1006/clim.1998.4683; GITTER MJ, 1991, ANN INTERN MED, V115, P277, DOI 10.7326/0003-4819-115-4-277; GRANT BF, 1990, DRUG ALCOHOL DEPEN, V25, P97, DOI 10.1016/0376-8716(90)90147-7; HEARN WL, 1991, J NEUROCHEM, V56, P698, DOI 10.1111/j.1471-4159.1991.tb08205.x; HEARN WL, 1991, PHARM BIOCH BEHAV, P531; HENDERSON CE, 1988, AM J PERINAT, V5, P142, DOI 10.1055/s-2007-999673; Hoffman RS, 1996, AM J EMERG MED, V14, P693, DOI 10.1016/S0735-6757(96)90091-1; Hollander J E, 1994, Acad Emerg Med, V1, P330; HOLLANDER J E, 1992, Journal of Emergency Medicine, V10, P169, DOI 10.1016/0736-4679(92)90212-C; HOLLANDER JE, 1995, ARCH INTERN MED, V155, P1081, DOI 10.1001/archinte.155.10.1081; HOLLANDER JE, 1995, ANN EMERG MED, V26, P671, DOI 10.1016/S0196-0644(95)70035-8; HOLLANDER JE, 1995, CHEST, V107, P1237, DOI 10.1378/chest.107.5.1237; HOLLANDER JE, 1995, ACAD EMERG MED, V2, P179, DOI 10.1111/j.1553-2712.1995.tb03191.x; Hollander JE, 1998, AM HEART J, V135, P245, DOI 10.1016/S0002-8703(98)70089-4; Hollander JE, 1997, VET HUM TOXICOL, V39, P276; HOLLANDER JE, 1992, NEW ENGL J MED, V327, P361; Huang L, 1997, AM J PHYSIOL-HEART C, V273, pH893, DOI 10.1152/ajpheart.1997.273.2.H893; INOUE H, 1988, J AM COLL CARDIOL, V11, P867, DOI 10.1016/0735-1097(88)90224-0; ISNER JM, 1986, NEW ENGL J MED, V315, P1438, DOI 10.1056/NEJM198612043152302; JEFFCOAT AR, 1989, DRUG METAB DISPOS, V17, P153; Kanani PM, 1998, J CARDIOVASC PHARM, V32, P42, DOI 10.1097/00005344-199807000-00007; Kerns William Ii, 1997, Journal of Emergency Medicine, V15, P321, DOI 10.1016/S0736-4679(97)00003-6; Kidwell DA, 1997, FORENSIC SCI INT, V84, P75, DOI 10.1016/S0379-0738(96)02051-8; Kolodgie FD, 1999, EXP MOL PATHOL, V66, P109, DOI 10.1006/exmp.1999.2253; KOLODGIE FD, 1991, J AM COLL CARDIOL, V17, P1553, DOI 10.1016/0735-1097(91)90646-Q; KUGELMASS AD, 1993, CIRCULATION, V88, P876, DOI 10.1161/01.CIR.88.3.876; LANGE RA, 1989, NEW ENGL J MED, V321, P1557, DOI 10.1056/NEJM198912073212301; LANGE RA, 1990, ANN INTERN MED, V112, P897, DOI 10.7326/0003-4819-112-12-897; Madu EC, 1999, ANGIOLOGY, V50, P163, DOI 10.1177/000331979905000212; Mao JT, 1997, CELL IMMUNOL, V181, P38, DOI 10.1006/cimm.1997.1185; MINOR RL, 1991, ANN INTERN MED, V115, P797, DOI 10.7326/0003-4819-115-10-797; Mittleman MA, 1999, CIRCULATION, V99, P2737, DOI 10.1161/01.CIR.99.21.2737; Mo W, 1998, AM J HYPERTENS, V11, P708, DOI 10.1016/S0895-7061(98)00041-7; MOLITERNO DJ, 1994, AM J MED, V96, P492, DOI 10.1016/0002-9343(94)90087-6; MOLITERNO DJ, 1994, NEW ENGL J MED, V330, P454, DOI 10.1056/NEJM199402173300702; NEGUS BH, 1994, AM J CARDIOL, V73, P510, DOI 10.1016/0002-9149(94)90684-X; Neiman J, 2000, EUR J NEUROL, V7, P595, DOI 10.1046/j.1468-1331.2000.00045.x; Ness RB, 1999, NEW ENGL J MED, V340, P333, DOI 10.1056/NEJM199902043400501; *OFF APPL STUD, 1999, DHHS PUBL; Parker RB, 1999, J CARDIOVASC PHARM, V34, P864, DOI 10.1097/00005344-199912000-00014; Perera R, 1997, J ELECTROCARDIOL, V30, P337, DOI 10.1016/S0022-0736(97)80047-7; Perreault C L, 1991, NIDA Res Monogr, V108, P139; PERREAULT CL, 1993, CARDIOVASC RES, V27, P262, DOI 10.1093/cvr/27.2.262; Perron AD, 1997, AM J EMERG MED, V15, P507, DOI 10.1016/S0735-6757(97)90196-0; PIRWITZ MJ, 1995, ARCH INTERN MED, V155, P1186, DOI 10.1001/archinte.155.11.1186; Pitts WR, 1997, PROG CARDIOVASC DIS, V40, P65, DOI 10.1016/S0033-0620(97)80023-0; Pitts WR, 1998, CIRCULATION, V97, P1270, DOI 10.1161/01.CIR.97.13.1270; RANDALL T, 1992, JAMA-J AM MED ASSOC, V267, P1043, DOI 10.1001/jama.267.8.1043; REZKALLA SH, 1993, AM J CARDIOL, V72, P243, DOI 10.1016/0002-9149(93)90173-A; RINDER HM, 1994, CIRCULATION, V90, P1162, DOI 10.1161/01.CIR.90.3.1162; SHIH RD, 1995, ANN EMERG MED, V26, P702, DOI 10.1016/S0196-0644(95)70041-2; Sofuoglu M, 2000, PHARMACOL BIOCHEM BE, V65, P255, DOI 10.1016/S0091-3057(99)00201-4; STENBERG RG, 1989, ARCH PATHOL LAB MED, V113, P521; *SUBST AB MENT HLT, 2000, DRUG AB WARN NETW AN; TAZELAAR HD, 1987, HUM PATHOL, V18, P195, DOI 10.1016/S0046-8177(87)80338-6; VIRMANI R, 1988, AM HEART J, V115, P1068, DOI 10.1016/0002-8703(88)90078-6; Wang RY, 1999, AM J EMERG MED, V17, P364, DOI 10.1016/S0735-6757(99)90088-8; WIENER RS, 1986, AM J MED, V81, P699, DOI 10.1016/0002-9343(86)90559-0; Wilbert-Lampen U, 1998, CIRCULATION, V98, P385, DOI 10.1161/01.CIR.98.5.385; WINNIFORD MD, 1986, CIRCULATION, V73, P662, DOI 10.1161/01.CIR.73.4.662; WIT AL, 1986, HEART CARDIOVASCULAR, V2, P1449; Xiao YJ, 2000, J PHARMACOL EXP THER, V292, P8; 2000, CIRCULATION S1, V102, P86; 2000, CIRCULATION S1, V102, P223	86	472	489	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2001	345	5					351	358		10.1056/NEJM200108023450507	http://dx.doi.org/10.1056/NEJM200108023450507			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458KM	11484693				2022-12-28	WOS:000170193600008
J	Saika-Voivod, I; Poole, PH; Sciortino, F				Saika-Voivod, I; Poole, PH; Sciortino, F			Fragile-to-strong transition and polyamorphism in the energy landscape of liquid silica	NATURE			English	Article							CONFIGURATIONAL ENTROPY; SUPERCOOLED LIQUIDS; GLASS-TRANSITION; VISCOUS SILICA; RELAXATION; VISCOSITY; WATER; MODEL	Liquid silica is the archetypal glass former, and compounds based on silica are ubiquitous as natural and man-made amorphous materials. Liquid silica is also the extreme case of a 'strong' liquid, in that the variation of viscosity with temperature closely follows the Arrhenius law as the liquid is cooled toward its glass transition temperature(1,2). In contrast, most liquids are to some degree 'fragile', showing significantly faster increases in their viscosity as the glass transition temperature is approached. Recent studies(3-6,35,36) have demonstrated the controlling influence of the potential energy hypersurface (or 'energy landscape') of the liquid on the transport properties near the glass transition. But the origin of strong liquid behaviour in terms of the energy landscape has not yet been resolved. Here we study the static and dynamic properties of liquid silica over a wide range of temperature and density using computer simulations. The results reveal a change in the energy landscape with decreasing temperature, which underlies a transition from a fragile liquid at high temperature to a strong liquid at low temperature. We also show that a specific heat anomaly is associated with this fragile-to-strong transition, and suggest that this anomaly is related to the polyamorphic behaviour of amorphous solid silica.	Univ Western Ontario, Dept Appl Math, London, ON N6A 5B7, Canada; Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; Univ Roma La Sapienza, Ist Nazl Fis Mat, I-00185 Rome, Italy	Western University (University of Western Ontario); Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Sapienza University Rome	Poole, PH (corresponding author), Univ Western Ontario, Dept Appl Math, London, ON N6A 5B7, Canada.	poole@cmrg.apmaths.uwo.ca	Poole, Peter/C-7943-2009; Sciortino, Francesco/B-4768-2012; Saika-Voivod, Ivan/D-1249-2009	Poole, Peter/0000-0001-5985-0585; Saika-Voivod, Ivan/0000-0002-3945-7003; SCIORTINO, Francesco/0000-0002-2418-2713				ADAM G, 1965, J CHEM PHYS, V43, P139, DOI 10.1063/1.1696442; ANGELL CA, 1993, J PHYS CHEM-US, V97, P6339, DOI 10.1021/j100126a005; ANGELL CA, 1991, J NON-CRYST SOLIDS, V131, P13, DOI 10.1016/0022-3093(91)90266-9; Mezei M, 1986, Ann N Y Acad Sci, V482, P1, DOI 10.1111/j.1749-6632.1986.tb20933.x; Barrat JL, 1997, MOL SIMULAT, V20, P17, DOI 10.1080/08927029708024165; BELL RJ, 1968, PHYS CHEM GLASSES, V9, P125; Buchner S, 1999, PHYS REV E, V60, P6507, DOI 10.1103/PhysRevE.60.6507; Coluzzi B, 2000, PHYS REV LETT, V84, P306, DOI 10.1103/PhysRevLett.84.306; Debenedetti PG, 2001, NATURE, V410, P259, DOI 10.1038/35065704; GOLDSTEIN M, 1969, J CHEM PHYS, V51, P3728, DOI 10.1063/1.1672587; HEMMATI M, IN PRESS J CHEM PHYS; Hess KU, 1996, CHEM GEOL, V128, P155, DOI 10.1016/0009-2541(95)00170-0; Horbach J, 1999, PHYS REV B, V60, P3169, DOI 10.1103/PhysRevB.60.3169; Jagla EA, 2001, MOL PHYS, V99, P753, DOI 10.1080/00268970010030031; Johari GP, 2000, J CHEM PHYS, V112, P7518, DOI 10.1063/1.481349; Martinez LM, 2001, NATURE, V410, P663, DOI 10.1038/35070517; Poole PH, 1997, SCIENCE, V275, P322, DOI 10.1126/science.275.5298.322; Rebelo LPN, 1998, J CHEM PHYS, V109, P626, DOI 10.1063/1.476600; RICHET P, 1984, GEOCHIM COSMOCHIM AC, V48, P471, DOI 10.1016/0016-7037(84)90275-8; Rossler E, 1998, J NON-CRYST SOLIDS, V223, P207, DOI 10.1016/S0022-3093(97)00365-7; Saika-Voivod I, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.011202; Sastry S, 1998, NATURE, V393, P554, DOI 10.1038/31146; Sastry S, 2001, NATURE, V409, P164, DOI 10.1038/35051524; Sastry S, 1996, PHYS REV E, V53, P6144, DOI 10.1103/PhysRevE.53.6144; Scala A, 2000, NATURE, V406, P166, DOI 10.1038/35018034; Scheidler P, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.104204; Sciortino F, 1999, PHYS REV LETT, V83, P3214, DOI 10.1103/PhysRevLett.83.3214; Sciortino F, 2001, PHYS REV LETT, V86, P107, DOI 10.1103/PhysRevLett.86.107; Speedy RJ, 1999, J PHYS CHEM B, V103, P4060, DOI 10.1021/jp983830w; Speedy RJ, 1998, MOL PHYS, V95, P169, DOI 10.1080/00268979809483148; Speedy RJ, 1996, MOL PHYS, V88, P1293, DOI 10.1080/00268979650025849; Starr FW, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.041201; STILLINGER FH, 1984, SCIENCE, V225, P983, DOI 10.1126/science.225.4666.983; STILLINGER FH, 1995, SCIENCE, V267, P1935, DOI 10.1126/science.267.5206.1935; Stillinger FH, 1998, J CHEM PHYS, V109, P3983, DOI 10.1063/1.476997; VANBEEST BWH, 1990, PHYS REV LETT, V64, P1955, DOI 10.1103/PhysRevLett.64.1955	36	333	335	3	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2001	412	6846					514	517		10.1038/35087524	http://dx.doi.org/10.1038/35087524			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484046	Green Submitted			2022-12-28	WOS:000170202900038
J	de Jong, JTVM; Komproe, IH; Van Ommeren, M; El Masri, M; Araya, M; Khaled, N; van de Put, W; Somasundaram, D				de Jong, JTVM; Komproe, IH; Van Ommeren, M; El Masri, M; Araya, M; Khaled, N; van de Put, W; Somasundaram, D			Lifetime events and posttraumatic stress disorder in 4 postconflict settings	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOSE-EFFECT RELATIONSHIPS; MENTAL-HEALTH; WAR TRAUMA; ASYLUM-SEEKERS; SYMPTOMS; REFUGEES; TORTURE; PTSD; COMORBIDITY; DEPRESSION	Context Little is known about the impact of trauma in postconflict, low-income countries where people have survived multiple traumatic experiences. Objective To establish the prevalence rates of and risk factors for posttraumatic stress disorder (PTSD) in 4 postconflict, low-income countries. Design, Setting, and Participants Epidemiological survey conducted between 1997 and 1999 among survivors of war or mass violence (aged greater than or equal to 16 years) who were randomly selected from community populations in Algeria (n=653), Cambodia (n=610), Ethiopia (n=1200), and Gaza (n=585). Main Outcome Measure Prevalence rates of PTSD assessed using the PTSD module of the Composite International Diagnostic Interview version 2.1 and evaluated in relation to traumatic events, assessed using an adapted version of the Life Events and Social History Questionnaire. Results The prevalence rate of assessed PTSD was 37.4% in Algeria, 28.4% in Cambodia, 15.8% in Ethiopia, and 17.8% in Gaza. Conflict-related trauma after age 12 years was the only risk factor for PTSD that was present in all 4 samples. Torture was a risk factor in all samples except Cambodia. Psychiatric history and current illness were risk factors in Cambodia (adjusted odds ratio [OR], 3.6; 95% confidence interval [CI], 2.3-5.4 and adjusted OR,1.6; 95% CI, 1.0-2.7, respectively) and Ethiopia (adjusted OR, 3.9; 95% CI, 2.0-7.4 and adjusted OR, 1.8; 95% CI, 1.1-2.7, respectively). Poor quality of camp was associated with PTSD in Algeria (adjusted OR, 1.8; 95% CI, 1.3-2.5) and in Gaza (adjusted OR, 1.7; 95% CI, 1.1-2.8). Daily hassles were associated with PTSD in Algeria (adjusted OR, 1.6; 95% CI, 1.1-2.4). Youth domestic stress, death or separation in the family, and alcohol abuse in parents were associated with PTSD in Cambodia (adjusted OR, 1.7; 95% CI, 1.1-2.6; adjusted OR, 1.7; 95% CI, 1.0-2.8; and adjusted OR, 2.2; 95% CI, 1.1-4.4, respectively). Conclusions Using the same assessment methods, a wide range of rates of symptoms of PTSD were found among 4 low-income populations who have experienced war, conflict, or mass violence. We identified specific patterns of risk factors per country. Our findings indicate the importance of contextual differences in the study of traumatic stress and human rights violations.	TPO, WHO Collaborating Ctr, NL-1016 EE Amsterdam, Netherlands; Vrije Univ Amsterdam, Amsterdam, Netherlands; Ctr Victims Torture, Kathmandu, Nepal; TPO, SARP, Algiers, Algeria; TPO Ethiopia, Addis Ababa, Ethiopia; TPO Cambodia, Phnom Penh, Cambodia; HealthNet Int, Amsterdam, Netherlands; Univ Jaffna, Jaffna, Sri Lanka	World Health Organization; Vrije Universiteit Amsterdam; University Jaffna	Komproe, IH (corresponding author), TPO, WHO Collaborating Ctr, Keizersgracht 329, NL-1016 EE Amsterdam, Netherlands.	ikomproe.top@pom.nl	Komproe, Ivan/AAJ-8699-2021					Ager A., 1993, MENTAL HLTH REFUGEE; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; ANDREWS G, 1995, AUST NZ J PSYCHIAT, V29, P124, DOI 10.3109/00048679509075901; Andrews G, 1998, SOC PSYCH PSYCH EPID, V33, P80, DOI 10.1007/s001270050026; [Anonymous], 1997, JAMA-J AM MED ASSOC, V277, P925; [Anonymous], 1995, WORLD MENTAL HLTH PR; [Anonymous], 1997, COMP INT DIAGN INT C; APTEKAR L, IN PRESS WAR VIOLENC; Bremner JD, 1996, AM J PSYCHIAT, V153, P369; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; Bromet E, 1998, AM J EPIDEMIOL, V147, P353; Cardozo BL, 2000, JAMA-J AM MED ASSOC, V284, P569, DOI 10.1001/jama.284.5.569; CARLIER IVE, 1995, J NERV MENT DIS, V183, P107, DOI 10.1097/00005053-199502000-00008; de Girolamo G., 1996, ETHNOCULTURAL ASPECT, P33, DOI [DOI 10.1037/10555-002, 10.1037/10555-002]; ElSarraj E, 1996, J TRAUMA STRESS, V9, P595; FLAHERTY JA, 1988, J NERV MENT DIS, V176, P257; Green BL, 2000, J TRAUMA STRESS, V13, P271, DOI 10.1023/A:1007758711939; GREEN BL, 1990, J APPL SOC PSYCHOL, V20, P1632, DOI 10.1111/j.1559-1816.1990.tb01498.x; HELZER JE, 1987, NEW ENGL J MED, V317, P1630, DOI 10.1056/NEJM198712243172604; HOUGEN HP, 1988, FORENSIC SCI INT, V39, P5, DOI 10.1016/0379-0738(88)90113-2; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; KILLPATRICK DG, 1993, POSTTRAUMATIC STRESS, P113; Kilpatrick DG, 1998, ADVERSITY, STRESS AND PSYCHOPATHOLOGY, P161; McCauley J, 1997, JAMA-J AM MED ASSOC, V277, P1362, DOI 10.1001/jama.277.17.1362; McFarlane Alexander C., 1996, P129; Mollica RF, 1998, J NERV MENT DIS, V186, P543, DOI 10.1097/00005053-199809000-00005; Mollica RF, 1998, BRIT J PSYCHIAT, V173, P482, DOI 10.1192/bjp.173.6.482; Mollica RF, 1999, JAMA-J AM MED ASSOC, V282, P433, DOI 10.1001/jama.282.5.433; MOLLICA RF, 1990, AM J PSYCHIAT, V147, P83; MOLLICA RF, 1993, JAMA-J AM MED ASSOC, V270, P581, DOI 10.1001/jama.270.5.581; NIXON A, 1990, SWEDISH SAVE CHILDRE, P21; NORUSIS MJ, 1999, SPSS WINDOWS BASE SY; Orley J., 1994, AMIDST PERIL PAIN ME, P193; *PAL HUM RIGHTS IN, 1991, 9 PHRIC; Peters L, 1996, INT J METHOD PSYCH, V6, P167, DOI 10.1002/(SICI)1234-988X(199610)6:3<167::AID-MPR159>3.3.CO;2-Z; QOUTA S, IN PRESS WAR VIOLENC; RESNICK HS, 1993, J CONSULT CLIN PSYCH, V61, P984, DOI 10.1037/0022-006X.61.6.984; ROGLER LH, 1992, J NERV MENT DIS, V180, P215, DOI 10.1097/00005053-199204000-00001; Salama P, 2000, JAMA-J AM MED ASSOC, V284, P578, DOI 10.1001/jama.284.5.578; SIDHOUM MAA, IN PRESS WAR VIOLENC; Silove D, 1997, BRIT J PSYCHIAT, V170, P351, DOI 10.1192/bjp.170.4.351; SMITH MC, 1992, J NERV MENT DIS, V180, P225, DOI 10.1097/00005053-199204000-00003; SOLOMON Z, 1995, PSYCHOL MED, V25, P1289, DOI 10.1017/S0033291700033250; SOMASUNDARAM DJ, 1994, BRIT J PSYCHIAT, V165, P524, DOI 10.1192/bjp.165.4.524; Steel Z, 1999, J TRAUMA STRESS, V12, P421, DOI 10.1023/A:1024710902534; VANDEPUT WAC, IN PRESS WAR VIOLENC; VANOMMEREM M, IN PRESS ARCH GEN PS; WESTERMEYER J, 1989, J TRAUMA STRESS, V2, P515; WILLIAMS CL, 1991, AM PSYCHOL, V46, P632, DOI 10.1037/0003-066X.46.6.632; WILSON JP, 1985, TRAUMA ITS WAKE; World Health Organization, 1992, PSYCH CONS DIS PREV; YEHUDA R, 1995, AM J PSYCHIAT, V152, P1705; 1996, J TRAUMA STRESS, V9, P25	54	435	442	0	68	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2001	286	5					555	562		10.1001/jama.286.5.555	http://dx.doi.org/10.1001/jama.286.5.555			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	458HE	11476657				2022-12-28	WOS:000170188300018
J	Brown, JH; Whitham, TG; Ernest, SKM; Gehring, CA				Brown, JH; Whitham, TG; Ernest, SKM; Gehring, CA			Complex species interactions and the dynamics of ecological systems: Long-term experiments	SCIENCE			English	Review							WESTERN SOUTH-AMERICA; PINYON PINE; ENVIRONMENTAL-STRESS; COMMUNITY STRUCTURE; DESERT RODENT; INTERSPECIFIC COMPETITION; DIPODOMYS-SPECTABILIS; FIELD EXPERIMENTS; BIODIVERSITY; HERBIVORY	Studies that combine experimental manipulations with long-term data collection reveal elaborate interactions among species that affect the structure and dynamics of ecosystems. Research programs in U.S. desert shrubland and pinyon-juniper woodland have shown that (i) complex dynamics of species populations reflect interactions with other organisms and fluctuating climate; (ii) genotype x environment interactions affect responses of species to environmental change; (Iii) herbivore-resistance traits of dominant plant species and impacts of "keystone" animal species cascade through the system to affect many organisms and ecosystem processes; and (iv) some environmental perturbations can cause wholesale reorganization of ecosystems because they exceed the ecological tolerances of dominant or keystone species, whereas other changes may be buffered because of the compensatory dynamics of complementary species.	Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; No Arizona Univ, Merriam Powell Ctr Environm Res, Flagstaff, AZ 86001 USA; No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86001 USA; Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA	University of New Mexico; Northern Arizona University; Northern Arizona University; Texas Tech University System; Texas Tech University	Brown, JH (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	jhbrown@unm.edu	Ernest, S.K. Morgan/O-2532-2015; Ernest, Morgan/A-4355-2008	Ernest, S.K. Morgan/0000-0002-6026-8530; Ernest, Morgan/0000-0002-6026-8530				ABRAMS PA, 1983, AM NAT, V121, P887, DOI 10.1086/284111; ABUZINADAH RA, 1986, NEW PHYTOL, V103, P481, DOI 10.1111/j.1469-8137.1986.tb02886.x; Allen CD, 1998, P NATL ACAD SCI USA, V95, P14839, DOI 10.1073/pnas.95.25.14839; BEATLEY JC, 1969, ECOLOGY, V50, P721, DOI 10.2307/1936267; BETANCOURT JL, 1993, USDA ROCKY, V236, P42; BILLICK L, 1984, ECOLOGY, V65, P1529; Brown J.H., 1975, P315; Brown JH, 1997, P NATL ACAD SCI USA, V94, P9729, DOI 10.1073/pnas.94.18.9729; Brown JH, 2001, OECOLOGIA, V126, P321, DOI 10.1007/s004420000536; BROWN JH, 1998, ISSUES PERSPECTIVES, P71; Carpenter S.D., 1988, COMPLEX INTERACTIONS; CHAPMAN SC, UNPUB; CHRISTENSEN KM, 1993, ECOLOGY, V74, P2270, DOI 10.2307/1939580; CHRISTENSEN KM, 1991, OECOLOGIA, V86, P402, DOI 10.1007/BF00317608; COBB NS, 1993, OECOLOGIA, V94, P496, DOI 10.1007/BF00566964; Cobb NS, 1997, OECOLOGIA, V109, P389, DOI 10.1007/s004420050098; Colwell R.K., 1984, P387; CONNELL JH, 1983, AM NAT, V122, P661, DOI 10.1086/284165; DELVECCHIO TA, 1993, ECOLOGY, V74, P2297, DOI 10.2307/1939582; Dungey HS, 2000, EVOLUTION, V54, P1938, DOI 10.1111/j.0014-3820.2000.tb01238.x; Ernest SKM, 2001, SCIENCE, V292, P101; Ernest SKM, 2000, OIKOS, V88, P470, DOI 10.1034/j.1600-0706.2000.880302.x; ERNEST SKM, IN PRESS ECOLOGY; FRENCH NR, 1974, ECOL MONOGR, V44, P45, DOI 10.2307/1942318; GARBAYE J, 1994, NEW PHYTOL, V128, P197, DOI 10.1111/j.1469-8137.1994.tb04003.x; Gause G. F., 1934, STRUGGLE EXISTENCE; GEHRING CA, 1995, ECOLOGY, V76, P2118, DOI 10.2307/1941686; GEHRING CA, 1994, AM J BOT, V81, P1509, DOI 10.2307/2445327; Gehring CA, 1997, AM NAT, V149, P824, DOI 10.1086/286026; Gehring CA, 1998, ECOLOGY, V79, P1562, DOI 10.1890/0012-9658(1998)079[1562:EFCSOP]2.0.CO;2; GEHRING CA, 1991, NATURE, V353, P556, DOI 10.1038/353556a0; GEHRING CA, 1992, OECOLOGIA, V89, P298, DOI 10.1007/BF00317231; GEHRING CA, UNPUB; Guo QF, 1996, OECOLOGIA, V106, P247, DOI 10.1007/BF00328605; HAWKINS LK, 1992, J ARID ENVIRON, V23, P199, DOI 10.1016/S0140-1963(18)30531-7; HESKE EJ, 1994, ECOLOGY, V75, P438, DOI 10.2307/1939547; Jaksic FM, 1997, OIKOS, V78, P341, DOI 10.2307/3546302; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Jones C. G., 1995, LINKING SPECIES ECOS; Krutch J. W., 1974, PARADOX LAVA FLOW; Kuske CR, 1999, SYST APPL MICROBIOL, V22, P300, DOI 10.1016/S0723-2020(99)80077-0; KUSKE CR, UNPUB; Lima M, 1999, AM NAT, V153, P476, DOI 10.1086/303191; LOTKA AJ, 1925, PRINCIPLES PHYSICAL; MESERVE PL, 1995, J MAMMAL, V76, P580, DOI 10.2307/1382367; Meserve PL, 1999, OIKOS, V85, P364, DOI 10.2307/3546502; MOPPER S, 1991, EVOLUTION, V45, P989, DOI [10.1111/j.1558-5646.1991.tb04365.x, 10.2307/2409704]; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Ogle K, 2000, ECOLOGY, V81, P3237, DOI 10.1890/0012-9658(2000)081[3237:TRVIPP]2.0.CO;2; PARKE JL, 1983, NEW PHYTOL, V95, P83, DOI 10.1111/j.1469-8137.1983.tb03471.x; Pierson LS, 1996, FEMS MICROBIOL LETT, V136, P101, DOI 10.1111/j.1574-6968.1996.tb08034.x; REICHMAN OJ, 1985, J MAMMAL, V66, P643, DOI 10.2307/1380790; ROSENZWEIG ML, 1973, ECOLOGY, V54, P111, DOI 10.2307/1934379; Roughgarden J, 1986, COMMUNITY ECOL, P333; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; Smith S., 1997, MYCORRHIZAL SYMBIOSI, V2nd Edn; Strong D.R., 1984, ECOLOGICAL COMMUNITI; VALONE TJ, 1995, SCIENCE, V267, P880, DOI 10.1126/science.7846530; VALONE TJ, 1995, J MAMMAL, V76, P428, DOI 10.2307/1382353; VALONE TJ, 1995, LONG TERM STUDIES VE, P555; VANDERWALL SB, 1977, ECOL MONOGR, V47, P89, DOI 10.2307/1942225; VanderWall SB, 1997, J MAMMAL, V78, P181, DOI 10.2307/1382651; VANDERWALL SB, 1981, Z TIERPSYCHOL, V56, P217; WALKER BH, 1992, CONSERV BIOL, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; Wardle DA, 1997, OIKOS, V79, P247, DOI 10.2307/3546010; WHITFORD WG, 1976, J MAMMAL, V57, P351, DOI 10.2307/1379694; WHITHAM TG, 1985, SCIENCE, V228, P1089, DOI 10.1126/science.228.4703.1089; Whitham TG, 1999, ECOLOGY, V80, P416; WIENS JA, 1977, AM SCI, V65, P590; YODZIS P, 1988, ECOLOGY, V69, P508, DOI 10.2307/1940449	71	275	293	8	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					643	650		10.1126/science.293.5530.643	http://dx.doi.org/10.1126/science.293.5530.643			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474100				2022-12-28	WOS:000170204600042
J	Giovannetti, V; Lloyd, S; Maccone, L				Giovannetti, V; Lloyd, S; Maccone, L			Quantum-enhanced positioning and clock synchronization	NATURE			English	Article							INTERFEROMETERS; ENTANGLEMENT; PROPAGATION; STATES; LIMIT; NOISE	A ide variety of positioning and ranging procedures are based on repeatedly sending electromagnetic pulses through space and measuring their time of arrival. The accuracy of such procedures is classically limited by the available power and bandwidth. Quantum entanglement and squeezing have been exploited in the context of interferometry(1-5), frequency measurements(6), lithography(7) and algorithms(8). Here we report that quantum entanglement and squeezing can also be employed to overcome the classical limits in procedures such as positioning systems, clock synchronization and ranging. Our use of frequency-entangled pulses to construct quantum versions of these protocols results in enhanced accuracy compared with their classical analogues. We describe in detail the problem of establishing a position with respect to a fixed array of reference points.	MIT, Dept Mech Engn, Cambridge, MA 02139 USA; MIT, Elect Res Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Lloyd, S (corresponding author), MIT, Dept Mech Engn, MIT3-160, Cambridge, MA 02139 USA.		GIOVANNETTI, Vittorio/AAW-9290-2021	GIOVANNETTI, VITTORIO/0000-0002-7636-9002; Maccone, Lorenzo/0000-0002-6729-5312				Bollinger JJ, 1996, PHYS REV A, V54, pR4649, DOI 10.1103/PhysRevA.54.R4649; BONDURANT RS, 1984, PHYS REV D, V30, P2548, DOI 10.1103/PhysRevD.30.2548; Boto AN, 2000, PHYS REV LETT, V85, P2733, DOI 10.1103/PhysRevLett.85.2733; CAVES CM, 1981, PHYS REV D, V23, P1693, DOI 10.1103/PhysRevD.23.1693; Chuang IL, 2000, PHYS REV LETT, V85, P2006, DOI 10.1103/PhysRevLett.85.2006; Dowling JP, 1998, PHYS REV A, V57, P4736, DOI 10.1103/PhysRevA.57.4736; Fonseca EJS, 1999, PHYS REV LETT, V82, P2868, DOI 10.1103/PhysRevLett.82.2868; Grover LK, 1997, PHYS REV LETT, V79, P325, DOI 10.1103/PhysRevLett.79.325; Hagelstein PL, 1996, PHYS REV A, V54, P2426, DOI 10.1103/PhysRevA.54.2426; HOLLAND MJ, 1993, PHYS REV LETT, V71, P1355, DOI 10.1103/PhysRevLett.71.1355; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; JACOBSON J, 1995, PHYS REV LETT, V74, P4853; Jozsa R, 2000, PHYS REV LETT, V85, P2010, DOI 10.1103/PhysRevLett.85.2010; Mandel L, 1995, OPTICAL COHERENCE QU; Margolus N, 1998, PHYSICA D, V120, P188, DOI 10.1016/S0167-2789(98)00054-2; Peres A., 1995, QUANTUM THEORY CONCE; STEINBERG AM, 1992, PHYS REV LETT, V68, P2421, DOI 10.1103/PhysRevLett.68.2421; YURKE B, 1986, PHYS REV A, V33, P4033, DOI 10.1103/PhysRevA.33.4033	18	323	356	2	80	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					417	419		10.1038/35086525	http://dx.doi.org/10.1038/35086525			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473311	Green Submitted			2022-12-28	WOS:000170068200041
J	Woodruff, PG; Fahy, JV				Woodruff, PG; Fahy, JV			Asthma: Prevalence, pathogenesis, and prospects for novel therapies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTI-IGE ANTIBODY; HOUSE-DUST MITE; CHILDHOOD ASTHMA; IMMUNOTHERAPY; PREGNANCY; MORTALITY; ALLERGENS; EXPOSURE; ATOPY; PHASE		Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Fahy, JV (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, 505 Parnassus Ave,Box 0111, San Francisco, CA 94143 USA.	jfahy@itsa.ucsf.edu			NHLBI NIH HHS [HL-07185, R01 HL-61662, P01 HL-56385] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056385, R01HL061662] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alm JS, 1997, LANCET, V350, P400, DOI 10.1016/S0140-6736(97)02207-1; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Borish LC, 1999, AM J RESP CRIT CARE, V160, P1816, DOI 10.1164/ajrccm.160.6.9808146; Boulet LP, 1997, AM J RESP CRIT CARE, V155, P1835, DOI 10.1164/ajrccm.155.6.9196083; Boushey HA, 2000, LANCET, V356, P2114, DOI 10.1016/S0140-6736(00)03486-3; BOUSHEY HA, 2000, TXB RESP MED, P1247; Bryan SA, 2000, LANCET, V356, P2149, DOI 10.1016/S0140-6736(00)03497-8; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Campbell D, 2000, CLIN IMMUNOL, V97, P193, DOI 10.1006/clim.2000.4926; Creticos PS, 1996, NEW ENGL J MED, V334, P501, DOI 10.1056/NEJM199602223340804; Custovic A, 2000, J ALLERGY CLIN IMMUN, V105, P252, DOI 10.1016/S0091-6749(00)90073-3; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Fahy JV, 1997, AM J RESP CRIT CARE, V155, P1828, DOI 10.1164/ajrccm.155.6.9196082; Grant EN, 1999, J ALLERGY CLIN IMMUN, V104, pS1, DOI 10.1016/S0091-6749(99)70268-X; Homa DM, 2000, AM J RESP CRIT CARE, V161, P504, DOI 10.1164/ajrccm.161.2.9906025; Kim TS, 1997, J IMMUNOL, V158, P4137; Lau S, 2000, LANCET, V356, P1392, DOI 10.1016/S0140-6736(00)02842-7; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Litonjua AA, 2001, J ALLERGY CLIN IMMUN, V107, P41, DOI 10.1067/mai.2001.111143; Los H, 1999, EUR RESPIR J, V14, P1210, DOI 10.1183/09031936.99.14512109; Maecker HT, 2001, J IMMUNOL, V166, P959, DOI 10.4049/jimmunol.166.2.959; Martinez FD, 2001, RESPIR RES, V2, P129, DOI 10.1186/rr48; Milgrom H, 1999, NEW ENGL J MED, V341, P1966, DOI 10.1056/NEJM199912233412603; PEAT JK, 1993, CLIN EXP ALLERGY, V23, P812, DOI 10.1111/j.1365-2222.1993.tb00258.x; Platts-Mills T, 2001, LANCET, V357, P752, DOI 10.1016/S0140-6736(00)04168-4; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; Ray A, 1999, J CLIN INVEST, V104, P985, DOI 10.1172/JCI8204; Ronmark E, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e37; Sly RM, 2000, ANN ALLERG ASTHMA IM, V85, P121, DOI 10.1016/S1081-1206(10)62451-9; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Tighe H, 2000, J ALLERGY CLIN IMMUN, V106, P124, DOI 10.1067/mai.2000.107927; von Mutius E, 2000, CLIN EXP ALLERGY, V30, P1230; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Wills-Karp M, 2000, IMMUNOPHARMACOLOGY, V48, P263, DOI 10.1016/S0162-3109(00)00223-X	37	36	44	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2001	286	4					395	398		10.1001/jama.286.4.395	http://dx.doi.org/10.1001/jama.286.4.395			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456DZ	11466111				2022-12-28	WOS:000170069000001
J	Aylin, P; Alves, B; Best, N; Cook, A; Elliott, P; Evans, SJW; Lawrence, AE; Murray, GD; Pollock, J; Spiegelhalter, D				Aylin, P; Alves, B; Best, N; Cook, A; Elliott, P; Evans, SJW; Lawrence, AE; Murray, GD; Pollock, J; Spiegelhalter, D			Comparison of UK paediatric cardiac surgical performance by analysis of routinely collected data 1984-96: was Bristol an outlier?	LANCET			English	Article								Background Reports of high mortality after paediatric cardiac surgery at the Bristol Royal Infirmary, UK, led to the establishment of an independent public inquiry. A hey question was whether or not the mortality statistics in Bristol were unusual compared with other specialist centres. To answer this question, we did a retrospective analysis of mortality in the UK using two datasets. Methods Data from the UK Cardiac Surgical Register (CSR; January, 1984, to March, 1996) and Hospital Episode Statistics (HES; April, 1991, to December, 1995) were obtained for all 12 major centres in which paediatric cardiac surgery is done in the UK. The main outcome measure was mortality within 30 days of a cardiac surgical procedure. We estimated excess deaths in Bristol using a random-effects model derived from the remaining 11 centres. Additionally, a sensitivity analysis was done and case-mix examined. Findings For children younger than 1 year, in open operations, the mortality rate in Bristol was around double that of the other centres during 1991-95: within the CSR, there were 19.0 excess deaths (95% interval 2-32) among 43 deaths; and in HES, there were 24.1 excess deaths (12-34) among 41 deaths recorded. There was no strong evidence for excess mortality in Bristol far closed operations or for open operations in children alder than 1 year. Interpretation Our results suggest that Bristol was an outlier, and we do not believe that statistical variation, systematic bias in data collection, case-mix, or data quality can explain a divergence in performance of this size.	Imperial Coll Sch Med, Dept Epidemiol & Publ Hlth, Div Primary Care & Populat Hlth Sci, London W2 1PG, England; Med Control Agcy, London, England; Univ Edinburgh, Sch Med, Dept Community Hlth Sci, Edinburgh, Midlothian, Scotland; Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England	Imperial College London; University of Edinburgh; MRC Biostatistics Unit; University of Cambridge	Aylin, P (corresponding author), Imperial Coll Sch Med, Dept Epidemiol & Publ Hlth, Div Primary Care & Populat Hlth Sci, St Marys Campus,Norfolk Pl, London W2 1PG, England.		Aylin, Paul/A-1073-2014	Evans, Stephen/0000-0002-1474-2596; Aylin, Paul/0000-0003-4589-1743; Murray, Gordon/0000-0001-9866-4734				Bristol Royal Infirmary, 2001, INQ MAN CAR CHILDR R; Carstairs V., 1991, DEPRIVATION HLTH SCO; *DEP HLTH, 2001, QUAL PERF NHS PERFOR; EVANS SJW, 2001, REPORT LOCAL DATA RE; Horton R, 2001, LANCET, V357, P82, DOI 10.1016/S0140-6736(00)03532-7; HUNTER S, 2001, REV CLIN OUTCOMES CH; Marshall EG, 1998, BRIT MED J, V316, P1701, DOI 10.1136/bmj.316.7146.1701; Mohammed MA, 2001, LANCET, V357, P463, DOI 10.1016/S0140-6736(00)04019-8; MURRAY G, 2001, LINKAGE HOSP EPISODE; *NHS EX, 2001, NHS PERF ASS FRAM; Ramsay S, 2000, LANCET, V356, P403, DOI 10.1016/S0140-6736(00)02538-1; *SECR STAT HLTH, 1997, CM3807; *SEL COMM SCI TECH, 2001, HUM GEN DAT CHALL OP; SPIEGELHALTER DJ, 2001, OVERVIEW STAT EVIDEN; 2001, INQUIRYS APPROACH MA; [No title captured]; 2001, BRIT ROYAL INFIRMARY	17	86	87	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 21	2001	358	9277					181	187		10.1016/S0140-6736(01)05404-6	http://dx.doi.org/10.1016/S0140-6736(01)05404-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454HL	11476833				2022-12-28	WOS:000169967100009
J	Knight, J				Knight, J			Physical sciences lose ground as US shifts towards biology	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					259	259		10.1038/35085706	http://dx.doi.org/10.1038/35085706			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460121	Bronze			2022-12-28	WOS:000169918200008
J	Weijnen, CF; Numans, ME; de Wit, NJ; Smout, AJPM; Moons, KGM; Verheij, TJM; Hoes, AW				Weijnen, CF; Numans, ME; de Wit, NJ; Smout, AJPM; Moons, KGM; Verheij, TJM; Hoes, AW			Testing for Helicobacter pylori in dyspeptic patients suspected of peptic ulcer disease in primary care: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE; TREAT STRATEGY; MANAGEMENT; SYMPTOMS; ENDOSCOPY; DIAGNOSIS; MODELS; TRIAL	Objectives To develop an easily applicable diagnostic scoring method to determine the presence of peptic ulcers in dyspeptic patients in a primary care setting; to evaluate whether Helicobacter pylori testing adds value to history taking. Design Cross sectional study Setting General practitioners' offices in the Utrecht area of the Netherlands. Participants 565 patients consulting a general practitioner about dyspeptic symptoms of at least two weeks' duration. Main outcome measures The presence or absence of peptic ulcer: independent predictors of the presence of peptic ulcer as obtained from history taking and the added value of H pylori testing were quantified by using multivariate logistic regression analyses. Results A history of peptic ulcer, pain on an empty stomach, and smoking were strong and independent diagnostic determinants of peptic ulcer disease, with odds ratios of 5.5 (95'%, confidence interval 2.6 to 11.8), 2.8 (1.0 to 4.0), and 2.0 (1.4 to 6.0) respectively: The area under the receiver operating characteristic curve (ROC area) of these determinants together was 0.71. Adding the H pylori test increased the ROC area only to 0.75. However, in a group of patients at high risk, identified by means of a simple scoring rule based on history taking, the predictive value for the presence of peptic ulcer increased from 16% to 26% after a positive H pylori test. Conclusions In the total group of dyspeptic patients in primary care, H pylori testing has no value in addition to history taking for diagnosing peptic ulcer disease. In a subgroup of patients at high risk of having peptic ulcer disease, however, it might be useful to rest for and treat H pylori infections.	Univ Utrecht, Med Ctr, Julius Ctr Gen Practice & Patient Oriented Res, NL-3584 CG Utrecht, Netherlands; Univ Utrecht, Med Ctr, Dept Gastroenterol, NL-3584 CG Utrecht, Netherlands	Utrecht University; Utrecht University	Weijnen, CF (corresponding author), Univ Utrecht, Med Ctr, Julius Ctr Gen Practice & Patient Oriented Res, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.	c.f.weijnen@med.uu.nl			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Asante MA, 1997, INT J CLIN PRACT, V51, P497; Bytzer P, 1997, SCAND J GASTROENTERO, V32, P118, DOI 10.3109/00365529709000181; Ciociola AA, 1999, AM J GASTROENTEROL, V94, P1834, DOI 10.1111/j.1572-0241.1999.01214.x; CREAN GP, 1994, GUT, V35, P191, DOI 10.1136/gut.35.2.191; de Boer WA, 1999, SCAND J GASTROENTERO, V34, P23, DOI 10.1080/003655299750025507; Fraser AG, 1996, NEW ZEAL MED J, V109, P95; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hansen JM, 1998, SCAND J GASTROENTERO, V33, P799; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HEIKKINEN M, 1995, SCAND J GASTROENTERO, V30, P519, DOI 10.3109/00365529509089783; Hobbs FDR, 1996, FAM PRACT, V13, P225, DOI 10.1093/fampra/13.3.225; Hosmer DW, 1989, APPL LOGISTIC REGRES, P140; JOHANNESSEN T, 1990, SCAND J GASTROENTERO, V25, P689, DOI 10.3109/00365529008997594; JONES R, 1989, BRIT MED J, V298, P30, DOI 10.1136/bmj.298.6665.30; Jones R, 1997, ALIMENT PHARM THERAP, V11, P101, DOI 10.1046/j.1365-2036.1997.125296000.x; Jones R, 1999, INT J CLIN PRACT, V53, P413; Joosen EAM, 2000, EUR J GASTROEN HEPAT, V12, P319, DOI 10.1097/00042737-200012030-00010; Laheij RJF, 1997, J CLIN GASTROENTEROL, V25, P563, DOI 10.1097/00004836-199712000-00002; Lassen AT, 2000, LANCET, V356, P455, DOI 10.1016/S0140-6736(00)02553-8; Moayyedi P, 1999, EUR J GASTROEN HEPAT, V11, P1245, DOI 10.1097/00042737-199911000-00010; Moayyedi P, 2000, BRIT MED J, V321, P659, DOI 10.1136/bmj.321.7262.659; MURIS JWM, 1994, J FAM PRACTICE, V38, P139; NUMANS ME, 1994, FAM PRACT, V11, P382, DOI 10.1093/fampra/11.4.382; NUMANS ME, 1996, HUISARTS WET, V39, P565; Quartero AO, 2000, BRIT J GEN PRACT, V50, P13; SPIEGELHALTER DJ, 1987, SCAND J GASTROENTERO, V22, P152, DOI 10.3109/00365528709090984; Stanghellini V, 1998, BRIT MED J, V316, P1388; Weinstein MC, 1980, CLIN DECISION ANAL	29	32	33	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2001	323	7304					71	75		10.1136/bmj.323.7304.71	http://dx.doi.org/10.1136/bmj.323.7304.71			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454GD	11451780	Green Published, Bronze			2022-12-28	WOS:000169964100014
J	Metz, JG; Roessler, P; Facciotti, D; Levering, C; Dittrich, F; Lassner, M; Valentine, R; Lardizabal, K; Domergue, F; Yamada, A; Yazawa, K; Knauf, V; Browse, J				Metz, JG; Roessler, P; Facciotti, D; Levering, C; Dittrich, F; Lassner, M; Valentine, R; Lardizabal, K; Domergue, F; Yamada, A; Yazawa, K; Knauf, V; Browse, J			Production of polyunsaturated fatty acids by polyketide synthases in both prokaryotes and eukaryotes	SCIENCE			English	Article							EICOSAPENTAENOIC ACID; ESCHERICHIA-COLI; BIOSYNTHESIS; DESATURATION; ELONGATION; BACTERIUM; MICROORGANISMS; ARABIDOPSIS; INITIATION; ENZYME	Polyunsaturated fatty acids (PUFAs) are essential membrane components in higher eukaryotes and are the precursors of many lipid-derived signaling molecules. Here, pathways for PUFA synthesis are described that do not require desaturation and elongation of saturated fatty acids. These pathways are catalyzed by polyketide synthases (PKSs) that are distinct from previously recognized PKSs in both structure and mechanism. Generation of cis double bonds probably involves position-specific isomerases; such enzymes might be useful in the production of new families of antibiotics. it is Likely that PUFA synthesis in cold marine ecosystems is accomplished in part by these PKS enzymes.	Omega Tech, Boulder, CO 80301 USA; Monsanto Co, Davis, CA 95616 USA; Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; Sagami Chem Res Ctr, Kanagawa 229, Japan	Monsanto; Washington State University	Metz, JG (corresponding author), Omega Tech, 4909 Nautilus Court N, Boulder, CO 80301 USA.			Domergue, Frederic/0000-0002-0183-7000; Browse, John/0000-0002-2554-2821				Allen EE, 1999, APPL ENVIRON MICROB, V65, P1710; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BARCLAY WR, 1994, J APPL PHYCOL, V6, P123, DOI 10.1007/BF02186066; Bentley R, 1999, ANNU REV MICROBIOL, V53, P411, DOI 10.1146/annurev.micro.53.1.411; Bisang C, 1999, NATURE, V401, P502, DOI 10.1038/46829; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; DELONG EF, 1986, APPL ENVIRON MICROB, V51, P730, DOI 10.1128/AEM.51.4.730-737.1986; GELLERMAN JL, 1979, BIOCHIM BIOPHYS ACTA, V573, P23, DOI 10.1016/0005-2760(79)90169-3; Heath RJ, 2000, NATURE, V406, P145, DOI 10.1038/35018162; Heath RJ, 1996, J BIOL CHEM, V271, P27795, DOI 10.1074/jbc.271.44.27795; Heller A, 1998, DRUGS, V55, P487, DOI 10.2165/00003495-199855040-00001; HOPWOOD DA, 1990, ANNU REV GENET, V24, P37, DOI 10.1146/annurev.ge.24.120190.000345; Keating TA, 1999, CURR OPIN CHEM BIOL, V3, P598, DOI 10.1016/S1367-5931(99)00015-0; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; McConn M, 1998, PLANT J, V15, P521, DOI 10.1046/j.1365-313X.1998.00229.x; MIQUEL M, 1992, J BIOL CHEM, V267, P1502; Muller-Navarra DC, 2000, NATURE, V403, P74, DOI 10.1038/47469; Nichols D, 1999, CURR OPIN BIOTECH, V10, P240, DOI 10.1016/S0958-1669(99)80042-1; Parker-Barnes JM, 2000, P NATL ACAD SCI USA, V97, P8284, DOI 10.1073/pnas.97.15.8284; Pearson W R, 2000, Methods Mol Biol, V132, P185; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; Sprecher H, 1999, Curr Opin Clin Nutr Metab Care, V2, P135, DOI 10.1097/00075197-199903000-00007; Tanaka M, 1999, BIOTECHNOL LETT, V21, P939, DOI 10.1023/A:1005601606929; Watanabe K, 1997, J BIOCHEM-TOKYO, V122, P467; Yazawa K, 1996, LIPIDS, V31, pS297, DOI 10.1007/BF02637095	26	517	610	8	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					290	293		10.1126/science.1059593	http://dx.doi.org/10.1126/science.1059593			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452122				2022-12-28	WOS:000169875200056
J	Jakosky, BM; Phillips, RJ				Jakosky, BM; Phillips, RJ			Mars' volatile and climate history	NATURE			English	Review							MARTIAN ATMOSPHERIC ARGON; ORBITER LASER ALTIMETER; CARBON-DIOXIDE CLOUDS; CHAOTIC OBLIQUITY; WATER RESERVOIRS; NORTHERN PLAINS; IMPACT EROSION; EVOLUTION; METEORITE; SURFACE	There is substantial evidence that the martian volatile inventory and climate have changed markedly throughout the planet's history. Clues come from areas as disparate as the history and properties of the deep interior, the composition of the crust and regolith, the morphology of the surface, composition of the present-day atmosphere, and the nature of the interactions between the upper atmosphere and the solar wind. We piece together the relevant observations into a coherent view of the evolution of the martian climate, focusing in particular on the observations that provide the strongest constraints.	Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA; Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; Washington Univ, McDonnell Ctr Space Sci, St Louis, MO 63130 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Washington University (WUSTL); Washington University (WUSTL)	Jakosky, BM (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA.	bruce.jakosky@lasp.colorado.edu; phillips@wustite.wustl.edu						Acuna MH, 1999, SCIENCE, V284, P790, DOI 10.1126/science.284.5415.790; Aharonson O, 1998, GEOPHYS RES LETT, V25, P4413, DOI 10.1029/1998GL900057; ANDERSON RC, IN PRESS J GEOPHYS R; Ayres TR, 1997, J GEOPHYS RES-PLANET, V102, P1641, DOI 10.1029/96JE03306; Baker V.R., 1982, THE CHANNELS OF MARS, DOI [10.1029/EO063i045p00862, DOI 10.1029/EO063I045P00862]; BAKER VR, 1986, J GEOPHYS RES-SOLID, V91, P3561, DOI 10.1029/JB091iB03p03561; Bjoraker G. L., 1989, B AM ASTRON SOC, V21, P991; Brain DA, 1998, J GEOPHYS RES-PLANET, V103, P22689, DOI 10.1029/98JE02074; BRASS GW, 1980, ICARUS, V42, P20, DOI 10.1016/0019-1035(80)90237-7; Cabrol NA, 1999, ICARUS, V142, P160, DOI 10.1006/icar.1999.6191; Carr M.H, 1996, WATER MARS; CARR MH, 1986, ICARUS, V68, P187, DOI 10.1016/0019-1035(86)90019-9; CARR MH, 1981, ICARUS, V48, P91, DOI 10.1016/0019-1035(81)90156-1; Carr MH, 1997, J GEOPHYS RES-PLANET, V102, P9145, DOI 10.1029/97JE00113; CARR MH, 1979, J GEOPHYS RES, V84, P2995, DOI 10.1029/JB084iB06p02995; Carr MH, 2000, ICARUS, V146, P366, DOI 10.1006/icar.2000.6428; CHAPMAN CR, 1977, ANNU REV EARTH PL SC, V5, P515, DOI 10.1146/annurev.ea.05.050177.002503; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; CHRISTENSEN PR, IN PRESS J GEOPHYS R; Chyba C.F., 1994, HAZARDS DUE COMETS A, P9; Connerney JEP, 1999, SCIENCE, V284, P794, DOI 10.1126/science.284.5415.794; Craddock RA, 1997, J GEOPHYS RES-PLANET, V102, P13321, DOI 10.1029/97JE01084; CRADDOCK RA, 1993, J GEOPHYS RES-PLANET, V98, P3453, DOI 10.1029/92JE02508; DONAHUE TM, 1995, NATURE, V374, P432, DOI 10.1038/374432a0; Forget F, 1997, SCIENCE, V278, P1273, DOI 10.1126/science.278.5341.1273; FREY HV, 2001, LUN PLAN SCI C, V32; GOLDSPIEL JM, 1991, ICARUS, V89, P392, DOI 10.1016/0019-1035(91)90186-W; Golombek MP, 2000, J GEOPHYS RES-PLANET, V105, P1841, DOI 10.1029/1999JE001043; GOODING JL, 1988, GEOCHIM COSMOCHIM AC, V52, P909, DOI 10.1016/0016-7037(88)90361-4; GREELEY R, IN PRESS MARS EXPLOR; Haberle RM, 1998, J GEOPHYS RES-PLANET, V103, P28467, DOI 10.1029/98JE01396; HARRISON KP, LUN PLAN SCI C, V32; Hartmann W.K., 1981, BASALTIC VOLCANISM T, P1049; Hartmann WK, 2000, J GEOPHYS RES-PLANET, V105, P15011, DOI 10.1029/1999JE001189; HARTMANN WK, IN PRESS SPACE SCI R; Head JW, 1999, SCIENCE, V286, P2134, DOI 10.1126/science.286.5447.2134; Head JW, 1998, GEOPHYS RES LETT, V25, P4401, DOI 10.1029/1998GL900116; HEAD JW, 2001, LUN PLAN SCI C, V32; Hiesinger H, 2000, J GEOPHYS RES-PLANET, V105, P11999, DOI 10.1029/1999JE001193; Hoffman N, 2000, ICARUS, V146, P326, DOI 10.1006/icar.2000.6398; Hutchins KS, 1996, J GEOPHYS RES-PLANET, V101, P14933, DOI 10.1029/96JE00860; Hutchins KS, 1997, J GEOPHYS RES-PLANET, V102, P9183, DOI 10.1029/96JE03838; Hynek BM, 2001, GEOLOGY, V29, P407, DOI 10.1130/0091-7613(2001)029<0407:EFEDOT>2.0.CO;2; Jakosky B. M., 1992, MARS, P969; Jakosky BM, 1997, REV GEOPHYS, V35, P1, DOI 10.1029/96RG02903; JAKOSKY BM, 1994, ICARUS, V111, P271, DOI 10.1006/icar.1994.1145; JAKOSKY BM, 1995, J GEOPHYS RES-PLANET, V100, P1579, DOI 10.1029/94JE02801; JAKOSKY BM, AM GEOPH UN SPRING M; JAKOSKY BM, 2000, WATER MANY MYSTERIES; Kasting J.F., 1991, SUN TIME, P447; KASTING JF, 1991, ICARUS, V94, P1, DOI 10.1016/0019-1035(91)90137-I; Kieffer H. H., 1992, MARS, P1180; KOMAR PD, 1980, ICARUS, V42, P317, DOI 10.1016/0019-1035(80)90097-4; Krasnopolsky V, 2000, ICARUS, V148, P597, DOI 10.1006/icar.2000.6534; Krasnopolsky VA, 1997, J GEOPHYS RES-PLANET, V102, P6525, DOI 10.1029/96JE03766; Lane MD, 2000, J GEOPHYS RES-PLANET, V105, P17617, DOI 10.1029/1999JE001197; Leshin LA, 2000, GEOPHYS RES LETT, V27, P2017, DOI 10.1029/1999GL008455; LIU SC, 1976, ICARUS, V28, P231, DOI 10.1016/0019-1035(76)90035-X; Lucchitta BK, 2001, GEOPHYS RES LETT, V28, P403, DOI 10.1029/2000GL011924; LUHMANN JG, 1992, GEOPHYS RES LETT, V19, P2151, DOI 10.1029/92GL02485; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; Malin MC, 1999, GEOPHYS RES LETT, V26, P3049, DOI 10.1029/1999GL002342; Marti K, 2000, GEOPHYS RES LETT, V27, P1463, DOI 10.1029/1999GL011064; Mathew KJ, 2001, J GEOPHYS RES-PLANET, V106, P1401, DOI 10.1029/2000JE001255; MCELROY MB, 1976, PLANET SPACE SCI, V24, P1107, DOI 10.1016/0032-0633(76)90148-3; MCSWEEN HY, 1985, REV GEOPHYS, V23, P391, DOI 10.1029/RG023i004p00391; MCSWEEN HY, 1994, METEORITICS, V29, P757, DOI 10.1111/j.1945-5100.1994.tb01092.x; McSween HY, 2001, NATURE, V409, P487, DOI 10.1038/35054011; MELLON MT, IN PRESS J GEOPHYS R; MELOSH HJ, 1989, NATURE, V338, P487, DOI 10.1038/338487a0; Mischna MA, 2000, ICARUS, V145, P546, DOI 10.1006/icar.2000.6380; MITCHELL DL, 2000, CRUSTAL MAGNETOCYLIN; Musselwhite DS, 2001, GEOPHYS RES LETT, V28, P1283, DOI 10.1029/2000GL012496; NEWMAN MJ, 1977, SCIENCE, V198, P1035, DOI 10.1126/science.198.4321.1035; OWEN T, 1995, ICARUS, V116, P215, DOI 10.1006/icar.1995.1122; OWEN T, 1988, SCIENCE, V240, P1767, DOI 10.1126/science.240.4860.1767; Owen T., 1992, COMPOSITION EARLY HI, P818; PARKER TJ, 1989, ICARUS, V82, P111, DOI 10.1016/0019-1035(89)90027-4; PARKER TJ, 1993, J GEOPHYS RES-PLANET, V98, P11061, DOI 10.1029/93JE00618; PARKER TJ, 2000, LUN PLAN SCI C, V31; PECHMANN JC, 1980, ICARUS, V42, P185, DOI 10.1016/0019-1035(80)90071-8; PEPIN RO, 1994, ICARUS, V111, P289, DOI 10.1006/icar.1994.1146; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; POLLACK JB, 1990, J GEOPHYS RES-SOLID, V95, P14595, DOI 10.1029/JB095iB09p14595; Purucker M, 2000, GEOPHYS RES LETT, V27, P2449, DOI 10.1029/2000GL000072; ROMANEK CS, 1994, NATURE, V372, P655, DOI 10.1038/372655a0; Schubert G, 2000, NATURE, V408, P666, DOI 10.1038/35047163; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; SQUYRES SW, 1994, SCIENCE, V265, P744, DOI 10.1126/science.265.5173.744; STEWART ST, UNPUB J GEOPHYS RES; Swindle TD, 2000, METEORIT PLANET SCI, V35, P107, DOI 10.1111/j.1945-5100.2000.tb01978.x; TANAKA K, 2000, GSA ABSTR PROGR, V32; Tanaka KL, 1999, J GEOPHYS RES-PLANET, V104, P8637, DOI 10.1029/98JE02552; TANAKA KL, 1986, J GEOPHYS RES-SOLID, V91, pE139, DOI 10.1029/JB091iB13p0E139; Tanaka KL, 1998, J GEOPHYS RES-PLANET, V103, P31407, DOI 10.1029/98JE01599; TOUMA J, 1993, SCIENCE, V259, P1294, DOI 10.1126/science.259.5099.1294; TREIMAN AH, 1993, METEORITICS, V28, P86, DOI 10.1111/j.1945-5100.1993.tb00251.x; Turner G, 1997, GEOCHIM COSMOCHIM AC, V61, P3835, DOI 10.1016/S0016-7037(97)00285-8; WARD WR, 1974, J GEOPHYS RES, V79, P3375, DOI 10.1029/JC079i024p03375; WATSON LL, 1994, SCIENCE, V265, P86, DOI 10.1126/science.265.5168.86; WEISS BP, 2001, LUN PLAN SCI C, V32; Withers P, 2001, NATURE, V410, P651, DOI 10.1038/35070640; YUNG YL, 1988, ICARUS, V76, P146, DOI 10.1016/0019-1035(88)90147-9; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788	106	321	324	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2001	412	6843					237	244		10.1038/35084184	http://dx.doi.org/10.1038/35084184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449285	Bronze			2022-12-28	WOS:000169778700063
J	Pethe, K; Alonso, S; Biet, F; Delogu, G; Brennan, MJ; Locht, C; Menozzi, FD				Pethe, K; Alonso, S; Biet, F; Delogu, G; Brennan, MJ; Locht, C; Menozzi, FD			The heparin-binding haemagglutinin of M-tuberculosis is required for extrapulmonary dissemination	NATURE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; HEMAGGLUTININ; GENE; IDENTIFICATION; MACROPHAGES; VIRULENCE; SURVIVAL; COMPLEX; ADHESIN; MICE	Tuberculosis remains the world's leading cause of death due to a single infectious agent, Mycobacterium tuberculosis, with 3 million deaths and 10 million new cases per year(1). The infection initiates in the lungs and can then spread rapidly to other tissues(2). The availability of the entire M. tuberculosis genome sequence(3) and advances in gene disruption technologies(4) have led to the identification of several mycobacterial determinants involved in virulence(5-8). However, no virulence factor specifically involved in the extrapulmonary dissemination of M. tuberculosis has been identified to date. Here we show that the disruption of the M. tuberculosis or Mycobacterium bovis Bacille Calmette-Guerin (BCG) hbhA gene encoding the heparin-binding haemagglutinin adhesin (HBHA) markedly affects mycobacterial interactions with epithelial cells, but not with macrophage-like cells. When nasally administered to mice, the mutant strains were severely impaired in spleen colonization, but not in lung colonization. Coating wild-type mycobacteria with anti-HBHA antibodies also impaired dissemination after intranasal infection. These results provide evidence that adhesins such as HBHA are required for extrapulmonary dissemination, and that interactions with non-phagocytic cells have an important role in the pathogenesis of tuberculosis. They also suggest that antibody responses to HBHA may add to immune protection against tuberculosis.	Inst Pasteur Lille, INSERM, U447, F-59019 Lille, France; US FDA, Ctr Biol Evaluat & Res, Lab Mycobacterial Dis, Bethesda, MD 20892 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; US Food & Drug Administration (FDA)	Locht, C (corresponding author), Inst Pasteur Lille, INSERM, U447, 1 Rue Prof Calmette, F-59019 Lille, France.		Pethe, Kevin/F-9495-2015; Delogu, Giovanni/I-3701-2012; Biet, Franck/ABA-4151-2021; Pethe, Kevin/L-1199-2013; Pethe, Kevin/D-4505-2011; Locht, Camille/L-3516-2018	Delogu, Giovanni/0000-0003-0182-8267; Biet, Franck/0000-0001-8425-6158; Pethe, Kevin/0000-0003-0297-0150; Pethe, Kevin/0000-0003-0916-8873				BALASUBRAMANIAN V, 1994, TUBERCLE LUNG DIS, V75, P168, DOI 10.1016/0962-8479(94)90002-7; Berthet FX, 1998, SCIENCE, V282, P759, DOI 10.1126/science.282.5389.759; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Delogu G, 1999, J BACTERIOL, V181, P7464, DOI 10.1128/JB.181.24.7464-7469.1999; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; HENDERSON HJ, 1963, J IMMUNOL, V90, P553; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993; Menozzi FD, 1998, P NATL ACAD SCI USA, V95, P12625, DOI 10.1073/pnas.95.21.12625; Pavelka MS, 1996, J BACTERIOL, V178, P6496, DOI 10.1128/jb.178.22.6496-6507.1996; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Pethe K, 2001, MOL MICROBIOL, V39, P89, DOI 10.1046/j.1365-2958.2001.02206.x; Pethe K, 2000, J BIOL CHEM, V275, P14273, DOI 10.1074/jbc.275.19.14273; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Reddy VM, 2000, J INFECT DIS, V181, P1189, DOI 10.1086/315327; Teitelbaum R, 1998, P NATL ACAD SCI USA, V95, P15688, DOI 10.1073/pnas.95.26.15688; Teitelbaum R, 1999, IMMUNITY, V10, P641, DOI 10.1016/S1074-7613(00)80063-1; Wei J, 2000, J BACTERIOL, V182, P377, DOI 10.1128/JB.182.2.377-384.2000	20	347	370	0	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					190	194		10.1038/35084083	http://dx.doi.org/10.1038/35084083			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449276				2022-12-28	WOS:000169778700054
J	Ibata, R; Irwin, M; Lewis, G; Ferguson, AMN; Tanvir, N				Ibata, R; Irwin, M; Lewis, G; Ferguson, AMN; Tanvir, N			A giant stream of metal-rich stars in the halo of the galaxy M31	NATURE			English	Article							HUBBLE-SPACE-TELESCOPE; SAGITTARIUS DWARF GALAXY; MILKY-WAY; LOCAL GROUP; STELLAR POPULATIONS; INTERSTELLAR-MEDIUM; NGC-205; DISRUPTION; DISK	Recent observations have revealed streams of gas and stars in the halo of the Milky Way(1-3) that are the debris from interactions between our Galaxy and some of its dwarf companion galaxies; the Sagittarius dwarf galaxy and the Magellanic clouds. Analysis of the material has shown that much of the halo is made up of cannibalized satellite galaxies(2,4), and that dark matter is distributed nearly spherically in the Milky Way. It remains unclear, however, whether cannibalized substructures are as common in the haloes of galaxies as predicted by galaxy-formation theory(5). Here we report the discovery of a giant stream of metal-rich stars within the halo of the nearest large galaxy, M31 (the Andromeda galaxy). The source of this stream could be the dwarf galaxies M32 and NGC205, which are close companions of M31 and which may have lost a substantial number of stars owing to tidal interactions. The results demonstrate that the epoch of galaxy building still continues, albeit at a modest rate, and that tidal streams may be a generic feature of galaxy haloes.	Observ Strasbourg, F-67000 Strasbourg, France; Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; Anglo Australian Observ, Epping, NSW 1710, Australia; Univ Groningen, Kapteyn Astron Inst, NL-9700 AV Groningen, Netherlands; Univ Hertfordshire, Hatfield AL10 9AB, Herts, England	University of Cambridge; University of Groningen; University of Hertfordshire	Ibata, R (corresponding author), Observ Strasbourg, 11 Rue Univ, F-67000 Strasbourg, France.	ibata@astro.u-strasbg.fr	Lewis, Geraint/F-9069-2015	Lewis, Geraint/0000-0003-3081-9319				BENDER R, 1991, ASTRON ASTROPHYS, V246, P349; COLE S, 1994, MON NOT R ASTRON SOC, V271, P781, DOI 10.1093/mnras/271.4.781; Davidge TJ, 2000, PUBL ASTRON SOC PAC, V112, P1177, DOI 10.1086/316618; DURRELL PR, 1999, AM ASTRON SOC M, V195; EGGEN OJ, 1962, ASTROPHYS J, V136, P748, DOI 10.1086/147433; Ferguson AMN, 1998, ASTRON J, V116, P673, DOI 10.1086/300456; FREEDMAN WL, 1989, ASTRON J, V98, P1285, DOI 10.1086/115216; Grillmair CJ, 1996, ASTRON J, V112, P1975, DOI 10.1086/118156; Helmi A, 1999, NATURE, V402, P53, DOI 10.1038/46980; HODGE PW, 1973, ASTROPHYS J, V182, P671, DOI 10.1086/152176; Holland S, 1996, ASTRON J, V112, P1035, DOI 10.1086/118075; Ibata R, 2001, ASTROPHYS J, V551, P294, DOI 10.1086/320060; Ibata R, 2001, ASTROPHYS J, V547, pL133, DOI 10.1086/318894; Ibata RA, 1998, ASTROPHYS J, V500, P575, DOI 10.1086/305773; Ibata RA, 1998, ASTRON ASTROPHYS, V336, P130; INNANEN KA, 1982, ASTROPHYS J, V254, P515, DOI 10.1086/159761; Irwin M, 2001, NEW ASTRON REV, V45, P105, DOI 10.1016/S1387-6473(00)00138-X; JOHNSTON KV, 1995, ASTROPHYS J, V451, P598, DOI 10.1086/176247; KLYIN A, 1999, ASTROPHYS J, V516, P530; Lee MG, 1996, ASTRON J, V112, P1438, DOI 10.1086/118112; Putman ME, 1998, NATURE, V394, P752, DOI 10.1038/29466; Reitzel DB, 1998, ASTRON J, V116, P707, DOI 10.1086/300458; Rich RM, 1996, ASTRON J, V111, P768, DOI 10.1086/117822; SACKETT PD, 1994, NATURE, V370, P441, DOI 10.1038/370441a0; SCHWARZSCHILD M, 1954, ASTRON J, V59, P273, DOI 10.1086/107013; Shang ZH, 1998, ASTROPHYS J, V504, pL23, DOI 10.1086/311563; Stanek KZ, 1998, ASTROPHYS J, V503, pL131, DOI 10.1086/311539; WALTERBOS RAM, 1987, ASTRON ASTROPHYS SUP, V69, P311; Welch GA, 1998, ASTROPHYS J, V499, P209, DOI 10.1086/305609; Young LM, 1997, ASTROPHYS J, V476, P127, DOI 10.1086/303618	30	476	481	0	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					49	52		10.1038/35083506	http://dx.doi.org/10.1038/35083506			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452300	Green Submitted			2022-12-28	WOS:000169644900037
J	Trappe, V; Prasad, V; Cipelletti, L; Segre, PN; Weitz, DA				Trappe, V; Prasad, V; Cipelletti, L; Segre, PN; Weitz, DA			Jamming phase diagram for attractive particles	NATURE			English	Article							SUSPENSIONS; TRANSITION; DYNAMICS; BEHAVIOR; SPHERES; GELS	A wide variety of systems, including granular media, colloidal suspensions and molecular systems, exhibit non-equilibrium transitions from a fluid-like to a solid-like state, characterized solely by the sudden arrest of their dynamics. Crowding or jamming of the constituent particles traps them kinetically, precluding further exploration of the phase space(1). The disordered fluid-like structure remains essentially unchanged at the transition. The jammed solid can be refluidized by thermalization, through temperature or vibration, or by an applied stress. The generality of the jamming transition led to the proposal(2) of a unifying description, based on a jamming phase diagram. It was further postulated that attractive interactions might have the same effect in jamming the system as a confining pressure, and thus could be incorporated into the generalized description. Here we study experimentally the fluid-to-solid transition of weakly attractive colloidal particles, which undergo markedly similar gelation behaviour with increasing concentration and decreasing thermalization or stress. Our results support the concept of a jamming phase diagram for attractive colloidal particles, providing a unifying link between the glass transition(3), gelation(4,5) and aggregation(6-8).	Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Harvard Univ, DEAS, Cambridge, MA 02138 USA	Harvard University; Harvard University	Weitz, DA (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.		Cipelletti, Luca/Q-2310-2018	Cipelletti, Luca/0000-0003-2956-7580				CARPINETI M, 1992, PHYS REV LETT, V68, P3327, DOI 10.1103/PhysRevLett.68.3327; Cates ME, 1998, PHYS REV LETT, V81, P1841, DOI 10.1103/PhysRevLett.81.1841; DEROOIJ R, 1994, PHYS REV E, V49, P3038, DOI 10.1103/PhysRevE.49.3038; Gisler T, 1999, PHYS REV LETT, V82, P1064, DOI 10.1103/PhysRevLett.82.1064; GRANT MC, 1993, PHYS REV E, V47, P2606, DOI 10.1103/PhysRevE.47.2606; Liu AJ, 1998, NATURE, V396, P21, DOI 10.1038/23819; MELROSE JR, 1995, EUROPHYS LETT, V32, P535, DOI 10.1209/0295-5075/32/6/013; Nagel SR., 2001, JAMMING RHEOLOGY CON, P80; O'Hern CS, 2001, PHYS REV LETT, V86, P111, DOI 10.1103/PhysRevLett.86.111; PUSEY PN, 1986, NATURE, V320, P340, DOI 10.1038/320340a0; PUSEY PN, 1993, PHYSICA A, V201, P322, DOI 10.1016/0378-4371(93)90430-C; PUSEY PN, 1987, PHYS REV LETT, V59, P2083, DOI 10.1103/PhysRevLett.59.2083; SEGRE PN, IN PRESS PHYS REV LE; Trappe V, 2000, PHYS REV LETT, V85, P449, DOI 10.1103/PhysRevLett.85.449; WEITZ DA, 1984, PHYS REV LETT, V52, P1432	15	728	743	13	286	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					772	775		10.1038/35081021	http://dx.doi.org/10.1038/35081021			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459050				2022-12-28	WOS:000169246400041
J	Tercero, JA; Diffley, JFX				Tercero, JA; Diffley, JFX			Regulation of DNA replication fork progression through damaged DNA by the Mec1/Rad53 checkpoint	NATURE			English	Article							CEREVISIAE CHROMOSOME-VI; SACCHAROMYCES-CEREVISIAE; S-PHASE; BUDDING YEAST; ORIGINS; ACTIVATION; INITIATION; SEQUENCES; TELOMERES; PROTEIN	The checkpoint kinase proteins Mec1 and Rad53 are required in the budding yeast, Saccharomyces cerevisiae, to maintain cell viability in the presence of drugs causing damage to DNA or arrest of DNA replication forks(1-3). It is thought that they act by inhibiting cell cycle progression, allowing time for DNA repair to take place. Mec1 and Rad53 also slow S phase progression in response to DNA alkylation(4), although the mechanism for this and its relative importance in protecting cells from DNA damage have not been determined. Here we show that the DNA-alkylating agent methyl methanesulphonate (MMS) profoundly reduces the rate of DNA replication fork progression; however, this moderation does not require Rad53 or Mec1. The accelerated S phase in checkpoint mutants(4), therefore, is primarily a consequence of inappropriate initiation events(5-7). Wild-type cells ultimately complete DNA replication in the presence of MMS. In contrast, replication forks in checkpoint mutants collapse irreversibly at high rates. Moreover, the cytotoxicity of MMS in checkpoint mutants occurs specifically when cells are allowed to enter S phase with DNA damage. Thus, preventing damage-induced DNA replication fork catastrophe seems to be a primary mechanism by which checkpoints preserve viability in the face of DNA alkylation.	Imperial Canc Res Fund, Clare Hall Labs, S Mimms EN6 3LD, Herts, England		Diffley, JFX (corresponding author), Imperial Canc Res Fund, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.		Tercero, José Antonio/D-7489-2016	Tercero, Jose Antonio/0000-0003-4829-3570; Diffley, John/0000-0001-5184-7680				Campbell JL, 1991, MOL CELLULAR BIOL YE, P41; CHAN CSM, 1983, CELL, V33, P563, DOI 10.1016/0092-8674(83)90437-3; Craven RJ, 2000, MOL CELL BIOL, V20, P2378, DOI 10.1128/MCB.20.7.2378-2384.2000; Dimitrova DS, 2000, NAT CELL BIOL, V2, P686, DOI 10.1038/35036309; Friedman KL, 1997, GENES CELLS, V2, P667, DOI 10.1046/j.1365-2443.1997.1520350.x; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; Longhese MP, 2000, GENETICS, V155, P1577; Lowndes NF, 2000, CURR OPIN GENET DEV, V10, P17, DOI 10.1016/S0959-437X(99)00050-7; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; REYNOLDS AE, 1989, MOL CELL BIOL, V9, P4488, DOI 10.1128/MCB.9.10.4488; Rhind N, 2000, CURR BIOL, V10, pR908, DOI 10.1016/S0960-9822(00)00849-6; RIVIN CJ, 1980, J CELL BIOL, V85, P108, DOI 10.1083/jcb.85.1.108; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Santocanale C, 1999, GENE DEV, V13, P2360, DOI 10.1101/gad.13.18.2360; SCHWARTZ JL, 1989, MUTAT RES, V216, P111, DOI 10.1016/0165-1161(89)90011-3; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; SHIRAHIGE K, 1993, MOL CELL BIOL, V13, P5043, DOI 10.1128/MCB.13.8.5043; Stevenson JB, 1999, GENE DEV, V13, P146, DOI 10.1101/gad.13.2.146; Tercero JA, 2000, EMBO J, V19, P2082, DOI 10.1093/emboj/19.9.2082; Yamashita M, 1997, GENES CELLS, V2, P655, DOI 10.1046/j.1365-2443.1997.1530351.x; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	22	547	557	0	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					553	557		10.1038/35087607	http://dx.doi.org/10.1038/35087607			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484057				2022-12-28	WOS:000170202900049
J	Tochio, H; Tsui, MMK; Banfield, DK; Zhang, MJ				Tochio, H; Tsui, MMK; Banfield, DK; Zhang, MJ			An autoinhibitory mechanism for nonsyntaxin SNARE proteins revealed by the structure of Ykt6p	SCIENCE			English	Article							N-TERMINAL DOMAIN; MEMBRANE-FUSION; COMPLEX; NMR; EXOCYTOSIS; PROGRAM; TRANSPORT; SYNTAXIN; YEAST; SSO1P	Ykt6p is a nonsyntaxin SNARE implicated in multiple intracellular membrane trafficking steps. Here we present the structure of the NH2-terminal domain of Ykt6p (Ykt6pN, residues 1 to 140). The structure of Ykt6pN differed entirety from that of syntaxin and resembled the overall fold of the actin regulatory protein, profilin. Like some syntaxins, Ykt6p adopted a folded back conformation in which Ykt6pN bound to its COOH-terminal core domain. The NH2-terminal domain plays an important biological rote in the function of Ykt6p, which in vitro studies revealed to include influencing the kinetics and proper assembly of SNARE complexes.	Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Dept Biol, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Banfield, DK (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Clear Water Bay, Kowloon, Hong Kong, Peoples R China.		Tochio, Hidehito/F-6109-2011; Tsui, Man-kin/E-9612-2010; Tochio, Hidehito/GWV-0429-2022	Tochio, Hidehito/0000-0003-3843-3330; Zhang, Mingjie/0000-0001-9404-0190				BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2001, NAT STRUCT BIOL, V8, P258, DOI 10.1038/85012; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; GOLEMIS E, 1996, INTERACTION TRAP 2 H; Gonzalez LC, 2001, J BIOL CHEM, V276, P24203, DOI 10.1074/jbc.M101584200; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lerman JC, 2000, BIOCHEMISTRY-US, V39, P8470, DOI 10.1021/bi0003994; Mahoney NM, 1997, NAT STRUCT BIOL, V4, P953, DOI 10.1038/nsb1197-953; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; McNew JA, 1997, J BIOL CHEM, V272, P17776, DOI 10.1074/jbc.272.28.17776; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Munson M, 2000, NAT STRUCT BIOL, V7, P894; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Nicholls A., 1992, GRASP GRAPHICAL REPR; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; Pelham HRB, 1999, EXP CELL RES, V247, P1, DOI 10.1006/excr.1998.4356; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TOCHIO H, UNPUB; Tsui MMK, 2000, J CELL SCI, V113, P145; Tsui MMK, 2001, MOL BIOL CELL, V12, P521, DOI 10.1091/mbc.12.3.521; Ungermann C, 1999, J CELL BIOL, V145, P1435, DOI 10.1083/jcb.145.7.1435	33	107	109	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					698	702		10.1126/science.1062950	http://dx.doi.org/10.1126/science.1062950			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474112				2022-12-28	WOS:000170204600055
J	Shekelle, P; Eccles, MP; Grimshaw, JM; Woolf, SH				Shekelle, P; Eccles, MP; Grimshaw, JM; Woolf, SH			When should clinical guidelines be updated?	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Greater Los Angeles Vet Affairs Healthcare Syst, Los Angeles, CA 90073 USA; Newcastle Univ, Ctr Hlth Serv Res, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England; Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland; Virginia Commonwealth Univ, Dept Family Practice, Fairfax, VA 22033 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Newcastle University - UK; University of Aberdeen; Virginia Commonwealth University	Shekelle, P (corresponding author), RAND Corp, 1700 Main St,POB 2138,M-26, Santa Monica, CA 90407 USA.	shekelle@rand.org	Grimshaw, Jeremy/D-8726-2013; Eccles, Martin P/AAD-4029-2020	Grimshaw, Jeremy/0000-0001-8015-8243				Bazzino O, 1998, NEW ENGL J MED, V338, P1488; CAMPBELL SE, 1999, J EPIDEMIOLOGY COMMU, V53, P669; Eccles M, 1999, FAM PRACT, V16, P103, DOI 10.1093/fampra/16.2.103; FIELDS WS, 1970, J AMER MED ASSOC, V211, P1993, DOI 10.1001/jama.211.12.1993; KONSTAM M, 1994, AHCPR PUBLICATION; Lincoff AM, 1999, NEW ENGL J MED, V341, P319, DOI 10.1056/NEJM199907293410503; Shekelle PG, 1999, BRIT MED J, V318, P593, DOI 10.1136/bmj.318.7183.593; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527	10	160	171	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 21	2001	323	7305					155	157		10.1136/bmj.323.7305.155	http://dx.doi.org/10.1136/bmj.323.7305.155			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456WR	11463690	Green Published			2022-12-28	WOS:000170106200024
J	Wadsworth, JDF; Joiner, S; Hill, AF; Campbell, TA; Desbruslais, M; Luthert, PJ; Collinge, J				Wadsworth, JDF; Joiner, S; Hill, AF; Campbell, TA; Desbruslais, M; Luthert, PJ; Collinge, J			Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay	LANCET			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; TRANSMISSIBLE MINK ENCEPHALOPATHY; FATAL FAMILIAL INSOMNIA; BLOOD-TRANSFUSION; STRAIN VARIATION; TRANSGENIC MICE; TONSIL BIOPSY; BSE AGENT; SCRAPIE; INFECTIVITY	Background Variant Creutzfeldt-Jakob disease (vCJD) has a pathogenesis distinct from other forms of human prion disease: disease-related prion protein (PrP(Sc)) is readily detectable in lymphoreticular tissues. Quantitation of risk of secondary transmission, and targeting of risk reduction strategies, is limited by lack of knowledge about relative prion titres in these and other peripheral tissues, the unknown prevalence of preclinical vCJD, and a transmission barrier which limits the sensitivity of bioassay. We aimed to improve immunoblotting methods for high sensitivity detection of PrP(Sc) to investigate the distribution of PrP(Sc) in a range of vCJD tissues. Methods We obtained tissues at necropsy from four patients with neuropathologically confirmed vCJD and from individuals without neurological disease. Tissues were analysed by sodium phosphotungstic acid precipitation of PrP(Sc) and western blotting using high sensitivity enhanced chemiluminescence. Findings We could reliably detect PrP(Sc) in the equivalent of 50 nL 10% vCJD brain homogenate, with a maximum limit of detection equivalent to 5 nl. PrP(Sc) could be detected in tissue homogenates when present at concentrations 10(4)-10(5) fold lower than those reported in brain. Tonsil, spleen, and lymph node were uniformly positive for PrP(Sc) at concentrations in the range of 0.1-15% of those found in brain: the highest concentrations were consistently seen in tonsil. PrP(Sc) was readily detected in the retina and proximal optic nerve of vCJD eye at levels of 2.5 and 25%, respectively of those found in brain. Other peripheral tissues studied were negative for PrP(Sc) with the exception of low concentrations in rectum, adrenal gland, and thymus from a single patient with vCJD. vCJD appendix and blood (Buffy coat fraction) were negative for PrP(Sc) at this level of assay sensitivity. Interpretation We have developed a highly sensitive immunoblot method for detection of PrP(Sc) in vCJD tissues that can be used to provide an upper limit on PrP(Sc) concentrations in peripheral tissues, including blood, to inform risk assessment models. Rectal and other gastrointestinal tissues should be further investigated to assess risk of iatrogenic transmission via biopsy instruments. Ophthalmic surgical instruments used in procedures involving optic nerve and the posterior segment populations; of the eye, in particular the retina, might represent a potential risk for iatrogenic transmission of vCJD. Tonsil is the tissue of choice for diagnostic biopsy and for population screening of surgical tissues to assess prevalence of preclinical vCJD infection within the UK and other populations.	Imperial Coll Sch Med St Marys, MRC, Prion Unit, London W2 1PG, England; Imperial Coll Sch Med St Marys, Dept Neurogenet, London W2 1PG, England; UCL, Inst Ophthalmol, Dept Pathol, London EC1V 9EL, England	Imperial College London; Imperial College London; University of London; University College London	Collinge, J (corresponding author), Imperial Coll Sch Med St Marys, MRC, Prion Unit, London W2 1PG, England.	pacollinge@ic.ac.uk	Hill, Andrew F./GZL-4124-2022; Hill, Andrew F./AAH-2854-2020; Hill, Andrew F/B-4527-2009	Hill, Andrew F./0000-0001-5581-2354; Hill, Andrew F/0000-0001-5581-2354; Luthert, Philip/0000-0001-7276-6898; Wadsworth, Jonathan/0000-0002-4797-2259	Medical Research Council [MC_U123160655] Funding Source: Medline; MRC [MC_U123160655] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		*ADV COMM DANG PAT, 1998, TRANSM SPONG ENC AG; Barbara J, 1998, BRIT MED J, V316, P717, DOI 10.1136/bmj.316.7133.717; BERNOULLI C, 1977, LANCET, V1, P478; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; Brown P, 1999, TRANSFUSION, V39, P1169, DOI 10.1046/j.1537-2995.1999.39111169.x; BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BUDKA H, 1995, BRAIN PATHOL, V5, P319, DOI 10.1111/j.1750-3639.1995.tb00609.x; BUELER H, 1993, CELL, V73, P1399; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; COLLINGE J, 1995, LANCET, V346, P569, DOI 10.1016/S0140-6736(95)91405-6; COLLINGE J, 1995, NATURE, V378, P779, DOI 10.1038/378779a0; Collinge J, 1996, LANCET, V348, P56, DOI 10.1016/S0140-6736(05)64378-4; Collins S, 1999, LANCET, V353, P693, DOI 10.1016/S0140-6736(98)08138-0; ESMONDE TFG, 1993, LANCET, V341, P205, DOI 10.1016/0140-6736(93)90068-R; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Fraser JR, 1996, J GEN VIROL, V77, P2663, DOI 10.1099/0022-1317-77-10-2663; Ghani AC, 2000, NATURE, V406, P583, DOI 10.1038/35020688; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Hill AF, 1997, LANCET, V349, P99, DOI 10.1016/S0140-6736(97)24002-X; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hill DP, 1997, DEV BRAIN RES, V102, P53, DOI 10.1016/S0165-3806(97)00076-X; Hilton DA, 1998, LANCET, V352, P703, DOI 10.1016/S0140-6736(98)24035-9; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; Ironside JW, 2000, LANCET, V355, P1693, DOI 10.1016/S0140-6736(00)02243-1; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KIMBERLIN RH, 1986, J GEN VIROL, V67, P255, DOI 10.1099/0022-1317-67-2-255; KIMBERLIN RH, 1988, CIBA F SYMP, V135, P37; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Lee DC, 2000, J VIROL METHODS, V84, P77, DOI 10.1016/S0166-0934(99)00135-4; Lloyd SE, 2001, P NATL ACAD SCI USA, V98, P6279, DOI 10.1073/pnas.101130398; MEDORI R, 1992, NEUROLOGY, V42, P669, DOI 10.1212/WNL.42.3.669; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Wadsworth JDF, 1999, NAT CELL BIOL, V1, P55, DOI 10.1038/9030; Wells GAH, 1998, VET REC, V142, P103, DOI 10.1136/vr.142.5.103; Wells GAH, 1999, VET REC, V144, P292, DOI 10.1136/vr.144.11.292; Zobeley E, 1999, MOL MED, V5, P240, DOI 10.1007/BF03402121	47	558	583	0	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 21	2001	358	9277					171	180		10.1016/S0140-6736(01)05403-4	http://dx.doi.org/10.1016/S0140-6736(01)05403-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454HL	11476832				2022-12-28	WOS:000169967100008
J	Calzada, A; Sacristan, M; Sanchez, E; Bueno, A				Calzada, A; Sacristan, M; Sanchez, E; Bueno, A			Cdc6 cooperates with Sic1 and Hct1 to inactivate mitotic cyclin-dependent kinases	NATURE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; ANAPHASE-PROMOTING COMPLEX; BUDDING YEAST; DNA-REPLICATION; MCM PROTEINS; S-PHASE; PROTEOLYSIS; GENES; CDK; ORIGINS	Exit from mitosis requires the inactivation of mitotic cyclin-dependent kinases (CDKs). In the budding yeast, Saccharomyces cerevisiae, inactivation of CDKs during late mitosis involves degradation of B-type cyclins as well as direct inhibition of cyclin-CDK complexes by the CDK-inhibitor protein Sic1 (refs 1-3). Several striking similarities exist between Sic1 and Cdc6, a DNA replication factor essential for the formation of pre-replicative complexes at origins of DNA replication(4-9). Transcription of both genes is activated during late mitosis by a process dependent on Swi5 (ref. 10). Like Sic1, Cdc6 binds CDK complexes in vivo(11,12) and downregulates them in vitro(11). Here we show that Cdc6, like Sic1, also contributes to inactivation of CDKs during late mitosis in S. cerevisiae. Deletion of the CDK-interacting domain of Cdc6 does not inhibit the function of origins of DNA replication during S phase, but instead causes a delay in mitotic exit; this delay is accentuated in the absence of Sic1 or of cyclin degradation. By contributing to mitotic exit and inactivation of CDKs, Cdc6 helps to create the conditions that are required for its subsequent role in the formation of pre-replicative complexes at origins of DNA replication.	Univ Salamanca, Inst Microbiol Bioquim, CSIC, Salamanca, Spain; Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Dept Genet & Microbiol, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Bueno, A (corresponding author), Univ Salamanca, Inst Microbiol Bioquim, CSIC, Campus Miguel de Unamuno, Salamanca, Spain.		Bueno, Avelino/A-9505-2016; Sánchez, Elisa/Z-3780-2019; Calzada, Arturo/M-1168-2014; Sacristán, María P/A-9587-2016; Sacristan, Maria/Y-4923-2019	Bueno, Avelino/0000-0002-0362-4391; Calzada, Arturo/0000-0002-3190-688X; Sacristán, María P/0000-0003-2314-8430; Sacristan, Maria/0000-0003-2314-8430				Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Calzada A, 2000, J BIOL CHEM, V275, P9734, DOI 10.1074/jbc.275.13.9734; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; CULOTTI J, 1971, EXP CELL RES, V67, P389, DOI 10.1016/0014-4827(71)90424-1; Detweiler CS, 1997, J CELL SCI, V110, P753; DONOVAN JD, 1994, GENE DEV, V8, P1640, DOI 10.1101/gad.8.14.1640; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Drury LS, 1997, EMBO J, V16, P5966, DOI 10.1093/emboj/16.19.5966; Elsasser S, 1996, MOL BIOL CELL, V7, P1723, DOI 10.1091/mbc.7.11.1723; HOGAN E, 1992, P NATL ACAD SCI USA, V89, P3098, DOI 10.1073/pnas.89.7.3098; IRNIGER S, 1995, CELL, V81, P269, DOI 10.1016/0092-8674(95)90337-2; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; LIANG C, 1995, CELL, V81, P667, DOI 10.1016/0092-8674(95)90528-6; Mizushima T, 2000, GENE DEV, V14, P1631; Peters JM, 1999, EXP CELL RES, V248, P339, DOI 10.1006/excr.1999.4443; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; Pichler S, 1997, EMBO J, V16, P5988, DOI 10.1093/emboj/16.19.5988; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Yeong FM, 2000, MOL CELL, V5, P501, DOI 10.1016/S1097-2765(00)80444-X; Yuste-Rojas M, 2000, MOL GEN GENET, V263, P60, DOI 10.1007/PL00008676; ZWERSCHKE W, 1994, J BIOL CHEM, V269, P23352	26	61	63	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					355	358		10.1038/35085610	http://dx.doi.org/10.1038/35085610			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460169				2022-12-28	WOS:000169918200052
J	Myers, KA; Farquhar, DRE				Myers, KA; Farquhar, DRE			Does this patient have clubbing?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HYPERTROPHIC OSTEOARTHROPATHY; PREVALENCE; DISEASE; FLOW	Context The association between digital clubbing and a host of diseases has been recognized since the time of Hippocrates. Although the features of advanced clubbing are familiar to most clinicians, the presence of early clubbing is often a source of debate. Objective To perform a systematic review of the literature for information on the precision and accuracy of clinical examination for clubbing. Data Sources The MEDLINE database from January 1966 to April 1999 was searched for English-language articles related to clubbing. Bibliographies of all retrieved articles and of standard textbooks of physical diagnosis were also searched. Study Selection Studies selected for data extraction were those in which quantitative or qualitative assessment for clubbing was described in a series of patients, Sixteen studies met these criteria and were included in the final analysis. Data Extraction Data were extracted by both authors, who independently reviewed and appraised the quality of each article. Data extracted included quantitative indices for distinguishing clubbed from normal digits, precision of clinical examination for clubbing, and accuracy of clubbing as a marker of selected diseases. Data Synthesis The profile angle, hyponychial angle, and phalangeal depth ratio can be used as quantitative indices to assist in identifying clubbing. In individuals without clubbing, values for these indices do not exceed 176 degrees, 192 degrees, and 1.0, respectively. When clinicians make a global assessment of clubbing at the bedside, interobserver agreement is variable, with kappa values ranging between 0.39 and 0.90. Because of the lack of an objective diagnostic criterion standard, accuracy of physical examination for clubbing is difficult to determine. The accuracy of clubbing as a marker of specific underlying disease has been determined for lung cancer (likelihood ratio, 3.9 with phalangeal depth ratio in excess of 1.0) and for inflammatory bowel disease (likelihood ratio, 2.8 and 3.7 for active Crohn disease and ulcerative colitis, respectively, if clubbing is present). Conclusions We recommend use of the profile angle and phalangeal depth ratio as quantitative indices in identifying clubbing. Clinical judgment must be exercised in determining the extent of further evaluation for underlying disease when these values exceed 180 degrees and 1.0, respectively.	Queens Univ, Dept Med, Div Gen Internal Med, Kingston, ON K7L 5G2, Canada	Queens University - Canada	Myers, KA (corresponding author), Queens Univ, Hop Hotel Dieu, 166 Brock St, Kingston, ON K7L 5G2, Canada.	myersk@hdh.kari.net	Myers, Kathryn/G-3338-2011					Adams F, 1891, GENUINE WORKS HIPPOC, V1, P206; ALVAREZ AS, 1975, GERONTOL CLIN, V17, P1, DOI 10.1159/000245547; ARMITAGE P, 1966, J R STAT SOC SER A-G, V129, P98, DOI 10.2307/2343899; BAMBERGER E, 1891, Z KLIN MED, V18, P193; Baughman RP, 1998, CLIN EXP RHEUMATOL, V16, P21; BENTLEY D, 1976, LANCET, V2, P164; BIGLER FC, 1958, AM J PATHOL, V34, P237; BUCHMAN D, 1956, ARCH INTERN MED, V97, P355, DOI 10.1001/archinte.1956.00250210101010; Carroll D G Jr, 1972, Trans Am Clin Climatol Assoc, V83, P198; COURY C, 1960, BRIT J DIS CHEST, V54, P202, DOI 10.1016/S0007-0971(60)80001-0; CUDOWICZ L, 1957, BRIT J TUBERC DIS CH, V51, P14; DICKINSON CJ, 1993, EUR J CLIN INVEST, V23, P330, DOI 10.1111/j.1365-2362.1993.tb02032.x; HANSENFLASCHEN J, 1987, CLIN CHEST MED, V8, P287; HOLLEMAN DR, 1995, JAMA-J AM MED ASSOC, V273, P313, DOI 10.1001/jama.273.4.313; Horsfall FL, 1936, CAN MED ASSOC J, V34, P145; KITIS G, 1979, BMJ-BRIT MED J, V2, P825, DOI 10.1136/bmj.2.6194.825; LAMPE RM, 1983, CLIN PEDIATR, V22, P125, DOI 10.1177/000992288302200207; LEMEN RJ, 1978, AM REV RESPIR DIS, V117, P639; Lovibond JL, 1938, LANCET, V1, P363; Marie P., 1890, REV MED, V10, P1; MARTINEZLAVIN M, 1987, J RHEUMATOL, V14, P6; MELLINS RB, 1966, CIRCULATION, V33, P143, DOI 10.1161/01.CIR.33.1.143; Mendlowitz M, 1942, MEDICINE, V21, P269, DOI 10.1097/00005792-194209010-00002; ONADEKO BO, 1979, TROP GEOGR MED, V31, P191; PATON JY, 1991, PEDIATR PULM, V10, P25, DOI 10.1002/ppul.1950100106; PITTSTUCKER TJ, 1986, ARCH DIS CHILD, V61, P576, DOI 10.1136/adc.61.6.576; PYKE DA, 1954, LANCET, V2, P352; RABIN CB, 1965, J AMER MED ASSOC, V194, P546; RACOCEANU SN, 1971, ANN INTERN MED, V75, P933, DOI 10.7326/0003-4819-75-6-933; REGAN GM, 1967, LANCET, V1, P530; RICE RE, 1961, THESIS TULANE U MED; SCHAMROTH L, 1976, S AFR MED J, V50, P297; SINNIAH D, 1979, ARCH DIS CHILD, V54, P145, DOI 10.1136/adc.54.2.145; SLY RM, 1973, CHEST, V64, P687, DOI 10.1378/chest.64.6.687; SMYLLIE HC, 1965, LANCET, V2, P412; SPITERI MA, 1988, LANCET, V1, P873; STAVEM P, 1959, LANCET, V2, P7; VAZQUEZABAD D, 1989, J RHEUMATOL, V16, P518; WARING WW, 1971, AM REV RESPIR DIS, V104, P166; WEST S, 1897, T CLIN SOC LONDON, V30, P60	40	81	82	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2001	286	3					341	347		10.1001/jama.286.3.341	http://dx.doi.org/10.1001/jama.286.3.341			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452QA	11466101				2022-12-28	WOS:000169869200026
J	Pulendran, B; Palucka, K; Banchereau, J				Pulendran, B; Palucka, K; Banchereau, J			Sensing pathogens and tuning immune responses	SCIENCE			English	Editorial Material							DENDRITIC CELL SUBSETS; T-HELPER CELL; IN-VIVO; LYMPH-NODES; INNATE; INTERFERON; INDUCTION; DIFFERENTIATION; EFFECTORS; PATHWAYS	The immune system is capable of making qualitatively distinct responses against different microbial infections, and recent advances are starting to reveal how it manages this complex task. An integral component of the immune system is a network of cells known 65 dendritic cells (DCs), which sense different microbial stimuli and convey this information to Lymphocytes. A better understanding of DC biology has allowed a model to be constructed in which the type of immune response to an infection is viewed as a function of several determinants, including the subpopulation of DCs, the nature of the microbe, microbe recognition receptors, and the cytokine microenvironment.	Baylor Inst Immunol Res, Dallas, TX 75204 USA	Baylor Scott & White Health	Pulendran, B (corresponding author), Baylor Inst Immunol Res, 3434 Live Oak, Dallas, TX 75204 USA.		Pulendran, Bali/AAW-9550-2021	Pulendran, Bali/0000-0001-6517-4333	NIAID NIH HHS [AI48638-01, 1R21AI/DE48154-01] Funding Source: Medline; NIDDK NIH HHS [DK 57665-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI048638, R01AI048638, R56AI048638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057665, R01DK057665] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Angeli V, 2001, J EXP MED, V193, P1135, DOI 10.1084/jem.193.10.1135; ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; d'Ostiani CF, 2000, J EXP MED, V191, P1661, DOI 10.1084/jem.191.10.1661; FugierVivier I, 1997, J EXP MED, V186, P813, DOI 10.1084/jem.186.6.813; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gilboa E, 1999, IMMUNITY, V11, P263, DOI 10.1016/S1074-7613(00)80101-6; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Hochrein H, 2000, J EXP MED, V192, P823, DOI 10.1084/jem.192.6.823; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Iwasaki A, 2001, J IMMUNOL, V166, P4884, DOI 10.4049/jimmunol.166.8.4884; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Kronin V, 1996, J IMMUNOL, V157, P3819; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Linsley PS, 2001, NAT IMMUNOL, V2, P139, DOI 10.1038/84233; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Pulendran B, 1997, J IMMUNOL, V159, P2222; PULENDRAN B, UNPUB; Reis E Sousa Caetano, 1997, Journal of Experimental Medicine, V186, P1819; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Stumbles PA, 1998, J EXP MED, V188, P2019, DOI 10.1084/jem.188.11.2019; Tanaka H, 2000, J EXP MED, V192, P405, DOI 10.1084/jem.192.3.405; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900	37	372	385	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					253	256		10.1126/science.1062060	http://dx.doi.org/10.1126/science.1062060			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452116				2022-12-28	WOS:000169875200046
J	Caligaris-Cappio, F				Caligaris-Cappio, F			How immunology is reshaping clinical disciplines: the example of haematology	LANCET			English	Review							MONOCLONAL-ANTIBODY THERAPY; FACTOR-CLEAVING PROTEASE; EPSTEIN-BARR-VIRUS; HEPATITIS-C VIRUS; THROMBOCYTOPENIC PURPURA; HODGKINS-DISEASE; CELL DEVELOPMENT; DENDRITIC CELLS; CD40 LIGAND; B-CELLS	Haematology represents a prime example of how rapidly immunology is moving towards the bedside. The diagnosis of blood disease has been modified by the "cluster of differentiation" (CD) nomenclature of leucocyte surface antigens, and the molecular genetics of the immune system has had a major effect on the diagnosis and treatment of blood malignancies. Lymphoid tumours represent a fertile area of interaction between immunology and haematology: B-cell malignancies are associated with dysregulation of the immune system, and antigen exposure might have an important role in the development of lymphoid malignant clones that interact with the microenvironment to avoid apoptosis and acquire better growing conditions. Understanding the pathophysiology of immune-mediated blood diseases has paved the way to the successful use of immunosuppressive agents, and the unravelling of the mechanisms of lymphocyte signal transduction and the relations between lymphocyte activation and apoptosis are allowing new therapeutic approaches. Paradoxically, lymphoid tumours are an excellent model to test the efficacy of manipulating the immune system for the purpose of tumour eradication.	Univ Turin, Div Clin Immunol & Haematol, Osped Mauriziano Umberto I, Dept Biomed Sci & Human Oncol, I-10128 Turin, Italy; IRCC Candiolo, Lab Tumor Immunol, Turin, Italy	A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; Mauritian Umberto I Hospital; University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia	Caligaris-Cappio, F (corresponding author), Univ Turin, Div Clin Immunol & Haematol, Osped Mauriziano Umberto I, Dept Biomed Sci & Human Oncol, Largo Turati 62, I-10128 Turin, Italy.	fcaligaris@mauriziano.it						Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Bendandi M, 1999, NAT MED, V5, P1171, DOI 10.1038/13928; Boon T, 1997, CURR OPIN IMMUNOL, V9, P681, DOI 10.1016/S0952-7915(97)80049-0; Boon T, 1996, J EXP MED, V183, P725, DOI 10.1084/jem.183.3.725; Brauninger A, 1999, NEW ENGL J MED, V340, P1239, DOI 10.1056/NEJM199904223401604; Breedveld FC, 2000, LANCET, V355, P735, DOI 10.1016/S0140-6736(00)01034-5; BURKHARD L, 2000, J EXP MED, V191, P795; CALIGARISCAPPIO F, 1982, J EXP MED, V155, P623, DOI 10.1084/jem.155.2.623; CALLARD RE, 1993, IMMUNOL TODAY, V14, P559, DOI 10.1016/0167-5699(93)90188-Q; CARON PC, 1994, BLOOD, V83, P1760; CLARK EA, 1994, NATURE, V367, P425, DOI 10.1038/367425a0; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; DeVita S, 1997, BLOOD, V90, P776, DOI 10.1182/blood.V90.2.776; Druker BJ, 2000, J CLIN INVEST, V105, P3, DOI 10.1172/JCI9083; Fauci AS, 1996, NATURE, V384, P529, DOI 10.1038/384529a0; Fischer M, 1997, J CLIN INVEST, V100, P1667, DOI 10.1172/JCI119691; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; George JN, 1996, BLOOD, V88, P3, DOI 10.1182/blood.V88.1.3.3; George JN, 1998, ANN INTERN MED, V129, P886, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00009; Ghia P, 1998, IMMUNOL TODAY, V19, P480, DOI 10.1016/S0167-5699(98)01330-9; Ghia P, 1998, BLOOD, V91, P244, DOI 10.1182/blood.V91.1.244.244_244_251; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; GREAVES MF, 1986, SCIENCE, V234, P697, DOI 10.1126/science.3535067; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Harris NL, 1999, J CLIN ONCOL, V17, P3835, DOI 10.1200/JCO.1999.17.12.3835; HARRIS NL, 1994, BLOOD, V84, P1361; Hart DNJ, 1997, BLOOD, V90, P3245, DOI 10.1182/blood.V90.9.3245; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.immunol.11.1.501; KHAMASHTA MA, 1995, NEW ENGL J MED, V332, P993, DOI 10.1056/NEJM199504133321504; King CA, 1998, NAT MED, V4, P1281, DOI 10.1038/3266; KIPPS TJ, 1993, BLOOD, V81, P2475; KLEIN B, 1991, BLOOD, V78, P1198; Kuppers R, 1999, NEW ENGL J MED, V341, P1520; Lutgens E, 1999, NAT MED, V5, P1313, DOI 10.1038/15271; Maloney DG, 1997, BLOOD, V90, P2188; MILLER RA, 1982, NEW ENGL J MED, V306, P517, DOI 10.1056/NEJM198203043060906; Ng VL, 1998, IMMUNOL REV, V162, P293, DOI 10.1111/j.1600-065X.1998.tb01449.x; NURR SL, 1999, NATURE, V401, P556; Osterborg A, 1997, J CLIN ONCOL, V15, P1567, DOI 10.1200/JCO.1997.15.4.1567; Pardoll DM, 1998, NAT MED, V4, P525, DOI 10.1038/nm0598supp-525; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; Rickinson AB, 1998, NEW ENGL J MED, V338, P1461, DOI 10.1056/NEJM199805143382011; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Sallusto F, 2000, IMMUNOL REV, V177, P134, DOI 10.1034/j.1600-065X.2000.17717.x; Sato Y, 1996, SCIENCE, V273, P352, DOI 10.1126/science.273.5273.352; Semenzato G, 1997, BLOOD, V89, P256; SHAPIRO S, 1999, SYSTEMIC LUPUS ERYTH, P871; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; STEVENSON GT, 1983, SPRINGER SEMIN IMMUN, V6, P99, DOI 10.1007/BF01857369; Straus SE, 1999, ANN INTERN MED, V130, P591, DOI 10.7326/0003-4819-130-7-199904060-00020; Taylor GM, 1996, LEUKEMIA, V10, P854; Tefferi A, 2000, NEW ENGL J MED, V342, P1255, DOI 10.1056/NEJM200004273421706; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; TURA S, 1994, NEW ENGL J MED, V330, P820; Voulgarelis M, 1999, ARTHRITIS RHEUM-US, V42, P1765, DOI 10.1002/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V; Warkentin TE, 1996, AM J MED, V101, P502, DOI 10.1016/S0002-9343(96)00258-6; WOTHERSPOON AC, 1993, LANCET, V342, P575, DOI 10.1016/0140-6736(93)91409-F; Youinou P, 1999, IMMUNOL TODAY, V20, P312, DOI 10.1016/S0167-5699(99)01476-0; Young NS, 1997, NEW ENGL J MED, V336, P1365, DOI 10.1056/NEJM199705083361906	68	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 7	2001	358	9275					49	55		10.1016/S0140-6736(00)05256-9	http://dx.doi.org/10.1016/S0140-6736(00)05256-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11454399				2022-12-28	WOS:000169710900034
J	Lindgren, E; Gustafson, R				Lindgren, E; Gustafson, R			Tick-borne encephalitis in Sweden and climate change	LANCET			English	Article							IXODES-SCAPULARIS ACARI; TEMPERATURE; IXODIDAE; DISEASE; RICINUS	Background The incidence of tick-borne encephalitis (TBE) in Sweden has substantially increased since the mid-1980s. During the same period the climate has become milder and ticks have become more abundant. We investigated whether there is a link between the change in climate and the increase in incidence of TEE. Methods Since the late 1950s all cases of encephalitis admitted in Stockholm County have been serologically tested for TEE. We analysed the period 1960-98 with multiple regressions. The number of days per season with temperatures of known importance for tick prevalence and pathogen transmission were studied. 2 years of temperature data were related to each TEE incidence rate to account for the tick's long life-span. Findings Increases in disease incidence was significantly related (R-2=0.58; p<0.0001) to a combination of two consecutive mild winters, temperatures favouring spring development (8-10<degrees>C) and extended autumn activity (5-8 degreesC) in the year prior to the incidence year, and temperatures allowing tick activity (5-8 degreesC) early in the incidence year. Interpretations The findings indicate that the increase in TBE incidence since the mid-1980s is related to the period's change towards milder winters and early arrival of spring. Other factors may have influenced TBE incidence such as more people in endemic locations, and increases in host animal populations; factors which are partly climate related. Access to TBE vaccination since 1986 and increased awareness of ticks might have caused an underestimation of the links found. Our findings also suggest that the incidence of other tick-borne zoonoses might have been affected by the milder climate.	Stockholm Univ, Dept Syst Ecol Nat Resources Management, SE-10691 Stockholm, Sweden; Huddinge Univ Hosp, Karolinska Inst, Div Clin Immunol, Dept Immunol Microbiol Pathol & Infect Dis, Stockholm, Sweden	Stockholm University; Karolinska Institutet	Lindgren, E (corresponding author), Stockholm Univ, Dept Syst Ecol Nat Resources Management, SE-10691 Stockholm, Sweden.							Balashov Y.S., 1972, MISC PIB ENTOMOL SOC, V8, P161; BERGLUND J, 1995, NEW ENGL J MED, V333, P1319, DOI 10.1056/NEJM199511163332004; Berry MO, 1981, HDB SNOW, P32; Bjoersdorff A, 1999, SCAND J INFECT DIS, V31, P51, DOI 10.1080/00365549950161880; DANIEL M, 1993, ACAROLOGIA, V34, P105; DUFFY DC, 1994, J MED ENTOMOL, V31, P178, DOI 10.1093/jmedent/31.1.178; FUJIMOTO K, 1994, JPN J SANIT ZOOL, V1, P333; GUSTAFSON R, 1994, SCAND J INFECT DI S1, V24, pS181; KAISER R, 1995, LANCET, V345, P463, DOI 10.1016/S0140-6736(95)90452-2; Lindblom U, 1998, EUR J PAIN-LONDON, V2, P1, DOI 10.1016/S1090-3801(98)90040-4; Lindgren E, 2000, ENVIRON HEALTH PERSP, V108, P119, DOI 10.2307/3454509; LINDSAY LR, 1995, J MED ENTOMOL, V32, P143, DOI 10.1093/jmedent/32.2.143; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; *WORLD MET ORG, 1999, STAT STAT GLOB CLIM; Zinyovera MC, 1998, IPCC REGIONAL IMPACA, P149	15	251	262	1	57	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 7	2001	358	9275					16	18		10.1016/S0140-6736(00)05250-8	http://dx.doi.org/10.1016/S0140-6736(00)05250-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11454371				2022-12-28	WOS:000169710900010
J	Li, LY; Luo, L; Wang, XD				Li, LY; Luo, L; Wang, XD			Endonuclease G is an apoptotic DNase when released from mitochondria	NATURE			English	Article							CYTOCHROME-C RELEASE; CELL-DEATH; CASPASE ACTIVATION; MICE LACKING; PROTEIN; FRAGMENTATION; BAX; PATHWAYS; BINDING; BRAIN	Nucleosomal fragmentation of DNA is a hallmark of apoptosis (programmed cell death)(1), and results from the activation of nucleases in cells undergoing apoptosis. One such nuclease, DNA fragmentation factor (DFF, a caspase-activated deoxyribonuclease (CAD) and its inhibitor (ICAD)), is capable of inducing DNA fragmentation and chromatin condensation after cleavage by caspase-3 (refs 2-4). However, although transgenic mice lacking DFF45 or its caspase cleavage site have significantly reduced DNA fragmentation(5,6), these mice still show residual DNA fragmentation and are phenotypically normal(5-7). Here we report the identification and characterization of another nuclease that is specifically activated by apoptotic stimuli and is able to induce nucleosomal fragmentation of DNA in fibroblast cells from embryonic mice lacking DFF. This nuclease is endonuclease G (endoG), a mitochondrion-specific nuclease that translocates to the nucleus during apoptosis. Once released from mitochondria, endoG cleaves chromatin DNA into nucleosomal fragments independently of caspases. Therefore, endoG represents a caspase-independent apoptotic pathway initiated from the mitochondria.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Wang, XD (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA.	xwang@biochem.swmed.edu		Wang, Xiaodong/0000-0001-9885-356X				Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chautan M, 1999, CURR BIOL, V9, P967, DOI 10.1016/S0960-9822(99)80425-4; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; COTE J, 1993, SCIENCE, V261, P765, DOI 10.1126/science.7688144; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Honarpour N, 2000, DEV BIOL, V218, P248, DOI 10.1006/dbio.1999.9585; Ikeda S, 1997, BIOCHEM BIOPH RES CO, V235, P291, DOI 10.1006/bbrc.1997.6786; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; McIlroy D, 2000, GENE DEV, V14, P549; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; TIRANTI V, 1995, GENOMICS, V25, P559, DOI 10.1016/0888-7543(95)80058-T; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; von Ahsen O, 2000, J CELL BIOL, V150, P1027, DOI 10.1083/jcb.150.5.1027; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zhang JH, 2000, CELL RES, V10, P205, DOI 10.1038/sj.cr.7290049; Zhang JH, 1998, P NATL ACAD SCI USA, V95, P12480, DOI 10.1073/pnas.95.21.12480; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	30	1273	1349	11	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					95	99		10.1038/35083620	http://dx.doi.org/10.1038/35083620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452314				2022-12-28	WOS:000169644900051
J	Yoo, BC; Lubec, G				Yoo, BC; Lubec, G			Neurobiology - p25 protein in neurodegeneration	NATURE			English	Article							ALZHEIMERS-DISEASE; P35; ACTIVATOR; CALPAIN; CDK5; CLEAVAGE		Univ Vienna, Dept Pediat, A-1090 Vienna, Austria	University of Vienna	Yoo, BC (corresponding author), Univ Vienna, Dept Pediat, A-1090 Vienna, Austria.			Lubec, Gert/0000-0002-6333-9461				Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Nath R, 2000, BIOCHEM BIOPH RES CO, V274, P16, DOI 10.1006/bbrc.2000.3070; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; TIERNEY MC, 1988, NEUROLOGY, V38, P359, DOI 10.1212/WNL.38.3.359	7	74	80	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					763	764		10.1038/35081146	http://dx.doi.org/10.1038/35081146			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459045				2022-12-28	WOS:000169246400034
J	Ourednik, V; Ourednik, J; Flax, JD; Zawada, WM; Hutt, C; Yang, CH; Park, KI; Kim, SU; Sidman, RL; Freed, CR; Snyder, EY				Ourednik, V; Ourednik, J; Flax, JD; Zawada, WM; Hutt, C; Yang, CH; Park, KI; Kim, SU; Sidman, RL; Freed, CR; Snyder, EY			Segregation of human neural stem cells in the developing primate forebrain	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; DEVELOPING CEREBRAL-CORTEX; ADULT HUMAN HIPPOCAMPUS; MAMMALIAN BRAIN; NEUROGENESIS; NEOCORTEX; MIGRATION; NEURONS; TRANSPLANTATION; PROGENITORS	Many central nervous system regions at all stages of Life contain neural stem cells (NSCs). We explored how these disparate NSC pools might emerge. A traceable clone of human NSCs was implanted intraventricularly to allow its integration into cerebral germinal zones of Old World monkey fetuses. The NSCs distributed into two subpopulations: One contributed to corticogenesis by migrating along radial glia to temporally appropriate layers of the cortical plate and differentiating into lamina-appropriate neurons or glia; the other remained undifferentiated and contributed to a secondary germinal zone (the subventricular zone) with occasional members interspersed throughout brain parenchyma. An early neurogenetic program allocates the progeny of NSCs either immediately for organogenesis or to undifferentiated pools for later use in the "postdevelopmental" brain.	Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Neurosurg, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA; Univ Colorado, Sch Med, Dept Med & Pharmacol, Denver, CO 80220 USA; Univ Colorado, Sch Med, Neurosci Program, Denver, CO 80220 USA; Yonsei Univ, Coll Med, Dept Pediat, Seoul, South Korea; Univ British Columbia, Dept Neurol, Vancouver, BC V6T 2B5, Canada; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurosurg,LMRC, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Yonsei University; Yonsei University Health System; University of British Columbia; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Ourednik, V (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, 855 Harvard Inst Med,77 Ave Louis Pasteur, Boston, MA 02115 USA.	vouredni@caregroup.harvard.edu; esnyder1@caregroup.harvard.edu						AUSTIN CP, 1990, DEVELOPMENT, V110, P713; BAYER SA, 1994, NEUROIMAGE, V1, P296, DOI 10.1006/nimg.1994.1014; Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481; Campbell K, 1995, NEURON, V15, P1259, DOI 10.1016/0896-6273(95)90006-3; Donoghue MJ, 1999, CEREB CORTEX, V9, P586, DOI 10.1093/cercor/9.6.586; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Goldman SA, 1998, TRENDS NEUROSCI, V21, P107, DOI 10.1016/S0166-2236(97)01191-0; Goldman-Rakic P S, 1982, Neurosci Res Program Bull, V20, P520; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; GRANGER B, 1995, J COMP NEUROL, V360, P363, DOI 10.1002/cne.903600212; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kakita A, 1999, NEURON, V23, P461, DOI 10.1016/S0896-6273(00)80800-4; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kornack DR, 1998, P NATL ACAD SCI USA, V95, P1242, DOI 10.1073/pnas.95.3.1242; KOSTOVIC I, 1990, J COMP NEUROL, V297, P441, DOI 10.1002/cne.902970309; Lacorazza HD, 1996, NAT MED, V2, P424, DOI 10.1038/nm0496-424; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Mehler MF, 1999, BRAIN PATHOL, V9, P515, DOI 10.1111/j.1750-3639.1999.tb00539.x; Morshead CM, 1998, DEVELOPMENT, V125, P2251; Ourednik J, 1998, J COMP NEUROL, V395, P91, DOI 10.1002/(SICI)1096-9861(19980525)395:1<91::AID-CNE7>3.0.CO;2-C; Ourednik V, 1999, CLIN GENET, V56, P267, DOI 10.1034/j.1399-0004.1999.560403.x; Palmer TD, 1999, J NEUROSCI, V19, P8487; Panchision DM, 2001, GENE DEV, V15, P2094, DOI 10.1101/gad.894701; Park K. I., 1998, Society for Neuroscience Abstracts, V24, P1310; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1995, P NATL ACAD SCI USA, V92, P11323, DOI 10.1073/pnas.92.25.11323; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roy NS, 2000, NAT MED, V6, P271; Rubio FJ, 2000, MOL CELL NEUROSCI, V16, P1, DOI 10.1006/mcne.2000.0854; Shen Q, 1998, J NEUROBIOL, V36, P162, DOI 10.1002/(SICI)1097-4695(199808)36:2<162::AID-NEU5>3.0.CO;2-#; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Sidman R. L., 1982, HISTOL HISTOPATHOL, P3; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Svendsen CN, 1997, EXP NEUROL, V148, P135, DOI 10.1006/exnr.1997.6634; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; WALSH C, 1993, NATURE, V362, P632, DOI 10.1038/362632a0	44	164	174	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1820	1824		10.1126/science.1060580	http://dx.doi.org/10.1126/science.1060580			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11474066				2022-12-28	WOS:000170894400044
J	Hutvagner, G; McLachlan, J; Pasquinelli, AE; Balint, E; Tuschl, T; Zamore, PD				Hutvagner, G; McLachlan, J; Pasquinelli, AE; Balint, E; Tuschl, T; Zamore, PD			A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; C-ELEGANS; REGULATORY RNA; MESSENGER-RNA; GENE; LIN-14; ARABIDOPSIS; DROSOPHILA; SEQUENCE	The 21-nucleotide small temporal RNA (stRNA) let-7 regulates developmental timing in Caenorhabditis elegans and probably in other bilateral animals. We present in vivo and in vitro evidence that in Drosophila melanogaster a developmentally regulated precursor RNA is cleaved by an RNA interference-like mechanism to produce mature let-7 stRNA. Targeted destruction in cultured human cells of the messenger RNA encoding the enzyme Dicer, which acts in the RNA interference pathway, leads to accumulation of the let-7 precursor. Thus, the RNA interference and stRNA pathways intersect. Both pathways require the RNA-processing enzyme Dicer to produce the active small-RNA component that represses gene expression.	Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA; Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Max Planck Society	Hutvagner, G (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA.	phillip.zamore@umassmed.edu	Zamore, Phillip D/A-8941-2013	Hutvagner, Gyorgy/0000-0002-7231-9446; Zamore, Phillip/0000-0002-4505-9618	NIGMS NIH HHS [GM62862-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062862, R37GM062862] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alefelder S, 1998, NUCLEIC ACIDS RES, V26, P4983, DOI 10.1093/nar/26.21.4983; ARASU P, 1991, GENE DEV, V5, P1825, DOI 10.1101/gad.5.10.1825; Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; CHELLADURAI B, 1993, BIOCHEMISTRY-US, V32, P7549, DOI 10.1021/bi00080a029; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Filippov V, 2000, GENE, V245, P213, DOI 10.1016/S0378-1119(99)00571-5; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Ha I, 1996, GENE DEV, V10, P3041, DOI 10.1101/gad.10.23.3041; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Lam G, 2000, CURR BIOL, V10, P957, DOI 10.1016/S0960-9822(00)00631-X; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Matsuda S, 2000, BBA-GENE STRUCT EXPR, V1490, P163, DOI 10.1016/S0167-4781(99)00221-3; Moss EG, 2000, CURR BIOL, V10, pR436, DOI 10.1016/S0960-9822(00)00528-5; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nicholson AW, 1999, FEMS MICROBIOL REV, V23, P371, DOI 10.1016/S0168-6445(99)00013-3; NYKANEN A, UNPUB; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; PASQUINELLI AE, UNPUB; Ray A, 1996, DEVELOPMENT, V122, P2631; Ray S, 1996, DEV BIOL, V180, P365, DOI 10.1006/dbio.1996.0309; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; RUVKUN G, 1991, DEVELOPMENT, P47; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; WIGHTMAN B, 1991, GENE DEV, V5, P1813, DOI 10.1101/gad.5.10.1813; Yang D, 2000, CURR BIOL, V10, P1191, DOI 10.1016/S0960-9822(00)00732-6; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; ZUKER M, 1999, PRACTICAL GUIDE RNA	36	2046	2332	6	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2001	293	5531					834	838		10.1126/science.1062961	http://dx.doi.org/10.1126/science.1062961			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11452083				2022-12-28	WOS:000170241000037
J	Lauder, JM; Oppenheim, R				Lauder, JM; Oppenheim, R			Viktor Hamburger (1900-2001) - Obituary	NATURE			English	Biographical-Item									Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Neurobiol & Anat, Winston Salem, NC 27157 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Wake Forest University; Wake Forest Baptist Medical Center	Lauder, JM (corresponding author), Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA.							HAMBURGER V, PUBLICATION LIST	1	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					496	496		10.1038/35087701	http://dx.doi.org/10.1038/35087701			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484037				2022-12-28	WOS:000170202900029
J	Lutz, W; Sanderson, W; Scherbov, S				Lutz, W; Sanderson, W; Scherbov, S			The end of world population growth	NATURE			English	Article							UNITED-STATES; FORECASTS; DECLINE	There has been enormous concern about the consequences of human population growth for the environment and for social and economic development. But this growth is likely to come to an end in the foreseeable future. Improving on earlier methods of probabilistic forecasting(1), here we show that there is around an 85 per cent chance that the world's population will stop growing before the end of the century. There is a 60 per cent probability that the world's population will not exceed 10 billion people before 2100, and around a 15 per cent probability that the world's population at the end of the century will be lower than it is today. For different regions, the date and size of the peak population will vary considerably.	Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; SUNY Stony Brook, Dept Econ, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Hist, Stony Brook, NY 11794 USA; Univ Groningen, NL-9700 AV Groningen, Netherlands	International Institute for Applied Systems Analysis (IIASA); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Groningen	Lutz, W (corresponding author), Int Inst Appl Syst Anal, Schlosspl 1, A-2361 Laxenburg, Austria.	lutz@iiasa.ac.at	Scherbov, Sergey/F-3158-2019; Sanderson, Warren/R-3398-2019	Scherbov, Sergey/0000-0001-5902-3790; Lutz, Wolfgang/0000-0001-7975-8145; Sanderson, Warren/0000-0002-2205-948X; Scherbov, Sergei/0000-0002-0881-1073				ALHO JM, 1990, INT J FORECASTING, V6, P521, DOI 10.1016/0169-2070(90)90030-F; Alho JM, 1997, J ROY STAT SOC A STA, V160, P71, DOI 10.1111/1467-985X.00046; [Anonymous], 2000, WORLD DEV IND; Bongaarts J., 2000, 6 BILLION PROJECTING, V1st ed.; Keilman N, 1998, POPUL DEV REV, V24, P15, DOI 10.2307/2808049; LEE RD, 1994, J AM STAT ASSOC, V89, P1175, DOI 10.2307/2290980; Lee RD, 1998, POPUL DEV REV, V24, P156, DOI 10.2307/2808055; LEE RD, 1992, J AM STAT ASSOC, V87, P659, DOI 10.2307/2290201; Lutz W, 1998, EUR J POPUL, V14, P1, DOI 10.1023/A:1006040321755; Lutz W, 1998, POPUL DEV REV, V24, P139, DOI 10.2307/2808054; Lutz W, 1997, NATURE, V387, P803, DOI 10.1038/42935; Lutz W, 1996, FUTURE POPULATION WO, P397; Lutz W., 1996, FUTURE POPULATION WO; O'Neill BC, 1999, POPUL DEV REV, V25, P749, DOI 10.1111/j.1728-4457.1999.00749.x; STOTO MA, 1983, J AM STAT ASSOC, V78, P13, DOI 10.2307/2287094; Tuljapurkar S, 2000, NATURE, V405, P789, DOI 10.1038/35015561; *UN, 1999, LONG RANG WORLD POP; US Census Bureau, 2000, INT DAT; Vaupel J. W., 1996, FUTURE POPULATION WO, P278	19	325	339	8	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2001	412	6846					543	545		10.1038/35087589	http://dx.doi.org/10.1038/35087589			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	458PC	11484054	Green Accepted			2022-12-28	WOS:000170202900046
J	Newman, JH; Wheeler, L; Lane, KB; Loyd, E; Gaddipati, R; Phillips, JA; Loyd, JE				Newman, JH; Wheeler, L; Lane, KB; Loyd, E; Gaddipati, R; Phillips, JA; Loyd, JE			Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GERMLINE MUTATIONS	Background: Most patients with primary pulmonary hypertension are thought to have sporadic, not inherited, disease. Because clinical disease develops in only 10 to 20 percent of persons carrying the gene for familial primary pulmonary hypertension, we hypothesized that many patients with apparently sporadic primary pulmonary hypertension may actually have familial primary pulmonary hypertension. Methods: In a study conducted over 20 years, we developed a registry of 67 families affected by familial primary pulmonary hypertension. Through patient referrals, extensive family histories, and correlation of family pedigrees, we discovered shared ancestry among five subfamilies. We assessed some family members for mutations in the gene encoding bone morphogenetic protein receptor II (BMPR2), which has recently been found to cause familial primary pulmonary hypertension. Results: We linked five separately identified subfamilies that included 394 known members spanning seven generations, which were traced back to a founding couple in the mid-1800s. Familial primary pulmonary hypertension has been diagnosed in 18 family members, 12 of whom were first thought to have sporadic disease. The conditions of 7 of the 18 were initially misdiagnosed as other cardiopulmonary diseases. Six members affected with familial primary pulmonary hypertension and 6 of 10 at risk for carriage have undergone genotype analysis, and they have the same mutation in BMPR2, a transversion of thymine to guanine at position 354 in exon 3. Conclusions: Many cases of apparently sporadic primary pulmonary hypertension may be familial. The recent discovery of mutations in BMPR2 should make it possible to identify those with susceptibility to the disease.	Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med,Ctr Lung Res, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Pediat, Div Med Genet, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University	Newman, JH (corresponding author), Vanderbilt Univ, Med Ctr N, Allergy Pulm & Crit Care Div, T-1218, Nashville, TN 37232 USA.			Loyd, James/0000-0002-5042-7390	NCRR NIH HHS [RR 00095] Funding Source: Medline; PHS HHS [R0I 48164-06] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; DRESDALE DT, 1954, B NEW YORK ACAD MED, V30, P195; DRESDALE DT, 1951, AM J MED, V11, P686, DOI 10.1016/0002-9343(51)90020-4; ELLIOTT G, 1995, CHEST, V108, P973, DOI 10.1378/chest.108.4.973; KINGDON HS, 1966, ARCH INTERN MED, V118, P422, DOI 10.1001/archinte.118.5.422; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; LOYD JE, 1995, AM J RESP CRIT CARE, V152, P93, DOI 10.1164/ajrccm.152.1.7599869; LOYD JE, 1984, AM REV RESPIR DIS, V129, P194; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Nichols WC, 1997, NAT GENET, V15, P277, DOI 10.1038/ng0397-277; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; Rich S, 1998, WORLD S PRIM PULM HY; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Zhou SB, 1999, NEW ENGL J MED, V341, P1144, DOI 10.1056/NEJM199910073411510	15	246	263	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2001	345	5					319	324		10.1056/NEJM200108023450502	http://dx.doi.org/10.1056/NEJM200108023450502			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458KM	11484688				2022-12-28	WOS:000170193600002
J	McCulloch, A				McCulloch, A			Social environments and health: cross sectional national survey	BRITISH MEDICAL JOURNAL			English	Article									Univ Essex, Inst Econ & Social Res, Colchester CO4 3SQ, Essex, England	University of Essex	McCulloch, A (corresponding author), Univ Essex, Inst Econ & Social Res, Colchester CO4 3SQ, Essex, England.							CAMPBELL C, 1999, SOCIAL CAPITAL HLTH; Goldberg D.P, 1972, DETECTION PSYCHIAT I; Marmot MG, 1998, LANCET, V351, P57, DOI 10.1016/S0140-6736(97)08084-7; SAMPSON RJ, 1989, AM J SOCIOL, V94, P774, DOI 10.1086/229068; TAYLOR MF, 1999, BRIT HOUSEHOLD PANEL, VA	5	87	88	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2001	323	7306					208	209		10.1136/bmj.323.7306.208	http://dx.doi.org/10.1136/bmj.323.7306.208			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459UQ	11473913	Green Published, Bronze			2022-12-28	WOS:000170270200020
J	DiAntonio, A; Haghighi, AP; Portman, SL; Lee, JD; Amaranto, AM; Goodman, CS				DiAntonio, A; Haghighi, AP; Portman, SL; Lee, JD; Amaranto, AM; Goodman, CS			Ubiquitination-dependent mechanisms regulate synaptic growth and function	NATURE			English	Article							FAT-FACETS GENE; DROSOPHILA; EXPRESSION; SYSTEM; LIGASE	The covalent attachment of ubiquitin to cellular proteins is a powerful mechanism for controlling protein activity and localization(1). Ubiquitination is a reversible modification promoted by ubiquitin ligases and antagonized by deubiquitinating proteases(2). Ubiquitin-dependent mechanisms regulate many important processes including cell-cycle progression, apoptosis and transcriptional regulation(3). Here we show that ubiquitin-dependent mechanisms regulate synaptic development at the Drosophila neuromuscular junction (NMJ). Neuronal overexpression of the deubiquitinating protease fat facets(4) leads to a profound disruption of synaptic growth control; there is a large increase in the number of synaptic boutons, an elaboration of the synaptic branching pattern, and a disruption of synaptic function. Antagonizing the ubiquitination pathway in neurons by expression of the yeast deubiquitinating protease UBP2 (ref. 5) also produces synaptic overgrowth and dysfunction. Genetic interactions between fat facets and highwire(6), a negative regulator of synaptic growth that has structural homology to a family of ubiquitin ligases, suggest that synaptic development may be controlled by the balance between positive and negative regulators of ubiquitination.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Washington University (WUSTL); University of California System; University of California Berkeley	DiAntonio, A (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, 660 S Euclid,Campus Box 8103, St Louis, MO 63110 USA.			DiAntonio, Aaron/0000-0002-7262-0968				[Anonymous], COMPREHENSIVE MENTAL; BRAND AH, 1993, DEVELOPMENT, V118, P401; CHAPMAN AP, 1994, NEUROSCI LETT, V168, P238, DOI 10.1016/0304-3940(94)90459-6; Chen X, 2000, GENETICS, V156, P1829; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; DiAntonio A, 1999, J NEUROSCI, V19, P3023; FISCHERVIZE JA, 1992, DEVELOPMENT, V116, P985; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; HUANG YZ, 1995, SCIENCE, V270, P1828, DOI 10.1126/science.270.5243.1828; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Rorth P, 1998, DEVELOPMENT, V125, P1049; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; SERDAROGLU P, 1992, NEUROPATH APPL NEURO, V18, P232, DOI 10.1111/j.1365-2990.1992.tb00785.x; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Wu ZR, 1999, DEV GENET, V25, P312, DOI 10.1002/(SICI)1520-6408(1999)25:4<312::AID-DVG5>3.0.CO;2-Z; YAO KM, 1994, J NEUROCHEM, V63, P41; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	23	315	325	0	23	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					449	452		10.1038/35086595	http://dx.doi.org/10.1038/35086595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473321				2022-12-28	WOS:000170068200051
J	Lynch, J; Smith, GD; Hillemeier, M; Shaw, M; Raghunathan, T; Kaplan, G				Lynch, J; Smith, GD; Hillemeier, M; Shaw, M; Raghunathan, T; Kaplan, G			Income inequality, the psychosocial environment, and health: comparisons of wealthy nations	LANCET			English	Article							CAUSE-SPECIFIC MORTALITY; UNITED-STATES; LIFE EXPECTANCY; RISK-FACTORS; COUNTRIES; POVERTY	Background The theory that income inequality and characteristics of the psychosocial environment (indexed by such things as social capital and sense of control over life's circumstances) are key determinants of health and could account for health differences between countries has become influential in health inequalities research and for population health policy. Methods We examined cross-sectional associations between income inequality and low birthweight, life expectancy, self-rated health, and age-specific and cause-specific mortality among countries providing data in wave III (around 1989-92) of the Luxembourg Income Study. We also used data from the 1990-91 wave of the World Values Survey (WVS). We obtained life expectancy, mortality, and low birthweight data from the WHO Statistical Information System. Findings Among the countries studied, higher income inequality was strongly associated with greater infant mortality (r=0.69, p=0.004 for women; r=0.74, p=0.002 for men). Associations between income inequality and mortality declined with age at death, and then reversed among those aged 65 years and older. Income inequality was inconsistently associated with specific causes of death and was not associated with coronary heart disease (CHD), breast or prostate cancer, cirrhosis, or diabetes mortality. Countries that had greater trade union membership and political representation by women had better child mortality profiles. Differences between countries in levels of social capital showed generally weak and somewhat inconsistent associations with cause-specific and age-specific mortality. Interpretation Income inequality and characteristics of the psychosocial environment like trust, control, and organisational membership do not seem to be key factors in understanding health differences between these wealthy countries. The associations that do exist are largely limited to child health outcomes and cirrhosis. Explanations for between-country differences in health will require an appreciation of the complex interactions of history, culture, politics, economics, and the status of women and ethnic minorities.	Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Social Res, Ann Arbor, MI 48109 USA; Univ Bristol, Dept Geog Sci, Bristol BS8 1TH, Avon, England; Univ Bristol, Dept Social Med, Bristol BS8 1TH, Avon, England	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Bristol; University of Bristol	Lynch, J (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.		Lynch, John W/A-4797-2008; Kaplan, George/AAJ-2398-2020; Hillemeier, Marianne/AAD-3566-2021; Davey Smith, George/A-7407-2013	Lynch, John W/0000-0003-2781-7902; Davey Smith, George/0000-0002-1407-8314				[Anonymous], 2000, BOWLING ALONE; Atkinson AB, 1995, INCOME DISTRIBUTION; Baum F, 1999, J EPIDEMIOL COMMUN H, V53, P195, DOI 10.1136/jech.53.4.195; DAVEYSMITH G, 1996, BRIT MED J, V312, P987; Ellison GTH, 1999, ANN NY ACAD SCI, V896, P325, DOI 10.1111/j.1749-6632.1999.tb08130.x; Everson SA, 1997, AM J EPIDEMIOL, V146, P142; Fiscella K, 1997, BRIT MED J, V314, P1724, DOI 10.1136/bmj.314.7096.1724; Gravelle H, 1998, BMJ-BRIT MED J, V316, P382, DOI 10.1136/bmj.316.7128.382; INGLEHART R, 1997, MODERNIZATOIN POSTMO; Judge K, 1998, SOC SCI MED, V46, P567, DOI 10.1016/S0277-9536(97)00204-9; JUDGE K, 1995, BRIT MED J, V311, P1282, DOI 10.1136/bmj.311.7015.1282; Kaplan GA, 1996, BRIT MED J, V312, P999; KAPLAN GA, 1994, EPIDEMIOLOGY, V5, P495; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Kennedy BP, 1996, BRIT MED J, V312, P1004, DOI 10.1136/bmj.312.7037.1004; Kunst AE, 1998, BMJ-BRIT MED J, V316, P1636, DOI 10.1136/bmj.316.7145.1636; Lobmayer P, 2000, SOCIOL HEALTH ILL, V22, P401, DOI 10.1111/1467-9566.00211; Lynch J, 2000, J EPIDEMIOL COMMUN H, V54, P404, DOI 10.1136/jech.54.6.404; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; Marmot M, 2000, BMJ-BRIT MED J, V321, P1124, DOI 10.1136/bmj.321.7269.1124; Marmot MG, 1998, LANCET, V351, P57, DOI 10.1016/S0140-6736(97)08084-7; Marmot MG, 1997, LANCET, V350, P235, DOI 10.1016/S0140-6736(97)04244-X; Mcisaac SJ, 1997, EUR J PUBLIC HEALTH, V7, P45, DOI 10.1093/eurpub/7.1.45; Organization W. H., 1992, WORLD HLTH STAT ANN; Ross NA, 2000, BRIT MED J, V320, P898, DOI 10.1136/bmj.320.7239.898; SMITH GD, 2001, LIFE COURSE APPROACH; *UN, 1992, WOM POL DEC MAK LAT; *UN DEV PROGR, 1993, HUM DEV REP 1993; Wagstaff A, 2000, ANNU REV PUBL HEALTH, V21, P543, DOI 10.1146/annurev.publhealth.21.1.543; Wilkinson R., 1996, UNHEALTHY SOC AFFLIC; WILKINSON RG, 1992, BRIT MED J, V304, P165, DOI 10.1136/bmj.304.6820.165; WILKINSON RG, 1995, BRIT MED J, V311, P1285, DOI 10.1136/bmj.311.7015.1285; WILKINSON RG, 1999, SOC POPULATION HLTH, P792; WILLIAMS RB, 1995, PSYCHOSOM MED, V57, P96; Wolfson M, 1999, BRIT MED J, V319, P953, DOI 10.1136/bmj.319.7215.953	35	285	295	2	70	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 21	2001	358	9277					194	200		10.1016/S0140-6736(01)05407-1	http://dx.doi.org/10.1016/S0140-6736(01)05407-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	454HL	11476836	Green Submitted			2022-12-28	WOS:000169967100012
J	Stevens, RC; Wilson, IA				Stevens, RC; Wilson, IA			Industrializing structural biology	SCIENCE			English	Editorial Material							CRYSTAL-STRUCTURE; PROTEIN-PRODUCTION; TECHNOLOGY; AUTOMATION; RIBOSOME; MODEL; CORE; RNA		Scripps Res Inst, Joint Ctr Struct Genom, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Stevens, RC (corresponding author), Scripps Res Inst, Joint Ctr Struct Genom, Dept Mol Biol, La Jolla, CA 92037 USA.		Stevens, Raymond/K-7272-2015	Stevens, Raymond/0000-0002-4522-8725	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM062411] Funding Source: NIH RePORTER; NIGMS NIH HHS [1P50 GM062411] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abola E, 2000, NAT STRUCT BIOL, V7, P973, DOI 10.1038/80754; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bernal JD, 1934, NATURE, V133, P794, DOI 10.1038/133794b0; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; Diller DJ, 1999, ACTA CRYSTALLOGR D, V55, P656, DOI 10.1107/S0907444998014589; Ealick SE, 2000, CURR OPIN CHEM BIOL, V4, P495, DOI 10.1016/S1367-5931(00)00122-8; Edwards AM, 2000, NAT STRUCT BIOL, V7, P970, DOI 10.1038/80751; Georgalis Yannis, 1999, Science Progress, V82, P271; HARRISON SC, 1978, NATURE, V276, P368, DOI 10.1038/276368a0; KENDREW JC, 1960, NATURE, V185, P422, DOI 10.1038/185422a0; Lamzin VS, 2000, NAT STRUCT BIOL, V7, P978, DOI 10.1038/80763; Lorber B, 1999, PRACT APPROACH SER, P17; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McPherson A., 1999, CRYSTALLIZATION BIOL; Muchmore SW, 2000, STRUCTURE, V8, pR243, DOI 10.1016/S0969-2126(00)00535-9; Mueller U, 2001, J BIOTECHNOL, V85, P7, DOI 10.1016/S0168-1656(00)00349-7; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ramakrishnan V, 2001, CURR OPIN STRUC BIOL, V11, P144, DOI 10.1016/S0959-440X(00)00184-6; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; ROENTGEN WC, 1895, WURZBURG PHYSICAL ME; Service RF, 2001, SCIENCE, V292, P187; Stevens RC, 2000, CURR OPIN STRUC BIOL, V10, P558, DOI 10.1016/S0959-440X(00)00131-7; Stevens RC, 2000, STRUCTURE, V8, pR177, DOI 10.1016/S0969-2126(00)00193-3; Sweet RM, 1998, NAT STRUCT BIOL, V5, P654, DOI 10.1038/1344; Thornton JM, 2001, SCIENCE, V292, P2095, DOI 10.1126/science.292.5524.2095; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	30	31	33	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2001	293	5529					519	520		10.1126/science.293.5529.519	http://dx.doi.org/10.1126/science.293.5529.519			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463918				2022-12-28	WOS:000169966700053
J	King, LS; Choi, M; Fernandez, PC; Cartron, J; Agre, P				King, LS; Choi, M; Fernandez, PC; Cartron, J; Agre, P			Brief report: Defective urinary concentrating ability due to a complete deficiency of aquaporin-1	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WATER CHANNELS; PROTEIN; VASOPRESSIN; CHIP; REABSORPTION; REQUIREMENT; EXPRESSION; MUTATIONS; RAT		Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Div Nephrol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21287 USA; Univ Penn, Sch Med, Penn Ctr Mol Kidney Dis, Philadelphia, PA 19104 USA; INSERM, U76, Paris, France	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Pennsylvania; Institut National de la Sante et de la Recherche Medicale (Inserm)	King, LS (corresponding author), Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, 600 N Wolfe St,Blalock 910, Baltimore, MD 21287 USA.	lsking@welch.jhu.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1 RR00052] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ATHERTON JC, 1986, RENAL PHYSIOL BIOCH, V9, P74; Berry V, 2000, NAT GENET, V25, P15, DOI 10.1038/75538; DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421; DENKER BM, 1988, J BIOL CHEM, V263, P15634; DIGIOVANNI SR, 1994, P NATL ACAD SCI USA, V91, P8984, DOI 10.1073/pnas.91.19.8984; HATCH FE, 1967, J CLIN INVEST, V46, P336, DOI 10.1172/JCI105535; KANNO K, 1995, NEW ENGL J MED, V332, P1540, DOI 10.1056/NEJM199506083322303; King LS, 1996, J CLIN INVEST, V97, P2183, DOI 10.1172/JCI118659; KLEEMAN CR, 1956, J CLIN INVEST, V35, P749, DOI 10.1172/JCI103326; LEVINSKY NG, 1992, HDB PHYSL, V1, P227; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Mathai JC, 1996, J BIOL CHEM, V271, P1309, DOI 10.1074/jbc.271.3.1309; MOON C, 1993, J BIOL CHEM, V268, P15772; NIELSEN S, 1993, J CELL BIOL, V120, P371, DOI 10.1083/jcb.120.2.371; NIELSEN S, 1995, AM J PHYSIOL-RENAL, V268, pF1023, DOI 10.1152/ajprenal.1995.268.6.F1023; Pallone TL, 2000, J CLIN INVEST, V105, P215, DOI 10.1172/JCI8214; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; PRESTON GM, 1994, SCIENCE, V265, P1585, DOI 10.1126/science.7521540; ROBERTSON GL, 1974, ANNU REV MED, V25, P315, DOI 10.1146/annurev.me.25.020174.001531; ROBERTSON GL, 1988, ANNU REV MED, V39, P425, DOI 10.1146/annurev.med.39.1.425; ROMBOLA G, 1987, Nephrology Dialysis Transplantation, V2, P212; Schnermann J, 1998, P NATL ACAD SCI USA, V95, P9660, DOI 10.1073/pnas.95.16.9660; SMITH BL, 1994, J CLIN INVEST, V94, P1043, DOI 10.1172/JCI117418; SMITH BL, 1991, J BIOL CHEM, V266, P6407; Steinfeld S, 2001, LAB INVEST, V81, P143, DOI 10.1038/labinvest.3780221; STEINMETZ PR, 1964, J LAB CLIN MED, V64, P238; Thomsen K, 1990, Kidney Int Suppl, V28, pS10; THOMSEN K, 1984, NEPHRON, V37, P217, DOI 10.1159/000183252; Tsubota K, 2001, LANCET, V357, P688, DOI 10.1016/S0140-6736(00)04140-4; ZELINSKI T, 1990, GENOMICS, V6, P623	30	145	152	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2001	345	3					175	179		10.1056/NEJM200107193450304	http://dx.doi.org/10.1056/NEJM200107193450304			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453JM	11463012				2022-12-28	WOS:000169912800004
J	Lamb, S				Lamb, S			Walking with producers - Is science on television often edited for impact rather than accuracy?	NATURE			English	Editorial Material									Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England	University of Oxford	Lamb, S (corresponding author), Univ Oxford, Dept Earth Sci, Parks Rd, Oxford OX1 3PR, England.								0	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					277	277		10.1038/35085658	http://dx.doi.org/10.1038/35085658			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460140				2022-12-28	WOS:000169918200025
J	Small, PM; Fujiwara, PI				Small, PM; Fujiwara, PI			Medical progress: Management of tuberculosis in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; NEW-YORK-CITY; DIRECTLY OBSERVED THERAPY; FOREIGN-BORN PERSONS; MYCOBACTERIUM-TUBERCULOSIS; HIV-INFECTION; RESISTANT TUBERCULOSIS; EXOGENOUS REINFECTION; PREVENTIVE THERAPY; EPIDEMIOLOGY		Stanford Univ, Med Ctr, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; New York City Dept Hlth, TB Control Program, New York, NY 10013 USA; Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA	Stanford University; New York City Department of Health & Mental Hygiene; Centers for Disease Control & Prevention - USA	Small, PM (corresponding author), Stanford Univ, Med Ctr, Div Infect Dis & Geog Med, Rm S-156, Stanford, CA 94305 USA.	peter@molepi.stanford.edu						*ADV COMM IMM PRAC, 1996, MMWR-MORBID MORTAL W, V45, P1; ALLAN WGL, 1977, AM REV RESPIR DIS, V115, P727; *AM THOR SOC, 1992, AM REV RESPIR DIS, V46, P1623; American Society of Heating Refrigerating and Air-Conditioning Engineers, 2000, ASHRAE GUIDELINE 12, P1; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], 1997, MMWR Recomm Rep, V46, P1; [Anonymous], COR CURR TUB WHAT CL; BARNES PF, 1987, TUBERCLE, V68, P255, DOI 10.1016/0041-3879(87)90065-1; BASS JB, 1994, AM J RESP CRIT CARE, V149, P1359, DOI 10.1164/ajrccm.149.5.8173779; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Bellamy R, 2000, P NATL ACAD SCI USA, V97, P8005, DOI 10.1073/pnas.140201897; BRUDNEY K, 1991, AM REV RESPIR DIS, V144, P745, DOI 10.1164/ajrccm/144.4.745; Bucher HC, 1999, AIDS, V13, P501, DOI 10.1097/00002030-199903110-00009; *BUR TUB CONTR, 1999, CLIN POL PROT; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; CANTWELL MF, 1994, JAMA-J AM MED ASSOC, V272, P535, DOI 10.1001/jama.272.7.535; *CDCP, 2001, SURV REP REP TUB US; *CDCP, 2000, REP TUB US 1999; *CDCP AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, pS221; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P289; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P291; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P269; Chaulk CP, 1998, JAMA-J AM MED ASSOC, V279, P943, DOI 10.1001/jama.279.12.943; CHAULK CP, 1998, JAMA-J AM MED ASSOC, V280, P134; Chin DP, 1996, AM J RESP CRIT CARE, V153, P1982, DOI 10.1164/ajrccm.153.6.8665065; Comstock GW, 1999, INT J TUBERC LUNG D, V3, P847; DeCock KM, 1996, JAMA-J AM MED ASSOC, V276, P1502, DOI 10.1001/jama.276.18.1502; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Ellner JJ, 2000, CLIN INFECT DIS, V30, pS279, DOI 10.1086/313874; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Fujiwara PI, 1997, CLIN CHEST MED, V18, P135, DOI 10.1016/S0272-5231(05)70363-4; FUJIWARA PI, 2000, LUNG BIOL HEALTH DIS, V144, P401; GEITER L, 2000, ENDING NEGLECT ELIMI; Gindler J. S., 1995, Morbidity and Mortality Weekly Report, V44, P1; Ginsberg AM, 2000, CLIN INFECT DIS, V30, pS233, DOI 10.1086/313867; GIRLING DJ, 1992, AM REV RESPIR DIS, V145, P36; Godfrey-Faussett P, 2000, LANCET, V356, P1066, DOI 10.1016/S0140-6736(00)02730-6; Gordin F, 2000, JAMA-J AM MED ASSOC, V283, P1445, DOI 10.1001/jama.283.11.1445; Gordin FM, 1997, NEW ENGL J MED, V337, P315, DOI 10.1056/NEJM199707313370505; Halsey NA, 1998, LANCET, V351, P786, DOI 10.1016/S0140-6736(97)06532-X; Hatfull GF, 2000, MOL GENETICS MYCOBAC; Holland S M, 2000, Adv Intern Med, V45, P431; HOPEWELL PC, 1992, CLIN INFECT DIS, V15, P540, DOI 10.1093/clind/15.3.540; ISCMAN MD, 2000, CLIN GUIDE TUBERCULO, P199; ISEMAN MD, 1993, NEW ENGL J MED, V329, P1435; ISEMAN MD, 2000, CLIN GUIDE TUBERCULO, P271; Jasmer RM, 1999, ANN INTERN MED, V130, P971, DOI 10.7326/0003-4819-130-12-199906150-00004; JONES BE, 1993, AM REV RESPIR DIS, V148, P1292, DOI 10.1164/ajrccm/148.5.1292; Jungblut PR, 1999, MOL MICROBIOL, V33, P1103, DOI 10.1046/j.1365-2958.1999.01549.x; MCKENNA MT, 1995, NEW ENGL J MED, V332, P1071, DOI 10.1056/NEJM199504203321606; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; MENZIES RI, 2000, LUNG BIOL HEALTH DIS, V144, P279; MOORE M, 1999, INT J TUBERC LUNG S, pS20; Mwinga A, 1998, AIDS, V12, P2447, DOI 10.1097/00002030-199818000-00014; Pelicic V, 1998, MOL MICROBIOL, V28, P413, DOI 10.1046/j.1365-2958.1998.00807.x; Peloquin CA, 1999, AM J RESP CRIT CARE, V159, P932, DOI 10.1164/ajrccm.159.3.9807131; PEREZSTABLE EJ, 1988, AM REV RESPIR DIS, V137, P801, DOI 10.1164/ajrccm/137.4.801; PIESSENS WF, 2000, LUNG BIOL HEALTH DIS, V144, P241; Pottumarthy S, 1999, J CLIN MICROBIOL, V37, P3229, DOI 10.1128/JCM.37.10.3229-3232.1999; Protection against viral hepatitis, 1990, MMWR RECOMM REP, V39, P1; REICHMAN LB, 1991, AM REV RESPIR DIS, V144, P741, DOI 10.1164/ajrccm/144.4.741; Riska PF, 2000, INT J TUBERC LUNG D, V4, pS4; Small PM, 2000, LANCET, V356, P1048, DOI 10.1016/S0140-6736(00)02724-0; SMALL PM, 1993, NEW ENGL J MED, V328, P1137, DOI 10.1056/NEJM199304223281601; SNIDER DE, 1986, JAMA-J AM MED ASSOC, V255, P1579, DOI 10.1001/jama.255.12.1579; Sutherland I., 10 YEAR INC CLIN TUB; Tahaoglu K, 2001, NEW ENGL J MED, V345, P170, DOI 10.1056/NEJM200107193450303; Temple ME, 1999, ANN PHARMACOTHER, V33, P1203, DOI 10.1345/aph.18450; THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; VANCLEEFF MRA, 1995, INT J EPIDEMIOL, V24, P637, DOI 10.1093/ije/24.3.637; Vernon A, 1999, LANCET, V353, P1843, DOI 10.1016/S0140-6736(98)11467-8; VERNON A, 2000, AM J RESP CRIT CARE, V161, pA252; Whalen CC, 1997, NEW ENGL J MED, V337, P801, DOI 10.1056/NEJM199709183371201; Wilson W, 1999, P NATL ACAD SCI USA, V96, P12833, DOI 10.1073/pnas.96.22.12833; Zuber PLF, 1997, JAMA-J AM MED ASSOC, V278, P304, DOI 10.1001/jama.278.4.304; Zumla A, 2000, POSTGRAD MED J, V76, P259, DOI 10.1136/pmj.76.895.259; 2000, DRUG FACTS COMP 2000, P1315; 1992, MMWR MORB MORTAL WKL, V41, P61; 1997, MMWR MORB MORTAL WKL, V46, P880	85	204	222	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2001	345	3					189	200		10.1056/NEJM200107193450307	http://dx.doi.org/10.1056/NEJM200107193450307			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453JM	11463015				2022-12-28	WOS:000169912800007
J	Folkman, J; Camphausen, K				Folkman, J; Camphausen, K			Cancer - What does radiotherapy do to endothelial cells?	SCIENCE			English	Editorial Material							ANGIOGENESIS; RADIATION; THERAPY		Childrens Hosp, Dept Surg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Joint Ctr Radiat Therapy, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Folkman, J (corresponding author), Childrens Hosp, Dept Surg, Boston, MA 02115 USA.							Browder T, 2000, CANCER RES, V60, P1878; FERTIL B, 1985, INT J RADIAT ONCOL, V11, P1699, DOI 10.1016/0360-3016(85)90223-8; Folkman J, 1998, ENDOCRINOLOGY, V139, P441, DOI 10.1210/en.139.2.441; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FOLKMAN J, 2000, CANC MED, P132; GREENE AE, COMMUNICATION; Mauceri HJ, 1998, NATURE, V394, P287, DOI 10.1038/28412; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Pena LA, 2000, CANCER RES, V60, P321; PEREZ C, 1992, PRINCIPLES RAD ONCOL; RAK JW, 1995, ANTI-CANCER DRUG, V6, P3, DOI 10.1097/00001813-199502000-00001; Rupnick MA, 1998, CIRCULATION, V98, P455; Stewart RJ, 2001, J UROLOGY, V165, P688, DOI 10.1097/00005392-200102000-00095; Teicher BA, 1994, RADIAT ONCOL INVEST, V2, P269, DOI DOI 10.1002/ROI.2970020604	14	82	83	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					227	228		10.1126/science.1062892	http://dx.doi.org/10.1126/science.1062892			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452105				2022-12-28	WOS:000169875200035
J	Gladman, B; Kavelaars, JJ; Holman, M; Nicholson, PD; Burns, JA; Hergenrother, CW; Petit, JM; Marsden, BG; Jacobson, R; Gray, W; Grav, T				Gladman, B; Kavelaars, JJ; Holman, M; Nicholson, PD; Burns, JA; Hergenrother, CW; Petit, JM; Marsden, BG; Jacobson, R; Gray, W; Grav, T			Discovery of 12 satellites of Saturn exhibiting orbital clustering	NATURE			English	Article							JOVIAN-SATELLITES; ASTEROIDS; URANUS; STABILITY; CAPTURE; ORIGIN; PHOEBE; SYSTEM; MOONS	The giant planets in the Solar System each have two groups of satellites. The regular satellites move along nearly circular orbits in the planet's orbital plane, revolving about it in the same sense as the planet spins. In contrast, the so-called irregular satellites are generally smaller in size and are characterized by large orbits with significant eccentricity, inclination or both. The differences in their characteristics suggest that the regular and irregular satellites formed by different mechanisms: the regular satellites are believed to have formed in an accretion disk around the planet, like a miniature Solar System, whereas the irregulars are generally thought to be captured planetesimals(1). Here we report the discovery of 12 irregular satellites of Saturn, along with the determinations of their orbits. These orbits, along with the orbits of irregular satellites of Jupiter and Uranus, fall into groups on the basis of their orbital inclinations. We interpret this result as indicating that most of the irregular moons are collisional remnants of larger satellites that were fragmented after capture, rather than being captured independently.	Observ Cote Azur, F-06304 Nice 4, France; McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Project Pluto, Bowdoinham, ME 04008 USA; Univ Oslo, Inst Theoret Astrophys, N-0315 Oslo, Norway	UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; McMaster University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Cornell University; University of Arizona; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Oslo	Gladman, B (corresponding author), Observ Cote Azur, BP 4229, F-06304 Nice 4, France.	gladman@obs-nice.fr						Clark R. N., 1986, SATELLITES, P437; COLOMBO G, 1971, ICARUS, V15, P186, DOI 10.1016/0019-1035(71)90073-X; COLWELL JE, 1993, J GEOPHYS RES-PLANET, V98, P7387, DOI 10.1029/93JE00329; FARINELLA P, 1993, ICARUS, V101, P174, DOI 10.1006/icar.1993.1016; Gladman B, 2000, ICARUS, V148, P320, DOI 10.1006/icar.2000.6538; Gladman B, 2000, ICARUS, V147, P320, DOI 10.1006/icar.2000.6463; Gladman B, 1998, ASTRON J, V116, P2042, DOI 10.1086/300573; Gladman BJ, 1998, NATURE, V392, P897, DOI 10.1038/31890; GREEN D, 2000, 7555 IAU; GREEN D, 2000, 7545 IAU; GREEN D, 2000, 7548 IAU; Hamilton DP, 1997, ICARUS, V128, P241, DOI 10.1006/icar.1997.5738; HAMILTON DP, 1991, ICARUS, V92, P118, DOI 10.1016/0019-1035(91)90039-V; HENON M, 1970, ASTRON ASTROPHYS, V9, P24; HEPPENHEIMER TA, 1977, ICARUS, V30, P385, DOI 10.1016/0019-1035(77)90173-7; Jarvis KS, 2000, ICARUS, V145, P445, DOI 10.1006/icar.2000.6344; Kinoshita H, 1991, CELEST MECH DYN ASTR, V52, P293, DOI 10.1007/BF00048489; KOZAI Y, 1962, ASTRON J, V67, P591, DOI 10.1086/108790; LUU J, 1991, ASTRON J, V102, P1213, DOI 10.1086/115949; MARSDEN BG, 2000, 7640 IAU; MARSDEN BG, 2000, 7539 IAU; MARSDEN BG, 2000, 7521 IAU; MARSDEN BG, 2000, 7513 IAU; MARSDEN BG, 2000, 7538 IAU; MARSDEN BG, 2000, 7512 IAU; MARSDEN BG, 2000, 7460 IAU; McKinnon WB, 1995, SPACE SCI S, P807; Peale SJ, 1999, ANNU REV ASTRON ASTR, V37, P533, DOI 10.1146/annurev.astro.37.1.533; POLLACK JB, 1979, ICARUS, V37, P587, DOI 10.1016/0019-1035(79)90016-2; Porco CC, 1995, SPACE SCI S, P703; SAHA P, 1993, ICARUS, V106, P549, DOI 10.1006/icar.1993.1192; Simonelli DP, 1999, ICARUS, V138, P249, DOI 10.1006/icar.1999.6077; SMITH BA, 1982, SCIENCE, V215, P504, DOI 10.1126/science.215.4532.504; Tanga P, 1999, ICARUS, V141, P65, DOI 10.1006/icar.1999.6148; THOMAS P, 1983, J GEOPHYS RES-SPACE, V88, P8736, DOI 10.1029/JA088iA11p08736; Wiegert P, 2000, ASTRON J, V119, P1978, DOI 10.1086/301291	36	86	86	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					163	166		10.1038/35084032	http://dx.doi.org/10.1038/35084032			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449267				2022-12-28	WOS:000169778700045
J	Li, J; Stein, D; McMullan, C; Branton, D; Aziz, MJ; Golovchenko, JA				Li, J; Stein, D; McMullan, C; Branton, D; Aziz, MJ; Golovchenko, JA			Ion-beam sculpting at nanometre length scales	NATURE			English	Article							POLYNUCLEOTIDE MOLECULES; BOMBARDED SI(001); DISCRIMINATION; CHANNEL; SIO2	Manipulating matter at the nanometre scale is important for many electronic, chemical and biological advances(1-3), but present solid-state fabrication methods do not reproducibly achieve dimensional control at the nanometre scale. Here we report a means of fashioning matter at these dimensions that uses low-energy ion beams and reveals surprising atomic transport phenomena that occur in a variety of materials and geometries. The method is implemented in a feedback-controlled sputtering system that provides fine control over ion beam exposure and sample temperature. We call the method "ion-beam sculpting'', and apply it to the problem of fabricating a molecular-scale hole, or nanopore, in a thin insulating solid-state membrane. Such pores can serve to localize molecular-scale electrical junctions and switches(4-6) and function as masks(7) to create other small-scale structures. Nanopores also function as membrane channels in all living systems, where they serve as extremely sensitive electro-mechanical devices that regulate electric potential, ionic flow, and molecular transport across cellular membranes(8). We show that ion-beam sculpting can be used to fashion an analogous solid-state device: a robust electronic detector consisting of a single nanopore in a Si(3)N(4) membrane, capable of registering single DNA molecules in aqueous solution.	Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Golovchenko, JA (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	golovchenko@physics.harvard.edu	Stein, Derek/AAV-4959-2020; Aziz, Michael/AAK-4866-2020	Stein, Derek/0000-0001-5917-4986; Aziz, Michael/0000-0001-9657-9456				Akeson M, 1999, BIOPHYS J, V77, P3227, DOI 10.1016/S0006-3495(99)77153-5; Bezrukov SM, 2000, J MEMBRANE BIOL, V174, P1, DOI 10.1007/s002320001026; BEZRUKOV SM, 1994, NATURE, V370, P279, DOI 10.1038/370279a0; Brongersma ML, 2000, J APPL PHYS, V88, P59, DOI 10.1063/1.373624; Carter G, 1997, SURF INTERFACE ANAL, V25, P952, DOI 10.1002/(SICI)1096-9918(199711)25:12<952::AID-SIA333>3.0.CO;2-F; Deshmukh MM, 1999, APPL PHYS LETT, V75, P1631, DOI 10.1063/1.124777; Erlebacher J, 1999, PHYS REV LETT, V82, P2330, DOI 10.1103/PhysRevLett.82.2330; Erlebacher J, 2000, J VAC SCI TECHNOL A, V18, P115, DOI 10.1116/1.582127; GNASET H, 1999, ION IRRADIATION SOLI; Gu LQ, 1999, NATURE, V398, P686, DOI 10.1038/19491; HAMMILL OP, 1981, PFLUGERS ARCH, V391, P85; Hille B., 1992, IONIC CHANNELS EXCIT; Ito T, 2000, NATURE, V406, P1027, DOI 10.1038/35023233; Joachim C, 2000, NATURE, V408, P541, DOI 10.1038/35046000; JOHNSON RE, 1993, KONG DANSK VIDENSK, P403; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; MAYER TM, 1994, J APPL PHYS, V76, P1633, DOI 10.1063/1.357748; Meller A, 2000, P NATL ACAD SCI USA, V97, P1079, DOI 10.1073/pnas.97.3.1079; NENADOVIC T, 1990, NUCL INSTRUM METH B, V48, P538, DOI 10.1016/0168-583X(90)90178-W; RAICHOUDHURY P, 1997, HDB MICROLITHOGRAPHY, P41; RALLS KS, 1989, APPL PHYS LETT, V55, P2459, DOI 10.1063/1.102001; RALPH DC, 1995, PHYS REV LETT, V74, P3241, DOI 10.1103/PhysRevLett.74.3241; Reed MA, 1998, ANN NY ACAD SCI, V852, P133, DOI 10.1111/j.1749-6632.1998.tb09868.x; SIGMUND P, 1993, DANSKE VIDENSK SELSK, V43, P7; Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242; WOLF S, 2000, SILICON PROCESSING V, P149; Zhou C, 1997, APPL PHYS LETT, V71, P611, DOI 10.1063/1.120195	27	1379	1538	27	545	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					166	169		10.1038/35084037	http://dx.doi.org/10.1038/35084037			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449268	Green Submitted			2022-12-28	WOS:000169778700046
J	Wadman, M				Wadman, M			US blood ban underlines CJD fears	NATURE			English	News Item																		Wadman M, 2001, NATURE, V409, P441, DOI 10.1038/35054193	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					7	7		10.1038/35083730	http://dx.doi.org/10.1038/35083730			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452271	Bronze			2022-12-28	WOS:000169644900010
J	Luecke, H; Schobert, B; Lanyi, JK; Spudich, EN; Spudich, JL				Luecke, H; Schobert, B; Lanyi, JK; Spudich, EN; Spudich, JL			Crystal structure of sensory rhodopsin II at 2.4 angstroms: Insights into color tuning and transducer interaction	SCIENCE			English	Article							MOLECULAR-MECHANISM; NATRONOBACTERIUM-PHARAONIS; PROTON TRANSLOCATION; BACTERIORHODOPSIN; PROTEIN; PHOBORHODOPSIN; PHOTOCYCLE; RECEPTOR; MODEL; TEMPERATURE	We report an atomic-resolution structure for a sensory member of the microbial rhodopsin family, the phototaxis receptor sensory rhodopsin II (NpSRII), which mediates blue-light avoidance by the haloarchaeon Natronobacterium pharaonis. The 2.4 angstrom structure reveals features responsible for the 70- to 80-nanometer blue shift of its absorption maximum relative to those of haloarchaeal transport rhodopsins, as well as structural differences due to its sensory, as opposed to transport, function. Multiple factors appear to account for the spectral tuning difference with respect to bacteriorhodopsin: (i) repositioning of the guanidinium group of arginine 72, a residue that interacts with the counterion to the retinylidene protonated Schiff base; (ii) rearrangement of the protein near the retinal ring; and (iii) changes in tilt and slant of the retinal polyene chain. Inspection of the surface topography reveals an exposed polar residue, tyrosine 199, not present in bacteriorhodopsin, in the middle of the membrane bilayer. We propose that this residue interacts with the adjacent helices of the cognate NpSRII transducer NpHtrII.	Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Univ Texas, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; Univ Texas, Sch Med, Struct Biol Ctr, Houston, TX 77030 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Texas System; University of Texas System	Luecke, H (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	hudel@uci.edu; jlanyi@orion.oac.uci.edu; john.l.spudich@uth.tmc.edu	Luecke, Hartmut/F-4712-2012; Lanyi, Janos/C-3808-2011	Luecke, Hartmut/0000-0002-4938-0775; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029498, R01GM027750, R01GM059970] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM027750, R01 GM029498, R01-GM27750, R01 GM059970, R01-GM29498, R01-GM59970] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balashov SP, 1996, BIOPHYS J, V70, P473, DOI 10.1016/S0006-3495(96)79591-7; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X; Bieszke JA, 1999, BIOCHEMISTRY-US, V38, P14138, DOI 10.1021/bi9916170; BOGOMOLNI RA, 1994, P NATL ACAD SCI USA, V91, P10188, DOI 10.1073/pnas.91.21.10188; Brown LS, 1998, BIOPHYS J, V75, P1455, DOI 10.1016/S0006-3495(98)74064-0; Brown LS, 1998, BIOCHEMISTRY-US, V37, P3982, DOI 10.1021/bi9728396; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chizhov I, 1998, BIOPHYS J, V75, P999, DOI 10.1016/S0006-3495(98)77588-5; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HIRAYAMA J, 1992, BIOCHEMISTRY-US, V31, P2093, DOI 10.1021/bi00122a029; Hoff WD, 1997, ANNU REV BIOPH BIOM, V26, P223, DOI 10.1146/annurev.biophys.26.1.223; KAMO N, IN PRESS BIOCHEMISTR; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Kunji ERS, 2001, J MOL BIOL, V308, P279, DOI 10.1006/jmbi.2001.4565; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Lanyi JK, 2000, J PHYS CHEM B, V104, P11441, DOI 10.1021/jp0023718; Luecke H, 1998, SCIENCE, V280, P1934, DOI 10.1126/science.280.5371.1934; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MILLER A, 1990, BIOCHIM BIOPHYS ACTA, V1020, P57, DOI 10.1016/0005-2728(90)90093-J; NAKANISHI K, 1979, PHOTOCHEM PHOTOBIOL, V29, P657, DOI 10.1111/j.1751-1097.1979.tb07745.x; Oesterhelt D, 1998, CURR OPIN STRUC BIOL, V8, P489, DOI 10.1016/S0959-440X(98)80128-0; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; Rammelsberg R, 1998, BIOCHEMISTRY-US, V37, P5001, DOI 10.1021/bi971701k; Richter HT, 1996, BIOCHEMISTRY-US, V35, P4054, DOI 10.1021/bi952883q; SACK JS, 1988, J MOL GRAPHICS, V6, P224, DOI 10.1016/S0263-7855(98)80040-4; Sasaki J, 1999, BIOPHYS J, V77, P2145, DOI 10.1016/S0006-3495(99)77055-4; Schmies G, 2000, BIOPHYS J, V78, P967, DOI 10.1016/S0006-3495(00)76654-9; Schmies G, 2001, P NATL ACAD SCI USA, V98, P1555, DOI 10.1073/pnas.031562298; SEIDEL R, 1995, P NATL ACAD SCI USA, V92, P3036, DOI 10.1073/pnas.92.7.3036; Shimono K, 2000, PHOTOCHEM PHOTOBIOL, V72, P141; SPUDICH JL, 1986, BIOPHYS J, V49, P479, DOI 10.1016/S0006-3495(86)83657-8; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Subramaniam S, 2000, NATURE, V406, P653, DOI 10.1038/35020614; Sudo Y, 2001, BIOPHYS J, V80, P916, DOI 10.1016/S0006-3495(01)76070-5; SUDO Y, 2000, BIOPHYS J, V78, P959; TAKAHASHI T, 1990, BIOCHEMISTRY-US, V29, P8467, DOI 10.1021/bi00488a038; Wegener AA, 2000, J MOL BIOL, V301, P881, DOI 10.1006/jmbi.2000.4008; YAN B, 1995, J BIOL CHEM, V270, P29668; YAO VJ, 1992, P NATL ACAD SCI USA, V89, P11915, DOI 10.1073/pnas.89.24.11915; Zhang WS, 1996, P NATL ACAD SCI USA, V93, P8230, DOI 10.1073/pnas.93.16.8230; Zhang XN, 1999, P NATL ACAD SCI USA, V96, P857, DOI 10.1073/pnas.96.3.857	43	311	321	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1499	1503		10.1126/science.1062977	http://dx.doi.org/10.1126/science.1062977			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11452084	Green Accepted			2022-12-28	WOS:000170616000047
J	Silverman, JG; Raj, A; Mucci, LA; Hathaway, JE				Silverman, JG; Raj, A; Mucci, LA; Hathaway, JE			Dating violence against adolescent girls and associated substance use, unhealthy weight control, sexual risk behavior, pregnancy, and suicidality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENDER-DIFFERENCES; ABUSE; PREVALENCE; INTERCOURSE; STUDENTS	Context Intimate partner violence against women is a major public health concern. Research among adults has shown that younger age is a consistent risk factor for experiencing and perpetrating intimate partner violence. However, no representative epidemiologic studies of lifetime prevalence of dating violence among adolescents have been conducted. Objective To assess lifetime prevalence of physical and sexual violence from dating partners among adolescent girls and associations of these forms of violence with specific health risks. Design, Setting, and Participants Female 9th- through 12th-grade students who participated in the 1997 and 1999 Massachusetts Youth Risk Behavior Surveys (n =1977 and 2186, respectively). Main Outcome Measures Lifetime prevalence rates of physical and sexual dating violence and whether such violence is independently associated with substance use, unhealthy weight control, sexual risk behavior, pregnancy, and suicidality. Results Approximately 1 in 5 female students (20.2% in 1997 and 18.0% in 1999) reported being physically and/or sexually abused by a dating partner. After controlling for the effects of potentially confounding demographics and risk behaviors, data from both surveys indicate that physical and sexual dating violence against adolescent girls is associated with increased risk of substance use (eg, cocaine use for 1997, odds ratio [OR], 4.7; 95% confidence interval [CI], 2.3-9.6; for 1999, OR, 3.4; 95% Cl, 1.7-6.7), unhealthy weight control behaviors (eg, use of laxatives and/or vomiting [for 1997, OR, 3.2; 95% Cl, 1.8-5.5; for 1999, OR, 3.7;95% CI, 2.2-6.5]), sexual risk behaviors (eg, first intercourse before age 15 years [for 1997, OR, 8.2; 95%. CI, 5.1-13.4; for 1999, OR, 2.4; 95% Cl, 1.4-4.2]), pregnancy (for 1997, OR, 6.3; 95% Cl, 3.4-11.7; for 1999, OR, 3.9; 95% CI, 1.9-7.8), and suicidality (eg, attempted suicide [for 1997, OR, 7.6; 95% Cl, 4.7-12.3; for 1999, OR, 8.6; 95% CI, 5.2-14.4]). Conclusion Dating violence is extremely prevalent among this population, and adolescent girls who report a history of experiencing dating violence are more likely to exhibit other serious health risk behaviors.	Harvard Univ, Harvard Childrens Initiat, Boston, MA 02115 USA; Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA; Massachusetts Dept Publ Hlth, Bur Hlth Stat Res & Evaluat, Boston, MA USA; Massachusetts Dept Publ Hlth, Bur Family & Commun Hlth, Boston, MA USA	Harvard University; Boston University; Massachusetts Department of Public Health; Massachusetts Department of Public Health	Silverman, JG (corresponding author), Harvard Univ, Sch Publ Hlth, Div Publ Hlth Practice, 1552 Tremont St, Boston, MA 02120 USA.	jsilverm@hsph.harvard.edu	Fahimifar, Sepideh/M-5303-2019; Duran, Bonnie m/A-3029-2009		PHS HHS [U17/CCU115221-02-1] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AveryLeaf S, 1997, J ADOLESCENT HEALTH, V21, P11, DOI 10.1016/S1054-139X(96)00309-6; BACHMAN R, 1995, PUBLICATION NCJ; Brener ND, 1999, J CONSULT CLIN PSYCH, V67, P252, DOI 10.1037/0022-006X.67.2.252; Brener ND, 1999, JAMA-J AM MED ASSOC, V282, P440, DOI 10.1001/jama.282.5.440; BRENER ND, 1995, AM J EPIDEMIOL, V141, P575, DOI 10.1093/oxfordjournals.aje.a117473; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Coker AL, 2000, AM J PREV MED, V19, P220, DOI 10.1016/S0749-3797(00)00227-0; CUNNINGHAM RN, 1994, CHILD ABUSE NEGLECT, V18, P233, DOI 10.1016/0145-2134(94)90108-2; Dansky BS, 1997, INT J EAT DISORDER, V21, P213, DOI 10.1002/(SICI)1098-108X(199704)21:3<213::AID-EAT2>3.0.CO;2-N; DEKESEREDY WS, 1993, SOCIOL SPECTRUM, V13, P393, DOI 10.1080/02732173.1993.9982041; Doyle JP, 1999, J WOMEN HEALTH GEN-B, V8, P955, DOI 10.1089/jwh.1.1999.8.955; Eisenstat SA, 1999, NEW ENGL J MED, V341, P886, DOI 10.1056/NEJM199909163411206; Fagan J. A., 1994, UNDERSTANDING PREVEN, V3, P115; Foshee VA, 1996, AM J PREV MED, V12, P39, DOI 10.1016/S0749-3797(18)30235-6; Foshee VA, 1996, HEALTH EDUC RES, V11, P275, DOI 10.1093/her/11.3.275-a; GREENFIELD L, 1998, PUBLICATION NCJ; Hamberger LK, 1998, PEDIATR CLIN N AM, V45, P381, DOI 10.1016/S0031-3955(05)70013-4; Hathaway JE, 2000, AM J PREV MED, V19, P302, DOI 10.1016/S0749-3797(00)00236-1; IRWIN KL, 1995, OBSTET GYNECOL, V85, P330, DOI 10.1016/0029-7844(94)00425-D; Jacoby M, 1999, AM J PREV MED, V16, P318, DOI 10.1016/S0749-3797(99)00029-X; Kreiter SR, 1999, PEDIATRICS, V104, P1286, DOI 10.1542/peds.104.6.1286; NAGY S, 1995, PEDIATRICS, V96, P944; *NAT RES COUNC, 1996, UND VIOL WOM; NELSON DE, 1994, J SCHOOL HEALTH, V64, P413, DOI 10.1111/j.1746-1561.1994.tb03264.x; Perkins DF, 1999, CHILD ABUSE NEGLECT, V23, P371, DOI 10.1016/S0145-2134(99)00009-5; Raj A, 2000, Matern Child Health J, V4, P125, DOI 10.1023/A:1009526422148; Rothman K., 1998, MODERN EPIDEMIOLOGY; Scholle SH, 1998, J GEN INTERN MED, V13, P607, DOI 10.1046/j.1525-1497.1998.00183.x; Sege R, 1996, ARCH PEDIAT ADOL MED, V150, P277, DOI 10.1001/archpedi.1996.02170280047008; Shah BV, 1996, SUDAAN USERS MANUAL; Shrier LA, 1998, ARCH PEDIAT ADOL MED, V152, P57; Silverman J G, 1997, Violence Vict, V12, P147; Tjaden P, 2000, PUBLICATION NCJ, VNCJ 181867; Valois RF, 1999, J ADOLESCENT HEALTH, V25, P328, DOI 10.1016/S1054-139X(99)00051-8; Wekerle C, 1999, CLIN PSYCHOL REV, V19, P435, DOI 10.1016/S0272-7358(98)00091-9	35	797	816	148	236	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2001	286	5					572	579		10.1001/jama.286.5.572	http://dx.doi.org/10.1001/jama.286.5.572			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	458HE	11476659				2022-12-28	WOS:000170188300020
J	Galibert, F; Finan, TM; Long, SR; Puhler, A; Abola, P; Ampe, F; Barloy-Hubler, F; Barnett, MJ; Becker, A; Boistard, P; Bothe, G; Boutry, M; Bowser, L; Buhrmester, J; Cadieu, E; Capela, D; Chain, P; Cowie, A; Davis, RW; Dreano, S; Federspiel, NA; Fisher, RF; Gloux, S; Godrie, T; Goffeau, A; Golding, B; Gouzy, J; Gurjal, M; Hernandez-Lucas, I; Hong, A; Huizar, L; Hyman, RW; Jones, T; Kahn, D; Kahn, ML; Kalman, S; Keating, DH; Kiss, E; Komp, C; Lalaure, V; Masuy, D; Palm, C; Peck, MC; Pohl, TM; Portetelle, D; Purnelle, B; Ramsperger, U; Surzycki, R; Thebault, P; Vandenbol, M; Vorholter, FJ; Weidner, S; Wells, DH; Wong, K; Yeh, KC; Batut, J				Galibert, F; Finan, TM; Long, SR; Puhler, A; Abola, P; Ampe, F; Barloy-Hubler, F; Barnett, MJ; Becker, A; Boistard, P; Bothe, G; Boutry, M; Bowser, L; Buhrmester, J; Cadieu, E; Capela, D; Chain, P; Cowie, A; Davis, RW; Dreano, S; Federspiel, NA; Fisher, RF; Gloux, S; Godrie, T; Goffeau, A; Golding, B; Gouzy, J; Gurjal, M; Hernandez-Lucas, I; Hong, A; Huizar, L; Hyman, RW; Jones, T; Kahn, D; Kahn, ML; Kalman, S; Keating, DH; Kiss, E; Komp, C; Lalaure, V; Masuy, D; Palm, C; Peck, MC; Pohl, TM; Portetelle, D; Purnelle, B; Ramsperger, U; Surzycki, R; Thebault, P; Vandenbol, M; Vorholter, FJ; Weidner, S; Wells, DH; Wong, K; Yeh, KC; Batut, J			The composite genome of the legume symbiont Sinorhizobium meliloti	SCIENCE			English	Article							MOLECULAR-BASIS; RHIZOBIUM; AGROBACTERIUM; GENES	The scarcity of usable nitrogen frequently limits plant growth. A tight metabolic association with rhizobial bacteria allows legumes to obtain nitrogen compounds by bacterial reduction of dinitrogen (N-2) to ammonium (NH4+). We present here the annotated DNA sequence of the alpha -proteobacterium Sinorhizobium meliloti, the symbiont of alfalfa. The tripartite 6.7-megabase (Mb) genome comprises a 3.65-Mb chromosome, and 1.35-Mb pSymA and 1.68-Mb pSymB megaplasmids. Genome sequence analysis indicates that all three elements contribute, in varying degrees, to symbiosis and reveals how this genome may have emerged during evolution. The genome sequence will be useful in understanding the dynamics of interkingdom associations and of life in soil environments.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Fac Med, Lab Genet & Dev, CNRS, UMR 6061, F-35043 Rennes, France; McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada; Univ Bielefeld, D-33615 Bielefeld, Germany; Stanford Ctr DNA Sequencing & Technol, Stanford, CA 94305 USA; INRA, Lab Biol Mol Relat Plantes Microorganisms, CNRS, UMR 215, F-31326 Castanet Tolosan, France; GATC Biotech AG, D-78467 Constance, Germany; Univ Catholique Louvain, Unite Biochim Physiol, B-1348 Louvain, Belgium; Fac Sci Agron Gembloux, Unite Biol Anim & Microbienne, B-5030 Gembloux, Belgium; Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Centre National de la Recherche Scientifique (CNRS); McMaster University; University of Bielefeld; Stanford University; Centre National de la Recherche Scientifique (CNRS); INRAE; Universite Catholique Louvain; Washington State University	Long, SR (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.		Thébault, Patricia/AAD-1105-2020; Gouzy, Jerome/AAH-4977-2020; Yeh, Kuo-Chen/AAG-4485-2021; chain, patrick/B-9777-2013; Albers, Pieter/I-2563-2017; Kahn, Daniel/B-9393-2013; Kiss, Ernö/B-4836-2008; BATUT, Jacques/B-6506-2008; Chain, Patrick/O-4140-2019	Thébault, Patricia/0000-0003-2276-4573; Gouzy, Jerome/0000-0001-5695-4557; Yeh, Kuo-Chen/0000-0002-3791-3423; Kahn, Daniel/0000-0001-8093-0854; Chain, Patrick/0000-0003-3949-3634; Kiss, Erno/0000-0002-7344-1750; Barloy-Hubler, Frederique/0000-0002-8277-6034; Puhler, Alfred/0000-0003-4723-2960; Wong, Kim/0000-0002-0984-1477; Barnett, Melanie/0000-0003-3350-278X; Boutry, Marc/0000-0002-2315-6900; Kahn, Michael/0000-0002-5204-561X	NIGMS NIH HHS [GM30962] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030962, R37GM030962] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARNETT MJ, IN PRESS P NATL ACAD; CAPELA D, IN PRESS P NATL ACAD; FINAN T, IN PRESS P NATL ACAD; FLORES M, 1987, J BACTERIOL, V169, P5782, DOI 10.1128/jb.169.12.5782-5788.1987; Freiberg C, 1997, NATURE, V387, P394, DOI 10.1038/387394a0; Gottfert M, 2001, J BACTERIOL, V183, P1405, DOI 10.1128/JB.183.4.1405-1412.2001; Kaneko T, 2000, DNA RES, V7, P331, DOI 10.1093/dnares/7.6.331; Matthysse AG, 1996, J BACTERIOL, V178, P5302, DOI 10.1128/jb.178.17.5302-5308.1996; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; Oresnik IJ, 2000, J BACTERIOL, V182, P3582, DOI 10.1128/JB.182.12.3582-3586.2000; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; RENALIER MH, 1987, J BACTERIOL, V169, P2239; SCHWEDOCK JS, 1992, GENETICS, V132, P899; SCHWEDOCK JS, 1994, MOL PLANT MICROBE IN, V11, P1119; Skerker JM, 2000, EMBO J, V19, P3223, DOI 10.1093/emboj/19.13.3223; Viprey V, 2000, Subcell Biochem, V33, P437; Viprey V, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-6-research0014	17	909	1838	1	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					668	672		10.1126/science.1060966	http://dx.doi.org/10.1126/science.1060966			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474104				2022-12-28	WOS:000170204600047
J	Otterbein, LR; Graceffa, P; Dominguez, R				Otterbein, LR; Graceffa, P; Dominguez, R			The crystal structure of uncomplexed actin in the ADP state	SCIENCE			English	Article							I-BINDING LOOP; F-ACTIN; SUBDOMAIN 2; DIVALENT-CATION; CONFORMATION; MECHANISM; PHOSPHATE; MOVEMENT; GELSOLIN; COMPLEX	The dynamics and polarity of actin filaments are controlled by a conformational change coupled to the hydrolysis of adenosine S'-triphosphate (ATP) by a mechanism that remains to be elucidated. Actin modified to block polymerization was crystallized in the adenosine 5'-diphosphate (ADP) state, and the structure was solved to 1.54 angstrom resolution. Compared with previous ATP-actin structures from complexes with deoxyribonuclease I, profilin, and gelsotin, monomeric ADP-actin is characterized by a marked conformational change in subdomain 2. The successful crystallization of monomeric actin opens the way to future structure determinations of actin complexes with actin-binding proteins such as myosin.	Boston Biomed Res Inst, Watertown, MA 02472 USA	Boston Biomedical Research Institute	Dominguez, R (corresponding author), Boston Biomed Res Inst, 64 Grove St, Watertown, MA 02472 USA.	dominguez@bbri.org	ID, IMCACAT/D-5867-2014		NCRR NIH HHS [RR07707] Funding Source: Medline; NIAMS NIH HHS [P01 AR41637, R01 AR46524, R01 AR046524] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046524, P01AR041637] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Allen PG, 1996, J BIOL CHEM, V271, P4665; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; Borovikov YS, 2000, BBA-PROTEIN STRUCT M, V1478, P138, DOI 10.1016/S0167-4838(00)00005-4; COMBEAU C, 1988, J BIOL CHEM, V263, P17429; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; ESTES JE, 1992, J MUSCLE RES CELL M, V13, P272, DOI 10.1007/BF01766455; Graceffa P, 2000, J BIOL CHEM, V275, P17143, DOI 10.1074/jbc.M001979200; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Hurley JH, 1996, ANNU REV BIOPH BIOM, V25, P137; KABSCH W, 1995, FASEB J, V9, P167, DOI 10.1096/fasebj.9.2.7781919; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KHAITLINA SY, 1993, EUR J BIOCHEM, V218, P911, DOI 10.1111/j.1432-1033.1993.tb18447.x; Kim E, 1995, BIOPHYS J, V69, P2024, DOI 10.1016/S0006-3495(95)80072-X; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; Moraczewska J, 1996, BIOCHEM J, V317, P605, DOI 10.1042/bj3170605; Moraczewska J, 1999, BIOPHYS J, V77, P373, DOI 10.1016/S0006-3495(99)76896-7; MUHLRAD A, 1994, J BIOL CHEM, V269, P11852; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; ORLOVA A, 1993, J MOL BIOL, V232, P334, DOI 10.1006/jmbi.1993.1393; ORLOVA A, 1992, J MOL BIOL, V227, P1043, DOI 10.1016/0022-2836(92)90520-T; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Robinson RC, 1999, SCIENCE, V286, P1939, DOI 10.1126/science.286.5446.1939; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Sheterline P, 1998, ACTIN	28	409	415	3	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2001	293	5530					708	711		10.1126/science.1059700	http://dx.doi.org/10.1126/science.1059700			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474115				2022-12-28	WOS:000170204600058
J	Boulay, RM; Podczaski, E				Boulay, RM; Podczaski, E			Bilateral ovarian dermoid cysts	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Lehigh Valley Hosp, Allentown, PA 18103 USA; Penn State Univ, Coll Med, Hershey, PA 17033 USA	Lehigh Valley Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Boulay, RM (corresponding author), Lehigh Valley Hosp, Allentown, PA 18103 USA.								0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2001	345	4					259	259		10.1056/NEJM200107263450405	http://dx.doi.org/10.1056/NEJM200107263450405			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455XZ	11474664				2022-12-28	WOS:000170054200005
J	Donley, EA; Claussen, NR; Cornish, SL; Roberts, JL; Cornell, EA; Wieman, CE				Donley, EA; Claussen, NR; Cornish, SL; Roberts, JL; Cornell, EA; Wieman, CE			Dynamics of collapsing and exploding Bose-Einstein condensates	NATURE			English	Article							FESHBACH RESONANCES; ATTRACTIVE INTERACTIONS; INELASTIC-COLLISIONS; SCATTERING LENGTH; CESIUM; RB-85; ATOMS	When atoms in a gas are cooled to extremely low temperatures, they will-under the appropriate conditions-condense into a single quantum-mechanical state known as a Bose-Einstein condensate. In such systems, quantum-mechanical behaviour is evident on a macroscopic scale. Here we explore the dynamics of how a Bose-Einstein condensate collapses and subsequently explodes when the balance of forces governing its size and shape is suddenly altered. A condensate's equilibrium size and shape is strongly affected by the interatomic interactions. Our ability to induce a collapse by switching the interactions from repulsive to attractive by tuning an externally applied magnetic field yields detailed information on the violent collapse process. We observe anisotropic atom bursts that explode from the condensate, atoms leaving the condensate in undetected forms, spikes appearing in the condensate wavefunction and oscillating remnant condensates that survive the collapse. All these processes have curious dependences on time, on the strength of the interaction and on the number of condensate atoms. Although the system would seem to be simple and well characterized, our measurements reveal many phenomena that challenge theoretical models.	Univ Colorado, JILA, Boulder, CO 80309 USA; Univ Colorado, Dept Phys, Boulder, CO 80309 USA; Natl Inst Stand & Technol, Joint Inst Lab Astrophys, Quantum Phys Div, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA	Donley, EA (corresponding author), Univ Colorado, JILA, Campus Box 440, Boulder, CO 80309 USA.		Donley, Elizabeth/O-4916-2019; Cornish, Simon/K-4966-2012; Donley, Elizabeth/A-4525-2010	Donley, Elizabeth/0000-0002-3439-4322; Cornish, Simon/0000-0003-1407-4126; Roberts, Jacob/0000-0002-6243-9233				Bradley CC, 1997, PHYS REV LETT, V78, P985, DOI 10.1103/PhysRevLett.78.985; Cornish SL, 2000, PHYS REV LETT, V85, P1795, DOI 10.1103/PhysRevLett.85.1795; Courteille P, 1998, PHYS REV LETT, V81, P69, DOI 10.1103/PhysRevLett.81.69; Dalfovo F, 1999, REV MOD PHYS, V71, P463, DOI 10.1103/RevModPhys.71.463; Duine RA, 2001, PHYS REV LETT, V86, P2204, DOI 10.1103/PhysRevLett.86.2204; GAMMAL A, UNPUB PHYS REV A; Gerton JM, 2000, NATURE, V408, P692, DOI 10.1038/35047030; Inouye S, 1998, NATURE, V392, P151, DOI 10.1038/32354; Kagan Y, 1998, PHYS REV LETT, V81, P933, DOI 10.1103/PhysRevLett.81.933; Kagan Y, 1997, PHYS REV LETT, V79, P2604, DOI 10.1103/PhysRevLett.79.2604; Myatt CJ, 1996, OPT LETT, V21, P290, DOI 10.1364/OL.21.000290; Pattanayak AK, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.033604; PerezGarcia VM, 1997, PHYS REV A, V56, P1424, DOI 10.1103/PhysRevA.56.1424; Roberts JL, 2000, PHYS REV LETT, V85, P728, DOI 10.1103/PhysRevLett.85.728; Roberts JL, 2001, PHYS REV LETT, V86, P4211, DOI 10.1103/PhysRevLett.86.4211; Roberts JL, 1998, PHYS REV LETT, V81, P5109, DOI 10.1103/PhysRevLett.81.5109; RUPRECHT PA, 1995, PHYS REV A, V51, P4704, DOI 10.1103/PhysRevA.51.4704; Sackett CA, 1999, PHYS REV LETT, V82, P876, DOI 10.1103/PhysRevLett.82.876; Saito H, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.043601; Saito H, 2001, PHYS REV LETT, V86, P1406, DOI 10.1103/PhysRevLett.86.1406; Stenger J, 1999, PHYS REV LETT, V82, P2422, DOI 10.1103/PhysRevLett.82.2422; TIESINGA E, 1992, PHYS REV A, V46, pR1167, DOI 10.1103/PhysRevA.46.R1167; TIESINGA E, 1993, PHYS REV A, V47, P4114, DOI 10.1103/PhysRevA.47.4114; Ueda M, 1999, PHYS REV A, V60, P3317, DOI 10.1103/PhysRevA.60.3317; Vuletic V, 1999, PHYS REV LETT, V82, P1406, DOI 10.1103/PhysRevLett.82.1406	25	658	663	1	38	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					295	299		10.1038/35085500	http://dx.doi.org/10.1038/35085500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460153	Green Submitted			2022-12-28	WOS:000169918200036
J	Jafar, TH; Schmid, CH; Landa, M; Giatras, I; Toto, R; Remuzzi, G; Maschio, G; Brenner, BM; Kamper, A; Zucchelli, P; Becker, G; Himmelmann, A; Bannister, K; Landais, P; Shahinfar, S; de Jong, PE; de Zeeuw, D; Lau, J; Levey, AS				Jafar, TH; Schmid, CH; Landa, M; Giatras, I; Toto, R; Remuzzi, G; Maschio, G; Brenner, BM; Kamper, A; Zucchelli, P; Becker, G; Himmelmann, A; Bannister, K; Landais, P; Shahinfar, S; de Jong, PE; de Zeeuw, D; Lau, J; Levey, AS		ACE Inhibition Progressive Renal D	Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease - A meta-analysis of patient-level data	ANNALS OF INTERNAL MEDICINE			English	Article							DEPENDENT DIABETES-MELLITUS; RANDOMIZED CONTROLLED TRIAL; KIDNEY-FUNCTION; FOLLOW-UP; NEPHROPATHY; ENALAPRIL; INSUFFICIENCY; CAPTOPRIL; FAILURE; PROTEINURIA	Purpose: To examine the efficacy of ACE inhibitors for treatment of nondiabetic renal disease. Data Sources: 11 randomized, controlled trials comparing the efficacy of antihypertensive regimens including ACE inhibitors to the efficacy of regimens without ACE inhibitors in predominantly nondiabetic renal disease. Study Selection: studies were identified by searching the MEDLINE database for English-language studies evaluating the effects of ACE inhibitors on renal disease in humans between May 1977 (when ACE inhibitors were approved for trials in humans) and September 1997. Data Extraction: Data on 1860 nondiabetic patients were analyzed. Data Synthesis: Mean duration of follow-up was 2.2 years. Patients in the ACE inhibitor group had a greater mean decrease in systolic and diastolic blood pressure (4.5 mm Hg [95% CI, 3.0 to 6.1 mm Hg]) and 2.3 mm Hg [CI, 1.4 to 3.2 mm Hg], respectively) and urinary protein excretion (0.46 g/d [CI, 0.33 to 0.59 g/d]), After adjustment for patient and study characteristics at baseline and changes in systolic blood pressure and urinary protein excretion during follow-up, relative risks in the ACE inhibitor group were 0.69 (CI, 0.51 to 0.94) for end-stage renal disease and 0.70 (CI, 0.55 to 0.88) far the combined outcome of doubling of the baseline serum creatinine concentration or end-stage renal disease. Patients with greater urinary protein excretion at baseline benefited more from ACE inhibitor therapy (P= 0.03 and P= 0.001, respectively), but the data were inconclusive as to whether the benefit extended to patients with baseline urinary protein excretion less than 0.5 g/d. Conclusion: Antihypertensive regimens that include ACE inhibitors are more effective than regimens without ACE inhibitors in slowing the progression of nondiabetic renal disease. The beneficial effect of ACE inhibitors is mediated by factors in addition to decreasing blood pressure and urinary protein excretion and is greater in patients with proteinuria. Angiotensin-converting inhibitors are indicated for treatment of nondiabetic patients with chronic renal disease and proteinuria and, possibly, those without proteinuria.	Tufts Univ New England Med Ctr, Div Nephrol, Boston, MA 02111 USA; Tufts Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02111 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Texas SW, Dallas, TX USA; Mario Negri Inst Pharmacol Res, I-24100 Bergamo, Italy; Osped Civile, I-37126 Verona, Italy; Osped M Malphigi, Bologna, Italy; Univ Copenhagen, DK-1168 Copenhagen, Denmark; Royal Melbourne Hosp, Melbourne, Vic, Australia; Royal Adelaide Hosp, Adelaide, SA 5000, Australia; Sahlgrens Univ Hosp, S-41345 Gothenburg, Sweden; Hop Necker Enfants Malad, F-75730 Paris, France; Merck Res Labs, West Point, PA USA; Univ Groningen, NL-9700 AB Groningen, Netherlands	Tufts Medical Center; Harvard University; Brigham & Women's Hospital; Tufts University; Harvard University; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Copenhagen; Royal Melbourne Hospital; Royal Adelaide Hospital; Sahlgrenska University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Merck & Company; University of Groningen	Levey, AS (corresponding author), Tufts Univ New England Med Ctr, Div Nephrol, 750 Washington St,Box 391, Boston, MA 02111 USA.		Schmid, Christopher H./J-2398-2014; Toto, Robert/AAQ-3336-2021; de Zeeuw, Dick/E-9080-2014; Remuzzi, Giuseppe/V-9766-2017	Schmid, Christopher H./0000-0002-0855-5313; de Zeeuw, Dick/0000-0003-3434-7777; Remuzzi, Giuseppe/0000-0002-6194-3446; Kamper, Anne-Lise/0000-0001-7523-6569	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS008532, R01HS010064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053869] Funding Source: NIH RePORTER; AHRQ HHS [R01 HS 10064, HS08532] Funding Source: Medline; NIDDK NIH HHS [R01 DK53869A] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 1997, Diabetes Care, V20 Suppl 1, pS1; Aurell M, 1997, NEPHROL DIAL TRANSPL, V12, P2289, DOI 10.1093/ndt/12.11.2289; Bakris GL, 1998, KIDNEY INT, V54, P1283, DOI 10.1046/j.1523-1755.1998.00083.x; BANNISTER KM, 1995, CONTRIB NEPHROL, V111, P184; Berggard I, 1970, Lakartidningen, V67, P5798; BIANCHI S, 1991, AM J NEPHROL, V11, P131, DOI 10.1159/000168289; BJORCK S, 1992, BMJ-BRIT MED J, V304, P339, DOI 10.1136/bmj.304.6823.339; BRENNER BM, 1982, NEW ENGL J MED, V307, P652, DOI 10.1056/NEJM198209093071104; BURSZTYN M, 1991, J CARDIOVASC PHARM, V18, P337, DOI 10.1097/00005344-199109000-00005; De Jong PE, 1999, LANCET, V354, P352, DOI 10.1016/S0140-6736(99)90122-8; Giatras I, 1997, ANN INTERN MED, V127, P337, DOI 10.7326/0003-4819-127-5-199709010-00001; Golan L, 1999, ANN INTERN MED, V131, P660, DOI 10.7326/0003-4819-131-9-199911020-00005; HANNEDOUCHE T, 1994, BRIT MED J, V309, P833, DOI 10.1136/bmj.309.6958.833; Himmelmann Anders, 1995, Blood Pressure, V4, P85, DOI 10.3109/08037059509077575; HUNSICKER LG, 1995, PRINCIPLES PRACTICE; Ihle BU, 1996, AM J KIDNEY DIS, V27, P489, DOI 10.1016/S0272-6386(96)90158-4; JACOBSON HR, 1995, AM J KIDNEY DIS, V25, P103, DOI 10.1016/0272-6386(95)90635-5; KAMPER AL, 1992, AM J HYPERTENS, V5, P423, DOI 10.1093/ajh/5.7.423; Klein JP., 2003, SURVIVAL ANAL TECHNI; LAFFEL LMB, 1995, AM J MED, V99, P497, DOI 10.1016/S0002-9343(99)80226-5; Levey AS, 1998, ANN INTERN MED, V128, P863, DOI 10.7326/0003-4819-128-10-199805150-00011; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; MANUEL Y, 1970, PROTEINS NORMAL PATH, P7; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; McCarthy JT, 1999, MAYO CLIN PROC, V74, P269, DOI 10.4065/74.3.269; McClellan WM, 1997, AM J KIDNEY DIS, V29, P368, DOI 10.1016/S0272-6386(97)90197-9; Mosconi L, 1996, KIDNEY INT, pS91; NEURINGER JR, 1993, AM J KIDNEY DIS, V22, P98, DOI 10.1016/S0272-6386(12)70174-9; *NIH NAT I DIAB DI, 1999, US REN DAT SYST ANN; OKAMURA M, 1991, CONTRIB NEPHROL, V90, P161; PARVING HH, 1988, BRIT MED J, V297, P1086, DOI 10.1136/bmj.297.6656.1086; Preston RA, 1996, ARCH INTERN MED, V156, P602, DOI 10.1001/archinte.156.6.602; Ravid M, 1998, ANN INTERN MED, V128, P982, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00004; Ravid M, 1996, ARCH INTERN MED, V156, P286, DOI 10.1001/archinte.156.3.286; REMUZZI G, 1990, KIDNEY INT, V38, P384, DOI 10.1038/ki.1990.217; Ruggenenti P, 1997, LANCET, V349, P1857; Ruggenenti P, 1999, LANCET, V354, P359, DOI 10.1016/S0140-6736(98)10363-X; *SEATTL MATHS, S PLUS 2000 GUID STA, V2; Therneau T. M., 1997, P 1 SEATTL S BIOST N; vanEssen GG, 1997, KIDNEY INT, pS58; VIBERTI G, 1994, JAMA-J AM MED ASSOC, V271, P275, DOI 10.1001/jama.271.4.275; Yusuf S, 2000, NEW ENGL J MED, V342, P145; ZUCCHELLI P, 1992, KIDNEY INT, V42, P452, DOI 10.1038/ki.1992.309; 1997, ARCH INTERN MED, V157, P2413	44	750	766	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2001	135	2					73	87		10.7326/0003-4819-135-2-200107170-00007	http://dx.doi.org/10.7326/0003-4819-135-2-200107170-00007			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452DR	11453706				2022-12-28	WOS:000169842300001
J	Cook-Deegan, RM; McCormack, SJ				Cook-Deegan, RM; McCormack, SJ			Intellectual property - Patents, secrecy, and DNA	SCIENCE			English	Editorial Material							ACADEMIC RESEARCH; TECHNOLOGY		Georgetown Univ, Kennedy Inst Eth, Washington, DC 20057 USA; Stanford Washington Program, Washington, DC 20008 USA; AlleCure Corp, Valencia, CA 91355 USA	Georgetown University; Stanford University	Cook-Deegan, RM (corresponding author), Georgetown Univ, Kennedy Inst Eth, Washington, DC 20057 USA.			Cook-Deegan, Robert/0000-0002-8251-4237				Cockburn I, 1996, P NATL ACAD SCI USA, V93, P12725, DOI 10.1073/pnas.93.23.12725; Gambardella A., 1995, SCI INNOVATION US PH; HASELTINE W, 1994, WORKSH OFF TECHN ASS; Henderson R, 1998, REV ECON STAT, V80, P119, DOI 10.1162/003465398557221; *INT COMM INT PROP, 1999, TRAD KNOWL FOLKL, P10; JACOBS P, 2000, LA TIMES        0228, pA1; JORDA KF, 1999, INTELLECTUAL PROPERT; MANSFIELD E, 1991, RES POLICY, V20, P1, DOI 10.1016/0048-7333(91)90080-A; MANSFIELD E, 1995, REV ECON STAT, V77, P55, DOI 10.2307/2109992; NARIN F, 1992, RES POLICY, V21, P237, DOI 10.1016/0048-7333(92)90018-Y; NARIN F, 1988, RES POLICY, V17, P139, DOI 10.1016/0048-7333(88)90039-X; National Academy of Engineering, 1992, TIME HORIZONS TECHNO; *OTA, 1988, MAPP OUR GEN GEN PRO, P167; *USPTO, 2000, FED REGISTER, V65, P57024; 2000, Patent No. 6025154	15	25	25	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					217	217		10.1126/science.1058032	http://dx.doi.org/10.1126/science.1058032			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	452TK	11452101				2022-12-28	WOS:000169875200027
J	Dupuis, S; Dargemont, C; Fieschi, C; Thomassin, N; Rosenzweig, S; Harris, J; Holland, SM; Schreiber, RD; Casanova, JL				Dupuis, S; Dargemont, C; Fieschi, C; Thomassin, N; Rosenzweig, S; Harris, J; Holland, SM; Schreiber, RD; Casanova, JL			Impairment od mycobacterial but not viral immunity by a germline human STAT1 mutation	SCIENCE			English	Article							INTERFERON-GAMMA-RECEPTOR; CALMETTE-GUERIN INFECTION; TARGETED DISRUPTION; DEFICIENCY; SUSCEPTIBILITY; MICE; GENE; DEFENSE; CHILD; CHAIN	Interferons (IFN) alpha/beta and gamma induce the formation of two transcriptional activators: gamma-activating factor (CAF) and interferon-stimulated gamma factor 3 (ISGF3). We report a natural heterozygous germline STAT1 mutation associated with susceptibility to mycobacterial but not viral disease. This mutation causes a loss of CAF and ISGF3 activation but is dominant for one cellular phenotype and recessive for the other. It impairs the nuclear accumulation of GAF but not of ISGF3 in heterozygous cells stimulated by IFNs. Thus, the antimycobacterial, but not the antiviral, effects of human IFNs are principally mediated by GAF.	Univ Paris 05, Fac Med Necker Enfants Malad, INSERM,UMR550, Lab Genet Humaine Malad Infect, F-75015 Paris, France; Hop Necker Enfants Malad, INSERM, U429, F-75015 Paris, France; Univ Paris 06, CNRS, Inst Jacques Monod, F-75005 Paris, France; Univ Paris 07, CNRS, UMR 7592, F-75005 Paris, France; Ctr Hosp Gen, F-58000 Nevers, France; NIAID, Host Def Lab, Bethesda, MD 20892 USA; Univ San Francisco, Dept Pediat, San Francisco, CA 94117 USA; Washington Univ, Dept Pathol, St Louis, MO 63110 USA; Hop Necker Enfants Malad, Unite Hematol Immunol Pediat, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of San Francisco; Washington University (WUSTL); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Casanova, JL (corresponding author), Univ Paris 05, Fac Med Necker Enfants Malad, INSERM,UMR550, Lab Genet Humaine Malad Infect, F-75015 Paris, France.		Boisson-Dupuis, Stéphanie/I-2040-2017; Schreiber, Robert/Q-7550-2019; Casanova, Jean-Laurent/I-3418-2017; Boisson-Dupuis, Stephanie/AAF-5066-2021; Schreiber, Robert D/A-1276-2013	Boisson-Dupuis, Stéphanie/0000-0002-7115-116X; Schreiber, Robert D/0000-0001-6311-0432; Casanova, Jean-Laurent/0000-0002-7782-4169; Schreiber, Robert/0000-0003-1590-2341	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000647, Z01AI000647] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altare F, 1998, J CLIN INVEST, V102, P2035, DOI 10.1172/JCI4950; Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; Casanova JL, 1996, PEDIATRICS, V98, P774; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; de Jong R, 1998, SCIENCE, V280, P1435; Doffinger R, 2000, J INFECT DIS, V181, P379, DOI 10.1086/315197; Dorman SE, 1998, J CLIN INVEST, V101, P2364, DOI 10.1172/JCI2901; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Jouanguy E, 1999, NAT GENET, V21, P370, DOI 10.1038/7701; KAMIJO R, 1993, J EXP MED, V178, P1435, DOI 10.1084/jem.178.4.1435; LEVIN M, 1995, LANCET, V345, P79, DOI 10.1016/S0140-6736(95)90059-4; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Park C, 1999, NUCLEIC ACIDS RES, V27, P4191, DOI 10.1093/nar/27.21.4191; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Qureshi SA, 1996, MOL CELL BIOL, V16, P288; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; vandenBroek MF, 1995, IMMUNOL REV, V148, P5; VERLIAC F, 1972, INFECT OSSEUSES BACT	24	359	367	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					300	303		10.1126/science.1061154	http://dx.doi.org/10.1126/science.1061154			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452125				2022-12-28	WOS:000169875200059
J	Carr, MH; Garvin, J				Carr, MH; Garvin, J			Mars exploration	NATURE			English	Editorial Material								An international flotilla of spacecraft are to be sent to Mars over the next decade in an effort to understand the planet's geology and climate history, and to determine whether some form of life ever started there. At least two spacecraft will be sent at each launch opportunity, and at times up to four spacecraft may be operating simultaneously at the planet.	US Geol Survey, Menlo Park, CA 94025 USA; NASA Headquarters, Washington, DC 20546 USA	United States Department of the Interior; United States Geological Survey; National Aeronautics & Space Administration (NASA)	Carr, MH (corresponding author), US Geol Survey, 345 Middlefield Rd, Menlo Park, CA 94025 USA.			Garvin, James/0000-0003-1606-5645				Acuna MH, 1998, SCIENCE, V279, P1676, DOI 10.1126/science.279.5357.1676; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9609, DOI 10.1029/1999JE001127; Gladman BJ, 1996, SCIENCE, V271, P1387, DOI 10.1126/science.271.5254.1387; Haberle RM, 1998, J GEOPHYS RES-PLANET, V103, P28467, DOI 10.1029/98JE01396; McKay C.P., 1992, MARS, P1234; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; STEVENS TO, 1995, SCIENCE, V270, P450, DOI 10.1126/science.270.5235.450; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788	9	6	7	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					250	253		10.1038/35084200	http://dx.doi.org/10.1038/35084200			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449287				2022-12-28	WOS:000169778700065
J	Klempner, MS; Hu, LT; Evans, J; Schmid, CH; Johnson, GM; Trevino, RP; Norton, D; Levy, L; Wall, D; McCall, J; Kosinski, M; Weinstein, A				Klempner, MS; Hu, LT; Evans, J; Schmid, CH; Johnson, GM; Trevino, RP; Norton, D; Levy, L; Wall, D; McCall, J; Kosinski, M; Weinstein, A			Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FIBROMYALGIA IMPACT QUESTIONNAIRE; BORRELIA-BURGDORFERI; DOUBLE-BLIND; MEDICAL OUTCOMES; NEUROBORRELIOSIS; TOOL	Background: It is controversial whether prolonged antibiotic treatment is effective for patients in whom symptoms persist after the recommended antibiotic treatment for acute Lyme disease. Methods: We conducted two randomized trials: one in 78 patients who were seropositive for IgG antibodies to Borrelia burgdorferi at the time of enrollment and the other in 51 patients who were seronegative. The patients received either intravenous ceftriaxone, 2 g daily for 30 days, followed by oral doxycycline, 200 mg daily for 60 days, or matching intravenous and oral placebos. Each patient had well-documented, previously treated Lyme disease but had persistent musculoskeletal pain, neurocognitive symptoms, or dysesthesia, often associated with fatigue. The primary outcome measures were improvement on the physical- and mental-health-component summary scales of the Medical Outcomes Study 36-Item Short-Form General Health Survey (SF-36) - a scale measuring the health-related quality of life - on day 180 of the study. Results: After a planned interim analysis, the data and safety monitoring board recommended that the studies be discontinued because data from the first 107 patients indicated that it was highly unlikely that a significant difference in treatment efficacy between the groups would be observed with the planned full enrollment of 260 patients. Base-line assessments documented severe impairment in the patients' health-related quality of life. In intention-to-treat analyses, there were no significant differences in the outcomes with prolonged antibiotic treatment as compared with placebo among either the seropositive or the seronegative patients. Conclusions: There is considerable impairment of health-related quality of life among patients with persistent symptoms despite previous antibiotic treatment for acute Lyme disease. However, in these two trials, treatment with intravenous and oral antibiotics for 90 days did not improve symptoms more than placebo. (N Engl J Med 2001;345:85-92.) Copyright (C) 2001 Massachusetts Medical Society.	Tufts Univ New England Med Ctr, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Yale New Haven Med Ctr, New Haven, CT 06504 USA; New York Med Coll, Valhalla, NY 10595 USA; Qual Metr, Lincoln, RI USA	Tufts Medical Center; Tufts University; Yale University; New York Medical College	Klempner, MS (corresponding author), Boston Univ, Sch Med, Dept Med, 715 Albany St, Boston, MA 02118 USA.	klempner@bu.edu	Hu, Linden/L-6314-2016; Schmid, Christopher H./J-2398-2014	Hu, Linden/0000-0003-1659-5558; Schmid, Christopher H./0000-0002-0855-5313	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI065308] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000054] Funding Source: Medline; NIAID NIH HHS [N01-AI-65308] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASCH ES, 1994, J RHEUMATOL, V21, P454; Bennett RM, 1998, AM J MED, V104, P227, DOI 10.1016/S0002-9343(97)00351-3; Bennett RM, 1996, J RHEUMATOL, V23, P521; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Bujak DI, 1996, J RHEUMATOL, V23, P1392; BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590; Donta ST, 1997, CLIN INFECT DIS, V25, pS52, DOI 10.1086/516171; Dunkl PR, 2000, J RHEUMATOL, V27, P2683; Fallon J, 1999, ARTHRIT CARE RES, V12, P42, DOI 10.1002/1529-0131(199902)12:1<42::AID-ART7>3.0.CO;2-3; FARRINGTON CP, 1990, STAT MED, V9, P1447, DOI 10.1002/sim.4780091208; Goldenberg D, 1996, ARTHRITIS RHEUM, V39, P1852, DOI 10.1002/art.1780391111; KLEMPNER MS, 1993, J INFECT DIS, V167, P1074, DOI 10.1093/infdis/167.5.1074; LAN KKG, 1988, BIOMETRICS, V44, P579, DOI 10.2307/2531870; Nocton JJ, 1996, J INFECT DIS, V174, P623, DOI 10.1093/infdis/174.3.623; Patel R, 2000, CLIN INFECT DIS, V31, P1107, DOI 10.1086/318138; Phillips SE, 1998, INFECTION, V26, P364, DOI 10.1007/BF02770837; SHERBOURNE CD, 1992, MEASURING FUNCTIONIN, P220; Sherbourne CD, 1992, MEASURING FUNCTIONIN, P205; STEERE AC, 1990, J INFECT DIS, V161, P1203, DOI 10.1093/infdis/161.6.1203; Stewart A.L., 1992, MEASURING FUNCTIONIN; TILLEY BC, 1995, ANN INTERN MED, V122, P81, DOI 10.7326/0003-4819-122-2-199501150-00001; Ware J.E, 1994, PHYS MENTAL HLTH SUM; Ware JE, 1996, JAMA-J AM MED ASSOC, V276, P1039, DOI 10.1001/jama.1996.03540130037027; Ware JE, 1993, SF36 HLTH SURVEY MAN; WELLS KB, 1992, ARCH GEN PSYCHIAT, V49, P788; Wormser GP, 2000, CLIN INFECT DIS, V31, pS1, DOI 10.1086/314053	27	453	467	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 12	2001	345	2					85	92		10.1056/NEJM200107123450202	http://dx.doi.org/10.1056/NEJM200107123450202			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451AH	11450676				2022-12-28	WOS:000169776900002
J	Westphal, S; Dierkes, J; Luley, C				Westphal, S; Dierkes, J; Luley, C			Effects of fenofibrate and gemfibrozil on plasma homocysteine	LANCET			English	Article							SERUM	Fenofibrate increases plasma homocysteine. Because the concentration of plasma homocysteine depends on renal function, we postulate that increases in plasma homocysteine are a result of the known impairment of renal function caused by fenofibrate. Gemfibrozil, another fibrate, does not affect renal function. In a crossover study we tested whether gemfibrozil would raise homocysteine. 22 patients who had hypertriglyceridaemia were given 900 mg gemfibrozil or 200 mg fenofibrate daily for 6 weeks. Lipids were altered similarly. but homocysteine, creatinine, and cystatin C were raised by fenofibrate but not by gemfibrozil (p for differences between treatment effects: 0.007, 0.006, and 0.040, respectively). We propose gemfibrozil should be the fibrate of choice.	Otto von Guericke Univ, Inst Clin Chem & Pathobiochem, D-39120 Magdeburg, Germany	Otto von Guericke University	Westphal, S (corresponding author), Otto von Guericke Univ, Inst Clin Chem & Pathobiochem, D-39120 Magdeburg, Germany.							Broeders N, 2000, NEPHROL DIAL TRANSPL, V15, P1993, DOI 10.1093/ndt/15.12.1993; Dierkes J, 1999, LANCET, V354, P219, DOI 10.1016/S0140-6736(99)02153-4; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Goffin E, 1999, LANCET, V354, P1209, DOI 10.1016/S0140-6736(05)75417-9; Yoshinari M, 1998, DIABETES RES CLIN PR, V42, P149, DOI 10.1016/S0168-8227(98)00107-7	5	71	72	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 7	2001	358	9275					39	40		10.1016/S0140-6736(00)05271-5	http://dx.doi.org/10.1016/S0140-6736(00)05271-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11454380				2022-12-28	WOS:000169710900019
J	Lorenz, MC; Fink, GR				Lorenz, MC; Fink, GR			The glyoxylate cycle is required for fungal virulence	NATURE			English	Article							YEAST YARROWIA-LIPOLYTICA; CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; MYCOBACTERIUM-TUBERCULOSIS; ISOCITRATE LYASE; GENE; EXPRESSION; DISRUPTION; MUTATIONS; CLONING	Candida albicans, a normal component of the mammalian gastrointestinal flora, is responsible for most fungal infections in immunosuppressed patients. Candida is normally phagocytosed by macrophages and neutrophils, which secrete cytokines and induce hyphal development in this fungus(1,2). Neutropenic patients, deficient in these immune cells, are particularly susceptible to systemic candidiasis(3,4). Here we use genome-wide expression profiles of the related yeast Saccharomyces cerevisiae to obtain a signature of the events that take place in the fungus on ingestion by a mammalian macrophage. Live S. cerevisiae cells isolated from the phagolysosome are induced for genes of the glyoxylate cycle, a metabolic pathway that permits the use of two-carbon compounds as carbon sources. In C. albicans, phagocytosis also upregulates the principal enzymes of the glyoxylate cycle, isocitrate lyase (ICL1) and malate synthase (MLS1). Candida albicans mutants lacking ICL1 are markedly less virulent in mice than the wild type. These findings in fungi, in conjunction with reports that isocitrate lyase is both upregulated and required for the virulence of Mycobacterium tuberculosis(5,6), demonstrate the wide-ranging significance of the glyoxylate cycle in microbial pathogenesis.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Fink, GR (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	fink@wi.mit.edu		Lorenz, Michael/0000-0002-7881-8027				ASHMAN RB, 1995, MICROBIOL REV, V59, P646, DOI 10.1128/MMBR.59.4.646-672.1995; Bentrup KHZ, 1999, J BACTERIOL, V181, P7161; BODEY G, 1992, EUR J CLIN MICROBIOL, V11, P99, DOI 10.1007/BF01967060; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; CANNON RD, 1992, MOL GEN GENET, V235, P453, DOI 10.1007/BF00279393; FONZI WA, 1993, GENETICS, V134, P717; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; KUJAU M, 1992, YEAST, V8, P193, DOI 10.1002/yea.320080305; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; MINARD KI, 1991, MOL CELL BIOL, V11, P370, DOI 10.1128/MCB.11.1.370; MORTIMER RK, 1986, GENETICS, V113, P35; SEDIVY JM, 1985, J MOL BIOL, V186, P307, DOI 10.1016/0022-2836(85)90107-X; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Tzschoppe K, 1999, YEAST, V15, P1645, DOI 10.1002/(SICI)1097-0061(199911)15:15<1645::AID-YEA491>3.0.CO;2-G; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Wright WL, 1997, INFECT DIS CLIN N AM, V11, P411, DOI 10.1016/S0891-5520(05)70363-9	18	559	580	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					83	86		10.1038/35083594	http://dx.doi.org/10.1038/35083594			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452311				2022-12-28	WOS:000169644900048
J	Navarro-Gonzalez, R; McKay, CP; Mvondo, DN				Navarro-Gonzalez, R; McKay, CP; Mvondo, DN			A possible nitrogen crisis for Archaean life due to reduced nitrogen fixation by lightning	NATURE			English	Article							EARTHS EARLY ATMOSPHERE; NITRIC-OXIDE; EVOLUTION; CARBON; ENERGY; OXYGEN	Nitrogen is an essential element for life and is often the limiting nutrient for terrestrial ecosystems(1,2). As most nitrogen is locked in the kinetically stable form(3), N-2, in the Earth's atmosphere, processes that can fix N-2 into biologically available forms-such as nitrate and ammonia-control the supply of nitrogen for organisms. On the early Earth, nitrogen is thought to have been fixed abiotically, as nitric oxide formed during lightning discharge(4-6). The advent of biological nitrogen fixation suggests that at some point the demand for fixed nitrogen exceeded the supply from abiotic sources, but the timing and causes of the onset of biological nitrogen fixation remain unclear(7-11). Here we report an experimental simulation of nitrogen fixation by lightning over a range of Hadean (4.5-3.8 Gyr ago) and Archaean (3.8-2.5 Gyr ago) atmospheric compositions, from predominantly carbon dioxide to predominantly dinitrogen (but always without oxygen). We infer that, as atmospheric CO2 decreased over the Archaean period, the production of nitric oxide from lightning discharge decreased by two orders of magnitude until about 2.2 Gyr. After this time, the rise in oxygen (or methane) concentrations probably initiated other abiotic sources of nitrogen. Although the temporary reduction in nitric oxide production may have lasted for only 100 Myr or less, this was potentially long enough to cause an ecological crisis that triggered the development of biological nitrogen fixation.	Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Lab Quim Plasmas & Estud Planetarios, Mexico City 04510, DF, Mexico; NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA	Universidad Nacional Autonoma de Mexico; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Navarro-Gonzalez, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Lab Quim Plasmas & Estud Planetarios, Circuito Exterior,Ciudad Univ,Apartado Postal 70-, Mexico City 04510, DF, Mexico.		Navarro-González, Rafael/D-1748-2009	Navarro-González, Rafael/0000-0002-6078-7621; NNA MVONDO, Delphine/0000-0001-7107-4988				Beaumont V, 1999, PRECAMBRIAN RES, V96, P63, DOI 10.1016/S0301-9268(99)00005-4; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; CHAMEIDES WL, 1981, ORIGINS LIFE EVOL B, V11, P291, DOI 10.1007/BF00931483; CHYBA C, 1991, ORIGINS LIFE EVOL B, V21, P3, DOI 10.1007/BF01809509; CLOUD PE, 1968, SCIENCE, V160, P729, DOI 10.1126/science.160.3829.729; Golubic S, 1995, LETHAIA, V28, P285, DOI 10.1111/j.1502-3931.1995.tb01817.x; Howard JB, 1996, CHEM REV, V96, P2965, DOI 10.1021/cr9500545; JEBENS DS, 1992, GEOPHYS RES LETT, V19, P273, DOI 10.1029/91GL02937; KASTING JF, 1990, ORIGINS LIFE EVOL B, V20, P199, DOI 10.1007/BF01808105; Kasting JF, 2001, ORIGINS LIFE EVOL B, V31, P271, DOI 10.1023/A:1010600401718; KASTING JF, 1981, J GEOPHYS RES-OCEANS, V86, P1147, DOI 10.1029/JC086iC02p01147; KNIPOVICH OM, 1988, RUSS J PHYS CHEM, V62, P867; LEVINE JS, 1982, GEOPHYS RES LETT, V9, P893, DOI 10.1029/GL009i008p00893; MANCINELLI RL, 1988, ORIGINS LIFE EVOL B, V18, P311, DOI 10.1007/BF01808213; Pavlov AA, 2000, J GEOPHYS RES-PLANET, V105, P11981, DOI 10.1029/1999JE001134; POSTGATE J, 1987, NITROGEN FIXATION, P73; Raven JA, 1998, NEW PHYTOL, V139, P205, DOI 10.1046/j.1469-8137.1998.00168.x; Rosswall T., 1981, SOME PERSPECTIVES MA; RYE R, 1995, NATURE, V378, P603, DOI 10.1038/378603a0; Rye R, 1998, AM J SCI, V298, P621, DOI 10.2475/ajs.298.8.621; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; Schopf JW, 2000, PROKARYOTIC DEVELOPMENT, P105; Schopf JW, 1983, EARTHS EARLIEST BIOS; The National Institute of Standards and Technology, NIST STAND REF DAT 1; Walker, 1977, EVOLUTION ATMOSPHERE, V32, P71; Wang Y, 1998, J GEOPHYS RES-ATMOS, V103, P19149, DOI 10.1029/98JD01356; Young J. P. W., 1992, BIOL NITROGEN FIXATI, V1544, P43; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963; YUNG YL, 1979, SCIENCE, V203, P1002, DOI 10.1126/science.203.4384.1002; ZAHNLE KJ, 1986, J GEOPHYS RES-ATMOS, V91, P2819, DOI 10.1029/JD091iD02p02819	30	181	185	5	92	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					61	64		10.1038/35083537	http://dx.doi.org/10.1038/35083537			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452304	Green Submitted			2022-12-28	WOS:000169644900041
J	Simmonds, RW; Marchenkov, A; Hoskinson, E; Davis, JC; Packard, RE				Simmonds, RW; Marchenkov, A; Hoskinson, E; Davis, JC; Packard, RE			Quantum interference of superfluid He-3	NATURE			English	Article							ROTATION MEASUREMENTS; EARTHS ROTATION; INTERFEROMETER; GYROSCOPE; GYROMETER; PHASE	Celebrated interference experiments have demonstrated the wave nature of light(1) and electrons(2), quantum interference being the manifestation of wave-particle duality. More recently, double-path interference experiments have also demonstrated the quantum-wave nature of beams of neutrons(3), atoms(4) and Bose-Einstein condensates(5). In condensed matter systems, double-path quantum interference is observed in the d.c. superconducting quantum interference device(6) (d.c. SQUID). Here we report a double-path quantum interference experiment involving a liquid: superfluid He-3. Using a geometry analogous to the superconducting d.c. SQUID, we control a quantum phase shift by using the rotation of the Earth, and rnd the classic interference pattern with periodicity determined by the He-3 quantum of circulation.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Packard, RE (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.			Simmonds, Raymond/0000-0003-2217-2965				Anderson P. W., 1967, PROGRESS LOW TEMPERA, V5, P1; Andrews MR, 1997, SCIENCE, V275, P637, DOI 10.1126/science.275.5300.637; Avenel O, 2000, PHYSICA B, V280, P130, DOI 10.1016/S0921-4526(99)01517-3; AVENEL O, 1988, PHYS REV LETT, V60, P416, DOI 10.1103/PhysRevLett.60.416; Avenel O, 1997, PHYS REV LETT, V78, P3602, DOI 10.1103/PhysRevLett.78.3602; BARONE A, 1982, PHYSICS APPL JOSEPHS; Clarke J., 1996, SQUID SENSORS FUNDAM; DAVISSON CJ, 1928, FRANKLIN I J, V205, P597; FEYNMAN RP, 1963, FEYNMAN LECT PHYSICS, V3, pCH21; Gustavson TL, 2000, CLASSICAL QUANT GRAV, V17, P2385, DOI 10.1088/0264-9381/17/12/311; Gustavson TL, 1997, PHYS REV LETT, V78, P2046, DOI 10.1103/PhysRevLett.78.2046; HERRING TA, 1991, REV GEOPHYS, V29, P172, DOI 10.1002/rog.1991.29.s1.172; Marchenkov A, 1999, PHYS REV LETT, V83, P3860, DOI 10.1103/PhysRevLett.83.3860; Marchenkov A, 2000, PHYS REV B, V61, P4196, DOI 10.1103/PhysRevB.61.4196; Mukharsky Y, 2000, PHYSICA B, V284, P287, DOI 10.1016/S0921-4526(99)02619-8; PACKARD RE, 1992, PHYS REV B, V46, P3540, DOI 10.1103/PhysRevB.46.3540; PAIK HJ, 1976, J APPL PHYS, V47, P1168, DOI 10.1063/1.322699; Pereverzev SV, 1997, NATURE, V388, P449, DOI 10.1038/41277; Rowe CH, 1999, APPL OPTICS, V38, P2516, DOI 10.1364/AO.38.002516; Schwab K, 1997, NATURE, V386, P585, DOI 10.1038/386585a0; Simmonds RW, 2000, PHYS REV LETT, V84, P6062, DOI 10.1103/PhysRevLett.84.6062; Stedman GE, 1997, REP PROG PHYS, V60, P615, DOI 10.1088/0034-4885/60/6/001; Tilley D.R., 1990, SUPERFLUIDITY SUPERC, P171; WERNER SA, 1979, PHYS REV LETT, V42, P1103, DOI 10.1103/PhysRevLett.42.1103; YOUNG TA, 1971, COURSE LECT NATURAL, V1, P364	26	47	52	3	16	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					55	58		10.1038/35083518	http://dx.doi.org/10.1038/35083518			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452302				2022-12-28	WOS:000169644900039
J	Gadjourova, Z; Andreev, YG; Tunstall, DP; Bruce, PG				Gadjourova, Z; Andreev, YG; Tunstall, DP; Bruce, PG			Ionic conductivity in crystalline polymer electrolytes	NATURE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; SOLID ELECTROLYTES; POLY(ETHYLENE OXIDE); BATTERIES	Polymer electrolytes are the subject of intensive study, in part because of their potential use as the electrolyte in all-solid-state rechargeable lithium batteries(1). These materials are formed by dissolving a salt (for example LiI) in a solid host polymer such as poly(ethylene oxide) (refs 2-6), and may be prepared as both crystalline and amorphous phases. Conductivity in polymer electrolytes has long been viewed as confined to the amorphous phase above the glass transition temperature, T-g, where polymer chain motion creates a dynamic, disordered environment that plays a critical role in facilitating ion transport(2,3,7-9). Here we show that, in contrast to this prevailing view, ionic conductivity in the static, ordered environment of the crystalline phase can be greater than that in the equivalent amorphous material above T-g. Moreover, we demonstrate that ion transport in crystalline polymer electrolytes can be dominated by the cations, whereas both ions are generally mobile in the amorphous phase(10). Restriction of mobility to the lithium cation is advantageous for battery applications. The realization that order can promote ion transport in polymers is interesting in the context of electronically conducting polymers, where crystallinity favours electron transport(11,12).	Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; Univ St Andrews, Sch Chem, St Andrews KY16 9ST, Fife, Scotland	University of St Andrews; University of St Andrews	Bruce, PG (corresponding author), Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland.		Stoeva, Zlatka/H-5062-2011; Bruce, Peter/AAB-2011-2019	Bruce, Peter/0000-0001-6748-3084				Andreev Y.G., 1996, J CHEM SOC CHEM COMM, P2169; Andreev YG, 1998, J CHEM SOC DALTON, P4071, DOI 10.1039/a805437a; Andreev YG, 1997, J APPL CRYSTALLOGR, V30, P294, DOI 10.1107/S0021889896013556; ANGELL CA, 1993, NATURE, V362, P137, DOI 10.1038/362137a0; [Anonymous], 1995, SOLID STATE ELECTROC; Armand M. B., 1979, Fast Ion Transport in Solids. Electrodes and Electrolytes, P131; BERTHIER C, 1983, SOLID STATE IONICS, V11, P91, DOI 10.1016/0167-2738(83)90068-1; Bruce PG, 1996, PHILOS T R SOC A, V354, P415, DOI 10.1098/rsta.1996.0015; BRUCE PG, 1984, J SOLID STATE CHEM, V53, P430, DOI 10.1016/0022-4596(84)90122-1; Chung SH, 1999, ELECTROCHEM SOLID ST, V2, P553, DOI 10.1149/1.1390901; Croce F, 1998, NATURE, V394, P456, DOI 10.1038/28818; DRUGER SD, 1983, SOLID STATE IONICS, V9-10, P1115, DOI 10.1016/0167-2738(83)90139-X; FENTON DE, 1973, POLYMER, V14, P589, DOI 10.1016/0032-3861(73)90146-8; Fueki, 1990, SOLID STATE IONICS; Gadjourova Z, 2001, CHEM MATER, V13, P1282, DOI 10.1021/cm000949k; GORECKI W, 1988, SOLID STATE IONICS, V28, P1018, DOI 10.1016/0167-2738(88)90323-2; Gray F. M., 1997, POLYM ELECTROLYTES; HEEGER AJ, 1989, FARADAY DISCUSS, V88, P203; INAGUMA Y, 1993, SOLID STATE COMMUN, V86, P689, DOI 10.1016/0038-1098(93)90841-A; LIGHTFOOT P, 1993, SCIENCE, V262, P883, DOI 10.1126/science.262.5135.883; MacFarlane DR, 1999, NATURE, V402, P792, DOI 10.1038/45514; MacGlashan GS, 1999, NATURE, V398, P792, DOI 10.1038/19730; Ratner M. A., 1987, POLYM ELECTROLYTE RE, V1, P173; Roux C, 1996, J PHYS-CONDENS MAT, V8, P7005, DOI 10.1088/0953-8984/8/38/005; SCROSATI B, 1993, APPL ELECTROACTIVE P; SHI J, 1993, SOLID STATE IONICS, V60, P11, DOI 10.1016/0167-2738(93)90268-8; SHIRAKAWA H, 1977, J CHEM SOC CHEM COMM, P578, DOI 10.1039/c39770000578; Wright PV, 1998, POLYM INT, V47, P34, DOI 10.1002/(SICI)1097-0126(199809)47:1<34::AID-PI2>3.0.CO;2-G	28	717	734	32	672	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					520	523		10.1038/35087538	http://dx.doi.org/10.1038/35087538			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484048				2022-12-28	WOS:000170202900040
J	Petrie, M; Schwabl, H; Brande-Lavridsen, N; Burke, T				Petrie, M; Schwabl, H; Brande-Lavridsen, N; Burke, T			Maternal investment - Sex differences in avian yolk hormone levels	NATURE			English	Article							ATTRACTIVENESS; TESTOSTERONE; RATIOS; EGGS		Univ Newcastle Upon Tyne, Dept Psychol, Evolut & Behav Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Newcastle University - UK; Washington State University; University of Sheffield	Petrie, M (corresponding author), Univ Newcastle Upon Tyne, Dept Psychol, Evolut & Behav Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.		Burke, Terry/B-3196-2011; Petrie, Marion/AFM-9857-2022	Burke, Terry/0000-0003-3848-1244; Petrie, Marion/0000-0001-5754-6678; Russell, Andy/0000-0002-1299-8555				BOGART MH, 1987, J THEOR BIOL, V128, P349, DOI 10.1016/S0022-5193(87)80077-2; Bowden RM, 2000, P ROY SOC B-BIOL SCI, V267, P1745, DOI 10.1098/rspb.2000.1205; BURLEY N, 1986, EVOLUTION, V40, P1191, DOI 10.1111/j.1558-5646.1986.tb05744.x; Crews D, 1996, GEN COMP ENDOCR, V102, P317, DOI 10.1006/gcen.1996.0075; Cunningham EJA, 2000, NATURE, V404, P74, DOI 10.1038/35003565; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; HOYT DF, 1979, AUK, V96, P73; JENNINGS DH, IN PRESS AM ZOOL; KRACKOW S, 1999, JOHANNESBURG BIRD LI; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Schwabl H., 1997, P3; Sheldon BC, 1999, NATURE, V402, P874, DOI 10.1038/47239; Sturkie P.D., 1986, AVIAN PHYSIOL, DOI DOI 10.1007/978-1-4612-4862-0_5	13	137	139	1	32	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					498	498		10.1038/35087652	http://dx.doi.org/10.1038/35087652			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484039				2022-12-28	WOS:000170202900031
J	Shandera, WX; Hayman, A				Shandera, WX; Hayman, A			Nail injury to the skull	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine	Shandera, WX (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.								0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2001	345	5					339	339		10.1056/NEJM200108023450505	http://dx.doi.org/10.1056/NEJM200108023450505			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458KM	11484691				2022-12-28	WOS:000170193600005
J	Hayward, RA; Hofer, TP				Hayward, RA; Hofer, TP			Estimating hospital deaths due to medical errors - Preventability is in the eye of the reviewer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVERSE EVENTS; QUALITY PROBLEMS; POOR-QUALITY; CARE; RELIABILITY; JUDGMENTS	Context Studies using physician implicit review have suggested that the number of deaths due to medical errors in US hospitals is extremely high. However, some have questioned the validity of these estimates. Objective To examine the reliability of reviewer ratings of medical error and the implications of a death described as "preventable by better care" in terms of the probability of immediate and short-term survival if care had been optimal. Design Retrospective implicit review of medical records from 1995-1996. Setting and Participants Fourteen board-certified, trained internists used a previously tested structured implicit review instrument to conduct 383 reviews of 111 hospital deaths at 7 Department of Veterans Affairs medical centers, oversampling for markers previously found to be associated with high rates of preventable deaths. Patients considered terminally ill who received comfort care only were excluded. Main Outcome Measures Reviewer estimates of whether deaths could have been prevented by optimal care (rated on a 5-point scale) and of the probability that patients would have lived to discharge or for 3 months or more if care had been optimal (rated from 0%-100%). Results Similar to previous studies, almost a quarter (22.7 %) of active-care patient deaths were rated as at least possibly preventable by optimal care, with 6.0% rated as probably or definitely preventable. Interrater reliability for these ratings was also similar to previous studies (0.34 for 2 reviewers). The reviewers' estimates of the percentage of patients who would have left the hospital alive had optimal care been provided was 6.0% (95% confidence interval [CI], 3.4%-8.6%). However, after considering 3-month prognosis and adjusting for the variability and skewness of reviewers' ratings, clinicians estimated that only 0.5% (95 % CI, 0.3 % -0.7%) of patients who died would have lived 3 months or more in good cognitive health if care had been optimal, representing roughly 1 patient per 10000 admissions to the study hospitals. Conclusions Medical errors are a major concern regardless of patients' life expectancies, but our study suggests that previous interpretations of medical error statistics are probably misleading. Our data place the estimates of preventable deaths in context, pointing out the limitations of this means of identifying medical errors and assessing their potential implications for patient outcomes.	Dept Vet Affairs, VA Ctr Practice Management & Outcomes Res, VA Ann Arbor Healthcare Syst, Ann Arbor, MI USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; Univ Michigan, Sch Publ Hlth, Dept Hlth Policy & Management, Ann Arbor, MI USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hayward, RA (corresponding author), POB 130170, Ann Arbor, MI 48113 USA.		Hofer, Timothy Philip/AAC-9238-2022	Hofer, Timothy/0000-0003-0434-8787				ADDINGTONHALL JM, 1990, BRIT J CANCER, V62, P695, DOI 10.1038/bjc.1990.360; Andrews LB, 1997, LANCET, V349, P309, DOI 10.1016/S0140-6736(96)08268-2; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; BRAVO G, 1991, J CLIN EPIDEMIOL, V44, P381, DOI 10.1016/0895-4356(91)90076-L; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Brennan TA, 2000, NEW ENGL J MED, V342, P1123, DOI 10.1056/NEJM200004133421510; BRENNAN TA, 1989, MED CARE, V27, P1148, DOI 10.1097/00005650-198912000-00006; BUTLER JJ, 1958, JAMA-J AM MED ASSOC, V167, P567, DOI 10.1001/jama.1958.02990220037011; CAPLAN RA, 1991, JAMA-J AM MED ASSOC, V265, P1957, DOI 10.1001/jama.265.15.1957; Christakis N A, 1998, Hosp J, V13, P71; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; DUBOIS RW, 1988, ANN INTERN MED, V109, P582, DOI 10.7326/0003-4819-109-7-582; EVANS C, 1985, LANCET, V1, P1204; EVANS WJ, 1981, MED CARE, V19, P1211, DOI 10.1097/00005650-198112000-00004; FORSTER LE, 1988, ARCH INTERN MED, V148, P2540, DOI 10.1001/archinte.148.12.2540; Gawande AA, 1999, SURGERY, V126, P66, DOI 10.1067/msy.1999.98664; Gillis J, 1999, WASHINGTON POST 0627, pA1; GOLDMAN RL, 1992, JAMA-J AM MED ASSOC, V267, P958, DOI 10.1001/jama.267.7.958; HAYWARD RA, 1993, MED CARE, V31, P394, DOI 10.1097/00005650-199305000-00002; HAYWARD RA, 1993, ANN INTERN MED, V118, P550, DOI 10.7326/0003-4819-118-7-199304010-00010; Hofer T P, 1997, Jt Comm J Qual Improv, V23, P455; Hofer TP, 1996, MED CARE, V34, P737, DOI 10.1097/00005650-199608000-00002; Hofer TP, 2000, MED CARE, V38, P152, DOI 10.1097/00005650-200002000-00005; Hofer TP, 2000, EFFECTIVE CLIN PRACT, V3, P1; Kahn KL, 1989, STRUCTURED IMPLICIT; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Leape LL, 2000, JAMA-J AM MED ASSOC, V284, P95, DOI 10.1001/jama.284.1.95; McDonald CJ, 2000, JAMA-J AM MED ASSOC, V284, P93, DOI 10.1001/jama.284.1.93; PERROW C, 1999, NORMAL ACCIDENTS LIV; RUBENSTEIN LV, 1990, JAMA-J AM MED ASSOC, V264, P1974, DOI 10.1001/jama.264.15.1974; RUBIN HR, 1992, JAMA-J AM MED ASSOC, V267, P2349, DOI 10.1001/jama.267.17.2349; Sox H C Jr, 2000, Eff Clin Pract, V3, P277; Thompson SC, 1998, PSYCHOL BULL, V123, P143, DOI 10.1037/0033-2909.123.2.143; 1999, FACTOID         0116; 1999, NY TIMES        1201, pA22	35	415	420	0	21	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2001	286	4					415	420		10.1001/jama.286.4.415	http://dx.doi.org/10.1001/jama.286.4.415			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456DZ	11466119				2022-12-28	WOS:000170069000012
J	Whitehead, M; Diderichsen, F				Whitehead, M; Diderichsen, F			Social capital and health: tip-toeing through the minefield of evidence	LANCET			English	Editorial Material							CORONARY HEART-DISEASE; JOB CONTROL; RISK		Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England; Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden	University of Liverpool; Karolinska Institutet	Whitehead, M (corresponding author), Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England.		Diderichsen, Finn/P-4654-2019	Diderichsen, Finn/0000-0002-9998-4972				BERKMAN LF, 1995, PSYCHOSOM MED, V57, P245, DOI 10.1097/00006842-199505000-00006; Bosma H, 1997, BRIT MED J, V314, P558, DOI 10.1136/bmj.314.7080.558; Diderichsen F., 2001, SOCIAL BASIS DISPARI; Durkheim E, 2002, DIVISION TRAVAIL SOC; Fukuyama F, 2000, WP0074 IMF; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Marmot MG, 1997, LANCET, V350, P235, DOI 10.1016/S0140-6736(97)04244-X; NAVARRO V, 2001, POLITICAL RCONOMY SO; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; Therborn Goran, 1995, EUROPEAN MODERNITY T; Wilkinson R., 1996, UNHEALTHY SOC AFFLIC	12	48	48	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 21	2001	358	9277					165	166		10.1016/S0140-6736(01)05398-3	http://dx.doi.org/10.1016/S0140-6736(01)05398-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454HL	11476827				2022-12-28	WOS:000169967100003
J	Orphan, VJ; House, CH; Hinrichs, KU; McKeegan, KD; DeLong, EF				Orphan, VJ; House, CH; Hinrichs, KU; McKeegan, KD; DeLong, EF			Methane-consuming archaea revealed by directly coupled isotopic and phylogenetic analysis	SCIENCE			English	Article							OXIDATION; SEDIMENTS; CONSORTIUM	Microorganisms Living in anoxic marine sediments consume more than 80% of the methane produced in the world's oceans. In addition to single-species aggregates, consortia of metabolically interdependent bacteria and archaea are found in methane-rich sediments. A combination of fluorescence in situ hybridization and secondary ion mass spectrometry shows that cells belonging to one specific archaeal group associated with the Methanosarcinales were all highly depleted in C-13 (to values of -96 parts per thousand). This depletion indicates assimilation of isotopically Light methane into specific archaeal cells. Additional microbial species apparently use other carbon sources, as indicated by significantly higher C-13/C-12 ratios in their cell carbon. Our results demonstrate the feasibility of simultaneous determination of the identity and the metabolic activity of naturally occurring microorganisms.	Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA	Monterey Bay Aquarium Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Woods Hole Oceanographic Institution; University of California System; University of California Los Angeles	DeLong, EF (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.		Orphan, Victoria J/K-1002-2014; Orphan, Victoria/AAS-5989-2020; McKeegan, Kevin D/A-4107-2008; Hinrichs, Kai-Uwe/C-7675-2009	Orphan, Victoria J/0000-0002-5374-6178; Orphan, Victoria/0000-0002-5374-6178; McKeegan, Kevin D/0000-0002-1827-729X; Hinrichs, Kai-Uwe/0000-0002-0739-9291				Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Boschker HTS, 1998, NATURE, V392, P801, DOI 10.1038/33900; BRUCHERT V, 1995, P ODP SCI RES 146 2, P219; Elvert M, 2000, ORG GEOCHEM, V31, P1175, DOI 10.1016/S0146-6380(00)00111-X; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; Hinrichs KU, 2000, ORG GEOCHEM, V31, P1685, DOI 10.1016/S0146-6380(00)00106-6; HINRICHS KU, IN PRESS OCEAN MARGI; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; House CH, 2000, GEOLOGY, V28, P707, DOI 10.1130/0091-7613(2000)28<707:CICOIP>2.0.CO;2; MARTENS CS, 1977, LIMNOL OCEANOGR, V22, P10, DOI 10.4319/lo.1977.22.1.0010; MCKEEGAN KD, 1985, GEOCHIM COSMOCHIM AC, V49, P1971, DOI 10.1016/0016-7037(85)90091-2; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; Orphan VJ, 2001, APPL ENVIRON MICROB, V67, P1922, DOI 10.1128/AEM.67.4.1922-1934.2001; PAULL CK, 2001, COMMUNICATION; Radajewski S, 2000, NATURE, V403, P646, DOI 10.1038/35001054; Summons RE, 1998, ORG GEOCHEM, V28, P465, DOI 10.1016/S0146-6380(98)00011-4; Valentine DL, 2000, ENVIRON MICROBIOL, V2, P477, DOI 10.1046/j.1462-2920.2000.00135.x	18	732	799	10	232	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2001	293	5529					484	487		10.1126/science.1061338	http://dx.doi.org/10.1126/science.1061338			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463914				2022-12-28	WOS:000169966700045
J	Marianneau, P; Georges-Courbot, MC; Deubel, V				Marianneau, P; Georges-Courbot, MC; Deubel, V			Rarity of adverse effects after 17D yellow-fever vaccination	LANCET			English	Editorial Material							VIRUS; STRAINS		Inst Pasteur, Unite Biol Infect Virales Emergentes, F-69007 Lyon, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Deubel, V (corresponding author), Inst Pasteur, Unite Biol Infect Virales Emergentes, F-69007 Lyon, France.							BARRETT ADT, 1987, B I PASTEUR, V85, P103; DIGOUETTE JP, 1995, YELLOW FEVER; DOSSANTOS CND, 1995, VIRUS RES, V35, P35; LIPRANDI F, 1981, J GEN VIROL, V56, P363, DOI 10.1099/0022-1317-56-2-363; LIPRANDI F, 1983, ARCH VIROL, V76, P51, DOI 10.1007/BF01315703; Marianneau P, 1999, B SOC PATHOL EXOT, V92, P432; Monath TP, 1999, VACCINES, P815; Proutski V, 1997, J GEN VIROL, V78, P1543, DOI 10.1099/0022-1317-78-7-1543; RICE C M, 1989, New Biologist, V1, P285; Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787; Zeng LL, 1996, J VIROL, V70, P3108, DOI 10.1128/JVI.70.5.3108-3117.1996	11	27	29	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 14	2001	358	9276					84	85		10.1016/S0140-6736(01)05374-0	http://dx.doi.org/10.1016/S0140-6736(01)05374-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452BR	11463403				2022-12-28	WOS:000169837700002
J	Gu, HH; Saito, K; Klaman, LD; Shen, JQ; Fleming, T; Wang, YP; Pratt, JC; Lin, GS; Lim, B; Kinet, JP; Neel, BG				Gu, HH; Saito, K; Klaman, LD; Shen, JQ; Fleming, T; Wang, YP; Pratt, JC; Lin, GS; Lim, B; Kinet, JP; Neel, BG			Essential role for Gab2 in the allergic response	NATURE			English	Article							PHOSPHOLIPASE C-GAMMA; GROWTH-FACTOR RECEPTORS; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; MAST-CELLS; ACTIVATION; PROTEIN; KINASE; CYTOKINE; PATHWAY	Dos/Gab family scaffolding adapters (Dos, Gab1, Gab2) bind several signal relay molecules, including the protein-tyrosine phosphatase Shp-2 and phosphatidylinositol-3-OH kinase (PI(3)K); they are also implicated in growth factor, cytokine and antigen receptor signal transduction(1). Mice lacking Gab1 die during embryogenesis and show defective responses to several stimuli(2,3). Here we report that Gab2(-/-) mice are viable and generally healthy; however, the response (for example, degranulation and cytokine gene expression) of Gab2(-/-) mast cells to stimulation of the high affinity immunoglobulin-epsilon (IgE) receptor Fc epsilon RI is defective. Accordingly, allergic reactions such as passive cutaneous and systemic anaphylaxis are markedly impaired in Gab2(-/-) mice. Biochemical analyses reveal that signalling pathways dependent on PI(3)K, a critical component of Fc epsilon RI signalling, are defective in Gab2(-/-) mast cells. Our data identify Gab2 as the principal activator of PI(3)K in response to FceRI activation, thereby providing genetic evidence that Dos/Gab family scaffolds regulate the PI(3)K pathway in vivo. Gab2 and/or its associated signalling molecules may be new targets for developing drugs to treat allergy.	Beth Israel Deaconess Med Ctr, Div Hematol & Oncol, Canc Biol Program, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Med, Div Expt Pathol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Franklin W Olin Coll Engn, Needham, MA 02492 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Franklin W. Olin College of Engineering	Gu, HH (corresponding author), Beth Israel Deaconess Med Ctr, Div Hematol & Oncol, Canc Biol Program, Boston, MA 02215 USA.	hgu@caregroup.harvard.edu						Bae YS, 1998, J BIOL CHEM, V273, P4465, DOI 10.1074/jbc.273.8.4465; Barker SA, 1999, J LEUKOCYTE BIOL, V65, P321, DOI 10.1002/jlb.65.3.321; Barkley R., 1995, ADHD REPORT, V3, P5; Craddock BL, 1999, J BIOL CHEM, V274, P10633, DOI 10.1074/jbc.274.15.10633; Dombrowicz D, 1997, J CLIN INVEST, V99, P915, DOI 10.1172/JCI119256; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Galli SJ, 2000, CURR OPIN HEMATOL, V7, P32, DOI 10.1097/00062752-200001000-00007; Gommerman JL, 2000, J IMMUNOL, V165, P6915, DOI 10.4049/jimmunol.165.12.6915; Gu HH, 2000, MOL CELL BIOL, V20, P7109, DOI 10.1128/MCB.20.19.7109-7120.2000; Gu HH, 1998, MOL CELL, V2, P729, DOI 10.1016/S1097-2765(00)80288-9; Hibi M, 2000, LEUKEMIA LYMPHOMA, V37, P299, DOI 10.3109/10428190009089430; Ishizuka T, 1999, J IMMUNOL, V162, P2087; Itoh M, 2000, MOL CELL BIOL, V20, P3695, DOI 10.1128/MCB.20.10.3695-3704.2000; Kawakami Y, 1998, J IMMUNOL, V161, P1795; Liu YC, 1998, CELL SIGNAL, V10, P377, DOI 10.1016/S0898-6568(97)00179-4; Lu-Kuo JM, 2000, J BIOL CHEM, V275, P6022, DOI 10.1074/jbc.275.8.6022; NAKANISHI S, 1995, CELL SIGNAL, V7, P545, DOI 10.1016/0898-6568(95)00033-L; Nishida K, 1999, BLOOD, V93, P1809, DOI 10.1182/blood.V93.6.1809.406k35_1809_1816; Pratt JC, 2000, J IMMUNOL, V165, P4158, DOI 10.4049/jimmunol.165.8.4158; Raabe T, 1996, CELL, V85, P911, DOI 10.1016/S0092-8674(00)81274-X; Rameh LE, 1998, J BIOL CHEM, V273, P23750, DOI 10.1074/jbc.273.37.23750; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Sachs M, 2000, J CELL BIOL, V150, P1375, DOI 10.1083/jcb.150.6.1375; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Scharenberg AM, 1998, EMBO J, V17, P1961, DOI 10.1093/emboj/17.7.1961; Schwaller J, 1998, EMBO J, V17, P5321, DOI 10.1093/emboj/17.18.5321; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Yang FC, 2000, IMMUNITY, V12, P557, DOI 10.1016/S1074-7613(00)80207-1	29	266	276	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2001	412	6843					186	190		10.1038/35084076	http://dx.doi.org/10.1038/35084076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449275				2022-12-28	WOS:000169778700053
J	Haile-Selassie, Y				Haile-Selassie, Y			Late Miocene hominids from the Middle Awash, Ethiopia	NATURE			English	Article							AUSTRALOPITHECUS-AFARENSIS; HOMINOIDS; LOTHAGAM; SEQUENCE; RIFT	Molecular studies suggest that the lineages leading to humans and chimpanzees diverged approximately 6.5-5.5 million years (Myr) ago, in the Late Miocene(1-3). Hominid fossils from this interval, however, are fragmentary and of uncertain phylogenetic status, age, or both(4-6). Here I report new hominid specimens from the Middle Awash area of Ethiopia that date to 5.2-5.8 Myr and are associated with a wooded palaeoenvironment(7). These Late Miocene fossils are assigned to the hominid genus Ardipithecus and represent the earliest definitive evidence of the hominid clade. Derived dental characters are shared exclusively with all younger hominids. This indicates that the fossils probably represent a hominid taxon that postdated the divergence of lineages leading to modern chimpanzees and humans. However, the persistence of primitive dental and postcranial characters in these new fossils indicates that Ardipithecus was phylogenetically close to the common ancestor of chimpanzees and humans. These new findings raise additional questions about the claimed hominid status of Orrorin tugenensis(8), recently described from Kenya and dated to similar to6 Myr(9).	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Human Evolut Studies Lab, Museum Vertebrate Zool, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Haile-Selassie, Y (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, 3060 VLSB, Berkeley, CA 94720 USA.							Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; DAY MH, 1969, NATURE, V47, P230; Hill A., 1994, INTEGRATIVE PATHS PA, P123; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; LATIMER B, 1990, AM J PHYS ANTHROPOL, V83, P13, DOI 10.1002/ajpa.1330830103; LATIMER BM, 1982, AM J PHYS ANTHROPOL, V57, P701, DOI 10.1002/ajpa.1330570412; Leakey MG, 1996, J VERTEBR PALEONTOL, V16, P556, DOI 10.1080/02724634.1996.10011339; McDougall I, 1999, J GEOL SOC LONDON, V156, P731, DOI 10.1144/gsjgs.156.4.0731; Ohman JC, 1997, AM J PHYS ANTHROPOL, V104, P117, DOI 10.1002/(SICI)1096-8644(199709)104:1<117::AID-AJPA8>3.0.CO;2-O; Pickford M, 2001, CR ACAD SCI II A, V332, P145, DOI 10.1016/S1251-8050(01)01528-2; Renne PR, 1999, GEOL SOC AM BULL, V111, P869, DOI 10.1130/0016-7606(1999)111<0869:COTMPS>2.3.CO;2; Ruvolo M, 1997, MOL BIOL EVOL, V14, P248, DOI 10.1093/oxfordjournals.molbev.a025761; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; WoldeGabriel G, 2001, NATURE, V412, P175, DOI 10.1038/35084058	15	279	291	4	65	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					178	181		10.1038/35084063	http://dx.doi.org/10.1038/35084063			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	451AJ	11449272				2022-12-28	WOS:000169778700050
J	Stevenson, DJ				Stevenson, DJ			Mars' core and magnetism	NATURE			English	Review							TERRESTRIAL PLANETS; THERMAL EVOLUTION; PLATE-TECTONICS; GEODYNAMO; CONSEQUENCES; PATHFINDER; CONVECTION; ACCRETION; DYNAMO	The detection of strongly magnetized ancient crust on Mars is one of the most surprising outcomes of recent Mars exploration, and provides important insight about the history and nature of the martian core. The iron-rich core probably formed during the hot accretion of Mars similar to4.5 billion years ago and subsequently cooled at a rate dictated by the overlying mantle. A core dynamo operated much like Earth's current dynamo, but was probably limited in duration to several hundred million years. The early demise of the dynamo could have arisen through a change in the cooling rate of the mantle, or even a switch in convective style that led to mantle heating. Presently, Mars probably has a liquid, conductive outer core and might have a solid inner core like Earth.	CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Stevenson, DJ (corresponding author), CALTECH, 150-21, Pasadena, CA 91125 USA.							Acuna MH, 1999, SCIENCE, V284, P790, DOI 10.1126/science.284.5415.790; Bertka CM, 1998, SCIENCE, V281, P1838, DOI 10.1126/science.281.5384.1838; Brain DA, 1998, J GEOPHYS RES-PLANET, V103, P22689, DOI 10.1029/98JE02074; Busse FH, 2000, ANNU REV FLUID MECH, V32, P383, DOI 10.1146/annurev.fluid.32.1.383; CHEN JH, 1986, GEOCHIM COSMOCHIM AC, V50, P955, DOI 10.1016/0016-7037(86)90376-5; Connerney JEP, 1999, SCIENCE, V284, P794, DOI 10.1126/science.284.5415.794; Fei YW, 1997, SCIENCE, V275, P1621, DOI 10.1126/science.275.5306.1621; Flasar FM, 1973, J GEOPHYS RES, V78, P6101, DOI 10.1029/JB078i026p06101; Folkner WM, 1997, SCIENCE, V278, P1749, DOI 10.1126/science.278.5344.1749; Gessmann CK, 2001, EARTH PLANET SC LETT, V184, P367, DOI 10.1016/S0012-821X(00)00325-3; GUBBINS D, 1979, GEOPHYS J ROY ASTR S, V59, P57, DOI 10.1111/j.1365-246X.1979.tb02553.x; Harder H, 1996, NATURE, V380, P507, DOI 10.1038/380507a0; Kutzner C, 2000, GEOPHYS RES LETT, V27, P29, DOI 10.1029/1999GL010937; Lee DC, 1997, NATURE, V388, P854, DOI 10.1038/42206; Li J, 2001, GEOPHYS RES LETT, V28, P81, DOI 10.1029/2000GL012114; LISTER JR, 1995, PHYS EARTH PLANET IN, V91, P17, DOI 10.1016/0031-9201(95)03042-U; LOPER DE, 1978, J GEOPHYS RES, V83, P5961, DOI 10.1029/JB083iB12p05961; MATSUI T, 1986, EARTH MOON PLANETS, V34, P223, DOI 10.1007/BF00145081; Merrill R., 1998, MAGNETIC FIELD EARTH, P531; Nimmo F, 2000, J GEOPHYS RES-PLANET, V105, P11969, DOI 10.1029/1999JE001216; Nimmo F, 2000, GEOLOGY, V28, P391, DOI 10.1130/0091-7613(2000)028<0391:DIAAPC>2.3.CO;2; Purucker M, 2000, GEOPHYS RES LETT, V27, P2449, DOI 10.1029/2000GL000072; Righter K, 1998, GEOCHIM COSMOCHIM AC, V62, P2167, DOI 10.1016/S0016-7037(98)00132-X; Roberts PH, 2000, REV MOD PHYS, V72, P1081, DOI 10.1103/RevModPhys.72.1081; Schubert G, 2000, NATURE, V408, P666, DOI 10.1038/35047163; Schubert G., 1988, MERCURY, P429; Schubert G., 1992, MARS, P147, DOI [10.2307/j.ctt207g59v.9, DOI 10.2307/J.CTT207G59V.9]; SLEEP NH, 1994, J GEOPHYS RES-PLANET, V99, P5639, DOI 10.1029/94JE00216; Sotin C, 2000, PLANET SPACE SCI, V48, P1143, DOI 10.1016/S0032-0633(00)00098-2; STEVENSON D, 1974, ICARUS, V22, P403, DOI 10.1016/0019-1035(74)90073-6; STEVENSON DJ, 1983, ICARUS, V54, P466, DOI 10.1016/0019-1035(83)90241-5; STEVENSON DJ, 1983, REP PROG PHYS, V46, P555, DOI 10.1088/0034-4885/46/5/001; Stevenson DJ., 1990, ORIGIN EARTH, P231; Thomas-Keprta KL, 2001, P NATL ACAD SCI USA, V98, P2164, DOI 10.1073/pnas.051500898; Tyburczy J. A., 1995, MINERAL PHYS CRYSTAL, P185; WEISS BP, UNPUB NATURE; WETHERILL GW, 1994, GEOCHIM COSMOCHIM AC, V58, P4513, DOI 10.1016/0016-7037(94)90352-2; Young RE, 1974, GEOPHYS RES LETT, V1, P157, DOI 10.1029/GL001i004p00157	40	178	183	4	52	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					214	219		10.1038/35084155	http://dx.doi.org/10.1038/35084155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449282				2022-12-28	WOS:000169778700060
J	Hensinger, WK; Haffer, H; Browaeys, A; Heckenberg, NR; Helmerson, K; McKenzie, C; Milburn, GJ; Phillips, WD; Rolston, SL; Rubinsztein-Dunlop, H; Upcroft, B				Hensinger, WK; Haffer, H; Browaeys, A; Heckenberg, NR; Helmerson, K; McKenzie, C; Milburn, GJ; Phillips, WD; Rolston, SL; Rubinsztein-Dunlop, H; Upcroft, B			Dynamical tunnelling of ultracold atoms	NATURE			English	Article							QUANTUM CHAOS; SYSTEM; WAVE	The divergence of quantum and classical descriptions of particle motion is clearly apparent in quantum tunnelling(1,2) between two regions of classically stable motion. An archetype of such nonclassical motion is tunnelling through an energy barrier. In the 1980s, a new process, 'dynamical' tunnelling(1-3), was predicted, involving no potential energy barrier; however, a constant of the motion (other than energy) still forbids classically the quantum-allowed motion. This process should occur, for example, in periodically driven, nonlinear hamiltonian systems with one degree of freedom(4-6). Such systems may be chaotic, consisting of regions in phase space of stable, regular motion embedded in a sea of chaos. Previous studies predicted(4) dynamical tunnelling between these stable regions. Here we observe dynamical tunnelling of ultracold atoms from a Bose-Einstein condensate in an amplitude-modulated optical standing wave. Atoms coherently tunnel back and forth between their initial state of oscillatory motion (corresponding to an island of regular motion) and the state oscillating 180 degrees out of phase with the initial state.	Natl Inst Stand & Technol, Gaithersburg, MD 20899 USA; Univ Queensland, Ctr Laser Sci, Dept Phys, Brisbane, Qld 4072, Australia; Univ Queensland, Ctr Quantum Comp Technol, Brisbane, Qld 4072, Australia	National Institute of Standards & Technology (NIST) - USA; University of Queensland; University of Queensland	Hensinger, WK (corresponding author), Natl Inst Stand & Technol, Gaithersburg, MD 20899 USA.		rolston, steven l/L-5175-2013; Helmerson, Kristian/E-3683-2013; MIlburn, Gerard J/B-6381-2008; Rubinsztein-Dunlop, Halina/C-6762-2009; Browaeys, Antoine/E-1547-2017; Rubinsztein-Dunlop, Halina/D-2387-2014; Haeffner, Hartmut/D-8046-2012	rolston, steven l/0000-0003-1671-4190; MIlburn, Gerard J/0000-0002-5404-9681; Rubinsztein-Dunlop, Halina/0000-0002-8332-2309; Browaeys, Antoine/0000-0001-9941-8869; Rubinsztein-Dunlop, Halina/0000-0002-8332-2309; Haeffner, Hartmut/0000-0002-5113-9622; Helmerson, Kristian/0000-0002-6387-0949; Hensinger, Winfried/0000-0001-8329-438X				ARNOLD VI, 1979, MATH METHODS CLASSIC; CALDEIRA AO, 1983, ANN PHYS-NEW YORK, V149, P374, DOI 10.1016/0003-4916(83)90202-6; DAVIS MJ, 1981, J CHEM PHYS, V75, P246, DOI 10.1063/1.441832; DYRTING S, 1993, PHYS REV E, V48, P969, DOI 10.1103/PhysRevE.48.969; GRAHAM R, 1992, PHYS REV A, V45, pR19, DOI 10.1103/PhysRevA.45.R19; Haake F., 1987, Zeitschrift fur Physik B (Condensed Matter), V65, P381, DOI 10.1007/BF01303727; Habib S, 1998, PHYS REV LETT, V80, P4361, DOI 10.1103/PhysRevLett.80.4361; Hensinger WK, 2000, J OPT B-QUANTUM S O, V2, P659, DOI 10.1088/1464-4266/2/5/314; HENSINGER WK, IN PRESS PHYS REV A; Kozuma M, 1999, PHYS REV LETT, V82, P871, DOI 10.1103/PhysRevLett.82.871; MOORE FL, 1995, PHYS REV LETT, V75, P4598, DOI 10.1103/PhysRevLett.75.4598; SANDERS BC, 1989, Z PHYS B CON MAT, V77, P497, DOI 10.1007/BF01453801; STECK DA, IN PRESS SCIENCE; Tomsovic S, 2001, PHYS SCRIPTA, VT90, P162, DOI 10.1238/Physica.Topical.090a00162	14	293	295	1	33	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					52	55		10.1038/35083510	http://dx.doi.org/10.1038/35083510			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452301				2022-12-28	WOS:000169644900038
J	Pockley, P				Pockley, P			Gene screens for nuclear veterans	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					5	5		10.1038/35083721	http://dx.doi.org/10.1038/35083721			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452267	Bronze			2022-12-28	WOS:000169644900006
J	Reich, PB; Knops, J; Tilman, D; Craine, J; Ellsworth, D; Tjoelker, M; Lee, T; Wedin, D; Naeem, S; Bahauddin, D; Hendrey, G; Jose, S; Wrage, K; Goth, J; Bengston, W				Reich, PB; Knops, J; Tilman, D; Craine, J; Ellsworth, D; Tjoelker, M; Lee, T; Wedin, D; Naeem, S; Bahauddin, D; Hendrey, G; Jose, S; Wrage, K; Goth, J; Bengston, W			Plant diversity enhances ecosystem responses to elevated CO2 and nitrogen deposition (vol 410, pg 809, 2001)	NATURE			English	Correction							CARBON-DIOXIDE ENRICHMENT; ATMOSPHERIC CO2; LONG-TERM; CALCAREOUS GRASSLAND; SPECIES COMPOSITION; BIOMASS; MONOCULTURES; PRODUCTIVITY; BIODIVERSITY; COMPETITION	Human actions are causing declines in plant biodiversity, increases in atmospheric CO2 concentrations and increases in nitrogen deposition; however, the interactive effects of these factors on ecosystem processes are unknown(1,2). Reduced biodiversity has raised numerous concerns, including the possibility that ecosystem functioning may be affected negatively(1-4), which might be particularly important in the face of other global changes (5,6). Here we present results of a grassland field experiment in Minnesota, USA, that tests the hypothesis that plant diversity and composition influence the enhancement of biomass and carbon acquisition in ecosystems subjected to elevated atmospheric CO2 concentrations and nitrogen deposition. The study experimentally controlled plant diversity (1, 4, 9 or 16 species), soil nitrogen (unamended versus deposition of 4 g of nitrogen per m(2) per yr) and atmospheric CO2 concentrations using free-air CO2 enrichment (ambient, 368 mu mol mol(-1), versus elevated, 560 mu mol mol(-1)). We found that the enhanced biomass accumulation in response to elevated levels of CO2 or nitrogen, or their combination, is less in species-poor than in species-rich assemblages.					Tilman, David/ABD-5309-2021; Wedin, David A/K-4093-2012; Craine, Joseph/D-4569-2009; Knops, Johannes/AAA-8546-2020; Tjoelker, Mark G/M-2413-2016	Craine, Joseph/0000-0001-6561-3244; Tjoelker, Mark G/0000-0003-4607-5238				BOLKER BM, 1995, GLOB CHANGE BIOL, V1, P373, DOI 10.1111/j.1365-2486.1995.tb00035.x; Cannell MGR, 1998, GLOBAL CHANGE BIOL, V4, P431, DOI 10.1046/j.1365-2486.1998.00167.x; DeLucia EH, 1999, SCIENCE, V284, P1177, DOI 10.1126/science.284.5417.1177; DIAZ S, 1993, NATURE, V364, P616, DOI 10.1038/364616a0; Hebeisen T, 1997, GLOB CHANGE BIOL, V3, P149, DOI 10.1046/j.1365-2486.1997.00073.x; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hu SJ, 1999, TRENDS ECOL EVOL, V14, P433, DOI 10.1016/S0169-5347(99)01682-1; Hungate BA, 1997, NATURE, V388, P576, DOI 10.1038/41550; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; KORNER C, 1996, CARBON DIOXIDE POPUL; Leadley PW, 1999, OECOLOGIA, V118, P39, DOI 10.1007/s004420050701; LEWIN KF, 1994, AGR FOREST METEOROL, V70, P15, DOI 10.1016/0168-1923(94)90045-0; Luscher A, 1998, OECOLOGIA, V113, P37, DOI 10.1007/s004420050351; Navas ML, 1999, NEW PHYTOL, V143, P323, DOI 10.1046/j.1469-8137.1999.00443.x; Owensby CE, 1999, GLOB CHANGE BIOL, V5, P497, DOI 10.1046/j.1365-2486.1999.00245.x; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schenk U, 1997, NEW PHYTOL, V135, P67, DOI 10.1046/j.1469-8137.1997.00615.x; Schimel D, 2000, SCIENCE, V287, P2004, DOI 10.1126/science.287.5460.2004; SCHMID B, IN PRESS FUNCTIONAL; Stocker R, 1999, GLOBAL CHANGE BIOL, V5, P95, DOI 10.1046/j.1365-2486.1998.00198.x; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; Warwick KR, 1998, GLOB CHANGE BIOL, V4, P375, DOI 10.1046/j.1365-2486.1998.00159.x; ZAK DR, 1993, PLANT SOIL, V151, P105, DOI 10.1007/BF00010791; Zak DR, 2000, ECOL APPL, V10, P34, DOI 10.1890/1051-0761(2000)010[0034:ACSNAA]2.0.CO;2; Zanetti S, 1997, OECOLOGIA, V112, P17, DOI 10.1007/s004420050278	30	7	8	6	84	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					824	+		10.1038/35081122	http://dx.doi.org/10.1038/35081122			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11460110	Bronze			2022-12-28	WOS:000169246400056
J	Butler, D				Butler, D			Public library set to turn publisher as boycott looms	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					469	469		10.1038/35087732	http://dx.doi.org/10.1038/35087732			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484014	Bronze			2022-12-28	WOS:000170202900011
J	Tod, AM; Read, C; Lacey, A; Abbott, J				Tod, AM; Read, C; Lacey, A; Abbott, J			Barriers to uptake of services for coronary heart disease: qualitative study	BRITISH MEDICAL JOURNAL			English	Article							PREVENTION; ANGINA	Objectives To identify factors within the South Yorkshire coalfields that influence use of health services by people with angina. Design Qualitative study using semistructured individual and group interviews. Setting General practice and community settings in Barnsley and Rotherham health authorities. Participants 14 patients with stable angina and nine primary care staff had individual interviews plus five community groups and one group of general practitioners. Main outcome measures Barriers to accessing health services. Results A complex web of factors was identified that prevented, delayed, or facilitated referral to secondary care. Delay, denial, and self management by patients meant that the Rill extent of symptoms often remained hidden from general practitioners, resulting in a delayed or missed referral. Barriers identified fell into six categories: structural personal, social and cultural, past experience and expectations, diagnostic confusion, and knowledge and awareness. Conclusions Many of the factors influencing referral operate before general practitioners become involved. Community development could be one way of tackling inequalities and promoting sustainable change. Structural changes are needed to improve access and increase the acceptability of general practice services. Primary care staff should be educated to detect under-reporting of symptoms and promote appropriate referral.	Rotherham Hlth Author, Rotherham S60 3AQ, S Yorkshire, England; Sheffield Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England	University of Sheffield	Tod, AM (corresponding author), Rotherham Hlth Author, Bevan House, Rotherham S60 3AQ, S Yorkshire, England.		Tod, Angela M/P-2330-2015	Tod, Angela M/0000-0001-6336-3747				Blaxter M., 1990, HLTH LIFESTYLES; Bowling A., 1997, RES METHODS HLTH; *BRIT HEART FDN, 1999, COR HEART DIS STAT; DAVISON C, 1991, SOCIOL HEALTH ILL, V13, P1, DOI 10.1111/1467-9566.ep11340301; DAVISON C, 1992, SOC SCI MED, V34, P675, DOI 10.1016/0277-9536(92)90195-V; Fisher B, 1999, BRIT MED J, V318, P749, DOI 10.1136/bmj.318.7186.749; Gardner K, 1999, BRIT MED J, V319, P418, DOI 10.1136/bmj.319.7207.418; Glaser B.G., 1965, AWARENESS DYING; Goddard M, 1998, EQUITY ACCESS HLTH C; GORDON D, 2000, INEQUALITIES HLTH EV; Hammersley M., 1995, ETHNOGRAPHY PRINCIPL; Lincon YS., 1985, NATURALISTIC INQUIRY; Maggs-Rapport F, 2000, J ADV NURS, V31, P219, DOI 10.1046/j.1365-2648.2000.01243.x; Mays N, 1996, QUALITATIVE RES HLTH; Payne N, 1997, BRIT MED J, V314, P257, DOI 10.1136/bmj.314.7076.257; Ritchie J, 2002, ANAL QUALITATIVE DAT, P187; ROSE G, 1977, BRIT J PREV SOC MED, V31, P42; *ROTH HLTH AUTH, 1998, HLTH ROTH PEOPL 1998; Ruston A, 1998, BRIT MED J, V316, P1060; SORRELL JM, 1995, J ADV NURS, V21, P117; Strauss A., 1990, BASICS QUALITATIVE R; Wiles R, 1998, SOC SCI MED, V46, P1477, DOI 10.1016/S0277-9536(97)10140-X	22	42	43	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2001	323	7306					214	217		10.1136/bmj.323.7306.214	http://dx.doi.org/10.1136/bmj.323.7306.214			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	459UQ	11473916	Green Published, Bronze			2022-12-28	WOS:000170270200022
J	Iguchi, I; Yamaguchi, T; Sugimoto, A				Iguchi, I; Yamaguchi, T; Sugimoto, A			Diamagnetic activity above T-c as a precursor to superconductivity in La2-xSrxCuO4 thin films	NATURE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTORS; PHASE FLUCTUATIONS; UNDERDOPED BI2SR2CACU2O8+DELTA; NORMAL-STATE; OXIDES; PSEUDOGAP; ONSET	Superconductors show zero resistance to electric current, and expel magnetic flux (the Meissner effect) below the transition temperature (T-c). In conventional superconductors, the `Cooper pairs' of electrons that are responsible for superconductivity form only below T-c. In the unconventional high-T-c superconductors, however, a strong electron correlation is essential for pair formation: there is evidence(1-5) that some pairs are formed above T-c in samples that have less than the optimal density of charge carriers (underdoped) and an energy gap-the `pseudogap'-appears to be present. Moreover, excitations that look like the vortices that carry magnetic flux inside the superconducting state have been reported above T-c (refs 6, 7). Although the origin of the pseudogap remains controversial(8-11), phase fluctuations above T-c, leading to some form of local superconductivity or local pairing, seem essential(9,12-16). Here we report magnetic imaging (scanning SQUID microscopy) of La2-xSrxCuO4 thin films. Clear quantized vortex patterns are visible below T-c (18-19 K), and we observe inhomogeneous magnetic domains that persist up to 80 K. We interpret the data as suggesting the existence of diamagnetic regions that are precursors to the Meissner state.	Tokyo Inst Technol, Dept Phys, Meguro Ku, Tokyo 1528551, Japan; Tokyo Inst Technol, CREST,JST, Meguro Ku, Tokyo 1528551, Japan	Tokyo Institute of Technology; Japan Science & Technology Agency (JST); Tokyo Institute of Technology	Iguchi, I (corresponding author), Tokyo Inst Technol, Dept Phys, Meguro Ku, 2-12-1 Oh Okayama, Tokyo 1528551, Japan.							Carlson EW, 1999, PHYS REV LETT, V83, P612, DOI 10.1103/PhysRevLett.83.612; Corson J, 1999, NATURE, V398, P221, DOI 10.1038/18402; DEMELO CARS, 1993, PHYS REV LETT, V71, P3202, DOI 10.1103/PhysRevLett.71.3202; Ding H, 1996, NATURE, V382, P51, DOI 10.1038/382051a0; DONIACH S, 1990, PHYS REV B, V41, P6668, DOI 10.1103/PhysRevB.41.6668; IMAI T, 1989, PHYSICA C, V162, P169, DOI 10.1016/0921-4534(89)90971-4; KIRYUKHIN V, 2000, PHYS REV B, V6324, P4201; Lee PA, 2000, NATURE, V406, P467, DOI 10.1038/35020173; Loeser AG, 1996, SCIENCE, V273, P325, DOI 10.1126/science.273.5273.325; MONTHOUX P, 1991, PHYS REV LETT, V67, P3448, DOI 10.1103/PhysRevLett.67.3448; MORIYA T, 1990, J PHYS SOC JPN, V59, P2905, DOI 10.1143/JPSJ.59.2905; Morooka T, 1999, JPN J APPL PHYS 2, V38, pL119, DOI 10.1143/JJAP.38.L119; Orenstein J, 2000, SCIENCE, V288, P468, DOI 10.1126/science.288.5465.468; RODDICK E, 1995, PHYS REV LETT, V74, P1430, DOI 10.1103/PhysRevLett.74.1430; ROSHSAR D, 1988, PHYS REV LETT, V61, P2376; Sugimoto A, 2000, APPL PHYS LETT, V77, P3069, DOI 10.1063/1.1323991; Timusk T, 1999, REP PROG PHYS, V62, P61, DOI 10.1088/0034-4885/62/1/002; TSUEI CC, 1994, PHYS REV LETT, V73, P592; Xu ZA, 2000, NATURE, V406, P486, DOI 10.1038/35020016; Zaanen J, 1999, SCIENCE, V286, P251, DOI 10.1126/science.286.5438.251	24	117	119	0	13	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					420	423		10.1038/35086540	http://dx.doi.org/10.1038/35086540			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473312				2022-12-28	WOS:000170068200042
J	Wilson, PA; Norris, RD				Wilson, PA; Norris, RD			Warm tropical ocean surface and global anoxia during the mid-Cretaceous period	NATURE			English	Article							PLANKTONIC-FORAMINIFERA; NORTH-ATLANTIC; TEMPERATURES; EVOLUTION; CLIMATE; EVENTS; ORIGIN; OXYGEN; MODEL; ROCKS	The middle of the Cretaceous period (about 120 to 80 Myr ago) was a time of unusually warm polar temperatures(1), repeated reef-drowning in the tropics(2) and a series of oceanic anoxic events (OAEs) that promoted both the widespread deposition of organic carbon-rich marine sediments and high biological turnover(3-8). The cause of the warm temperatures is unproven but widely attributed to high levels of atmospheric greenhouse gases such as carbon dioxide(7-12). In contrast, there is no consensus on the climatic causes and effects of the OAEs, with both high biological productivity and ocean `stagnation' being invoked as the cause of ocean anoxia(3-8). Here we show, using stable isotope records from multiple species of well-preserved foraminifera, that the thermal structure of surface waters in the western tropical Atlantic Ocean underwent pronounced variability about 100 Myr ago, with maximum sea surface temperatures 3-5 degreesC warmer than today. This variability culminated in a collapse of upper-ocean stratification during OAE-1d (the `Breistroffer' event), a globally significant period of organic-carbon burial that we show to have fundamental, stratigraphically valuable, geochemical similarities to the main OAEs of the Mesozoic era. Our records are consistent with greenhouse forcing being responsible for the warm temperatures, but are inconsistent both with explanations for OAEs based on ocean stagnation, and with the traditional view (reviewed in ref. 12) that past warm periods were more stable than today's climate.	Southampton Oceanog Ctr, Sch Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England; Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	NERC National Oceanography Centre; University of Southampton; Woods Hole Oceanographic Institution	Wilson, PA (corresponding author), Southampton Oceanog Ctr, Sch Ocean & Earth Sci, European Way, Southampton SO14 3ZH, Hants, England.	paw1@soc.soton.ac.uk		Wilson, Paul/0000-0001-6425-8906				Arthur M.A., 1985, CARBON CYCLE ATMOSPH, P504, DOI [10.1159/000020165, DOI 10.1029/GM032P0504]; ARTHUR MA, 1990, NATO ADV SCI I C-MAT, V304, P75; ARTHUR MA, 1988, NATURE, V335, P714, DOI 10.1038/335714a0; Barron E. J, 1985, CARBON CYCLE ATMOSPH, P546, DOI [10.1029/GM032p0546, DOI 10.1029/GM032P0546]; Barron EJ, 1995, STUDIES GEOPHYSICS, P108; Bemis BE, 1998, PALEOCEANOGRAPHY, V13, P150, DOI 10.1029/98PA00070; Crowley TJ, 1991, PALEOCEANOGRAPHY, V6, P387, DOI 10.1029/91PA00432; Crowley TJ, 2000, WARM CLIMATES EARTH, P50, DOI DOI 10.1017/CBO9780511564512.004; Erba E, 1999, J FORAMIN RES, V29, P371; Erbacher J, 1997, MAR MICROPALEONTOL, V30, P139, DOI 10.1016/S0377-8398(96)00023-0; Erbacher J, 2001, NATURE, V409, P325, DOI 10.1038/35053041; Fischer A.G., 1982, CLIMATE EARTH HIST, P97, DOI DOI 10.17226/11798; Gale AS, 1996, CRETACEOUS RES, V17, P515, DOI 10.1006/cres.1996.0032; HERBERT TD, 1986, NATURE, V321, P739, DOI 10.1038/321739a0; Hesselbo SP, 2000, NATURE, V406, P392, DOI 10.1038/35019044; Hofmann P, 2000, PALAEOGEOGR PALAEOCL, V163, P97, DOI 10.1016/S0031-0182(00)00147-4; HUBER BT, 1995, GEOL SOC AM BULL, V107, P1164, DOI 10.1130/0016-7606(1995)107<1164:MLCCOT>2.3.CO;2; JENKYNS HC, 1980, J GEOL SOC LONDON, V137, P171, DOI 10.1144/gsjgs.137.2.0171; MANABE S, 1985, J GEOPHYS RES-OCEANS, V90, P1689, DOI 10.1029/JC090iC06p11689; Norris RD, 1998, GEOLOGY, V26, P823, DOI 10.1130/0091-7613(1998)026<0823:LLSSTF>2.3.CO;2; OPDYKE BN, 1999, EOS, V80, pF486; Poulsen CJ, 1999, PALEOCEANOGRAPHY, V14, P679, DOI 10.1029/1999PA900034; Sarmiento JL, 1988, GLOBAL BIOGEOCHEM CY, V2, P115, DOI 10.1029/GB002i002p00115; SCHLANGER SO, 1981, EARTH PLANET SC LETT, V52, P435, DOI 10.1016/0012-821X(81)90196-5; *SHIPB SCI PART, 1995, P ODP INIT REP, V144, P20; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; Stoll HM, 2000, GEOL SOC AM BULL, V112, P308, DOI 10.1130/0016-7606(2000)112<308:HSIRFT>2.0.CO;2; Wilson PA, 1998, NATURE, V392, P889, DOI 10.1038/31865; Wilson PA, 1996, GEOLOGY, V24, P555, DOI 10.1130/0091-7613(1996)024<0555:ESSTFT>2.3.CO;2; Wolff T, 1999, PALEOCEANOGRAPHY, V14, P374, DOI 10.1029/1999PA900011	30	315	327	4	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2001	412	6845					425	429		10.1038/35086553	http://dx.doi.org/10.1038/35086553			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473314				2022-12-28	WOS:000170068200044
J	Guthrie, E; Kapur, N; Mackway-Jones, K; Chew-Graham, C; Moorey, J; Mendel, E; Marino-Francis, F; Sanderson, S; Turpin, C; Boddy, G; Tomenson, B				Guthrie, E; Kapur, N; Mackway-Jones, K; Chew-Graham, C; Moorey, J; Mendel, E; Marino-Francis, F; Sanderson, S; Turpin, C; Boddy, G; Tomenson, B			Randomised controlled trial of brief psychological intervention after deliberate self poisoning	BRITISH MEDICAL JOURNAL			English	Article							PSYCHODYNAMIC-INTERPERSONAL PSYCHOTHERAPY; TREATMENT DURATION; SUICIDAL IDEATION; FOLLOW-UP; DEPRESSION; SEVERITY; SCALE; HARM; CARE	Objectives To determine the effects of a brief psychological intervention (brief psychodynamic interpersonal therapy) for patients after deliberate self poisoning compared with usual treatment To compare the impact of the active intervention and usual treatment on patients' satisfaction with care. Design Randomised controlled trial. Participants 119 adults who had deliberately poisoned themselves and presented to the emergency department of a teaching hospital. Setting Community based study Intervention four sessions of therapy delivered in the patient's home. Control patients received "treatment as usual," which in most cases consisted of referral back to their general practitioner. Outcome measures Severity of suicidal ideation six months after treatment as assessed by the Beck scale for suicidal ideation. Secondary outcome measures at six month follow up included depressive symptoms as measured by the Beck depression inventory, patient satisfaction with treatment, and self reported subsequent attempts at self harm. Results Participants randomised to the intervention had a significantly greater reduction in suicidal ideation at six month follow up compared with those in the control group (reduction in the mean (SD) Beck scale 8.0 upsilon 1.5). They were more satisfied with their treatment and were less likely to report repealed attempts to harm themselves at follow up (proportion repeating 9% upsilon 28% in control group; difference 19%, 95% confidence interval 9% to 30%, P = 0.009). Conclusion Brief psychodynamic interpersonal therapy may be a valuable treatment after people have deliberately tried to poison themselves.	Univ Manchester, Manchester Royal Infirm, Sch Psychiat & Behav Sci, Manchester M13 9WL, Lancs, England; Manchester Royal Infirm, Emergency Dept, Manchester, Lancs, England; Univ Manchester, Dept Gen Practice, Manchester M14 5NP, Lancs, England; Manchester Royal Infirm, Dept Psychol, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester	Guthrie, E (corresponding author), Univ Manchester, Manchester Royal Infirm, Sch Psychiat & Behav Sci, Rawnsley Bldg, Manchester M13 9WL, Lancs, England.			Guthrie, Elspeth/0000-0002-5834-6616				[Anonymous], EFF HLTH CARE B; BANCROFT J, 1977, PSYCHOL MED, V7, P289, DOI 10.1017/S0033291700029391; BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; BECK AT, 1988, J CLIN PSYCHOL, V44, P499, DOI 10.1002/1097-4679(198807)44:4<499::AID-JCLP2270440404>3.0.CO;2-6; BECK AT, 1985, AM J PSYCHIAT, V142, P559; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; GUTHRIE E, 1991, GASTROENTEROLOGY, V100, P450, DOI 10.1016/0016-5085(91)90215-7; Guthrie E, 1999, ARCH GEN PSYCHIAT, V56, P519, DOI 10.1001/archpsyc.56.6.519; Hall DJ, 1998, BRIT J PSYCHIAT, V172, P239, DOI 10.1192/bjp.172.3.239; Hawton K, 1998, BRIT MED J, V317, P441; HAWTON K, 1988, BRIT J PSYCHIAT, V152, P359, DOI 10.1192/bjp.152.3.359; HAWTON K, 1987, PSYCHOL MED, V17, P751, DOI 10.1017/S0033291700025988; HOBSON R, 1985, FORMS FEELING; Kapur N, 1998, BRIT MED J, V316, P831, DOI 10.1136/bmj.316.7134.831; NORDENTOFT M, 1993, BRIT MED J, V306, P1637, DOI 10.1136/bmj.306.6893.1637; Schmidtke A, 1996, ACTA PSYCHIAT SCAND, V93, P327, DOI 10.1111/j.1600-0447.1996.tb10656.x; SHAPIRO DA, 1995, J CONSULT CLIN PSYCH, V63, P378, DOI 10.1037/0022-006X.63.3.378; SHAPIRO DA, 1994, J CONSULT CLIN PSYCH, V62, P522, DOI 10.1037/0022-006X.62.3.522; Shapiro DA, 1990, RATERS MANUAL SHEFFI; Slinn R., 2001, PSYCHIAT B, V25, P53, DOI https://doi.org/10.1192/pb.25.2.53; STEER RA, 1993, BEHAV RES THER, V31, P229, DOI 10.1016/0005-7967(93)90090-H; VanderSande R, 1997, BRIT J PSYCHIAT, V171, P35, DOI 10.1192/bjp.171.1.35	22	257	257	1	29	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2001	323	7305					135	137		10.1136/bmj.323.7305.135	http://dx.doi.org/10.1136/bmj.323.7305.135			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	456WR	11463679	Green Published, Bronze			2022-12-28	WOS:000170106200013
J	Martini, IB; Barthel, ER; Schwartz, BJ				Martini, IB; Barthel, ER; Schwartz, BJ			Optical control of electrons during electron transfer	SCIENCE			English	Article							RELAXATION DYNAMICS; SOLVATED ELECTRON; SOLVENT; TETRAHYDROFURAN; SPECTRA; CATION; NA	The dynamics of electron transfer reactions in solution can be controlled with the use of a sequence of femtosecond laser pulses. In the charge transfer to solvent (CTTS) reaction of sodide (Na-) in tetrahydrofuran, an initial Light pulse Launched the CTTS reaction, ejecting an electron into either an immediate or a solvent-separated Na-o:solvated electron contact pair. A second pulse was used to excite the electrons in the contact pairs, and a third pulse monitored the amount of Na- produced through the back electron transfer. Excitation of the electrons in immediate contact pairs shut off the back electron transfer, whereas excitation of the electrons in solvent-separated pairs both enhanced and hindered the back electron transfer.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Schwartz, BJ (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	schwartz@chem.ucla.edu		Schwartz, Benjamin/0000-0003-3257-9152				Assion A, 1998, SCIENCE, V282, P919, DOI 10.1126/science.282.5390.919; Barbara PF, 1996, J PHYS CHEM-US, V100, P13148, DOI 10.1021/jp9605663; Barthel ER, 2000, J CHEM PHYS, V112, P9433, DOI 10.1063/1.481563; BARTHEL ER, IN PRESS J PHYS CHEM; BLANDAMER MJ, 1970, CHEM REV, V70, P59, DOI 10.1021/cr60263a002; BOCKRATH B, 1975, J PHYS CHEM-US, V79, P1509, DOI 10.1021/j100582a005; DAVIS HT, 1975, ADV CHEM PHYS, V31, P329; Debreczeny MP, 1996, J AM CHEM SOC, V118, P8174, DOI 10.1021/ja961804a; DORFMAN LM, 1971, BERICH BUNSEN GESELL, V75, P681, DOI 10.1002/bbpc.19710750729; DYE JL, 1984, PROG INORG CHEM, V32, P327, DOI 10.1002/9780470166338.ch4; KEE TW, IN PRESS J PHYS CHEM; LOK MT, 1972, J PHYS CHEM-US, V76, P2975, DOI 10.1021/j100665a009; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; Martini IB, 2000, J CHEM PHYS, V113, P11245, DOI 10.1063/1.1328071; PIOTROWIAK P, 1991, J AM CHEM SOC, V113, P5086, DOI 10.1021/ja00013a069; Reynolds L, 1996, J PHYS CHEM-US, V100, P10337, DOI 10.1021/jp953110e; SEDDON WA, 1980, J PHYS CHEM-US, V84, P1104, DOI 10.1021/j100447a006; Sheu WS, 1996, J PHYS CHEM-US, V100, P1295, DOI 10.1021/jp9513531; SON DH, IN PRESS J AM CHEM S; Vilchiz VH, 2001, J PHYS CHEM A, V105, P1711, DOI 10.1021/jp003974m; WANG Z, UNPUB; Wang ZH, 2001, SPRINGER SERIES CHEM, V66, P624	22	59	59	2	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2001	293	5529					462	465		10.1126/science.1061612	http://dx.doi.org/10.1126/science.1061612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463907				2022-12-28	WOS:000169966700038
J	Gillam, S; Abbott, S; Banks-Smith, J				Gillam, S; Abbott, S; Banks-Smith, J			Primary care groups - Can primary care groups and trusts improve health?	BRITISH MEDICAL JOURNAL			English	Article									Kings Fund, Primary Care Programme, London W1M 0AN, England		Gillam, S (corresponding author), Kings Fund, Primary Care Programme, London W1M 0AN, England.							ABBOTT S, 2000, PRIMARY CARE GROUPS; ABBOTT S, 2000, HLTH SERV J, V2, P32; ABBOTT S, 2000, BR J HLTH CARE MANAG, V6, P202; APPLEBY J, 2000, HLTH CARE UK, P28; Audit commission, 2000, PCG AG EARL PROGR PR; CONNELLY J, 2000, UNDERSTANDING MANAGI; *DEP HLTH, 1998, 1998228LAC9832 HSC D; Faculty of Public Health Medicine, 2000, DEV PUBL HLTH PRIM C; Fitzpatrick M., 2001, TYRANNY HLTH DOCTORS; Fraser Health Authority, 2019, CHIEF MED HLTH OFF R; FULOP N, 1998, HLTH NATION POLICY A; GILLAM S, 1997, COPC PUBLIC HLTH EXP; Glendinning C, 2001, BRIT MED J, V323, P28, DOI 10.1136/bmj.323.7303.28; Griffiths S, 2001, Health Serv J, V111, P30; Macdonald J.J., 2013, PRIMARY HLTH CARE ME; MAHON A, 1998, DO TOTAL PURCHASING; Majeed A, 2000, BRIT MED J, V321, P1057, DOI 10.1136/bmj.321.7268.1057; MAJEED A, 1999, PUBLIC HLTH MED, V1, P4; MARKS L, 1998, DEV PRIMARY CARE GRO; *NHS CTR REV DISS, 1995, 3 CRD NHS; Pratt J, 1995, PRACTITIONERS PRACTI; *SCOTT EX, 2001, NURS HLTH REV CONTR; *SECR STAT HLTH, 1997, CM3807; Social Exclusion Unit, 2001, NEW COMM NEIGHB REN; Wilkin D, 2001, BRIT MED J, V322, P1464, DOI 10.1136/bmj.322.7300.1464; WILKIN D, IN PRESS NATL TRACKE; WILKIN D, 2000, NATL TRACKER SURVEY	27	14	14	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 14	2001	323	7304					89	92		10.1136/bmj.323.7304.89	http://dx.doi.org/10.1136/bmj.323.7304.89			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454GD	11451785	Green Published, Bronze			2022-12-28	WOS:000169964100019
J	Schilte, AF; Portegijs, PJM; Blankenstein, AH; van der Horst, HE; Latour, MBF; van Eijk, JTM; Knottnerus, JA				Schilte, AF; Portegijs, PJM; Blankenstein, AH; van der Horst, HE; Latour, MBF; van Eijk, JTM; Knottnerus, JA			Randomised controlled trial of disclosure of emotionally important events in somatisation in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ABRIDGED SOMATIZATION; CONSTRUCT; HEALTH	Objective To test whether a disclosure intervention improves subjective health and reduces medical consumption and sick leave in somatising patients in general practice. Design Non-blind randomised controlled trial. Setting 10 general practices in the Netherlands. Participants 161 patients who frequently attended general practice with somatising symptoms. Intervention Patients in the intervention group were visited two to three times and invited to disclose emotionally important events in their life. Control patients received normal care from their general practitioners. Main outcome measures Use of medical services (drugs and healthcare visits), subjective health, and sick leave assessed by self completion questionnaires after 6, 12, and 24 months. Results Of the 161 patients, 137 completed the trial (85%). Both groups were comparable at baseline. The intervention had no effect on the main outcome measures at any point. Intervention patients made one more visit to health care (95% confidence interval - 4 to 6): the use of medicines did not change in both groups(- 1 to 1); subjective health improved 3.6 points more in the control group (- 11.2 to 4.3); and disclosure patients were oil sick leave one more week (- 1 to 3). Patients often had a depression or anxiety disorder for which they were not receiving adequate care. Conclusion Although the intervention was well received by patients and doctors, disclosure had no effect on the health of somatising patients in general practice.	Univ Maastricht, Dept Gen Practice, NL-6200 MD Maastricht, Netherlands; Vrije Univ Amsterdam, Inst Res Extramural Med, Amsterdam, Netherlands; Univ Maastricht, Dept Med Sociol, NL-6200 MD Maastricht, Netherlands	Maastricht University; Vrije Universiteit Amsterdam; Maastricht University	Schilte, AF (corresponding author), Univ Maastricht, Dept Gen Practice, POB 616, NL-6200 MD Maastricht, Netherlands.	Bert.Schilte@hag.unimaas.nl	Knottnerus, Andre/F-4866-2013; Knottnerus, Johannes A/A-3829-2009					American Psychiatric Association, 1987, DIAGN STAT MAN MENT, P261; Cape J, 1999, BRIT J GEN PRACT, V49, P875; DEBAKKER D, 1998, ANN REPORT INFORMATI; DEROGATIS LR, 1977, J CLIN PSYCHOL, V33, P981, DOI 10.1002/1097-4679(197710)33:4<981::AID-JCLP2270330412>3.0.CO;2-0; Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6; Escobar JI, 1998, PSYCHOSOM MED, V60, P466, DOI 10.1097/00006842-199807000-00012; ESCOBAR JI, 1989, J NERV MENT DIS, V177, P140, DOI 10.1097/00005053-198903000-00003; Georges Eugenia, 1995, EMOTION DISCLOSURE H, P11; GOLDBERG DP, 1988, J PSYCHOSOM RES, V32, P137, DOI 10.1016/0022-3999(88)90048-7; KATON W, 1992, GEN HOSP PSYCHIAT, V14, P86, DOI 10.1016/0163-8343(92)90033-7; LIPOWSKI ZJ, 1988, AM J PSYCHIAT, V145, P1358; METSEMAKERS JFM, 1992, BRIT J GEN PRACT, V42, P102; Morriss RK, 1999, BRIT J GEN PRACT, V49, P263; Pennebaker JW, 1997, PSYCHOL SCI, V8, P162, DOI 10.1111/j.1467-9280.1997.tb00403.x; PENNEBAKER JW, 1989, PSYCHOSOM MED, V51, P577, DOI 10.1097/00006842-198909000-00009; Portegijs PJM, 1996, SOC PSYCH PSYCH EPID, V31, P29, DOI 10.1007/BF00789119; Portegijs PJM, 1996, FAM PRACT, V13, P1, DOI 10.1093/fampra/13.1.1; PORTEGIJS PJM, 1996, THESIS U MAASTRICHT; Salmon P, 1999, BRIT MED J, V318, P372, DOI 10.1136/bmj.318.7180.372; Schilte AF, 2000, SOC PSYCH PSYCH EPID, V35, P276, DOI 10.1007/s001270050239; Smyth JM, 1998, J CONSULT CLIN PSYCH, V66, P174, DOI 10.1037/0022-006X.66.1.174; SPECKENS AEM, 1995, BRIT MED J, V311, P1328, DOI 10.1136/bmj.311.7016.1328	22	51	52	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2001	323	7304					86	89		10.1136/bmj.323.7304.86	http://dx.doi.org/10.1136/bmj.323.7304.86			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	454GD	11451784	Green Published, Bronze			2022-12-28	WOS:000169964100018
J	Clark, PU; Marshall, SJ; Clarke, GKC; Hostetler, SW; Licciardi, JM; Teller, JT				Clark, PU; Marshall, SJ; Clarke, GKC; Hostetler, SW; Licciardi, JM; Teller, JT			Freshwater forcing of abrupt climate change during the last glaciation	SCIENCE			English	Article							ATLANTIC THERMOHALINE CIRCULATION; YOUNGER DRYAS EVENT; NORTH-ATLANTIC; LAKE AGASSIZ; RADIOCARBON CALIBRATION; ISOTOPE RECORDS; ICE MARGIN; MELTWATER; DRAINAGE; HOLOCENE	Large millennial-scale fluctuations of the southern margin of the North American Laurentide Ice Sheet occurred during the Last deglaciation, when the margin was Located between about 43 degrees and 49 degreesN. Fluctuations of the ice margin triggered episodic increases in the flux of freshwater to the North Atlantic by rerouting continental runoff from the Mississippi River drainage to the Hudson or St. Lawrence Rivers. We found that periods of increased freshwater flow to the North Atlantic occurred at the same time as reductions in the formation of North Atlantic Deep Water, thus providing a mechanism for observed climate variability that may be generally characteristic of times of intermediate global ice volume.	Oregon State Univ, Dept Geosci, Corvallis, OR 97333 USA; Univ Calgary, Dept Geog, Calgary, AB T2N 1N4, Canada; Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada; Oregon State Univ, Dept Geosci, US Geol Survey, Corvallis, OR 97331 USA; Univ Manitoba, Dept Geol Sci, Winnipeg, MB R3T 2N2, Canada	Oregon State University; University of Calgary; University of British Columbia; Oregon State University; United States Department of the Interior; United States Geological Survey; University of Manitoba	Clark, PU (corresponding author), Oregon State Univ, Dept Geosci, Corvallis, OR 97333 USA.	clarkp@ucs.orst.edu						Alley RB, 1997, GEOLOGY, V25, P483, DOI 10.1130/0091-7613(1997)025<0483:HCIAPW>2.3.CO;2; ANDREWS JT, 1995, PALEOCEANOGRAPHY, V10, P943, DOI 10.1029/95PA01426; Barber DC, 1999, NATURE, V400, P344, DOI 10.1038/22504; Bard E, 1998, RADIOCARBON, V40, P1085, DOI 10.1017/S0033822200019135; Bjorck S, 1996, SCIENCE, V274, P1155, DOI 10.1126/science.274.5290.1155; BJORCK S, UNPUB; Boden P, 1997, PALEOCEANOGRAPHY, V12, P39, DOI 10.1029/96PA02879; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; BOYLE EA, 1987, NATURE, V330, P35, DOI 10.1038/330035a0; Broecker WS, 1990, PALEOCEANOGRAPHY, V5, P469, DOI 10.1029/PA005i004p00469; BROECKER WS, 1989, NATURE, V341, P318, DOI 10.1038/341318a0; BROECKER WS, 1985, NATURE, V315, P21, DOI 10.1038/315021a0; de Vernal A, 1996, NATURE, V381, P774, DOI 10.1038/381774a0; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Fanning AF, 1997, PALEOCEANOGRAPHY, V12, P307, DOI 10.1029/96PA03726; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; Hostetler SW, 2000, NATURE, V405, P334, DOI 10.1038/35012581; Hostetler SW, 1999, J GEOPHYS RES-ATMOS, V104, P3947, DOI 10.1029/1998JD200067; Hughen KA, 1996, NATURE, V380, P51, DOI 10.1038/380051a0; Hughen KA, 2000, SCIENCE, V290, P1951, DOI 10.1126/science.290.5498.1951; Jenson JW, 1996, J GEOPHYS RES-SOL EA, V101, P8717, DOI 10.1029/96JB00169; Kitagawa H, 2000, RADIOCARBON, V42, P369; Kutzbach J, 1998, QUATERNARY SCI REV, V17, P473, DOI 10.1016/S0277-3791(98)00009-2; Lagerklint IM, 1999, GEOLOGY, V27, P1099; Laj C, 2000, PHILOS T ROY SOC A, V358, P1009, DOI 10.1098/rsta.2000.0571; Leverington DW, 2000, QUATERNARY RES, V54, P174, DOI 10.1006/qres.2000.2157; Licciardi JM, 1998, QUATERNARY SCI REV, V17, P427, DOI 10.1016/S0277-3791(97)00044-9; Licciardi JM, 1999, GEOPH MONOG SERIES, V112, P177; Manabe S, 1997, PALEOCEANOGRAPHY, V12, P321, DOI 10.1029/96PA03932; Marshall SJ, 1999, QUATERNARY RES, V52, P300, DOI 10.1006/qres.1999.2079; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Meese DA, 1997, J GEOPHYS RES-OCEANS, V102, P26411, DOI 10.1029/97JC00269; Moore TC, 2000, PALEOCEANOGRAPHY, V15, P4, DOI 10.1029/1999PA000437; Muscheler R, 2000, NATURE, V408, P567, DOI 10.1038/35046041; RAHMSTORF S, 1995, NATURE, V378, P145, DOI 10.1038/378145a0; Ridge JC, 1997, GEOL SOC AM BULL, V109, P652, DOI 10.1130/0016-7606(1997)109<0652:SBDALF>2.3.CO;2; RODRIGUES CG, 1994, QUATERNARY SCI REV, V13, P923, DOI 10.1016/0277-3791(94)90009-4; Schulz M, 1999, GEOPHYS RES LETT, V26, P3385, DOI 10.1029/1999GL006069; Severinghaus JP, 1999, SCIENCE, V286, P930, DOI 10.1126/science.286.5441.930; STOCKER TF, 1991, NATURE, V351, P729, DOI 10.1038/351729a0; Stocker TF, 1992, PALEOCEANOGRAPHY, V7, P529, DOI 10.1029/92PA01695; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; TELLER JT, IN PRESS QUAT SCI RE; Tziperman E, 1997, NATURE, V386, P592, DOI 10.1038/386592a0; Zahn R, 1991, PALEOCEANOGRAPHY, V6, P1, DOI 10.1029/90PA01882; [No title captured]	47	409	418	1	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2001	293	5528					283	287		10.1126/science.1062517	http://dx.doi.org/10.1126/science.1062517			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452120				2022-12-28	WOS:000169875200054
J	Fisk, HA; Winey, M				Fisk, HA; Winey, M			The mouse Mps1p-like kinase regulates centrosome duplication	CELL			English	Article							POLE BODY DUPLICATION; CYCLIN-DEPENDENT KINASES; HAMSTER OVARY CELLS; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; MITOTIC CHECKPOINT; BUDDING YEAST; DNA-SYNTHESIS; GENE MPS1; REPRODUCTION	The yeast Mps1p protein kinase acts in centrosome duplication and the spindle assembly checkpoint. We demonstrate here that a mouse Mps1p ortholog (esk, which we designate mMps1p) regulates centrosome duplication. Endogenous mMps1p and overexpressed GFP-mMps1p localize to centrosomes and kinetochores in mouse cells. Overexpression of GFP-mMps1p causes reduplication of centrosomes during S phase arrest. In contrast, a kinase-deficient mutant blocks centrosome duplication altogether. Control of centrosome duplication by mMps1p requires a known regulator of the process, Cdk2. Inhibition of Cdk2 prevents centrosome reduplication and destabilizes mMps1p, causing its subsequent loss from centrosomes, suggesting that Cdk2 promotes mMps1p's centrosome duplication function by regulating its stability during S phase. Thus, mMps1p, an in vitro Cdk2 substrate, regulates centrosome duplication jointly with Cdk2.	Univ Colorado, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Winey, M (corresponding author), Univ Colorado, UCB 347, Boulder, CO 80309 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051312] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM51312] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Adams IR, 2000, TRENDS CELL BIOL, V10, P329, DOI 10.1016/S0962-8924(00)01798-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amon A, 1999, CURR OPIN GENET DEV, V9, P69, DOI 10.1016/S0959-437X(99)80010-0; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Cahill DP, 1999, GENOMICS, V58, P181, DOI 10.1006/geno.1999.5831; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Clarke DJ, 2000, BIOESSAYS, V22, P351, DOI 10.1002/(SICI)1521-1878(200004)22:4<351::AID-BIES5>3.0.CO;2-W; DOUVILLE EMJ, 1992, MOL CELL BIOL, V12, P2681, DOI 10.1128/MCB.12.6.2681; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; GARD DL, 1990, J CELL BIOL, V110, P2033, DOI 10.1083/jcb.110.6.2033; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; Hartley RS, 1997, DEV BIOL, V188, P312, DOI 10.1006/dbio.1997.8647; HE X, 1997, J CELL SCI, V111, P1635; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; HOGG D, 1994, ONCOGENE, V9, P89; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; KURIYAMA R, 1986, CELL MOTIL CYTOSKEL, V6, P355, DOI 10.1002/cm.970060402; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; LAUZE E, 1995, EMBO J, V14, P1655, DOI 10.1002/j.1460-2075.1995.tb07154.x; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; LINDBERG RA, 1993, ONCOGENE, V8, P351; Lingle WL, 2000, CURR TOP DEV BIOL, V49, P313; Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; MCDONALD K, 1984, J ULTRA MOL STRUCT R, V86, P107, DOI 10.1016/S0022-5320(84)80051-9; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Meijer L, 1997, METHOD ENZYMOL, V283, P113; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; MILLS GB, 1992, J BIOL CHEM, V267, P16000; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; SANDERS MA, 1994, J CELL BIOL, V124, P795, DOI 10.1083/jcb.124.5.795; Schnackenberg BJ, 1999, BIOL CELL, V91, P429, DOI 10.1016/S0248-4900(99)80084-7; Schutz AR, 1998, MOL BIOL CELL, V9, P759, DOI 10.1091/mbc.9.4.759; SLUDER G, 1990, J CELL BIOL, V110, P2025, DOI 10.1083/jcb.110.6.2025; Stearns T, 2001, CELL, V105, P417, DOI 10.1016/S0092-8674(01)00366-X; STEIN GS, 1994, CELL BIOL LAB HDB, P282; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745; Yucel JK, 2000, J CELL BIOL, V150, P1, DOI 10.1083/jcb.150.1.1	44	180	187	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2001	106	1					95	104		10.1016/S0092-8674(01)00411-1	http://dx.doi.org/10.1016/S0092-8674(01)00411-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461705	Green Published, Bronze			2022-12-28	WOS:000169870300012
J	Porter, GF; Gentles, TL				Porter, GF; Gentles, TL			Giant coronary-artery aneurysm in Kawasaki's disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Green Lane Hosp, Auckland 3, New Zealand		Porter, GF (corresponding author), Green Lane Hosp, Auckland 3, New Zealand.		Gentles, Tom/AAH-2087-2019						0	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 12	2001	345	2					98	98		10.1056/NEJM200107123450204	http://dx.doi.org/10.1056/NEJM200107123450204			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451AH	11450678				2022-12-28	WOS:000169776900004
J	MacArthur, C; Shennan, AH; May, A; Whyte, J; Hickman, N; Cooper, G; Bick, D; Crewe, L; Garston, H; Gold, L; Lancashire, R; Lewis, M; Moore, P; Wilson, M; Bharmal, S; Elton, C; Halligan, A; Hussain, W; Patterson, M; Squire, P; de Swiet, M				MacArthur, C; Shennan, AH; May, A; Whyte, J; Hickman, N; Cooper, G; Bick, D; Crewe, L; Garston, H; Gold, L; Lancashire, R; Lewis, M; Moore, P; Wilson, M; Bharmal, S; Elton, C; Halligan, A; Hussain, W; Patterson, M; Squire, P; de Swiet, M		Comparative Obstet Mobile Epidural	Effect of low-dose mobile versus traditional epidural techniques on mode of delivery: a randomised controlled trial	LANCET			English	Article							LABOR; ANALGESIA; BUPIVACAINE; FENTANYL	Background Epidural analgesia is the most effective labour pain relief but is associated with increased rates of instrumental vaginal delivery and other effects, which might be related to the poor motor function associated with traditional epidural. New techniques that preserve motor function could reduce obstetric intervention. We did a randomised controlled trial to compare low-dose combined spinal epidural and low-dose infusion [mobile) techniques with traditional epidural technique. Methods Between Feb 1, 1999, and April 30, 2000, we randomly assigned 1054 nulliparous women requesting epidural pain relief to traditional (n=353), low-dose combined spinal epidural (n=351), or low-dose infusion epidural (n=350). Primary outcome was mode of delivery, and secondary outcomes were progress of labour, efficacy of procedure, and effect on neonates. We obtained data during labour and interviewed women postnatally. Findings The normal vaginal delivery rate was 35.1% in the traditional epidural group, 42.7% in the low-dose combined spinal group (odds ratio 1.38 [95% CI 1.01-1.89]; p=0.04); and 42.9% in the low-dose infusion group (1.39 [1.01-1.90]; p=0.04). These differences were accounted for by a reduction in instrumental vaginal delivery. Overall, 5 min APGAR scores of 7 or less were more frequent with low-dose technique. High-level resuscitation was more frequent in the low-dose infusion group. Interpretation The use of low-dose epidural techniques for labour analgesia has benefits for delivery outcome. Continued routine use of traditional epidurals might not be justified.	Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Dept Anaesthet, Birmingham B15 2TT, W Midlands, England; Univ Leicester, Dept Anaesthet, Leicester LE1 7RH, Leics, England; Univ Leicester, Dept Obstet, Leicester LE1 7RH, Leics, England; Univ Leicester, Dept Gynaecol, Leicester LE1 7RH, Leics, England	University of Birmingham; University of Birmingham; University of Leicester; University of Leicester; University of Leicester	Shennan, AH (corresponding author), St Thomas Hosp, Univ London Kings Coll, Guys Kings & St Thomas Sch Med, Maternal & Fetal Res Unit, London SE1 7EH, England.		Bick, Debra/P-9575-2018; MacArthur, Christine/ABA-8601-2021	Bick, Debra/0000-0002-8557-7276; MacArthur, Christine/0000-0003-0434-2158; Wilson, Matthew/0000-0002-9704-5189				Bloom SL, 1998, NEW ENGL J MED, V339, P76, DOI 10.1056/NEJM199807093390203; BREEN TW, 1993, ANESTH ANALG, V77, P919; Burnstein R, 1999, ANAESTHESIA, V54, P634, DOI 10.1046/j.1365-2044.1999.00894.x; COLLIS RE, 1995, LANCET, V345, P1413, DOI 10.1016/S0140-6736(95)92602-X; Fernando R, 1997, ANAESTHESIA, V52, P517, DOI 10.1111/j.1365-2044.1997.154-az0160.x; HOWELL CJ, COCHRANE LIB; Khor LJH, 2000, ANAESTHESIA, V55, P1168, DOI 10.1046/j.1365-2044.2000.01720.x; MURPHY JD, 1991, BRIT MED J, V302, P564, DOI 10.1136/bmj.302.6776.564; Nageotte MP, 1997, NEW ENGL J MED, V337, P1715, DOI 10.1056/NEJM199712113372402; Russell R, 1999, INT J OBSTET ANESTH, V8, P56, DOI 10.1016/S0959-289X(99)80153-8	10	210	217	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 7	2001	358	9275					19	23						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11454372				2022-12-28	WOS:000169710900011
J	Allison, TJ; Winter, CC; Fournie, JJ; Bonneville, M; Garboczi, DN				Allison, TJ; Winter, CC; Fournie, JJ; Bonneville, M; Garboczi, DN			Structure of a human gamma delta T-cell antigen receptor	NATURE			English	Article							NONPEPTIDIC MYCOBACTERIAL LIGANDS; RECOGNITION; STIMULATION; CRYSTALLOGRAPHY; PYROPHOSPHATE; SUBSET; SUITE	T-cell antigen receptors composed of gamma and delta polypeptide chains (gamma delta TCRs) can directly recognize antigens in the form of intact proteins or non-peptide compounds, unlike alpha beta TCRs, which recognize antigens bound to major histocompatibility complex molecules (MHC). About 5% of peripheral blood T cells bear gamma delta TCRs, most of which recognize non-peptide phosphorylated antigens(1,2). Here we describe the 3.1 Angstrom resolution structure of a human gamma delta TCR from a T-cell clone(3) that is phosphoantigen-reactive. The orientation of the variable (V) and constant (C) regions of the gamma delta TCR is unique when compared with alpha beta TCRs or antibodies, and results from an unusually small angle between the V gamma and C gamma domains. The complementarity-determining regions (CDRs) of the V domains exhibit a chemically reasonable binding site for phosphorylated antigens, providing a possible explanation for the canonical usage of the V gamma9 and V delta2 gene segments by phosphoantigen-reactive receptors. Although the gamma delta TCR V domains are similar in overall structure to those of alpha beta TCRs, gamma delta TCR C domains are markedly different. Structural differences in C gamma and C delta, and in the location of the disulphide bond between them, may enable gamma delta TCRs to form different recognition/signalling complexes than alpha beta TCRs.	NIAID, Struct Biol Sect, Immunogenet Lab, Rockville, MD 20852 USA; CHU Purpan, INSERM, U395, F-31024 Toulouse, France; Inst Biol, INSERM, U463, F-44035 Nantes, France	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Allison, TJ (corresponding author), NIAID, Struct Biol Sect, Immunogenet Lab, 12441 Parklawn Dr, Rockville, MD 20852 USA.		Fournie, Jean-Jacques/J-7805-2013	Fournie, Jean-Jacques/0000-0001-6542-6908	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000835] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belman C, 1999, J BIOL CHEM, V274, P32079, DOI 10.1074/jbc.274.45.32079; Belmant C, 2000, FASEB J, V14, P1669, DOI 10.1096/fj.99-0909fje; BENTLEY GA, 1995, SCIENCE, V267, P1984, DOI 10.1126/science.7701320; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bukowski JF, 1999, IMMUNITY, V11, P57, DOI 10.1016/S1074-7613(00)80081-3; Chien YH, 1996, ANNU REV IMMUNOL, V14, P511, DOI 10.1146/annurev.immunol.14.1.511; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; DAVODEAU F, 1993, J IMMUNOL, V151, P1214; DAVODEAU F, 1993, EUR J IMMUNOL, V23, P804, DOI 10.1002/eji.1830230405; DAVODEAU F, 1993, J BIOL CHEM, V268, P15455; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Fournie JJ, 1996, RES IMMUNOL, V147, P338, DOI 10.1016/0923-2494(96)89648-9; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1994, 1 MAP FINAL MODEL, P59; Kunzmann V, 2000, BLOOD, V96, P384; LANG F, 1995, J IMMUNOL, V154, P5986; Li HM, 1998, IMMUNITY, V9, P807, DOI 10.1016/S1074-7613(00)80646-9; Li HM, 1998, NATURE, V391, P502, DOI 10.1038/35172; LOH EY, 1994, J IMMUNOL, V152, P3324; MORITA CT, 1995, IMMUNITY, V3, P495, DOI 10.1016/1074-7613(95)90178-7; Morita CT, 2001, IMMUNITY, V14, P331, DOI 10.1016/S1074-7613(01)00113-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PANCHAMOORTHY G, 1991, J IMMUNOL, V147, P3360; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; SCIAMMAS R, 1994, J IMMUNOL, V152, P5392; Smith GD, 1998, ACTA CRYSTALLOGR D, V54, P799, DOI 10.1107/S0907444997018805; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10	30	196	206	0	14	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					820	824		10.1038/35081115	http://dx.doi.org/10.1038/35081115			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459064	Green Published			2022-12-28	WOS:000169246400055
J	Farmer, EE				Farmer, EE			Surface-to-air signals	NATURE			English	Article							INTERPLANT COMMUNICATION; PLANT VOLATILES; JASMONIC ACID; CIS-JASMONE; RESISTANCE; PATHWAY; BIOSYNTHESIS; SUBSTANCES; SALICYLATE; HERBIVORY	Powerful volatile regulators of gene expression, pheromones and other airborne signals are of great interest in biology. Plants are masters of volatile production and release, not just from flowers and fruits, but also from vegetative tissues. The controlled release of bouquets of volatiles from leaves during attack by herbivores helps plants to deter herbivores or attract their predators, but volatiles have other roles in development and in the control of defence gene expression. Some of these roles may include long-distance signalling within and perhaps between plants.	Univ Lausanne, Inst Ecol, Gene Express Lab, CH-1015 Lausanne, Switzerland	University of Lausanne	Farmer, EE (corresponding author), Univ Lausanne, Inst Ecol, Gene Express Lab, Biol Bldg, CH-1015 Lausanne, Switzerland.	edwardelliston.farmer@ie-bpv.unil.ch	Farmer, Edward E/H-1635-2011					Alborn HT, 1997, SCIENCE, V276, P945, DOI 10.1126/science.276.5314.945; Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072; BALDWIN IT, 1983, SCIENCE, V221, P277, DOI 10.1126/science.221.4607.277; Bate NJ, 1998, PLANT J, V16, P561, DOI 10.1046/j.1365-313x.1998.00324.x; Birkett MA, 2000, P NATL ACAD SCI USA, V97, P9329, DOI 10.1073/pnas.160241697; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; BRUIN J, 1992, EXPERIENTIA, V48, P525, DOI 10.1007/BF01928181; BRUIN J, 1995, TRENDS ECOL EVOL, V10, P167, DOI 10.1016/S0169-5347(00)89033-3; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; CROFT KPC, 1993, PLANT PHYSIOL, V101, P13, DOI 10.1104/pp.101.1.13; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; DICKE M, 2001, BIOCH SYST ECOL, V29; Dolch R, 2000, OECOLOGIA, V125, P504, DOI 10.1007/s004420000482; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; FUJIWARA M, 1987, J PHYTOPATHOL, V120, P81, DOI 10.1111/j.1439-0434.1987.tb04418.x; HAUKIOJA E, 1985, OECOLOGIA, V65, P363, DOI 10.1007/BF00378910; Karban R, 2000, OECOLOGIA, V125, P66, DOI 10.1007/PL00008892; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Knoester M, 1998, P NATL ACAD SCI USA, V95, P1933, DOI 10.1073/pnas.95.4.1933; Koch T, 1997, HELV CHIM ACTA, V80, P838, DOI 10.1002/hlca.19970800318; Logan BA, 2000, TRENDS PLANT SCI, V5, P477, DOI 10.1016/S1360-1385(00)01765-9; LORETO F, 1993, PLANT CELL ENVIRON, V16, P563, DOI 10.1111/j.1365-3040.1993.tb00904.x; LYR H, 1983, ACTA PHYTOPATHOL HUN, V18, P3; Pickett JA, 2001, TRENDS PLANT SCI, V6, P137, DOI 10.1016/S1360-1385(01)01899-4; Reymond P, 1998, CURR OPIN PLANT BIOL, V1, P404, DOI 10.1016/S1369-5266(98)80264-1; Rhoades D.F., 1985, Recent Advances in Phytochemistry, V19, P195; RHOADES DF, 1983, ACS SYM SER, V208, P55; Seo HS, 2001, P NATL ACAD SCI USA, V98, P4788, DOI 10.1073/pnas.081557298; SHONLE I, 1995, ECOLOGY, V76, P2660, DOI 10.2307/2265837; Shulaev V, 1997, NATURE, V385, P718, DOI 10.1038/385718a0; Thaler JS, 1999, NATURE, V399, P686, DOI 10.1038/21420; TURLINGS TCJ, 1992, P NATL ACAD SCI USA, V89, P8399, DOI 10.1073/pnas.89.17.8399; Vollenweider S, 2000, PLANT J, V24, P467, DOI 10.1046/j.1365-313x.2000.00897.x; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; ZERINGUE HJ, 1992, PHYTOCHEMISTRY, V31, P2305, DOI 10.1016/0031-9422(92)83269-5	35	202	252	4	74	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 14	2001	411	6839					854	856		10.1038/35081189	http://dx.doi.org/10.1038/35081189			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459069				2022-12-28	WOS:000169246400063
J	Pimm, SL; van Aarde, RJ				Pimm, SL; van Aarde, RJ			Population control - African elephants and contraception	NATURE			English	Article									Columbia Univ, Ctr Environm Res & Conservat, New York, NY 10027 USA; Univ Pretoria, Conservat Ecol Res Unit, ZA-0002 Pretoria, South Africa	Columbia University; University of Pretoria	Pimm, SL (corresponding author), Columbia Univ, Ctr Environm Res & Conservat, 1200 Amsterdam Ave, New York, NY 10027 USA.							Fayrer-Hosken RA, 2000, NATURE, V407, P149, DOI 10.1038/35025136; van Aarde R, 1999, ANIM CONSERV, V2, P287, DOI 10.1017/S1367943099000621; Whyte I, 1998, ANIM CONSERV, V1, P77, DOI 10.1111/j.1469-1795.1998.tb00014.x	3	17	18	0	19	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					766	766		10.1038/35081154	http://dx.doi.org/10.1038/35081154			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459047	Bronze			2022-12-28	WOS:000169246400037
J	Wohlgemuth, S; Ronacher, B; Wehner, R				Wohlgemuth, S; Ronacher, B; Wehner, R			Ant odometry in the third dimension	NATURE			English	Article							PATH-INTEGRATION; CATAGLYPHIS-FORTIS; DESERT ANTS; HONEYBEE NAVIGATION; DISTANCE ESTIMATION; OPTIC FLOW; ORIENTATION; GOAL	Desert ants (Cataglyphis) are renowned for their ability to perform large-scale foraging excursions and then return to the nest by path integration. They do so by integrating courses steered and the distances travelled into a continually updated home vector(1). Whereas the angular orientation is based on skylight cues(2), how the ants gauge the distances travelled has remained largely unclear(3,4). Furthermore, almost all studies on path integration in Cataglyphis(5,6), as well as in spiders(7,8), rodents(9), and humans(10,11), have aimed at understanding how the animals compute home-bound courses in the horizontal plane. Here, we investigate for the first time how an animal's odometer operates when a path integration task has to be accomplished that includes a vertical component. We trained Cataglyphis ants within arrays of uphill and downhill channels, and later tested them on flat terrain, or vice versa. In all these cases, the ants indicated homing distances that corresponded not to the distances actually travelled but to the ground distances; that is, to the sum of the horizontal projections of the uphill and downhill segments of the ants' paths.	Univ Zurich, Dept Zool, CH-8057 Zurich, Switzerland; Humboldt Univ, Inst Biol, D-10099 Berlin, Germany	University of Zurich; Humboldt University of Berlin	Ronacher, B (corresponding author), Univ Zurich, Dept Zool, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	bernhard.ronacher@rz.hu-berlin.de						Bardunias PM, 2000, NATURWISSENSCHAFTEN, V87, P532, DOI 10.1007/s001140050772; Esch HE, 1996, J EXP BIOL, V199, P155; Etienne AS, 1996, J EXP BIOL, V199, P201; Gorner P., 1985, P275; HERAN H, 1956, Z VERGL PHYSIOL, V38, P168, DOI 10.1007/BF00338625; HILL DE, 1979, BEHAV ECOL SOCIOBIOL, V5, P301, DOI 10.1007/BF00293678; LOOMIS JM, 1993, J EXP PSYCHOL GEN, V122, P73, DOI 10.1037/0096-3445.122.1.73; MARKL H, 1962, Z VERGL PHYSIOL, V45, P475, DOI 10.1007/BF00342998; Mittelstaedt H., 1973, FORTSCHR ZOOL, V21, P46; MULLER M, 1994, J COMP PHYSIOL A, V175, P525, DOI 10.1007/BF00199474; MULLER M, 1988, P NATL ACAD SCI USA, V85, P5287, DOI 10.1073/pnas.85.14.5287; Ronacher B, 2000, J EXP BIOL, V203, P1113; RONACHER B, 1995, J COMP PHYSIOL A, V177, P21; SAUVE JP, 1989, THESIS U AIX MARSEIL; Schafer M, 1993, VERH DTSCH ZOOL GES, V86, P270; SEYFARTH EA, 1982, BEHAV ECOL SOCIOBIOL, V11, P139, DOI 10.1007/BF00300103; Srinivasan MV, 1996, J EXP BIOL, V199, P237; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Srinivasan MV, 1997, J EXP BIOL, V200, P2513; TAYLOR CR, 1972, SCIENCE, V178, P1096, DOI 10.1126/science.178.4065.1096; von Frisch K., 1967, DANCE LANGUAGE ORIEN; WEHNER R, 1994, FORTS ZOOL, V39, P103; WEHNER R, 1990, ETHOL ECOL EVOL, V2, P27, DOI 10.1080/08927014.1990.9525492; WEHNER R, 1981, J COMP PHYSIOL, V142, P315, DOI 10.1007/BF00605445; WEHNER R, 1997, ORIENTATION COMMUNIC, P145	25	99	99	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					795	798		10.1038/35081069	http://dx.doi.org/10.1038/35081069			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459057				2022-12-28	WOS:000169246400048
J	Salghetti, SE; Caudy, AA; Chenoweth, JG; Tansey, WP				Salghetti, SE; Caudy, AA; Chenoweth, JG; Tansey, WP			Regulation of transcriptional activation domain function by ubiquitin	SCIENCE			English	Article							MEDIATED PROTEOLYSIS; DNA-REPLICATION; DEGRADATION; PROTEASOME; PROTEINS; COMPLEX; SIGNAL; CHAIN; MET4	The ability of transcriptional activation domains (TADs) to signal ubiquitin-mediated proteolysis suggests an involvement of the ubiquitin-proteasome pathway in transcription. To probe this involvement, we asked how ubiquitylation regulates the activity of a transcription factor containing the VP16 TAD. We show that the VP16 TAD signals ubiquitylation through the Met30 ubiquitin-ligase and that Met30 is also required for the VP16 TAD to activate transcription. The requirement for Met30 in transcription is circumvented by fusion of ubiquitin to the VP16 activator, demonstrating that activator ubiquitylation is essential for transcriptional activation. We propose that ubiquitylation regulates TAD function by serving as a dual signal for activation and activator destruction.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Grad Program Mol & Cellular Biol, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Tansey, WP (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd,POB 100, Cold Spring Harbor, NY 11724 USA.			Caudy, Amy/0000-0001-6307-8137	NCI NIH HHS [CA45508, CA-13106] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA013106, P30CA045508] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARBERIS A, 1995, CELL, V81, P359, DOI 10.1016/0092-8674(95)90389-5; BRENT R, 1985, CELL, V43, P729, DOI 10.1016/0092-8674(85)90246-6; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Hecht A, 1999, METHOD ENZYMOL, V304, P399; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Li R, 1998, MOL CELL BIOL, V18, P1296, DOI 10.1128/MCB.18.3.1296; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; Patton EE, 2000, EMBO J, V19, P1613, DOI 10.1093/emboj/19.7.1613; Rouillon A, 2000, EMBO J, V19, P282, DOI 10.1093/emboj/19.2.282; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Thomas D, 2000, CURR BIOL, V10, pR341, DOI 10.1016/S0960-9822(00)00462-0; TRIEZENBERG SJ, 1988, GENE DEV, V2, P718, DOI 10.1101/gad.2.6.718; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015	18	311	318	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1651	1653		10.1126/science.1062079	http://dx.doi.org/10.1126/science.1062079			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11463878				2022-12-28	WOS:000170802900061
J	Cuffey, KM; Vimeux, F				Cuffey, KM; Vimeux, F			Covariation of carbon dioxide and temperature from the Vostok ice core after deuterium-excess correction	NATURE			English	Article							ATMOSPHERIC CO2; HUON PENINSULA; CLIMATE; RECORD; OCEAN; CIRCULATION; MODEL; CYCLE	Ice-core measurements of carbon dioxide(1,2) and the deuterium palaeothermometer reveal significant covariation of temperature and atmospheric CO2 concentrations throughout the climate cycles of the past ice ages. This covariation provides compelling evidence that CO2 is an important forcing factor for climate(3-5). But this interpretation is challenged by some substantial mismatches of the CO2 and deuterium records, especially during the onset of the last glaciation, about 120 kyr ago. Here we incorporate measurements of deuterium excess from Vostok(6,7) in the temperature reconstruction and show that much of the mismatch is an artefact caused by variations of climate in the water vapour source regions. Using a model that corrects for this effect, we derive a new estimate for the covariation of CO2 and temperature, of r(2) = 0.89 for the past 150 kyr and r(2) = 0.84 for the period 350-150 kyr ago. Given the complexity of the biogeochemical systems involved, this close relationship strongly supports the importance of carbon dioxide as a forcing factor of climate. Our results also suggest that the mechanisms responsible for the drawdown of CO2 may be more responsive to temperature than previously thought.	Univ Calif Berkeley, Dept Geog, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; CEA Saclay, Lab Sci Climat & Environm, CNRS, UMR 1572, F-91191 Gif Sur Yvette, France	University of California System; University of California Berkeley; University of California System; University of California Berkeley; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Cuffey, KM (corresponding author), Univ Calif Berkeley, Dept Geog, 507 McCone Hall, Berkeley, CA 94720 USA.							BARD E, 1990, NATURE, V345, P405, DOI 10.1038/345405a0; BARNOLA JM, 1987, NATURE, V329, P408, DOI 10.1038/329408a0; BASSINOT FC, 1994, EARTH PLANET SC LETT, V126, P91, DOI 10.1016/0012-821X(94)90244-5; Braconnot P, 1997, CLIM DYNAM, V13, P507, DOI 10.1007/s003820050179; Chappell J, 1996, EARTH PLANET SC LETT, V141, P227, DOI 10.1016/0012-821X(96)00062-3; CUFFEY KM, 1995, SCIENCE, V270, P455, DOI 10.1126/science.270.5235.455; DANSGAARD W, 1964, TELLUS, V16, P436; DELAYGUE G, 2000, THESIS U AIX MARSEIL; Esat TM, 1999, SCIENCE, V283, P197, DOI 10.1126/science.283.5399.197; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; GENTHON C, 1987, NATURE, V329, P414, DOI 10.1038/329414a0; HANSEN JE, 1984, GEOPHYSICAL MONOGRAP, V29; Johnsen SJ, 1989, TELLUS B, V41, P452, DOI 10.1111/j.1600-0889.1989.tb00321.x; JOUZEL J, 1987, J GEOPHYS RES-ATMOS, V92, P14739, DOI 10.1029/JD092iD12p14739; JOUZEL J, 1993, NATURE, V364, P407, DOI 10.1038/364407a0; Jouzel J, 1997, J GEOPHYS RES-OCEANS, V102, P26471, DOI 10.1029/97JC01283; Khodri M, 2001, NATURE, V410, P570, DOI 10.1038/35069044; LORIUS C, 1990, NATURE, V347, P139, DOI 10.1038/347139a0; Loutre M. F., 1993, THESIS U CATHOLIQUE; MERLIVAT L, 1979, J GEOPHYS RES-OCEANS, V84, P5029, DOI 10.1029/JC084iC08p05029; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; PEPIN L, IN PRESS J GEOPHYS R; PETIT JR, 1991, J GEOPHYS RES-ATMOS, V96, P5113, DOI 10.1029/90JD02232; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Schrag DP, 1996, SCIENCE, V272, P1930, DOI 10.1126/science.272.5270.1930; Stirling CH, 1998, EARTH PLANET SC LETT, V160, P745, DOI 10.1016/S0012-821X(98)00125-3; Veizer J, 2000, NATURE, V408, P698, DOI 10.1038/35047044; Vimeux F, 2001, CLIM DYNAM, V17, P503, DOI 10.1007/PL00007928; Vimeux F, 1999, NATURE, V398, P410, DOI 10.1038/18860; VIMEUX F, IN PRESS J GEOPHYS R	30	97	101	1	26	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					523	527		10.1038/35087544	http://dx.doi.org/10.1038/35087544			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484049				2022-12-28	WOS:000170202900041
J	Fiorillo, L; Zucker, M; Sawyer, D; Lin, AN				Fiorillo, L; Zucker, M; Sawyer, D; Lin, AN			The pseudomonas hot-foot syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	6th Congress of the European-Society-for-Pediatric-Dermatology	SEP 13-18, 1999	CATHOLIC UNIV OF THE SACRED HEART, ROME, ITALY	European Soc Pediat Dermatol	CATHOLIC UNIV OF THE SACRED HEART		IDIOPATHIC PALMOPLANTAR HIDRADENITIS; PLANTAR HIDRADENITIS; ECCRINE HIDRADENITIS; CHILDREN; AERUGINOSA; EXPOSURE; WET	Background: Between March and May 1998, there was an outbreak of a clinically distinct skin eruption on the soles of the feet of children who used a community wading pool. Methods: We reviewed the medical records of 40 children in whom this syndrome developed during this time. We treated 17 children and advised the attending physicians on the care of the other 23. Follow-up data were obtained for up to one year. Results: Exquisitely painful erythematous plantar nodules developed in 40 children (age, 2 to 15 years) within 40 hours after they had used a wading pool whose floor was coated with abrasive grit. Culture of the plantar pustules from one child yielded Pseudomonas aeruginosa with a pattern on pulsed-field gel electrophoresis that was identical to that of a strain of P. aeruginosa cultured from the pool water. A skin-biopsy specimen from this patient showed a perivascular and perieccrine neutrophilic infiltrate, and a specimen from another patient showed a dermal microabscess. Thirty-seven patients were treated symptomatically; three others were treated with cephalexin. All patients recovered within 14 days, but three children had recurrences of the painful plantar nodules within 24 hours after using the pool again. Folliculitis developed in one patient. Conclusions: The "pseudomonas hot-foot syndrome'' is characterized by the acute onset in children of exquisitely tender plantar nodules and a benign, self-limited course. This community outbreak developed after exposure to pool water containing high concentrations of P. aeruginosa.	Univ Alberta, Div Dermatol & Cutaneous Sci, Edmonton, AB T6G 2G3, Canada; Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; Univ Calgary, Dept Pathol, Calgary, AB T2N 1N4, Canada	University of Alberta; University of Calgary; University of Calgary	Lin, AN (corresponding author), Univ Alberta, Div Dermatol & Cutaneous Sci, 2-104 Clin Sci Bldg, Edmonton, AB T6G 2G3, Canada.							Aleman CT, 1999, CUTIS, V63, P161; Bartolo E, 1998, J EUR ACAD DERMATOL, V10, P257; BLAUVELT A, 1992, J AM ACAD DERMATOL, V27, P111, DOI 10.1016/S0190-9622(08)80819-5; Buezo GF, 1996, AM J DERMATOPATH, V18, P413, DOI 10.1097/00000372-199608000-00015; HAY RJ, 1998, ROOK WILKINSON EBLIN, V2, P1097; HERN AE, 1992, J AM ACAD DERMATOL, V26, P259, DOI 10.1016/S0190-9622(08)80304-0; KOSATSKY T, 1985, AM J MED, V79, P10, DOI 10.1016/0002-9343(85)90539-X; Landau M, 1998, PEDIATR DERMATOL, V15, P97, DOI 10.1046/j.1525-1470.1998.1998015097.x; METZKER A, 1988, J AM ACAD DERMATOL, V18, P144, DOI 10.1016/S0190-9622(88)80055-0; Naimer SA, 2000, PEDIATR EMERG CARE, V16, P182, DOI 10.1097/00006565-200006000-00013; Pique E, 1997, DERMATOLOGY, V195, P379, DOI 10.1159/000245992; RABINOWITZ LG, 1995, ARCH DERMATOL, V131, P817, DOI 10.1001/archderm.131.7.817; RASMUSSEN JE, 1982, AM J DIS CHILD, V136, P553, DOI 10.1001/archpedi.1982.03970420077018; REED RK, 1976, J PEDIATR-US, V88, P977, DOI 10.1016/S0022-3476(76)81054-2; Simon M, 1998, ARCH DERMATOL, V134, P76, DOI 10.1001/archderm.134.1.76; STAHR BJ, 1994, J CUTAN PATHOL, V21, P289, DOI 10.1111/j.1600-0560.1994.tb00702.x; Weigl L, 2000, BRIT J DERMATOL, V142, P1048, DOI 10.1046/j.1365-2133.2000.03497.x	17	49	52	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2001	345	5					335	338		10.1056/NEJM200108023450504	http://dx.doi.org/10.1056/NEJM200108023450504			4	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458KM	11484690				2022-12-28	WOS:000170193600004
J	Schmitt, JHMM; Wichmann, R				Schmitt, JHMM; Wichmann, R			Ground-based observation of emission lines from the corona of a red-dwarf star	NATURE			English	Article								All 'solar-like' stars 1 are surrounded by coronae(2), which contain magnetically confined plasma at temperatures above 10(6) K. (Until now, only the Sun's corona could be observed in the optical-as a shimmering envelope during a total solar eclipse.) As the underlying stellar 'surfaces'-the photospheres-are much cooler, some non-radiative process must be responsible for heating the coronae. The heating mechanism is generally thought to be magnetic in origin, but is not yet understood even for the case of the Sun. Ultraviolet emission lines first led to the discovery of the enormous temperature of the Sun's corona(3,4), but thermal emission from the coronae of other stars has hitherto been detectable only from space, at X-ray wavelengths. Here we report the detection of emission from highly ionized iron (Fe XIII at 3,388.1 Angstrom) in the corona of the red-dwarf star CN Leonis, using a ground-based telescope. The X-ray flux inferred from our data is consistent with previously measured X-ray fluxes, and the non-thermal line width of 18.4 kms(-1) indicates great similarities between solar and stellar coronal heating mechanisms. The accessibility and spectral resolution (45,000) of the ground-based instrument are much better than those of X-ray satellites, so a new window to the study of stellar coronae has been opened.	Univ Hamburg, Hamburger Sternwarte, D-21029 Hamburg, Germany	University of Hamburg	Schmitt, JHMM (corresponding author), Univ Hamburg, Hamburger Sternwarte, Gojenbergsweg 112, D-21029 Hamburg, Germany.							ARNAUD M, 1992, ASTROPHYS J, V398, P394, DOI 10.1086/171864; BARBERA M, 1993, ASTROPHYS J, V414, P846, DOI 10.1086/173127; Chae J, 1998, ASTROPHYS J, V505, P957, DOI 10.1086/306179; CHENG CC, 1979, ASTROPHYS J, V227, P1037, DOI 10.1086/156811; DODORICO S, 2000, VLT UVES MANUAL; Edlen B, 1942, Z ASTROPHYS, V22, P30; FLOWER DR, 1973, ASTRON ASTROPHYS, V24, P181; Grotrian W., 1939, NW, V27, P214, DOI [10.1007/BF01488890, DOI 10.1007/BF01488890]; Guillout P, 1999, ASTRON ASTROPHYS, V351, P1003; HARRIS DE, 1990, EINSTEIN OBSERVATORY, V4; LINSKY JL, 1985, SOL PHYS, V100, P333, DOI 10.1007/BF00158435; Linsky JL, 1998, ASTROPHYS J, V492, P767, DOI 10.1086/305075; ROBINSON RD, 1995, ASTROPHYS J, V451, P795, DOI 10.1086/176266; Schmitt JHMM, 1997, ASTRON ASTROPHYS, V318, P215; SCHMITT JHMM, 1995, ASTROPHYS J, V450, P392, DOI 10.1086/176149; TAYLOR AR, 1996, ASP C SER, V93; Vaiana G. S., 1981, APJ, V245, P163; WALLERSTEIN G, 1991, EXTREME ULTRAVIOLET, P113	18	14	14	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					508	510		10.1038/35087513	http://dx.doi.org/10.1038/35087513			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484044				2022-12-28	WOS:000170202900036
J	Gottesman, S; Maurizi, MR				Gottesman, S; Maurizi, MR			Cell biology - Surviving starvation	SCIENCE			English	Editorial Material							INORGANIC POLYPHOSPHATE; PROTEIN-DEGRADATION; ESCHERICHIA-COLI		NCI, Mol Biol Lab, Bethesda, MD 20892 USA; NCI, Cell Biol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gottesman, S (corresponding author), NCI, Mol Biol Lab, Bldg 37, Bethesda, MD 20892 USA.	susang@helix.nih.gov						Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; GOLDBERG AL, 1976, ANNU REV BIOCHEM, V45, P747, DOI 10.1146/annurev.bi.45.070176.003531; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kuroda A, 1997, J BIOL CHEM, V272, P21240, DOI 10.1074/jbc.272.34.21240; Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315; Kuroda A, 1999, P NATL ACAD SCI USA, V96, P14264, DOI 10.1073/pnas.96.25.14264; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; ZHOU Y, 2001, GENE DEV, V289, P2354; Zhou YN, 2001, GENE DEV, V15, P627, DOI 10.1101/gad.864401	9	23	25	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2001	293	5530					614	615		10.1126/science.1063371	http://dx.doi.org/10.1126/science.1063371			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474088				2022-12-28	WOS:000170204600030
J	Chinsamy, A; Elzanowski, A				Chinsamy, A; Elzanowski, A			Bone histology - Evolution of growth pattern in birds	NATURE			English	Article									Univ Cape Town, Dept Zool, ZA-7700 Rondebosch, South Africa; S African Museum, ZA-8000 Cape Town, South Africa; Univ Wroclaw, Inst Zool, PL-50335 Wroclaw, Poland	University of Cape Town; University of Wroclaw	Chinsamy, A (corresponding author), Univ Cape Town, Dept Zool, Private Bag, ZA-7700 Rondebosch, South Africa.		Elzanowski, Andrzej/ABD-5511-2020	Chinsamy-Turan, Anusuya/0000-0002-9786-5080				CHINSAMY A, 1994, NATURE, V368, P196, DOI 10.1038/368196a0; CHINSAMY A, 1990, Palaeontologia Africana, V27, P77; ELZANOWSKI A, 1981, PALAEONTOL POLON, V42, P147; HOUDE P, 1987, AUK, V104, P125, DOI 10.2307/4087243; Norell MA, 2001, NATURE, V409, P181, DOI 10.1038/35051563; Reid R.E.H., 1993, Modern Geology, V18, P391; RICKLEFS RE, 1973, IBIS, V115, P177, DOI 10.1111/j.1474-919X.1973.tb02636.x; Sanz JL, 1997, SCIENCE, V276, P1543, DOI 10.1126/science.276.5318.1543; Starck J.M., 1998, AVIAN GROWTH DEV EVO, P3; Starck J.M., 1998, AVIAN GROWTH DEV EVO, P247; STARCK JM, 1994, J MORPHOL, V222, P113, DOI 10.1002/jmor.1052220202; Varricchio David J., 1993, Journal of Vertebrate Paleontology, V13, P99; [No title captured]	13	66	69	0	14	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					402	403		10.1038/35086650	http://dx.doi.org/10.1038/35086650			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473304				2022-12-28	WOS:000170068200034
J	Lockey, D; Davies, G; Coats, T				Lockey, D; Davies, G; Coats, T			Survival of trauma patients who have prehospital tracheal intubation without anaesthesia or muscle relaxants: observational study	BRITISH MEDICAL JOURNAL			English	Article							ESOPHAGEAL		Royal London Hosp, Dept Accid & Emergency, London E1 1BB, England	Barts Health NHS Trust; Royal London Hospital	Lockey, D (corresponding author), Royal London Hosp, Dept Accid & Emergency, London E1 1BB, England.		Coats, Timothy/AAW-1254-2021	Coats, Timothy/0000-0003-2736-2784				Blostein PA, 1998, J TRAUMA, V44, P534, DOI 10.1097/00005373-199803000-00021; Cooke MW, 1999, BRIT MED J, V319, P1150, DOI 10.1136/bmj.319.7218.1150; GULY UM, 1995, BRIT MED J, V310, P1091, DOI 10.1136/bmj.310.6987.1091; HUSSAIN LM, 1994, BRIT MED J, V308, P1077, DOI 10.1136/bmj.308.6936.1077; Pelucio M, 1997, ACAD EMERG MED, V4, P563, DOI 10.1111/j.1553-2712.1997.tb03579.x	5	52	54	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2001	323	7305					141	141		10.1136/bmj.323.7305.141	http://dx.doi.org/10.1136/bmj.323.7305.141			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456WR	11463683	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000170106200017
J	Baudouin-Cornu, P; Surdin-Kerjan, Y; Marliere, P; Thomas, D				Baudouin-Cornu, P; Surdin-Kerjan, Y; Marliere, P; Thomas, D			Molecular evolution of protein atomic composition	SCIENCE			English	Article							AMINO-ACID-COMPOSITION; SACCHAROMYCES-CEREVISIAE; METABOLISM; CYSTEINE	Living organisms encounter various growth conditions in their habitats, raising the question of whether ecological fluctuations could alter biological macromolecules. The advent of complete genome sequences and the characterization of whole metabolic pathways allowed us to search for such ecological imprints. Significant correlations between atomic composition and metabolic function were found in sulfur- and carbon-assimilatory enzymes, which appear depleted in sulfur and carbon, respectively, in both the bacterium Escherichia coli and the eukaryote Saccharomyces cerevisiae, In addition to genetic instructions, genomic data thus also provide paleontological records of environmental nutrient availability and of metabolic costs.	CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; Evol SA, F-91000 Evry, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Thomas, D (corresponding author), CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France.			Baudouin-Cornu, Peggy/0000-0001-7296-099X				CHEREST H, 1993, J BACTERIOL, V175, P5366, DOI 10.1128/JB.175.17.5366-5374.1993; Creighton TE, 1983, PROTEINS STRUCTURES; Fraenkel D., 1996, ESCHERICHIA COLI SAL, P189; GRIFFITH OW, 1987, METHOD ENZYMOL, V143, P366; JOHNSTON M, 1992, MOL CELLULAR BIOL YE, P193; KARLIN S, 1992, PROTEIN ENG, V5, P729, DOI 10.1093/protein/5.8.729; KARLIN S, 1992, SCIENCE, V257, P39, DOI 10.1126/science.1621093; Kimura M., 1983, NEUTRAL THEORY MOL E; KREDICH NM, 1996, ESCHERICHIA COLI SAL, P419; KRUGER WD, 1994, P NATL ACAD SCI USA, V91, P6614, DOI 10.1073/pnas.91.14.6614; LEYH TS, 1992, J BIOL CHEM, V267, P542; LI WH, 1997, MOL EVOLUTOIN; MAGASANIK B, 1992, MOL CELLULAR BIOL YE, V2, P283; MAZEL D, 1989, NATURE, V341, P245, DOI 10.1038/341245a0; Nei M., 1987, MOL EVOLUTIONARY GEN; Singer GAC, 2000, MOL BIOL EVOL, V17, P1581, DOI 10.1093/oxfordjournals.molbev.a026257; SUEKOA N, 1961, COLD SPRING HARB SYM, V26, P35; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; Tourasse NJ, 2000, MOL BIOL EVOL, V17, P656, DOI 10.1093/oxfordjournals.molbev.a026344	19	102	108	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					297	300		10.1126/science.1061052	http://dx.doi.org/10.1126/science.1061052			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452124				2022-12-28	WOS:000169875200058
J	Richardson, JE; Weitz, FM; Fay, MF; Cronk, QCB; Linder, HP; Reeves, G; Chase, MW				Richardson, JE; Weitz, FM; Fay, MF; Cronk, QCB; Linder, HP; Reeves, G; Chase, MW			Rapid and recent origin of species richness in the Cape flora of South Africa	NATURE			English	Article							DNA; EVOLUTION	The Cape flora of South Africa grows in a continental area with many diverse and endemic species(1-4). We need to understand the evolutionary origins and ages of such 'hotspots' to conserve them effectively(5). In volcanic islands the timing of diversification can be precisely measured with potassium-argon dating. In contrast, the history of these continental species is based upon an incomplete fossil record and relatively imprecise isotopic palaeotemperature signatures. Here we use molecular phylogenetics and precise dating of two island species within the same clade as the continental taxa to show recent speciation in a species-rich genus characteristic of the Cape flora. The results indicate that diversification began approximately(7-8) Myr ago, coincident with extensive aridification caused by changes in ocean currents. The recent origin of endemic species diversity in the Cape flora shows that large continental bursts of speciation can occur rapidly over timescales comparable to those previously associated with oceanic island radiations(6,7).	Royal Bot Gardens, Jodrell Lab, Richmond TW9 3DS, Surrey, England; Univ Western Cape, Dept Bot, ZA-7535 Bellville, Cape Province, South Africa; Univ Cape Town, Bolus Herbarium, Dept Bot, ZA-7700 Rondebosch, South Africa; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Royal Bot Garden, Edinburgh EH3 5LR, Midlothian, Scotland	Royal Botanic Gardens, Kew; University of the Western Cape; University of Cape Town; University of Edinburgh	Richardson, JE (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolut Biol, Santa Cruz, CA 95064 USA.	jamesr@darwin.ucsc.edu	Chase, Mark W/A-6642-2011; Fay, Michael/AAU-5861-2021; Richardson, James-Edward/L-2768-2016; Linder, Hans Peter/F-5316-2010; Fay, Michael F/G-4741-2010	Richardson, James-Edward/0000-0001-9014-4865; Fay, Michael F/0000-0003-3491-9093; Cronk, Quentin/0000-0002-4027-7368				Axelrod D. I., 1978, Monographiae Biologicae, V31, P79; Baldwin Bruce G., 1995, P259; COETZEE J A, 1983, Bothalia, V14, P345; Coetzee J. A., 1978, ANTARCTIC GLACIAL HI, P115; CRONK QCB, 2000, ENDEMIC FLORA ST HEL, P23; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Givnish Thomas J., 1995, P288; GOLDBLATT P, 1978, ANN MO BOT GARD, V65, P369, DOI 10.2307/2398858; GOOD R, 1974, GEOGRAPHY FLOWERING, P190; HODGES SA, 1994, P NATL ACAD SCI USA, V91, P5129, DOI 10.1073/pnas.91.11.5129; Johnson SD, 1996, TAXON, V45, P59, DOI 10.2307/1222585; KENNETT JP, 1980, PALAEOGEOGR PALAEOCL, V31, P123, DOI 10.1016/0031-0182(80)90017-6; Linder H.P., 1992, P113; Linder HP, 1998, BOT J LINN SOC, V128, P319; LINDER HP, 1985, TRANSVAAL MUSEUM MON, V4, P53; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; RAMBAUT A, 2000, TREEEDIT VERSION 1 0; Richardson JE, 2000, AM J BOT, V87, P1309, DOI 10.2307/2656724; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; SWOFFORD DL, 1998, PAUPSTAR4 0 B2 PHYLO; TAKHTAJAN A, 1986, FLORISTIC REGIONS WO, P263; Wojciechowski MF, 1999, SYST BOT, V24, P409, DOI 10.2307/2419698	24	213	218	4	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 12	2001	412	6843					181	183		10.1038/35084067	http://dx.doi.org/10.1038/35084067			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449273				2022-12-28	WOS:000169778700051
J	WoldeGabriel, G; Haile-Selassie, Y; Renne, PR; Hart, WK; Ambrose, SH; Asfaw, B; Heiken, G; White, T				WoldeGabriel, G; Haile-Selassie, Y; Renne, PR; Hart, WK; Ambrose, SH; Asfaw, B; Heiken, G; White, T			Geology and palaeontology of the Late Miocene Middle Awash valley, Afar rift, Ethiopia	NATURE			English	Article							EARLY HOMINID; AUSTRALOPITHECUS; CLIMATE; CARBON; AFRICA; ARAMIS	The Middle Awash study area of Ethiopia's Afar rift has yielded abundant vertebrate fossils (approximate to 10,000), including several hominid taxa(1-4). The study area contains a long sedimentary record spanning Late Miocene (5.3-11.2 Myr ago) to Holocene times. Exposed in a unique tectonic and volcanic transition zone between the main Ethiopian rift (MER) and the Afar rift, sediments along the western Afar rift margin in the Middle Awash provide a unique window on the Late Miocene of Ethiopia. These deposits have now yielded the earliest hominids, described in an accompanying paper(5) and dated here to between 5.54 and 5.77 Myr. These geological and palaeobiological data from the Middle Awash provide fresh perspectives on hominid origins and early evolution. Here we show that these earliest hominids derive from relatively wet and wooded environments that were modulated by tectonic, volcanic, climatic and geomorphic processes. A similar wooded habitat also has been suggested for the 6.0 Myr hominoid fossils recently recovered from Lukeino, Kenya(6). These findings require fundamental reassessment of models that invoke a significant role for global climatic change and/or savannah habitat in the origin of hominids.	Univ Calif Los Alamos Natl Lab, Inst Geophys & Planetary Phys, Los Alamos, NM 87545 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Human Evolut Studies Lab, Museum Vertebrate Zool, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94709 USA; Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; Miami Univ, Dept Geol, Oxford, OH 45056 USA; Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; Rift Valley Res Serv, Addis Ababa, Ethiopia	United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Berkeley Geochronolgy Center; University System of Ohio; Miami University; University of Illinois System; University of Illinois Urbana-Champaign	WoldeGabriel, G (corresponding author), Univ Calif Los Alamos Natl Lab, Inst Geophys & Planetary Phys, EES-6-MS D462, Los Alamos, NM 87545 USA.			Renne, Paul/0000-0003-1769-5235				Asfaw B, 1999, SCIENCE, V284, P629, DOI 10.1126/science.284.5414.629; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; CERLING TE, 1989, NATURE, V341, P138, DOI 10.1038/341138a0; CONROY GC, 1978, NATURE, V275, P67; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; Griffin DL, 1999, J GEOL SOC LONDON, V156, P817, DOI 10.1144/gsjgs.156.4.0817; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; Harland W.B., 1990, GEOLOGIC TIME SCALE; HEDBERG H. D., 1976, INT STRATIGRAPHIC GU; Kalb J.E., 1982, Newsletters on Stratigraphy, V11, P95; KALB JE, 1993, NEWSL STRATIGR, V29, P21; KINGDOM J, 1974, E AFRICAN MAMMALS B, V2; Leakey MG, 1996, J VERTEBR PALEONTOL, V16, P556, DOI 10.1080/02724634.1996.10011339; MOHR P, 1983, TECTONOPHYSICS, V94, P509, DOI 10.1016/0040-1951(83)90032-X; MORLEY CK, 1990, AAPG BULL, V74, P1234; MORTON WH, 1975, AFAR DEPRESSION ETHI, P55; Pickford M, 2001, CR ACAD SCI II A, V332, P145, DOI 10.1016/S1251-8050(01)01528-2; QUADE J, 1989, GEOL SOC AM BULL, V101, P464, DOI 10.1130/0016-7606(1989)101&lt;0464:SVITCA&gt;2.3.CO;2; Renne PR, 1999, GEOL SOC AM BULL, V111, P869, DOI 10.1130/0016-7606(1999)111<0869:COTMPS>2.3.CO;2; Ruddiman W., 1989, P OCEAN DRILLING PG, V108, P463, DOI DOI 10.2973/0DP.PR0C.SR.108.173.1989; TIERCELIN JJ, 1980, ACCAD NAZ LINCEI ROM, V47, P491; Van Campo E., 1991, P OCEAN DRILLING PRO, V117, P277; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; WHITE TD, 1993, NATURE, V366, P261, DOI 10.1038/366261a0; WOLDEGABRIEL G, 1994, NATURE, V371, P330, DOI 10.1038/371330a0; YEMANE K, 1985, NATURE, V318, P653, DOI 10.1038/318653a0	26	141	147	1	32	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					175	178		10.1038/35084058	http://dx.doi.org/10.1038/35084058			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449271				2022-12-28	WOS:000169778700049
J	Cunnane, G				Cunnane, G			Amyloid proteins in pathogenesis of AA amyloidosis	LANCET			English	Editorial Material							P COMPONENT; RHEUMATOID-ARTHRITIS		Univ Calif San Francisco, Vet Adm Med Ctr, Div Rheumatol, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Cunnane, G (corresponding author), Univ Calif San Francisco, Vet Adm Med Ctr, Div Rheumatol, San Francisco, CA 94121 USA.							Buxbaum J., 1998, RHEUMATOLOGY, V13, P615; Charles P, 1999, J IMMUNOL, V163, P1521; Cunnane G, 2001, CURR OPIN RHEUMATOL, V13, P67, DOI 10.1097/00002281-200101000-00011; HAWKINS PN, 1994, CLIN SCI, V87, P289, DOI 10.1042/cs0870289; HAWKINS PN, 1990, NEW ENGL J MED, V323, P508, DOI 10.1056/NEJM199008233230803; HAZENBERG BPC, 1994, BAILLIERE CLIN RHEUM, V8, P661, DOI 10.1016/S0950-3579(05)80121-9; HUSEBEKK A, 1985, SCAND J IMMUNOL, V21, P283, DOI 10.1111/j.1365-3083.1985.tb01431.x; Kisilevsky R, 2000, J STRUCT BIOL, V130, P99, DOI 10.1006/jsbi.2000.4222; Moriguchi M, 1999, HUM GENET, V105, P360, DOI 10.1007/s004390051115; Rocken C, 2001, AM J PATHOL, V158, P1029, DOI 10.1016/S0002-9440(10)64050-3; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; Urieli-Shoval S, 1998, J HISTOCHEM CYTOCHEM, V46, P1377, DOI 10.1177/002215549804601206; Yu J, 2000, LAB INVEST, V80, P1797, DOI 10.1038/labinvest.3780191	13	15	17	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 7	2001	358	9275					4	5		10.1016/S0140-6736(00)05297-1	http://dx.doi.org/10.1016/S0140-6736(00)05297-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11454365				2022-12-28	WOS:000169710900004
J	Adams, H; Ashworth, E; Breault, GA; Guo, J; Hunter, CA; Mayers, PC				Adams, H; Ashworth, E; Breault, GA; Guo, J; Hunter, CA; Mayers, PC			Knot tied around an octahedral metal centre	NATURE			English	Article							MOLECULAR TREFOIL KNOT; TOPOLOGY		Univ Sheffield, Dept Chem, Krebs Inst Biomolec Sci, Ctr Chem Biol, Sheffield S3 7HF, S Yorkshire, England; AstraZeneca, Macclesfield SK10 4TG, Cheshire, England	University of Sheffield; AstraZeneca	Adams, H (corresponding author), Univ Sheffield, Dept Chem, Krebs Inst Biomolec Sci, Ctr Chem Biol, Sheffield S3 7HF, S Yorkshire, England.		Hunter, Christopher Alexander/AFS-7239-2022	Hunter, Christopher Alexander/0000-0002-5182-1859				Arai Y, 1999, NATURE, V399, P446, DOI 10.1038/20894; Ashton PR, 1997, LIEBIGS ANN-RECL, P2485; Breault GA, 1999, TETRAHEDRON, V55, P5265, DOI 10.1016/S0040-4020(99)00282-3; Breault GA, 1998, J AM CHEM SOC, V120, P3402, DOI 10.1021/ja973938+; Carina RF, 1996, J AM CHEM SOC, V118, P9110, DOI 10.1021/ja961459p; Dietrich-Buchecker C., 1999, MOL CATENANES ROTAXA, P107; DIETRICHBUCHECKER CO, 1989, ANGEW CHEM INT EDIT, V28, P189, DOI 10.1002/anie.198901891; Safarowsky O, 2000, ANGEW CHEM INT EDIT, V39, P1616, DOI 10.1002/(SICI)1521-3773(20000502)39:9<1616::AID-ANIE1616>3.0.CO;2-Y; Seeman NC, 1998, ANGEW CHEM INT EDIT, V37, P3220, DOI 10.1002/(SICI)1521-3773(19981217)37:23<3220::AID-ANIE3220>3.0.CO;2-C; Sokolov V. I., 1973, RUSS CHEM REV, V42, P452, DOI DOI 10.1070/RC1973V042N06ABEH002636; Wang H, 1996, P NATL ACAD SCI USA, V93, P9477, DOI 10.1073/pnas.93.18.9477	11	89	89	1	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					763	763		10.1038/35081143	http://dx.doi.org/10.1038/35081143			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459044				2022-12-28	WOS:000169246400033
J	Gupta, R; Kim, JY; Espinal, MA; Caudron, JM; Pecoul, B; Farmer, PE; Raviglione, MC				Gupta, R; Kim, JY; Espinal, MA; Caudron, JM; Pecoul, B; Farmer, PE; Raviglione, MC			Public health - Responding to market failures in tuberculosis control	SCIENCE			English	Editorial Material							RESISTANT TUBERCULOSIS; COUNTRIES		WHO, Stop TB Dept, Geneva, Switzerland; Harvard Univ, Sch Med, Program Infect Dis & Social Change, Boston, MA 02115 USA; Med Sans Frontieres, B-1090 Brussels, Belgium; MSF, Access Essential Med, CH-1211 Geneva 6, Switzerland	World Health Organization; Harvard University; Harvard Medical School; Doctors Without Borders; Doctors Without Borders	Gupta, R (corresponding author), WHO, Stop TB Dept, 20 Ave Appia, Geneva, Switzerland.	guptara@who.int		RAVIGLIONE, Mario/0000-0002-9331-2067; Gupta, Rajesh/0000-0002-3307-6541				Baleta A, 2001, LANCET, V357, P775, DOI 10.1016/S0140-6736(00)04158-1; Bond P, 1999, INT J HEALTH SERV, V29, P765, DOI 10.2190/4MA6-53E3-LE1X-C1YY; CROFTON J, 1960, BRIT MED J, V17, P679; DIMASI JA, 1991, J HEALTH ECON, V10, P107, DOI 10.1016/0167-6296(91)90001-4; DYE C, UNPUB; ENARSON DA, 2000, MANGEMENT TUBERCULOS; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; Farmer P., 2000, INFECT INEQUALITIES; GUPTA R, 2001, GUIDELINES ESTABLISH; GUPTA R, 2000, P PROC 2 LIN ANT DRU; Harvard Medical School and Open Society Institute, 1999, GLOB IMP DRUG RES TU; ISEMAN MD, 1993, NEW ENGL J MED, V328, P576, DOI 10.1056/NEJM199302253280811; Kim J., 2000, DYING GROWTH; *MED SANS FRONT, 1999, CAMP ACC ESSMED PRIC; MIGLIORI GB, 1999, B WORLD HEALTH ORGAN, V76, P475; Pecoul B, 1999, JAMA-J AM MED ASSOC, V281, P361, DOI 10.1001/jama.281.4.361; Raviglione M C, 1997, AIDS, V11 Suppl B, pS115; Schwartlander B, 2001, SCIENCE, V292, P2434, DOI 10.1126/science.1062876; SUAREZ PG, IN PRESS J INFECT DI; White VLC, 2000, THORAX, V55, P962, DOI 10.1136/thorax.55.11.962; WHO, 1997, GUID MAN DRUG RES TU; World Health Organization (WHO), 2001, HUM RIGHTS APPR TUB	23	114	114	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1049	1051		10.1126/science.1061861	http://dx.doi.org/10.1126/science.1061861			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11463877				2022-12-28	WOS:000170432600028
J	Altman, DG				Altman, DG			Systematic reviews in health care - Systematic reviews of evaluations of prognostic variables	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; HIV-INFECTION; RISK-FACTOR; METAANALYSES; QUALITY; EXAMPLE; USERS; BIAS		Imperial Canc Res Fund, Med Stat Grp, Ctr Stat Med, Inst Hlth Sci, Oxford OX3 7LF, England	University of Oxford	Altman, DG (corresponding author), Imperial Canc Res Fund, Med Stat Grp, Ctr Stat Med, Inst Hlth Sci, Oxford OX3 7LF, England.							ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Altman DG, 1998, BREAST CANCER RES TR, V52, P289, DOI 10.1023/A:1006193704132; Altman DG, 2001, BMJ-BRIT MED J, V323, P224, DOI 10.1136/bmj.323.7306.224; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Blettner M, 1999, INT J EPIDEMIOL, V28, P1, DOI 10.1093/ije/28.1.1; Borghouts JAJ, 1998, PAIN, V77, P1, DOI 10.1016/S0304-3959(98)00058-X; Brocklehurst P, 1998, BRIT J OBSTET GYNAEC, V105, P836, DOI 10.1111/j.1471-0528.1998.tb10227.x; Buettner P, 1997, J CLIN EPIDEMIOL, V50, P1201, DOI 10.1016/S0895-4356(97)00155-8; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; COHEN J, 1983, APPL PSYCH MEAS, V7, P249, DOI 10.1177/014662168300700301; DEAR KBG, 1994, BIOMETRICS, V50, P989, DOI 10.2307/2533438; Deeks JJ, 2001, SYSTEMATIC REV HLTH, P285, DOI DOI 10.1002/9780470693926.CH15; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; FOX SB, 1994, BREAST CANCER RES TR, V29, P41, DOI 10.1007/BF00666180; Hudak PL, 1996, ARCH PHYS MED REHAB, V77, P586, DOI 10.1016/S0003-9993(96)90300-7; HUNINK MGM, 1994, MED DECIS MAKING, V14, P59, DOI 10.1177/0272989X9401400108; JUNI P, 2001, BMJ; KERNAN WN, 1991, STROKE, V22, P1108, DOI 10.1161/01.STR.22.9.1108; Key TJ, 1999, AM J CLIN NUTR, V70, p516S, DOI 10.1093/ajcn/70.3.516s; LAUPACIS A, 1994, JAMA-J AM MED ASSOC, V272, P234, DOI 10.1001/jama.272.3.234; LEVINE MN, 1991, J CLIN ONCOL, V9, P348, DOI 10.1200/JCO.1991.9.2.348; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Low N, 1998, SEX TRANSM INFECT, V74, P149, DOI 10.1136/sti.74.2.149; Marx BE, 1997, KIDNEY INT, V51, P873, DOI 10.1038/ki.1997.123; MCKIBBON K, 1999, EVIDENCE BASED PRINC; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moher D., 1999, HEALTH TECHNOL ASSES, V3, pi, DOI [DOI 10.3310/HTA3120, 10.3310/hta3120]; MORGAN TM, 1986, J AM STAT ASSOC, V81, P917, DOI 10.2307/2289060; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Ray JG, 1998, ARCH INTERN MED, V158, P2101, DOI 10.1001/archinte.158.19.2101; Shaheen NJ, 2000, GASTROENTEROLOGY, V119, P333, DOI 10.1053/gast.2000.9302; Shea B., 2001, SYSTEMATIC REV HLTH, P122, DOI [10.1002/9780470693926.ch7, DOI 10.1002/9780470693926.CH7]; SIMON R, 1994, BRIT J CANCER, V69, P979, DOI 10.1038/bjc.1994.192; Smith-Warner SA, 1998, JAMA-J AM MED ASSOC, V279, P535, DOI 10.1001/jama.279.7.535; Stephenson JM, 1998, AIDS, V12, P545, DOI 10.1097/00002030-199806000-00002; Wang CC, 1999, J ACQ IMMUN DEF SYND, V21, P51, DOI 10.1097/00126334-199905010-00007; Windeler J, 2000, STAT MED, V19, P425, DOI 10.1002/(SICI)1097-0258(20000229)19:4<425::AID-SIM347>3.0.CO;2-J; Wu YW, 2000, JAMA-J AM MED ASSOC, V284, P1417, DOI 10.1001/jama.284.11.1417	39	659	669	1	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2001	323	7306					224	228		10.1136/bmj.323.7306.224	http://dx.doi.org/10.1136/bmj.323.7306.224			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459UQ	11473921	Green Published			2022-12-28	WOS:000170270200025
J	Thomson, H; Petticrew, M; Morrison, D				Thomson, H; Petticrew, M; Morrison, D			Health effects of housing improvement: systematic review of intervention studies	BRITISH MEDICAL JOURNAL			English	Article							GROUNDS	Objective To review the evidence on the effects of interventions to improve housing on health. Design Systematic review of experimental and non-experimental housing intervention studies that measured quantitative health outcomes. Data sources Studies dating from 1887, in any language or format, identified from clinical, social science, and grey literature databases, personal collections, expert consultation, and reference lists. Main outcome measures Socioeconomic change and health, illness, and social measures. Results 18 completed primary intervention studies were identified. 11 studies were prospective, of which six had control groups. Three of the seven retrospective studies used a control group. The interventions included rehousing, refurbishment, and energy efficiency measures. Many studies showed health gains after the intervention, but the small study populations and lack of controlling for confounders limit the generalisability of these findings. Conclusions The lack of evidence linking housing and health may be attributable to pragmatic difficulties with housing studies as well as the political climate in the United Kingdom. A holistic approach is needed that recognises the multifactorial and complex nature of poor housing and deprivation. Large scale studies that investigate the wider social context of housing interventions are required.	MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT	Thomson, H (corresponding author), MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland.		Petticrew, Mark/AAY-6274-2021	Morrison, David/0000-0002-0617-3047				Acheson D., 1998, INDEPENDENT INQUIRY; Ambrose P., 2000, DROP OCEAN HLTH GAIN; [Anonymous], [No title captured]; BABA K, 1994, ANN JAP PUBLIC HLTH, V41, P404; BAUM F, 1995, SOC SCI MED, V40, P459, DOI 10.1016/0277-9536(94)E0103-Y; BLACKMAN T, 2001, IN PRESS HLTH PLACE; Bradshaw N, 1999, OAKDALE RENEWAL SCHE; Burridge R, 1993, UNHEALTHY HOUSING RE; CARP FM, 1977, GERONTOLOGIST, V17, P242, DOI 10.1093/geront/17.3.242; CARP FM, 1975, GERONTOLOGIST, V15, P511, DOI 10.1093/geront/15.6.511; COLE O, 1986, PUBLIC HEALTH, V100, P229, DOI 10.1016/S0033-3506(86)80072-5; Dedman DJ, 2001, J EPIDEMIOL COMMUN H, V55, P10, DOI 10.1136/jech.55.1.10; ELTON PJ, 1987, PUBLIC HEALTH, V101, P233, DOI 10.1016/S0033-3506(87)80074-4; ELTON PJ, 1986, J CHRON DIS, V39, P221, DOI 10.1016/0021-9681(86)90027-5; Gauldie Enid, 1974, CRUEL HABITATIONS HI; Green G, 1999, OPEN HOUSE INT, V24, P41; HALPERN D, 1995, MENTAL HLTH BUILT EN, P173; HAMMARQUIST C, 2000, COCHRANE DATABASE SY; Hopton J, 1996, HOUSING STUD, V11, P271, DOI 10.1080/02673039608720856; Hunt S., 1993, UNHEALTHY HOUSING RE, P67; IVERSEN M, 1986, Environment International, V12, P161, DOI 10.1016/0160-4120(86)90026-7; MANT D, 1993, UNHEALTHY HOUSING RE, P3; Marsh A., 1999, HOME SWEET HOME IMPA; MCGONIGLE G, 1936, POVERTY PUBLIC HLTH, P108; *NHS CTR REV DISS, 1996, EFFECTIVE HLTH CARE, V2; *NHS CTR REV DISS, 2000, SYST REV PUBL WAT FL; Oakley A, 1998, BRIT MED J, V317, P1239, DOI 10.1136/bmj.317.7167.1239; *SECR STAT HLTH, 1999, SAV LIV OUR HLTH NAT; SMITH SJ, 1990, SOC SCI MED, V31, P753, DOI 10.1016/0277-9536(90)90170-W; SMITH SJ, 1989, HOUSING HLTH REV RES; Smith SJ, 1997, HEALTH PLACE, V3, P203, DOI 10.1016/S1353-8292(97)00015-4; Somerville M, 2000, PUBLIC HEALTH, V114, P434, DOI 10.1016/S0033-3506(00)00383-8; SOMERVILLE M, 2001, TORBAY HOUSING PROJE; Somerville M, 1999, HOUSING HLTH CORNWAL; THUNHURST C, 1993, UNHEALTHY HOUSING RE, P23; Wadhams C, 1996, JUST WHAT DOCTOR ORD; WAMBEM DB, 1973, HEALTH SERV REP, V88, P47, DOI 10.2307/4594728; WELLS N, 2000, HOUSING 21 CENTURY; Wilkinson D., 1999, POOR HOUSING ILL HLT; WILNER DM, 1960, AM J PUBLIC HEALTH N, V50, P55, DOI 10.2105/AJPH.50.1.55; WILNER DM, 1958, AM J PUBLIC HEALTH N, V48, P1607, DOI 10.2105/AJPH.48.12.1607	41	212	214	2	43	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2001	323	7306					187	190		10.1136/bmj.323.7306.187	http://dx.doi.org/10.1136/bmj.323.7306.187			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	459UQ	11473906	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000170270200013
J	Bae, SH; Bae, KH; Kim, JA; Seo, YS				Bae, SH; Bae, KH; Kim, JA; Seo, YS			RPA governs endonuclease switching during processing of Okazaki fragments in eukaryotes	NATURE			English	Article							REPLICATION PROTEIN-A; DNA-BINDING-PROTEIN; ESSENTIAL IN-VIVO; SACCHAROMYCES-CEREVISIAE; STRANDED-DNA; POLYMERASE-DELTA; SV40 ORIGIN; YEAST; GENE; METABOLISM	Extensive work on the maturation of lagging strands during the replication of simian virus 40 DNA suggests that the initiator RNA primers of Okazaki fragments are removed by the combined action of two nucleases, RNase HI and Fen1, before the Okazaki fragments join(1-5). Despite the well established in vitro roles of these two enzymes(6), genetic analyses in yeast revealed that null mutants of RNase HI and/or Fen1 are not lethal(7-9), suggesting that an additional enzymatic activity may be required for the removal of RNA. One such enzyme is the Saccharomyces cerevisiae Dna2 helicase(10-12)/endonuclease(12), which is essential for cell viability(13,14) and is well suited to removing RNA primers of Okazaki fragments(15). In addition, Dna2 interacts genetically and physically with several proteins involved in the elongation or maturation of Okazaki fragments(10,16). Here we show that the endonucleases Dna2 and Fen1 act sequentially to facilitate the complete removal of the primer RNA. The sequential action of these enzymes is governed by a single-stranded DNA-binding protein, replication protein-A (RPA). Our results demonstrate that the processing of Okazaki fragments in eukaryotes differs significantly from, and is more complicated than, that occurring in prokaryotes. We propose a novel biochemical mechanism for the maturation of eukaryotic Okazaki fragments.	Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Natl Creat Res Initiat Ctr Cell Cycle Control, Suwon 440746, South Korea	Sungkyunkwan University (SKKU)	Seo, YS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Natl Creat Res Initiat Ctr Cell Cycle Control, 300 Chunchun Dong, Suwon 440746, South Korea.	ysseo@med.skku.ac.kr	Seo, Yeonsoo/C-1605-2011	Bae, Kwang-Hee/0000-0002-5868-2556				Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2000, J BIOCHEM MOL BIOL, V33, P155; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; BRILL SJ, 1989, NATURE, V342, P92, DOI 10.1038/342092a0; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; CHALLBERG MD, 1989, ANNU REV BIOCHEM, V58, P671; Frank P, 1998, FEBS LETT, V421, P23, DOI 10.1016/S0014-5793(97)01528-7; Gary R, 1999, MOL CELL BIOL, V19, P5373; Gomes XV, 2000, EMBO J, V19, P3811, DOI 10.1093/emboj/19.14.3811; Holmes AM, 1999, CELL, V96, P415, DOI 10.1016/S0092-8674(00)80554-1; HURWITZ J, 1990, J BIOL CHEM, V265, P18043; Iftode C, 1997, MOL CELL BIOL, V17, P3876, DOI 10.1128/MCB.17.7.3876; Kang HY, 2000, GENETICS, V155, P1055; KENNY MK, 1989, P NATL ACAD SCI USA, V86, P9757, DOI 10.1073/pnas.86.24.9757; Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873; Lieber MR, 1997, BIOESSAYS, V19, P233, DOI 10.1002/bies.950190309; Mass G, 1998, MOL CELL BIOL, V18, P6399, DOI 10.1128/MCB.18.11.6399; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; SOMMERS CH, 1995, J BIOL CHEM, V270, P4193, DOI 10.1074/jbc.270.9.4193; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; TOMKINSON AE, 1992, BIOCHEMISTRY-US, V31, P11762, DOI 10.1021/bi00162a013; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Zuo SJ, 2000, J BIOL CHEM, V275, P5153, DOI 10.1074/jbc.275.7.5153	30	274	278	1	18	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					456	461		10.1038/35086609	http://dx.doi.org/10.1038/35086609			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473323				2022-12-28	WOS:000170068200053
J	Klein, R				Klein, R			What's happening to Britain's National Health Service?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									London Sch Econ, London, England; London Sch Hyg & Trop Med, London WC1, England	University of London; London School Economics & Political Science; University of London; London School of Hygiene & Tropical Medicine	Klein, R (corresponding author), London Sch Econ, London, England.							AARON HJ, 1984, PAINFUL PRESCRIPTION; Beecham L, 2001, BRIT MED J, V322, P1381, DOI 10.1136/bmj.322.7299.1381; ENTHOVEN A, 1999, PURSUIT IMPROVING NA; *GEN MED COUNC, 2001, PROT PAT SUMM CONS D; KLEIN R, 2000, NEW POLITICS NATL HL; Klein RDP, 1996, MANAGING SCARCITY PR; LEGRAND J, 1998, LEARNING NHS INTERMA; *NHS EX, 2001, ASS QUAL MED PRACT; *NHS EX, 1998, NAT FRAM ASS PERF; Secretary of State for Health, 2000, NHS PLAN; Secretary of State for Health, 1997, NEW NHS MOD DEP	11	8	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2001	345	4					305	308		10.1056/NEJM200107263450422	http://dx.doi.org/10.1056/NEJM200107263450422			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455XZ	11474684	Green Published			2022-12-28	WOS:000170054200032
J	Llevadot, J; Giugliano, RP; Antman, EM				Llevadot, J; Giugliano, RP; Antman, EM			Bolus fibrinolytic therapy in acute myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TISSUE-PLASMINOGEN-ACTIVATOR; RECOMBINANT STAPHYLOKINASE VARIANTS; THROMBOLYTIC THERAPY; INTRACRANIAL HEMORRHAGE; ALTERED IMMUNOREACTIVITY; CORONARY THROMBOLYSIS; REPERFUSION THERAPY; THROMBIN INHIBITION; PLATELET ACTIVATION; ABCIXIMAB	Context New bolus fibrinolytics derived from the human tissue-type plasminogen activator (tPA) have emerged as a means of dissolution of occlusive thrombosis associated with acute myocardial infarction. Objective To review the new bolus fibrinolytic drugs derived from tPA, reteplase, lanoteplase, and tenecteplase, Data Sources The MEDLINE, EMBASE, and Current Contents databases were searched for articles from 1983 to 2001, using the index terms pharmacokinetics, pharmacodynamics, plasminogen activator, reteplase, lanoteplase, and tenecteplase. Additional data sources included bibliographies of articles identified on MEDLINE, EMBASE, and Current Content, inquiry of experts and pharmaceutical companies, and preliminary data presented at recent national and international cardiology conferences. Study Selection We selected for review studies that evaluated the pharmacokinetics and pharmacodynamics of reteplase, lanoteplase, and tenecteplase, and assessed the effects of these bolus fibrinolytic drugs on the angiographic and immediate and long-term outcomes of patients, Of 138 articles identified, 38 were analyzed. Data Extraction Data quality was determined by publication in the peer-reviewed literature or presentation at an official cardiology society-sponsored meeting. Data Synthesis Tenecteplase and reteplase are comparable with accelerated infusion recombinant tPA in terms of efficacy and safety but more convenient because they are administered by bolus injection. Lanoteplase and heparin bolus plus infusion is as effective as tPA with regard to mortality, but the rate of intracranial hemorrhage is significantly higher. Conclusion Given the ease of administration and the similar outcomes compared with accelerated infusion recombinant tPA, it is likely that a key component of contemporary reperfusion will include a bolus fibrinolytic.	Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Giugliano, RP (corresponding author), TIMI Study Grp, 333 Longwood Ave,Suite 402, Boston, MA 02115 USA.	rgiugliano@partners.org	Giugliano, Robert/N-7233-2017	Giugliano, Robert/0000-0003-4110-7675				[Anonymous], 1986, LANCET, V1, P397; [Anonymous], 1989, NEW ENGL J MED, V320, P618; Antman EM, 2000, EUR HEART J, V21, P1944, DOI 10.1053/euhj.2000.2243; ANTMAN EM, 1994, CIRCULATION, V90, P1624, DOI 10.1161/01.CIR.90.4.1624; Antman EM, 1999, CIRCULATION, V99, P2720, DOI 10.1161/01.CIR.99.21.2720; Antman EM, 1996, CIRCULATION, V94, P911, DOI 10.1161/01.CIR.94.5.911; Armstrong PW, 2001, CIRCULATION, V103, P1171, DOI 10.1161/01.CIR.103.8.1171; BENEDICT CR, 1995, CIRCULATION, V92, P3032, DOI 10.1161/01.CIR.92.10.3032; Bode C, 1996, CIRCULATION, V94, P891, DOI 10.1161/01.CIR.94.5.891; BRAUNWALD E, 1993, NEW ENGL J MED, V329, P1650, DOI 10.1056/NEJM199311253292211; Braunwald E, 2000, EUR HEART J, V21, P2005; Cannon CP, 2000, AM J CARDIOL, V85, p17C; Cannon CP, 1998, CIRCULATION, V98, P2805, DOI 10.1161/01.CIR.98.25.2805; CANNON CP, 1994, J AM COLL CARDIOL, V24, P1602, DOI 10.1016/0735-1097(94)90163-5; Cannon CP, 1997, CIRCULATION, V95, P351; Cannon CP, 1999, J THROMB THROMBOLYS, V7, P171, DOI 10.1023/A:1008841721975; Collen D, 2000, CIRCULATION, V102, P1766; Collen D, 1996, CIRCULATION, V93, P857, DOI 10.1161/01.CIR.93.5.857; Collen D, 1996, CIRCULATION, V94, P207, DOI 10.1161/01.CIR.94.2.207; Collen D, 1996, CIRCULATION, V94, P197, DOI 10.1161/01.CIR.94.2.197; COLLEN D, 1988, BLOOD, V71, P216; COLLEN D, 1999, MOL BASIS CARDIOVASC, P537; Coller BS, 1997, THROMB HAEMOSTASIS, V78, P730; Coulter SA, 2000, CIRCULATION, V101, P2690, DOI 10.1161/01.CIR.101.23.2690; de Lemos JA, 2000, CIRCULATION, V101, P239, DOI 10.1161/01.CIR.101.3.239; den Heijer P, 1998, CIRCULATION, V98, P2117, DOI 10.1161/01.CIR.98.20.2117; DEWOOD MA, 1980, NEW ENGL J MED, V303, P897, DOI 10.1056/NEJM198010163031601; Eikelboom JW, 2001, JAMA-J AM MED ASSOC, V285, P444, DOI 10.1001/jama.285.4.444; FITZGERALD DJ, 1988, CIRCULATION, V77, P142, DOI 10.1161/01.CIR.77.1.142; Giugliano RP, 2000, J AM COLL CARDIOL, V35, p407A; Giugliano RP, 2001, AM HEART J, V141, P742, DOI 10.1067/mhj.2001.114975; GIUGLIANO RP, 1997, CIRCULATION S1, V96, P535; *GLOB UT STREPT TI, 1993, NEW ENGL J MED, V329, P673; Granger CB, 1996, CIRCULATION, V93, P870, DOI 10.1161/01.CIR.93.5.870; Granger CB, 2000, CIRCULATION, V102, P590; HANSEN L, 1988, J BIOL CHEM, V263, P15713; Harrington RA, 1998, J AM COLL CARDIOL, V32, P2003; *INT JOINT EFF COM, 1995, LANCET, V346, P329; KEYT BA, 1994, P NATL ACAD SCI USA, V91, P3670, DOI 10.1073/pnas.91.9.3670; KOHNERT U, 1992, PROTEIN ENG, V5, P93, DOI 10.1093/protein/5.1.93; LARSEN GR, 1989, BLOOD, V73, P1842, DOI 10.1182/blood.V73.7.1842.1842; LARSEN GR, 1991, J BIOL CHEM, V266, P8156; LEIZOROVICZ A, 1993, NEW ENGL J MED, V329, P383; Mehta SR, 2000, LANCET, V356, P449, DOI 10.1016/S0140-6736(00)02552-6; MERLINI PA, 1995, J AM COLL CARDIOL, V25, P203, DOI 10.1016/0735-1097(94)00360-3; NEUHAUS KL, 1994, J AM COLL CARDIOL, V24, P55, DOI 10.1016/0735-1097(94)90541-X; Ohman EM, 1997, CIRCULATION, V95, P846; OWEN J, 1988, BLOOD, V72, P616; Paoni NF, 1996, THROMB HAEMOSTASIS, V75, P820; PAONI NF, 1993, THROMB HAEMOSTASIS, V70, P307; PASSAMANI E, 1985, NEW ENGL J MED, V312, P932; RAWLES J, 1994, J AM COLL CARDIOL, V23, P1, DOI 10.1016/0735-1097(94)90494-4; Roe Matthew T., 2001, HeartDrug, V1, P5, DOI 10.1159/000022704; ROSS A, 2000, AM COLL CARD 49 SCI; ROSS AM, 1993, NEW ENGL J MED, V329, P1615; SIMES RJ, 1995, CIRCULATION, V91, P1923, DOI 10.1161/01.CIR.91.7.1923; SIMOONS ML, 1993, LANCET, V342, P1523, DOI 10.1016/S0140-6736(05)80089-3; SMALLING RW, 1995, CIRCULATION, V91, P2725, DOI 10.1161/01.CIR.91.11.2725; TEBBE U, 1993, AM J CARDIOL, V72, P518, DOI 10.1016/0002-9149(93)90345-D; TOPOL E, 1994, CIRCULATION, V90, P1631; Topol E, 1997, NEW ENGL J MED, V337, P1118; Topol EJ, 2000, CIRCULATION, V101, P2788; Topol EJ, 1996, NEW ENGL J MED, V335, P775; Topol EJ, 2001, LANCET, V357, P1905; Van de Werf F, 1999, LANCET, V354, P716, DOI 10.1016/S0140-6736(99)07403-6; Van de Werf F, 1999, AM HEART J, V137, P786, DOI 10.1016/S0002-8703(99)70400-X; VandeWerf F, 1997, NEW ENGL J MED, V337, P1124; WALLENTIN L, 2000, G WASH U 16 INT S TH; Ware JH, 1997, NEW ENGL J MED, V337, P1159, DOI 10.1056/NEJM199710163371610; WEAVER WD, 1993, JAMA-J AM MED ASSOC, V270, P1211, DOI 10.1001/jama.270.10.1211; 2000, LANCET, V356, P1848	71	56	59	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2001	286	4					442	449		10.1001/jama.286.4.442	http://dx.doi.org/10.1001/jama.286.4.442			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456DZ	11466123				2022-12-28	WOS:000170069000016
J	Dorling, J; Salt, A				Dorling, J; Salt, A			Evidence based case report - Assessing developmental delay	BRITISH MEDICAL JOURNAL			English	Review							DUCHENNE MUSCULAR-DYSTROPHY; EARLY DIAGNOSIS		Norfolk & Norwich Univ Hosp Trust, Jenny Lind Childrens Dept, Norwich NR1 3SR, Norfolk, England; Wolfson Ctr, Neurodisabil Serv, London WC1N 2AP, England	University of London; University College London	Dorling, J (corresponding author), Norfolk & Norwich Univ Hosp Trust, Jenny Lind Childrens Dept, Norwich NR1 3SR, Norfolk, England.		Dorling, Jon/B-7409-2015	Dorling, Jon/0000-0002-1691-3221				APPLETON RE, 1995, LANCET, V345, P1243, DOI 10.1016/S0140-6736(95)92029-3; BECKMANN R, 1978, KLIN PADIATR, V190, P531; BECKMANN R, 1978, LANCET, V2, P105, DOI 10.1016/S0140-6736(78)91419-8; BECKMANN R, 1979, FORTSCHR MED, V97, P1733; BRADLEY DM, 1993, BRIT MED J, V306, P357, DOI 10.1136/bmj.306.6874.357; Bushby KMD, 1999, LANCET, V353, P557, DOI 10.1016/S0140-6736(98)05279-9; CHAPLAIS JD, 1984, ARCH DIS CHILD, V59, P512, DOI 10.1136/adc.59.6.512; EDWARDS JH, 1979, LANCET, V1, P772; GARDNERMEDWIN D, 1976, ARCH DIS CHILD, V51, P982; GARDNERMEDWIN D, 1978, LANCET, V2, P1102; LEAL MA, 1994, GACETA MED MEXICO, V130, P459; MOOSA A, 1982, S AFR MED J, V62, P765; READ L, 1986, J BONE JOINT SURG BR, V68, P481, DOI 10.1302/0301-620X.68B3.3733820; Sackett D. L., 1998, EVIDENCE BASED MED P; SIEGEL IM, 1976, LANCET, V2, P90; SMITH RA, 1989, ARCH DIS CHILD, V64, P787, DOI 10.1136/adc.64.6.787	16	1	1	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2001	323	7305					148	149		10.1136/bmj.323.7305.148	http://dx.doi.org/10.1136/bmj.323.7305.148			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456WR	11463687	Green Published			2022-12-28	WOS:000170106200020
J	Shortle, D; Ackerman, MS				Shortle, D; Ackerman, MS			Persistence of native-like topology in a denatured protein in 8 M urea	SCIENCE			English	Article							RESIDUAL DIPOLAR COUPLINGS; STAPHYLOCOCCAL NUCLEASE; 131-RESIDUE FRAGMENT; BACKBONE DYNAMICS; NMR; RESTRAINTS; ALIGNMENT; STATE; COMPACT; GELS	Experimental methods have demonstrated that when a protein unfolds, not all of its structure is Lost. Here we report measurement of residual dipolar couplings in denatured forms of the small protein staphylococcal nuclease oriented in strained polyacrylamide gels. A highly significant correlation among the dipolar couplings for individual residues suggests that a native-like spatial positioning and orientation of chain segments (topology) persists to concentrations of at least 8 molar urea. These data demonstrate that long-range ordering can occur well before a folding protein attains a compact conformation, a conclusion not anticipated by any of the standard models of protein folding.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Shortle, D (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.				NIGMS NIH HHS [GM34171] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034171] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALEXANDRESCU AT, 1994, J MOL BIOL, V242, P527, DOI 10.1006/jmbi.1994.1598; ALEXANDRESCU AT, 1994, BIOCHEMISTRY-US, V33, P1063, DOI 10.1021/bi00171a004; Bonneau R, 2001, PROTEINS, V43, P1, DOI 10.1002/1097-0134(20010401)43:1<1::AID-PROT1012>3.0.CO;2-A; Delaglio F, 2000, J AM CHEM SOC, V122, P2142, DOI 10.1021/ja993603n; DILL KA, 1991, ANNU REV BIOCHEM, V60, P795, DOI 10.1146/annurev.bi.60.070191.004051; FLANAGAN JM, 1992, P NATL ACAD SCI USA, V89, P748, DOI 10.1073/pnas.89.2.748; GILLESPIE JH, UNPUB; Gillespie JR, 1997, J MOL BIOL, V268, P170, DOI 10.1006/jmbi.1997.0953; Meiler J, 2000, J BIOMOL NMR, V16, P245, DOI 10.1023/A:1008378624590; Mok YK, 1999, J MOL BIOL, V289, P619, DOI 10.1006/jmbi.1999.2769; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147; Shortle D, 1998, P NATL ACAD SCI USA, V95, P11158, DOI 10.1073/pnas.95.19.11158; Shortle DR, 1996, CURR OPIN STRUC BIOL, V6, P24, DOI 10.1016/S0959-440X(96)80091-1; Sinclair JF, 1999, PROTEIN SCI, V8, P991, DOI 10.1110/ps.8.5.991; Skrynnikov NR, 2000, J BIOMOL NMR, V18, P239, DOI 10.1023/A:1026501101716; Srinivasan R, 1999, P NATL ACAD SCI USA, V96, P14258, DOI 10.1073/pnas.96.25.14258; TJANDRA N, 1999, STRUCT FOLD DES, V9, pR205; Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q	20	525	532	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2001	293	5529					487	489		10.1126/science.1060438	http://dx.doi.org/10.1126/science.1060438			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463915				2022-12-28	WOS:000169966700046
J	Siveter, DJ; Williams, M; Waloszek, D				Siveter, DJ; Williams, M; Waloszek, D			A phosphatocopid crustacean with appendages from the Lower Cambrian	SCIENCE			English	Article							3-DIMENSIONAL PRESERVATION; ANIMAL EMBRYOS; FOSSILS	Here we describe a phosphatocopid arthropod with preserved soft anatomy from Lower Cambrian rocks of 5hropshire, England, which provides evidence for the occurrence of Crustacea, including Eucrustacea, in the Early Cambrian. The find identifies an important, stratigraphically early source of well-preserved fossils (Konservat-Lagerstatte).	Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; British Geol Survey, Nottingham NG12 5GG, England; Univ Ulm, Sect Biosystemat Documentat, D-89069 Ulm, Germany	University of Leicester; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; Ulm University	Siveter, DJ (corresponding author), Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England.	djs@leicester.ac.uk	Williams, Mark/B-7590-2009	Williams, Mark/0000-0002-7987-6069				Bengtson S, 1997, SCIENCE, V277, P1645, DOI 10.1126/science.277.5332.1645; Budd G.E., 1998, ARTHROPOD RELATIONSH, V55, P125; Budd GE, 2000, BIOL REV, V75, P253, DOI 10.1017/S000632310000548X; Fortey RA, 1997, BIOESSAYS, V19, P429, DOI 10.1002/bies.950190510; Fortey RA, 1996, BIOL J LINN SOC, V57, P13, DOI 10.1006/bijl.1995.0002; Geyer G, 1997, J PALEONTOL, V71, P620, DOI 10.1017/S0022336000040117; HINZ I, 1987, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V198, P41; Hinz-Schallreuter Ingelore, 1993, Archiv fuer Geschiebekunde, V1, P329; Hinz-Schallreuter Ingelore, 1998, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V1, P103; Hou Xianguang, 1997, Fossils and Strata, V45, P1; Kouchinsky A, 1999, GEOLOGY, V27, P609, DOI 10.1130/0091-7613(1999)027<0609:CLEAWT>2.3.CO;2; Landing E, 1998, CAN J EARTH SCI, V35, P329, DOI 10.1139/cjes-35-4-329; Maas A., UNPUB; Morris SC, 1997, CURR BIOL, V7, pR71, DOI 10.1016/S0960-9822(06)00039-X; Muller K.J., 1982, P276; MULLER KJ, 1979, LETHAIA, V12, P1, DOI 10.1111/j.1502-3931.1979.tb01234.x; Muller Klaus J., 1995, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V197, P101; RuSHTON A. W.A., 1999, BRIT CAMBRIAN ORDOVI, pi; Sylvester-Bradley P.C, 1961, TREATISE INVERTEBR Q, pQ100; WALOSSEK D, 1990, LETHAIA, V23, P409, DOI 10.1111/j.1502-3931.1990.tb01373.x; WALOSSEK D, 1993, LETHAIA, V26, P7, DOI 10.1111/j.1502-3931.1993.tb01504.x; Walossek Dieter, 1999, P3; Williams Mark, 1998, Monograph of the Palaeontographical Society, V152, P1; Xiao SH, 1999, LETHAIA, V32, P219, DOI 10.1111/j.1502-3931.1999.tb00541.x; Xiao SH, 2000, J PALEONTOL, V74, P767, DOI 10.1666/0022-3360(2000)074<0767:PAEFTN>2.0.CO;2; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; Yue Z., 1999, LETHAIA, V32, P181, DOI DOI 10.1111/J.1502-3931.1999.TB00538.X	27	89	95	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2001	293	5529					479	481		10.1126/science.1061697	http://dx.doi.org/10.1126/science.1061697			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463912				2022-12-28	WOS:000169966700043
J	Wigley, TML; Raper, SCB				Wigley, TML; Raper, SCB			Interpretation of high projections for global-mean warming	SCIENCE			English	Article							SEA-LEVEL; CLIMATE; UNCERTAINTY; CARBON; MODEL	The Intergovernmental Panel on Climate Change (IPCC) has recently released its Third Assessment Report (TAR), in which new projections are given for global-mean warming in the absence of policies to limit climate change. The full warming range over 1990 to 2100, 1.4 degrees to 5.8 degreesC, is substantially higher than the range given previously in the IPCC Second Assessment Report. Here we interpret the new warming range in probabilistic terms, accounting for uncertainties in emissions, the climate sensitivity, the carbon cycle, ocean mixing, and aerosol forcing. We show that the probabilities of warming values at both the high and Low ends of the TAR range are very Low. In the absence of climate-mitigation policies, the 90% probability interval for 1990 to 2100 warming is 1.7 degrees to 4.9 degreesC.	Natl Ctr Atmospher Res, Boulder, CO 80307 USA; Univ E Anglia, Climat Res Unit, Norwich NR4 7TJ, Norfolk, England; Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany	National Center Atmospheric Research (NCAR) - USA; University of East Anglia; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Wigley, TML (corresponding author), Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA.	wigley@ucar.edu	Wigley, Tom M.L./B-4705-2008					Allen MR, 2000, NATURE, V407, P617, DOI 10.1038/35036559; ANDRONOVA N, IN PRESS J GEOPHYS R; Cubasch U., 2001, PROJECTIONS FUTURE C, P525; DOWLATABADI H, 1993, ENERG POLICY, V21, P209, DOI 10.1016/0301-4215(93)90243-9; Ehhalt D, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P239; Houghton J. T., 2001, CLIMATE CHANGE 2001; Jain AK, 1996, TELLUS B, V48, P583, DOI 10.1034/j.1600-0889.1996.t01-1-00012.x; Jones RN, 2000, CLIMATIC CHANGE, V45, P403, DOI 10.1023/A:1005551626280; Joos F, 1996, TELLUS B, V48, P397, DOI 10.1034/j.1600-0889.1996.t01-2-00006.x; Kattenberg A., 1996, CLIMATE CHANGE 1995, P285; MANNE A, 1995, ENERG POLICY, V23, P17, DOI 10.1016/0301-4215(95)90763-W; Mitchell JFB, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P695; Morgan M G, 1995, Environ Sci Technol, V29, p468A, DOI [10.1021/es00010a753, 10.1021/es00010a003]; Morgan M. G., 1990, UNCERTAINTY; Moss R. H., 2000, GUIDANCE PAPERS CROS, P33; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Prentice IC, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P183; Ramaswamy V., 2001, CLIMATE CHANGE 2001, P349; Raper S.C.B., 1996, SEA LEVEL RISE COAST, P11, DOI DOI 10.1007/978-94-015-8719-8_2; Raper SCB, 2001, CLIM DYNAM, V17, P601, DOI 10.1007/PL00007931; Schneider SH, 2001, NATURE, V411, P17, DOI 10.1038/35075167; Smith SJ, 2000, TECHNOL FORECAST SOC, V65, P195, DOI 10.1016/S0040-1625(99)00099-2; Titus JG, 1996, CLIMATIC CHANGE, V33, P151, DOI 10.1007/BF00140246; TOL RSJ, 1999, SPECIAL ISSUE COSTS, P130; Visser H, 2000, CLIMATIC CHANGE, V45, P421, DOI 10.1023/A:1005516020996; Wigley T.M.L., 1998, DO WE UNDERSTAND GLO, P185; Wigley TML, 1996, NATURE, V379, P240, DOI 10.1038/379240a0; WIGLEY TML, 1993, TELLUS B, V45, P409, DOI 10.1034/j.1600-0889.1993.t01-4-00002.x; WIGLEY TML, 1992, NATURE, V357, P293, DOI 10.1038/357293a0; Wigley TML, 2000, GEOPHYS RES LETT, V27, P4101, DOI 10.1029/2000GL012159; WIGLEY TML, 1994, CLIMATE CHANGE AGEND, P169; Wigley TML, 1993, CLIMATE SEA LEVEL CH, P111	32	362	395	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2001	293	5529					451	454		10.1126/science.1061604	http://dx.doi.org/10.1126/science.1061604			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463906	Green Submitted			2022-12-28	WOS:000169966700036
J	Parnell, RJ; Buchanan-Smith, HM				Parnell, RJ; Buchanan-Smith, HM			Animal behaviour - An unusual social display by gorillas	NATURE			English	Article									Univ Stirling, Dept Psychol, Scottish Primate Res Grp, Stirling FK9 4LA, Scotland; New York Zool Soc, Wildlife Conservat Soc, Bronx, NY 10460 USA	University of Stirling; Wildlife Conservation Society	Parnell, RJ (corresponding author), Univ Stirling, Dept Psychol, Scottish Primate Res Grp, Stirling FK9 4LA, Scotland.		Buchanan-Smith, Hannah M/A-5350-2009	Buchanan-Smith, Hannah M/0000-0002-2516-7734				Beck B. B., 1980, ANIMAL TOOL BEHAV US; Byrne Richard W., 1996, P111; WILLIAMSON EA, 1990, AM J PRIMATOL, V21, P265, DOI 10.1002/ajp.1350210403	3	21	23	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					294	294		10.1038/35085631	http://dx.doi.org/10.1038/35085631			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460152				2022-12-28	WOS:000169918200035
J	Van Vliet, G				Van Vliet, G			Treatment of congenital hypothyroidism	LANCET			English	Editorial Material									Univ Montreal, Dept Pediat, Montreal, PQ H3T 1C5, Canada	Universite de Montreal	Van Vliet, G (corresponding author), Univ Montreal, Dept Pediat, Montreal, PQ H3T 1C5, Canada.							Bongers-Schokking JJ, 2000, J PEDIATR-US, V136, P292, DOI 10.1067/mpd.2000.103351; Delange F, 1998, THYROID, V8, P1185, DOI 10.1089/thy.1998.8.1185; Devos H, 1999, J CLIN ENDOCR METAB, V84, P2502, DOI 10.1210/jc.84.7.2502; Dubuis JM, 1996, J CLIN ENDOCR METAB, V81, P222, DOI 10.1210/jc.81.1.222; Dussault JH, 1999, J CLIN ENDOCR METAB, V84, P4332, DOI 10.1210/jc.84.12.4332; Fisher DA, 2000, J CLIN ENDOCR METAB, V85, P2722, DOI 10.1210/jc.85.8.2722; FISHER DA, 1989, PEDIATRICS, V83, P785; Hanukoglu A, 2001, J CLIN ENDOCR METAB, V86, P186, DOI 10.1210/jcem.86.1.7124; KLEIN RZ, 1981, LANCET, V2, P1095; TILLOTSON SL, 1994, BRIT MED J, V309, P440, DOI 10.1136/bmj.309.6952.440; Van Vliet G, 1999, THYROID, V9, P79, DOI 10.1089/thy.1999.9.79; Zurakowski D, 1999, CLIN CHEM, V45, P1087	12	31	31	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 14	2001	358	9276					86	87		10.1016/S0140-6736(01)05376-4	http://dx.doi.org/10.1016/S0140-6736(01)05376-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452BR	11463405				2022-12-28	WOS:000169837700004
J	Di Fiore, PP; De Camilli, P				Di Fiore, PP; De Camilli, P			Endocytosis and signaling: An inseparable partnership	CELL			English	Review							CLATHRIN-MEDIATED ENDOCYTOSIS; RECEPTOR; TRANSDUCTION; DISSOCIATION; TRAFFICKING; PATHWAY; ROLES; NOTCH		European Inst Oncol, I-20141 Milan, Italy; Univ Milan, Sch Med, I-20122 Milan, Italy; FIRC Inst Mol Oncol, I-20134 Milan, Italy; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	IRCCS European Institute of Oncology (IEO); University of Milan; IFOM - FIRC Institute of Molecular Oncology; Yale University; Howard Hughes Medical Institute; Yale University	Di Fiore, PP (corresponding author), European Inst Oncol, Via Ripamonti 435, I-20141 Milan, Italy.		Di Fiore, Pier Paolo/K-2130-2012	Di Fiore, Pier Paolo/0000-0002-2252-0950				Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Ceresa BP, 1998, MOL CELL BIOL, V18, P3862, DOI 10.1128/MCB.18.7.3862; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Fish KN, 2000, J CELL BIOL, V150, P145, DOI 10.1083/jcb.150.1.145; Herz J, 2001, NEURON, V29, P571, DOI 10.1016/S0896-6273(01)00234-3; Krishnan KS, 2001, NEURON, V30, P197, DOI 10.1016/S0896-6273(01)00273-2; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Li LM, 2001, P NATL ACAD SCI USA, V98, P1619, DOI 10.1073/pnas.98.4.1619; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; Miller WE, 2001, CURR OPIN CELL BIOL, V13, P139, DOI 10.1016/S0955-0674(00)00190-3; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Otsuki Y, 2001, P NATL ACAD SCI USA, V98, P4385, DOI 10.1073/pnas.071411598; Parks AL, 2000, DEVELOPMENT, V127, P1373; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Whistler JL, 1999, J BIOL CHEM, V274, P24575, DOI 10.1074/jbc.274.35.24575	20	295	300	1	25	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2001	106	1					1	4		10.1016/S0092-8674(01)00428-7	http://dx.doi.org/10.1016/S0092-8674(01)00428-7			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461694	Green Published, Bronze			2022-12-28	WOS:000169870300001
J	Garattini, S; Bertele, V				Garattini, S; Bertele, V			Adjusting Europe's drug regulation to public health needs	LANCET			English	Editorial Material									Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Garattini, S (corresponding author), Mario Negri Inst Pharmacol Res, Via Eritrea 62, I-20157 Milan, Italy.		Bertele, Vittorio/AAA-6461-2020; Garattini, Silvio/AAA-6390-2020	Bertele, Vittorio/0000-0002-0032-7033; Garattini, Silvio/0000-0003-0647-9297				Bertele V, 1999, HEART, V81, P675, DOI 10.1136/hrt.81.6.675; *EUR COMM, 1998, EUROPEAN COMMUNITI A, V2, P51; *EUR COMM, 1998, EUROPEAN COMMUNITI A, V2, P15; *EUR COMM, 1998, EUROPEAN COMMUNITI B, V2, P24; *EUR FED PHARM IND, 2001, POINTS CONS SWITCH S; European Commission, 1998, RES HUM RIGHTS VIOL, P1; Garattini S, 1999, LANCET, V353, P930, DOI 10.1016/S0140-6736(05)75042-X; 1965, OFF J EUR COMM, P369; 1989, OFF J EUR COMM, P8; 1993, OFF J EUR COMM; 1997, OFF J EUR COMM; 2001, INT C HARM	12	45	46	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 7	2001	358	9275					64	67		10.1016/S0140-6736(00)05258-2	http://dx.doi.org/10.1016/S0140-6736(00)05258-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11454401				2022-12-28	WOS:000169710900036
J	Weber, B				Weber, B			Annie's box: Charles Darwin, his daughter and human evolution	NATURE			English	Book Review									Calif State Univ Fullerton, Dept Chem & Biochem, Fullerton, CA 92834 USA; Bennington Coll, Div Sci, Bennington, VT 05201 USA	California State University System; California State University Fullerton	Weber, B (corresponding author), Calif State Univ Fullerton, Dept Chem & Biochem, Fullerton, CA 92834 USA.							Keynes Randal., 2001, ANNIES BOX C DARWIN	1	0	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					739	740		10.1038/35081240z	http://dx.doi.org/10.1038/35081240z			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11460103	Bronze			2022-12-28	WOS:000169246400020
J	Annas, GJ				Annas, GJ			The limits of state laws to protect genetic information	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Hlth Law Dept, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Hlth Law Dept, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				ABELSON R, 2001, NY TIMES        0610, P1; Andrews L. B., 2001, FUTURE PERFECT CONFR; ANNAS GJ, 1993, JAMA-J AM MED ASSOC, V270, P2346, DOI 10.1001/jama.270.19.2346; CUMMINGS J, 2001, WALL STREET J   0625, pB2; Fedder RS, 2000, J LEGAL MED, V21, P557, DOI 10.1080/019476400455807; Greely H T, 2000, Jurimetrics, V40, P153; JAGUTIS MA, 1999, MARQ L REV, V82, P429; LASALANDRA M, 2001, BOSTON HERALD   0225, P3; Laurie GT, 2001, J LEGAL MED, V22, P1, DOI 10.1080/019476401750171115; Mariner WK, 1996, NEW ENGL J MED, V335, P1986, DOI 10.1056/NEJM199612263352610; MURRAY TH, 1997, GENETIC SECRETS PROT, P60; National Bioethics Advisory Commission, 1999, RES INV HUM BIOL MAT; Nelkin D, 2001, NAT REV GENET, V2, P555, DOI 10.1038/35080583; Roche PA, 2001, NAT REV GENET, V2, P392, DOI 10.1038/35072029; ROCHE PA, 1996, JURIMETICS, V31, P1; SIXEL LM, 2001, HOUSTON CHRONIC 0216, pB1; SWAZEY JP, 1992, GENE MAPPING USING L, P45; 2000, FDCH POLITICAL  0602, P20; 2000, NY TIMES        0627, pF8	19	18	18	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2001	345	5					385	388		10.1056/NEJM200108023450523	http://dx.doi.org/10.1056/NEJM200108023450523			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458KM	11484711	Green Published			2022-12-28	WOS:000170193600030
J	Krause, DW				Krause, DW			Fossil molar from a Madagascan marsupial - The discovery of a tiny tooth from the Late Cretaceous period has sizeable implications.	NATURE			English	Article									SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Krause, DW (corresponding author), SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA.							Cifelli Richard L., 1997, Journal of Mammalian Evolution, V4, P241, DOI 10.1023/A:1027394430433; CIFELLI RL, 1987, NATURE, V325, P520, DOI 10.1038/325520a0; CIFELLI RL, 1993, P NATL ACAD SCI USA, V90, P9413, DOI 10.1073/pnas.90.20.9413; Clemens W.A., 1986, CONTRIBUTIONS GEOLOG, V3, P55, DOI DOI 10.2113/GSR0CKY.24.SPECIAL_; FOX RC, 1975, CAN J EARTH SCI, V12, P412, DOI 10.1139/e75-037; Fox Richard C., 1995, P247; KRAUSE DW, 1999, GSA TODAY, V9, P1; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; Masters JC, 1995, CREATURES OF THE DARK, P31; PRASAD GVR, 1988, NATURE, V332, P638, DOI 10.1038/332638a0; Rogers RR, 2000, J GEOL, V108, P275, DOI 10.1086/314403; SLAUGHTER BH, 1968, SCIENCE, V162, P254, DOI 10.1126/science.162.3850.254; STOREY M, 1995, SCIENCE, V267, P852, DOI 10.1126/science.267.5199.852; Woodburne Michael O., 1996, Journal of Mammalian Evolution, V3, P121, DOI 10.1007/BF01454359; [No title captured]	15	55	58	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					497	498		10.1038/35087649	http://dx.doi.org/10.1038/35087649			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484038				2022-12-28	WOS:000170202900030
J	Scott, S; Spender, Q; Doolan, M; Jacobs, B; Aspland, H				Scott, S; Spender, Q; Doolan, M; Jacobs, B; Aspland, H			Multicentre controlled trial of parenting groups for childhood antisocial behaviour in clinical practice	BRITISH MEDICAL JOURNAL			English	Article							CONDUCT PROBLEMS; FAMILIES; CHILDREN	Objective To see whether a behaviourally based group parenting programme, delivered in regular clinical practice, is an effective treatment for antisocial behaviour in children. Design Controlled trial with permuted block design with allocation by date of referral. Setting Four local child and adolescent mental health services. Participants 141 children aged 3-8 years referred with antisocial behaviour and allocated to parenting groups (90) or waiting list control (51) I ntervention Webster-Stratton basic videotape programme administered to parents of six to eight children over 13-16 weeks. This programme emphasises engagement with parental emotions, rehearsal of behavioural strategies, and parental understanding of its scientific rationale. Main outcome measures Semistructured parent interview and questionnaires about antisocial behaviour in children administered 5-7 months after entering trial; direct observation of parent-child interaction. Results Referred children were highly antisocial (above the 97th centile on interview measure). Children in the intervention group showed a large reduction in antisocial behaviour; those in the waiting list group did not change (effect size between groups 1.06 SD (95% confidence interval 0.71 to 1.41), P < 0.001). Parents in the intervention group increased the proportion of praise to ineffective commands they gave their children threefold, while control parents reduced it by a third (effect size between groups 0.76 (0.16 to 1.36), P = 0.018). If the 31 children lost to follow up were included in an intention to treat analysis the effect size on antisocial behaviour was reduced by 16%. Conclusions Parenting groups effectively reduce serious antisocial behaviour in children in real life conditions. Follow up is needed to see if the children's poor prognosis is improved and criminality prevented.	Univ London Kings Coll, Inst Psychiat, London SE5 8AF, England; St Georges Hosp, Sch Med, London SW17 0RE, England; Maudsley Hosp, London SE5 8AZ, England	University of London; King's College London; St Georges University London; South London & Maudsley NHS Trust	Scott, S (corresponding author), Univ London Kings Coll, Inst Psychiat, London SE5 8AF, England.		Scott, Stephen/B-5700-2013		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALTMAN DG, 1982, PRACTICAL STAT MED R; Andrade AR, 2000, J AM ACAD CHILD PSY, V39, P161, DOI 10.1097/00004583-200002000-00014; [Anonymous], 1991, MANUAL CHILD BEHAV C; ASPLAND H, 2001, THESIS U LONDON LOND; Audit Commission, 1999, CHILDR MIND; Bierman KL, 1999, J CONSULT CLIN PSYCH, V67, P631; CHAMBERLAIN P, 1987, BEHAV ASSESS, V9, P97; FARRINGTON DP, 1995, J CHILD PSYCHOL PSYC, V36, P929, DOI 10.1111/j.1469-7610.1995.tb01342.x; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Henggeler SW, 1997, J CONSULT CLIN PSYCH, V65, P821, DOI 10.1037/0022-006X.65.5.821; KAZDIN AE, 1997, J AM ACAD CHILD ADOL, V36, P10; Meltzer H., 2000, MENTAL HLTH CHILDREN; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Rutter M., 1998, ANTISOCIAL BEHAV YOU; Scott S, 1998, BRIT MED J, V316, P202; Scott S, 2001, BRIT MED J, V323, P191, DOI 10.1136/bmj.323.7306.191; SCOTT SB, IN PRESS CHILD ADOLE; SILBERG J, 1996, GENETICS CRIMINAL AN; Taylor E, 1996, J AM ACAD CHILD PSY, V35, P1213, DOI 10.1097/00004583-199609000-00019; Webster-Stratton C, 1998, J CONSULT CLIN PSYCH, V66, P715, DOI 10.1037/0022-006X.66.5.715; Webster-Stratton C, 1998, HDB PARENT TRAINING; WEBSTERSTRATTON C, 1989, J CONSULT CLIN PSYCH, V57, P550, DOI 10.1037/0022-006X.57.4.550; WEISZ JR, 1992, AM PSYCHOL, V47, P1578, DOI 10.1037/0003-066X.47.12.1578; WHO, 2012, ICD 10 CLASS MENT BE	25	181	183	1	19	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2001	323	7306					194	197		10.1136/bmj.323.7306.194	http://dx.doi.org/10.1136/bmj.323.7306.194			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	459UQ	11473908	Green Published, Bronze			2022-12-28	WOS:000170270200015
J	Carmody, J				Carmody, J			Celebrating science - Scientists feel passion, but they need to convey it in their writing, too.	NATURE			English	Editorial Material									Univ New S Wales, Sch Physiol & Pharmacol, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Carmody, J (corresponding author), Univ New S Wales, Sch Physiol & Pharmacol, Sydney, NSW 2052, Australia.							Simmons R, 2001, NATURE, V411, P243, DOI 10.1038/35077175	1	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					383	383		10.1038/35086659	http://dx.doi.org/10.1038/35086659			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473290	Bronze			2022-12-28	WOS:000170068200022
J	Melcher, D				Melcher, D			Persistence of visual memory for scenes - A medium-term memory may help us to keep track of objects during visual tasks.	NATURE			English	Article							KNOWLEDGE; SEARCH; TIME		Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Melcher, D (corresponding author), Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA.		Melcher, David/D-1775-2010	Melcher, David/0000-0003-0926-585X				Baddeley A.D., 2000, OXFORD HDB MEMORY, P77; BALLARD DH, 1995, J COGNITIVE NEUROSCI, V7, P66, DOI 10.1162/jocn.1995.7.1.66; Chun MM, 2000, VIS COGN, V7, P65, DOI 10.1080/135062800394685; DENNETT DC, 1992, BEHAV BRAIN SCI, V15, P183, DOI 10.1017/S0140525X00068229; EPELBOIM J, 1995, VISION RES, V35, P3401, DOI 10.1016/0042-6989(95)00080-X; FRIEDMAN A, 1979, J EXP PSYCHOL GEN, V108, P316, DOI 10.1037/0096-3445.108.3.316; HAYHOE M, 1998, VISION RES, V38, P215; Hollingworth A, 2000, VIS COGN, V7, P213, DOI 10.1080/135062800394775; Horowitz TS, 1998, NATURE, V394, P575, DOI 10.1038/29068; Land MF, 1997, PHILOS T ROY SOC B, V352, P1231, DOI 10.1098/rstb.1997.0105; LOFTUS GR, 1992, J EXP PSYCHOL HUMAN, V18, P530, DOI 10.1037/0096-1523.18.2.530; Miller MB, 1998, NEUROPSYCHOLOGIA, V36, P513, DOI 10.1016/S0028-3932(97)00148-6; O'Regan JK, 1999, NATURE, V398, P34, DOI 10.1038/17953; OREGAN JK, 1992, CAN J PSYCHOL, V46, P461, DOI 10.1037/h0084327; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419	15	87	89	1	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					401	401		10.1038/35086646	http://dx.doi.org/10.1038/35086646			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	456DQ	11473303	Bronze			2022-12-28	WOS:000170068200033
J	Fortey, R				Fortey, R			Evolution - The Cambrian explosion exploded?	SCIENCE			English	Editorial Material							FUSE		Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Natural History Museum London; University of Oxford	Fortey, R (corresponding author), Nat Hist Museum, Dept Palaeontol, Cromwell Rd, London SW7 5BD, England.							Bengtson S, 1997, SCIENCE, V277, P1645, DOI 10.1126/science.277.5332.1645; Bromham L, 1998, P NATL ACAD SCI USA, V95, P12386, DOI 10.1073/pnas.95.21.12386; Cooper A, 1998, TRENDS ECOL EVOL, V13, P151, DOI 10.1016/S0169-5347(97)01277-9; Dohle W., 1998, Arthropod relationships., P305; Fortey RA, 1996, BIOL J LINN SOC, V57, P13, DOI 10.1006/bijl.1995.0002; MCMENAMIN MAS, 1990, EMERGENCE ANIMALS, P167; Morris SC, 2000, P NATL ACAD SCI USA, V97, P4426, DOI 10.1073/pnas.97.9.4426; Schram F.R., 1986, CRUSTACEA; Siveter DJ, 2001, SCIENCE, V293, P479, DOI 10.1126/science.1061697; WALOSSEK D, 1995, HYDROBIOLOGIA, V298, P1, DOI 10.1007/BF00033797	10	24	25	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2001	293	5529					438	439		10.1126/science.1062987	http://dx.doi.org/10.1126/science.1062987			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463899				2022-12-28	WOS:000169966700029
J	van Nieuwenhoven, CA; Buskens, E; van Tiel, FH; Bonten, MJM				van Nieuwenhoven, CA; Buskens, E; van Tiel, FH; Bonten, MJM			Relationship between methodological trial quality and the effects of selective digestive decontamination on pneumonia and mortality in critically ill patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE-CARE UNIT; VENTILATOR-ASSOCIATED PNEUMONIA; MULTIPLE TRAUMA PATIENTS; RESPIRATORY-TRACT INFECTIONS; RANDOMIZED CONTROLLED TRIALS; DOUBLE-BLIND; INTESTINAL DECONTAMINATION; OROPHARYNGEAL DECONTAMINATION; ANTIBIOTIC-PROPHYLAXIS; NOSOCOMIAL INFECTION	Context Although meta-analyses of randomized trials have shown that selective digestive decontamination (SDD) prevents nosocomial pneumonia in critically ill patients, the influence of trial quality on the effectiveness of SDD has not been rigorously evaluated. Objective To assess the methodological quality of individual studies of SDD and its relation to the reported effects on pneumonia and mortality. Design Thirty-two studies were identified in a MEDLINE and reference list search and their methodological quality was assessed using a scoring system (range, 0-13 points) based on allocation and concealment, patient selection, patient characteristics, blinding of the intervention, and the definition of pneumonia. Main Outcome Measure Methodological quality of the primary trials and its effect on the relative risk reductions (RRRs) of SDD on pneumonia and mortality. Results The mean (SD) methodological quality score was 7.8 (2.9) (range, 1-11). The RRRs ranged from -0.1 to 1.0 for pneumonia and from -0.1 to 0.6 for mortality. The methodological quality score was associated with the RRR for pneumonia so that for each quality-point added, the RRR decreased by 5.8% (95% confidence interval, 2.4%-9.3%). No association between trial quality and the impact of SDD was found on mortality. Of the individual trial quality characteristics, patient selection, allocation of intervention, and blinding most strongly influenced the treatment effect. Conclusions The inverse relationship between methodological quality score and the benefit of SDD on the incidence of pneumonia may have resulted in overly optimistic estimates of SDD in prior meta-analyses, This emphasizes the importance of rigorous trial design in evaluating preventive interventions in the intensive care unit.	Univ Hosp Heidekberglaan, Julius Ctr Gen Practice & Patient Oriented Res, Utrecht, Netherlands; Univ Hosp Heidekberglaan, Dept Internal Med, Div Infect Dis & AIDS, Utrecht, Netherlands; Univ Hosp Maastricht, Dept Med Microbiol, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	Bonten, MJM (corresponding author), Univ Utrecht Hosp, Dept Internal Med, Div Infect Dis & AIDS, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.							AbeleHorn M, 1997, INTENS CARE MED, V23, P187, DOI 10.1007/s001340050314; AERDTS SJA, 1993, BRIT MED J, V307, P525; AERDTS SJA, 1991, CHEST, V100, P783, DOI 10.1378/chest.100.3.783; BLAIR P, 1991, SURGERY, V110, P303; Bonten MJM, 2000, J ANTIMICROB CHEMOTH, V46, P351, DOI 10.1093/jac/46.3.351; BORZAK S, 1995, ANN INTERN MED, V123, P873, DOI 10.7326/0003-4819-123-11-199512010-00010; BRUNBUISSON C, 1989, ANN INTERN MED, V110, P873, DOI 10.7326/0003-4819-110-11-873; CERRA FB, 1992, ARCH SURG-CHICAGO, V127, P163; COCKERILL FR, 1992, ANN INTERN MED, V117, P545, DOI 10.7326/0003-4819-117-7-545; COOK DJ, 1991, CHEST, V100, P7, DOI 10.1378/chest.100.1.7; D'Amico R, 1998, BMJ-BRIT MED J, V316, P1275, DOI 10.1136/bmj.316.7140.1275; FERRER M, 1994, ANN INTERN MED, V120, P389, DOI 10.7326/0003-4819-120-5-199403010-00006; Garcia MS, 1998, AM J RESP CRIT CARE, V158, P908, DOI 10.1164/ajrccm.158.3.9712079; GASTINNE H, 1992, NEW ENGL J MED, V326, P594, DOI 10.1056/NEJM199202273260903; Gaussorgues P., 1991, REANIMATION SOINS IN, V7, P169; GODARD J, 1990, INTENS CARE MED, V16, P307, DOI 10.1007/BF01706355; HAMMOND JMJ, 1992, LANCET, V340, P5, DOI 10.1016/0140-6736(92)92422-C; HARTENAUER U, 1991, CRIT CARE MED, V19, P463, DOI 10.1097/00003246-199104000-00003; HEYLAND DK, 1994, CHEST, V105, P1221, DOI 10.1378/chest.105.4.1221; Jacobs S., 1992, CLIN INTENSIVE CARE, V3, P52; JAESCHKE R, 1995, CAN MED ASSOC J, V152, P351; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; KERVER AJH, 1988, CRIT CARE MED, V16, P1087, DOI 10.1097/00003246-198811000-00001; KOLLEF MH, 1994, CHEST, V105, P1101, DOI 10.1378/chest.105.4.1101; Kollef MH, 1999, NEW ENGL J MED, V340, P627, DOI 10.1056/NEJM199902253400807; KORINEK AM, 1993, CRIT CARE MED, V21, P1466, DOI 10.1097/00003246-199310000-00013; LAGGNER AN, 1994, WIEN KLIN WOCHENSCHR, V106, P15; LEDINGHAM IM, 1988, LANCET, V1, P785; Lingnau W, 1997, J TRAUMA, V42, P687, DOI 10.1097/00005373-199704000-00018; MCCLELLAND P, 1990, CRIT CARE MED, V18, P935, DOI 10.1097/00003246-199009000-00006; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Nathens AB, 1999, ARCH SURG-CHICAGO, V134, P170, DOI 10.1001/archsurg.134.2.170; Palomar M., 1997, CLIN INTENSIVE CARE, V8, P228, DOI [10.3109/tcic.8.5.228.235, DOI 10.3109/TCIC.8.5.228.235]; PINGLETON SK, 1992, CHEST, V102, pS553, DOI 10.1378/chest.102.5_Supplement_1.553S; PUGIN J, 1991, JAMA-J AM MED ASSOC, V265, P2704, DOI 10.1001/jama.265.20.2704; Quinio B, 1996, CHEST, V109, P765, DOI 10.1378/chest.109.3.765; ROCHA LA, 1992, INTENS CARE MED, V18, P398, DOI 10.1007/BF01694341; RODRIGUEZROLDAN JM, 1990, CRIT CARE MED, V18, P1239, DOI 10.1097/00003246-199011000-00011; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; STOUTENBEEK CP, 1984, INTENS CARE MED, V10, P185, DOI 10.1007/BF00259435; ULRICH C, 1989, INTENS CARE MED, V15, P424, DOI 10.1007/BF00255597; UNERTL K, 1987, INTENS CARE MED, V13, P106; van Saene HKF, 1999, NEW ENGL J MED, V341, P293; VANDENBROUCKEGRAULS CMJE, 1991, LANCET, V338, P859, DOI 10.1016/0140-6736(91)91510-2; Verwaest C, 1997, CRIT CARE MED, V25, P63, DOI 10.1097/00003246-199701000-00014; VILLAR J, 1995, LANCET, V345, P772, DOI 10.1016/S0140-6736(95)90646-0; WIENER J, 1995, CLIN INFECT DIS, V20, P861, DOI 10.1093/clinids/20.4.861; WINTER R, 1992, J ANTIMICROB CHEMOTH, V30, P73, DOI 10.1093/jac/30.1.73	48	102	100	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2001	286	3					335	340		10.1001/jama.286.3.335	http://dx.doi.org/10.1001/jama.286.3.335			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452QA	11466100	Bronze			2022-12-28	WOS:000169869200025
J	Roux, AVD; Merkin, SS; Arnett, D; Chambless, L; Massing, M; Nieto, FJ; Sorlie, P; Szklo, M; Tyroler, HA; Watson, RL				Roux, AVD; Merkin, SS; Arnett, D; Chambless, L; Massing, M; Nieto, FJ; Sorlie, P; Szklo, M; Tyroler, HA; Watson, RL			Neighborhood of residence and incidence of coronary heart disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALAMEDA-COUNTY; CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS RISK; SOCIOECONOMIC-STATUS; MULTILEVEL ANALYSIS; PHYSICAL-ACTIVITY; UNITED-STATES; SOCIAL-CLASS; HEALTH; MORTALITY	Background: Where a person lives is not usually thought of as an independent predictor of his or her health, although physical and social features of places of residence may affect health and health-related behavior. Methods: Using data from the Atherosclerosis Risk in Communities Study, we examined the relation between characteristics of neighborhoods and the incidence of coronary heart disease. Participants were 45 to 64 years of age at base line and were sampled from four study sites in the United States: Forsyth County, North Carolina; Jackson, Mississippi; the northwestern suburbs of Minneapolis; and Washington County, Maryland. As proxies for neighborhoods, we used block groups containing an average of 1000 people, as defined by the U.S. Census. We constructed a summary score for the socioeconomic environment of each neighborhood that included information about wealth and income, education, and occupation. Results: During a median of 9.1 years of follow-up, 615 coronary events occurred in 13,009 participants. Residents of disadvantaged neighborhoods (those with lower summary scores) had a higher risk of disease than residents of advantaged neighborhoods, even after we controlled for personal income, education, and occupation. Hazard ratios for coronary heart disease among low-income persons living in the most disadvantaged neighborhoods, as compared with high-income persons in the most advantaged neighborhoods, were 3.1 among whites (95 percent confidence interval, 2.1 to 4.8) and 2.5 among blacks (95 percent confidence interval, 1.4 to 4.5). These associations remained unchanged after adjustment for established risk factors for coronary heart disease. Conclusions: Even after controlling for personal income, education, and occupation, we found that living in a disadvantaged neighborhood is associated with an increased incidence of coronary heart disease. (N Engl J Med 2001;345:99-106.) Copyright (C) 2001 Massachusetts Medical Society.	Columbia Univ, Columbia Coll Phys & Surg, Div Gen Med, New York, NY USA; Columbia Univ, Joseph T Mailman Sch Publ Hlth, Div Epidemiol, New York, NY USA; Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA; Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; Univ N Carolina, Collaborat Studies Coordinating Ctr, Chapel Hill, NC USA; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD USA; NHLBI, Div Epidemiol & Clin Applicat, Bethesda, MD 20892 USA; Univ Mississippi, Med Ctr, Dept Prevent Med, Jackson, MS 39216 USA	Columbia University; Columbia University; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Mississippi; University of Mississippi Medical Center	Roux, AVD (corresponding author), Columbia Presbyterian Med Ctr, Div Gen Med, 622 W 168th St,PH9 E,Rm 105, New York, NY 10032 USA.			Szklo, Moyses/0000-0001-9433-6266	NHLBI NIH HHS [N01-HC-55015, N01-HC-55016, R29 HL59386] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055016, N01HC055015] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL059386] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON JT, 1979, PREV MED, V8, P525, DOI 10.1016/0091-7435(79)90328-1; Anderson RT, 1997, EPIDEMIOLOGY, V8, P42, DOI 10.1097/00001648-199701000-00007; [Anonymous], [No title captured]; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; *BUR CENS, 1982, 1980 CENS POP; CHEADLE A, 1991, PREV MED, V20, P250, DOI 10.1016/0091-7435(91)90024-X; COX DR, 1972, J R STAT SOC B, V34, P187; Diez-Roux AV, 1999, J EPIDEMIOL COMMUN H, V53, P55, DOI 10.1136/jech.53.1.55; DiezRoux AV, 1997, AM J EPIDEMIOL, V146, P48, DOI 10.1093/oxfordjournals.aje.a009191; Duncan C, 1999, SOC SCI MED, V48, P497, DOI 10.1016/S0277-9536(98)00360-8; ELFORD J, 1989, LANCET, V1, P343; FABSITZ R, 1980, AM J EPIDEMIOL, V111, P315, DOI 10.1093/oxfordjournals.aje.a112903; GREEN M, 1991, POOR PAY MORE LESS 1; HAAN M, 1987, AM J EPIDEMIOL, V125, P989, DOI 10.1093/oxfordjournals.aje.a114637; HACKBARTH DP, 1995, J PUBLIC HEALTH POL, V16, P213, DOI 10.2307/3342593; Hart C, 1997, SOC SCI MED, V45, P893, DOI 10.1016/S0277-9536(96)00431-5; HENRY JP, 1986, POSTGRAD MED J, V62, P687, DOI 10.1136/pgmj.62.729.687; Jargowsky PA, 1996, AM SOCIOL REV, V61, P984, DOI 10.2307/2096304; Kahn HA, 1989, STAT METHODS EPIDEMI; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Kaplan GA, 1996, INT J HEALTH SERV, V26, P507, DOI 10.2190/4CUU-7B3G-G4XR-0K0B; KING AC, 1992, MED SCI SPORTS EXERC, V24, P221; Kleinschmidt I, 1995, J EPIDEMIOL COMMUN H, V49, pS72, DOI 10.1136/jech.49.Suppl_2.S72; MACINTYRE S, 1993, J SOC POLICY, V22, P213, DOI 10.1017/S0047279400019310; Massey DS, 1996, DEMOGRAPHY, V33, P395, DOI 10.2307/2061773; Mooney C., 1990, Journal of Human Nutrition and Dietetics, V3, P111, DOI 10.1111/j.1365-277X.1990.tb00058.x; Pucci LG, 1998, AM J PREV MED, V15, P155, DOI 10.1016/S0749-3797(98)00034-8; RAUTAHARJU PM, 1981, CIRCULATION, V64, P249, DOI 10.1161/01.CIR.64.2.249; Robert SA, 1999, ANNU REV SOCIOL, V25, P489, DOI 10.1146/annurev.soc.25.1.489; Robert SA, 1998, J HEALTH SOC BEHAV, V39, P18, DOI 10.2307/2676387; ROBINS JM, 1992, EPIDEMIOLOGY, V3, P143, DOI 10.1097/00001648-199203000-00013; Shah BV, 1997, SUDAAN USERS MANUAL; Shumaker SA, 1994, SOCIAL SUPPORT CARDI; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P399, DOI 10.1136/jech.52.6.399; SZKKO M, 2000, EPIDEMIOLOGY BASICS; TROUTT DD, 1993, THIN RED LINE POOR S; Waitzman NJ, 1998, AM J PUBLIC HEALTH, V88, P1122; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; WING S, 1987, LANCET, V2, P1067; WING S, 1988, AM J PUBLIC HEALTH, V78, P923, DOI 10.2105/AJPH.78.8.923; Yen IH, 1998, AM J PUBLIC HEALTH, V88, P1709, DOI 10.2105/AJPH.88.11.1709; Yen IH, 1999, AM J EPIDEMIOL, V149, P898; 1999, MMWR MORB MORTAL WKL, V48, P143	44	1253	1266	0	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 12	2001	345	2					99	106		10.1056/NEJM200107123450205	http://dx.doi.org/10.1056/NEJM200107123450205			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	451AH	11450679	Green Published			2022-12-28	WOS:000169776900005
J	Knight, J				Knight, J			Meet the Herod bug	NATURE			English	News Item							MALE-KILLING WOLBACHIA; ARMADILLIDIUM-VULGARE LATR; CYTOPLASMIC INCOMPATIBILITY; MOLECULAR-IDENTIFICATION; DROSOPHILA; ENDOSYMBIONT; HYMENOPTERA; SEQUENCES; SEX											Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543; BROWER JH, 1976, ANN ENTOMOL SOC AM, V69, P1011, DOI 10.1093/aesa/69.6.1011; Campbell B.C., 1993, Insect Molecular Biology, V2, P225; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Fialho RF, 2000, P ROY SOC B-BIOL SCI, V267, P1469, DOI 10.1098/rspb.2000.1166; HOFFMANN AA, 1986, EVOLUTION, V40, P692, DOI 10.1111/j.1558-5646.1986.tb00531.x; Hoffmann AA, 1998, GENETICS, V148, P221; Hurst GDD, 1999, P ROY SOC B-BIOL SCI, V266, P735, DOI 10.1098/rspb.1999.0698; Hurst GDD, 2000, GENETICS, V156, P699; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Jiggins FM, 2001, P ROY SOC B-BIOL SCI, V268, P1123, DOI 10.1098/rspb.2001.1632; Majerus TMO, 1999, INSECT MOL BIOL, V8, P551, DOI 10.1046/j.1365-2583.1999.00151.x; Masui S, 2000, J MOL EVOL, V51, P491, DOI 10.1007/s002390010112; RICHARDSON PM, 1987, J INVERTEBR PATHOL, V50, P176, DOI 10.1016/0022-2011(87)90080-2; RIGAUD T, 1993, GENETICS, V133, P247; RIGAUD T, 1991, ENDOCYTOBIOSIS CELL, V7, P259; STOUTHAMER R, 1993, NATURE, V361, P66, DOI 10.1038/361066a0; STOUTHAMER R, 1990, P NATL ACAD SCI USA, V87, P2424, DOI 10.1073/pnas.87.7.2424; Stouthamer R, 2001, P ROY SOC B-BIOL SCI, V268, P617, DOI 10.1098/rspb.2000.1404; Taylor MJ, 2000, PARASITOL TODAY, V16, P179, DOI 10.1016/S0169-4758(00)01661-6; Van Opijnen T, 1999, EXP APPL ACAROL, V23, P871, DOI 10.1023/A:1006363604916; WADE MJ, 1985, SCIENCE, V227, P527, DOI 10.1126/science.3966160; Werren J.H., 1995, P ROY SOC LOND B BIO, V262, P147; YEN JH, 1971, NATURE, V232, P657, DOI 10.1038/232657a0	24	13	14	0	14	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					12	14		10.1038/35083744	http://dx.doi.org/10.1038/35083744			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452274	Bronze			2022-12-28	WOS:000169644900012
J	Lam, E; Kato, N; Lawton, M				Lam, E; Kato, N; Lawton, M			Programmed cell death, mitochondria and the plant hypersensitive response	NATURE			English	Review							TOBACCO-MOSAIC-VIRUS; ARABIDOPSIS-THALIANA; BAX INHIBITOR-1; SALICYLIC-ACID; SUBCELLULAR-LOCALIZATION; TRANSCRIPTION FACTORS; GENE ENCODES; RESISTANCE; PROTEIN; APOPTOSIS	The plant response to attempted infection by microbial pathogens is often accompanied by rapid cell death in and around the initial infection site, a reaction known as the hypersensitive response. This response is associated with restricted pathogen growth and represents a form of programmed cell death (PCD). Recent pharmacological and molecular studies have provided functional evidence for the conservation of some of the basic regulatory mechanisms underlying the response to pathogens and the activation of PCD in animal and plant systems. In animals, the mitochondrion integrates diverse cellular stress signals and initiates the death execution pathway, and studies indicate a similar involvement for mitochondria in regulating PCD in plants. But many of the cell-death regulators that have been characterized in humans, worms and flies are absent from the Arabidopsis genome, indicating that plants probably use other regulators to control this process.	Rutgers State Univ, Biotechnol Ctr Agr & Environm, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Lam, E (corresponding author), Rutgers State Univ, Biotechnol Ctr Agr & Environm, 59 Dudley Rd, New Brunswick, NJ 08901 USA.	Lam@aesop.rutgers.edu	Kato, Naohiro/B-2353-2008	Kato, Naohiro/0000-0002-4571-3456				Aravind L, 2001, SCIENCE, V291, P1279, DOI 10.1126/science.291.5507.1279; Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P47, DOI 10.1016/S0968-0004(98)01341-3; Baker B, 1997, SCIENCE, V276, P726, DOI 10.1126/science.276.5313.726; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Blackstone NW, 1999, BIOESSAYS, V21, P84, DOI 10.1002/(SICI)1521-1878(199901)21:1<84::AID-BIES11>3.0.CO;2-0; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chivasa S, 1998, PLANT CELL, V10, P1489, DOI 10.1105/tpc.10.9.1489; Clarke A, 2000, PLANT J, V24, P667, DOI 10.1046/j.1365-313x.2000.00911.x; Clem RJ, 1996, CELL DEATH DIFFER, V3, P9; Clough SJ, 2000, P NATL ACAD SCI USA, V97, P9323, DOI 10.1073/pnas.150005697; Daniel X, 1999, PLANT J, V20, P57, DOI 10.1046/j.1365-313X.1999.00578.x; del Pozo O, 1998, CURR BIOL, V8, P1129, DOI 10.1016/S0960-9822(98)70469-5; DEPRAT J, 1912, SERV GEOL MEM HANOI, V1, P1; Devoto A, 1999, J BIOL CHEM, V274, P34993, DOI 10.1074/jbc.274.49.34993; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P14789, DOI 10.1073/pnas.97.26.14789; Erickson FL, 1999, PLANT J, V18, P67, DOI 10.1046/j.1365-313X.1999.00426.x; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Ferri KF, 2001, BIOESSAYS, V23, P111, DOI 10.1002/1521-1878(200102)23:2<111::AID-BIES1016>3.3.CO;2-P; Feys BJ, 2000, TRENDS GENET, V16, P449, DOI 10.1016/S0168-9525(00)02107-7; Gao MG, 1999, PLANT J, V19, P321, DOI 10.1046/j.1365-313X.1999.00544.x; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; HammondKosack KE, 1996, PLANT PHYSIOL, V110, P1381, DOI 10.1104/pp.110.4.1381; Harris MH, 2000, MOL CELL BIOL, V20, P3590, DOI 10.1128/MCB.20.10.3590-3596.2000; Heath MC, 2000, CURR OPIN PLANT BIOL, V3, P315, DOI 10.1016/S1369-5266(00)00087-X; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Jabs T, 1996, SCIENCE, V273, P1853, DOI 10.1126/science.273.5283.1853; Johnson DE, 2000, LEUKEMIA, V14, P1695, DOI 10.1038/sj.leu.2401879; Kampranis SC, 2000, J BIOL CHEM, V275, P29207, DOI 10.1074/jbc.M002359200; Kawai M, 1999, FEBS LETT, V464, P143, DOI 10.1016/S0014-5793(99)01695-6; Kawasaki T, 1999, P NATL ACAD SCI USA, V96, P10922, DOI 10.1073/pnas.96.19.10922; Keller T, 1998, PLANT CELL, V10, P255, DOI 10.1105/tpc.10.2.255; Korthout HAAJ, 2000, FEBS LETT, V475, P139, DOI 10.1016/S0014-5793(00)01643-4; Lacomme C, 1999, P NATL ACAD SCI USA, V96, P7956, DOI 10.1073/pnas.96.14.7956; Lam E, 1999, CURR OPIN PLANT BIOL, V2, P502, DOI 10.1016/S1369-5266(99)00026-6; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Maxwell DP, 1999, P NATL ACAD SCI USA, V96, P8271, DOI 10.1073/pnas.96.14.8271; Mayda E, 1999, PLANT J, V20, P591, DOI 10.1046/j.1365-313X.1999.00633.x; McCabe PF, 1997, PLANT J, V12, P267, DOI 10.1046/j.1365-313X.1997.12020267.x; Mitsuhara I, 1999, CURR BIOL, V9, P775, DOI 10.1016/S0960-9822(99)80341-8; MITTLER R, 1995, PLANT CELL, V7, P29, DOI 10.1105/tpc.7.1.29; Morel JB, 1997, CELL DEATH DIFFER, V4, P671, DOI 10.1038/sj.cdd.4400309; Navarre WW, 2000, CELL MICROBIOL, V2, P265, DOI 10.1046/j.1462-5822.2000.00056.x; Sanchez P, 2000, PLANT J, V21, P393, DOI 10.1046/j.1365-313x.2000.00690.x; Seo S, 2000, PLANT CELL, V12, P917, DOI 10.1105/tpc.12.6.917; Shirasu K, 2000, PLANT MOL BIOL, V44, P371, DOI 10.1023/A:1026552827716; Simons BH, 1999, PLANT PHYSIOL, V120, P529, DOI 10.1104/pp.120.2.529; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; Solomon M, 1999, PLANT CELL, V11, P431, DOI 10.1105/tpc.11.3.431; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Torres MA, 1998, PLANT J, V14, P365, DOI 10.1046/j.1365-313X.1998.00136.x; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; Vander Heiden MG, 2000, P NATL ACAD SCI USA, V97, P4666, DOI 10.1073/pnas.090082297; White E, 1996, GENE DEV, V10, P1, DOI 10.1101/gad.10.1.1; Wilson I, 1997, CURR BIOL, V7, pR175, DOI 10.1016/S0960-9822(97)70082-4; Xie ZX, 2000, MOL PLANT MICROBE IN, V13, P183, DOI 10.1094/MPMI.2000.13.2.183; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Zha HB, 1996, MOL CELL BIOL, V16, P6494; Zhang YL, 1999, P NATL ACAD SCI USA, V96, P6523, DOI 10.1073/pnas.96.11.6523; Zhou JM, 2000, MOL PLANT MICROBE IN, V13, P191, DOI 10.1094/MPMI.2000.13.2.191	63	656	722	7	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2001	411	6839					848	853		10.1038/35081184	http://dx.doi.org/10.1038/35081184			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459068				2022-12-28	WOS:000169246400062
J	Tommasi, A; Gibert, B; Seipold, U; Mainprice, D				Tommasi, A; Gibert, B; Seipold, U; Mainprice, D			Anisotropy of thermal diffusivity in the upper mantle	NATURE			English	Article							SEISMIC ANISOTROPY; CONDUCTIVITY; OLIVINE; ROCKS	Heat transfer in the mantle is a key process controlling the Earth's dynamics. Upper-mantle mineral phases, especially olivine, have been shown to display highly anisotropic thermal diffusivity at ambient conditions(1,2), and seismic anisotropy data(3) show that preferred orientations of olivine induced by deformation(4) are coherent at large scales (>50 km) in the upper mantle. Thus heat transport in the upper mantle should be anisotropic. But the thermal anisotropy of mantle minerals at high temperature(1,5) and its relationship with deformation have not been well constrained. Here we present petrophysical modelling and laboratory measurements of thermal diffusivity in deformed mantle rocks between temperatures of 290 and 1,250 K that demonstrate that deformation may induce a significant anisotropy of thermal diffusivity in the uppermost mantle. We found that heat transport parallel to the flow direction is up to 30 per cent faster than that normal to the flow plane. Such a strain-induced thermal anisotropy implies that the upper-mantle temperature distribution, rheology and, consequently, its dynamics, will depend on deformation history. In oceans, resistive drag flow would result in lower vertical diffusivities in both the lithosphere and asthenosphere(6) and hence in less effective heat transfer from the convective mantle. In continents, olivine orientations frozen in the lithosphere may induce anisotropic heating above mantle plumes, favouring the reactivation of pre-existing structures.	Univ Montpellier 2, CNRS, Lab Tectonophys, F-34095 Montpellier 5, France; Geoforschungszentrum Potsdam, D-14473 Potsdam, Germany	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences	Tommasi, A (corresponding author), Univ Montpellier 2, CNRS, Lab Tectonophys, F-34095 Montpellier 5, France.		Tommasi, Andrea/A-7507-2008	Tommasi, Andrea/0000-0002-6457-1852				ABRAMSON EH, 1997, J GEOPHYS RES, V102, P12252; ACHAUER U, 1994, TECTONOPHYSICS, V236, P305, DOI 10.1016/0040-1951(94)90182-1; Blackman DK, 1996, GEOPHYS J INT, V127, P415, DOI 10.1111/j.1365-246X.1996.tb04730.x; BOUHIFD MA, 1996, GEOPHYS RES LETT, V23, P134; Chai M, 1996, PHYS CHEM MINER, V23, P470, DOI 10.1007/BF00202033; CHASTEL YB, 1993, J GEOPHYS RES-SOL EA, V98, P17757, DOI 10.1029/93JB01161; DUFFY TS, 1988, J GEOPHYS RES-SOLID, V93, P383, DOI 10.1029/JB093iB01p00383; Hofmeister AM, 1999, SCIENCE, V283, P1699, DOI 10.1126/science.283.5408.1699; HOLT JB, 1975, EARTH PLANET SC LETT, V27, P404, DOI 10.1016/0012-821X(75)90059-X; HORAI K, 1989, PHYS EARTH PLANET IN, V55, P292, DOI 10.1016/0031-9201(89)90077-0; KANAMORI H, 1968, J GEOPHYS RES, V73, P595, DOI 10.1029/JB073i002p00595; KASAHARA J, 1968, ZISIN, V21, P222; KATSURA T, 1995, GEOPHYS J INT, V122, P63, DOI 10.1111/j.1365-246X.1995.tb03536.x; KLEMENS PG, 1958, SOLID STATE PHYS, V7, P1, DOI 10.1016/S0081-1947(08)60551-2; Kobayashi Y., 1974, Journal of Physics of the Earth, V22, P359, DOI 10.4294/jpe1952.22.359; MAINPRICE D, 1994, SURV GEOPHYS, V15, P575, DOI 10.1007/BF00690175; Nicolas A., 1987, COMPOSITION STRUCTUR, V16, P111, DOI [10.1029/GD016p0111, DOI 10.1029/GD016P0111]; Scharmeli G.H., 1982, HIGH PRESSURE RES GE, P349; SCHATZ JF, 1972, J GEOPHYS RES, V77, P6966, DOI 10.1029/JB077i035p06966; Seipold U., 1988, High Temperatures - High Pressures, V20, P609; Seipold U, 1998, TECTONOPHYSICS, V291, P161, DOI 10.1016/S0040-1951(98)00037-7; Seipold U, 1998, PHYS CHEM EARTH, V23, P357; SHANKLAND TJ, 1979, J GEOPHYS RES, V84, P1603, DOI 10.1029/JB084iB04p01603; Silver PG, 1996, ANNU REV EARTH PL SC, V24, P385, DOI 10.1146/annurev.earth.24.1.385; Tommasi A, 1998, EARTH PLANET SC LETT, V160, P1, DOI 10.1016/S0012-821X(98)00081-8; Tommasi A, 2000, J GEOPHYS RES-SOL EA, V105, P7893, DOI 10.1029/1999JB900411; Tommasi A, 2001, EARTH PLANET SC LETT, V185, P199, DOI 10.1016/S0012-821X(00)00350-2; Vauchez A, 1997, TERRA NOVA, V9, P62, DOI 10.1111/j.1365-3121.1997.tb00003.x	28	60	68	3	33	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					783	786		10.1038/35081046	http://dx.doi.org/10.1038/35081046			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459053	Green Submitted			2022-12-28	WOS:000169246400044
J	Wainger, BJ; DeGennaro, M; Santoro, B; Siegelbaum, SA; Tibbs, GR				Wainger, BJ; DeGennaro, M; Santoro, B; Siegelbaum, SA; Tibbs, GR			Molecular mechanism of cAMP modulation of HCN pacemaker channels	NATURE			English	Article							K+ CHANNEL; T1 DOMAIN; C-LINKER; LIGAND; IDENTIFICATION; ACTIVATION; SUBUNIT; BINDING; FAMILY	Hyperpolarization-activated cation channels of the HCN gene family(1-6) contribute to spontaneous rhythmic activity in both heart(7) and brain(5,6,8). All four family members contain both a core transmembrane segment domain, homologous to the S1-S6 regions of voltage-gated K+ channels, and a carboxy-terminal 120 amino-acid cyclic nucleotide-binding domain (CNBD) motif. Homologous CNBDs are responsible for the direct activation of cyclic nucleotide-gated channels and for modulation of the HERG voltage-gated K+ channel-important for visual and olfactory signalling(9) and for cardiac repolarization(10), respectively. The direct binding of cyclic AMP to the cytoplasmic site on HCN channels permits the channels to open more rapidly and completely after repolarization of the action potential(1,2,11), thereby accelerating rhythmogenesis(6-8). However, the mechanism by which cAMP binding modulates HCN channel gating and the basis for functional differences between HCN isoforms remain unknown. Here we demonstrate by constructing truncation mutants that the CNBD inhibits activation of the core transmembrane domain. cAMP binding relieves this inhibition. Differences in activation gating and extent of cAMP modulation between the HCN1 and HCN2 isoforms result largely from differences in the efficacy of CNBD inhibition.	Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Dept Anesthesiol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University	Tibbs, GR (corresponding author), Columbia Univ, Dept Pharmacol, New York, NY 10032 USA.	grt1@columbia.edu	Wainger, Brian/L-7553-2017; DeGennaro, Matthew/H-4975-2015	Santoro, Bina/0000-0002-4277-1992; DeGennaro, Matthew/0000-0003-3837-4430				Barbuti A, 1999, J PHYSIOL-LONDON, V520, P737, DOI 10.1111/j.1469-7793.1999.00737.x; Chen J, 2000, J BIOL CHEM, V275, P36465, DOI 10.1074/jbc.M007034200; CHEN S, 2000, SOC NEUR ABSTR, V26, P2139; Cui J, 2000, CURR BIOL, V10, P671, DOI 10.1016/S0960-9822(00)00516-9; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Paoletti P, 1999, J GEN PHYSIOL, V113, P17, DOI 10.1085/jgp.113.1.17; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; Tibbs GR, 1998, J BIOL CHEM, V273, P4497, DOI 10.1074/jbc.273.8.4497; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zong XG, 1998, EMBO J, V17, P353, DOI 10.1093/emboj/17.2.353	28	365	380	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2001	411	6839					805	810		10.1038/35081088	http://dx.doi.org/10.1038/35081088			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459060				2022-12-28	WOS:000169246400051
J	Wilkinson, DM				Wilkinson, DM			At cross purposes - How do we cope with scientific terms that have two different definitions?	NATURE			English	Editorial Material									Liverpool John Moores Univ, Sch Biol & Earth Sci, Liverpool L3 3AF, Merseyside, England	Liverpool John Moores University	Wilkinson, DM (corresponding author), Liverpool John Moores Univ, Sch Biol & Earth Sci, Liverpool L3 3AF, Merseyside, England.							Douglas AE, 1994, SYMBIOTIC INTERACTIO; Margulis L., 1998, SYMBIOTIC PLANET	2	30	33	1	16	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					485	485		10.1038/35087676	http://dx.doi.org/10.1038/35087676			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484028				2022-12-28	WOS:000170202900022
J	Kreitman, RJ; Wilson, WH; Bergeron, K; Raggio, M; Stetler-Stevenson, M; FitzGerald, DJ; Pastan, I				Kreitman, RJ; Wilson, WH; Bergeron, K; Raggio, M; Stetler-Stevenson, M; FitzGerald, DJ; Pastan, I			Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MINIMAL RESIDUAL DISEASE; PHASE-I TRIAL; CONTINUOUS-INFUSION; ENDOTHELIAL-CELLS; CHAIN IMMUNOTOXIN; FOLLOW-UP; 2-CHLORODEOXYADENOSINE; INTERFERON; REMISSIONS; LYMPHOMA	Background Hairy-cell leukemia that is resistant to treatment with purine analogues, including cladribine, has a poor prognosis. We tested the safety and efficacy of an immunotoxin directed against a surface antigen that is strongly expressed by leukemic hairy cells. Methods RFB4(dsFv)-PE38 (BL22), a recombinant immunotoxin containing an anti-CD22 variable domain (Fv) fused to truncated pseudomonas exotoxin, was administered in a dose-escalation trial by intravenous infusion every other day for a total of three doses. Results Of 16 patients who were resistant to cladribine, 11 had a complete remission and 2 had a partial remission with BL22. The three patients who did not have a response received low doses of BL22 or had preexisting toxin-neutralizing antibodies. Of the 11 patients in complete remission, 2 had minimal residual disease in the bone marrow or blood. During a median follow-up of 16 months ( range, 10 to 23), 3 of the 11 patients who had a complete response relapsed and were retreated; all of these patients had a second complete remission. In 2 of the 16 patients, a serious but completely reversible hemolytic uremic syndrome developed during the second cycle of treatment with BL22. Common toxic effects included transient hypoalbuminemia and elevated aminotransferase levels. Conclusions BL22 can induce complete remissions in patients with hairy-cell leukemia that is resistant to treatment with purine analogues. (N Engl J Med 2001; 345: 241-7.) Copyright (C) 2001 Massachusetts Medical Society.	NCI, Mol Biol Lab, Bethesda, MD 20892 USA; NCI, Med Branch, Bethesda, MD 20892 USA; NCI, Clin Pathol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kreitman, RJ (corresponding author), NCI, Mol Biol Lab, Bldg 37,Rm 4B27,37 Convent Dr,MSC 4255, Bethesda, MD 20892 USA.	kreitmar@mail.nih.gov	Stetler-Stevenson, Maryalice/AAV-7393-2020; pastan, ira/P-9319-2019	pastan, ira/0000-0002-9223-0270				AMLOT PL, 1993, BLOOD, V82, P2624; Baluna R, 1999, P NATL ACAD SCI USA, V96, P3957, DOI 10.1073/pnas.96.7.3957; BERNSTEIN L, 1990, CANCER RES, V50, P3605; BlasinskaMorawiec M, 1997, LEUKEMIA LYMPHOMA, V25, P381, DOI 10.3109/10428199709114177; BOURONCLE BA, 1958, BLOOD, V13, P609, DOI 10.1182/blood.V13.7.609.609; BOURONCLE BA, 1984, SEMIN ONCOL, V11, P479; CARBONE A, 1994, LEUKEMIA, V8, P2019; CATOVSKY D, 1994, LEUKEMIA LYMPHOMA, V14, P109; Cheson, 2000, J CLIN ONCOL, V18, P2351; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; CLARK EA, 1993, J IMMUNOL, V150, P4715; Conry RM, 1995, J IMMUNOTHER, V18, P231, DOI 10.1097/00002371-199511000-00004; CORDONE I, 1995, J CLIN PATHOL, V48, P955, DOI 10.1136/jcp.48.10.955; ELLISON DJ, 1994, BLOOD, V84, P4310, DOI 10.1182/blood.V84.12.4310.bloodjournal84124310; FILLEUL B, 1994, LEUKEMIA, V8, P1153; FLANDRIN G, 1984, SEMIN ONCOL, V11, P458; FRASSOLDATI A, 1994, LEUKEMIA LYMPHOMA, V13, P307, DOI 10.3109/10428199409056295; GOLOMB HM, 1986, J CLIN ONCOL, V4, P900, DOI 10.1200/JCO.1986.4.6.900; GREVER M, 1995, J CLIN ONCOL, V13, P974, DOI 10.1200/JCO.1995.13.4.974; HUANG D, 1992, BRIT J HAEMATOL, V81, P231, DOI 10.1111/j.1365-2141.1992.tb08212.x; Kreitman RJ, 1999, CURR OPIN IMMUNOL, V11, P570, DOI 10.1016/S0952-7915(99)00005-9; Kreitman RJ, 1999, INT J CANCER, V81, P148; Kreitman RJ, 2000, CLIN CANCER RES, V6, P1476; Kreitman RJ, 1999, BLOOD, V94, P3340, DOI 10.1182/blood.V94.10.3340.422k19_3340_3348; Kreitman RJ, 2000, J CLIN ONCOL, V18, P1622, DOI 10.1200/JCO.2000.18.8.1622; Kuan CT, 1995, CLIN CANCER RES, V1, P1589; Messmann RA, 2000, CLIN CANCER RES, V6, P1302; PIRO LD, 1990, NEW ENGL J MED, V322, P1117, DOI 10.1056/NEJM199004193221605; QUESADA JR, 1984, NEW ENGL J MED, V310, P15, DOI 10.1056/NEJM198401053100104; Rak K, 1998, BLOOD, V92, p282B; ROBBINS BA, 1993, BLOOD, V82, P1277; Robbins DH, 2000, CLIN CANCER RES, V6, P693; SAUSVILLE EA, 1995, BLOOD, V85, P3457, DOI 10.1182/blood.V85.12.3457.bloodjournal85123457; Saven A, 1998, BLOOD, V92, P1918, DOI 10.1182/blood.V92.6.1918; SCHWAGER I, 1994, BLOOD, V83, P152, DOI 10.1182/blood.V83.1.152.bloodjournal831152; SEYMOUR JF, 1994, BLOOD, V83, P2906, DOI 10.1182/blood.V83.10.2906.2906; Seymour JF, 1997, LEUKEMIA, V11, P42, DOI 10.1038/sj.leu.2400513; SPIERS ASD, 1987, NEW ENGL J MED, V316, P825, DOI 10.1056/NEJM198704023161401; Stone MJ, 1996, BLOOD, V88, P1188, DOI 10.1182/blood.V88.4.1188.bloodjournal8841188; Tallman MS, 1999, SEMIN HEMATOL, V36, P155; Tallman MS, 1999, CLIN CANCER RES, V5, P1665; Tetreault S, 1998, BLOOD, V92, p283B; VITETTA ES, 1991, CANCER RES, V51, P4052; Wheaton S, 1996, BLOOD, V87, P1556, DOI 10.1182/blood.V87.4.1556.bloodjournal8741556	44	423	476	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2001	345	4					241	247		10.1056/NEJM200107263450402	http://dx.doi.org/10.1056/NEJM200107263450402			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455XZ	11474661				2022-12-28	WOS:000170054200002
J	Tewksbury, JJ; Nabhan, GP				Tewksbury, JJ; Nabhan, GP			Seed dispersal - Directed deterrence by capsaicin in chillies	NATURE			English	Article							FRUIT; PAIN		Univ Montana, Dept Biol Sci, Missoula, MT 59812 USA; No Arizona Univ, Ctr Sustainable Environm, Flagstaff, AZ 86011 USA	University of Montana System; University of Montana; Northern Arizona University	Tewksbury, JJ (corresponding author), Univ Florida, Dept Zool, Box 118525, Gainesville, FL 32611 USA.			Tewksbury, Joshua/0000-0002-9786-1477				Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cipollini ML, 1997, AM NAT, V150, P346, DOI 10.1086/286069; CORDELL GA, 1993, ANN PHARMACOTHER, V27, P330, DOI 10.1177/106002809302700316; GOVINDARAJAN VS, 1991, CRIT REV FOOD SCI, V29, P435, DOI 10.1080/10408399109527536; HERRERA CM, 1982, AM NAT, V120, P218, DOI 10.1086/283984; JANSEN DH, 1969, EVOLUTION, V23, P1; MASON JR, 1991, J CHEM ECOL, V17, P2539, DOI 10.1007/BF00994601; McKey D., 1975, COEVOLUTION ANIMALS, P158; NORMAN DM, 1992, WILSON BULL, V104, P549; SNOW DW, 1971, IBIS, V113, P194, DOI 10.1111/j.1474-919X.1971.tb05144.x; Tewksbury JJ, 1999, CONSERV BIOL, V13, P98, DOI 10.1046/j.1523-1739.1999.97399.x	11	200	211	3	94	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					403	404		10.1038/35086653	http://dx.doi.org/10.1038/35086653			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473305				2022-12-28	WOS:000170068200035
J	Drummond, PD				Drummond, PD			Mechanism of complex regional pain syndrome: no longer excessive sympathetic outflow?	LANCET			English	Editorial Material							PERIAQUEDUCTAL GRAY; LOCUS-COERULEUS; DYSTROPHY; RESPONSES; RATS		Murdoch Univ, Sch Psychol, Murdoch, WA 6150, Australia	Murdoch University	Drummond, PD (corresponding author), Murdoch Univ, Sch Psychol, Murdoch, WA 6150, Australia.							Ali Z, 2000, PAIN, V88, P161, DOI 10.1016/S0304-3959(00)00327-4; ARNOLD JMO, 1993, ANN INTERN MED, V118, P619, DOI 10.7326/0003-4819-118-8-199304150-00008; Bajic D, 1999, J COMP NEUROL, V405, P359; BANDLER R, 1994, TRENDS NEUROSCI, V17, P379, DOI 10.1016/0166-2236(94)90047-7; Butler SH, 2000, PROG PAIN RES MANAG, V16, P657; HODGE CJ, 1983, BRAIN RES, V288, P325, DOI 10.1016/0006-8993(83)90111-7; JONES SL, 1991, PROG BRAIN RES, V88, P381; Ochoa JL, 1999, J NEUROL, V246, P875, DOI 10.1007/s004150050476; Perl ER, 1999, P NATL ACAD SCI USA, V96, P7664, DOI 10.1073/pnas.96.14.7664; Rommel O, 1999, PAIN, V80, P95, DOI 10.1016/S0304-3959(98)00202-4; SATO J, 1993, NEUROSCI LETT, V164, P225, DOI 10.1016/0304-3940(93)90897-T; TRACEY DJ, 1995, INFLAMM RES, V44, P407, DOI 10.1007/BF01757696; Wasner G, 2001, BRAIN, V124, P587, DOI 10.1093/brain/124.3.587; Zhang C, 1998, BRAIN RES, V784, P116, DOI 10.1016/S0006-8993(97)01197-9; Zhang YH, 1997, J PHYSIOL-LONDON, V503, P177, DOI 10.1111/j.1469-7793.1997.177bi.x	15	31	31	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 21	2001	358	9277					168	170		10.1016/S0140-6736(01)05400-9	http://dx.doi.org/10.1016/S0140-6736(01)05400-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454HL	11476829				2022-12-28	WOS:000169967100005
J	Tettelin, H; Nelson, KE; Paulsen, IT; Eisen, JA; Read, TD; Peterson, S; Heidelberg, J; DeBoy, RT; Haft, DH; Dodson, RJ; Durkin, AS; Gwinn, M; Kolonay, JF; Nelson, WC; Peterson, JD; Umayam, LA; White, O; Salzberg, SL; Lewis, MR; Radune, D; Holtzapple, E; Khouri, H; Wolf, AM; Utterback, TR; Hansen, CL; McDonald, LA; Feldblyum, TV; Angiuoli, S; Dickinson, T; Hickey, EK; Holt, IE; Loftus, BJ; Yang, F; Smith, HO; Venter, JC; Dougherty, BA; Morrison, DA; Hollingshead, SK; Fraser, CM				Tettelin, H; Nelson, KE; Paulsen, IT; Eisen, JA; Read, TD; Peterson, S; Heidelberg, J; DeBoy, RT; Haft, DH; Dodson, RJ; Durkin, AS; Gwinn, M; Kolonay, JF; Nelson, WC; Peterson, JD; Umayam, LA; White, O; Salzberg, SL; Lewis, MR; Radune, D; Holtzapple, E; Khouri, H; Wolf, AM; Utterback, TR; Hansen, CL; McDonald, LA; Feldblyum, TV; Angiuoli, S; Dickinson, T; Hickey, EK; Holt, IE; Loftus, BJ; Yang, F; Smith, HO; Venter, JC; Dougherty, BA; Morrison, DA; Hollingshead, SK; Fraser, CM			Complete genome sequence of a virulent isolate of Streptococcus pneumoniae	SCIENCE			English	Article							CAPSULAR POLYSACCHARIDE BIOSYNTHESIS; MICROBIAL GENE IDENTIFICATION; HAEMOPHILUS-INFLUENZAE; MARKOV-MODELS; TRANSFORMATION; ELEMENT; LIPOPROTEINS; COMPETENCE; CHROMOSOME; EXPRESSION	The 2,160,837-base pair genome sequence of an isolate of Streptococcus pneumoniae, a Cram-positive pathogen that causes pneumonia, bacteremia, meningitis, and otitis media, contains 2236 predicted coding regions; of these, 1440 (64%) were assigned a biological role. Approximately 5% of the genome is composed of insertion sequences that may contribute to genome rearrangements through uptake of foreign DNA. Extracellular enzyme systems for the metabolism of polysaccharides and hexosamines provide a substantial source of carbon and nitrogen for S. pneumoniae and also damage host tissues and facilitate colonization. A motif identified within the signal peptide of proteins is potentially involved in targeting these proteins to the cell surface of low-guanine/cytosine (GC) Gram-positive species. Several surface-exposed proteins that may serve as potential vaccine candidates were identified. Comparative genome hybridization with DNA arrays revealed strain differences in S. pneumoniae that could contribute to differences in virulence and antigenicity.	Inst Genome Res TIGR, Rockville, MD 20850 USA; Johns Hopkins Univ, Baltimore, MD 21218 USA; George Washington Univ, Med Ctr, Washington, DC 20037 USA; Bristol Myers Squibb Co, Pharmaceut Res Inst, Wallingford, CT 06492 USA; Univ Illinois, Chicago, IL 60607 USA; Univ Alabama, Birmingham, AL 35294 USA	J. Craig Venter Institute; Johns Hopkins University; George Washington University; Bristol-Myers Squibb; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Alabama System; University of Alabama Birmingham	Fraser, CM (corresponding author), Inst Genome Res TIGR, 9712 Med Ctr Dr, Rockville, MD 20850 USA.		Read, Timothy/E-6240-2011; Salzberg, Steven L/F-6162-2011; Paulsen, Ian T/K-3832-2012; Salzberg, Steven/Q-6514-2019; Nelson, William C/E-9263-2016; Angiuoli, Samuel V/H-7340-2014; Eisen, Jonathan A./H-2706-2019	Salzberg, Steven L/0000-0002-8859-7432; Paulsen, Ian T/0000-0001-9015-9418; Salzberg, Steven/0000-0002-8859-7432; Nelson, William C/0000-0002-1873-3929; Eisen, Jonathan A./0000-0002-0159-2197; Read, Timothy/0000-0001-8966-9680; Angiuoli, Samuel/0000-0001-9525-4350; Heidelberg, John/0000-0003-0673-3224; Fraser, Claire/0000-0003-1462-2428; loftus, brendan/0000-0001-8871-8356	NIAID NIH HHS [R01 AI40645-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040645] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AABERGE IS, 1995, MICROB PATHOGENESIS, V18, P141, DOI 10.1016/S0882-4010(95)90125-6; ALLOING G, 1994, J MOL BIOL, V241, P44, DOI 10.1006/jmbi.1994.1472; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; BANERJEI L, COMMUNICATION; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BENSON G, 1994, NUCLEIC ACIDS RES, V22, P4828, DOI 10.1093/nar/22.22.4828; Berry AM, 1996, INFECT IMMUN, V64, P5255, DOI 10.1128/IAI.64.12.5255-5262.1996; Bricker AL, 1999, FEMS MICROBIOL LETT, V172, P131, DOI 10.1016/S0378-1097(99)00027-0; CHANDLER M, 1993, MOL MICROBIOL, V7, P497, DOI 10.1111/j.1365-2958.1993.tb01140.x; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; DAVIES J, 1995, INFECT IMMUN, V63, P2485, DOI 10.1128/IAI.63.7.2485-2492.1995; de Saizieu A, 2000, J BACTERIOL, V182, P4696, DOI 10.1128/JB.182.17.4696-4703.2000; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DILLARD JP, 1995, J EXP MED, V181, P973, DOI 10.1084/jem.181.3.973; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Doern GV, 1999, EMERG INFECT DIS, V5, P757, DOI 10.3201/eid0506.990603; Dybvig K, 1998, P NATL ACAD SCI USA, V95, P13923, DOI 10.1073/pnas.95.23.13923; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Garcia E, 2000, RES MICROBIOL, V151, P429, DOI 10.1016/S0923-2508(00)00173-X; Garcia JL, 2000, STREPTOCOCCUS PNEUMO, P231; GASC AM, 1991, J BACTERIOL, V173, P7361, DOI 10.1128/jb.173.22.7361-7367.1991; Gill SI, COMMUNICATION; Greenwood B, 1999, PHILOS T R SOC B, V354, P777, DOI 10.1098/rstb.1999.0430; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; Hakenbeck R, 2001, INFECT IMMUN, V69, P2477, DOI 10.1128/IAI.69.4.2477-2486.2001; HAYASHI S, 1990, J BIOENERG BIOMEMBR, V22, P451, DOI 10.1007/BF00763177; Hegde P, 2000, BIOTECHNIQUES, V29, P548, DOI 10.2144/00293bi01; Hollingshead SK, 2001, CURR OPIN MICROBIOL, V4, P71, DOI 10.1016/S1369-5274(00)00167-3; HUMBERT O, 1995, P NATL ACAD SCI USA, V92, P9052, DOI 10.1073/pnas.92.20.9052; Jakubovics NS, 2000, MOL MICROBIOL, V38, P140, DOI 10.1046/j.1365-2958.2000.02122.x; Kim JO, 1999, INFECT IMMUN, V67, P2327, DOI 10.1128/IAI.67.5.2327-2333.1999; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; LUTCKE H, 1995, EUR J BIOCHEM, V228, P531, DOI 10.1111/j.1432-1033.1995.0531m.x; MARTIN B, 1992, NUCLEIC ACIDS RES, V20, P3479, DOI 10.1093/nar/20.13.3479; MUSHER DM, 1992, CLIN INFECT DIS, V14, P801, DOI 10.1093/clinids/14.4.801; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; Oggioni MR, 1999, MICROBIOL-SGM, V145, P2647, DOI 10.1099/00221287-145-10-2647; PACE NR, 1995, J BACTERIOL, V177, P1919, DOI 10.1128/jb.177.8.1919-1928.1995; Pallen MJ, 2001, TRENDS MICROBIOL, V9, P97, DOI 10.1016/S0966-842X(01)01956-4; Paulsen IT, 2000, J MOL BIOL, V301, P75, DOI 10.1006/jmbi.2000.3961; PEARCE BJ, 1994, MOL MICROBIOL, V12, P881, DOI 10.1111/j.1365-2958.1994.tb01076.x; Peterson S, 2000, J BACTERIOL, V182, P6192, DOI 10.1128/JB.182.21.6192-6202.2000; Quivey RG, 2000, ADV MICROB PHYSIOL, V42, P239, DOI 10.1016/S0065-2911(00)42004-7; RILEY M, 1993, MICROBIOL REV, V57, P862, DOI 10.1128/MMBR.57.4.862-952.1993; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Santagati M, 2000, ANTIMICROB AGENTS CH, V44, P2585, DOI 10.1128/AAC.44.9.2585-2587.2000; Saunders NJ, 2000, MOL MICROBIOL, V37, P207, DOI 10.1046/j.1365-2958.2000.02000.x; SMITH MD, 1979, J BACTERIOL, V137, P735, DOI 10.1128/JB.137.2.735-739.1979; Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]; Tettelin H, 1999, GENOMICS, V62, P500, DOI 10.1006/geno.1999.6048; TOMASZ A, 1995, NEW ENGL J MED, V333, P514, DOI 10.1056/NEJM199508243330810; VIDGREN G, 1992, J BACTERIOL, V174, P7419, DOI 10.1128/jb.174.22.7419-7427.1992; WEISER JN, 2000, STREPTOCOCCUS PNEUMO, P245; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001; WOOD WB, 1949, J EXP MED, V90	60	1060	1662	2	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2001	293	5529					498	506		10.1126/science.1061217	http://dx.doi.org/10.1126/science.1061217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463916				2022-12-28	WOS:000169966700049
J	Pocock, SJ; McCormack, V; Gueyffier, F; Boutitie, F; Fagard, RH; Boissel, JP				Pocock, SJ; McCormack, V; Gueyffier, F; Boutitie, F; Fagard, RH; Boissel, JP		INDANA Project Steering Comm	A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							STROKE; MEN; METAANALYSIS; HYPERTENSION; STRATEGY	Objective To create a risk score for death hum cardiovascular disease that can be easily used. Design Data from eight randomised controlled trials of antihypertensive treatment. Setting Europe and North America. Participants 47 088 men and women from trials that had differing age ranges and differing eligibility criteria for blood pressure. Main outcome measure 1639 deaths from cardiovascular causes during a mean 5.2 years of follow up. Results Baseline factors were related to risk of death from cardiovascular disease using a multivariate Cox model, adjusting for trial and treatment group (active versus control). A risk score was del eloped from ii factors: age, sex, systolic blood pressure, serum total cholesterol concentration, height serum creatinine concentration, cigarette smoking, diabetes, left ventricular hypertrophy, history of stroke, and history of myocardial infarction. The risk score is an integer, with points added fur each factor according to its association with risk. Smoking contributed more in women and in younger age groups. In women total cholesterol concentration mattered less than in men, whereas diabetes had more of an effect. Antihypertensive treatment reduced the score. The five year risk of death front cardiovascular disease for scores of 10, 20, 30, 40, 50, and 60 was 0.1%. 0.3%, 0.8'%,, 2.3%, 6.1%, and 15.6%, respectively. Age and sex distributions of the score from the two UK trials enabled individual risk assessment to be age and sex specific. Risk prediction models are also presented for fatal coronary heart disease, fatal stroke, and all cause mortality. Conclusion The risk score is an objective aid tu assessing an individual's risk of cardiovascular disease, including stroke and coronary heart disease. It is useful for physicians when determining an individual's need for antihypertensive treatment and other management strategies tur cardiovascular risk.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; Fac RTH Laennec, Serv Pharmacol Clin, F-69376 Lyon 08, France; Univ Louvain, UZ Gasthuisberg, Hypertens & Cardiovasc Rehabil Unit, B-3000 Louvain, Belgium	University of London; London School of Hygiene & Tropical Medicine; KU Leuven; University Hospital Leuven	Pocock, SJ (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	stuart.pocock@lsthm.ac.uk	Gueyffier, François/B-8545-2008	Gueyffier, François/0000-0002-9921-0977; McCormack, Valerie/0000-0001-7397-3442				AMERY A, 1985, LANCET, V1, P1349; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; [Anonymous], 1991, JAMA, V265, P3255; Chalmers J, 1999, J HYPERTENS, V17, P151; COOPE J, 1986, BRIT MED J, V293, P1145, DOI 10.1136/bmj.293.6555.1145; COPPOLA WGT, 1995, BRIT J GEN PRACT, V45, P185; Cullen P, 1998, EUR HEART J, V19, pO13; D'Agostino RB, 2000, AM HEART J, V139, P272, DOI 10.1016/S0002-8703(00)90236-9; DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; Gueyffier F, 1997, ANN INTERN MED, V126, P761, DOI 10.7326/0003-4819-126-10-199705150-00002; GUEYFFIER F, 1995, THERAPIE, V50, P353; *HYP DET FOLL UP P, 1979, JAMA-J AM MED ASSOC, V242, P2562; KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035; Kannel WB, 1999, AM HEART J, V138, pS205, DOI 10.1016/S0002-8703(99)70311-X; KJELSBERG MO, 1982, JAMA-J AM MED ASSOC, V248, P1465; Menotti A, 1996, J Cardiovasc Risk, V3, P69, DOI 10.1097/00043798-199602000-00010; Montgomery AA, 2000, BRIT J GEN PRACT, V50, P127; *POOL PROJ RES GRO, 1978, J CHRON DIS, V31, P201, DOI DOI 10.1016/0021-9681(78)90073-5; SHAPER AG, 1986, BRIT MED J, V293, P474, DOI 10.1136/bmj.293.6545.474; SHAPER AG, 1991, BRIT MED J, V302, P1111, DOI 10.1136/bmj.302.6785.1111; TUNSTALLPEDOE H, 1991, BRIT MED J, V303, P744, DOI 10.1136/bmj.303.6805.744; Wannamethee SG, 1997, STROKE, V28, P557, DOI 10.1161/01.STR.28.3.557; Wannamethee SG, 1998, AM J EPIDEMIOL, V148, P1069; World Health Organization, 1998, WORLD HLTH STAT ANN	25	192	203	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2001	323	7304					75	81		10.1136/bmj.323.7304.75	http://dx.doi.org/10.1136/bmj.323.7304.75			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454GD	11451781	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000169964100015
J	Stuiver, MH; Custers, JHHV				Stuiver, MH; Custers, JHHV			Engineering disease resistance in plants	NATURE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; SALICYLIC-ACID; HYPERSENSITIVE RESPONSE; TRANSGENIC TOBACCO; SIGNALING PATHWAYS; AVIRULENCE GENE; CELL-DEATH; ARABIDOPSIS; PATHOGENS; DEFENSE	Ever since the initial discovery of the molecules and genes involved in disease resistance in plants, attempts have been made to engineer durable disease resistance in economically important crop plants. Unfortunately, many of these attempts have failed, owing to the complexity of disease-resistance signalling and the sheer diversity of infection mechanisms that different pathogens use. Although disease-resistant transgenic plants or seeds are not yet available commercially, future product development seems likely as our current level of understanding of pathogenesis and plant defence improves.	Syngenta MOGEN, NL-2333 CB Leiden, Netherlands	Syngenta	Stuiver, MH (corresponding author), Syngenta MOGEN, Einsteinweg 97, NL-2333 CB Leiden, Netherlands.							Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; ALEXANDER D, 1993, P NATL ACAD SCI USA, V90, P7327, DOI 10.1073/pnas.90.15.7327; BIDNEY DL, 1999, Patent No. 9904012; Bonnet P, 1996, EUR J PLANT PATHOL, V102, P181, DOI 10.1007/BF01877105; BOWLING SA, 1994, PLANT CELL, V6, P1845, DOI 10.1105/tpc.6.12.1845; Cao H, 1998, P NATL ACAD SCI USA, V95, P6531, DOI 10.1073/pnas.95.11.6531; Cessna SG, 2000, PLANT CELL, V12, P2191, DOI 10.1105/tpc.12.11.2191; Costet L, 1999, MOL PLANT MICROBE IN, V12, P655, DOI 10.1094/MPMI.1999.12.8.655; Daub ME, 2000, ANNU REV PHYTOPATHOL, V38, P461, DOI 10.1146/annurev.phyto.38.1.461; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; DEWIT PJGM, 1992, ANNU REV PHYTOPATHOL, V30, P391, DOI 10.1146/annurev.py.30.090192.002135; DICKMAN MB, 2000, Patent No. 0026391; DOARES SH, 1995, PLANT PHYSIOL, V108, P1741, DOI 10.1104/pp.108.4.1741; Dorey S, 1997, MOL PLANT MICROBE IN, V10, P646, DOI 10.1094/MPMI.1997.10.5.646; Feys BJ, 2000, TRENDS GENET, V16, P449, DOI 10.1016/S0168-9525(00)02107-7; Frye CA, 2001, P NATL ACAD SCI USA, V98, P373, DOI 10.1073/pnas.011405198; Gassmann W, 2000, J BACTERIOL, V182, P7053, DOI 10.1128/JB.182.24.7053-7059.2000; Gilchrist D, 2000, BIOLOGY OF PLANT-MICROBE INTERACTIONS, VOL 2, P406; Gorlach J, 1996, PLANT CELL, V8, P629, DOI 10.1105/tpc.8.4.629; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Grant JJ, 2000, PLANT J, V24, P569, DOI 10.1046/j.1365-313x.2000.00902.x; HAIN R, 1993, NATURE, V361, P153, DOI 10.1038/361153a0; HARTMAN CL, Patent No. 9214824; He XZ, 2000, PLANT CELL, V12, P1689, DOI 10.1105/tpc.12.9.1689; Heath MC, 2000, CURR OPIN PLANT BIOL, V3, P315, DOI 10.1016/S1369-5266(00)00087-X; Hipskind JD, 2000, MOL PLANT MICROBE IN, V13, P551, DOI 10.1094/MPMI.2000.13.5.551; Hoffman T, 1999, PLANT PHYSIOL, V119, P935, DOI 10.1104/pp.119.3.935; Jarosch B, 1999, MOL PLANT MICROBE IN, V12, P508, DOI 10.1094/MPMI.1999.12.6.508; JOHAL GS, 1992, SCIENCE, V258, P985, DOI 10.1126/science.1359642; JOOSTEN MHAJ, 1994, NATURE, V367, P384, DOI 10.1038/367384a0; Kamoun S, 1998, PLANT CELL, V10, P1413, DOI 10.1105/tpc.10.9.1413; Keller H, 1999, PLANT CELL, V11, P223, DOI 10.1105/tpc.11.2.223; Kesarwani M, 2000, J BIOL CHEM, V275, P7230, DOI 10.1074/jbc.275.10.7230; Lauge R, 1998, P NATL ACAD SCI USA, V95, P9014, DOI 10.1073/pnas.95.15.9014; LESLIE CA, 1988, PLANT PHYSIOL, V88, P833, DOI 10.1104/pp.88.3.833; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Melchers LS, 2000, CURR OPIN PLANT BIOL, V3, P147, DOI 10.1016/S1369-5266(99)00055-2; Morel JB, 1997, CELL DEATH DIFFER, V4, P671, DOI 10.1038/sj.cdd.4400309; Parker JE, 1996, PLANT CELL, V8, P2033, DOI 10.1105/tpc.8.11.2033; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Pieterse CMJ, 1999, TRENDS PLANT SCI, V4, P52, DOI 10.1016/S1360-1385(98)01364-8; Pieterse CMJ, 1998, PLANT CELL, V10, P1571, DOI 10.1105/tpc.10.9.1571; Pink D, 1999, TRENDS PLANT SCI, V4, P71, DOI 10.1016/S1360-1385(98)01372-7; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Punja ZK, 1996, PLANT DIS, V80, P999, DOI 10.1094/PD-80-0999; Rommens CM, 2000, CURR OPIN BIOTECH, V11, P120, DOI 10.1016/S0958-1669(00)00083-5; Schaefer Wilhelm, 1993, Trends in Microbiology, V1, P69, DOI 10.1016/0966-842X(93)90037-R; STINTZI A, 1993, BIOCHIMIE, V75, P687, DOI 10.1016/0300-9084(93)90100-7; Tanaka A, 1999, MOL PLANT MICROBE IN, V12, P691, DOI 10.1094/MPMI.1999.12.8.691; Thomma BPHJ, 2001, CURR OPIN IMMUNOL, V13, P63, DOI 10.1016/S0952-7915(00)00183-7; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; Walton JD, 1996, PLANT CELL, V8, P1723, DOI 10.1105/tpc.8.10.1723; White FF, 2000, CURR OPIN PLANT BIOL, V3, P291, DOI 10.1016/S1369-5266(00)00082-0	54	96	110	4	36	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					865	868		10.1038/35081200	http://dx.doi.org/10.1038/35081200			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459071	Green Accepted			2022-12-28	WOS:000169246400065
J	Wiltshire, S; Bancroft, A; Amos, A; Parry, O				Wiltshire, S; Bancroft, A; Amos, A; Parry, O			"They're doing people a service" - qualitative study of smoking, smuggling, and social deprivation	BRITISH MEDICAL JOURNAL			English	Article							CIGARETTE	Objectives To examine the behaviour and attitudes related to smoking and contraband tobacco products among smokers in two socially deprived areas. Design Cross sectional study with qualitative semistructured interviews, augmented by smokers' day grid. Setting Two areas of socioeconomic deprivation in Edinburgh. Participants 50 male and 50 female smokers aged 25-40 years randomly selected from general practitioners' lists from two health centres, each located in an area of deprivation. Results Most smokers wanted to quit but felt unable to because of the importance of smoking in their daily routine and their addiction to nicotine. Strategies for maintaining consumption levels in the face of increasing cigarette prices and low income included purchasing contraband cigarettes and tobacco. Vendors were contacted through social networks, family, and friends as well as common knowledge of people and places, particularly pubs where contraband was available. Most users of contraband considered that smugglers were providing a valuable service. Purchasing contraband tobacco was viewed as rational in the face of material hardship. Many smokers criticised the government for its high tobacco taxation and the lack of local services to help them to stop smoking. Conclusions Smokers in deprived areas perceive a lack of support to help them to stop smoking. Cigarette and tobacco smuggling is therefore viewed positively by low income smokers as a way of dealing with the increasing cost of cigarettes. Smokers in areas of deprivation may thus show little support for tackling smuggling until more action is taken to deal with the material and personal factors that make it difficult for them to quit.	Univ Edinburgh, Sch Med, Dept Community Hlth Sci, Res Unit Hlth Behav & Change, Edinburgh EH8 9AG, Midlothian, Scotland	University of Edinburgh	Amos, A (corresponding author), Univ Edinburgh, Sch Med, Dept Community Hlth Sci, Res Unit Hlth Behav & Change, Edinburgh EH8 9AG, Midlothian, Scotland.							BRIDGWOOD A, 2000, LIVING BRITAIN 1998; CARSTAIRS V R M, 1990, Health Bulletin (Edinburgh), V48, P162; CROSIER A, 2001, RAPID MAPPING STUDY; DORSET R, 1998, HLTH TRAP POV SMOK L; GAUNTRICHARDSON P, 1999, WOMEN LOW INCOME SMO; Graham H, 1999, HEALTH PROMOT INT, V14, P231, DOI 10.1093/heapro/14.3.231; Graham H, 1999, EUR J PUBLIC HEALTH, V9, P137, DOI 10.1093/eurpub/9.2.137; Jha P, 2000, BRIT MED J, V321, P358, DOI 10.1136/bmj.321.7257.358; Joossens L, 2000, BRIT MED J, V321, P947, DOI 10.1136/bmj.321.7266.947; Joossens L, 1998, TOB CONTROL, V7, P66, DOI 10.1136/tc.7.1.66; Joossens L, 1999, SMUGGLING CROSS BORD; Parry O., 1999, SOCIOLOGICAL RES ONL, V4; ROWELL A, 2000, TOBACCO SMUGGLING UK; *SECR STAT HLTH, 1999, SMOK KILLS; *SECR STAT HLTH, 1999, SAV LIV OUR HLTH NAT; *SECR STAT SCOTL, 1999, TOW HLTH SCOTL	16	82	82	0	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2001	323	7306					203	207		10.1136/bmj.323.7306.203	http://dx.doi.org/10.1136/bmj.323.7306.203			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459UQ	11473911	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000170270200018
J	Cohen, JE; Gurtler, RE				Cohen, JE; Gurtler, RE			Modeling household transmission of American trypanosomiasis	SCIENCE			English	Article							NORTH-WEST ARGENTINA; TRIATOMA-INFESTANS HEMIPTERA; CHAGAS-DISEASE TRANSMISSION; CRUZI; PREVALENCE; INFECTION; VECTOR; SEROPOSITIVITY; POPULATIONS; REDUVIIDAE	American trypanosomiasis, or Chagas disease, caused by the protozoan parasite Trypanosoma cruzi and transmitted by blood-feeding triatomine bugs, is a chronic, frequently fatal infection that is common in Latin America. Neither adequate drugs nor a vaccine is available. A mathematical model calibrated to detailed household data from three villages in northwest Argentina shows that householders could greatly reduce the risk of human infection by excluding domestic animals, especially infected dogs, from bedrooms; removing potential refuges for bugs from waits and ceilings; and using domestically applied insecticides. Low-cost, locally practicable environmental management combined with intermittent use of insecticides can sustainably control transmission of T. cruzi to humans in rural Argentina and probably elsewhere.	Rockefeller Univ, Lab Populat, New York, NY 10021 USA; Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Ecol Gen, Buenos Aires, DF, Argentina	Rockefeller University; University of Buenos Aires	Cohen, JE (corresponding author), Rockefeller Univ, Lab Populat, 1230 York Ave,Box 20, New York, NY 10021 USA.	cohen@rockefeller.edu						AULT SK, 1994, AM J TROP MED HYG, V50, P35, DOI 10.4269/ajtmh.1994.50.35; BUSENBERG SN, 1991, LECT NOTES PURE APPL, V131, P283; CANALS M, 1992, REV MED CHILE, V120, P1359; Castanera M. B., 1999, THESIS U BUENOS AIRE; CATALA S, 1991, MED VET ENTOMOL, V5, P325, DOI 10.1111/j.1365-2915.1991.tb00558.x; Cecere MC, 1997, MED VET ENTOMOL, V11, P383, DOI 10.1111/j.1365-2915.1997.tb00426.x; Cecere MC, 1998, B WORLD HEALTH ORGAN, V76, P373; da Silva G R, 1969, Rev Saude Publica, V3, P23, DOI 10.1590/S0034-89101969000100004; GIOJALAS LC, 1990, T ROY SOC TROP MED H, V84, P439, DOI 10.1016/0035-9203(90)90355-I; Gurtler RE, 1996, J MED ENTOMOL, V33, P15, DOI 10.1093/jmedent/33.1.15; GURTLER RE, 1993, T ROY SOC TROP MED H, V87, P12, DOI 10.1016/0035-9203(93)90400-K; Gurtler RE, 1998, AM J TROP MED HYG, V59, P741; Gurtler RE, 1997, J APPL ECOL, V34, P699, DOI 10.2307/2404917; GURTLER RE, 1991, T ROY SOC TROP MED H, V85, P741, DOI 10.1016/0035-9203(91)90440-A; Gurtler RE, 1998, AM J TROP MED HYG, V58, P748, DOI 10.4269/ajtmh.1998.58.748; HEWITT S, 1994, MED VET ENTOMOL, V8, P160, DOI 10.1111/j.1365-2915.1994.tb00156.x; Himschoot P. H, 1993, THESIS U BUENOS AIRE; KITRON U, 1989, REV INFECT DIS, V11, P391; LEHANE MJ, 1992, ACTA TROP, V52, P27, DOI 10.1016/0001-706X(92)90004-H; MINTER DM, 1976, PAN AM HLTH ORG SCI, V318, P330; Moncayo Alvaro, 1997, World Health Statistics Quarterly, V50, P195; RABINOVICH JE, 1990, B WORLD HEALTH ORGAN, V68, P737; RABINOVICH JE, 1990, ECOL MODEL, V52, P249, DOI 10.1016/0304-3800(90)90019-D; RABINOVICH JE, 1987, CHAGAS DIS VECTORS, V1, P119; Schmunis GA, 1996, LANCET, V348, P1171, DOI 10.1016/S0140-6736(05)65305-6; Schofield C. J., 1990, Appropriate technology in vector control., P187; Segura EL, 2000, AM J TROP MED HYG, V62, P353, DOI 10.4269/ajtmh.2000.62.353; SERVICE MW, 1991, REV SAUDE PUBL, V25, P165, DOI 10.1590/S0034-89101991000300002; VELASCOHERNANDEZ JX, 1994, THEOR POPUL BIOL, V46, P1, DOI 10.1006/tpbi.1994.1017; *WHO, 1999, SPEC PROGR RES TRAIN	30	188	195	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					694	698		10.1126/science.1060638	http://dx.doi.org/10.1126/science.1060638			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474111	Green Submitted			2022-12-28	WOS:000170204600054
J	Kabarowski, JHS; Zhu, K; Le, LQ; Witte, ON; Xu, Y				Kabarowski, JHS; Zhu, K; Le, LQ; Witte, ON; Xu, Y			RETRACTED: Lysophosphatidylcholine as a ligand for the immunoregutatory receptor G2A (Retracted article. See vol 307, pg 206, 2005)	SCIENCE			English	Article; Retracted Publication							PROTEIN-COUPLED RECEPTORS; ENDOTHELIAL-CELLS; CULTURED HUMAN; IDENTIFICATION; ACTIVATION; LIPOPROTEINS; CYTOKINES; COMPONENT; ARTERIAL	Although the biological actions of the cell membrane and serum lipid lysophosphatidylcholine (LPC) in atherosclerosis and systemic autoimmune disease are well recognized, LPC has not been linked to a specific cell-surface receptor. We show that LPC is a high-affinity ligand for G2A, a lymphocyte-expressed G protein-coupled receptor whose genetic ablation results in the development of autoimmunity. Activation of G2A by LPC increased intracellular calcium concentration, induced receptor internalization, activated ERK mitogen-activated protein kinase, and modified migratory responses of Jurkat T lymphocytes. This finding implicates a role for LPC-G2A interaction in the etiology of inflammatory autoimmune disease and atherosclerosis.	Lerner Res Inst, Dept Microbiol Immunol & Mol Genet, Cleveland, OH 44195 USA; Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Cleveland Clin Fdn, Dept Gynecol & Obstet, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Cleveland Clinic Foundation	Witte, ON (corresponding author), Lerner Res Inst, Dept Microbiol Immunol & Mol Genet, 9500 Euclid Ave, Cleveland, OH 44195 USA.	owenw@microblo.ucia.edu; xuy@ccf.org			NATIONAL CANCER INSTITUTE [R21CA084038, R01CA076204, T32CA009056] Funding Source: NIH RePORTER; NCI NIH HHS [CA76204, 1 R21 CA84038-01, T32 CA09056] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amberger A, 1997, CELL STRESS CHAPERON, V2, P94, DOI 10.1379/1466-1268(1997)002<0094:CEOIVE>2.3.CO;2; BAUDHUIN LM, UNPUB; Choi JW, 1996, CELL IMMUNOL, V168, P78, DOI 10.1006/cimm.1996.0051; Fang XJ, 1997, J BIOL CHEM, V272, P13683, DOI 10.1074/jbc.272.21.13683; HEIBER M, 1995, DNA CELL BIOL, V14, P25, DOI 10.1089/dna.1995.14.25; Huang YH, 1999, CLIN EXP IMMUNOL, V116, P326; Im DS, 2001, J CELL BIOL, V153, P429, DOI 10.1083/jcb.153.2.429; Jing Q, 2000, CIRC RES, V87, P52, DOI 10.1161/01.RES.87.1.52; Kabarowski JHS, 2000, P NATL ACAD SCI USA, V97, P12109, DOI 10.1073/pnas.97.22.12109; Koh JS, 2000, J IMMUNOL, V165, P4190, DOI 10.4049/jimmunol.165.8.4190; KUME N, 1992, J CLIN INVEST, V90, P1138, DOI 10.1172/JCI115932; KUME N, 1994, J CLIN INVEST, V93, P907, DOI 10.1172/JCI117047; Le LQ, 2001, IMMUNITY, V14, P561, DOI 10.1016/S1074-7613(01)00145-5; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MCMURRAY HF, 1993, J CLIN INVEST, V92, P1004, DOI 10.1172/JCI116605; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; Okita M, 1997, INT J CANCER, V71, P31, DOI 10.1002/(SICI)1097-0215(19970328)71:1<31::AID-IJC7>3.0.CO;2-4; SPIEGEL S, 1995, J MEMBRANE BIOL, V146, P225; Weng ZG, 1998, P NATL ACAD SCI USA, V95, P12334, DOI 10.1073/pnas.95.21.12334; Xu Y, 2000, NAT CELL BIOL, V2, P261, DOI 10.1038/35010529; YAMAMOTO N, 1991, J IMMUNOL, V147, P273	21	264	274	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2001	293	5530					702	705		10.1126/science.1061781	http://dx.doi.org/10.1126/science.1061781			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474113				2022-12-28	WOS:000170204600056
J	Olive, DL; Pritts, EA				Olive, DL; Pritts, EA			Drug therapy: Treatment of endometriosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							IN-VITRO FERTILIZATION; HORMONE REPLACEMENT THERAPY; RANDOMIZED CONTROLLED-TRIAL; DEPOT LEUPROLIDE ACETATE; MILD ENDOMETRIOSIS; PELVIC PAIN; PRESACRAL NEURECTOMY; SYMPTOMATIC ENDOMETRIOSIS; MEDICAL-TREATMENT; DOUBLE-BLIND		Univ Texas, SW Med Sch, Dept Obstet & Gynecol, Dallas, TX 75230 USA; Univ Calif San Francisco, Sch Med, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco	Olive, DL (corresponding author), 50 S San Mateo Dr,Suite 370, San Mateo, CA 94401 USA.	lapskyboy@aol.com						ADAMSON GD, 1994, INT J FERTIL MENOP S, V39, P215; *AM FERT SOC, 1985, FERTIL STERIL, V43, P351; Arici A, 1996, FERTIL STERIL, V65, P603, DOI 10.1016/S0015-0282(16)58162-X; Balasch J, 1997, HUM REPROD, V12, P2046, DOI 10.1093/humrep/12.9.2046; BARBIERI RL, 1977, FERTIL STERIL, V28, P809; BATEMAN BG, 1994, FERTIL STERIL, V62, P690; BAYER SR, 1988, J REPROD MED, V33, P179; Burns WN, 1999, CLIN OBSTET GYNECOL, V42, P586, DOI 10.1097/00003081-199909000-00014; Busacca M, 1998, HUM REPROD, V13, P2271, DOI 10.1093/humrep/13.8.2271; BUTTRAM VC, 1982, FERTIL STERIL, V37, P478; CANDIANI GB, 1992, AM J OBSTET GYNECOL, V167, P100, DOI 10.1016/S0002-9378(11)91636-6; Canis M, 1997, FERTIL STERIL, V67, P817; Catalano G F, 1996, J Am Assoc Gynecol Laparosc, V3, P267, DOI 10.1016/S1074-3804(96)80011-9; Chang S P, 1996, Zhonghua Yi Xue Za Zhi (Taipei), V57, P431; CHILLIK CF, 1985, FERTIL STERIL, V44, P56; CIRKEL U, 1995, EUR J OBSTET GYN R B, V59, P61, DOI 10.1016/0028-2243(94)02016-8; CORNILLIE FJ, 1986, INT J GYNECOL PATHOL, V5, P95, DOI 10.1097/00004347-198605020-00001; COUTINHO EM, 1984, MED MANAGEMENT ENDOM, P249; Crosignani PG, 1996, FERTIL STERIL, V66, P706, DOI 10.1016/S0015-0282(16)58622-1; CROSIGNANI PG, 1992, CLIN THER, V14, P29; DAWOOD MY, 1995, FERTIL STERIL, V63, P1177, DOI 10.1016/S0015-0282(16)57593-1; DEATON JL, 1990, FERTIL STERIL, V54, P1083; DELANCEY JOL, 1992, TELINDES OPERATIVE G, P33; DICKER D, 1992, FERTIL STERIL, V57, P597; DLUGI AM, 1990, FERTIL STERIL, V54, P419; DMOWSKI WP, 1995, FERTIL STERIL, V63, P555, DOI 10.1016/S0015-0282(16)57425-1; DMOWSKI WP, 1989, FERTIL STERIL, V51, P395; DMOWSKI WP, 1995, ENDOMETRIOSIS ADV MA, P229; Dokras A, 1999, CLIN OBSTET GYNECOL, V42, P687, DOI 10.1097/00003081-199909000-00020; DOSWELL L, 1992, FERTIL STERIL, V57, P514; EDMONDS DK, 1994, BRIT J OBSTET GYNAEC, V101, P24, DOI 10.1111/j.1471-0528.1994.tb13681.x; FEDELE L, 1992, FERTIL STERIL, V58, P28; FEDELE L, 1989, FERTIL STERIL, V51, P781; FEDELE L, 1989, AM J OBSTET GYNECOL, V161, P871, DOI 10.1016/0002-9378(89)90739-4; FEDELE L, 1992, AM J OBSTET GYNECOL, V166, P1345, DOI 10.1016/0002-9378(92)91602-7; FLOYD WS, 1980, INT J FERTIL, V25, P75; FRASER IS, 1991, AUST NZ J OBSTET GYN, V31, P158, DOI 10.1111/j.1479-828X.1991.tb01807.x; GEBER S, 1995, HUM REPROD, V10, P1507, DOI 10.1093/HUMREP/10.6.1507; GOEBEL R, 1977, Acta Endocrinologica Supplementum, V212, P134; HENZL MR, 1988, NEW ENGL J MED, V318, P485, DOI 10.1056/NEJM198802253180805; Hornstein MD, 1998, OBSTET GYNECOL, V91, P16, DOI 10.1016/S0029-7844(97)00620-0; Hornstein MD, 1997, FERTIL STERIL, V68, P860, DOI 10.1016/S0015-0282(97)00360-9; HUGHES E, 2000, COCHRANE LIB, V1; HUGHES EG, 1992, FERTIL STERIL, V58, P888; HUGHES EG, 1993, FERTIL STERIL, V59, P963; INOUE M, 1992, AM J OBSTET GYNECOL, V167, P278, DOI 10.1016/S0002-9378(11)91675-5; KENNEDY SH, 1990, FERTIL STERIL, V53, P998; KIILHOLMA P, 1995, FERTIL STERIL, V64, P903, DOI 10.1016/S0015-0282(16)57900-X; Kodama H, 1996, FERTIL STERIL, V66, P974, DOI 10.1016/S0015-0282(16)58692-0; LEE RB, 1986, OBSTET GYNECOL, V68, P517; Makarainen L, 1996, FERTIL STERIL, V65, P29; Marcoux S, 1997, NEW ENGL J MED, V337, P217, DOI 10.1056/NEJM199707243370401; MATSON PL, 1986, FERTIL STERIL, V46, P432; MCGINLEY R, 1979, STEROIDS, V33, P127, DOI 10.1016/0039-128X(79)90021-7; MELEGA C, 1991, ANN NY ACAD SCI, V622, P256; Moghissi KS, 1999, CLIN OBSTET GYNECOL, V42, P620, DOI 10.1097/00003081-199909000-00016; Moghissi KS, 1998, FERTIL STERIL, V69, P1056, DOI 10.1016/S0015-0282(98)00086-7; NAMNOUM AB, 1995, FERTIL STERIL, V64, P898, DOI 10.1016/S0015-0282(16)57899-6; NOBLE AD, 1979, POSTGRAD MED J, V55, P37; OCHNINGER S, 1988, J IN VITRO FERTIL EM, V5, P249; OLIVE DL, 1986, FERTIL STERIL, V45, P157; OLIVE DL, 1986, AM J OBSTET GYNECOL, V154, P613, DOI 10.1016/0002-9378(86)90611-3; OLIVE DL, 1996, ENDOSCOPIC MANAGEMEN, P403; OLIVE DL, 1989, ENDOMETRIOSIS CONT C, P189; OLIVENNES F, 1995, FERTIL STERIL, V64, P392, DOI 10.1016/S0015-0282(16)57740-1; Oral E, 1997, OBSTET GYN CLIN N AM, V24, P219, DOI 10.1016/S0889-8545(05)70301-6; Pagidas K, 1996, FERTIL STERIL, V65, P791, DOI 10.1016/S0015-0282(16)58215-6; Parazzini F, 1999, HUM REPROD, V14, P1332; PARAZZINI F, 1994, AM J OBSTET GYNECOL, V171, P1205, DOI 10.1016/0002-9378(94)90133-3; PEREZ JJ, 1990, J REPROD MED, V35, P625; PRENTICE A, 1999, COCHRANE LIB, V3; ROBYN C, 1984, MED MANAGEMENT ENDOM, P207; ROCK JA, 1991, FERTIL STERIL, V56, pS49; ROLLAND R, 1990, AM J OBSTET GYNECOL, V162, P586, DOI 10.1016/0002-9378(90)90437-C; Sharp HT, 1998, CHRONIC PELVIC PAIN, P153; SHAW RW, 1992, FERTIL STERIL, V58, P265; SURREY ES, 1995, FERTIL STERIL, V63, P747, DOI 10.1016/S0015-0282(16)57476-7; SURREY ES, 1992, J CLIN ENDOCR METAB, V75, P558, DOI 10.1210/jc.75.2.558; Sutton CJG, 1997, FERTIL STERIL, V68, P1070, DOI 10.1016/S0015-0282(97)00403-2; SUTTON CJG, 1994, FERTIL STERIL, V62, P696; Taskin O, 1997, FERTIL STERIL, V67, P40, DOI 10.1016/S0015-0282(97)81853-5; Telimaa S, 1987, Gynecol Endocrinol, V1, P363, DOI 10.3109/09513598709082709; TELIMAA S, 1988, FERTIL STERIL, V50, P872; Telimaa S, 1987, Gynecol Endocrinol, V1, P13, DOI 10.3109/09513598709082692; THOMAS EJ, 1987, BRIT MED J, V294, P1117, DOI 10.1136/bmj.294.6580.1117; TJADEN B, 1990, OBSTET GYNECOL, V76, P89; Tulandi T, 1998, FERTIL STERIL, V69, P229, DOI 10.1016/S0015-0282(97)00469-X; Tummon IS, 1997, FERTIL STERIL, V68, P8, DOI 10.1016/S0015-0282(97)81467-7; VERCELLINI P, 1994, FERTIL STERIL, V62, P1136; VERCELLINI P, 1993, FERTIL STERIL, V60, P75; WHEELER JM, 1992, AM J OBSTET GYNECOL, V167, P1367, DOI 10.1016/S0002-9378(11)91718-9; WILSON ML, 2000, COCHRANE LIB, V1; Wingfield M, 1996, AUST NZ J OBSTET GYN, V36, P55; Zeitoun KM, 1999, FERTIL STERIL, V72, P961, DOI 10.1016/S0015-0282(99)00393-3	94	245	268	2	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2001	345	4					266	275		10.1056/NEJM200107263450407	http://dx.doi.org/10.1056/NEJM200107263450407			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455XZ	11474666				2022-12-28	WOS:000170054200007
J	Mair, A; Vaziri, A; Weihs, G; Zeilinger, A				Mair, A; Vaziri, A; Weihs, G; Zeilinger, A			Entanglement of the orbital angular momentum states of photons	NATURE			English	Article							HORNE-ZEILINGER ENTANGLEMENT; PARAMETRIC DOWN-CONVERSION; PARTICLES; LIGHT; SYSTEMS; MODES; BEAM	Entangled quantum states are not separable, regardless of the spatial separation of their components. This is a manifestation of an aspect of quantum mechanics known as quantum nonlocality(1,2). An important consequence of this is that the measurement of the state of one particle in a two-particle entangled state defines the state of the second particle instantaneously, whereas neither particle possesses its own well-defined state before the measurement. Experimental realizations of entanglement have hitherto been restricted to two-state quantum systems(3-6), involving, for example, the two orthogonal polarization states of photons. Here we demonstrate entanglement involving the spatial modes of the electromagnetic field carrying orbital angular momentum. As these modes can be used to define an infinitely dimensional discrete Hilbert space, this approach provides a practical route to entanglement that involves many orthogonal quantum states, rather than just two Multi-dimensional entangled states could be of considerable importance in the field of quantum information(7,8), enabling, for example, more efficient use of communication channels in quantum cryptography(9-11).	Univ Vienna, Inst Phys Expt, A-1090 Vienna, Austria	University of Vienna	Zeilinger, A (corresponding author), Univ Vienna, Inst Phys Expt, Boltzmanngasse 5, A-1090 Vienna, Austria.		Weihs, Gregor/G-2564-2013; Zeilinger, Anton/A-1170-2011	Weihs, Gregor/0000-0003-2260-3008; 				ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; Arlt J, 1998, J MOD OPTIC, V45, P1231, DOI 10.1080/09500349808230913; Arlt J, 1999, PHYS REV A, V59, P3950, DOI 10.1103/PhysRevA.59.3950; Arnaut HH, 2000, PHYS REV LETT, V85, P286, DOI 10.1103/PhysRevLett.85.286; BARTLETT SD, 2000, QUANTPH0011080; Bechmann-Pasquinucci H, 2000, PHYS REV LETT, V85, P3313, DOI 10.1103/PhysRevLett.85.3313; BEJERSBERGEN MW, 1993, OPT COMMUN, V96, P123; BOURENNANE M, IN PRESS PHYS REV A; Bouwmeester D, 1999, PHYS REV LETT, V82, P1345, DOI 10.1103/PhysRevLett.82.1345; DIVINCENZO DP, 1999, QUANTPH9908070; FRANKEARNOLD S, IN PRESS PHYS REV A; Friese MEJ, 1996, PHYS REV A, V54, P1593, DOI 10.1103/PhysRevA.54.1593; Galajda P, 2001, APPL PHYS LETT, V78, P249, DOI 10.1063/1.1339258; HE H, 1995, PHYS REV LETT, V75, P826, DOI 10.1103/PhysRevLett.75.826; Kaszlikowski D, 2000, PHYS REV LETT, V85, P4418, DOI 10.1103/PhysRevLett.85.4418; Pan JW, 2001, PHYS REV LETT, V86, P4435, DOI 10.1103/PhysRevLett.86.4435; RECK M, 1994, PHYS REV LETT, V73, P58, DOI 10.1103/PhysRevLett.73.58; RECK M, 1996, THESIS U INNSBRUCK; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; Schrodinger E, 1935, P CAMB PHILOS SOC, V31, P555, DOI 10.1017/S0305004100013554; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P844, DOI 10.1007/BF01491987; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P807, DOI 10.1007/BF01491891; Schroedinger E., 1935, NATURWISSENSCHAFTEN, V23, P823, DOI [DOI 10.1007/BF01491914, 10.1007/BF01491914]; Simpson NB, 1997, OPT LETT, V22, P52, DOI 10.1364/OL.22.000052; Zukowski M, 1997, PHYS REV A, V55, P2564, DOI 10.1103/PhysRevA.55.2564	26	2285	2347	21	432	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					313	316		10.1038/35085529	http://dx.doi.org/10.1038/35085529			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460157	Green Submitted			2022-12-28	WOS:000169918200040
J	Zewail, AH				Zewail, AH			The fog that was not	NATURE			English	Editorial Material									CALTECH, Div Chem, Pasadena, CA 91125 USA; CALTECH, Div Phys, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Zewail, AH (corresponding author), CALTECH, Div Chem, Pasadena, CA 91125 USA.			gaber, sarah/0000-0002-5995-7291					0	22	23	0	13	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					279	279		10.1038/35085661	http://dx.doi.org/10.1038/35085661			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460141	Bronze			2022-12-28	WOS:000169918200026
J	Kearon, C; Ginsberg, JS; Douketis, J; Crowther, M; Brill-Edwards, P; Weitz, JI; Hirsh, J				Kearon, C; Ginsberg, JS; Douketis, J; Crowther, M; Brill-Edwards, P; Weitz, JI; Hirsh, J			Management of suspected deep venous thrombosis in outpatients by using clinical assessment and D-dimer testing	ANNALS OF INTERNAL MEDICINE			English	Article							WHOLE-BLOOD ASSAY; SIMPLIRED-D-DIMER; VEIN THROMBOSIS; PULMONARY-EMBOLISM; NONINVASIVE DIAGNOSIS; THROMBOEMBOLISM; SCORE; MODEL	Background: When deep venous thrombosis is suspected, objective testing is required to confirm or refute the diagnosis. Objective: To determine whether the combination of a low clinical suspicion and a normal D-dimer result rules out deep venous thrombosis. Design: Prospective cohort study. Setting: Three tertiary care hospitals in Canada. Patients: 445 outpatients with a suspected first episode of deep venous thrombosis. Interventions: Patients were categorized as having low, moderate, or high pretest probability of thrombosis and underwent whole-blood D-dimer testing. Patients with a low pretest probability and a negative result on the D-dimer test had no further diagnostic testing and received no anticoagulant therapy. Additional diagnostic testing was done in all other patients. Measurements: Venous thromboembolic events during 3-month follow-up. Results: 177 (40%) patients had both a low pretest probability and a negative D-dimer result. One of these patients had deep venous thrombosis during follow-up (negative predictive value, 99.4% [95% CI, 96.9% to 100%]). Conclusion: The combination of a low pretest probability of deep venous thrombosis and a negative result on a whole-blood D-dimer test rules out deep venous thrombosis in a large proportion of symptomatic outpatients.	Hamilton Civ Hosp, Res Ctr, Hamilton, ON, Canada; McMaster Univ, Hamilton, ON L8S 4L8, Canada	McMaster University; McMaster University	Kearon, C (corresponding author), McMaster Univ, Henderson Gen Hosp, Room 401,711 Concess St, Hamilton, ON L8V 1C3, Canada.		Weitz, Jeffrey/AAD-1929-2019; Douketis, James/AAO-5659-2021; ginsberg, jeffrey s/ABC-1065-2020	Weitz, Jeffrey/0000-0002-1092-7550; 				Anand SS, 1998, JAMA-J AM MED ASSOC, V279, P1094, DOI 10.1001/jama.279.14.1094; Becker DM, 1996, ARCH INTERN MED, V156, P939, DOI 10.1001/archinte.156.9.939; Bigaroni A, 2000, THROMB HAEMOSTASIS, V83, P788, DOI 10.1055/s-0037-1613912; BOUNAMEAUX H, 1994, THROMB HAEMOSTASIS, V71, P1; Ginsberg JS, 1997, ARCH INTERN MED, V157, P1077, DOI 10.1001/archinte.157.10.1077; Ginsberg JS, 1998, ANN INTERN MED, V129, P1006, DOI 10.7326/0003-4819-129-12-199812150-00003; JOHN MA, 1990, THROMB RES, V58, P273, DOI 10.1016/0049-3848(90)90097-V; Kearon C, 1998, ANN INTERN MED, V128, P663, DOI 10.7326/0003-4819-128-8-199804150-00011; KEARON C, 1995, HAEMOSTASIS, V25, P72; Lee AYY, 1998, BAILLIERE CLIN HAEM, V11, P587, DOI 10.1016/S0950-3536(98)80084-X; Miron MJ, 2000, J INTERN MED, V247, P249, DOI 10.1046/j.1365-2796.2000.00605.x; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; van der Graaf F, 2000, THROMB HAEMOSTASIS, V83, P191; Wells PS, 1998, J INTERN MED, V243, P15; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002; WELLS PS, 1995, LANCET, V345, P1326, DOI 10.1016/S0140-6736(95)92535-X; WELLS PS, 1995, CIRCULATION, V91, P2184, DOI 10.1161/01.CIR.91.8.2184; Wells PS, 1998, LANCET, V351, P1405, DOI 10.1016/S0140-6736(05)79444-7	18	149	155	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2001	135	2					108	111		10.7326/0003-4819-135-2-200107170-00011	http://dx.doi.org/10.7326/0003-4819-135-2-200107170-00011			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452DR	11453710				2022-12-28	WOS:000169842300004
J	Sharma, P; Wang, T; Brown, MJ; Schapira, AHV				Sharma, P; Wang, T; Brown, MJ; Schapira, AHV			Fits and strokes	LANCET			English	Editorial Material							NOTCH3 MUTATIONS; CADASIL; DEMENTIA		Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England; Univ London, Natl Hosp Neurol & Neurosurg, Dept Clin Neurol, London, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Sharma, P (corresponding author), Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England.		Schapira, Anthony H V/A-1245-2010	Schapira, Anthony H V/0000-0002-3018-3966				CHABRIAT H, 1995, LANCET, V346, P934, DOI 10.1016/S0140-6736(95)91557-5; Joutel A, 2000, ANN NEUROL, V47, P388, DOI 10.1002/1531-8249(200003)47:3<388::AID-ANA19>3.3.CO;2-H; Joutel A, 1997, LANCET, V350, P1511, DOI 10.1016/S0140-6736(97)08083-5; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Wang T, 2000, J NEUROL NEUROSUR PS, V69, P652, DOI 10.1136/jnnp.69.5.652	5	6	6	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 14	2001	358	9276					120	120		10.1016/S0140-6736(01)05331-4	http://dx.doi.org/10.1016/S0140-6736(01)05331-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452BR	11463414				2022-12-28	WOS:000169837700013
J	Allers, T; Lichten, M				Allers, T; Lichten, M			Differential timing and control of noncrossover and crossover recombination during meiosis	CELL			English	Article							MEIOTIC GENE CONVERSION; DOUBLE-STRAND BREAKS; YEAST SACCHAROMYCES-CEREVISIAE; MISMATCH REPAIR; INITIATION SITE; CROSSING-OVER; HOLLIDAY JUNCTIONS; PACHYTENE ARREST; HETERODUPLEX DNA; BRANCH MIGRATION	Unitary models of meiotic recombination postulate that a central intermediate containing Holliday junctions is resolved to generate either noncrossover or crossover recombinants, both of which contain heteroduplex DNA. Contrary to this expectation, we find that during meiosis in Saccharomyces cerevisiae, noncrossover heteroduplex products are formed at the same time as Holliday junction intermediates. Crossovers appear later, when these intermediates are resolved. Furthermore, noncrossover and crossover recombination are regulated differently. ndt80 mutants arrest in meiosis with unresolved Holliday junction intermediates and very few crossovers, while noncrossover heteroduplex products are formed at normal levels and with normal timing. These results suggest that crossovers are formed by resolution of Holliday junction intermediates, while most noncrossover recombinants arise by a different, earlier pathway.	NCI, Biochem Lab, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lichten, M (corresponding author), NCI, Biochem Lab, Ctr Canc Res, Bethesda, MD 20892 USA.	lichten@helix.nih.gov	Allers, Thorsten/G-5503-2010; Lichten, Michael/C-5795-2013	Allers, Thorsten/0000-0002-7308-3332; Lichten, Michael/0000-0001-9707-2956	NATIONAL CANCER INSTITUTE [Z01BC005268] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allers T, 2000, Nucleic Acids Res, V28, pe6, DOI 10.1093/nar/28.2.e6; ALLERS T, 2001, IN PRESS MOL CELL; BELL L, 1983, ANAL BIOCHEM, V130, P527, DOI 10.1016/0003-2697(83)90628-0; BELL LR, 1982, COLD SPRING HARB SYM, V47, P829, DOI 10.1101/SQB.1983.047.01.095; BISHOP JO, 1979, J MOL BIOL, V128, P545, DOI 10.1016/0022-2836(79)90292-4; BORTS RH, 1987, SCIENCE, V237, P1459, DOI 10.1126/science.2820060; BYERS B, 1982, MOL GEN GENET, V187, P47, DOI 10.1007/BF00384382; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; CARPENTER ATC, 1987, BIOESSAYS, V6, P232, DOI 10.1002/bies.950060510; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; COLLINS I, 1994, CELL, V76, P65, DOI 10.1016/0092-8674(94)90173-2; Cromie GA, 2000, MOL CELL, V6, P815, DOI 10.1016/S1097-2765(00)00079-4; DAVIDOW LS, 1984, GENETICS, V106, P165; FOGEL S, 1981, MOL BIOL YEAST SACCH, P289; Gilbertson LA, 1996, GENETICS, V144, P27; GOYON C, 1993, MOL CELL BIOL, V13, P373, DOI 10.1128/MCB.13.1.373; Guthrie C, 1991, GUIDE YEAST GENETICS; HAYDEN MS, 1992, DEV GENET, V13, P498, DOI 10.1002/dvg.1020130611; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Hunter N, 1997, GENE DEV, V11, P1573, DOI 10.1101/gad.11.12.1573; JACKSON JA, 1985, GENETICS, V109, P303; JINKSROBERTSON S, 1985, P NATL ACAD SCI USA, V82, P3350, DOI 10.1073/pnas.82.10.3350; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; KLAR AJS, 1984, NATURE, V310, P744, DOI 10.1038/310744a0; KLEIN HL, 1984, NATURE, V310, P748, DOI 10.1038/310748a0; LICHTEN M, 1987, GENETICS, V115, P233; NAG DK, 1993, MOL CELL BIOL, V13, P2324, DOI 10.1128/MCB.13.4.2324; NAG DK, 1989, NATURE, V340, P318, DOI 10.1038/340318a0; Nakagawa T, 1999, EMBO J, V18, P5714, DOI 10.1093/emboj/18.20.5714; NICOLAS A, 1989, NATURE, V338, P35, DOI 10.1038/338035a0; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; PANYUTIN IG, 1994, P NATL ACAD SCI USA, V91, P2021, DOI 10.1073/pnas.91.6.2021; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petes T. D., 1991, MOL CELLULAR BIOL YE, P407; PORTER SE, 1993, GENETICS, V134, P5; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; ROMAN H, 1985, ENVIRON MUTAGEN, V7, P923, DOI 10.1002/em.2860070614; ROMAN H, 1958, COLD SPRING HARB SYM, V23, P155, DOI 10.1101/SQB.1958.023.01.019; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Sha R, 2000, BIOCHEMISTRY-US, V39, P11514, DOI 10.1021/bi0010468; SHUSTER EO, 1989, GENETICS, V123, P29; Storlazzi A, 1996, P NATL ACAD SCI USA, V93, P9043, DOI 10.1073/pnas.93.17.9043; STORLAZZI A, 1995, P NATL ACAD SCI USA, V92, P8512, DOI 10.1073/pnas.92.18.8512; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; SUN H, 1989, NATURE, V338, P87, DOI 10.1038/338087a0; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; SYMINGTON LS, 1988, MOL CELL BIOL, V8, P595, DOI 10.1128/MCB.8.2.595; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; XU LZ, 1995, MOL CELL BIOL, V15, P6572; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	58	512	524	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2001	106	1					47	57		10.1016/S0092-8674(01)00416-0	http://dx.doi.org/10.1016/S0092-8674(01)00416-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461701	Bronze			2022-12-28	WOS:000169870300008
J	Reizes, O; Lincecum, J; Wang, ZH; Goldberger, O; Huang, L; Kaksonen, M; Ahima, R; Hinkes, MT; Barsh, GS; Rauvala, H; Bernfield, M				Reizes, O; Lincecum, J; Wang, ZH; Goldberger, O; Huang, L; Kaksonen, M; Ahima, R; Hinkes, MT; Barsh, GS; Rauvala, H; Bernfield, M			Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3	CELL			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; AGOUTI-RELATED PROTEIN; CENTRAL-NERVOUS-SYSTEM; CELL-SURFACE; MELANOCORTIN RECEPTORS; FIBROBLAST GROWTH; FOOD-INTAKE; N-SYNDECAN; IN-VIVO; OBESITY	Transgenic expression in the hypothalamus of syndecan-1, a cell surface heparan sulfate proteoglycan (HSPG) and modulator of ligand-receptor encounters, produces mice with hyperphagia and maturity-onset obesity resembling mice with reduced action of alpha melanocyte stimulating hormone (alpha MSH). Via their HS chains, syndecans potentiate the action of agouti-related protein and agouti signaling protein, endogenous inhibitors of alpha MSH. In wild-type mice, syndecan-3, the predominantly neural syndecan, is expressed in hypothalamic regions that control energy balance. Food deprivation increases hypothalamic syndecan-3 levels several-fold. Syndecan-3 null mice, otherwise apparently normal, respond to food deprivation with markedly reduced reflex hyperphagia. We propose that oscillation of hypothalamic syndecan-3 levels physiologically modulates feeding behavior.	Harvard Univ, Sch Med, Dept Pediat & Cell Biol, Div Newborn Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Hosp, Div Endocrinol, Boston, MA 02115 USA; Stanford Univ, Med Ctr, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA; Univ Helsinki, Inst Biotechnol, Program Mol Neurobiol, Helsinki 00014, Finland; Univ Helsinki, Dept Biosci, Helsinki 00014, Finland	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; University of Helsinki; University of Helsinki	Bernfield, M (corresponding author), Harvard Univ, Sch Med, Dept Pediat & Cell Biol, Div Newborn Med, 300 Longwood Ave, Boston, MA 02115 USA.		Ahima, Rexford/W-1394-2019; Reizes, Ofer/ABA-4179-2021	Reizes, Ofer/0000-0003-0075-6871; Rauvala, Heikki/0000-0001-7809-9811; Kaksonen, Marko/0000-0003-3645-7689	NICHD NIH HHS [HD06763, HD18655] Funding Source: Medline; NIDDK NIH HHS [DK28506] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD006763, R37HD006763] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bagnol D, 1999, J NEUROSCI, V19; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bray GA, 2000, NATURE, V404, P672, DOI 10.1038/35007544; Carey DJ, 1997, J BIOL CHEM, V272, P2873, DOI 10.1074/jbc.272.5.2873; Cone RD, 1996, RECENT PROG HORM RES, V51, P287; Conrad H. E., 1998, HEPARIN BINDING PROT; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Flier JS, 1998, CELL, V92, P437, DOI 10.1016/S0092-8674(00)80937-X; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Hagan MM, 2000, AM J PHYSIOL-REG I, V279, pR47, DOI 10.1152/ajpregu.2000.279.1.R47; He L, 2001, NAT GENET, V27, P40, DOI 10.1038/83741; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Hsueh YP, 1999, J NEUROSCI, V19, P7415, DOI 10.1523/JNEUROSCI.19-17-07415.1999; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; JALKANEN M, 1985, J CELL BIOL, V101, P976, DOI 10.1083/jcb.101.3.976; KANDEL E, 1995, SCIENCE, V268, P825, DOI 10.1126/science.7754367; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kiefer LL, 1998, BIOCHEMISTRY-US, V37, P991, DOI 10.1021/bi971913h; Lauri SE, 1999, J NEUROSCI, V19, P1226; Loeb JA, 1999, DEVELOPMENT, V126, P781; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Mizuno TM, 1999, ENDOCRINOLOGY, V140, P814, DOI 10.1210/en.140.2.814; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Nagle DL, 1999, NATURE, V398, P148, DOI 10.1038/18210; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Palmiter RD, 1998, RECENT PROG HORM RES, V53, P163; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Paxinos G, 1995, RAT NERVOUS SYSTEM, V2nd; Porte D, 1998, DIABETOLOGIA, V41, P863, DOI 10.1007/s001250051002; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; RAULO E, 1994, J BIOL CHEM, V269, P12999; SALMIVIRTA M, 1991, J BIOL CHEM, V266, P7733; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Steinfeld R, 1996, J CELL BIOL, V133, P405, DOI 10.1083/jcb.133.2.405; Subramanian SV, 1997, J BIOL CHEM, V272, P14713, DOI 10.1074/jbc.272.23.14713; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; YANAGISHITA M, 1984, J BIOL CHEM, V259, P270; Yang YK, 1999, MOL ENDOCRINOL, V13, P148, DOI 10.1210/me.13.1.148; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; YEN TT, 1994, FASEB J, V8, P479, DOI 10.1096/fasebj.8.8.8181666	45	171	177	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2001	106	1					105	116		10.1016/S0092-8674(01)00415-9	http://dx.doi.org/10.1016/S0092-8674(01)00415-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461706	Bronze			2022-12-28	WOS:000169870300013
J	Grimm, PC; Nickerson, P; Jeffery, J; Savani, RC; Gough, J; McKenna, RM; Stern, E; Rush, DN				Grimm, PC; Nickerson, P; Jeffery, J; Savani, RC; Gough, J; McKenna, RM; Stern, E; Rush, DN			Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SMOOTH-MUSCLE CELLS; CHRONIC TRANSPLANT REJECTION; INTERNATIONAL STANDARDIZATION; MYOFIBROBLAST INVOLVEMENT; SUBCLINICAL REJECTION; HISTOLOGIC DIAGNOSIS; INJURY; HYALURONAN; DIFFERENTIATION; VASCULOPATHY	Background: Tissue remodeling depends on mesenchymal cells (fibroblasts and myofibroblasts) and is a prominent feature of chronic renal-transplant rejection. It is not known whether the mesenchymal cells that participate in remodeling originate locally or from circulating precursor cells. Methods: We obtained biopsy specimens of renal allografts from six male recipients of an allograft from a female donor, four female recipients of an allograft from a male donor, two male recipients of an allograft from a male donor, and two female recipients of an allograft from a female donor. All the allografts were undergoing chronic rejection. We used immunohistochemical methods to identify mesenchymal cells with smooth-muscle alpha- actin and in situ hybridization to identify mesenchymal cells with Y-chromosome DNA. Results: No Y-chromosome bodies were identified in the case of the two renal-allograft specimens in which both the donor and the recipient were female. In the case of the two renal-allograft specimens in which both the donor and the recipient were male, approximately 40 percent of mesenchymal cells contained a Y-chromosome body. In the case of the six specimens in which the donor was female and the recipient was male, a mean (+/-SD) of 34+/-16 percent of mesenchymal cells in the neointima, 38+/-12 percent of such cells in the adventitia, and 30+/-7 percent of such cells in the interstitium contained the Y-chromosomal marker, indicating that they originated from the recipient rather than the donor. In the case of the four renal-allograft specimens in which the donor was male and the recipient was female, the respective values were 24+/-15 percent, 33+/-9 percent, and 23+/-8 percent, indicating a persistent population of donor mesenchymal cells. Conclusions: The presence of mesenchymal cells of host origin in the vascular and interstitial compartments of renal allografts undergoing chronic rejection provides evidence that a circulating mesenchymal precursor cell has the potential to migrate to areas of inflammation. (N Engl J Med 2001;345:93-7.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada; Univ Manitoba, Dept Pathol, Winnipeg, MB, Canada; Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	University of California System; University of California San Diego; University of Manitoba; University of Manitoba; University of Pennsylvania	Grimm, PC (corresponding author), Univ Calif San Diego, Dept Pediat, 9500 Gilman Dr,MC 0831, La Jolla, CA 92093 USA.		Rashmin C. Savani, MBChB/AAG-2041-2021	Rashmin C. Savani, MBChB/0000-0002-9533-5422; Nickerson, Peter/0000-0002-7393-7799; Grimm, Paul/0000-0001-7870-8592	NIAID NIH HHS [R01-AI43655-02] Funding Source: Medline; NIDDK NIH HHS [R21 DK53610-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK053610] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akyurek LM, 1996, TRANSPLANTATION, V62, P1526; ANDERSEN CB, 1991, APMIS, V99, P645, DOI 10.1111/j.1699-0463.1991.tb01240.x; Brazelton T. R., 1997, Journal of Heart and Lung Transplantation, V16, P72; Brazelton TR, 1999, INFLAMM RES, V48, pS134; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; COOKE HJ, 1982, CHROMOSOMA, V87, P491, DOI 10.1007/BF00333470; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; Geraghty JG, 1996, TRANSPLANTATION, V62, P502, DOI 10.1097/00007890-199608270-00013; Gizycki MJ, 1997, AM J RESP CELL MOL, V16, P664, DOI 10.1165/ajrcmb.16.6.9191468; GRIMM PC, 1995, TRANSPLANTATION, V59, P579; Grimm PC, 1999, J AM SOC NEPHROL, V10, P1582; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Huynh T, 1999, NAT BIOTECHNOL, V17, P1083, DOI 10.1038/15062; Jain M, 1996, J CLIN INVEST, V97, P596, DOI 10.1172/JCI118455; Katoh Y, 1996, TRENDS CARDIOVAS MED, V6, P100, DOI 10.1016/1050-1738(96)00014-X; LI J, 1995, EXP HEMATOL, V23, P133; Ng YY, 1998, KIDNEY INT, V54, P864, DOI 10.1046/j.1523-1755.1998.00076.x; Pedagogos E, 1997, TRANSPLANTATION, V64, P1192, DOI 10.1097/00007890-199710270-00019; Pethig K, 1998, AM HEART J, V135, P628, DOI 10.1016/S0002-8703(98)70278-9; PLISSONNIER D, 1995, TRANSPLANTATION, V60, P414, DOI 10.1097/00007890-199509000-00003; Routledge MW, 1997, TRANSPLANT P, V29, P2603, DOI 10.1016/S0041-1345(97)00525-3; Rush D, 1998, J AM SOC NEPHROL, V9, P2129; RUSH DN, 1994, TRANSPLANTATION, V57, P208, DOI 10.1097/00007890-199401001-00009; SALOMON RN, 1991, AM J PATHOL, V138, P791; SAVANI RC, 1995, J CLIN INVEST, V95, P1158, DOI 10.1172/JCI117764; SAVANI RC, 1995, P W PHARMACOL SOC, V38, P131; Shi Y, 1996, CIRCULATION, V93, P340, DOI 10.1161/01.CIR.93.2.340; SKALLI O, 1987, DIFFERENTIATION, V33, P232, DOI 10.1111/j.1432-0436.1987.tb01562.x; SOLEZ K, 1994, CLIN TRANSPLANT, V8, P345; SOLEZ K, 1993, KIDNEY INT, V44, P411, DOI 10.1038/ki.1993.259	30	215	225	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 12	2001	345	2					93	97		10.1056/NEJM200107123450203	http://dx.doi.org/10.1056/NEJM200107123450203			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451AH	11450677	Bronze			2022-12-28	WOS:000169776900003
J	Leovy, C				Leovy, C			Weather and climate on Mars	NATURE			English	Review							THERMAL INFRARED PROPERTIES; MARTIAN ATMOSPHERE; INTERANNUAL VARIABILITY; DUST STORMS; TEMPERATURES; SIMULATION; TIDES; TES	Imagine a planet very much like the Earth, with similar size, rotation rate and inclination of rotation axis, possessing an atmosphere and a solid surface, but lacking oceans and dense clouds of liquid water. We might expect such a desert planet to be dominated by large variations in day-night and winter-summer weather. Dust storms would be common. Observations and simulations of martian climate confirm these expectations and provide a wealth of detail that can help resolve problems of climate evolution.	Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Leovy, C (corresponding author), Univ Washington, Dept Atmospher Sci, Box 351640, Seattle, WA 98195 USA.	conway@atmos.washington.edu						ANDERSON E, 1978, J ATMOS SCI, V35, P723, DOI 10.1175/1520-0469(1978)035<0723:MTLOOD>2.0.CO;2; Anderson FS, 1999, J GEOPHYS RES-PLANET, V104, P18991, DOI 10.1029/1999JE900024; ARVIDSON RE, 1983, SCIENCE, V222, P463, DOI 10.1126/science.222.4623.463; BARNES JR, 1984, J ATMOS SCI, V41, P1536, DOI 10.1175/1520-0469(1984)041<1536:LBIITM>2.0.CO;2; BARNES JR, 1981, J ATMOS SCI, V38, P225, DOI 10.1175/1520-0469(1981)038<0225:MDITMA>2.0.CO;2; BRIGGS G, 1972, B AM METEOROL SOC, V55, P278; CANTOR B, IN PRESS J GEOPHYS R, V106; Clancy RT, 2000, J GEOPHYS RES-PLANET, V105, P9553, DOI 10.1029/1999JE001089; CONRATH B, 1999, J GEOPHYS RES, V104, P9509; CONRATH BJ, 1981, ICARUS, V48, P246, DOI 10.1016/0019-1035(81)90107-X; Forget F, 1999, J GEOPHYS RES-PLANET, V104, P24155, DOI 10.1029/1999JE001025; GIERASCH P, 1979, GEOPHYS RES LETT, V6, P405, DOI 10.1029/GL006i005p00405; GIERASCH PJ, 1972, J ATMOS SCI, V29, P400, DOI 10.1175/1520-0469(1972)029<0400:TEODOT>2.0.CO;2; GREELEY R, 1993, J GEOPHYS RES-PLANET, V98, P3183, DOI 10.1029/92JE02580; GREELEY R, 1992, MARS, P835; HABERLE RM, 1986, SCIENCE, V234, P459, DOI 10.1126/science.234.4775.459; Haberle RM, 1997, J GEOPHYS RES-PLANET, V102, P13301, DOI 10.1029/97JE01334; Hartmann DL, 1994, GLOBAL PHYSICAL CLIM, P140; HINSON D, IN PRESS J GEOPHYS R, V106; Hinson DP, 1999, J GEOPHYS RES-PLANET, V104, P26997, DOI 10.1029/1999JE001069; Hollingsworth JL, 1996, J ATMOS SCI, V53, P428, DOI 10.1175/1520-0469(1996)053<0428:FSPWIM>2.0.CO;2; Hollingsworth JL, 1996, NATURE, V380, P413, DOI 10.1038/380413a0; James PB, 1999, ICARUS, V138, P64, DOI 10.1006/icar.1998.6060; JAMES PB, 1992, MARS, P934; JOSHI MM, 1994, NATURE, V367, P548, DOI 10.1038/367548a0; Kahn R. A., 1992, MARS, P1017; KEATING G, 2000, B AM ASTRON SOC, V32; Leovy C. B., 1985, Recent Advances in Planetary Meteorology. Seymour Hess Memorial Symposium at the 1983 IUGG General Assembly, P69; LEOVY CB, 1973, J ATMOS SCI, V30, P749, DOI 10.1175/1520-0469(1973)030<0749:MFMDS>2.0.CO;2; Lewis SR, 1999, J GEOPHYS RES-PLANET, V104, P24177, DOI 10.1029/1999JE001024; MARTIN TZ, 1979, J GEOPHYS RES, V84, P2843, DOI 10.1029/JB084iB06p02843; Murphy JR, 1995, J GEOPHYS RES-PLANET, V100, P26357, DOI 10.1029/95JE02984; MURPHY JR, 1990, J GEOPHYS RES-SOLID, V95, P14555, DOI 10.1029/JB095iB09p14555; PETERFREUND AR, 1979, J GEOPHYS RES, V84, P2853, DOI 10.1029/JB084iB06p02853; RYAN JA, 1970, J GEOPHYS RES, V75, P531, DOI 10.1029/JC075i003p00531; RYAN JA, 1981, GEOPHYS RES LETT, V8, P899, DOI 10.1029/GL008i008p00899; SANTEE M, 1993, J GEOPHYS RES-PLANET, V98, P3261, DOI 10.1029/92JE01896; Schofield JT, 1997, SCIENCE, V278, P1752, DOI 10.1126/science.278.5344.1752; Seiff A., 1977, Journal of Geophysical Research, V82, P4364, DOI 10.1029/JS082i028p04364; SMITH M, IN PRESS J GEOPHYS R, V106; Smith MD, 2000, J GEOPHYS RES-PLANET, V105, P9539, DOI 10.1029/1999JE001097; THOMAS P, 1985, SCIENCE, V230, P175, DOI 10.1126/science.230.4722.175; THOMAS PG, 1984, ICARUS, V58, P396, DOI 10.1016/0019-1035(84)90085-X; TILLMAN JE, 1988, J GEOPHYS RES-ATMOS, V93, P9433, DOI 10.1029/JD093iD08p09433; TILLMAN JE, 1993, J GEOPHYS RES-PLANET, V98, P10963, DOI 10.1029/93JE01084; Wilson RJ, 2000, ICARUS, V145, P555, DOI 10.1006/icar.2000.6378; Wilson RJ, 1996, J ATMOS SCI, V53, P1290, DOI 10.1175/1520-0469(1996)053<1290:CMSOTT>2.0.CO;2; Zurek R.W., 1992, MARS, P835; ZUREK RW, 1981, SCIENCE, V213, P437, DOI 10.1126/science.213.4506.437; ZUREK RW, 1976, J ATMOS SCI, V33, P321, DOI 10.1175/1520-0469(1976)033<0321:DTITMA>2.0.CO;2; ZUREK RW, 1993, J GEOPHYS RES-PLANET, V98, P3247, DOI 10.1029/92JE02936; ZUREK RW, 1988, J ATMOS SCI, V45, P2469, DOI 10.1175/1520-0469(1988)045<2469:ZSRTAT>2.0.CO;2; [No title captured]	53	87	89	5	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2001	412	6843					245	249		10.1038/35084192	http://dx.doi.org/10.1038/35084192			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449286				2022-12-28	WOS:000169778700064
J	Firneisz, G; Woller, J; Ferenci, P; Szalay, F				Firneisz, G; Woller, J; Ferenci, P; Szalay, F			Postcremation diagnosis from an electric shaver	LANCET			English	Editorial Material							WILSON-DISEASE		Semmelweis Univ, Dept Med 1, Budapest, Hungary; Inst Forens Sci, DNA Lab, Budapest, Hungary; Univ Vienna, Dept Gastroenterol & Med, A-1010 Vienna, Austria	Semmelweis University; University of Vienna	Firneisz, G (corresponding author), Semmelweis Univ, Dept Med 1, Budapest, Hungary.		Firneisz, Gabor/AAC-9654-2021	Firneisz, Gabor/0000-0002-9123-8131				COMEY CT, 1994, J FORENSIC SCI, V39, P1254; KENNEY S, 2001, WILSON DIS MUTATION; MaierDobersberger T, 1997, ANN INTERN MED, V127, P21, DOI 10.7326/0003-4819-127-1-199707010-00004; Szalay F., 1997, Hepatology, V26, p609A; THOMAS GR, 1995, NAT GENET, V9, P210, DOI 10.1038/ng0295-210	5	3	3	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 7	2001	358	9275					34	34		10.1016/S0140-6736(00)05254-5	http://dx.doi.org/10.1016/S0140-6736(00)05254-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11454376				2022-12-28	WOS:000169710900015
J	Johnston, AM; Raven, JA; Beardall, J; Leegood, RC				Johnston, AM; Raven, JA; Beardall, J; Leegood, RC			Carbon fixation - Photosynthesis in a marine diatom	NATURE			English	Article							INORGANIC CARBON; ACQUISITION		Scottish Crop Res Inst, Dundee DD2 5DA, Scotland; Univ Dundee, Inst Biol Sci, Dundee DD1 4HN, Scotland; Monash Univ, Dept Biol Sci, Clayton, Vic 3800, Australia; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	James Hutton Institute; University of Dundee; Monash University; University of Sheffield	Johnston, AM (corresponding author), Scottish Crop Res Inst, Dundee DD2 5DA, Scotland.	ajohn@scri.sari.ac.uk	Beardall, John/A-1250-2008; Beardall, John/L-5262-2019	Beardall, John/0000-0001-7684-446X; Beardall, John/0000-0001-7684-446X				Badger Murray R., 2000, Advances in Photosynthesis, V9, P369; BEARDALL J, 1976, J PHYCOL, V12, P409; BEARDALL J, 1989, AQUAT BOT, V34, P105, DOI 10.1016/0304-3770(89)90052-1; JOHNSTON AM, 1991, CAN J BOT, V69, P1123, DOI 10.1139/b91-144; JOHNSTON AM, 1987, PHYCOLOGIA, V26, P159, DOI 10.2216/i0031-8884-26-2-159.1; JOHNSTON AM, 1992, MARINE ECOL PROG SER, V87, P517; Raven JA, 1997, ADV BOT RES, V27, P85; Reinfelder JR, 2000, NATURE, V407, P996, DOI 10.1038/35039612; Riebesell U, 2000, NATURE, V407, P959, DOI 10.1038/35039665; Sage R. F., 1999, C4 PLANT BIOL, P596	10	35	38	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					40	41		10.1038/35083694	http://dx.doi.org/10.1038/35083694			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452295				2022-12-28	WOS:000169644900032
J	Beja, O; Spudich, EN; Spudich, JL; Leclerc, M; DeLong, EF				Beja, O; Spudich, EN; Spudich, JL; Leclerc, M; DeLong, EF			Proteorhodopsin phototrophy in the ocean	NATURE			English	Article							SENSORY RHODOPSIN-II; HALOBACTERIUM-HALOBIUM; PURPLE MEMBRANE; PROCHLOROCOCCUS; PHOBORHODOPSIN; CYANOBACTERIA; COMMUNITY; BACTERIA; ATLANTIC; PROTEIN	Proteorhodopsin(1), a retinal-containing integral membrane protein that functions as a light-driven proton pump, was discovered in the genome of an uncultivated marine bacterium; however, the prevalence, expression and genetic variability of this protein in native marine microbial populations remain unknown. Here we report that photoactive proteorhodopsin is present in oceanic surface waters. We also provide evidence of an extensive family of globally distributed proteorhodopsin variants. The protein pigments comprising this rhodopsin family seem to be spectrally tuned to different habitats-absorbing light at different wavelengths in accordance with light available in the environment. Together, our data suggest that proteorhodopsin-based phototrophy is a globally significant oceanic microbial process.	Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Univ Texas, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	Monterey Bay Aquarium Research Institute; University of Texas System	DeLong, EF (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.		Leclerc, Marion/AAZ-3950-2021	Leclerc, Marion/0000-0001-8684-2847				Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2000, ENVIRON MICROBIOL, V2, P516, DOI 10.1046/j.1462-2920.2000.00133.x; Bowmaker James K., 1999, Novartis Foundation Symposium, V224, P21, DOI 10.1002/9780470515693.ch3; DANON A, 1974, P NATL ACAD SCI USA, V71, P1234, DOI 10.1073/pnas.71.4.1234; DeLong EF, 1999, APPL ENVIRON MICROB, V65, P5554; DeLong EF, 1998, APPL ENVIRON MICROB, V64, P1133; Eilers H, 2000, APPL ENVIRON MICROB, V66, P3044, DOI 10.1128/AEM.66.7.3044-3051.2000; Ferris MJ, 1998, NATURE, V396, P226, DOI 10.1038/24297; Gonzalez JM, 2000, APPL ENVIRON MICROB, V66, P4237, DOI 10.1128/AEM.66.10.4237-4246.2000; HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0; Karl DM, 1996, DEEP-SEA RES PT II, V43, P129, DOI 10.1016/0967-0645(96)00005-7; KIRK JTO, 1983, LIGHT PHOTOSYNTHESIS, P104; Kolber ZS, 2000, NATURE, V407, P177, DOI 10.1038/35025044; MICHEL H, 1980, BIOCHEMISTRY-US, V19, P4607, DOI 10.1021/bi00561a011; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; MULLINS TD, 1995, LIMNOL OCEANOGR, V40, P148, DOI 10.4319/lo.1995.40.1.0148; NEUGEBAUER DC, 1983, METHOD ENZYMOL, V97, P218; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; Palenik B, 2001, APPL ENVIRON MICROB, V67, P991, DOI 10.1128/AEM.67.2.991-994.2001; Rappe MS, 2000, FEMS MICROBIOL ECOL, V33, P219, DOI 10.1016/S0168-6496(00)00064-7; Sasaki J, 1998, BIOPHYS J, V75, P2435, DOI 10.1016/S0006-3495(98)77687-8; Shimono K, 1997, FEBS LETT, V420, P54, DOI 10.1016/S0014-5793(97)01487-7; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; TAKAHASHI T, 1990, BIOCHEMISTRY-US, V29, P8467, DOI 10.1021/bi00488a038; Urbach E, 1998, J MOL EVOL, V46, P188, DOI 10.1007/PL00006294	25	578	613	9	128	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					786	789		10.1038/35081051	http://dx.doi.org/10.1038/35081051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459054				2022-12-28	WOS:000169246400045
J	Gilbert, IR; Jarvis, PG; Smith, H				Gilbert, IR; Jarvis, PG; Smith, H			Proximity signal and shade avoidance differences between early and late successional trees	NATURE			English	Article							NATURAL-ENVIRONMENT; LIGHT QUALITY; PHYTOCHROME; PLANTS; PERCEPTION; CANOPIES; GROWTH	Competitive interactions between plants determine the success of individuals and species. In developing forests, competition for light is the predominant factor. Shade tolerators acclimate photo-synthetically to low light(1-3) and are capable of long-term survival under the shade cast by others, whereas shade avoiders rapidly dominate gaps but are overtaken in due course by shade-tolerant, later successional species. Shade avoidance(4-6) results from the phytochrome-mediated perception of far-red radiation (700- 800 nm) scattered from the leaves of neighbours, provides early warning of shading(7), and induces developmental responses that, when successful, result in the overgrowth of those neighbours(8). Shade tolerators cast a deep shade, whereas less-tolerant species cast light shade(9), and saplings tend to have high survivorship in shade cast by conspecific adults, but high rates of mortality when shaded by more-tolerant species(9). Here we report a parallel relationship in which the shade-avoidance responses of three tree species are inversely proportional to proximity signals generated by those species. On this basis, early successional species generate small proximity signals but react strongly to them, whereas late successional species react weakly but generate strong signals.	Univ Nottingham, Div Plant Sci, Loughborough LE12 5RD, Leics, England; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JU, Midlothian, Scotland; Univ Edinburgh, Inst Ecol & Resource Management, Edinburgh EH9 3JU, Midlothian, Scotland	University of Nottingham; University of Edinburgh; University of Edinburgh	Smith, H (corresponding author), Univ Nottingham, Div Plant Sci, Sutton Bonington Campus, Loughborough LE12 5RD, Leics, England.	Harry.Smith@Nottingham.ac.uk						Bj÷rkman O., 1981, ENCY PLANT PHYSL A, P57; BOARDMAN NK, 1977, ANNU REV PLANT PHYS, V28, P355, DOI 10.1146/annurev.pp.28.060177.002035; CANHAM CD, 1994, CAN J FOREST RES, V24, P337, DOI 10.1139/x94-046; CASAL JJ, 1989, PLANT CELL ENVIRON, V12, P855, DOI 10.1111/j.1365-3040.1989.tb01966.x; CHILD R, 1981, NEW PHYTOL, V89, P545, DOI 10.1111/j.1469-8137.1981.tb02334.x; GILBERT IR, 1995, PLANT CELL ENVIRON, V18, P475, DOI 10.1111/j.1365-3040.1995.tb00549.x; HAYWARD PM, 1984, TECHNIQUES PHOTOMORP, P159; Kull O, 1998, FUNCT ECOL, V12, P472, DOI 10.1046/j.1365-2435.1998.00214.x; Lei TT, 1998, ANN BOT-LONDON, V82, P9, DOI 10.1006/anbo.1998.0644; MORGAN DC, 1979, PLANTA, V145, P253, DOI 10.1007/BF00454449; MORGAN DC, 1976, NATURE, V262, P210, DOI 10.1038/262210a0; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; SMITH H, 1982, ANNU REV PLANT PHYS, V33, P481, DOI 10.1146/annurev.pp.33.060182.002405; SMITH H, 1977, PHOTOCHEM PHOTOBIOL, V25, P547; SMITH H, 1995, ANNU REV PLANT PHYS, V46, P289, DOI 10.1146/annurev.pp.46.060195.001445	16	91	98	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2001	411	6839					792	795		10.1038/35081062	http://dx.doi.org/10.1038/35081062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459056	Green Published			2022-12-28	WOS:000169246400047
J	Packer, C; Pusey, AE; Eberly, LE				Packer, C; Pusey, AE; Eberly, LE			Egalitarianism in female African lions	SCIENCE			English	Article							REPRODUCTIVE SKEW; PANTHERA-LEO; COOPERATION; EVOLUTION; TERRITORIALITY; DOMINANCE; SOCIETIES; CONTESTS	Because most cooperative societies are despotic, it has been difficult to test models of egalitarianism. Female African lions demonstrate a unique form of plural breeding in which companions consistently produce similar numbers of surviving offspring. Consistent with theoretical predictions from models of reproductive skew, female lions are unable to control each other's reproduction because of high costs of fighting and low access to each other's newborn cubs. A female also tacks incentives to reduce her companions' reproduction, because her own survival and reproduction depend on group territoriality and synchronous breeding. Consequently, female relationships are highly symmetrical, and female lions are "free agents" who only contribute to communal care when they have cubs of their own.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Packer, C (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.			Eberly, Lynn/0000-0003-4763-330X; Pusey, Anne/0000-0002-2280-8954				BERTRAM BCR, 1975, J ZOOL, V177, P463; Boehm Christopher, 1997, American Naturalist, V150, P100; Brown J.L., 1987, HELPING COMMUNAL BRE; Clutton-Brock TH, 2001, SCIENCE, V291, P478, DOI 10.1126/science.291.5503.478; Clutton-Brock TH, 1998, TRENDS ECOL EVOL, V13, P288, DOI 10.1016/S0169-5347(98)01402-5; COX DR, 1972, J R STAT SOC B, V34, P187; Creel SR, 1991, BEHAV ECOL, V2, P7, DOI 10.1093/beheco/2.1.7; De Luca DW, 2001, ANIM BEHAV, V61, P17, DOI 10.1006/anbe.2000.1559; EMLEN ST, 1982, AM NAT, V119, P40, DOI 10.1086/283889; FRANK LG, 1986, ANIM BEHAV, V34, P1510, DOI 10.1016/S0003-3472(86)80221-4; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; HAMMERSTEIN P, 1981, ANIM BEHAV, V29, P193, DOI 10.1016/S0003-3472(81)80166-2; Hammerstein P, 1988, EVOL ECOL, V2, P115, DOI 10.1007/BF02067272; Hanby J. P., 1995, SERENGETI, P315; Heinsohn R, 1996, P ROY SOC B-BIOL SCI, V263, P475, DOI 10.1098/rspb.1996.0071; Heinsohn R, 1997, ANIM BEHAV, V53, P1143, DOI 10.1006/anbe.1996.0316; HEINSOHN R, 1995, SCIENCE, V269, P1260, DOI 10.1126/science.7652573; Johnstone RA, 1999, AM NAT, V153, P315, DOI 10.1086/303169; LIMA SL, 1989, AM NAT, V134, P828, DOI 10.1086/285015; Macdonald D. W., 1982, PERSPECTIVES ETHOLOG, P433; MCCOMB K, 1994, ANIM BEHAV, V47, P379, DOI 10.1006/anbe.1994.1052; PACKER C, 1983, AM NAT, V121, P716, DOI 10.1086/284097; Packer C, 1998, NATURE, V392, P807, DOI 10.1038/33910; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; Packer C., 1988, P363; PACKER C, 1982, NATURE, V296, P740, DOI 10.1038/296740a0; Packer C., 1985, P173; PACKER C, 1983, ANIM BEHAV, V31, P334, DOI 10.1016/S0003-3472(83)80051-7; PACKER C, 1991, NATURE, V351, P562, DOI 10.1038/351562a0; PACKER C, 1995, NATURE, V373, P60, DOI 10.1038/373060a0; Packer C., 1986, P429; Pusey A, 1997, SCIENCE, V277, P828, DOI 10.1126/science.277.5327.828; PUSEY AE, 1987, BEHAVIOUR, V101, P275, DOI 10.1163/156853987X00026; PUSEY AE, 1994, BEHAV ECOL, V5, P362, DOI 10.1093/beheco/5.4.362; PUSEY AE, 1994, PROTECTION ABUSE YOU, P277; Reeve HK, 2001, ANNU REV ENTOMOL, V46, P347, DOI 10.1146/annurev.ento.46.1.347; Reeve HK, 1998, BEHAV ECOL, V9, P267, DOI 10.1093/beheco/9.3.267; Reeve Hudson K., 1993, P45; Schaller G. B., 1972, SERENGETI LION; Silk J.B., 1987, P318; Sober E., 1999, OTHERS EVOLUTION PSY; Solomon N. G., 1997, COOPERATIVE BREEDING; Stacey P.B., 1990, COOPERATIVE BREEDING; VEHRENCAMP SL, 1983, ANIM BEHAV, V31, P667, DOI 10.1016/S0003-3472(83)80222-X; Walters J.R., 1987, P306	45	146	147	2	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					690	693		10.1126/science.1062320	http://dx.doi.org/10.1126/science.1062320			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474110				2022-12-28	WOS:000170204600053
J	von Dohlen, CD; Kohler, S; Alsop, ST; McManus, WR				von Dohlen, CD; Kohler, S; Alsop, ST; McManus, WR			Mealybug beta-proteobacterial endosymbionts contain gamma-proteobacterial symbionts	NATURE			English	Article							BACTERIAL ENDOSYMBIONTS; RIBOSOMAL-RNA; EVOLUTION; BUCHNERA; APHIDS; HOMOPTERA; HEMIPTERA; SEQUENCE; INSECTS	Some insects have cultivated intimate relationships with mutualistic bacteria since their early evolutionary history. Most ancient `primary' endosymbionts live within the cytoplasm of large, polyploid host cells of a specialized organ (bacteriome)(1). Within their large, ovoid bacteriomes, mealybugs (Pseudococcidae) package the intracellular endosymbionts into `mucus-filled' spheres, which surround the host cell nucleus and occupy most of the cytoplasm(2). The genesis of symbiotic spheres has not been determined, and they are structurally unlike eukaryotic cell vesicles. Recent molecular phylogenetic and fluorescent in situ hybridization (FISH) studies suggested that two unrelated bacterial species may share individual host cells(3,4), and that bacteria within spheres comprise these two species(5). Here we show that mealybug host cells do indeed harbour both beta- and gamma -subdivision Proteobacteria, but they are not co-inhabitants of the spheres. Rather, we show that the symbiotic spheres themselves are beta -proteobacterial cells. Thus, gamma -Proteobacteria live symbiotically inside beta -Proteobacteria. This is the first report, to our knowledge, of an intracellular symbiosis involving two species of bacteria.	Utah State Univ, Dept Biol, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	von Dohlen, CD (corresponding author), Utah State Univ, Dept Biol, 5305 Old Main Hill, Logan, UT 84322 USA.			von Dohlen, Carol/0000-0002-3961-251X				Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Ausubel FM., 1992, CURRENT PROTOCOLS MO, V3; Baumann P, 2000, PROKARYOTES HDB BIOL; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Clark MA, 1999, MOL BIOL EVOL, V16, P1586, DOI 10.1093/oxfordjournals.molbev.a026071; COSTA HS, 1993, PROTOPLASMA, V176, P106, DOI 10.1007/BF01378946; DOUGLAS AE, 1989, BIOL REV, V64, P409, DOI 10.1111/j.1469-185X.1989.tb00682.x; DU YB, 1994, P NATL ACAD SCI USA, V91, P8437, DOI 10.1073/pnas.91.18.8437; FINK R, 1962, Z MORPHOL OKOL TIERE, V41, P78; Fukatsu T, 2000, APPL ENVIRON MICROB, V66, P643, DOI 10.1128/AEM.66.2.643-650.2000; GRUNEWALDJANHO S, 1996, NONRADIOACTIVE IN SI; HOUK EJ, 1980, ANNU REV ENTOMOL, V25, P161, DOI 10.1146/annurev.en.25.010180.001113; Kantheti P, 1996, INSECT BIOCHEM MOLEC, V26, P997, DOI 10.1016/S0965-1748(96)00009-4; KOHLER M, 1962, Z ALLG MIKROBIOL, V2, P190; Komaki K, 1999, J MOL EVOL, V48, P717, DOI 10.1007/PL00006516; Lambert JD, 1998, P NATL ACAD SCI USA, V95, P4458, DOI 10.1073/pnas.95.8.4458; LOUIS C, 1972, CR ACAD SCI D NAT, V274, P715; LOUIS C, 1974, B OBSERVATOIRE MER, P43; MORAN N, 1994, TRENDS ECOL EVOL, V9, P15, DOI 10.1016/0169-5347(94)90226-7; Moran NA, 1998, BIOSCIENCE, V48, P295, DOI 10.2307/1313356; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Munson MA, 1992, MOL PHYLOGENET EVOL, V1, P26, DOI 10.1016/1055-7903(92)90032-C; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Smith DC, 1987, BIOL SYMBIOSIS; Spaulding AW, 1998, MOL BIOL EVOL, V15, P1506, DOI 10.1093/oxfordjournals.molbev.a025878; Spaulding AW, 2001, INSECT MOL BIOL, V10, P57, DOI 10.1046/j.1365-2583.2001.00231.x; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Tremblay E., 1989, P145; Van Ham RCHJ, 2000, P NATL ACAD SCI USA, V97, P10855, DOI 10.1073/pnas.180310197; Wernegreen JJ, 1999, MOL BIOL EVOL, V16, P83, DOI 10.1093/oxfordjournals.molbev.a026040	30	241	250	1	53	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					433	436		10.1038/35086563	http://dx.doi.org/10.1038/35086563			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473316				2022-12-28	WOS:000170068200046
J	Nuesch, R; Schroeder, K; Dieterle, T; Martina, B; Battegay, E				Nuesch, R; Schroeder, K; Dieterle, T; Martina, B; Battegay, E			Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: a prospective case-control study	BRITISH MEDICAL JOURNAL			English	Article							BLOOD-PRESSURE CONTROL; PATIENT COMPLIANCE; MEDICATION COMPLIANCE; MONITORING COMPLIANCE; REGIMEN; HYPERTENSION; THERAPY	Objectives To prospectively compare compliance with treatment in patients with hypertension responsive to treatment versus patients with treatment resistant hypertension. Design Prospective case control study. Setting Outpatient department in large city hospital in Switzerland, providing primary, secondary, and tertiary care. Participants 110 consecutive medial outpatients with hypertension and taking stable treatment with at least two antihypertensive drugs for at least four weeks. Main outcome measures Treatment compliance assess with MEM devices; blood pressure determined by 12 hour daytime ambulatory monitoring (pressure <135/85 mm Hg in patients age <less than or equal to>60 years and <155/90 mm Hg in patients aged >60 indicated hypertension responsive to treatment). Results Complete data were available for 103 patients, of whom 86 took greater than or equal to 80% of their prescribed doses ("compliant") and 17 took <80% ("non-compliant"). Of the 49 patients with treatment resistant hypertension, 40 (82%) were compliant, while 46 (85%) of the patients responsive to treatment were compliant. Conclusion Non-compliance with treatment was not more prevalent in patients with treatment resistant hypertension than in treatment responsive patients.	Univ Basel Hosp, Outpatient Dept Internal Med, CH-4031 Basel, Switzerland	University of Basel	Battegay, E (corresponding author), Univ Basel Hosp, Outpatient Dept Internal Med, CH-4031 Basel, Switzerland.		Dieterle, Thomas/AAG-3619-2019; Dieterle, Thomas/CAA-2532-2022	Dieterle, Thomas/0000-0002-3740-1903				Altman DG., 1982, STATISTICS PRACTICE, P6; Andrejak M, 2000, AM J HYPERTENS, V13, P184, DOI 10.1016/S0895-7061(99)00175-2; BATTEGAY E, 1996, MED HYG, V54, P541; Black HR, 1997, ARCH INTERN MED, V157, P2413; Boissel JP, 1996, EUR J CLIN PHARMACOL, V50, P63, DOI 10.1007/s002280050070; CALDERBANK PH, 1976, FLUIDIZATION TECHNOL, V1, P115; CONRAD P, 1985, SOC SCI MED, V20, P29, DOI 10.1016/0277-9536(85)90308-9; CRAMER JA, 1990, ARCH INTERN MED, V150, P1509, DOI 10.1001/archinte.150.7.1509; EISEN SA, 1990, ARCH INTERN MED, V150, P1881, DOI 10.1001/archinte.150.9.1881; ERAKER SA, 1984, ANN INTERN MED, V100, P258, DOI 10.7326/0003-4819-100-2-258; Graves John W., 2000, Mayo Clinic Proceedings, V75, P278; GUERRERO D, 1993, AM J HYPERTENS, V6, P586, DOI 10.1093/ajh/6.7.586; KJELLGREN KI, 1995, INT J CARDIOL, V47, P257, DOI 10.1016/0167-5273(94)02203-U; Krall RL, 1991, PATIENT COMPLIANCE M, P19; KRUSE W, 1990, EUR J CLIN PHARMACOL, V38, P561, DOI 10.1007/BF00278582; Leenen FHH, 1997, CAN J CARDIOL, V13, P914; Mallion JM, 1998, J HYPERTENS, V16, pS75; Mallion JM, 1996, J HYPERTENS, V14, P137; MALLION JM, 1992, J CARDIOVASC PHARM, V19, pS41, DOI 10.1097/00005344-199219002-00011; MCKENNEY JM, 1992, J CLIN PHARMACOL, V32, P277, DOI 10.1002/j.1552-4604.1992.tb03837.x; MELNIKOW J, 1994, J GEN INTERN MED, V9, P96, DOI 10.1007/BF02600211; OBRIEN E, 1993, J HYPERTENS, V11, P673, DOI 10.1097/00004872-199306000-00012; Sackett D L, 1978, Patient Couns Health Educ, V1, P18; SETARO J, 1992, NEW ENGL J MED, V327, P534; URQUHART J, 1994, CLIN PHARMACOKINET, V27, P202, DOI 10.2165/00003088-199427030-00004; Waeber B, 1999, INT J CLIN PRACT, V53, P37; Waeber B, 1999, J HYPERTENS, V17, P1041, DOI 10.1097/00004872-199917070-00022; WRIGHT EC, 1993, LANCET, V342, P909, DOI 10.1016/0140-6736(93)91951-H	28	77	84	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2001	323	7305					142	146		10.1136/bmj.323.7305.142	http://dx.doi.org/10.1136/bmj.323.7305.142			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456WR	11463685	Green Published, Bronze			2022-12-28	WOS:000170106200018
J	Jeppesen, C; Wong, JY; Kuhl, TL; Israelachvili, JN; Mullah, N; Zalipsky, S; Marques, CM				Jeppesen, C; Wong, JY; Kuhl, TL; Israelachvili, JN; Mullah, N; Zalipsky, S; Marques, CM			Impact of polymer tether length on multiple ligand-receptor bond formation	SCIENCE			English	Article								The promoters of cell adhesion are ligands, which are often attached to flexible tethers that bind to surface receptors on adjacent cells. Using a combination of Monte Carte simulations, diffusion reaction theory, and direct experiments (surface force measurements) of the biotin-streptavidin system, we have quantified polymer chain dynamics and the kinetics and spatial range of tethered ligand-receptor binding. The results show that the efficiency of strong binding does not depend solely on the molecular architecture or binding energy of the receptor-ligand pair, nor on the equilibrium configuration of the polymer tether, but rather on its "rare" extended conformations.	LDFC Inst Phys, F-67084 Strasbourg, France; Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Mat Res Lab, Santa Barbara, CA 93106 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA; ALZA Corp, Mt View, CA 94043 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Boston University; University of California System; University of California Davis; Johnson & Johnson; Johnson & Johnson USA	Marques, CM (corresponding author), LDFC Inst Phys, 3 Rue Univ, F-67084 Strasbourg, France.		Wong, Joyce Y./AAF-5759-2019; Marques, Carlos M/B-2322-2010; Wong, Joyce Y/F-3732-2011	Wong, Joyce Y./0000-0002-3526-6381; Marques, Carlos M/0000-0002-3952-0498; Wong, Joyce Y/0000-0002-3526-6381; Marques, Carlos/0000-0002-6526-1258	NIGMS NIH HHS [GM-47334, GM-17876] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM017876, R01GM047334] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1992, INTERMOLECULAR SURFA; De Gennes P.-G., 1979, SCALING CONCEPTS POL; DEGENNES PG, 1982, J CHEM PHYS, V76, P3316, DOI 10.1063/1.443328; DOI M, 1975, CHEM PHYS, V9, P455, DOI 10.1016/0301-0104(75)80083-8; FERRENBERG AM, 1989, PHYS REV LETT, V63, P1195, DOI 10.1103/PhysRevLett.63.1195; FERRENBERG AM, 1988, PHYS REV LETT, V61, P2635, DOI 10.1103/PhysRevLett.61.2635; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; HELM CA, 1991, P NATL ACAD SCI USA, V88, P8169, DOI 10.1073/pnas.88.18.8169; Kolb A, 1997, MACROMOL THEOR SIMUL, V6, P169, DOI 10.1002/mats.1997.040060112; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; LECKBAND DE, 1994, BIOCHEMISTRY-US, V33, P4611, DOI 10.1021/bi00181a023; WILEMSKI G, 1973, J CHEM PHYS, V58, P4009, DOI 10.1063/1.1679757; Wong JY, 1997, SCIENCE, V275, P820, DOI 10.1126/science.275.5301.820	14	191	205	2	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2001	293	5529					465	468		10.1126/science.293.5529.465	http://dx.doi.org/10.1126/science.293.5529.465			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463908				2022-12-28	WOS:000169966700039
J	Russell, TP				Russell, TP			Polymer dynamics - Chance encounters	SCIENCE			English	Editorial Material							ADHESION		Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Russell, TP (corresponding author), Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA.	russell@mail.pse.umass.edu	Russell, Thomas Paul/ADL-3689-2022	Russell, Thomas Paul/0000-0001-6384-5826				ANASTASIADIS SH, 1990, J CHEM PHYS, V92, P5677, DOI 10.1063/1.458499; CHAR K, 1993, MACROMOLECULES, V26, P4164, DOI 10.1021/ma00068a015; Han J, 2000, SCIENCE, V288, P1026, DOI 10.1126/science.288.5468.1026; HELFAND E, 1972, J CHEM PHYS, V56, P3592, DOI 10.1063/1.1677735; HOAGLAND DA, 1992, MACROMOLECULES, V25, P6696, DOI 10.1021/ma00050a046; HOLMES OW, 1858, PROFESSOR BREAKFAST; ISRAELACHVILI J, 1993, INTERMOLECULAR SURFA; Jeppesen C, 2001, SCIENCE, V293, P465, DOI 10.1126/science.293.5529.465; Leger L, 1999, ADV POLYM SCI, V138, P185; Muthukumar M, 1999, J CHEM PHYS, V111, P10371, DOI 10.1063/1.480386; Senshu K, 1999, LANGMUIR, V15, P1754, DOI 10.1021/la980815+; SMITH JW, 1994, J POLYM SCI POL PHYS, V32, P1731, DOI 10.1002/polb.1994.090321005	12	10	12	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2001	293	5529					446	447		10.1126/science.1063289	http://dx.doi.org/10.1126/science.1063289			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463905				2022-12-28	WOS:000169966700035
J	Bach, PB; Cramer, LD; Schrag, D; Downey, RJ; Gelfand, SE; Begg, CB				Bach, PB; Cramer, LD; Schrag, D; Downey, RJ; Gelfand, SE; Begg, CB			The influence of hospital volume on survival after resection for lung cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEW-YORK-STATE; ADMINISTRATIVE DATA; OUTCOMES RESEARCH; PATIENT OUTCOMES; RANDOMIZED TRIAL; SURGICAL VOLUME; MORTALITY; SURGERY; QUALITY; CARE	Background: Among patients who have undergone high-risk operations for cancer, postoperative mortality rates are often lower at hospitals where more of these procedures are performed. We undertook a population-based study to estimate the extent to which the number of procedures performed at a hospital (hospital volume) is associated with survival after resection for lung cancer. Methods: We studied patients 65 years old or older who received a diagnosis of stage I, II, or IIIA non-small-cell lung cancer between 1985 and 1996, resided in 1 of the 10 study areas covered by the Surveillance, Epidemiology, and End Results Program, and underwent surgery at a hospital that participates in the Nationwide Inpatient Sample (2118 patients and 76 hospitals). Results: The volume of procedures at the hospital was positively associated with the survival of patients (P<0.001). Five years after surgery, 44 percent of patients who underwent operations at the hospitals with the highest volume were alive, as compared with 33 percent of those who underwent operations at the hospitals with the lowest volume. Patients at the highest-volume hospitals also had lower rates of postoperative complications (20 percent vs. 44 percent) and lower 30-day mortality (3 percent vs. 6 percent) than those at the lowest-volume hospitals. Conclusions: Patients who undergo resection for lung cancer at hospitals that perform large numbers of such procedures are likely to survive longer than patients who have such surgery at hospitals with a low volume of lung-resection procedures. (N Engl J Med 2001;345:181-8.) Copyright (C) 2001 Massachusetts Medical Society.	Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Hlth Outcomes Res Grp, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Hlth Outcomes Res Grp, 1275 York Ave,Box 221, New York, NY 10021 USA.			Schrag, Deborah/0000-0002-4334-5717	NATIONAL CANCER INSTITUTE [R01CA090226] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA-090226] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allison PD, 1999, LOGISTIC REGRESSION, P179; Asamura H, 1996, J THORAC CARDIOV SUR, V111, P1125, DOI 10.1016/S0022-5223(96)70213-1; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Begg MD, 1999, BIOMETRICS, V55, P302, DOI 10.1111/j.0006-341X.1999.00302.x; Best A E, 1999, J Med Syst, V23, P175, DOI 10.1023/A:1020515419714; Birkmeyer JD, 1999, SURGERY, V126, P178, DOI 10.1016/S0039-6060(99)70152-2; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Diggle PJ, 1995, J AM STAT ASSOC; Edwards EB, 1999, NEW ENGL J MED, V341, P2049, DOI 10.1056/NEJM199912303412703; Ellison LM, 2000, J UROLOGY, V163, P867, DOI 10.1016/S0022-5347(05)67821-4; Ettinger D S, 1996, Oncology (Williston Park), V10, P81; GRUMBACH K, 1995, JAMA-J AM MED ASSOC, V274, P1282, DOI 10.1001/jama.274.16.1282; Hannan EL, 1998, STROKE, V29, P2292, DOI 10.1161/01.STR.29.11.2292; HANNAN EL, 1989, JAMA-J AM MED ASSOC, V262, P503, DOI 10.1001/jama.262.4.503; Hewitt M, 2000, INTERPRETING VOLUME; Hillner BE, 2000, J CLIN ONCOL, V18, P2327, DOI 10.1200/JCO.2000.18.11.2327; Hillner BE, 1998, JAMA-J AM MED ASSOC, V280, P1783, DOI 10.1001/jama.280.20.1783; Holm T, 1997, BRIT J SURG, V84, P657, DOI 10.1046/j.1365-2168.1997.02745.x; HUGHES RG, 1987, MED CARE, V25, P489, DOI 10.1097/00005650-198706000-00004; IEZZONI LI, 1994, INQUIRY-J HEALTH CAR, V31, P40; ISHIDA T, 1990, ANN THORAC SURG, V50, P708, DOI 10.1016/0003-4975(90)90666-T; JOLLIS JG, 1993, ANN INTERN MED, V119, P844, DOI 10.7326/0003-4819-119-8-199310150-00011; Keller SM, 2000, NEW ENGL J MED, V343, P1217, DOI 10.1056/NEJM200010263431703; Khuri SF, 1999, ANN SURG, V230, P414, DOI 10.1097/00000658-199909000-00014; Lawthers AG, 2000, MED CARE, V38, P785, DOI 10.1097/00005650-200008000-00003; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; MOUNTAIN CF, 1986, CHEST, V89, pS225, DOI 10.1378/chest.89.4.225S; Percy C., 1990, INT CLASSIFICATION D; Phillips KA, 1997, INT J QUAL HEALTH C, V9, P341, DOI 10.1093/intqhc/9.5.341; POTOSKY AL, 1993, MED CARE, V31, P732; ROMANO PS, 1992, CHEST, V101, P1332, DOI 10.1378/chest.101.5.1332; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Roohan PJ, 1998, AM J PUBLIC HEALTH, V88, P454, DOI 10.2105/AJPH.88.3.454; ROSELL R, 1994, NEW ENGL J MED, V330, P153, DOI 10.1056/NEJM199401203300301; Rosenthal GE, 1997, JAMA-J AM MED ASSOC, V278, P485, DOI 10.1001/jama.278.6.485; Schrag D, 2000, JAMA-J AM MED ASSOC, V284, P3028, DOI 10.1001/jama.284.23.3028; Sosa JA, 1998, ANN SURG, V228, P429, DOI 10.1097/00000658-199809000-00016; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106; WHITE H, 1982, ECONOMETRICA, V50, P1, DOI 10.2307/1912526; Yao SL, 1999, J NATL CANCER I, V91, P1950, DOI 10.1093/jnci/91.22.1950; 1999, HOSP PAYOR ICD9CM IN	42	545	552	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2001	345	3					181	188		10.1056/NEJM200107193450306	http://dx.doi.org/10.1056/NEJM200107193450306			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453JM	11463014				2022-12-28	WOS:000169912800006
J	Bostom, AG; Selhub, J; Jacques, PF; Rosenberg, IH				Bostom, AG; Selhub, J; Jacques, PF; Rosenberg, IH			Power shortage: Clinical trials testing the "homocysteine hypothesis" against a background of folic acid-fortified cereal grain flour	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CONVERTING ENZYME-INHIBITION; METAANALYSIS	Large randomized, controlled trials of total homocysteine-lowering therapy for the potential reduction of cardiovascular disease outcomes are ongoing in the United States and Canada, These trials are the Vitamin Intervention for Stroke Prevention (VISP) trial, the Women's Antioxidant Cardiovascular Disease Study (WACS), and the Heart Outcomes Prevention Evaluation (HOPE-2). However, the dramatic effect of policies mandating fortification of cereal grain flour products with folic acid may reduce the statistical power of these trials. All three trials assume that the active treatment groups will achieve the same mean effects of total homocysteine-lowering therapy as those reported in the absence of folic acid-fortified cereal grain flour. This paper examines this assumption using data from studies of total homocysteine-lowering therapy in U.S. and Canadian patients with cardiovascular disease who were exposed to products made with folic acid-fortified cereal grain flour, These data showed that the VISP trial, HOPE-2, and WACS will probably achieve only approximately 20% to 25% of the projected treatment effects of mean total homocysteine-lowering therapy (1.0 to 1.5 mu mol/L vs. 4.0 to 6.0 mu mol/L). As a result, all three trials will be substantially underpowered to test the specific hypotheses of total homocysteine- lowering therapy identified a priori. In contrast, renal transplant recipients have a persistent excess prevalence of hyperhomocysteinemia in the era of fortification but remain very responsive to supraphysiologic doses of folic acid-based supplementation (mean reduction in total homocysteine level, 5.0 to 6.0 mu mol/L). Therefore, unlike other populations with normal renal function that are at high risk for cardiovascular disease but are profoundly affected by fortification efforts, renal transplant recipients continue to merit serious consideration for a controlled trial of the "homocysteine hypothesis.".	Univ Colorado, Hlth Sci Ctr, Denver, CO 80262 USA; Denver Hlth, Denver, CO 80204 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Denver Health Medical Center	Bostom, AG (corresponding author), Univ Colorado, Hlth Sci Ctr, 4200 E 9th Ave,Room 6403, Denver, CO 80262 USA.	abostom@loa.com						GANSEVOORT RT, 1995, NEPHROL DIAL TRANSPL, V10, P1963; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; KASISKE BL, 1993, ANN INTERN MED, V118, P129, DOI 10.7326/0003-4819-118-2-199301150-00009; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Mosconi L, 1996, KIDNEY INT, pS91; Ravid M, 1996, ARCH INTERN MED, V156, P286, DOI 10.1001/archinte.156.3.286; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; WEIDMANN P, 1995, NEPHROL DIAL TRANSPL, V10, P39	9	81	82	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2001	135	2					133	139		10.7326/0003-4819-135-2-200107170-00014	http://dx.doi.org/10.7326/0003-4819-135-2-200107170-00014			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452DR	11453713				2022-12-28	WOS:000169842300007
J	Gundersen, L				Gundersen, L			Physician burnout	ANNALS OF INTERNAL MEDICINE			English	Article																			0	175	184	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2001	135	2					145	148		10.7326/0003-4819-135-2-200107170-00023	http://dx.doi.org/10.7326/0003-4819-135-2-200107170-00023			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452DR	11453722				2022-12-28	WOS:000169842300013
J	Vasconcelos, PFC; Luna, EJ; Galler, R; Silva, LJ; Coimbra, TL; Barros, VLRS; Monath, TP; Rodigues, SG; Laval, C; Costa, ZG; Vilela, MFG; Santos, CLS; Papaiordanou, CMO; Alves, VAF; Andrade, LD; Sato, HK; Rosa, EST; Froguas, GB; Lacava, E; Almeida, LMR; Cruz, ACR; Rocco, IM; Santos, RTM; Oliva, OFP				Vasconcelos, PFC; Luna, EJ; Galler, R; Silva, LJ; Coimbra, TL; Barros, VLRS; Monath, TP; Rodigues, SG; Laval, C; Costa, ZG; Vilela, MFG; Santos, CLS; Papaiordanou, CMO; Alves, VAF; Andrade, LD; Sato, HK; Rosa, EST; Froguas, GB; Lacava, E; Almeida, LMR; Cruz, ACR; Rocco, IM; Santos, RTM; Oliva, OFP		Brazilian Yellow Fever Vaccine Eva	Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases	LANCET			English	Article							VIRUS; EPIDEMIC; STRAINS; REGION	Background The yellow fever vaccine is regarded as one of the safest attenuated virus vaccines. with few side-effects or adverse events. We report the occurrence of two fatal cases of haemorrhagic fever associated with yellow fever 17DD substrain vaccine in Brazil. Methods We obtained epidemiological, serological, virological, pathological, immunocytochemical, and molecular biological data on the two cases to determine the cause of the illnesses. Findings The first case, in a 5-year-old white girl, was characterised by sudden onset of fever accompanied by headache. malaise, and vomiting 3 days after receiving yellow fever and measles-mumps-rubella vaccines. Afterwards she decompensated with icterus and haemorrhagic signs and died after a 5-day illness. The second patient-a 22-year-old black woman-developed a sore throat and fever accompanied by headache, myalgia, nausea, and vomiting 4 days after yellow fever vaccination. She then developed icterus, renal failure, and haemorrhagic diathesis, and died after 6 days of illness. Yellow fever virus was recovered in suckling mice and C6/36 cells from blood in both cases, as well as from fragments of liver, spleen, skin, and heart from the first case and from these and other viscera fragments in case 2. RNA of yellow fever virus was identical to that previously described for 17D genomic sequences. IgM ELISA tests for yellow fever virus were negative in case 1 and positive in case 2; similar tests for dengue, hantaviruses, arenaviruses, Leptospira, and hepatitis viruses A-D were negative. Tissue injuries from both patients were typical of wild-type yellow fever. Interpretation These serious and hitherto unknown complications of yellow fever vaccination are extremely rare. but the safety of yellow fever 17DD vaccine needs to be reviewed. Host factors, probably idiosyncratic reactions, might have had a substantial contributed to the unexpected outcome.	FUNASA, Inst Evandro Chagas, Dept Arbovirus, WHO Collaborating Ctr Reference & Res Arbovirus, BR-66090000 Belem, Para, Brazil; Inst Adolfo Luz, Sao Paulo, Brazil; Univ Campinas, Campinas, SP, Brazil; Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil; FUNASA, CENEPI, Brasilia, DF, Brazil; Secretaria Municipal Saude, Goiania, Go, Brazil; Secretaria Saude Estado Sao Paulo, Sao Paulo, Brazil; Acambis Inc, Cambridge, MA USA; Secretaria Municipal Saude, Americana, Brazil; Secretaria Municipal Saude, Santa Barbara, Brazil; Pan Amer Hlth Org, Washington, DC USA	Instituto Evandro Chagas; Universidade Estadual de Campinas; Fundacao Oswaldo Cruz; Sanofi-Aventis; Pan American Health Organization	Vasconcelos, PFC (corresponding author), FUNASA, Inst Evandro Chagas, Dept Arbovirus, WHO Collaborating Ctr Reference & Res Arbovirus, Av Almirante Barroso 492, BR-66090000 Belem, Para, Brazil.		Nogueira, Raquel Tayar/F-6475-2019; Santos, Raimunda Telma/H-5973-2012; Galler, Ricardo/B-3280-2014; Vasconcelos, Pedro/AAH-3142-2019; Luna, Expedito J A/B-7948-2012; Ribeiro Cruz, Ana Cecilia/V-9276-2019	Nogueira, Raquel Tayar/0000-0002-0581-763X; Luna, Expedito J A/0000-0002-1145-9672; Ribeiro Cruz, Ana Cecilia/0000-0002-4607-9346; Alves, Venancio/0000-0001-5285-4460				BARRETT ADT, 1989, VACCINE, V7, P333, DOI 10.1016/0264-410X(89)90196-5; Beaty BJ, 1989, DIAGNOSTIC PROCEDURE, P797; CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561; da Rosa APAT, 2000, EMERG INFECT DIS, V6, P298; DOSSANTOS CND, 1995, VIRUS RES, V35, P35; HALL WC, 1991, AM J TROP MED HYG, V45, P408, DOI 10.4269/ajtmh.1991.45.408; JENNINGS AD, 1994, J INFECT DIS, V169, P512, DOI 10.1093/infdis/169.3.512; KUNO G, 1987, AM J TROP MED HYG, V36, P153, DOI 10.4269/ajtmh.1987.36.153; Monath TP, 1999, VACCINES, P815; Robertson SE, 1996, JAMA-J AM MED ASSOC, V276, P1157, DOI 10.1001/jama.276.14.1157; ROBERTSON SE, 1993, WHOEIPGEN9318; SHOPE ROBERT E., 1963, AN MICROBIOL, V11, P167; Sibailly TS, 1997, PEDIATR INFECT DIS J, V16, P1177, DOI 10.1097/00006454-199712000-00015; TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053; Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787; THEILER M, 1951, YELLOW FEVER, P46; Vasconcelos P. F. C., 1999, Dengue Bulletin, V23, P55; Vasconcelos PFC, 1997, AM J TROP MED HYG, V57, P132, DOI 10.4269/ajtmh.1997.57.132; VASCONCELOS PFC, IN PRESS J MED VIROL; VASCONCELOS PFC, IN PRESS EMERG INFEC; Wang E, 1996, VIROLOGY, V225, P274, DOI 10.1006/viro.1996.0601; *WHO GLOB PROGR AI, 1995, WHO GPA STD, V1, P1	22	191	207	0	37	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 14	2001	358	9276					91	97		10.1016/S0140-6736(01)05326-0	http://dx.doi.org/10.1016/S0140-6736(01)05326-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452BR	11463409	Green Published			2022-12-28	WOS:000169837700008
J	Waise, A; Fisken, RA				Waise, A; Fisken, RA			Lesson of the week - Unsuspected nephrogenic diabetes insipidus	BRITISH MEDICAL JOURNAL			English	Review							LITHIUM		Friarage Hosp, Endocrine Clin, Northallerton DL6 1JG, N Yorkshire, England		Waise, A (corresponding author), Friarage Hosp, Endocrine Clin, Northallerton DL6 1JG, N Yorkshire, England.							COX M, 1975, AM J MED, V59, P153, DOI 10.1016/0002-9343(75)90348-4; NIAUDER P, 1984, FRONTIERS HORMONE RE, V13, P224; SIMON NM, 1977, ANN INTERN MED, V86, P446, DOI 10.7326/0003-4819-86-4-446; SINGER I, 1976, KIDNEY INT, V10, P82, DOI 10.1038/ki.1976.80; Thompson CJ, 1997, SCOT MED J, V42, P16, DOI 10.1177/003693309704200106; WALLER DG, 1984, Q J MED, V53, P369; WALLER DG, 1989, PSYCHOL MED, V19, P825, DOI 10.1017/S0033291700005535	7	11	11	1	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 14	2001	323	7304					96	97		10.1136/bmj.323.7304.96	http://dx.doi.org/10.1136/bmj.323.7304.96			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454GD	11451787	Green Published			2022-12-28	WOS:000169964100021
J	Hunter, N; Kleckner, N				Hunter, N; Kleckner, N			The single-end invasion: An asymmetric intermediate at the double-strand break to double-holliday junction transition of meiotic recombination	CELL			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; CHROMOSOME SYNAPSIS; ALLOHEXAPLOID WHEAT; SORDARIA-MACROSPORA; INITIATION SITE; GENE CONVERSION; CROSSING-OVER; MEIOSIS	We identify a novel meiotic recombination intermediate, the single-end invasion (SEI), which occurs during the transition from double-strand breaks (DSBs) to double-Holliday junction (dHJs). SEIs are products of strand exchange between one DSB end and its homolog. The structural asymmetry of SEIs indicates that the two ends of a DSB interact with the homolog in temporal succession, via structurally (and thus biochemically) distinct processes. SEIs arise surprisingly late in prophase, concomitant with synaptonemal complex (SC) formation. These and other data imply that SEIs are preceded by nascent DSB-partner intermediates, which then undergo selective differentiation into crossover and noncrossover types, with SC formation and strand exchange as downstream consequences. Late occurrence of strand exchange provides opportunity to reverse recombinational fate even after homologs are coaligned and/or synapsed. This feature can explain crossover suppression between homeologous and structurally heterozygous chromosomes.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Kleckner, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	kleckner@fas.harvard.edu			NIGMS NIH HHS [GM44794] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; ALBINI SM, 1987, CHROMOSOMA, V95, P324, DOI 10.1007/BF00293179; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Allers T, 2000, Nucleic Acids Res, V28, pe6, DOI 10.1093/nar/28.2.e6; Arbel A, 1999, EMBO J, V18, P2648, DOI 10.1093/emboj/18.9.2648; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; BELL LR, 1982, COLD SPRING HARB SYM, V47, P829, DOI 10.1101/SQB.1983.047.01.095; BELMAAZA A, 1994, MUTAT RES, V314, P199, DOI 10.1016/0921-8777(94)90065-5; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Bishop DK, 1999, GENES CELLS, V4, P425, DOI 10.1046/j.1365-2443.1999.00273.x; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Borts RH, 2000, MUTAT RES-FUND MOL M, V451, P129, DOI 10.1016/S0027-5107(00)00044-0; CARPENTER ATC, 1994, CELL, V77, P959, DOI 10.1016/0092-8674(94)90434-0; Cha RS, 2000, GENE DEV, V14, P493; DEMASSY B, 1995, EMBO J, V14, P4589, DOI 10.1002/j.1460-2075.1995.tb00138.x; FOSS E, 1993, GENETICS, V133, P681; Franklin AE, 1999, PLANT CELL, V11, P809, DOI 10.1105/tpc.11.5.809; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Grushcow JM, 1999, GENETICS, V153, P607; Havekes FWJ, 1994, CHROMOSOME RES, V2, P315, DOI 10.1007/BF01552725; HOBOLTH P, 1981, CARLSBERG RES COMMUN, V46, P129, DOI 10.1007/BF02910465; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; HOLM PB, 1986, CARLSBERG RES COMMUN, V51, P239, DOI 10.1007/BF02906837; Hunter N, 2001, NAT GENET, V27, P236, DOI 10.1038/85781; Jones G.H., 1984, Symposia of the Society for Experimental Biology, P293; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kleckner N, 1996, P NATL ACAD SCI USA, V93, P8167, DOI 10.1073/pnas.93.16.8167; KLECKNER N, 1993, COLD SPRING HARB SYM, V58, P553, DOI 10.1101/SQB.1993.058.01.062; MAGUIRE MP, 1994, GENETICS, V137, P281; Masson JY, 2001, TRENDS BIOCHEM SCI, V26, P131, DOI 10.1016/S0968-0004(00)01742-4; MOSES MJ, 1984, CONTROLLING EVENTS M, P245; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; ROCKMILL B, 1995, GENE DEV, V9, P2684, DOI 10.1101/gad.9.21.2684; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; STACK SM, 1993, CHROMOSOMES TODAY, V11, P301; Storlazzi A, 1996, P NATL ACAD SCI USA, V93, P9043, DOI 10.1073/pnas.93.17.9043; STORLAZZI A, 1995, P NATL ACAD SCI USA, V92, P8512, DOI 10.1073/pnas.92.18.8512; SUN H, 1989, NATURE, V338, P87, DOI 10.1038/338087a0; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; Tarsounas M, 1999, J CELL BIOL, V147, P207, DOI 10.1083/jcb.147.2.207; Villemure JF, 1997, MOL GEN GENET, V256, P533, DOI 10.1007/s004380050598; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Worth L, 1998, J BIOL CHEM, V273, P23176, DOI 10.1074/jbc.273.36.23176; XU LH, 1995, EMBO J, V14, P5115, DOI 10.1002/j.1460-2075.1995.tb00194.x; YAMAMOTO K, 1992, MOL GEN GENET, V234, P1; ZICKLER D, 1977, CHROMOSOMA, V61, P289, DOI 10.1007/BF00288615; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619; ZICKLER D, 1992, GENETICS, V132, P135	55	507	518	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2001	106	1					59	70		10.1016/S0092-8674(01)00430-5	http://dx.doi.org/10.1016/S0092-8674(01)00430-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461702	Bronze			2022-12-28	WOS:000169870300009
J	Emery, J; Lucassen, A; Murphy, M				Emery, J; Lucassen, A; Murphy, M			Common hereditary cancers and implications for primary care	LANCET			English	Review							NONPOLYPOSIS COLORECTAL-CANCER; FAMILIAL ADENOMATOUS POLYPOSIS; BILATERAL PROPHYLACTIC MASTECTOMY; ASHKENAZI-JEWISH INDIVIDUALS; BREAST-OVARIAN CANCER; RANDOMIZED TRIAL; BRCA2 MUTATIONS; SCREENING MAMMOGRAPHY; CARRIER FREQUENCY; RISK	The identification of genes that place individuals at high risk of breast, ovarian, and colorectal cancer has greatly advanced our understanding of cancer predisposition over the past decade. This knowledge has received much attention from the media, and referrals to geneticists and surgeons, and requests for genetic testing, have risen. We review the published evidence for the management of people at increased risk of hereditary cancers, to draw attention to areas of uncertainty and to discuss implications for primary care. We focus on common inherited cancers, since they will have the greatest effect on clinical practice over the next decade. Cancer genetics offers a model of how information on the genetics of other common diseases could affect primary care in the future. Strategies to support the integration of genetic medicine in primary care are needed to enable primary-care practitioners to identify individuals at raised genetic risk and to reassure patients for whom genetic testing and increased surveillance offer little benefit.	Univ Cambridge, Dept Publ Hlth & Primary Care, Gen Practice & Primary Care Res Unit, Cambridge CB2 2SR, England; Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; Univ Oxford, Inst Hlth Sci, Imperial Canc Res Fund, Gen Practice Res Grp,Dept Primary Hlth Care, Oxford OX1 2JD, England	University of Cambridge; University of Oxford	Emery, J (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Gen Practice & Primary Care Res Unit, Forvie Site, Cambridge CB2 2SR, England.	jde10@medschl.cam.ac.uk	Lucassen, Anneke/D-7764-2017	Lucassen, Anneke/0000-0003-3324-4338				AALTONEN LA, 1994, CANCER RES, V54, P1645; Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.3.CO;2-C; *AM COLL MED GEN, 1999, GEN SUSC BREAST OV C; Bellacosa A, 1996, AM J MED GENET, V62, P353, DOI 10.1002/(SICI)1096-8628(19960424)62:4<353::AID-AJMG7>3.0.CO;2-S; Berry DA, 1997, J NATL CANCER I, V89, P227, DOI 10.1093/jnci/89.3.227; BISHOP DT, 1990, CANCER SURV, V9, P585; BONDY ML, 1994, J NATL CANCER I, V86, P620, DOI 10.1093/jnci/86.8.620; Brain K, 2000, J NATL CANCER I, V92, P1345, DOI 10.1093/jnci/92.16.1345; Burn J, 1998, P NUTR SOC, V57, P183, DOI 10.1079/PNS19980030; BURN J, 1991, J MED GENET, V28, P289, DOI 10.1136/jmg.28.5.289; Chang-Claude J, 1998, J MED GENET, V35, P116, DOI 10.1136/jmg.35.2.116; CLAUS EB, 1991, AM J HUM GENET, V48, P232; Couch FJ, 1997, NEW ENGL J MED, V336, P1409, DOI 10.1056/NEJM199705153362002; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Devilee P, 1999, AM J HUM GENET, V64, P943, DOI 10.1086/302350; Easton DF, 1997, AM J HUM GENET, V61, P120, DOI 10.1086/513891; EASTON DF, 1993, AM J HUM GENET, V52, P678; Eccles DM, 2000, J MED GENET, V37, P203, DOI 10.1136/jmg.37.3.203; Ellis D, 2000, J MED GENET, V37, P792, DOI 10.1136/jmg.37.10.792; Emery J, 1999, FAM PRACT, V16, P426, DOI 10.1093/fampra/16.4.426; Emery J, 2000, BMJ-BRIT MED J, V321, P28, DOI 10.1136/bmj.321.7252.28; Evans DGR, 1997, BRIT J SURG, V84, P1281; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Fodor FH, 1998, AM J HUM GENET, V63, P45, DOI 10.1086/301903; FORD D, 1995, AM J HUM GENET, V57, P1457; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Friedman L C, 1997, J Cancer Educ, V12, P199; Frost MH, 2000, JAMA-J AM MED ASSOC, V284, P319, DOI 10.1001/jama.284.3.319; FUCHS CS, 1994, NEW ENGL J MED, V331, P1669, DOI 10.1056/NEJM199412223312501; Gabrick DM, 2000, JAMA-J AM MED ASSOC, V284, P1791, DOI 10.1001/jama.284.14.1791; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; Hayflick S J, 1998, Community Genet, V1, P18, DOI 10.1159/000016131; Jacobs IJ, 1999, LANCET, V353, P1207, DOI 10.1016/S0140-6736(98)10261-1; Janne PA, 2000, NEW ENGL J MED, V342, P1960, DOI 10.1056/NEJM200006293422606; JARVINEN HJ, 1992, GUT, V33, P357, DOI 10.1136/gut.33.3.357; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; JOHNSON N, 1995, FAM PRACT, V12, P287, DOI 10.1093/fampra/12.3.287; Kerlikowske K, 2000, ANN INTERN MED, V133, P855, DOI 10.7326/0003-4819-133-11-200012050-00009; KERLIKOWSKE K, 1995, JAMA-J AM MED ASSOC, V273, P149, DOI 10.1001/jama.273.2.149; Lerman C, 1996, JAMA-J AM MED ASSOC, V275, P1885, DOI 10.1001/jama.275.24.1885; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535, DOI 10.1016/0016-5085(93)90368-M; MAHER ER, 1993, J MED GENET, V30, P675, DOI 10.1136/jmg.30.8.675; McTiernan A, 1997, J CLIN EPIDEMIOL, V50, P547, DOI 10.1016/S0895-4356(97)00013-9; Meijers-Heijboer EJ, 2000, LANCET, V355, P2015, DOI 10.1016/S0140-6736(00)02347-3; Narod SA, 1998, NEW ENGL J MED, V339, P424, DOI 10.1056/NEJM199808133390702; Newman B, 1998, JAMA-J AM MED ASSOC, V279, P915, DOI 10.1001/jama.279.12.915; Oddoux C, 1996, NAT GENET, V14, P188, DOI 10.1038/ng1096-188; Pharoah PDP, 1997, INT J CANCER, V71, P800, DOI 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.3.CO;2-R; PIVER MS, 1993, CANCER-AM CANCER SOC, V71, P2751, DOI 10.1002/1097-0142(19930501)71:9<2751::AID-CNCR2820710911>3.0.CO;2-J; Powles T, 1998, LANCET, V352, P98; Rebbeck TR, 1999, J NATL CANCER I, V91, P1475, DOI 10.1093/jnci/91.17.1475; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; Schrag D, 1997, NEW ENGL J MED, V336, P1465, DOI 10.1056/NEJM199705153362022; SPIEGELMAN D, 1994, J NATL CANCER I, V86, P600, DOI 10.1093/jnci/86.8.600; SPIGELMAN AD, 1994, FAMILIAL ADENOMATOUS; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Syngal S, 1999, JAMA-J AM MED ASSOC, V282, P247, DOI 10.1001/jama.282.3.247; Syngal S, 2000, J MED GENET, V37, P641, DOI 10.1136/jmg.37.9.641; Syrjakoski K, 2000, J NATL CANCER I, V92, P1529, DOI 10.1093/jnci/92.18.1529; Thorlacius S, 1998, LANCET, V352, P1337, DOI 10.1016/S0140-6736(98)03300-5; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Veronesi U, 1998, LANCET, V352, P93; Warner E, 1999, J NATL CANCER I, V91, P1241, DOI 10.1093/jnci/91.14.1241; Watson M, 1999, BRIT J CANCER, V79, P868, DOI 10.1038/sj.bjc.6690139; Wijnen JT, 1998, NEW ENGL J MED, V339, P511, DOI 10.1056/NEJM199808203390804; 1994, SCREENING COLORECTAL	71	52	52	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 7	2001	358	9275					56	63		10.1016/S0140-6736(00)05257-0	http://dx.doi.org/10.1016/S0140-6736(00)05257-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11454400				2022-12-28	WOS:000169710900035
J	Javaux, EJ; Knoll, AH; Walter, MR				Javaux, EJ; Knoll, AH; Walter, MR			Morphological and ecological complexity in early eukaryotic ecosystems	NATURE			English	Article							ROCKS; MICROFOSSILS; EXAMPLE; FOSSILS; BASIN	Molecular phylogeny and biogeochemistry indicate that eukaryotes differentiated early in Earth history. Sequence comparisons of small-subunit ribosomal RNA genes suggest a deep evolutionary divergence of Eukarya and Archaea(1); C-27-C-29 steranes (derived from sterols synthesized by eukaryotes) and strong depletion of C-13 (a biogeochemical signature of methanogenic Archaea) in 2,700 Myr old kerogens independently place a minimum age on this split(2,3). Steranes, large spheroidal microfossils, and rare macrofossils of possible eukaryotic origin occur in Palaeoproterozoic rocks(4-6). Until now, however, evidence for morphological and taxonomic diversification within the domain has generally been restricted to very late Mesoproterozoic and Neoproterozoic successions(7). Here we show that the cytoskeletal and ecological prerequisites for eukaryotic diversification were already established in eukaryotic microorganisms fossilized nearly 1,500 Myr ago in shales of the early Mesoproterozoic Roper Group in northern Australia.	Harvard Univ, Bot Museum, Cambridge, MA 02138 USA; Macquarie Univ, Australian Ctr Astrobiol, Dept Earth & Planetary Sci, Sydney, NSW 2109, Australia	Harvard University; Macquarie University	Knoll, AH (corresponding author), Harvard Univ, Bot Museum, Cambridge, MA 02138 USA.	aknoll@oeb.harvard.edu						Abbott ST, 2000, AUST J EARTH SCI, V47, P637, DOI 10.1046/j.1440-0952.2000.00795.x; ANBAR AD, 1999, 1999 AM GEOPH UN FAL; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Butterfield Nicholas J., 1994, Fossils and Strata, V34, P1; BUTTERFIELD NJ, 1992, PALAEONTOLOGY, V35, P943; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; GERMAN TN, 1990, ORGANIC WORLD 1 BILL, P1; HAN TM, 1992, SCIENCE, V257, P232, DOI 10.1126/science.1631544; Hayes J. M., 1994, EARLY LIFE EARTH, P220; Jackson M.J., 1999, INTEGRATED BASIN ANA; JACKSON MJ, 1991, PRECAMBRIAN RES, V54, P81, DOI 10.1016/0301-9268(91)90070-Q; JACOBSON SR, 1979, J PALEONTOL, V53, P1197; JANKAUSKAS TV, 1989, PRECAMBRIAN MICROFOS, P5; Jansen RP, 1999, FASEB J, V13, P455, DOI 10.1096/fasebj.13.3.455; Knoll A.H., 1996, PALYNOLOGY PRINCIPLE, V1, P51; KRALIK M, 1982, PRECAMBRIAN RES, V18, P157, DOI 10.1016/0301-9268(82)90044-4; PEAT C J, 1978, BMR (Bureau of Mineral Resources) Journal of Australian Geology and Geophysics, V3, P1; PETROV PY, 1995, STRATIGR GEO CORREL+, V3, P435; Samuelsson J, 1999, PRECAMBRIAN RES, V96, P1, DOI 10.1016/S0301-9268(98)00123-5; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; SUMMONS RE, 1987, GEOCHIM COSMOCHIM AC, V51, P3075, DOI 10.1016/0016-7037(87)90381-4; VEIS AF, 1992, IZV AN SSSR GEOL, V8, P114; VIDAL G, 1990, AM J SCI, V290A, P170; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Xiao SH, 1997, PRECAMBRIAN RES, V84, P197, DOI 10.1016/S0301-9268(97)00029-6; Yin LM, 1997, REV PALAEOBOT PALYNO, V98, P15, DOI 10.1016/S0034-6667(97)00022-5; Zhang Zhongying, 1986, Journal of Micropalaeontology, V5, P9; ZHOU H, 1999, SEQUENCE STRATIGRAPH, P5	28	284	321	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					66	69		10.1038/35083562	http://dx.doi.org/10.1038/35083562			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452306				2022-12-28	WOS:000169644900043
J	Rhode, SC; Pawlowski, M; Tollrian, R				Rhode, SC; Pawlowski, M; Tollrian, R			The impact of ultraviolet radiation on the vertical distribution of zooplankton of the genus Daphnia	NATURE			English	Article							SOLAR UV-RADIATION; ADAPTIVE SIGNIFICANCE; MIGRATION; EXPOSURE; MAGNA	The vertical migration of zooplankton into lower and darker water strata by day is generally explained by the avoidance of visually orienting predators, mainly fish(1-4); however, it is unclear why daily zooplankton migration has been maintained in fishless areas(5). In addition to predation, ultraviolet radiation-a hazardous factor for zooplankton in the surface layers of marine and freshwater environments(6-8) - has been suspected as a possible cause of daytime downward migration(9). Here we test this hypothesis by studying several Daphnia species, both in a controlled laboratory system and under natural sunlight in an outdoor system. We selected Daphnia species that differed in their pigmentation as both melanin and carotenoids have been shown to protect Daphnia from ultraviolet light(10,11). All Daphnia species escaped into significantly deeper water layers under ultraviolet radiation. The extent to which the daphnids responded to this radiation was inversely linked to their pigmentation, which reduced ultraviolet transmission. These results suggest that ultraviolet avoidance is an additional factor in explaining daytime downward migration. Synergistic benefits might have shaped the evolution of this complex behaviour.	Univ Munich, Dept Ecol, Inst Zool, D-80333 Munich, Germany	University of Munich	Tollrian, R (corresponding author), Univ Munich, Dept Ecol, Inst Zool, Karlstr 25, D-80333 Munich, Germany.	ralph.tollrian@lrz.uni-muenchen.de						BOLLENS SM, 1994, J PLANKTON RES, V16, P555, DOI 10.1093/plankt/16.5.555; CALKINS J, 1980, NATURE, V283, P563, DOI 10.1038/283563a0; CONFER JL, 1978, OIKOS, V31, P27, DOI 10.2307/3543380; DAMKAER DM, 1982, ROLE SOLAR ULTRAVIOL, P701; De Meester L, 1998, ECOLOGY AND EVOLUTION OF INDUCIBLE DEFENSES, P160; DEMEESTER L, 1995, NATURE, V378, P483; DODSON S, 1990, LIMNOL OCEANOGR, V35, P1195, DOI 10.4319/lo.1990.35.5.1195; FLEISCHMANN EM, 1989, LIMNOL OCEANOGR, V34, P1623, DOI 10.4319/lo.1989.34.8.1623; HAIRSTON NG, 1976, P NATL ACAD SCI USA, V73, P971, DOI 10.1073/pnas.73.3.971; HEBERT PDN, 1990, FUNCT ECOL, V4, P703; HESSEN DO, 1994, ARCH HYDROBIOL BEIH, V43, P85; Kerfoot W.C., 1985, Contributions in Marine Science, V27, P91; LAMPERT W, 1989, FUNCT ECOL, V3, P21, DOI 10.2307/2389671; Leech DM, 2001, LIMNOL OCEANOGR, V46, P416, DOI 10.4319/lo.2001.46.2.0416; LOOSE CJ, 1994, ECOLOGY, V75, P2255, DOI 10.2307/1940881; MADRONICH S, 1995, AMBIO, V24, P143; Merker E., 1930, Zoologische Jahrbuecher Jena Allgemeine Zoologie, V48, P277; Morris DP, 1995, LIMNOL OCEANOGR, V40, P1381, DOI 10.4319/lo.1995.40.8.1381; NEILL WE, 1990, NATURE, V345, P524, DOI 10.1038/345524a0; Ringelberg J., 1964, Netherlands Journal of Sea Research, V2, P319, DOI 10.1016/0077-7579(64)90001-8; Siebeck O., 1994, Advances in Limnology, V43, P197; SMITH KC, 1990, J COMP PHYSIOL A, V166, P597; SMITH RC, 1981, APPL OPTICS, V20, P177, DOI 10.1364/AO.20.000177; STICH HB, 1981, NATURE, V293, P396, DOI 10.1038/293396a0; Storz UC, 1998, J COMP PHYSIOL A, V183, P709, DOI 10.1007/s003590050293; VINYARD GL, 1976, J FISH RES BOARD CAN, V33, P2845, DOI 10.1139/f76-342; WILLIAMSON CE, 1994, J PLANKTON RES, V16, P205, DOI 10.1093/plankt/16.3.205; WILLIAMSON CE, IN PRESS ECOLOGY; ZARET TM, 1976, LIMNOL OCEANOGR, V21, P804, DOI 10.4319/lo.1976.21.6.0804	29	184	199	6	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					69	72		10.1038/35083567	http://dx.doi.org/10.1038/35083567			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452307				2022-12-28	WOS:000169644900044
J	Orme, CA; Noy, A; Wierzbicki, A; McBride, MT; Grantham, M; Teng, HH; Dove, PM; DeYoreo, JJ				Orme, CA; Noy, A; Wierzbicki, A; McBride, MT; Grantham, M; Teng, HH; Dove, PM; DeYoreo, JJ			Formation of chiral morphologies through selective binding of amino acids to calcite surface steps	NATURE			English	Article							FREE-ENERGIES; ELECTROSTATIC POTENTIALS; CRYSTAL NUCLEATION; AQUEOUS-SOLUTION; GROWTH; CRYSTALLIZATION; INTERFACES; SOLVATION; MODEL; DIFFRACTION	Many living organisms contain biominerals and composites with finely tuned properties, reflecting a remarkable level of control over the nucleation, growth and shape of the constituent crystals(1-6). Peptides and proteins play an important role in achieving this control(1,7,8). But the general view that organic molecules affect mineralization through stereochemical recognition, where geometrical and chemical constraints dictate their binding to a mineral, seems difficult to reconcile(4) with a mechanistic understanding, where crystallization is controlled by thermodynamic and kinetic factors(9). Indeed, traditional crystal growth models emphasize the inhibiting effect of so-called 'modifiers' on surface-step growth, rather than stereochemical matching to newly expressed crystal facets. Here we report in situ atomic force microscope observations and molecular modelling studies of calcite growth in the presence of chiral amino acids that reconcile these two seemingly divergent views. We rnd that enantiomer-specific binding of the amino acids to those surface-step edges that offer the best geometric and chemical rt changes the step-edge free energies, which in turn results in macroscopic crystal shape modifications. Our results emphasize that the mechanism underlying crystal modification through organic molecules is best understood by considering both stereochemical recognition and the effects of binding on the interfacial energies of the growing crystal.	Lawrence Livermore Natl Lab, Dept Chem & Mat Sci, Livermore, CA 94551 USA; Univ S Alabama, Dept Chem, Mobile, AL 36688 USA; Virginia Polytech Inst & State Univ, Dept Geol Sci, Blacksburg, VA 24061 USA; George Washington Univ, Dept Earth & Environm Sci, Washington, DC 20052 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of South Alabama; Virginia Polytechnic Institute & State University; George Washington University	Orme, CA (corresponding author), Lawrence Livermore Natl Lab, Dept Chem & Mat Sci, Livermore, CA 94551 USA.	orme1@llnl.gov	Dove, Patricia M/A-7911-2010; Orme, Christine A/A-4109-2009	Orme, Christine A/0000-0003-3652-3367; Noy, Aleksandr/0000-0003-4924-2652				ADDADI L, 1986, TOP STEREOCHEM, V16, P1, DOI 10.1002/9780470147252.ch1; ADDADI L, 1987, P NATL ACAD SCI USA, V84, P2732, DOI 10.1073/pnas.84.9.2732; Aizenberg J, 1999, NATURE, V398, P495, DOI 10.1038/19047; AIZENBERG J, 1995, CHEM-EUR J, V1, P414, DOI 10.1002/chem.19950010705; ALBECK S, 1993, J AM CHEM SOC, V115, P11691, DOI 10.1021/ja00078a005; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; BERMAN A, 1993, SCIENCE, V259, P776, DOI 10.1126/science.259.5096.776; BERMAN A, 1988, NATURE, V331, P546, DOI 10.1038/331546a0; BRENEMAN CM, 1990, J COMPUT CHEM, V11, P361, DOI 10.1002/jcc.540110311; BURTON WK, 1951, PHILOS T R SOC S-A, V243, P299, DOI 10.1098/rsta.1951.0006; CHIRLIAN LE, 1987, J COMPUT CHEM, V8, P894, DOI 10.1002/jcc.540080616; CRAMER CJ, 1991, J AM CHEM SOC, V113, P8305, DOI 10.1021/ja00022a017; CRAMER CJ, 1992, J COMPUT AID MOL DES, V6, P629, DOI 10.1007/BF00126219; CRAMER CJ, 1992, SCIENCE, V256, P213, DOI 10.1126/science.256.5054.213; Davis KJ, 2000, SCIENCE, V290, P1134, DOI 10.1126/science.290.5494.1134; Didymus J.M., 1991, P267; DIDYMUS JM, 1994, P ROY SOC B-BIOL SCI, V258, P237, DOI 10.1098/rspb.1994.0168; FEIDENHANSL R, 1989, SURF SCI REP, V10, P105, DOI 10.1016/0167-5729(89)90002-2; Fenter P, 2000, GEOCHIM COSMOCHIM AC, V64, P1221, DOI 10.1016/S0016-7037(99)00403-2; HONESS AP, 1937, 35 PENNS STAT COLL M, P667; Land TA, 1999, NATURE, V399, P442, DOI 10.1038/20886; MADURA JD, 1994, J AM CHEM SOC, V116, P417, DOI 10.1021/ja00080a066; MANN S, 1993, SCIENCE, V261, P1286, DOI 10.1126/science.261.5126.1286; MANN S, 1990, J CHEM SOC FARADAY T, V86, P1873, DOI 10.1039/ft9908601873; MANN S, 1987, PROC R SOC SER B-BIO, V231, P477, DOI 10.1098/rspb.1987.0056; REEDER RJ, 1983, CARBONATES MINERALOG, V2, P1; Robinson IK, 1998, ACTA CRYSTALLOGR A, V54, P772, DOI 10.1107/S0108767398008125; SIKES CS, 1991, ACS SYM SER, V444, P50; STEWART JJP, 1989, J COMPUT CHEM, V10, P221, DOI 10.1002/jcc.540100209; STIPP SL, 1991, GEOCHIM COSMOCHIM AC, V55, P1723, DOI 10.1016/0016-7037(91)90142-R; Teng HH, 1998, SCIENCE, V282, P724, DOI 10.1126/science.282.5389.724; WEISSBUCH I, 1991, SCIENCE, V253, P637, DOI 10.1126/science.253.5020.637; Wulff G, 1901, Z KRYSTALLOGR MINERA, V34, P449, DOI 10.1524/zkri.1901.34.1.449; Zhao XY, 2000, LANGMUIR, V16, P9812, DOI 10.1021/la000378a	34	550	562	15	303	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2001	411	6839					775	779		10.1038/35081034	http://dx.doi.org/10.1038/35081034			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459051				2022-12-28	WOS:000169246400042
J	Pearce, G; Moura, DS; Stratmann, J; Ryan, CA				Pearce, G; Moura, DS; Stratmann, J; Ryan, CA			Production of multiple plant hormones from a single polyprotein precursor	NATURE			English	Article							SELF-INCOMPATIBILITY; TOMATO LEAVES; SYSTEMIN; RECEPTOR; PROTEIN; PHYTOSULFOKINE; CLAVATA3; BRASSICA; PEPTIDE; CELLS	Some animal and yeast hormone genes produce prohormone polypeptides that are proteolytically processed to produce multiple copies of hormones with the same or different functions(1). In plants, four polypeptides have been identified that can be classed as hormones(2-5) (intercellular chemical messengers(6)) but none are known to be produced as multiple copies from a single precursor. Here we describe a polyprotein hormone precursor, present in tobacco plants, that gives rise to two polypeptide hormones, as often found in animals and yeast. The tobacco polypeptides activate the synthesis of defensive proteinase-inhibitor proteins in a manner similar to that of systemin, an 18-amino-acid polypeptide found in tomato plants(2). The two tobacco polypeptides are derived from each end of a 165-amino-acid precursor that bears no homology to tomato prosystemin. The data show that structurally diverse polypeptide hormones in different plant species can serve similar signalling roles, a condition not found in animals or yeast.	Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	Washington State University	Ryan, CA (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.		Moura, Daniel S/D-6673-2012; Moura, Daniel/F-3011-2010	Moura, Daniel S/0000-0003-2042-1403; 				BRYANT J, 1976, BIOCHEMISTRY-US, V15, P3418, DOI 10.1021/bi00661a004; Constabel CP, 1998, PLANT MOL BIOL, V36, P55, DOI 10.1023/A:1005986004615; DOMBROWSKI JE, 1994, PLANT MOL BIOL MANUA, V3, P1; Ferris PJ, 2001, BIOCHEMISTRY-US, V40, P2978, DOI 10.1021/bi0023605; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Matsubayashi Y, 2000, J BIOL CHEM, V275, P15520, DOI 10.1074/jbc.275.20.15520; Matsubayashi Y, 1996, P NATL ACAD SCI USA, V93, P7623, DOI 10.1073/pnas.93.15.7623; MCGURL B, 1992, SCIENCE, V255, P1570, DOI 10.1126/science.1549783; Meindl T, 1998, PLANT CELL, V10, P1561, DOI 10.1105/tpc.10.9.1561; NIALL HD, 1982, ANNU REV PHYSIOL, V44, P615, DOI 10.1146/annurev.ph.44.030182.003151; PATTERSON DH, 1995, ANAL CHEM, V67, P3971, DOI 10.1021/ac00117a024; PEARCE G, 1991, SCIENCE, V253, P895, DOI 10.1126/science.253.5022.895; PEARCE G, 1993, PLANT PHYSIOL, V102, P639, DOI 10.1104/pp.102.2.639; Ryan CA, 2000, BBA-PROTEIN STRUCT M, V1477, P112, DOI 10.1016/S0167-4838(99)00269-1; Schaller A, 1999, PLANT CELL, V11, P263, DOI 10.1105/tpc.11.2.263; Scheer JM, 1999, PLANT CELL, V11, P1525, DOI 10.1105/tpc.11.8.1525; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Sommer-Knudsen J, 1998, PHYTOCHEMISTRY, V47, P483, DOI 10.1016/S0031-9422(97)00724-3; STEIN JC, 1991, P NATL ACAD SCI USA, V88, P8816, DOI 10.1073/pnas.88.19.8816; Stratmann JW, 1997, P NATL ACAD SCI USA, V94, P11085, DOI 10.1073/pnas.94.20.11085; Trotochaud AE, 1999, PLANT CELL, V11, P393, DOI 10.1105/tpc.11.3.393; VOET D, 1995, BIOCHEMISTRY-US, P1261	23	180	209	1	55	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					817	820		10.1038/35081107	http://dx.doi.org/10.1038/35081107			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459063				2022-12-28	WOS:000169246400054
